FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ekins, S
   Perryman, AL
   Andrade, CH
AF Ekins, Sean
   Perryman, Alexander L.
   Andrade, Carolina Horta
TI OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus
   Drug Discovery
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB The Zika virus outbreak in the Americas has caused global concern. To help accelerate this fight against Zika, we launched the OpenZika project. OpenZika is an IBM World Community Grid Project that uses distributed computing on millions of computers and Android devices to run docking experiments, in order to dock tens of millions of drug-like compounds against crystal structures and homology models of Zika proteins (and other related flavivirus targets). This will enable the identification of new candidates that can then be tested in vitro, to advance the discovery and development of new antiviral drugs against the Zika virus. The docking data is being made openly accessible so that all members of the global research community can use it to further advance drug discovery studies against Zika and other related flaviviruses.
C1 [Ekins, Sean] Collaborat Pharmaceut Inc, Fuquay Varina, NC 27526 USA.
   [Perryman, Alexander L.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.
   [Andrade, Carolina Horta] Univ Fedral Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, Goiania, Go, Brazil.
RP Ekins, S (corresponding author), Collaborat Pharmaceut Inc, Fuquay Varina, NC 27526 USA.; Perryman, AL (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.; Andrade, CH (corresponding author), Univ Fedral Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, Goiania, Go, Brazil.
EM ekinssean@yahoo.com; Alex.L.Perryman@njms.rutgers.edu; carolina@ufg.br
CR [Anonymous], 2016, WHO DIRECTOR GEN SUM
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Ekins S, 2016, PHARM RES-DORDR, V33, P809, DOI 10.1007/s11095-015-1841-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Kincaid VA, 2015, ACS CHEM BIOL, V10, P2209, DOI 10.1021/acschembio.5b00370
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
NR 9
TC 17
Z9 17
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005023
DI 10.1371/journal.pntd.0005023
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200017
PM 27764115
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haddow, AD
   Nasar, F
   Guzman, H
   Ponlawat, A
   Jarman, RG
   Tesh, RB
   Weaver, SC
AF Haddow, Andrew D.
   Nasar, Farooq
   Guzman, Hilda
   Ponlawat, Alongkot
   Jarman, Richard G.
   Tesh, Robert B.
   Weaver, Scott C.
TI Genetic Characterization of Spondweni and Zika Viruses and
   Susceptibility of Geographically Distinct Strains of Aedes aegypti,
   Aedes albopictus and Culex quinquefasciatus (Diptera: Culicidae) to
   Spondweni Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ARTHROPOD-BORNE VIRUSES; YELLOW-FEVER VIRUS; SOUTH-AFRICA; INDIGENOUS
   RESIDENTS; SEQUENCE ALIGNMENT; DENGUE VIRUSES; ASIAN-LINEAGE; INFECTION;
   MOSQUITOS; FLAVIVIRUSES
AB Background
   Zika virus (ZIKV) has extended its known geographic distribution to the New World and is now responsible for severe clinical complications in a subset of patients. While substantial genetic and vector susceptibility data exist for ZIKV, less is known for the closest related flavivirus, Spondweni virus (SPONV). Both ZIKV and SPONV have been known to circulate in Africa since the mid-1900s, but neither has been genetically characterized by gene and compared in parallel. Furthermore, the susceptibility of peridomestic mosquito species incriminated or suspected in the transmission of ZIKV to SPONV was unknown.
   Methodology/Principal Findings
   In this study, two geographically distinct strains of SPONV were genetically characterized and compared to nine genetically and geographically distinct ZIKV strains. Additionally, the susceptibility of both SPONV strains was determined in three mosquito species. The open reading frame (ORF) of the SPONV 1952 Nigerian Chuku strain, exhibited a nucleotide and amino acid identity of 97.8% and 99.2%, respectively, when compared to the SPONV 1954 prototype South African SA Ar 94 strain. The ORF of the SPONV Chuku strain exhibited a nucleotide and amino acid identity that ranged from 68.3% to 69.0% and 74.6% to 75.0%, respectively, when compared to nine geographically and genetically distinct strains of ZIKV. The ORF of the nine African and Asian lineage ZIKV strains exhibited limited nucleotide divergence. Aedes aegypti, Ae. albopictus and Culex quinquefasciatus susceptibility and dissemination was low or non-existent following artificial infectious blood feeding of moderate doses of both SPONV strains.
   Conclusions/Significance
   SPONV and ZIKV nucleotide and amino acid divergence coupled with differences in geographic distribution, ecology and vector species support previous reports that these viruses are separate species. Furthermore, the low degree of SPONV infection or dissemination in Ae. albopictus, Ae. aegypti and Cx. quinquefasciatus following exposure to two geographically and genetically distinct virus strains suggest a low potential for these species to serve as vectors.
C1 [Haddow, Andrew D.; Nasar, Farooq; Guzman, Hilda; Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Haddow, Andrew D.; Nasar, Farooq; Guzman, Hilda; Tesh, Robert B.; Weaver, Scott C.] Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Haddow, Andrew D.; Nasar, Farooq] USAMRIID, Ft Detrick, MD 21702 USA.
   [Ponlawat, Alongkot] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok, Thailand.
   [Jarman, Richard G.] AFRIMS, Dept Virol, Bangkok, Thailand.
   [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Haddow, AD (corresponding author), Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Haddow, AD (corresponding author), Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.; Haddow, AD (corresponding author), USAMRIID, Ft Detrick, MD 21702 USA.
EM andrew.d.haddow.ctr@mail.mil
RI Nasar, Farooq/C-7659-2019; Weaver, Scott C/D-6490-2011; Haddow, Andrew
   D/C-5902-2008
OI Nasar, Farooq/0000-0003-3658-9649; Weaver, Scott C/0000-0001-8016-8556;
   Haddow, Andrew D/0000-0002-8957-2608
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI069145, AI120942, N01-AI 30027];
   DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA); Robert E. Shope International Fellowship in
   Infectious Diseases from the American Society of Tropical Medicine and
   Hygiene;  [A1007536]
FX This study was supported in part by NIH grants AI069145, AI120942, and
   N01-AI 30027 (SCW and RBT). Additional funding was provided by DARPA
   (ADH and FN). ADH was supported by T32 grant A1007536 and a Robert E.
   Shope International Fellowship in Infectious Diseases from the American
   Society of Tropical Medicine and Hygiene. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   American Committee for Arthropod-Borne Viruses, 2016, ARB CAT
   Amraoui F, 2016, EURO SURVEILL, V21
   ARDOIN P, 1976, TROP GEOGR MED, V28, P309
   Baronti C, 2014, GENOME ANNOUNC, V2
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Boccolini D, 2016, EURO SURVEILL, V21
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BROTTES H, 1966, B WORLD HEALTH ORGAN, V35, P811
   CASALS J, 1961, B WORLD HEALTH ORGAN, V24, P723
   Casals J., 1957, NEW YORK ACAD SC, V2, P219
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Di Luca M, 2016, EURO SURVEILL, V21
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   Guedes D. R. D., 2016, ZIKA VIRUS REPLICATI, DOI 10.1101/073197
   Guerbois M., 2016, J INFECT DIS
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huang YS, 2016, VECTOR BORNE ZOONOTI
   International Committee on Taxonomy of Viruses, 2012, VIR TAX CLASS NOM VI
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   KOKERNOT RH, 1961, ANN TROP MED PARASIT, V55, P73, DOI 10.1080/00034983.1961.11686021
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFEC IN PRESS
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McIntosh B, 1980, THESIS
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P63, DOI 10.1016/0035-9203(61)90041-4
   MCINTOSH BM, 1972, J MED ENTOMOL, V9, P155
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen L.R., 2016, N ENGL J MED
   PILITT DR, 1972, J MED ENTOMOL, V9, P334, DOI 10.1093/jmedent/9.4.334
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   THEILER M, 1973, ARTHROPOD BORNE VIRU
   Tsai WY, 2008, STAT MED, V27, P15, DOI 10.1002/sim.2930
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   WOLFE MS, 1982, LANCET, V2, P1306
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   WORTH CB, 1961, AM J TROP MED HYG, V10, P583, DOI 10.4269/ajtmh.1961.10.583
NR 73
TC 27
Z9 28
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005083
DI 10.1371/journal.pntd.0005083
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200058
PM 27783682
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, J
   Ruckert, C
   Chotiwan, N
   Nguyen, C
   Luna, SMG
   Fauver, JR
   Foy, BD
   Perera, R
   Black, WC
   Kading, RC
   Ebel, GD
AF Weger-Lucarelli, James
   Ruckert, Claudia
   Chotiwan, Nunya
   Nguyen, Chilinh
   Luna, Selene M. Garcia
   Fauver, Joseph R.
   Foy, Brian D.
   Perera, Rushika
   Black, William C.
   Kading, Rebekah C.
   Ebel, Gregory D.
TI Vector Competence of American Mosquitoes for Three Strains of Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI MOSQUITOS; VALLEY FEVER VIRUS; DIPTERA-CULICIDAE;
   CHIKUNGUNYA VIRUS; POTENTIAL VECTOR; FEEDING PATTERN; CULEX MOSQUITOS;
   SPP. MOSQUITOS; ORAL INFECTION; NS1 PROTEIN
AB In 2015, Zika virus (ZIKV; Flaviviridae; Flavivirus) emerged in the Americas, causing millions of infections in dozens of countries. The rapid spread of the virus and the association with disease outcomes such as Guillain-Barre A syndrome and microcephaly make understanding transmission dynamics essential. Currently, there are no reports of vector competence (VC) of American mosquitoes for ZIKV isolates from the Americas. Further, it is not clear whether ZIKV strains from other genetic lineages can be transmitted by American Aedes aegypti populations, and whether the scope of the current epidemic is in part facilitated by viral factors such as enhanced replicative fitness or increased vector competence. Therefore, we characterized replication of three ZIKV strains, one from each of the three phylogenetic clades in several cell lines and assessed their abilities to be transmitted by Ae. aegypti mosquitoes. Additionally, laboratory colonies of different Culex spp. were infected with an American outbreak strain of ZIKV to assess VC. Replication rates were variable and depended on virus strain, cell line and MOI. African strains used in this study out-competed the American strain in vitro in both mammalian and mosquito cell culture. West and East African strains of ZIKV tested here were more efficiently transmitted by Ae. aegypti from Mexico than was the currently circulating American strain of the Asian lineage. Long-established laboratory colonies of Culex mosquitoes were not efficient ZIKV vectors. These data demonstrate the capacity for additional ZIKV strains to infect and replicate in American Aedes mosquitoes and suggest that neither enhanced virus replicative fitness nor virus adaptation to local vector mosquitoes seems likely to explain the extent and intensity of ZIKV transmission in the Americas.
C1 [Weger-Lucarelli, James; Ruckert, Claudia; Chotiwan, Nunya; Nguyen, Chilinh; Luna, Selene M. Garcia; Fauver, Joseph R.; Foy, Brian D.; Perera, Rushika; Black, William C.; Kading, Rebekah C.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM Gregory.Ebel@colostate.edu
RI Foy, Brian/E-6230-2017; Ebel, Gregory/D-8324-2017; Perera,
   Rushika/E-7183-2017; Kading, Rebekah/E-5633-2017
OI Foy, Brian/0000-0002-9117-203X; Perera, Rushika/0000-0001-6798-2537;
   Kading, Rebekah/0000-0002-4996-915X; Weger-Lucarelli,
   James/0000-0002-9483-1694; Chotiwan, Nunya/0000-0003-3214-6605; Ruckert,
   Claudia/0000-0003-3732-6752; Garcia-Luna, Selene M./0000-0001-8420-5078
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI067380, AI125996];
   Colorado State University office of the Vice President For Research,
   CVMBS; DMIP
FX This work was supported by National Institutes of Health grant #AI067380
   and #AI125996. In addition, the work was supported in part by funds from
   the Colorado State University office of the Vice President For Research,
   CVMBS and DMIP. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EURO SURVEILL, V21
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Dejnirattisai W, 2016, NAT IMMUNOL
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Gordon A, 2011, SCIENCE TRANSLATIONA
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Guerbois M., 2016, J INFECT DIS
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall GS, 2007, J VIROL METHODS, V146, P22, DOI 10.1016/j.jviromet.2007.05.029
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Huang YS, 2016, VECTOR BORNE ZOONOTI
   Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226
   Kent RJ, 2010, J AM MOSQUITO CONTR, V26, P332, DOI 10.2987/09-5953.1
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maharaj PD, 2014, AM J TROP MED HYG, V91, P1066, DOI 10.4269/ajtmh.14-0289
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MILLER BR, 1982, AM J TROP MED HYG, V31, P1232, DOI 10.4269/ajtmh.1982.31.1232
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   OKUNO T, 1973, B WORLD HEALTH ORGAN, V49, P347
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Richards SL, 2007, VIRUS RES
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Samuel PP, 2004, J MED ENTOMOL, V41, P442, DOI 10.1603/0022-2585-41.3.442
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Waggoner JJ, 2016, CLIN INFECT DIS
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 52
TC 104
Z9 105
U1 2
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005101
DI 10.1371/journal.pntd.0005101
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200063
PM 27783679
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira-Szejnfeld, PS
   Levine, D
   Melo, ASD
   Amorim, MMR
   Batista, AGM
   Chimelli, L
   Tanuri, A
   Aguiar, RS
   Malinger, G
   Ximenes, R
   Robertson, R
   Szejnfeld, J
   Tovar-Moll, F
AF de Oliveira-Szejnfeld, Patricia Soares
   Levine, Deborah
   de Oliveira Melo, Adriana Suely
   Ramos Amorim, Melania Maria
   Batista, Alba Gean M.
   Chimelli, Leila
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Malinger, Gustavo
   Ximenes, Renato
   Robertson, Richard
   Szejnfeld, Jacob
   Tovar-Moll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can
   Expect to See Prenatally and Postnatally
SO RADIOLOGY
LA English
DT Article
ID INFECTION; ULTRASOUND; OUTBREAK; GROWTH; BRAZIL
AB Purpose: To document the imaging findings associated with congenital Zika virus infection as found in the Instituto de Pesquisa in Campina Grande State Paraiba (IPESQ) in northeastern Brazil, where the congenital infection has been particularly severe.
   Materials and Methods: From June 2015 to May 2016, 438 patients were referred to the IPESQ for rash occurring during pregnancy or for suspected fetal central nervous system abnormality. Patients who underwent imaging at IPESQ were included, as well as those with documented Zika virus infection in fluid or tissue (n = 17, confirmed infection cohort) or those with brain findings suspicious for Zika virus infection, with intracranial calcifications (n = 28, presumed infection cohort). Imaging examinations included 12 fetal magnetic resonance (MR) examinations, 42 postnatal brain computed tomographic examinations, and 11 postnatal brain MR examinations. Images were reviewed by four radiologists, with final opinion achieved by means of consensus.
   Results: Brain abnormalities seen in confirmed (n = 17) and presumed (n = 28) congenital Zika virus infections were similar, with ventriculomegaly in 16 of 17 (94%) and 27 of 28 (96%) infections, respectively; abnormalities of the corpus callosum in 16 of 17 (94%) and 22 of 28 (78%) infections, respectively; and cortical migrational abnormalities in 16 of 17 (94%) and 28 of 28 (100%) infections, respectively. Although most fetuses underwent at least one examination that showed head circumference below the 5th percentile, head circumference could be normal in the presence of severe ventriculomegaly (seen in three fetuses). Intracranial calcifications were most commonly seen at the gray matter-white matter junction, in 15 of 17 (88%) and 28 of 28 (100%) confirmed and presumed infections, respectively. The basal ganglia and/or thalamus were also commonly involved with calcifications in 11 of 17 (65%) and 18 of 28 (64%) infections, respectively. The skull frequently had a collapsed appearance with overlapping sutures and redundant skin folds and, occasionally, intracranial herniation of orbital fat and clot in the confluence of sinuses.
   Conclusion: The spectrum of findings associated with congenital Zika virus infection in the IPESQ in northeastern Brazil is illustrated to aid the radiologist in identifying Zika virus infection at imaging. (C) RSNA, 2016
C1 [de Oliveira-Szejnfeld, Patricia Soares; Ximenes, Renato; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Batista, Alba Gean M.] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Div Ultrasound Obstet & Gynecol, Tel Aviv Sourasky Med Ctr,Lis Matern Hosp, Tel Aviv, Israel.
   [Ximenes, Renato] Fetal Med Fdn Latinamerica FMFLA, Centrus Fetal Med, Campinas, SP, Brazil.
   [Robertson, Richard] Boston Childrens Hosp, Boston, MA USA.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Amorim, Melania M/C-5807-2013; Aguiar, Renato S/G-3542-2015; Melo,
   Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; Aguiar, Renato
   S/0000-0001-5180-3717; Robertson, Richard/0000-0001-8811-4405
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
CR [Anonymous], 2016, HEAD CIRC FOR AG
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Brazilian Ministry of Health, 2016, MIN SAUD CONF 1656 C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo A, JAMA NEUROL IN PRESS
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 32
TC 119
Z9 125
U1 0
U2 13
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD OCT
PY 2016
VL 281
IS 1
BP 203
EP 218
DI 10.1148/radiol.2016161584
PG 16
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG8NJ
UT WOS:000391313600023
PM 27552432
OA Bronze
DA 2020-07-08
ER

PT J
AU Mario, LC
   Borghesi, J
   Crivellari-Damasceno, WT
   Favaron, PO
   Carreira, ACO
   Will, SEAL
   Maria, DA
   Miglino, MA
AF Mario, Lara C.
   Borghesi, Jessica
   Crivellari-Damasceno, Wilson T.
   Favaron, Phelipe O.
   Carreira, Ana Claudia O.
   Will, Sonia E. A. L.
   Maria, Durvanei A.
   Miglino, Maria A.
TI Egg and fourth instar larvae gut of Aedes aegypti as a source of stem
   cells
SO TISSUE & CELL
LA English
DT Article
DE Dengue; Cell culture; Morphology; Emerging diseases
ID MIDGUT VISCERAL MUSCLE; DIPTERA-CULICIDAE; IN-VITRO; EPITHELIUM; LINES;
   ULTRASTRUCTURE; SUSCEPTIBILITY; ESTABLISHMENT; APOPTOSIS
AB According to the World Health Organization, 2015 registered more than 1.206.172 cases of Dengue in the Americas. Recently, the Aedes aegypti has been not only related to Dengue, but also with cases of Zika virus and Chikungunya. Due to its epidemiological importance, this study characterized the morphology of the embryonated eggs of A. aegypti and provided a protocol to culture stem cells from eggs and digestive tract of fourth instar larvae in order to examine cell biology and expression of markers in these vectors. Cells were isolated and cultured in DMEM-High at 28 degrees C, and their morphology, cell cycle and immunophenotyping were examined. Morphologically, embryos were at the end of the embryonic period and showed: head, thorax, and abdomen with eight abdominal segments. The embryonic tissues expressed markers related to cell proliferation (PCNA), pluripotency (Sox2 and OCT3/4), neural cells (Nestin), mesenchymal cells (Vimentin and Stro-1), and endosomal cells (GM130 and RAB5). In culture, cells from both tissues (eggs and larvae gut) were composed by a heterogeneous population. The cells had a globoid shape and small size. Cell cycle analysis on passage 1 (P1) showed 27.5% +/- 2.0% of cell debris, 68% of cells on GO-G1 phase, 30.2% on S phase, 1.9% +/- 0.5% on G2-M phase. In addition, cells on passage 2 showed: 10% of cell debris, 92.4% of cells on G0-G1 phase, 6.8% on S phase, 0.6% on G2-M phase. Embryonated eggs expressed markers involved with pluripotency (Sox2 and Oct 3/4), mesenchymal cells (vimentin and Stro-1), neural cells (Nestin), and cellular death by apoptosis (Caspase 3). Specific endosomal markers for insect cells (GM130 and RAB5) were also highly expressed. In cell culture of A. aegypti larvae gut the same labeling pattern was observed, with a small decrease in the expression of mesenchymal (vimentin and Stro-1) and neural (Nestin) markers. In summary, we were able to establish a protocol to culture embryonated eggs and larvae gut of A. aegypti, describing the characteristics of undifferentiated cells, as well as the cell cycle and expression of markers, which can be used for biotechnology studies for the biological control of this vector. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Mario, Lara C.; Borghesi, Jessica; Crivellari-Damasceno, Wilson T.; Favaron, Phelipe O.; Maria, Durvanei A.; Miglino, Maria A.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil.
   [Crivellari-Damasceno, Wilson T.; Will, Sonia E. A. L.; Maria, Durvanei A.] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, SP, Brazil.
   [Carreira, Ana Claudia O.] Univ Sao Paulo, Sch Med, Ctr Mol & Cellular Therapy NUCEL, Sao Paulo, SP, Brazil.
   [Carreira, Ana Claudia O.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, Sao Paulo, SP, Brazil.
RP Mario, LC (corresponding author), Av Prof Orlando Marques de Paiva 87,Cidade Univ, BR-05508270 Sao Paulo, SP, Brazil.
EM laracarolina-mario@hotmail.com
RI borghesi, jessica/U-5708-2018; Carreira, Ana Claudia O./B-7655-2012;
   Mario, Lara Carolina/H-1089-2018
OI borghesi, jessica/0000-0003-0037-7556; Carreira, Ana Claudia
   O./0000-0002-9142-1155; Mario, Lara Carolina/0000-0002-0062-9322
FU FAPESP (Support Foundation of Sao Paulo Research) [2013/07649-2]
FX The authors acknowledge FAPESP (Support Foundation of Sao Paulo
   Research), for funding this research [grant number 2013/07649-2];
   researchers: Dr. Connie McManus, Dr. Juliana Guimaraes, Dr. Margareth de
   Lara Capurro-Guimalhaes, Ms. Danilo de Oliveira Carvalho, Dra. Valeria
   Cristina Soares Pinheiro, Dr. Vera Margarete Scarpassa, Ms. Gersonval
   Leandro Monte, Dr. Ronildo Baiatone Alencar, Dr. Ormezinda Celeste
   Fernandes Christ, Ms. Silmara Mundim, Dr. Maria Marta Antoniazzi, Dr.
   Claudia Regina Stricagnolo; the technicians Dr. Rose Eli Grassi Rici;
   Ronaldo Augustine; Claudio Arroyo, and to all who directly or indirectly
   contributed to the realization of this research.
CR Abreu S.C., 2008, PULMAO RJ, V17, P91
   Alberts B., 2002, THE CELL
   Americas World Health Organization, 2015, STAT ART PREV CONTR
   Baton LA, 2007, J INVERTEBR PATHOL, V96, P244, DOI 10.1016/j.jip.2007.05.005
   Belles X., 2014, BIOCHIM BIOPHYS ACTA, V6, P1
   Bello B.C., 2008, BIOMED CENTRAL, V3, P1
   Bernick EP, 2008, TISSUE CELL, V40, P127, DOI 10.1016/j.tice.2007.11.001
   Bernick EP, 2007, TISSUE CELL, V39, P277, DOI 10.1016/j.tice.2007.05.003
   Bydlowski Sergio P., 2009, Rev. Bras. Hematol. Hemoter., V31, P25
   Carrion Maria Julia M., 2009, Rev. Bras. Hematol. Hemoter., V31, P112
   Clark TM, 2005, TISSUE CELL, V37, P457, DOI 10.1016/j.tice.2005.08.001
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   GRACE TDC, 1959, ANN NY ACAD SCI, V77, P275, DOI 10.1111/j.1749-6632.1959.tb36908.x
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hakim RS, 2009, IN VITRO CELL DEV-AN, V45, P106, DOI 10.1007/s11626-009-9176-7
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Jia DY, 2014, DEV BIOL, V392, P52, DOI 10.1016/j.ydbio.2014.04.024
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   Lawrie CH, 2004, MED VET ENTOMOL, V18, P268, DOI 10.1111/j.0269-283X.2004.00505.x
   Lehane M.J., 1996, BIOL INSECT MIDGUT
   Loeb MJ, 1996, J INSECT PHYSIOL, V42, P1103, DOI 10.1016/S0022-1910(96)00050-9
   Loeb MJ, 1999, ARCH INSECT BIOCHEM, V40, P129, DOI 10.1002/(SICI)1520-6327(1999)40:3&lt;129::AID-ARCH2&gt;3.0.CO;2-B
   Loeb MJ, 2003, ARCH INSECT BIOCHEM, V53, P186, DOI 10.1002/arch.10098
   Lynn DE, 1996, CYTOTECHNOLOGY, V20, P3, DOI 10.1007/BF00350384
   Lynn DE, 2001, IN VITRO CELL DEV-AN, V37, P319, DOI 10.1007/BF02577564
   Meca KKOL, 2010, ARQ BRAS MED VET ZOO, V62, P258, DOI 10.1590/S0102-09352010000200003
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Ministerio da Saude. Dengue, 2009, INSTR PESS COMB AO V
   Nardi JB, 2010, J INSECT PHYSIOL, V56, P296, DOI 10.1016/j.jinsphys.2009.11.001
   Navascues J., 2012, EMBO J, V31
   Nikolic N, 2011, ARCH BIOL SCI, V63, P933, DOI 10.2298/ABS1104933N
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   Organizacao Pan-Americana de Saude. (OMS), 2014, SIT CHIK NAS AM
   Organizacao Panamericana de Saude (OPS), 2015, AL EP INF VIR ZIK CH
   Pathak SK, 2012, J BIOL CHEM, V287, P13731, DOI 10.1074/jbc.M111.336545
   Pessoa I., 2005, J BRAS PATOL MED LAB, V41, P313
   Roth S, 2001, CURR BIOL, V11, pR779, DOI 10.1016/S0960-9822(01)00469-9
   Sahai-Hernandez P, 2012, WIRES DEV BIOL, V1, P447, DOI 10.1002/wdev.36
   Segura NA, 2012, MEM I OSWALDO CRUZ, V107, P89, DOI 10.1590/S0074-02762012000100013
   SILVA HHG, 1998, REV PATOL TROP, V27, P53
   Sudeep AB, 2009, IN VITRO CELL DEV-AN, V45, P491, DOI 10.1007/s11626-009-9218-1
   Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012
   Swevers L, 2005, COMPREHENSIVE MOL IN
   Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25
   Wang S., 2014, PLOS BIOL, V12, P1001
   Yarak S, 2010, AN BRAS DERMATOL, V85, P647, DOI 10.1590/S0365-05962010000500008
   Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305
   Zschatzsch M, 2014, ELIFE, V3, DOI 10.7554/eLife.01699
NR 50
TC 0
Z9 1
U1 0
U2 12
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0040-8166
J9 TISSUE CELL
JI Tissue Cell
PD OCT
PY 2016
VL 48
IS 5
BP 558
EP 565
DI 10.1016/j.tice.2016.05.004
PG 8
WC Anatomy & Morphology; Cell Biology
SC Anatomy & Morphology; Cell Biology
GA DY8IM
UT WOS:000385373100019
PM 27401144
DA 2020-07-08
ER

PT J
AU Cahyanto, I
   Wiblishauser, M
   Pennington-Gray, L
   Schroeder, A
AF Cahyanto, Ignatius
   Wiblishauser, Michael
   Pennington-Gray, Lori
   Schroeder, Ashley
TI The dynamics of travel avoidance: The case of Ebola in the U.S.
SO TOURISM MANAGEMENT PERSPECTIVES
LA English
DT Article
DE Ebola; Health Belief Model; Travel avoidance; United States
ID HEALTH BELIEF MODEL; SELF-EFFICACY; RISK PERCEPTIONS; PANDEMIC
   INFLUENZA; AVIAN INFLUENZA; PRECAUTIONARY BEHAVIOR; MEDICATION
   ADHERENCE; VACCINATION; PREDICTORS; PREVENTION
AB The study examined factors that influenced Americans' avoidance of domestic travel due to confirmed cases of Ebola in the United States in late 2014. The Health Belief Model served as a theoretical framework for the study. Data were generated from 1613 Americans from an online survey. Perceived susceptibility and self-efficacy were found to significantly influence domestic travel avoidance. The findings also supported the significant role of perceived risk, subjective knowledge, age, and gender. Given the possibility that an Ebola outbreak may reemerge in the future and the emergence of additional health-related crises (e.g., Zika virus), the findings may also aid the tourism industry in planning for and responding to other health pandemics. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cahyanto, Ignatius] Black Hills State Univ, Sch Business, Tourism & Hospitality Management, Meier Hall 335,1200 Univ St Unit 9007, Spearfish, SD 57799 USA.
   [Wiblishauser, Michael] Lock Haven Univ, Dept Hlth Sci, Hlth Educ, 142 Hlth Profess Ctr, Lock Haven, PA 17745 USA.
   [Pennington-Gray, Lori] Univ Florida, Tourism Crisis Management Initiat, 325 FLG,POB 118209, Gainesville, FL 32611 USA.
   [Schroeder, Ashley] Univ Hawaii Manoa, Sch Travel Ind Management, 2560 Campus, Honolulu, HI 96822 USA.
RP Cahyanto, I (corresponding author), Black Hills State Univ, Sch Business, Tourism & Hospitality Management, Meier Hall 335,1200 Univ St Unit 9007, Spearfish, SD 57799 USA.
EM ignatius.cahyanto@bhsu.edu; mjw939@lhup.edu; pengray@hhp.ufl.edu;
   aschroe@hawaii.edu
OI Schroeder, Ashley/0000-0001-7241-4796; cahyanto,
   ignatius/0000-0003-1278-0377
CR Adams J, 2000, ACTA PSYCHIAT SCAND, V101, P119, DOI 10.1034/j.1600-0447.2000.90061.x
   Akompab DA, 2013, INT J ENV RES PUB HE, V10, P2164, DOI 10.3390/ijerph10062164
   Anagnostopoulos F, 2013, PSYCHO-ONCOLOGY, V22, P1912, DOI 10.1002/pon.3212
   Arda B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-87
   Ayele K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035515
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Barbisch D., 2015, DISASTER MED PUBLIC, P1
   Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117
   Barton L., 1994, Cornell Hotel and Restaurant Administration Quarterly, V35, P59, DOI 10.1177/001088049403500219
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Brewer NT, 2006, CLIN INFECT DIS, V43, P1379, DOI 10.1086/508466
   Brug J., 2004, EMERGING INFECT DIS
   Buglar ME, 2010, PATIENT EDUC COUNS, V78, P269, DOI 10.1016/j.pec.2009.06.014
   Buttle F., 1996, International Journal of Contemporary Hospitality Management, V8, P5, DOI 10.1108/09596119610115943
   Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906
   Carr N, 2001, TOURISM MANAGE, V22, P565, DOI 10.1016/S0261-5177(01)00014-0
   Centers for Disease Control and Prevention, 2015, EB EB VIR DIS EB OUT
   Centers for Disease Control and Prevention, 2015, EB EB VIR DIS PREV
   CERKONEY KAB, 1980, DIABETES CARE, V3, P594, DOI 10.2337/diacare.3.5.594
   CHAMPION VL, 2008, HLTH BEHAV HLTH ED T, V4, P45
   Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535
   Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7
   Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087
   Clinic M., 2014, SYMPTOMS
   Coe Antoinette B, 2012, Innov Pharm, V3, P1
   Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811
   Craighill P. M., 2014, WASHINGTON POST
   Cross MJ, 2006, RHEUMATOLOGY, V45, P92, DOI 10.1093/rheumatology/kei114
   de Zwart O, 2007, EMERG INFECT DIS, V13, P290, DOI 10.3201/eid1302.060303
   de Zwart O, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-114
   Deshpande Sameer, 2009, Health Mark Q, V26, P145, DOI 10.1080/07359680802619834
   Dillman D.A., 2009, INTERNET MAIL MIXED
   Elsrud T, 2001, ANN TOURISM RES, V28, P597, DOI 10.1016/S0160-7383(00)00061-X
   Epstein JA, 2000, PREV MED, V31, P107, DOI 10.1006/pmed.2000.0674
   Floyd M. F., 2003, Journal of Travel & Tourism Marketing, V15, P19
   Folayan M., 2015, DISASTER MED PUBLIC, P1
   Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903
   Gao X, 2000, AIDS CARE, V12, P387, DOI 10.1080/09540120050123783
   Gomes M. F. C., 2014, PLOS CURRENTS, V6
   Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176
   HALES C, 1991, EUR J MARKETING, V25, P7, DOI DOI 10.1108/03090569110144197
   Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105
   Hanson JA, 2002, J NUTR EDUC BEHAV, V34, pS25, DOI 10.1016/S1499-4046(06)60308-4
   Hartjes LB, 2009, J TRAVEL MED, V16, P338, DOI 10.1111/j.1708-8305.2009.00322.x
   Hounton SH, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-8
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Iskender M, 2010, COMPUT EDUC, V54, P1101, DOI 10.1016/j.compedu.2009.10.014
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   KELLY RB, 1991, SOC SCI MED, V32, P311, DOI 10.1016/0277-9536(91)90109-P
   Kuo HI, 2008, TOURISM MANAGE, V29, P917, DOI 10.1016/j.tourman.2007.10.006
   Larsen S, 2009, TOURISM MANAGE, V30, P260, DOI 10.1016/j.tourman.2008.06.004
   Lau J. T. F., 2009, J INFECTION, V20, P1
   Lau JTF, 2010, VACCINE, V28, P4632, DOI 10.1016/j.vaccine.2010.04.076
   Law R., 2006, INT J TOUR RES, V8, P289, DOI DOI 10.1002/JTR.576
   Lee CK, 2012, TOURISM MANAGE, V33, P89, DOI 10.1016/j.tourman.2011.02.006
   Leggat PA, 2001, J TRAVEL MED, V8, P46
   Leggat PA, 2010, J TRAVEL MED, V17, P291, DOI 10.1111/j.1708-8305.2010.00445.x
   Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350
   Mackenzie D., 2014, NEW SCI, V224, P4
   MADDUX JE, 1982, COGNITIVE THER RES, V6, P207, DOI 10.1007/BF01183893
   Martin H., 2014, EBOLA SCARE HAS HAD
   Maser B., 1998, Journal of Travel & Tourism Marketing, V7, P107, DOI 10.1300/J073v07n04_06
   McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6499
   MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847
   Morison A., 2005, S CHINA MORNING 0103
   Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050
   Pine R., 2004, International Journal of Contemporary Hospitality Management, V16, P139, DOI 10.1108/09596110410520034
   Pizam A., 1996, TOURISM CRIMES INT S
   Poletto C., 2014, EUROSURVEILLANCE, V19
   Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8
   Reisinger Y., 2005, Journal of Travel Research, V43, P212, DOI 10.1177/0047287504272017
   Richter L. K., 2002, Journal of Travel Research, V41, P340, DOI 10.1177/0047287503041004002
   Roehl W. S., 1992, Journal of Travel Research, V30, P17, DOI 10.1177/004728759203000403
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372
   SCHIFFMAN LW, 1991, CONSUMER BEHAV
   Schroeder A, 2013, TOURISM MANAGE, V38, P107, DOI 10.1016/j.tourman.2013.03.001
   Seale H, 2011, VACCINE, V29, P1605, DOI 10.1016/j.vaccine.2010.12.077
   Seddighi HR, 2001, TOURISM MANAGE, V22, P181, DOI 10.1016/S0261-5177(00)00046-7
   Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054
   Sharifirad G, 2009, J RES MED SCI, V14, P1
   Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215
   Sonmez SF, 1998, ANN TOURISM RES, V25, P112, DOI 10.1016/S0160-7383(97)00072-8
   Stroud N, 2009, DISABIL REHABIL, V31, P2216, DOI 10.3109/09638280902980928
   Tavafian Sedigheh Sadat, 2009, BMC Womens Health, V9, P37, DOI 10.1186/1472-6874-9-37
   Tsaur SH, 1997, ANN TOURISM RES, V24, P796, DOI 10.1016/S0160-7383(97)00059-5
   WHO, 2014, EB VIR DIS FACT SHEE
   Wilks J, 2003, TOURISM RISK MANAGEM
   Yanni EA, 2010, J TRAVEL MED, V17, P374, DOI 10.1111/j.1708-8305.2010.00458.x
   Yavas U., 1990, J PROF SERV MARK, V5, P3, DOI DOI 10.1300/J090V05N02_
   Yuksel A, 2007, TOURISM MANAGE, V28, P703, DOI 10.1016/j.tourman.2006.04.025
NR 94
TC 4
Z9 4
U1 13
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2211-9736
EI 2211-9744
J9 TOUR MANAG PERSPECT
JI Tour. Manag. Perspect.
PD OCT
PY 2016
VL 20
BP 195
EP 203
DI 10.1016/j.tmp.2016.09.004
PG 9
WC Hospitality, Leisure, Sport & Tourism; Management
SC Social Sciences - Other Topics; Business & Economics
GA EC4MZ
UT WOS:000388107200022
PM 32289007
OA Green Published
DA 2020-07-08
ER

PT J
AU Levy-Blitchtein, S
   del Valle-Mendoza, J
AF Levy-Blitchtein, Saul
   del Valle-Mendoza, Juana
TI Zika virus is arriving at the American continent
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Arbovirosis; Dengue virus; Chikungunya; Aedes aegypti
ID DENGUE; COINFECTION; INFECTION; SPREADS
AB Zika virus is the last arbovirosis arriving at the American continent and it is able to produce severe complications due to its neurotropism, such as microcephaly and it is also associated with Guillain-Barre syndrome (GBS). Presence of Aedes aegypti in many regions of Peru makes it easier to spread and it could be present in population, not being detected because there is a lack of rapid diagnosis methods. It is important to make a quick, effective and combined response to this new threat.
C1 [Levy-Blitchtein, Saul; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Fac Hlth Sci, Lima, Peru.
   [Levy-Blitchtein, Saul; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res Ctr & Innovat, Lima, Peru.
   [del Valle-Mendoza, Juana] Inst Invest Nutr, Lima, Peru.
   [Levy-Blitchtein, Saul] Univ Peruana Ciencias Aplicadas UPC, Av Primavera 2390, Lima, Peru.
RP del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Av Primavera 2390, Lima, Peru.
EM jdelvall@upc.edu.pc
RI del Valle Mendoza, Juana/C-9805-2018
OI del Valle Mendoza, Juana/0000-0002-6011-5040; Levy Blitchtein,
   Saul/0000-0001-5673-5477
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kindhauser MK, 2016, B WHO
   Leiva G Nélida, 2004, Rev. perú. med. exp. salud publica, V21, P157
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pan American Health Organization, ZIK VIR INF
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peru Ministerio de Salud, 2011, APR EXP LECC APR PRE
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Yáñez Pamela, 2013, Rev. perú. med. exp. salud publica, V30, P246
NR 26
TC 7
Z9 7
U1 0
U2 77
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD OCT
PY 2016
VL 9
IS 10
BP 997
EP 999
DI 10.1016/j.apjtm.2016.07.030
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV4LA
UT WOS:000382895900016
PM 27794382
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Estimated number of local transmission cases of Zika virus infection
   imported from Brazil to France
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Zika virus; Infection; Importation; Transmission
AB The Zika virus infection becomes the present public health threat and the control of this disease needs international collaboration. An important problem is the international travel that promotes the importation of Zika virus disease to the new setting. The local transmission of the imported infection is the big problem. Based on the available data on published articles, in this letter, the authors estimated the number of local transmission cases, by both mosquito borne and sexually transmitted modes, of Zika virus infection imported from Brazil to France.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Maria AT, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 6
TC 1
Z9 1
U1 0
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD OCT
PY 2016
VL 9
IS 10
BP 1000
EP 1000
DI 10.1016/j.apjtm.2016.07.032
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV4LA
UT WOS:000382895900017
PM 27794383
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Haque, U
   Ball, JD
   Zhang, WY
   Khan, MMH
   Trevino, JA
AF Haque, Ubydul
   Ball, Jacob D.
   Zhang, Wenyi
   Khan, Md. Mobarak Hossain
   Trevino C, Jesus A.
TI Clinical and spatial features of Zika virus in Mexico
SO ACTA TROPICA
LA English
DT Article
ID UNITED-STATES; TRAVEL; AGE
AB Background: Zika virus (ZIKV) is an emerging arbovirus transmitted to humans by Aedes mosquitoes, the same vectors that transmit dengue virus and chikungunya. Recent work has suggested that prior infection with dengue could lead to more severe clinical disease in ZIKV patients. Here, we describe the spatial distribution of and clinical symptoms experienced by ZIKV cases in Mexico.
   Methods: We performed Fisher's Exact test and Pearson's Chi-Square tests on data from Mexico's national surveillance system on the demographic and clinical characteristics of ZIKV patients (N=84), and then a multivariate logistic regression analysis to determine demographic risk factors for patients presenting with at least 9 symptoms. We also mapped the cases to describe the spatial distribution of ZIKV in Mexico.
   Results: Results from the multivariate logistic regression analysis indicate that, controlling for all covariates, sex (male) is a significant protective factor in reporting a high number of symptoms (OR = 0.36, 95% CI: 0.14, 0.92), and that a one-year increase in age is associated with a 4% increase in odds of having at least 9 symptoms (95% CI: 1.00, 1.08). Spatial analysis revealed more than 50% cases reported within 50 km of railways.
   Conclusion: We found that sex and age are both significant risk factors for ZIKV infection severity, using number of reported symptoms as a proxy. The presence of cases along railways indicates that transportation networks within Mexico may be relevant for the national and international spread of the disease. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Haque, Ubydul] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Haque, Ubydul; Ball, Jacob D.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ball, Jacob D.] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Zhang, Wenyi] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.
   [Khan, Md. Mobarak Hossain] King Faisal Univ, Dept Publ Hlth, Al Hufuf, Al Ahsa, Saudi Arabia.
   [Trevino C, Jesus A.] Univ Autonoma Nuevo Leon, San Nicolas De Los Garza, Nuevo Leon, Mexico.
RP Trevino, JA (corresponding author), Univ Autonoma Nuevo Leon, San Nicolas De Los Garza, Nuevo Leon, Mexico.
EM jtrevino41@hotmail.com
RI Trevino, Jesus/L-1896-2019; Trevino, Jesus/I-3753-2017
OI Trevino, Jesus/0000-0002-0211-2140; Trevino, Jesus/0000-0002-0211-2140
FU Emerging Pathogens Institute at the University of Florida; College of
   Liberal Arts and Sciences, as part of the University of Florida
   Pre-eminence Initiative; King Faisal University; SMART Scholarship
   Program; US Assistant Secretary of Defense for Research and Education,
   National Defense Education Program (NDEP)/BA-1, Basic Research
   [Defense-Wide/PE0601120D8Z]
FX Ubydul Hague was supported in part by the Emerging Pathogens Institute
   at the University of Florida and the College of Liberal Arts and
   Sciences, as part of the University of Florida Pre-eminence Initiative.
   Md. Mobarak Hossain Khan was supported by King Faisal University. Jacob
   D. Ball was supported by the SMART Scholarship Program, which is funded
   by the US Assistant Secretary of Defense for Research and Education,
   Defense-Wide/PE0601120D8Z National Defense Education Program
   (NDEP)/BA-1, Basic Research. The authors appreciate the constructive
   comments of Maria Eugenia Jimenez Corona, from the General Directorate
   of Epidemiology, Ministry of Health, Mexico.
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Direccion General de Epidemiologia, 2016, SECR SAL LIN EST VIG
   Egger JR, 2007, EMERG INFECT DIS, V13, P924, DOI 10.3201/eid1306.070008
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Jenkins Nash, 2016, 1 3 DEATHS COLOMBIA
   Jimenez Corona M.E., 2016, PLOS CURRENTS OUTBRE
   Karimi Faith, 2016, 3 DEATHS LINKED ZIKA
   Kindhauser MK, 2016, B WHO
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan Ai., 2016, PLOS CURR, V8
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rodriguez-Morales A.J., 2016, B WHO
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Secretaria de Salud, 2016, MEX ZIK UPD MEX 2016
NR 18
TC 5
Z9 5
U1 0
U2 141
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD OCT
PY 2016
VL 162
BP 5
EP 10
DI 10.1016/j.actatropica.2016.06.010
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DT9RS
UT WOS:000381840600002
PM 27311388
DA 2020-07-08
ER

PT J
AU Murugan, K
   Anitha, J
   Dinesh, D
   Suresh, U
   Rajaganesh, R
   Chandramohan, B
   Subramaniam, J
   Paulpandi, M
   Vadivalagan, C
   Amuthavalli, P
   Wang, L
   Hwang, JS
   Wei, H
   Alsalhi, MS
   Devanesan, S
   Kumar, S
   Pugazhendy, K
   Higuchi, A
   Nicoletti, M
   Benelli, G
AF Murugan, Kadarkarai
   Anitha, Jaganathan
   Dinesh, Devakumar
   Suresh, Udaiyan
   Rajaganesh, Rajapandian
   Chandramohan, Balamurugan
   Subramaniam, Jayapal
   Paulpandi, Manickam
   Vadivalagan, Chitravel
   Amuthavalli, Pandiyan
   Wang, Lan
   Hwang, Jiang-Shiou
   Wei, Hui
   Alsalhi, Mohamad Saleh
   Devanesan, Sandhanasamy
   Kumar, Suresh
   Pugazhendy, Kannaiyan
   Higuchi, Akon
   Nicoletti, Marcello
   Benelli, Giovanni
TI Fabrication of nano-mosquitocides using chitosan from crab shells:
   Impact on non-target organisms in the aquatic environment
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Anopheles stephensi; biosafety; Culicidae; Danio rerio; Non-target
   effects; Plasmodium
ID SYNTHESIZED SILVER NANOPARTICLES; OXIDATIVE STRESS BIOMARKERS; ONE-POT
   FABRICATION; AEDES-AEGYPTI; MEDIATED SYNTHESIS; DENGUE VECTOR; ZIKA
   VIRUS; VETERINARY IMPORTANCE; PREDATION EFFICIENCY; MUD CRAB
AB Mosquitoes are arthropods of huge medical and veterinary relevance, since they vector pathogens and parasites of public health importance, including malaria, dengue and Zika virus. Currently, nano technology is considered a potential eco-friendly approach in mosquito control research. We proposed a novel method of biofabrication of silver nanopartides (AgNP) using chitosan (Ch) from crab shells. Ch-AgNP nanocomposite was characterized by UV-vis spectroscopy, FTIR, SEM, EDX and XRD. Ch-AgNP were tested against larvae and pupae of the malaria vector Anopheles stephensi obtaining LC50 ranging from 3.18 ppm (I) to 6.54 ppm (pupae). The antibacterial properties of Ch-AgNP were proved against Bacillus subtilis, Kiebsiella pneumoniae and Salmonella typhi, while no growth inhibition was reported in assays conducted on Proteus vulgaris. Concerning non-target effects, in standard laboratory considtions the predation efficiency of Danio rerio zebrafishes was 68.8% and 61.6% against I and II instar larvae of A. stephensi, respectively. In a Ch-AgNP-contaminated environment, fish predation was boosted to 89.5% and 77.3%, respectively. Quantitative analysis of antioxidant enzymes SOD, CAT and 120 from hepatopancreas of fresh water crabs Parateiphusa hydmdromous exposed for 16 clays to a Ch-AgNP-contaminated aquatic environment were conducted. Notably, deleterious effects of Ch-AgNP contaminating aquatic enviroment on the non-target crab P. hydrodromous were observed, particularly when doses higher than 8-10 ppm are tested. Overall, this research highlights the potential of Ch-AGNP for the development of newer control tools against young instar populations of malaria mosquitoes, also highlighting some risks concerned the employ of nanopartides in aquatic environments. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Murugan, Kadarkarai; Anitha, Jaganathan; Dinesh, Devakumar; Suresh, Udaiyan; Rajaganesh, Rajapandian; Chandramohan, Balamurugan; Subramaniam, Jayapal; Paulpandi, Manickam; Vadivalagan, Chitravel; Amuthavalli, Pandiyan] Bharathiar Univ, Sch Life Sci, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Wang, Lan] Shanxi Univ, Sch Life Sci & Technol, Taiyuan 030006, Peoples R China.
   [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Wei, Hui] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou 350013, Fujian, Peoples R China.
   [Alsalhi, Mohamad Saleh; Devanesan, Sandhanasamy] King Saud Univ, Dept Phys & Astron, Res Chair Laser Diag Canc, Riyadh, Saudi Arabia.
   [Kumar, Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Fac Med & Hlth Sci, Seri Kembangan, Malaysia.
   [Pugazhendy, Kannaiyan] Annamalai Univ, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongli, Taoyuan 32001, Taiwan.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Vale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI AlSalhi, Mohamad S/F-2217-2019; Higuchi, Akon/AAA-9711-2019; alsalhi,
   mohamad/M-5013-2019; Devanesan, S./AAH-9593-2020; Benelli,
   Giovanni/A-9100-2013; Murugan, Kadarkarai/AAP-3937-2020; Higuchi,
   Akon/D-4039-2014; Kumar S, Suresh/J-2423-2017
OI AlSalhi, Mohamad S/0000-0002-4557-8821; Devanesan,
   S./0000-0002-5897-9237; Benelli, Giovanni/0000-0001-8971-6010; Higuchi,
   Akon/0000-0003-2970-8531; VADIVALAGAN, Chithravel/0000-0002-1751-4361;
   Kumar S, Suresh/0000-0002-0505-7554
FU King Saud University, through the Vice Deanship of Research Chairs;
   PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. K. Kannan and three anonymous reviewers improved an earlier
   version of the manuscript. The authors would like to thank the financial
   support rendered by King Saud University, through the Vice Deanship of
   Research Chairs. G. Benelli is supported by PROAPI (PRAF 2015) and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abozid M, 2011, AZ J PHARM SCI, V43, P123
   Aebi H., 1974, METHOD ENZYMAT AN, P671
   Ali SW, 2011, CARBOHYD POLYM, V83, P438, DOI 10.1016/j.carbpol.2010.08.004
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2015, PARASITOL RES, DOI 101007/s00436-014-4267-0
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Bittelli M, 2001, AGR FOREST METEOROL, V107, P167, DOI 10.1016/S0168-1923(00)00242-2
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cahu TB, 2012, PROCESS BIOCHEM, V47, P570, DOI 10.1016/j.procbio.2011.12.012
   Casals P, 2002, P 10 IUPAC INT C CHE, V1, P228
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Company R, 2004, MAR ENVIRON RES, V58, P377, DOI 10.1016/j.marenvres.2004.03.083
   Deduve C, 1985, TISSUE BIOCH J, V60, P604
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Ruas CBG, 2008, ECOTOX ENVIRON SAFE, V71, P86, DOI 10.1016/j.ecoenv.2007.08.018
   Gibson R., 1979, Oceanography and Marine Biology an Annual Review, V17, P285
   Govindan S, 2012, APPL NANOSCI, V2, P299, DOI 10.1007/s13204-012-0109-5
   Govindarajan M., 2016, ENZYM MICROB TECHNOL
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Harris V.C, 2010, PLOS PATHOG, V6
   Howard A.F.B., 2007, STUDY BMC PUBL HLTH, V7, P7
   Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   Kappus H., 1985, OXIDATIVE STRESS, P273, DOI DOI 10.1016/B978-0-12-642760-8.50016-8
   Kong Xianghui, 2007, Chinese Journal of Oceanology and Limnology, V25, P221, DOI 10.1007/S00343-007-0221-7
   Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357
   Lee YG, 2009, PROTEIN EXPRES PURIF, V65, P244, DOI 10.1016/j.pep.2008.12.004
   Lertsutthiwong P., 2002, J METALS MAT MINERAL, V12, P11
   Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1
   MacFarlane G., 2007, ARCH ENV CONTAM TOXI, V51, P584
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Murugadoss A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015603
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Pavasovic M, 2004, AQUACULTURE, V242, P641, DOI 10.1016/j.aquaculture.2004.08.036
   Pavela R., 2015, PARASITOL RES
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pugazhendy K., 2015, INT J ADV RES BIOL S, V2, P183
   Rai R.V., 2011, SCI MICROBIAL PATHOG, P197
   Reinecke AJ, 2003, WATER AIR SOIL POLL, V145, P395, DOI 10.1023/A:1023602121272
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Sastry K.V., 2004, NAT S BIOD BIOT ENV, V75
   Sayeed I, 2003, ECOTOX ENVIRON SAFE, V56, P295, DOI 10.1016/S0147-6513(03)00009-5
   Schuwerack PMM, 2001, ECOTOXICOLOGY, V10, P159, DOI 10.1023/A:1016689810391
   Sereemaspun A, 2008, INT J PHARMACEUT, V4, P492, DOI DOI 10.3923/IJP.2008.492.495
   Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005
   SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005
   Shwetha V., 2012, INT J CURR PHARM RES, V4
   SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7
   Soenen SJ, 2015, CHEM REV, V115, P2109, DOI 10.1021/cr400714j
   Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x
   Sreenivasan R. S., 2011, INT J BIOL MED RES, V2, P784
   Stuart B., 2002, POLYM ANAL
   Subramaniam J., 2016, ENV SCI POLL RES
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tankhiwale R, 2010, J APPL POLYM SCI, V115, P1894, DOI 10.1002/app.31168
   TING DR, 2005, DYEING FINISHING, V14, P12
   Trang S.T., 2015, INT J CARB CHEM, DOI 101155/2015/706259
   Trung TS, 2006, BIORESOURCE TECHNOL, V97, P659, DOI 10.1016/j.biortech.2005.03.023
   Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013
   Wazed Ali S., 2001, CARBOHYD POLYM, V83, P438
   Wenshui X, 2003, J CHIN I FOOD SCI TE, V3, P77
   Yilmaz S, 2006, TOXICOLOGY, V218, P164, DOI 10.1016/j.tox.2005.10.015
   Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/0883911503039019
NR 95
TC 19
Z9 19
U1 0
U2 176
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD OCT
PY 2016
VL 132
BP 318
EP 328
DI 10.1016/j.ecoenv.2016.06.021
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DS6BR
UT WOS:000380867200039
PM 27344400
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Leonardi, W
   Zilbermintz, L
   Cheng, LW
   Zozaya, J
   Tran, SH
   Elliott, JH
   Polukhina, K
   Manasherob, R
   Li, A
   Chi, XL
   Gharaibeh, D
   Kenny, T
   Zamani, R
   Soloveva, V
   Haddow, AD
   Nasar, F
   Bavari, S
   Bassik, MC
   Cohen, SN
   Levitin, A
   Martchenko, M
AF Leonardi, William
   Zilbermintz, Leeor
   Cheng, Luisa W.
   Zozaya, Josue
   Tran, Sharon H.
   Elliott, Jeffrey H.
   Polukhina, Kseniya
   Manasherob, Robert
   Li, Amy
   Chi, Xiaoli
   Gharaibeh, Dima
   Kenny, Tara
   Zamani, Rouzbeh
   Soloveva, Veronica
   Haddow, Andrew D.
   Nasar, Farooq
   Bavari, Sina
   Bassik, Michael C.
   Cohen, Stanley N.
   Levitin, Anastasia
   Martchenko, Mikhail
TI Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika
   virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA EXOTOXIN; ANTHRAX LETHAL; CELL-DEATH; ACTIVATION;
   SUSCEPTIBILITY; POLYMORPHISMS; APOPTOSIS; NEUROTOXINS; INVOLVEMENT;
   DISEASE
AB Diverse pathogenic agents often utilize overlapping host networks, and hub proteins within these networks represent attractive targets for broad-spectrum drugs. Using bacterial toxins, we describe a new approach for discovering broad-spectrum therapies capable of inhibiting host proteins that mediate multiple pathogenic pathways. This approach can be widely used, as it combines genetic-based target identification with cell survival-based and protein function-based multiplex drug screens, and concurrently discovers therapeutic compounds and their protein targets. Using B-lymphoblastoid cells derived from the HapMap Project cohort of persons of African, European, and Asian ancestry we identified host caspases as hub proteins that mediate the lethality of multiple pathogenic agents. We discovered that an approved drug, Bithionol, inhibits host caspases and also reduces the detrimental effects of anthrax lethal toxin, diphtheria toxin, cholera toxin, Pseudomonas aeruginosa exotoxin A, Botulinum neurotoxin, ricin, and Zika virus. Our study reveals the practicality of identifying host proteins that mediate multiple disease pathways and discovering broad-spectrum therapies that target these hub proteins.
C1 [Leonardi, William; Zilbermintz, Leeor; Zozaya, Josue; Tran, Sharon H.; Elliott, Jeffrey H.; Polukhina, Kseniya; Levitin, Anastasia; Martchenko, Mikhail] Keck Grad Inst, Claremont, CA 91711 USA.
   [Cheng, Luisa W.] USDA, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, Albany, CA 94710 USA.
   [Manasherob, Robert; Li, Amy; Bassik, Michael C.; Cohen, Stanley N.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.
   [Chi, Xiaoli; Gharaibeh, Dima; Kenny, Tara; Zamani, Rouzbeh; Soloveva, Veronica; Haddow, Andrew D.; Nasar, Farooq; Bavari, Sina] US Army, Med Res Inst Infect Dis, USAMRIID, Ft Detrick, MD 21702 USA.
   [Soloveva, Veronica] Henry M Jackson Fdn, Bethesda, MD 20817 USA.
   [Soloveva, Veronica] Biotechnol High Performance Comp Software Applica, Frederick, MD 21702 USA.
RP Martchenko, M (corresponding author), Keck Grad Inst, Claremont, CA 91711 USA.
EM mikhail_martchenko@kgi.edu
RI Nasar, Farooq/C-7659-2019; Bavari, Sina/L-3642-2019; Haddow, Andrew
   D/C-5902-2008
OI Nasar, Farooq/0000-0003-3658-9649; Bavari, Sina/0000-0001-8424-5635;
   Haddow, Andrew D/0000-0002-8957-2608; Zamani,
   Rouzbeh/0000-0001-9559-6828
FU Kenneth T. and Eileen L. Norris Foundation
FX We thank Dr. Stephen Leppla of the NIAID for a kind gift of FP59 toxin.
   A.L. acknowledges support from The Kenneth T. and Eileen L. Norris
   Foundation.
CR Allam M, 1997, CANCER RES, V57, P2615
   Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   ARORA N, 1992, J BIOL CHEM, V267, P15542
   Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
   Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h
   Chen KX, 2008, CLIN CANCER RES, V14, P6343, DOI 10.1158/1078-0432.CCR-08-1198
   Choi D.W., 1990, Korean Journal of Parasitology, V28, P79, DOI 10.3347/kjp.1990.28.Suppl.79
   Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806
   Cosme A, 2003, J CLIN ULTRASOUND, V31, P358, DOI 10.1002/jcu.10189
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dolly JO, 2011, FEBS J, V278, P4454, DOI 10.1111/j.1742-4658.2011.08205.x
   Eleuteri S, 2015, NEUROBIOL DIS, V74, P144, DOI 10.1016/j.nbd.2014.08.017
   Garcia-Lozano JR, 2007, RHEUMATOLOGY, V46, P1243, DOI 10.1093/rheumatology/kem096
   Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813
   Hosgood HD, 2008, HEMATOL ONCOL, V26, P148, DOI 10.1002/hon.852
   Johannes L, 2005, GENE THER, V12, P1360, DOI 10.1038/sj.gt.3302557
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Komatsu N, 1998, J BIOCHEM-TOKYO, V124, P1038, DOI 10.1093/oxfordjournals.jbchem.a022197
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Li B, 2014, CELL BIOCHEM BIOPHYS, V70, P1647, DOI 10.1007/s12013-014-0108-0
   Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012
   Lourenssen S, 2009, AM J PHYSIOL-GASTR L, V297, pG228, DOI 10.1152/ajpgi.90705.2008
   Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131
   Monnier PP, 2011, J NEUROSCI, V31, P10494, DOI 10.1523/JNEUROSCI.0148-11.2011
   NWOKOLO C, 1974, B WORLD HEALTH ORGAN, V50, P569
   Oprea TI, 2012, AAPS J, V14, P759, DOI 10.1208/s12248-012-9390-1
   Park C, 2012, HUM IMMUNOL, V73, P736, DOI 10.1016/j.humimm.2012.04.017
   Payne AM, 2013, J CLIN MICROBIOL, V51, P2970, DOI 10.1128/JCM.01161-13
   Polyethylene glycol [MAK Value Documentation, 1998, MAK COLLECTION OCCUP
   Richard A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.18
   SABORIO P, 1995, J TROP MED HYG, V98, P316
   Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275
   Takahashi T, 1969, RADIOISOTOPES, V18, P552
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   VIDAL DR, 1993, TOXICON, V31, P27, DOI 10.1016/0041-0101(93)90353-K
   Wahome PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049075
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x
   Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279
   Zilbermintz L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13476
NR 40
TC 13
Z9 13
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 30
PY 2016
VL 6
AR 34475
DI 10.1038/srep34475
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX3RR
UT WOS:000384291100001
PM 27686742
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leis, AA
   Stokic, DS
AF Leis, A. Arturo
   Stokic, Dobrivoje S.
TI Zika virus and Guillain-Barre syndrome: is there sufficient evidence for
   causality?
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; acute flaccid paralysis;
   neurotropic virus; electrodiagnostic studies; nerve conduction studies;
   electromyography
ID OUTBREAK; ILLNESS
AB Worldwide concern over Zika virus causing Guillain-Barre syndrome (GBS) soared after recent reports that Zika-related weakness was due to GBS. A global strategic response plan was initiated with recommendations for at-risk countries to prepare for GBS. This plan has major economic implications, as nations with limited resources struggle to implement costly immunotherapy. Since confirmation of causality is prerequisite to providing specific management recommendations, it is prudent to review data endorsing a GBS diagnosis. We searched PubMed for manuscripts reporting original clinical, laboratory, and electrodiagnostic data on Zika virus and GBS. Five papers met criteria; four case reports and one large case-control study (French Polynesia) that attributed 42 paralysis cases to a motor variant of GBS. Brighton criteria were reportedly used to diagnose GBS, but no differential diagnosis was presented, which violates criteria. GBS was characterized by early onset (median 6 days post-viral syndrome), rapid progression (median 6 days from onset to nadir), and atypical clinical features (52% lacked areflexia, 48% of facial palsies were unilateral). Electrodiagnostic evaluations fell short of guidelines endorsed by American Academy of Neurology. Typical anti-ganglioside antibodies in GBS motor variants were rarely present. We conclude that there is no causal relationship between Zika virus and GBS because data failed to confirm GBS and exclude other causes of paralysis. Focus should be redirected at differential diagnosis, proper use of diagnostic criteria, and electrodiagnosis that follows recommended guidelines. We also call for a moratorium on recommendations for at-risk countries to prepare costly immunotherapies directed at GBS.
C1 [Leis, A. Arturo; Stokic, Dobrivoje S.] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA.
   [Leis, A. Arturo] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA.
RP Leis, AA (corresponding author), Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA.; Leis, AA (corresponding author), Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA.
EM aleis@mmrcrehab.org
OI Stokic, Dobrivoje/0000-0002-1891-5730
FU Wilson Research Foundation, Jackson, Mississippi
FX This work was supported in part by the Wilson Research Foundation,
   Jackson, Mississippi.
CR American Association of Neuromuscular and Electrodiagnostic Medicine, 2014, POS STAT REC POL EL
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Fratkin JD, 2004, ARCH PATHOL LAB MED, V128, P533
   Friedrich MJ, 2016, JAMA-J AM MED ASSOC, V315, P1554
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Gorson KC, 2001, ARCH NEUROL-CHICAGO, V58, P1460, DOI 10.1001/archneur.58.9.1460
   Kimura J., 1998, ELECTRODIAGNOSIS DIS, P462
   Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260
   Larik Ashfaq, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.12.2011.5378
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nickerson, 1998, REV GEN PSYCHOL, V2, P175, DOI DOI 10.1037/1089-2680.2.2.175
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schellinger PD, 2000, NEUROLOGY, V55, P299, DOI 10.1212/WNL.55.2.299
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Thomas DL, 2016, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6506e2
   Verma Rajesh, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007094
   Wakerley Benjamin R, 2015, Pract Neurol, V15, P90, DOI 10.1136/practneurol-2014-000937
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   World Health Organization, 2016, SITUAT REP, V21, P2016
NR 33
TC 10
Z9 10
U1 0
U2 174
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD SEP 30
PY 2016
VL 7
AR 170
DI 10.3389/fneur.2016.00170
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DX4TT
UT WOS:000384374700001
PM 27746763
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Likos, A
   Griffin, I
   Bingham, AM
   Stanek, D
   Fischer, M
   White, S
   Hamilton, J
   Eisenstein, L
   Atrubin, D
   Mulay, P
   Scott, B
   Jenkins, P
   Fernandez, D
   Rico, E
   Gillis, L
   Jean, R
   Cone, M
   Blackmore, C
   McAllister, J
   Vasquez, C
   Rivera, L
   Philip, C
AF Likos, Anna
   Griffin, Isabel
   Bingham, Andrea M.
   Stanek, Danielle
   Fischer, Marc
   White, Stephen
   Hamilton, Janet
   Eisenstein, Leah
   Atrubin, David
   Mulay, Prakash
   Scott, Blake
   Jenkins, Patrick
   Fernandez, Danielle
   Rico, Edhelene
   Gillis, Leah
   Jean, Reynald
   Cone, Marshall
   Blackmore, Carina
   McAllister, Janet
   Vasquez, Chalmers
   Rivera, Lillian
   Philip, Celeste
TI Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward
   Counties, Florida, June-August 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID DENGUE; DISEASE
C1 [Likos, Anna; Griffin, Isabel; Bingham, Andrea M.; Stanek, Danielle; White, Stephen; Hamilton, Janet; Eisenstein, Leah; Atrubin, David; Mulay, Prakash; Scott, Blake; Jenkins, Patrick; Fernandez, Danielle; Rico, Edhelene; Gillis, Leah; Jean, Reynald; Cone, Marshall; Blackmore, Carina; Rivera, Lillian; Philip, Celeste] Florida Dept Hlth, Gainesville, FL 32641 USA.
   [Fischer, Marc; McAllister, Janet] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Vasquez, Chalmers] Miami Dade Cty Mosquito Control Dist, Miami, FL USA.
RP Likos, A (corresponding author), Florida Dept Hlth, Gainesville, FL 32641 USA.
EM anna.likos@flhealth.gov
OI White, Stephen/0000-0002-2112-1560
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   *CDC, 2005, MMWR-MORBID MORTAL W, V54, P529
   CDC, 2016, GUID TRAV TEST PREGN
   Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
NR 10
TC 106
Z9 108
U1 1
U2 25
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 30
PY 2016
VL 65
IS 38
BP 1032
EP 1038
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX9IK
UT WOS:000384706600003
PM 27684886
OA Bronze
DA 2020-07-08
ER

PT J
AU Marston, HD
   Lurie, N
   Borio, LL
   Fauci, AS
AF Marston, Hilary D.
   Lurie, Nicole
   Borio, Luciana L.
   Fauci, Anthony S.
TI Considerations for Developing a Zika Virus Vaccine
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID INFECTION
C1 [Marston, Hilary D.; Fauci, Anthony S.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Borio, Luciana L.] US FDA, Off Commissioner, Silver Spring, MD USA.
   [Lurie, Nicole] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA.
RP Marston, HD (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Miller FG, 2001, CLIN INFECT DIS, V33, P1028, DOI 10.1086/322664
NR 4
TC 37
Z9 38
U1 0
U2 30
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 29
PY 2016
VL 375
IS 13
BP 1209
EP 1212
DI 10.1056/NEJMp1607762
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX3HU
UT WOS:000384265000001
PM 27682031
OA Bronze
DA 2020-07-08
ER

PT J
AU Thomas, SJ
   L'Azou, M
   Barrett, ADT
   Jackson, NAC
AF Thomas, Stephen J.
   L'Azou, Maina
   Barrett, Alan D. T.
   Jackson, Nicholas A. C.
TI Fast-Track Zika Vaccine Development - Is It Possible?
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [L'Azou, Maina; Jackson, Nicholas A. C.] Sanofi Pasteur, Lyon, France.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Thomas, SJ (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
CR Abbink P, 2016, SCIENCE
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Nicastri E., 2016, EURO SURVEILL, V21
NR 5
TC 31
Z9 31
U1 1
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 29
PY 2016
VL 375
IS 13
BP 1212
EP 1216
DI 10.1056/NEJMp1609300
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX3HU
UT WOS:000384265000002
PM 27682032
OA Bronze
DA 2020-07-08
ER

PT J
AU Falcao, MB
   Cimerman, S
   Luz, KG
   Chebabo, A
   Brigido, HA
   Lobo, IM
   Timerman, A
   Angerami, RN
   da Cunha, CA
   Bacha, HA
   Alves, JR
   Barbosa, AN
   Teixeira, RF
   Weissmann, L
   Oliveira, PR
   Cyrillo, MA
   Bandeira, AC
AF Falcao, Melissa Barreto
   Cimerman, Sergio
   Luz, Kleber Giovanni
   Chebabo, Alberto
   Brigido, Helena Andrade
   Lobo, Iza Maria
   Timerman, Artur
   Angerami, Rodrigo Nogueira
   da Cunha, Clovis Arns
   Bacha, Helio Arthur
   Alves, Jesse Reis
   Barbosa, Alexandre Naime
   Teixeira, Ralcyon Francis
   Weissmann, Leonardo
   Oliveira, Priscila Rosalba
   Cyrillo, Marco Antonio
   Bandeira, Antonio Carlos
TI Management of infection by the Zika virus
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Review
DE Zika virus infection; Guideline; Diagnosis; Therapeutics
ID FRENCH-POLYNESIA; OUTBREAK; TRANSMISSION; EPIDEMIOLOGY; STATES; BRAZIL
AB A panel of national experts was convened by the Brazilian Infectious Diseases Society in order to organize the national recommendations for the management of zika virus infection. The focus of this document is the diagnosis, both clinical and laboratorial, and appropriate treatment of the diverse manifestations of this infection, ranging from acute mild disease to Guillain-Barre syndrome and also microcephaly and congenital malformations.
C1 [Falcao, Melissa Barreto] Univ Estadual Feira de Santana, Ave Transnordestina S-N, BR-44036900 Feira De Santana, BA, Brazil.
   [Cimerman, Sergio; Alves, Jesse Reis; Teixeira, Ralcyon Francis; Weissmann, Leonardo] Inst Infectol Emilio Ribas, Ave Doutor Arnaldo 165, BR-01246000 Sao Paulo, SP, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Rua Conego Monte S-N, BR-59037170 Natal, RN, Brazil.
   [Chebabo, Alberto] Univ Fed Rio de Janeiro, Ave Prof Rodolpho Paulo Rocco 255,50 Andar, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Brigido, Helena Andrade] Fed Univ Para, Rua Mundurucus S-N, BR-66060060 Belem, Para, Brazil.
   [Lobo, Iza Maria] Univ Fed Sergipe, Ave Claudio Batista S-N,30 Andar, BR-49060100 Aracaju, SE, Brazil.
   [Timerman, Artur] Hosp Prof Edmundo Vasconcelos, Rua Borges Lagoa 1450, BR-04038905 Sao Paulo, SP, Brazil.
   [Angerami, Rodrigo Nogueira] Univ Estadual Campinas, Rua Alexander Fleming 181, BR-13083970 Campinas, SP, Brazil.
   [da Cunha, Clovis Arns] Univ Fed Parana, Rua Gen Carneiro 181, BR-80060900 Curitiba, Parana, Brazil.
   [Bacha, Helio Arthur] Hosp Israelita Albert Einstein, Ave Albert Einstein 627,Bloco A1,Sala 220, BR-05651901 Sao Paulo, SP, Brazil.
   [Oliveira, Priscila Rosalba] Univ Sao Paulo, Rua Doutor Ovidio Pires Campos 333, BR-05403010 Sao Paulo, SP, Brazil.
   [Cyrillo, Marco Antonio] Hosp Servidor Publ Municipal, Rua Castro Alves 60, BR-01532000 Sao Paulo, SP, Brazil.
   [Bandeira, Antonio Carlos] Hosp Alianca, R Juracy Magalhaes Jr 2096, BR-41920000 Salvador, BA, Brazil.
RP Oliveira, PR (corresponding author), Univ Sao Paulo, Rua Doutor Ovidio Pires Campos 333, BR-05403010 Sao Paulo, SP, Brazil.
EM priscila.rosalba@hc.fm.usp.br
RI Angerami, Rodrigo Nogueira/A-8926-2013; Weissmann, Leonardo/S-4605-2019;
   Oliveira, Priscila Rosalba/J-7531-2012; Barbosa, Alexandre
   Naime/F-5668-2012
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Weissmann,
   Leonardo/0000-0002-4702-3221; Oliveira, Priscila
   Rosalba/0000-0003-1377-6556; Barbosa, Alexandre
   Naime/0000-0002-2187-4722
CR [Anonymous], 2016, BRAZIL REPORTS ZIKA
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   BRASIL. Ministerio da Saude, 2016, PROT VIG RESP OC MIC
   BRASIL. Ministerio da Saude, 2016, NOT INF
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/nejmMoa1602412, DOI 10.1056/NEJMMOA1602412]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, ZIK VIR TRANSM
   De Noronha L, 2015, MEM I O CRUZ RIO DE, V110, P569
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Federacao Brasileira das Associacoes de Ginecologia e Obstetricia, 2016, OR REC FEBRASGO INF
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   LaBeaud AD, 2016, ZIKA VIRUS INFECT OV
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2016, WHO ZIK SIT REP 21 J
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parreira R, 2013, CHIKUNGUNIYA ZIKA VI, V54, P9
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR MORB MORTAL REP, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales A. J, 2015, ARCH MED, V11
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silvia Sardi, 2016, J CLIN MICROBIOL, DOI [10.1128/JCM.00877-16, DOI 10.1128/JCM.00877-16]
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization-, ID MAN GUILL BARR SY
   World Health Organization, GUILL BARR SYNDR BRA
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 13
Z9 13
U1 0
U2 67
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD SEP 29
PY 2016
VL 15
AR 57
DI 10.1186/s12941-016-0172-y
PG 15
WC Microbiology
SC Microbiology
GA DX4QR
UT WOS:000384366700001
PM 27686610
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Faria, NR
   Sabino, EC
   Nunes, MRT
   Alcantara, LC
   Loman, NJ
   Pybus, OG
AF Faria, Nuno Rodrigues
   Sabino, Ester C.
   Nunes, Marcio R. T.
   Junior Alcantara, Luiz Carlos
   Loman, Nicholas J.
   Pybus, Oliver G.
TI Mobile real-time surveillance of Zika virus in Brazil
SO GENOME MEDICINE
LA English
DT Article
C1 [Faria, Nuno Rodrigues; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Junior Alcantara, Luiz Carlos] Oswaldo Cruz Fdn FIOCRUZ, BR-40296710 Salvador, BA, Brazil.
   [Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Loman, NJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
EM n.j.loman@bham.ac.uk
RI Sabino, Ester Cerdeira/F-7750-2010; Pybus, Oliver g/B-2640-2012; Loman,
   Nicholas/Z-1573-2019; Faria, Nuno/I-2975-2012
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Pybus, Oliver
   g/0000-0002-8797-2667; Faria, Nuno/0000-0001-8839-2798; Alcantara,
   Luiz/0000-0002-6769-9931; Loman, Nicholas/0000-0002-9843-8988
FU Medical Research Council/Wellcome Trust/Newton Fund Zika Rapid Response
   Initiative [ZK/16-078]; Medical Research Council Bioinformatics
   Fellowship, Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
   project; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15100, MR/M501621/1, MR/L015080/1]
FX We are grateful to Wanderson Kleber de Oliveira (Coordinator of the
   Surveillance and Response Program to Public Health Emergencies (CGVR),
   Brazilian Ministry of Health), Giovanini Evelim Coelho and Livia Carla
   Vinhal Frutuoso (National Control of Dengue (PNCD), Brazilian Ministry
   of Health), Mariana Pastorello Verotti (Coordinator of the Central
   Laboratories of Public Health (CGLAB), Brazilian Ministry of Health),
   Eduardo Hage Carmo and Claudio Maerovich (Department of Infectious
   Disease Surveillance (DEVIT), Brazilian Ministry of Health). The ZiBRA
   project is supported by the Medical Research Council/Wellcome
   Trust/Newton Fund Zika Rapid Response Initiative (grant number
   ZK/16-078). NJL is supported by a Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   World Health Organization, 2016, WHO ZIK VIR SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 65
Z9 66
U1 3
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD SEP 29
PY 2016
VL 8
AR 97
DI 10.1186/s13073-016-0356-2
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DX4UM
UT WOS:000384376600001
PM 27683027
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Silverstein, PS
   Aljouda, NA
   Kumar, A
AF Silverstein, Peter S.
   Aljouda, Nour A.
   Kumar, Anil
TI Recent developments in vertical transmission of ZIKA virus
SO ONCOTARGET
LA English
DT Editorial Material
DE ZIKA virus; vertical transmission; placenta; mice; microcephaly
C1 [Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.
RP Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.
EM kumaran@umkc.edu
CR Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Tabata T, 2016, CELL HOST MICROBE
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 7
TC 0
Z9 0
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD SEP 27
PY 2016
VL 7
IS 39
BP 62797
EP 62798
DI 10.18632/oncotarget.11619
PG 2
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EB2DN
UT WOS:000387167800001
PM 27579616
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Abbasi, J
AF Abbasi, Jennifer
TI Zika Vaccine Enters Clinical Trials
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 4
Z9 5
U1 0
U2 9
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD SEP 27
PY 2016
VL 316
IS 12
BP 1249
EP 1249
DI 10.1001/jama.2016.12760
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW9EW
UT WOS:000383959800003
PM 27673295
DA 2020-07-08
ER

PT J
AU Lyon, J
AF Lyon, Jeff
TI Zika: Worse Than Thalidomide?
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
ID INFLUENZA; VIRUS
CR Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896
   SCHOGGINS JW, 2016, CELL REP, V15, P2315
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 5
TC 4
Z9 4
U1 0
U2 6
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD SEP 27
PY 2016
VL 316
IS 12
BP 1246
EP 1248
DI 10.1001/jama.2016.11054
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW9EW
UT WOS:000383959800002
PM 27556748
OA Bronze
DA 2020-07-08
ER

PT J
AU Londono-Renteria, B
   Troupin, A
   Colpitts, TM
AF Londono-Renteria, Berlin
   Troupin, Andrea
   Colpitts, Tonya M.
TI Arbovirosis and potential transmission blocking vaccines
SO PARASITES & VECTORS
LA English
DT Review
DE Transmission blocking vaccines; Arbovirus; Arthropod; Vectors
ID WEST-NILE-VIRUS; TICK-BORNE DISEASES; RIFT-VALLEY FEVER;
   ANTIBODY-DEPENDENT ENHANCEMENT; PHLEBOTOMINE SAND FLIES; LONE STAR TICK;
   AEDES-AEGYPTI; BOOPHILUS-MICROPLUS; UNITED-STATES; INSECTICIDE
   RESISTANCE
AB Infectious diseases caused by arboviruses (viruses transmitted by arthropods) are undergoing unprecedented epidemic activity and geographic expansion. With the recent introduction of West Nile virus (1999), chikungunya virus (2013) and Zika virus (2015) to the Americas, stopping or even preventing the expansion of viruses into susceptible populations is an increasing concern. With a few exceptions, available vaccines protecting against arboviral infections are nonexistent and current disease prevention relies on vector control interventions. However, due to the emergence of and rapidly spreading insecticide resistance, different disease control methods are needed. A feasible method of reducing emerging tropical diseases is the implementation of vaccines that prevent or decrease viral infection in the vector. These vaccines are designated 'transmission blocking vaccines', or TBVs. Here, we summarize previous TBV work, discuss current research on arboviral TBVs and present several promising TBV candidates.
C1 [Londono-Renteria, Berlin; Troupin, Andrea; Colpitts, Tonya M.] Univ South Carolina, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
RP Londono-Renteria, B (corresponding author), Univ South Carolina, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
EM blondono@uscmed.sc.edu
RI Londono, Berlin/I-8830-2019
OI Londono, Berlin/0000-0001-5956-5274; Colpitts, Tonya/0000-0003-3915-1554
CR Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005
   Allan SA, 2009, J AM MOSQUITO CONTR, V25, P338, DOI 10.2987/09-5854.1
   Amaro F, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0407-0
   [Anonymous], 2013, CDC NEWSR CDC REL FI
   [Anonymous], 2016, ESTIMATED RANGE AEDE
   Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x
   Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Baly A, 2016, TROP MED INT HEALTH, V21, P597, DOI 10.1111/tmi.12693
   Barre N, 2010, REV SCI TECH OIE, V29, P149
   Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038
   Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bergmann-Leitner ES, 2014, VACCINES, V2, P252, DOI 10.3390/vaccines2020252
   Bergsman LD, 2016, MATH BIOSCI ENG, V13, P401, DOI 10.3934/mbe.2015009
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BLOCH H, 1993, AM J DIS CHILD, V147, P772, DOI 10.1001/archpedi.1993.02160310074022
   Busch JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-188
   Chambers TJ, 2003, ADV VIRUS RES, V60, pxiii
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   COMER JA, 1991, J MED ENTOMOL, V28, P289, DOI 10.1093/jmedent/28.2.289
   CONNAT JL, 1991, PARASITOL RES, V77, P452, DOI 10.1007/BF00931644
   Cooper CL, 2012, CURR OPIN INFECT DIS, V25, P26, DOI 10.1097/QCO.0b013e32834ef56c
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Coutinho-Abreu IV, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000901
   Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001
   CUPP EW, 1991, VET CLIN N AM-SMALL, V21, P1, DOI 10.1016/S0195-5616(91)50001-2
   Danforth ME, 2016, J MED ENTOMOL, V53, P681, DOI 10.1093/jme/tjw013
   DAROSA APAT, 1984, AM J TROP MED HYG, V33, P999, DOI 10.4269/ajtmh.1984.33.999
   Day JF, 2015, J MED ENTOMOL, V52, P743, DOI 10.1093/jme/tjv076
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   De la Fuente J, 2006, PARASITE IMMUNOL, V28, P275, DOI 10.1111/j.1365-3024.2006.00828.x
   de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9
   De La Fuente J, 2000, ANN NY ACAD SCI, V916, P617
   de la Fuente Jose, 2003, Expert Rev Vaccines, V2, P583
   de la Fuente J, 2010, VACCINE, V28, P1786, DOI 10.1016/j.vaccine.2009.12.007
   de Leon AAP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00195
   Delpeyroux F, 2013, M S-MED SCI, V29, P1034, DOI 10.1051/medsci/20132911021
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   DeWeerdt S, 2012, NATURE, V484, pS24, DOI 10.1038/484S24a
   Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002
   Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104
   Djouaka R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1723-y
   Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Flicek Barbara Fouts, 2007, Crit Care Nurs Clin North Am, V19, P27, DOI 10.1016/j.ccell.2006.11.001
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119
   Gardner AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-9
   Gholam BIA, 1999, CAN MED ASSOC J, V161, P1419
   GOLDFIELD M, 1973, AM J TROP MED HYG, V22, P78, DOI 10.4269/ajtmh.1973.22.78
   Gomes-Solecki M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00136
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gujarati TP, 2014, J MATH BIOL, V69, P1773, DOI 10.1007/s00285-013-0749-4
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737
   Halstead SB, 2007, LANCET, V369, P1410, DOI 10.1016/S0140-6736(07)60645-X
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Havlikova S, 2009, INT J PARASITOL, V39, P1485, DOI 10.1016/j.ijpara.2009.05.005
   Hermance ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155889
   Hernandez-Jover M, 2013, PREV VET MED, V109, P186, DOI 10.1016/j.prevetmed.2012.09.018
   Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI [10.1586/eri.09.118, 10.1586/ERI.09.118]
   Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101
   Imam I Z, 1978, J Egypt Public Health Assoc, V53, P205
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Jonsson NN, 2001, AUST VET J, V79, P826, DOI 10.1111/j.1751-0813.2001.tb10929.x
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kaslow DC, 1997, INT J PARASITOL, V27, P183, DOI 10.1016/S0020-7519(96)00148-8
   KAY BH, 1994, AM J TROP MED HYG, V50, P87, DOI 10.4269/ajtmh.1994.50.87
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   KOCH HG, 1981, J MED ENTOMOL, V18, P93, DOI 10.1093/jmedent/18.2.93
   Kosoy OI, 2015, EMERG INFECT DIS, V21, P760, DOI 10.3201/eid2105.150150
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Labuda M, 2006, PLOS PATHOG, V2, P251, DOI 10.1371/journal.ppat.0020027
   Lai AA, 2001, P NATL ACAD SCI USA, V98, P5228, DOI 10.1073/pnas.091447398
   LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723
   Leger E, 2013, EXP APPL ACAROL, V59, P219, DOI 10.1007/s10493-012-9615-0
   Leitner WW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004107
   Lew-Tabor AE, 2016, TICKS TICK-BORNE DIS, V7, P573, DOI 10.1016/j.ttbdis.2015.12.012
   Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002566
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2016, METHODS MOL BIOL, V1435, P1, DOI 10.1007/978-1-4939-3670-0_1
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8
   Matuschewski K, 2007, FEBS J, V274, P4680, DOI 10.1111/j.1742-4658.2007.05998.x
   Mbaeyi C, 2015, MMWR-MORBID MORTAL W, V64, P1166, DOI 10.15585/mmwr.mm6441a2
   MCBEAN AM, 1984, REV INFECT DIS, V6, pS552
   Medlock JM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0751-3
   Merino O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00030
   Miller MA SJ, 2006, DIS MORTALITY SUBSAH
   Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021
   Moreno A, 2015, CURR OPIN IMMUNOL, V35, P98, DOI 10.1016/j.coi.2015.06.008
   MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7
   Parish LA, 2011, J PROTEOME RES, V10, P5150, DOI 10.1021/pr2006268
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117
   Prommalikit Olarn, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P29
   Puerta JM, 2015, J MED ENTOMOL, V52, P1309, DOI 10.1093/jme/tjv129
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073
   Ratovonjato J, 2011, VECTOR-BORNE ZOONOT, V11, P753, DOI 10.1089/vbz.2010.0031
   Reeves WK, 2008, J AM MOSQUITO CONTR, V24, P444, DOI 10.2987/5745.1
   Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P21
   Robles-Murguia M, 2014, MEM I OSWALDO CRUZ, V109, P1064, DOI 10.1590/0074-0276140382
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Savage HM, 2016, J MED ENTOMOL
   Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65
   Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034
   SIAM AL, 1980, BRIT J OPHTHALMOL, V64, P366, DOI 10.1136/bjo.64.5.366
   Sojka D., 2014, ENCY PARASITOLOGY, P1
   Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314
   Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Tonteri E, 2015, EURO SURVEILL, V20
   Toole MJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0594-6
   Trimnell AR, 2005, VACCINE, V23, P4329, DOI 10.1016/j.vaccine.2005.03.041
   Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2
   Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1007/s10493-004-1389-6
   van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Walsh B, 2016, HEALTH AFFAIR, V35, P356, DOI [10.1377/hlthaff.2015.10, 10.1377/hlthaff.2015.1019]
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Whiten SR, 2016, J MED ENTOMOL, V53, P139, DOI 10.1093/jme/tjv159
   Whitty CJM, 2015, INT HEALTH, V7, P302, DOI 10.1093/inthealth/ihv049
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
   Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6
   Willadsen P, 2004, PARASITOLOGY, V129, pS367, DOI 10.1017/S0031182003004657
   WILLADSEN P, 1989, J IMMUNOL, V143, P1346
   Winkelmann ER, 2016, F1000RESEARCH, V5
   WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872
NR 158
TC 9
Z9 10
U1 0
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 23
PY 2016
VL 9
AR 516
DI 10.1186/s13071-016-1802-0
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DW7TC
UT WOS:000383853600002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dittmer, DP
AF Dittmer, Dirk P.
TI Zika vaccine: Clinical trial and error?
SO SCIENCE
LA English
DT Letter
C1 [Dittmer, Dirk P.] Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27516 USA.
RP Dittmer, DP (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27516 USA.
EM ddittmer@med.unc.edu
OI dittmer, dirk/0000-0003-4968-5656
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Champ D., 2003, DEV BIOL, V114, P221
   Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Polio Global Eradication Initiative, 2014, AV PRIC IN POL VACC
   Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782
NR 6
TC 2
Z9 2
U1 1
U2 20
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 23
PY 2016
VL 353
IS 6306
BP 1375
EP 1375
DI 10.1126/science.aai8117
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW5TB
UT WOS:000383708700028
PM 27708030
DA 2020-07-08
ER

PT J
AU Mains, JW
   Brelsfoard, CL
   Rose, RI
   Dobson, SL
AF Mains, James W.
   Brelsfoard, Corey L.
   Rose, Robert I.
   Dobson, Stephen L.
TI Female Adult Aedes albopictus Suppression by Wolbachia-Infected Male
   Mosquitoes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; DIPTERA-CULICIDAE; RELEASE; ESTABLISHMENT;
   PERFORMANCE; POPULATION; DISPERSAL; INSECTS; BIOLOGY; STRAIN
AB Dengue, chikungunya and zika viruses are pathogens with an increasing global impact. In the absence of an approved vaccine or therapy, their management relies on controlling the mosquito vectors. But traditional controls are inadequate, and the range of invasive species such as Aedes albopictus (Asian Tiger Mosquito) is expanding. Genetically modified mosquitoes are being tested, but their use has encountered regulatory barriers and public opposition in some countries. Wolbachia bacteria can cause a form of conditional sterility, which can provide an alternative to genetic modification or irradiation. It is unknown however, whether openly released, artificially infected male Ae. albopictus can competitively mate and sterilize females at a level adequate to suppress a field population. Also, the unintended establishment of Wolbachia at the introduction site could result from horizontal transmission or inadvertent female release. In 2014, an Experimental Use Permit from the United States Environmental Protection Agency approved a pilot field trial in Lexington, Kentucky, USA. Here, we present data showing localized reduction of both egg hatch and adult female numbers. The artificial Wolbachia type was not observed to establish in the field. The results are discussed in relation to the applied use of Wolbachia-infected males as a biopesticide to suppress field populations of Ae. albopictus.
C1 [Mains, James W.; Brelsfoard, Corey L.; Dobson, Stephen L.] MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.
   [Rose, Robert I.] 8322 Sharon Dr, Frederick, MD 21704 USA.
   [Dobson, Stephen L.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.
RP Dobson, SL (corresponding author), MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.; Dobson, SL (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.
EM sdobson@mosquitomate.com
RI Dobson, Stephen L/E-5852-2010
OI Dobson, Stephen L/0000-0001-5486-8225
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-098179]; Kentucky
   Cabinet for Economic Development [KSTC-184-512-12-142,
   KSTC-184-512-14-198]
FX We thank Katherine Evans, Jeannie Haak and Karen Dobson for technical
   assistance. This work was supported by grants from the National
   Institutes of Health [AI-098179] and the Kentucky Cabinet for Economic
   Development [KSTC-184-512-12-142, KSTC-184-512-14-198].
CR Achee NL, 2015, VECTOR-BORNE ZOONOT, V15, P89, DOI 10.1089/vbz.2014.1628
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Aultman KS, 2000, SCIENCE, V288, P2321, DOI 10.1126/science.288.5475.2321
   Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184
   Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
NR 25
TC 48
Z9 48
U1 0
U2 87
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 23
PY 2016
VL 6
AR 33846
DI 10.1038/srep33846
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX0HX
UT WOS:000384043500001
PM 27659038
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maurer-Stroh, S
   Mak, T
   Ng, Y
   Phuah, S
   Huber, R
   Marzinek, J
   Holdbrook, DA
   Lee, RT
   Cui, L
   Lin, RT
AF Maurer-Stroh, S.
   Mak, T.
   Ng, Y.
   Phuah, S.
   Huber, R. G.
   Marzinek, J. K.
   Holdbrook, D. A.
   Lee, R. T.
   Cui, L.
   Lin, R. T.
TI South-east Asian Zika virus strain linked to cluster of cases in
   Singapore, August 2016
SO EUROSURVEILLANCE
LA English
DT Article
AB Zika virus (ZIKV) is an ongoing global public health emergency with 70 countries and territories reporting evidence of ZIKV transmission since 2015. On 27 August 2016, Singapore reported its first case of local ZIKV transmission and identified an ongoing cluster. Here, we report the genome sequences of ZIKV strains from two cases and find through phylogenetic analysis that these strains form an earlier branch distinct from the recent large outbreak in the Americas.
C1 [Maurer-Stroh, S.; Huber, R. G.; Marzinek, J. K.; Holdbrook, D. A.; Lee, R. T.] ASTAR, Bioinformat Inst BII, Singapore, Singapore.
   [Maurer-Stroh, S.; Marzinek, J. K.] Natl Univ Singapore, DBS, Singapore, Singapore.
   [Maurer-Stroh, S.] Natl Univ Singapore, SBS, Singapore, Singapore.
   [Maurer-Stroh, S.; Mak, T.; Ng, Y.; Phuah, S.; Cui, L.; Lin, R. T.] Minist Hlth MOH, CDC2, NPHL, Singapore, Singapore.
   [Lin, R. T.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.
RP Maurer-Stroh, S (corresponding author), ASTAR, Bioinformat Inst BII, Singapore, Singapore.; Maurer-Stroh, S (corresponding author), Natl Univ Singapore, DBS, Singapore, Singapore.; Maurer-Stroh, S (corresponding author), Natl Univ Singapore, SBS, Singapore, Singapore.; Maurer-Stroh, S (corresponding author), Minist Hlth MOH, CDC2, NPHL, Singapore, Singapore.
EM sebastianms@bii.a-star.edu.sg
RI Huber, Roland/AAG-6353-2019; Maurer-Stroh, Sebastian/Q-9476-2019
OI Huber, Roland/0000-0001-5093-5988; Maurer-Stroh,
   Sebastian/0000-0003-0813-9640; Mak, Tze Minn/0000-0002-8249-8353;
   Holdbrook, Daniel Aitor/0000-0002-8116-9208; Marzinek,
   Jan/0000-0002-5493-8753
FU Ministry of Health (MOH), Singapore; Agency for Science Technology and
   Research (AstarSTAR) Singapore (HEIDI programme); Ministry of Education
   in Singapore (MOE AcRF Tier 3) [MOE2012-T3-1-008]
FX NPHL and its surveillance programmes are fully funded by Ministry of
   Health (MOH), Singapore and the other authors are funded by the Agency
   for Science Technology and Research (A<SUP>star</SUP>STAR) Singapore
   (HEIDI programme) and the Ministry of Education in Singapore (MOE AcRF
   Tier 3 Grant Number MOE2012-T3-1-008 co-held by Chandra Verma and Peter
   Bond of the Bioinformatics Institute (A<SUP>star</SUP>STAR)). The
   authors would like to thank Communicable Disease Division, MOH,
   Singapore, for its roles in field investigation and sample collection.
CR Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organisation, ZIK VIR COMPL
NR 15
TC 22
Z9 24
U1 0
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP 22
PY 2016
VL 21
IS 38
BP 7
EP 10
AR 30347
DI 10.2807/1560-7917.ES.2016.21.38.30347
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DX1SA
UT WOS:000384146100002
PM 27684526
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, DBL
   Almeida, FJ
   Durigon, EL
AF Oliveira, Danielle B. L.
   Almeida, Flavia J.
   Durigon, Edison L.
TI Prolonged Shedding of Zika Virus Associated with Congenital Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Oliveira, Danielle B. L.; Durigon, Edison L.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Almeida, Flavia J.] Irmandade Santa Casa de Misericordia Sao Paulo, Sao Paulo, Brazil.
RP Durigon, EL (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.
EM eldurigo@usp.br
RI Mendes, Erica/L-7333-2018; de A. Zanotto, Paolo M./B-9286-2019; safadi,
   marco aurelio palazzi/B-7157-2015; Araujo, Danielle B/M-9540-2013;
   Almeida, Flavia/N-6714-2019; Botosso, Viviane/I-5591-2014; Oliveira,
   Danielle BL/H-8030-2015; Braconi, Carla T./B-3320-2014
OI Mendes, Erica/0000-0001-9007-1053; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; safadi, marco aurelio
   palazzi/0000-0002-4401-9446; Almeida, Flavia/0000-0002-8587-9733;
   Botosso, Viviane/0000-0002-7876-3687; Oliveira, Danielle
   BL/0000-0002-3452-1336; Braconi, Carla T./0000-0002-5370-8980; Mesquita,
   Flavio/0000-0002-4200-7943; Oliveira, Danielle/0000-0002-0534-0886
CR D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 5
TC 51
Z9 51
U1 0
U2 12
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 22
PY 2016
VL 375
IS 12
BP 1202
EP 1204
DI 10.1056/NEJMc1607583
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3JE
UT WOS:000383537100034
PM 27653589
OA Bronze
DA 2020-07-08
ER

PT J
AU Di Guardo, G
   Braga, PBB
   Peron, JPS
AF Di Guardo, Giovanni
   Beltrao Braga, Patricia Baleeiro
   Schatzmann Peron, Jean Pierre
TI Zika virus-associated brain damage: animal models and open issues
SO EMERGING MICROBES & INFECTIONS
LA English
DT Editorial Material
ID INFECTION
C1 [Di Guardo, Giovanni] Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy.
   [Beltrao Braga, Patricia Baleeiro] Univ Sao Paulo, Stem Cell Lab, Dept Surg, BR-05508270 St Paul, Brazil.
   [Schatzmann Peron, Jean Pierre] Univ Sao Paulo, Neuroimmune Interact Lab, Dept Immunol, BR-05508000 St Paul, Brazil.
RP Di Guardo, G (corresponding author), Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy.
EM gdiguardo@unite.it
RI Peron, Jean Pierre S/F-9248-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091
CR Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519
   Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, 2016, 32 BRAZ MIN HLTH CTR
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayden EC, 2016, NATURE, V530, P142
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 17
TC 2
Z9 2
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 21
PY 2016
VL 5
AR e106
DI 10.1038/emi.2016.103
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EH5MJ
UT WOS:000391816900001
PM 27651092
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coloma, J
   Jain, R
   Rajashankar, KR
   Garcia-Sastre, A
   Aggarwal, AK
AF Coloma, Javier
   Jain, Rinku
   Rajashankar, Kanagalaghatta R.
   Garcia-Sastre, Adolfo
   Aggarwal, Aneel K.
TI Structures of NS5 Methyltransferase from Zika Virus
SO CELL REPORTS
LA English
DT Article
ID CRYSTAL-STRUCTURE; RNA CAP; DOMAIN; RECOGNITION; METHYLATION;
   INHIBITION; VALIDATION
AB The Zika virus (ZIKV) poses a major public health emergency. To aid in the development of antivirals, we present two high-resolution crystal structures of the ZIKV NS5 methyltransferase: one bound to S-adenosylmethionine (SAM) and the other bound to SAM and 7-methyl guanosine diphosphate (7-MeGpp). We identify features of ZIKV NS5 methyltransferase that lend to structure-based antiviral drug discovery. Specifically, SAM analogs with functionalities on the Cb atom of the methionine portion of the molecules that occupy the RNA binding tunnel may provide better specificity relative to human RNA methyltransferases.
C1 [Coloma, Javier; Jain, Rinku; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.
   [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.
   [Rajashankar, Kanagalaghatta R.] Adv Photon Source, NE CAT, Argonne, IL 60439 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Aggarwal, AK (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.
EM aneel.aggarwal@mssm.edu
OI Coloma, Javier/0000-0001-9247-4163
FU National Institute of General Medical Sciences (NIGMS) from the NIH [P41
   GM103403]; National Cancer InstituteUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [ACB-12002]; NIGMSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [AGM-12006];
   NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science by Argonne
   National LaboratoryUnited States Department of Energy (DOE)
   [DE-AC02-06CH11357]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI118610]
FX We thank Jian Jin for helpful discussions. This work is based upon
   research conducted at the Northeastern Collaborative Access Team (NECAT)
   and GM/CA@APS beamlines at the Argonne National Laboratory. The NECAT
   beamlines are funded by the National Institute of General Medical
   Sciences (NIGMS) from the NIH (P41 GM103403). The GM/CA@APS beamlines
   have been funded in whole or in part with funds from the National Cancer
   Institute (ACB-12002) and NIGMS (AGM-12006). The Pilatus 6M detector on
   24-ID-C beam line is funded by an NIH-ORIP HEI grant (S10 RR029205).
   This research used resources of the Advanced Photon Source, a US
   Department of Energy (DOE) Office of Science User Facility operated for
   the DOE Office of Science by Argonne National Laboratory under contract
   no. DE-AC02-06CH11357. A.G.-S. is partly supported by NIH grant
   U19AI118610.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Kaniskan HU, 2015, ACS CHEM BIOL, V10, P40, DOI 10.1021/cb500785t
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Wu H, 2008, PROTEINS, V72, P519, DOI 10.1002/prot.22065
   Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 29
TC 51
Z9 55
U1 0
U2 29
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 20
PY 2016
VL 16
IS 12
BP 3097
EP 3102
DI 10.1016/j.celrep.2016.08.091
PG 6
WC Cell Biology
SC Cell Biology
GA DW8DQ
UT WOS:000383884200002
PM 27633330
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Miner, JJ
   Sene, A
   Richner, JM
   Smith, AM
   Santeford, A
   Ban, N
   Weger-Lucarelli, J
   Manzella, F
   Ruckert, C
   Govero, J
   Noguchi, KK
   Ebel, GD
   Diamond, MS
   Apte, RS
AF Miner, Jonathan J.
   Sene, Abdoulaye
   Richner, Justin M.
   Smith, Amber M.
   Santeford, Andrea
   Ban, Norimitsu
   Weger-Lucarelli, James
   Manzella, Francesca
   Rueuckert, Claudia
   Govero, Jennifer
   Noguchi, Kevin K.
   Ebel, Gregory D.
   Diamond, Michael S.
   Apte, Rajendra S.
TI Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in
   Tears
SO CELL REPORTS
LA English
DT Article
ID HEPATITIS-C VIRUS; EBOLA-VIRUS; TRANSMISSION; ALPHA/BETA; RESPONSES;
   CELLS; MODEL
AB Zika virus (ZIKV) is an emerging flavivirus that causes congenital abnormalities and Guillain-Barre syndrome. ZIKV infection also results in severe eye disease characterized by optic neuritis, chorioretinal atrophy, and blindness in newborns and conjunctivitis and uveitis in adults. We evaluated ZIKV infection of the eye by using recently developed mouse models of pathogenesis. ZIKV-inoculated mice developed conjunctivitis, panuveitis, and infection of the cornea, iris, optic nerve, and ganglion and bipolar cells in the retina. This phenotype was independent of the entry receptors Axl or Mertk, given that Axl(-/-), Mertk(-/-), and Axl(-/-) Mertk(-/-) double knockout mice sustained levels of infection similar to those of control animals. We also detected abundant viral RNA in tears, suggesting that virus might be secreted from lacrimal glands or shed from the cornea. This model provides a foundation for studying ZIK-Vinduced ocular disease, defining mechanisms of viral persistence, and developing therapeutic approaches for viral infections of the eye.
C1 [Miner, Jonathan J.; Richner, Justin M.; Smith, Amber M.; Govero, Jennifer; Diamond, Michael S.; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Sene, Abdoulaye; Santeford, Andrea; Ban, Norimitsu; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.
   [Weger-Lucarelli, James; Rueuckert, Claudia; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Manzella, Francesca; Noguchi, Kevin K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.
RP Miner, JJ; Diamond, MS; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.
EM miner@wustl.edu; diamond@borcim.wustl.edu; apte@vision.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Ebel, Gregory/D-8324-2017
OI Diamond, Michael/0000-0002-8791-3165; Weger-Lucarelli,
   James/0000-0002-9483-1694; Ruckert, Claudia/0000-0003-3732-6752;
   Richner, Justin/0000-0002-5344-118X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI101400, R01
   AI104972, R01 EY019287, P30 EY02687, R01 AI067380]; Research to Prevent
   BlindnessResearch to Prevent Blindness (RPB); Schulak Family Gift Fund
   for Retinal Research; Jeffrey Fort Innovation Fund; Rheumatology
   Research Foundation Scientist Development Award; Intellectual and
   Developmental Disabilities Research Center at Washington University
   [NIH/NICHD U54 HD087011]; Moderna; SanofiSanofi-Aventis; Visterra
FX This study was supported by grants from the NIH (R01 AI073755, R01
   AI101400, and R01 AI104972 [to M.S.D.], R01 EY019287 [to R.S.A.], P30
   EY02687 [Vision Core Grant], and R01 AI067380 [to G.D.E.]). R.S.A. also
   was supported by a Physician-Scientist Award from Research to Prevent
   Blindness, the Schulak Family Gift Fund for Retinal Research, and the
   Jeffrey Fort Innovation Fund. J.J.M. was supported by a Rheumatology
   Research Foundation Scientist Development Award. K.N. was supported by
   the Intellectual and Developmental Disabilities Research Center at
   Washington University (NIH/NICHD U54 HD087011). Additional funding comes
   from an unrestricted grant to the Department of Ophthalmology and Visual
   Sciences of Washington University School of Medicine from Research to
   Prevent Blindness. M.S.D. is a consultant for Inbios, Visterra, Sanofi,
   and Takeda Pharmaceuticals, is on the Scientific Advisory Boards of
   Moderna and OraGene, and is a recipient of research grants from Moderna,
   Sanofi, and Visterra.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Chong EM, 2004, AM J OPHTHALMOL, V138, P474, DOI 10.1016/j.ajo.2004.04.027
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Derbent M, 2004, AM J MED GENET A, V128A, P232, DOI 10.1002/ajmg.a.30109
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hershberger VS, 2003, OPHTHALMOLOGY, V110, P1732, DOI 10.1016/S0161-6420(03)00720-6
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Kaiser PK, 2003, AM J OPHTHALMOL, V136, P928, DOI 10.1016/S0002-9394(03)00866-3
   Kuchtey RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P1648, DOI 10.1001/archopht.121.11.1648
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HM, 2001, CORNEA, V20, P37, DOI 10.1097/00003226-200101000-00007
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sakala IG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005342
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008
   Valverde P, 2004, EXP EYE RES, V78, P27, DOI 10.1016/j.exer.2003.10.002
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 42
TC 143
Z9 148
U1 0
U2 472
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 20
PY 2016
VL 16
IS 12
BP 3208
EP 3218
DI 10.1016/j.celrep.2016.08.079
PG 11
WC Cell Biology
SC Cell Biology
GA DW8DQ
UT WOS:000383884200013
PM 27612415
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Swannell, C
AF Swannell, Cate
TI Anti-Zika drugs on the way
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD SEP 19
PY 2016
VL 205
IS 6
BP 244
EP 244
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DY9RZ
UT WOS:000385474100002
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI Preliminary results from case- control study confirm Zika virus causes
   microcephaly
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Araujo TV, 2016, LANCET INFECT DIS, DOI [10.1016/S1473-3099(16)30318-8, DOI 10.1016/S1473-3099(16)30318-8]
NR 1
TC 1
Z9 1
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 16
PY 2016
VL 354
AR i5031
DI 10.1136/bmj.i5031
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3OJ
UT WOS:000383550600011
PM 27638290
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gupta, AK
   Kaur, K
   Rajput, A
   Dhanda, SK
   Sehgal, M
   Khan, MS
   Monga, I
   Dar, SA
   Singh, S
   Nagpal, G
   Usmani, SS
   Thakur, A
   Kaur, G
   Sharma, S
   Bhardwaj, A
   Qureshi, A
   Raghava, GPS
   Kumar, M
AF Gupta, Amit Kumar
   Kaur, Karambir
   Rajput, Akanksha
   Dhanda, Sandeep Kumar
   Sehgal, Manika
   Khan, Md. Shoaib
   Monga, Isha
   Dar, Showkat Ahmad
   Singh, Sandeep
   Nagpal, Gandharva
   Usmani, Salman Sadullah
   Thakur, Anamika
   Kaur, Gazaldeep
   Sharma, Shivangi
   Bhardwaj, Aman
   Qureshi, Abid
   Raghava, Gajendra Pal Singh
   Kumar, Manoj
TI ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics,
   Phylogenetic and Therapeutic Analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID C-MANNOSYLATION; PREDICTION; VACCINE; RNA; GLYCOSYLATION; SEQUENCE;
   DATABASE; IDENTIFICATION; TRANSMISSION; INFECTION
AB Current Zika virus (ZIKV) outbreaks that spread in several areas of Africa, Southeast Asia, and in pacific islands is declared as a global health emergency by World Health Organization (WHO). It causes Zika fever and illness ranging from severe autoimmune to neurological complications in humans. To facilitate research on this virus, we have developed an integrative multi-omics platform; ZikaVR (http://bioinfo.imtech.res.in/manojk/zikavr/), dedicated to the ZIKV genomic, proteomic and therapeutic knowledge. It comprises of whole genome sequences, their respective functional information regarding proteins, genes, and structural content. Additionally, it also delivers sophisticated analysis such as whole-genome alignments, conservation and variation, CpG islands, codon context, usage bias and phylogenetic inferences at whole genome and proteome level with user-friendly visual environment. Further, glycosylation sites and molecular diagnostic primers were also analyzed. Most importantly, we also proposed potential therapeutically imperative constituents namely vaccine epitopes, siRNAs, miRNAs, sgRNAs and repurposing drug candidates.
C1 [Gupta, Amit Kumar; Kaur, Karambir; Rajput, Akanksha; Dhanda, Sandeep Kumar; Sehgal, Manika; Khan, Md. Shoaib; Monga, Isha; Dar, Showkat Ahmad; Singh, Sandeep; Nagpal, Gandharva; Usmani, Salman Sadullah; Thakur, Anamika; Kaur, Gazaldeep; Sharma, Shivangi; Bhardwaj, Aman; Qureshi, Abid; Raghava, Gajendra Pal Singh; Kumar, Manoj] CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39A, Chandigarh 160036, India.
RP Kumar, M (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39A, Chandigarh 160036, India.
EM manojk@imtech.res.in
RI Raghava, Gajendra/B-1717-2009; Gupta, Amit/M-4358-2017; Dhanda, Sandeep
   Kumar/J-8471-2016; Kumar, Manoj/G-1274-2010
OI Gupta, Amit/0000-0002-8395-1201; Dhanda, Sandeep
   Kumar/0000-0003-1381-7434; Singh, Sandeep/0000-0001-5361-4303; Usmani,
   Salman Sadullah/0000-0001-6624-4428; RAJPUT,
   AKANKSHA/0000-0001-8176-6697; monga, isha/0000-0002-4683-9456; Kumar,
   Manoj/0000-0003-3769-052X; Raghava, Gajendra/0000-0002-8902-2876;
   Qureshi, Dr. Abid/0000-0002-1140-1649
FU Council of Scientific and Industrial Research, IndiaCouncil of
   Scientific & Industrial Research (CSIR) - India [BSC0121]; Department of
   Biotechnology, Government of IndiaDepartment of Biotechnology (DBT)
   India [GAP0001]
FX Financial support for this work is provided by Council of Scientific and
   Industrial Research, India (BSC0121) and Department of Biotechnology,
   Government of India (GAP0001). Open access charges by: CSIR-Institute of
   Microbial Technology, Chandigarh, India.
CR Ahmed F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023443
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-276
   Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111
   Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939
   Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005
   Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771
   Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Chaudhary K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20678
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dar SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20031
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Dhanda SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep24782
   Dhanda SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/263952
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1
   Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843
   Goto Y, 2014, INT J ONCOL, V45, P344, DOI 10.3892/ijo.2014.2438
   Gupta AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12522
   Gupta Ramneek, 2002, Pac Symp Biocomput, P310
   Haasnoot J, 2003, J BIOMED SCI, V10, P607, DOI 10.1007/BF02256311
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151
   Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050
   Kaur K, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav055
   Khan MS, 2016, EPIGENOMICS-UK, V8, P67, DOI 10.2217/epi.15.95
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438
   Koshy R, 1996, TRENDS BIOTECHNOL, V14, P364, DOI 10.1016/0167-7799(96)10049-4
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moriel DG, 2008, HUM VACCINES, V4, P184, DOI 10.4161/hv.4.3.6313
   Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595
   Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007
   Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112
   Qureshi A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau103
   Qureshi A, 2014, NUCLEIC ACIDS RES, V42, pD1147, DOI 10.1093/nar/gkt1191
   Qureshi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-305
   Rajput A, 2016, NUCLEIC ACIDS RES, V44, pD634, DOI 10.1093/nar/gkv1076
   Rajput A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120066
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SERAFINOWSKI P, 1992, J MED CHEM, V35, P4576, DOI 10.1021/jm00102a010
   Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37, DOI DOI 10.1017/CBO9781107415324.004
   Shawan M. M. A. K., 2014, INDIAN J PHARM BIOL, V2, P44
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216
   Sintchenko V, 2010, INFECTIOUS DISEASE INFORMATICS, P1, DOI 10.1007/978-1-4419-1327-2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438
   Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450
   Thakur N, 2012, NUCLEIC ACIDS RES, V40, pD230, DOI 10.1093/nar/gkr1147
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yoon H, 2015, BIOINFORMATICS, V31, P1472, DOI 10.1093/bioinformatics/btu832
NR 109
TC 22
Z9 22
U1 0
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 16
PY 2016
VL 6
AR 32713
DI 10.1038/srep32713
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW0JW
UT WOS:000383327700001
PM 27633273
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brent, C
   Dunn, A
   Savage, H
   Faraji, A
   Rubin, M
   Risk, I
   Garcia, W
   Cortese, M
   Novosad, S
   Krow-Lucal, ER
   Crain, J
   Hill, M
   Atkinson, A
   Peterson, D
   Christensen, K
   Dimond, M
   Staples, JE
   Nakashima, A
AF Brent, Carolyn
   Dunn, Angela
   Savage, Harry
   Faraji, Ary
   Rubin, Mike
   Risk, Ilene
   Garcia, Wendy
   Cortese, Margaret
   Novosad, Shannon
   Krow-Lucal, Elisabeth Raquel
   Crain, Jacqueline
   Hill, Mary
   Atkinson, Annette
   Peterson, Dallin
   Christensen, Kimberly
   Dimond, Melissa
   Staples, J. Erin
   Nakashima, Allyn
TI Preliminary Findings from an Investigation of Zika Virus Infection in a
   Patient with No Known Risk Factors - Utah, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Brent, Carolyn; Risk, Ilene; Hill, Mary] Salt Lake Cty Hlth Dept, Salt Lake City, UT 84190 USA.
   [Brent, Carolyn; Crain, Jacqueline] CDC, Publ Hlth Associates Program Off, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Dunn, Angela; Crain, Jacqueline; Peterson, Dallin; Dimond, Melissa; Nakashima, Allyn] Utah Dept Hlth, Salt Lake City, UT USA.
   [Savage, Harry; Krow-Lucal, Elisabeth Raquel; Staples, J. Erin] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.
   [Rubin, Mike] Univ Utah Hosp, Salt Lake City, UT USA.
   [Garcia, Wendy] Davis Cty Hlth Dept, Clearfield, UT USA.
   [Cortese, Margaret] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Novosad, Shannon] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Atkinson, Annette; Christensen, Kimberly] Utah Publ Hlth Lab, Taylorsville, UT USA.
RP Brent, C (corresponding author), Salt Lake Cty Hlth Dept, Salt Lake City, UT 84190 USA.; Brent, C (corresponding author), CDC, Publ Hlth Associates Program Off, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
EM cbrent@slco.org
CR CDC, 2016, ZIK VIR TRANSM RISKS
   Centres for Disease Control, 2007, 2007 GUID IS PREC PR
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 3
TC 15
Z9 15
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 16
PY 2016
VL 65
IS 36
BP 981
EP 982
DI 10.15585/mmwr.mm6536e4
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW1EP
UT WOS:000383386100009
PM 27631467
OA Bronze
DA 2020-07-08
ER

PT J
AU Walker, WL
   Lindsey, NP
   Lehman, JA
   Krow-Lucal, ER
   Rabe, IB
   Hills, SL
   Martin, SW
   Fischer, M
   Staples, JE
AF Walker, William L.
   Lindsey, Nicole P.
   Lehman, Jennifer A.
   Krow-Lucal, Elisabeth R.
   Rabe, Ingrid B.
   Hills, Susan L.
   Martin, Stacey W.
   Fischer, Marc
   Staples, J. Erin
TI Zika Virus Disease Cases-50 States and the District of Columbia, January
   1-July 31, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Walker, William L.; Krow-Lucal, Elisabeth R.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Walker, William L.; Lindsey, Nicole P.; Lehman, Jennifer A.; Krow-Lucal, Elisabeth R.; Rabe, Ingrid B.; Hills, Susan L.; Martin, Stacey W.; Fischer, Marc; Staples, J. Erin] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Staples, JE (corresponding author), CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM auv1@cdc.gov
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Brent C, 2016, MMWR MORB M IN PRESS
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FDA, 2016, REV REC RED RISK ZIK
   Frieden T. R., 2016, JAMA
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 10
TC 32
Z9 32
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 16
PY 2016
VL 65
IS 36
BP 983
EP 986
DI 10.15585/mmwr.mm6536e5
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW1EP
UT WOS:000383386100010
PM 27631604
OA Bronze
DA 2020-07-08
ER

PT J
AU Culjat, M
   Darling, SE
   Nerurkar, VR
   Ching, N
   Kumar, M
   Min, SK
   Wong, R
   Grant, L
   Melish, ME
AF Culjat, Marko
   Darling, Stephen E.
   Nerurkar, Vivek R.
   Ching, Natascha
   Kumar, Mukesh
   Min, Sarah K.
   Wong, Rupa
   Grant, Leon
   Melish, Marian E.
TI Clinical and Imaging Findings in an Infant With Zika Embryopathy
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; microcephaly; MRI; fetal brain disruption sequence;
   ultrasound
ID VIRUS-INFECTION; INTERIM GUIDELINES; UNITED-STATES; OUTBREAK; ISLAND
AB Recent Zika virus (ZIKV) outbreaks have been associated with an increased incidence of neonatal microcephaly. Subsequently, tropism for the brain was established in human fetal brain tissue. We present the first congenital ZIKV infection in the United States, confirmed by high ZIKV immunoglobulin M antibody titers in serum and cerebrospinal fluid. The phenotypic characteristics of the patient fall within fetal brain disruption sequence, suggesting impaired brain development in the second half of gestation. Brain imaging revealed an almost agyric brain with diffuse parenchymal calcifications, hydrocephalus ex vacuo, and cerebellar hypoplasia. Ophthalmologic examination revealed macular pigment stippling and optic nerve atrophy. Liver, lungs, heart, and bone marrow were not affected. The patient had progressive neurologic deterioration in the first month of life. The discovery of ZIKV infection in human fetal brain tissue along with serologic confirmation proves the vertical transmission of ZIKV. Therefore, ZIKV has joined the group of congenital infections.
C1 [Culjat, Marko; Ching, Natascha; Min, Sarah K.; Grant, Leon] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Kapiolani Med Ctr Women & Children, Honolulu, HI 96822 USA.
   [Darling, Stephen E.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Radiol, Kapiolani Med Ctr Women & Children, Honolulu, HI 96822 USA.
   [Nerurkar, Vivek R.; Kumar, Mukesh] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
   [Wong, Rupa; Melish, Marian E.] John A Burns Sch Med, Kapiolani Med Ctr Women & Children, Honolulu, HI USA.
   [Melish, Marian E.] John A Burns Sch Med, Dept Pediat, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI USA.
RP Melish, ME (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96826 USA.
EM mmelish@hawaii.edu
RI Kumar, Mukesh/AAI-1046-2019; Kumar, Mukesh/N-8814-2015; Nerurkar, Vivek
   R/F-5533-2011
OI Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875; 
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences, National Institutes of Health [P30GM114737]
FX V. R. N. and M. K. are partly supported by the Centers of Biomedical
   Research Excellence, National Institute of General Medical Sciences,
   National Institutes of Health (grant number P30GM114737).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO, P1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITH DW, 1973, J PEDIATR-US, V83, P374, DOI 10.1016/S0022-3476(73)80258-6
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
NR 34
TC 43
Z9 44
U1 1
U2 24
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2016
VL 63
IS 6
BP 805
EP 811
DI 10.1093/cid/ciw324
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DW7UK
UT WOS:000383857500017
PM 27193747
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Motta, IJF
   Spencer, BR
   Ferreira, OC
AF Motta, Iara J. F.
   Spencer, Bryan R.
   Ferreira, Orlando C., Jr.
TI Evidence for Transmission of Zika Virus by Platelet Transfusion
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID FRENCH-POLYNESIA
C1 [Motta, Iara J. F.] Inst Nacl Canc Jose Alencar Gomes da Silva, Rio De Janeiro, Brazil.
   [Spencer, Bryan R.] Amer Red Cross, Massachusetts Reg, Dedham, MA USA.
   [Ferreira, Orlando C., Jr.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Ferreira, OC (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
EM orlandocfj@gmail.com
RI Spencer, Bryan/AAF-4896-2019; Voloch, Carolina M/F-8874-2013; Higa,
   Luiza/W-2698-2019
OI Spencer, Bryan/0000-0002-9008-9154; Voloch, Carolina
   M/0000-0001-5182-4366; Lima Monteiro, Fabio Luis/0000-0002-9107-6865
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 5
TC 148
Z9 148
U1 1
U2 19
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 15
PY 2016
VL 375
IS 11
BP 1101
EP 1103
DI 10.1056/NEJMc1607262
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV6ZG
UT WOS:000383085000030
PM 27532622
OA Bronze
DA 2020-07-08
ER

PT J
AU Dourado, ME
   Ferreira, LC
   Freire-Neto, FP
   Jeronimo, SMB
AF Dourado Junior, Mario Emilio
   Ferreira, Leonardo Capistrano
   Freire-Neto, Francisco Paulo
   Jeronimo, Selma M. B.
TI No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barre
   Syndrome in a Brazilian population
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Guillain-Barre Syndrome; FCGR; Polymorphism; Genetics
ID FC-RECEPTOR POLYMORPHISMS; ZIKA VIRUS OUTBREAK; CAMPYLOBACTER-JEJUNI;
   ANTIGANGLIOSIDE ANTIBODIES; INFECTION; IIA; SUSCEPTIBILITY;
   POLYNEUROPATHY; IMMUNOGLOBULIN; SEVERITY
AB The pathogenesis of Guillain-Barre Syndrome (GBS) is not entirely understood, but includes infection-induced aberrant immune responses. Genetic polymorphisms in Fc gamma receptor genes (FCGR) have been associated with GBS. We assessed whether polymorphisms rs1801274 in FCGR2A and rs396991 in FCGR3A were associated with GBS in a Brazilian population. We genotyped 141 GBS cases and 364 healthy controls from Brazil for both polymorphisms. The FCGR genotypes and alleles frequencies did not differ significantly between GBS and controls. In addition, there was no genetic association with either severity or clinical outcomes. We conclude that these FCGR polymorphisms are not associated with susceptibility to Guillain-Barre Syndrome in this Brazilian population. (C) 2016 Published by Elsevier B.V.
C1 [Dourado Junior, Mario Emilio] Univ Fed Rio Grande do Norte, Dept Integrat Med, Natal, RN, Brazil.
   [Dourado Junior, Mario Emilio; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Postgrad Program, Natal, RN, Brazil.
   [Ferreira, Leonardo Capistrano; Freire-Neto, Francisco Paulo; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Dept Biochem, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Ferreira, Leonardo Capistrano/D-7097-2019
OI Ferreira, Leonardo Capistrano/0000-0001-9268-4881
FU Brazilian Research Council (CNPq)National Council for Scientific and
   Technological Development (CNPq) [482017/2009-0]
FX We thank John Donelson, PhD (University of Iowa, Iowa City, IA, USA) and
   Cleni M Marzocchi-Machado, PhD (FCFRP-USP, Ribeirao Preto, Brazil) for
   their helpful revision of this manuscript. This study was supported by a
   grant 482017/2009-0 from the Brazilian Research Council (CNPq).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Vigato-Ferreira ICC, 2014, AUTOIMMUNITY, V47, P451, DOI 10.3109/08916934.2014.921809
   Dalakas MC, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.6_Suppl_5.S2
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dourado ME, 2003, ACTA NEUROL SCAND, V108, P102, DOI 10.1034/j.1600-0404.2003.00103.x
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254
   Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32
   GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Kuwano ST, 2000, TRANSFUSION, V40, P1388, DOI 10.1046/j.1537-2995.2000.40111388.x
   McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610
   Moriya H, 2014, BIOMED REP, V2, P265, DOI 10.3892/br.2013.210
   Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624
   Odaka M, 2001, J NEUROL NEUROSUR PS, V70, P50, DOI 10.1136/jnnp.70.1.50
   Rodrigues F.N., 2016, PLOS CURR, V8
   SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994
   SALMON JE, 1990, J CLIN INVEST, V85, P1287, DOI 10.1172/JCI114566
   Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Siqueira JF, 2011, J ENDODONT, V37, P1345, DOI 10.1016/j.joen.2011.06.025
   Siqueira JF, 2009, J ENDODONT, V35, P1186, DOI 10.1016/j.joen.2009.05.006
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856
   van der Pol WL, 2000, NEUROLOGY, V54, P1661, DOI 10.1212/WNL.54.8.1661
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Sorge NM, 2005, J NEUROIMMUNOL, V162, P157, DOI 10.1016/j.jneuroim.2005.01.016
   van Sorge NM, 2003, ANN NEUROL, V53, P570, DOI 10.1002/ana.10503
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Vedeler CA, 2000, NEUROLOGY, V55, P705, DOI 10.1212/WNL.55.5.705
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zhang G., 2014, PLOS ONE, V11
NR 40
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD SEP 15
PY 2016
VL 298
BP 160
EP 164
DI 10.1016/j.jneuroim.2016.07.020
PG 5
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA DW8WQ
UT WOS:000383936600023
PM 27609290
DA 2020-07-08
ER

PT J
AU Chatel-Chaix, L
   Cortese, M
   Romero-Brey, I
   Bender, S
   Neufeldt, CJ
   Fischl, W
   Scaturro, P
   Schieber, N
   Schwab, Y
   Fischer, B
   Ruggieri, A
   Bartenschlager, R
AF Chatel-Chaix, Laurent
   Cortese, Mirko
   Romero-Brey, Ines
   Bender, Silke
   Neufeldt, Christopher John
   Fischl, Wolfgang
   Scaturro, Pietro
   Schieber, Nicole
   Schwab, Yannick
   Fischer, Bernd
   Ruggieri, Alessia
   Bartenschlager, Ralf
TI Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate
   Immune Responses
SO CELL HOST & MICROBE
LA English
DT Article
ID HEPATITIS-C VIRUS; MAMMALIAN-CELLS; MITOFUSIN 2; MEMBRANES MAM; NS4B
   PROTEIN; REPLICATION; FISSION; APOPTOSIS; RECEPTOR; FUSION
AB With no antiviral drugs or widely available vaccines, Dengue virus (DENV) constitutes a public health concern. DENV replicates at ER-derived cytoplasmic structures that include substructures called convoluted membranes (CMs); however, the purpose of these membrane alterations remains unclear. We determine that DENV nonstructural protein (NS)4B, a promising drug target with unknown function, associates with mitochondrial proteins and alters mitochondria morphology to promote infection. During infection, NS4B induces elongation of mitochondria, which physically contact CMs. This restructuring compromises the integrity of mitochondria-associated membranes, sites of ER-mitochondria interface critical for innate immune signaling. The spatio-temporal parameters of CM biogenesis and mitochondria elongation are linked to loss of activation of the fission factor Dynamin-Related Protein-1. Mitochondria elongation promotes DENV replication and alleviates RIG-I-dependent activation of interferon responses. As Zika virus infection induces similar mitochondria elongation, this perturbation may protect DENV and related viruses from innate immunity and create a favorable replicative environment.
C1 [Chatel-Chaix, Laurent; Cortese, Mirko; Romero-Brey, Ines; Bender, Silke; Neufeldt, Christopher John; Fischl, Wolfgang; Scaturro, Pietro; Ruggieri, Alessia; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.
   [Romero-Brey, Ines; Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res, D-69120 Heidelberg, Germany.
   [Schieber, Nicole; Schwab, Yannick] European Mol Biol Lab, D-69117 Heidelberg, Germany.
   [Fischer, Bernd] German Canc Res Ctr, Computat Genome Biol, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
RP Chatel-Chaix, L; Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.; Bartenschlager, R (corresponding author), Heidelberg Univ, German Ctr Infect Res, D-69120 Heidelberg, Germany.
EM laurent.chatel-chaix@iaf.inrs.ca;
   ralf.bartenschlager@med.uni-heidelberg.de
RI Neufeldt, Christopher/AAD-1702-2019; Bartenschlager, Ralf/L-2582-2015
OI Neufeldt, Christopher/0000-0002-4551-1811; Bartenschlager,
   Ralf/0000-0001-5601-9307; Schieber, Nicole L./0000-0002-3212-5057;
   Romero Brey, Ines/0000-0002-9073-9612; Schwab,
   Yannick/0000-0001-8027-1836; Scaturro, Pietro/0000-0001-9098-3087;
   Ruggieri, Alessia/0000-0001-9981-3308; Cortese,
   Mirko/0000-0003-1786-4211
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB
   638, TP A5, SFB 1129, TP11, SFB 1129 (TP13)]
FX We are grateful to Dr. Vibor Laketa and the Infectious Diseases Imaging
   Platform (IDIP) at the Department of Infectious Diseases, University
   Hospital Heidelberg, for providing excellent microscopy support. We
   acknowledge Progen Biotechnik GmbH, Heidelberg for providing DENV
   serotypes 1, 3, and 4; Andrew Davidson for the NGC strain; Jonas
   Schmidt-Chanasit for the WNV NY99 strain; and the European Virus Archive
   for ZIKV strains. We thank Uta Haselmann, Marie Bartenschlager, Ulrike
   Herian, and Jacomine Krijnse-Locker for technical help; Dr. Didier Trono
   for lentivirus packaging constructs; Dr. Nathan R. Brady for DRP1 cDNA;
   Dr. Gualtiero Alvisi for constructing the YFP-Sec61 beta-encoding
   plasmid; and Drs. Eliana G. Acosta, Anil Kumar, David Paul, and Philippe
   Metz for virus stock production. We thank Dr. Birgit Voigt, proteomics
   platform of the Institute of Microbiology, University of Greifswald, for
   mass spectrometry-based analysis of the DENV NS4B interactome. We are
   grateful to the Electron Microscopy Core Facility of the University of
   Heidelberg and at the EMBL for expert support and providing access to
   their equipment. This work was supported by grants from the Deutsche
   Forschungsgemeinschaft (SFB 638, TP A5, and SFB 1129, TP11) to R.B. and
   SFB 1129 (TP13) to A.R.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111
   Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041
   Lee H, 2014, MOL CELLS, V37, P89, DOI 10.14348/molcells.2014.2329
   Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Naghdi S, 2016, BIOCH BIOPHYS ACTA
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018
   Pyakurel A, 2015, MOL CELL, V58, P244, DOI 10.1016/j.molcel.2015.02.021
   Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105
   Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802
   van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009
   Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xia M, 2014, J VIROL, V88, P5152, DOI 10.1128/JVI.03851-13
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287
   Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 49
TC 72
Z9 72
U1 1
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD SEP 14
PY 2016
VL 20
IS 3
BP 342
EP 356
DI 10.1016/j.chom.2016.07.008
PG 15
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DX1QW
UT WOS:000384143100011
PM 27545046
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Gerardin, P
   Randrianaivo, H
   Schaub, B
   Cesaire, R
   Doray, B
   LaBeaud, AD
AF Gerardin, Patrick
   Randrianaivo, Hanitra
   Schaub, Bruno
   Cesaire, Raymond
   Doray, Berenice
   LaBeaud, A. Desiree
TI CONGENITAL ZIKA SYNDROME Congenital Zika syndrome: time to move from
   case series to case-control studies and data sharing
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Gerardin, Patrick] CHU Reunion, INSERM, CIC 1410, BP 350, St Pierre 97448, Reunion, France.
   [Randrianaivo, Hanitra] JRC, EUROCAT Affiliated Registry Congenital Birth Defe, St Pierre, Reunion, France.
   [Schaub, Bruno] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal, Fort De France, France.
   [Cesaire, Raymond] CHU Martinique, Virol Unit, Fort De France, France.
   [Doray, Berenice] CHU Reunion, Dept Genet, St Denis, Reunion, France.
   [LaBeaud, A. Desiree] Stanford Sch Med, Dept Pediat, Palo Alto, CA 94305 USA.
RP Gerardin, P (corresponding author), CHU Reunion, INSERM, CIC 1410, BP 350, St Pierre 97448, Reunion, France.
EM patrick.gerardin@chu-reunion.fr
CR Bayram Y, 2016, J CLIN INVEST, V126, P762, DOI 10.1172/JCI84457
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
NR 5
TC 3
Z9 3
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 14
PY 2016
VL 354
AR i4850
DI 10.1136/bmj.i4850
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3NK
UT WOS:000383548100008
PM 27629599
DA 2020-07-08
ER

PT J
AU Lyon, J
AF Lyon, Jeff
TI Republicans Critical of White House for Zika Reaching the United States
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD SEP 13
PY 2016
VL 316
IS 10
BP 1035
EP 1035
DI 10.1001/jama.2016.12339
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV5TB
UT WOS:000382991100005
PM 27623452
DA 2020-07-08
ER

PT J
AU Vythilingam, I
   Sam, JIC
   Chan, YF
   Khaw, LT
   Sulaiman, WYW
AF Vythilingam, Indra
   Sam, Jamal I-C.
   Chan, Yoke F.
   Khaw, Loke T.
   Sulaiman, Wan Y. Wan
TI New Paradigms for Virus Detection, Surveillance and Control of Zika
   Virus Vectors in the Settings of Southeast Asia
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; vectors; diagnostic tools; new paradigms; control
ID AEDES STEGOMYIA AEGYPTI; WATER STORAGE CONTAINERS; DENGUE VECTOR;
   FIELD-EVALUATION; DESICCATED MOSQUITOS; NS1 ANTIGEN; INSECTICIDE;
   CHIKUNGUNYA; INFECTION; DIPTERA
AB Zika virus (ZIKV) has now become a global public health concern. The vectors for ZIKV are Aedes aegypti and A. albopictus. Both these mosquitoes are predominant in Southeast Asia and are also responsible for the spread of other arboviral diseases like dengue virus and chikungunya virus. The incidence of dengue has been increasing over the years and this is of concern to public health workers. Simple laboratory tools for the detection of ZIKV is also lacking. In the absence of drugs and vaccine for these arboviral diseases, vector control is the main option for surveillance and control. Aedes larval surveys have been the hallmark of dengue control along with larviciding and fogging when cases are reported. However, we need new paradigms and options for control of these vectors. The current situation in Southeast Asia clearly proves that effective strategies for vector control need to be proactive and not reactive. This will be the way forward to control epidemics of these diseases inclusive of ZIKV until a vaccine becomes available.
C1 [Vythilingam, Indra; Khaw, Loke T.; Sulaiman, Wan Y. Wan] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.
   [Sam, Jamal I-C.; Chan, Yoke F.] Univ Malaya, Fac Med, Dept Microbiol, Kuala Lumpur, Malaysia.
RP Vythilingam, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.
EM indrav@um.edu.my
RI Sam, Jamal I-Ching/B-8688-2010; sulaiman, wan yusoff wan/C-1030-2010;
   VYTHILINGAM, INDRA/Q-5019-2016; Wan Sulaiman, Wan Yusoff/L-5295-2016;
   Chan, Yoke Fun/B-5351-2010; Vythilingam, Indra/E-8334-2010
OI Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke
   Fun/0000-0001-7089-0510; 
FU University of MalayaUniversiti Malaya [E000013-20001]
FX JS and YC received funding from the University of Malaya (HIR grant
   E000013-20001).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, Saudi Med J, V37, P471
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Aumentado C, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.3.HYN_018, 10.5365/wpsar.2015.6.3.HYN_018]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIAGN TEST
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chang MS, 2011, WEST PAC SURVEILL RE, V2, P9, DOI [10.5365/WPSAR.2010.1.1.012, 10.5365/wpsar.2010.1.1.012]
   Chao DY, 2015, J VECTOR DIS, V52, P134
   CHEONG WH, 1967, B WORLD HEALTH ORGAN, V36, P586
   Cheong WH, 1986, BULLETIN, V23, P155
   Chung YK, 2001, MED VET ENTOMOL, V15, P321, DOI 10.1046/j.0269-283x.2001.00311.x
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Resende MC, 2013, MEM I OSWALDO CRUZ, V108, P1024, DOI 10.1590/0074-0276130128
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gretchen V., 2016, TOP MOSQUITO SUSPECT
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ho T., 1980, MED J MALAYSIA, V24, P409
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Invest J., 2008, P 6 INT C URB PESTS, P239
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   Koou SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0471-0
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lee HL, 1997, J VECTOR ECOL, V22, P146
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   de Santos EMM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-195
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305
   Mudin R. N., 2015, INT MED J MALAYSIA, V14, P05
   Muller DA, 2012, J VIROL METHODS, V183, P90, DOI 10.1016/j.jviromet.2012.03.033
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oo TT, 2011, TROP BIOMED, V28, P302
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Ponlawat A, 2013, SE ASIAN J TROP MED, V44, P167
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Saiful A. N., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P315, DOI 10.1016/S2221-1691(12)60031-8
   Sam J I C, 2016, Med J Malaysia, V71, P66
   Samuel PP, 2006, INDIAN J MED RES, V123, P615
   Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2
   Seng Chang Moh, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P822
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sulaiman S, 2000, J VECTOR ECOL, V25, P94
   Sulaiman S, 2002, J VECTOR ECOL, V27, P230
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Tanrang Y., 2004, TROP BIOMED, V21, P57
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tewari SC, 1999, T ROY SOC TROP MED H, V93, P525, DOI 10.1016/S0035-9203(99)90365-6
   Thenmozhi V, 2005, TROP MED INT HEALTH, V10, P187, DOI 10.1111/j.1365-3156.2004.01360.x
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tsunoda T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-6
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   VYTHILINGAM I, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P102
   Vythilingam I, 2005, J AM MOSQUITO CONTR, V21, P296, DOI 10.2987/8756-971X(2005)21[296:LAFEOT]2.0.CO;2
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   WHO, 2016, EB SIT REP, P2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 123
TC 7
Z9 7
U1 0
U2 88
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 13
PY 2016
VL 7
AR 1452
DI 10.3389/fmicb.2016.01452
PG 9
WC Microbiology
SC Microbiology
GA DV5KY
UT WOS:000382967300001
PM 27679623
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Morris, JK
   Rankin, J
   Garne, E
   Loane, M
   Greenlees, R
   Addor, MC
   Arriola, L
   Barisic, I
   Bergman, JEH
   Csaky-Szunyogh, M
   Dias, C
   Draper, ES
   Gatt, M
   Khoshnood, B
   Klungsoyr, K
   Kurinczuk, JJ
   Lynch, C
   McDonnell, R
   Nelen, V
   Neville, AJ
   O'Mahony, MT
   Pierini, A
   Randrianaivo, H
   Rissmann, A
   Tucker, D
   Verellen-Dumoulin, C
   de Walle, HEK
   Wellesley, D
   Wiesel, A
   Dolk, H
AF Morris, Joan K.
   Rankin, Judith
   Garne, Ester
   Loane, Maria
   Greenlees, Ruth
   Addor, Marie-Claude
   Arriola, Larraitz
   Barisic, Ingeborg
   Bergman, Jorieke E. H.
   Csaky-Szunyogh, Melinda
   Dias, Carlos
   Draper, Elizabeth S.
   Gatt, Miriam
   Khoshnood, Babak
   Klungsoyr, Kari
   Kurinczuk, Jennifer J.
   Lynch, Catherine
   McDonnell, Robert
   Nelen, Vera
   Neville, Amanda J.
   O'Mahony, Mary T.
   Pierini, Anna
   Randrianaivo, Hanitra
   Rissmann, Anke
   Tucker, David
   Verellen-Dumoulin, Christine
   de Walle, Hermien E. K.
   Wellesley, Diana
   Wiesel, Awi
   Dolk, Helen
TI Prevalence of microcephaly in Europe: population based study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID ZIKA VIRUS-INFECTION; CONGENITAL-ANOMALIES
AB OBJECTIVES
   To provide contemporary estimates of the prevalence of microcephaly in Europe, determine if the diagnosis of microcephaly is consistent across Europe, and evaluate whether changes in prevalence would be detected using the current European surveillance performed by EUROCAT (the European Surveillance of Congenital Anomalies).
   DESIGN
   Questionnaire and population based observational study.
   SETTING
   24 EUROCAT registries covering 570 000 births annually in 15 countries.
   PARTICIPANTS
   Cases of microcephaly not associated with a genetic condition among live births, fetal deaths from 20 weeks' gestation, and terminations of pregnancy for fetal anomaly at any gestation.
   MAIN OUTCOME MEASURES
   Prevalence of microcephaly (1 Jan 2003-31 Dec 2012) analysed with random effects Poisson regression models to account for heterogeneity across registries.
   RESULTS
   16 registries responded to the questionnaire, of which 44% (7/16) used the EUROCAT definition of microcephaly (a reduction in the size of the brain with a skull circumference more than 3 SD below the mean for sex, age, and ethnic origin), 19% (3/16) used a 2 SD cut off, 31% (5/16) were reliant on the criteria used by individual clinicians, and one changed criteria between 2003 and 2012. Prevalence of microcephaly in Europe was 1.53 (95% confidence interval 1.16 to 1.96) per 10 000 births, with registries varying from 0.4 (0.2 to 0.7) to 4.3 (3.6 to 5.0) per 10 000 (X-2= 338, df= 23, I-2=93%). Registries with a 3 SD cut off reported a prevalence of 1.74 per 10 000 (0.86 to 2.93) compared with those with the less stringent 2 SD cut off of 1.21 per 10 000 (0.21 to 2.93). The prevalence of microcephaly would need to increase in one year by over 35% in Europe or by over 300% in a single registry to reach statistical significance (P<0.01).
   CONCLUSIONS
   EUROCAT could detect increases in the prevalence of microcephaly from the Zika virus of a similar magnitude to those observed in Brazil. Because of the rarity of microcephaly and discrepant diagnostic criteria, however, the smaller increases expected in Europe would probably not be detected. Clear diagnostic criteria for microcephaly must be adopted across Europe.
C1 [Morris, Joan K.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
   [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Garne, Ester] Hosp Lillebaelt, Dept Paediat, Kolding, Denmark.
   [Loane, Maria; Greenlees, Ruth; Dolk, Helen] Univ Ulster, Newtownabbey, Antrim, North Ireland.
   [Addor, Marie-Claude] Div Med Genet, Lausanne, Switzerland.
   [Arriola, Larraitz] CIBER Epidemiol & Salud Publ CIBERESP, Basque Govt, Inst BIODonostia, Publ Hlth Div Gipuzkoa, Madrid, Spain.
   [Barisic, Ingeborg] Univ Zagreb, Childrens Hosp Zagreb, Sch Med, Zagreb, Croatia.
   [Bergman, Jorieke E. H.; de Walle, Hermien E. K.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Csaky-Szunyogh, Melinda] Hungarian Congenital Abnormal Registry, Natl Publ Hlth & Med Officer Serv, Budapest, Hungary.
   [Dias, Carlos] Ctr Estudos & Registo AC, Lisbon, Portugal.
   [Draper, Elizabeth S.] Univ Leicester, Leicester, Leics, England.
   [Gatt, Miriam] Dept Hlth Informat & Res, Guardamangia, Malta.
   [Khoshnood, Babak] INSERM, Paris, France.
   [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway.
   [Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.
   [Lynch, Catherine] Hlth Serv Execut, Kilkenny, Ireland.
   [McDonnell, Robert] Hlth Serv Execut, Dublin, Ireland.
   [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium.
   [Neville, Amanda J.] Univ Ferrara, Ctr Clin & Epidemiol Res, IMER Registry, Ferrara, Italy.
   [Neville, Amanda J.] Azienda Osped Univ Ferrara, Ferrara, Italy.
   [O'Mahony, Mary T.] Hlth Serv Execut, Cork, Ireland.
   [Pierini, Anna] CNR Inst Clin Physiol, Pisa, Italy.
   [Randrianaivo, Hanitra] Registre Malformat Congenitales Reunion, St Pierre, Reunion, France.
   [Rissmann, Anke] Univ Magdeburg, Fac Med, Malformat Monitoring Ctr Saxony Anhalt, Magdeburg, Germany.
   [Tucker, David] Publ Hlth Wales, Swansea, W Glam, Wales.
   [Verellen-Dumoulin, Christine] Inst Pathol & Genet, Charleroi, Belgium.
   [Wellesley, Diana] Univ Southampton, Southampton, Hants, England.
   [Wellesley, Diana] Wessex Clin Genet Serv, Southampton, Hants, England.
   [Wiesel, Awi] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Birth Registry Mainz Model, Mainz, Germany.
RP Morris, JK (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
EM j.k.morris@qmul.ac.uk
RI Pierini, Anna/A-9622-2013; Khoshnood, Babak/N-9096-2017; Draper,
   Elizabeth S/I-6304-2018; Draper, Elizabeth/S-6874-2019; Dias,
   Carlos/I-6335-2012
OI Pierini, Anna/0000-0003-3321-9343; Draper, Elizabeth
   S/0000-0001-9340-8176; Draper, Elizabeth/0000-0001-9340-8176; Dias,
   Carlos/0000-0002-0206-5874; Morris, Joan/0000-0002-7164-612X; Klungsoyr,
   Kari/0000-0003-2482-1690; Khoshnood, Babak/0000-0002-4031-4915; Loane,
   Maria/0000-0002-1206-3637
FU European UnionEuropean Union (EU) [2008-13]
FX This study was funded by the European Union in the framework of the
   Health Programme (2008-13). The funders had no role in the study design;
   in the collection, analysis, and interpretation of data; in the writing
   of the report; and in the decision to submit the article for
   publication. Researchers were independent of the funders.
CR Bhide P, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.172080, DOI 10.2471/BLT.16.172080]
   Boyd PA, 2011, BIRTH DEFECTS RES A, V91, pS2, DOI 10.1002/bdra.20780
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   EUROCAT, 2014, EUROCAT STAT MON PRO
   EUROCAT, 2015, EUROCAT STAT MON REP
   Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157
   Loane M, 2011, BIRTH DEFECTS RES A, V91, pS23, DOI 10.1002/bdra.20779
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Springett A, 2015, AM J MED GENET A, V167, P3062, DOI 10.1002/ajmg.a.37355
   Teljeur C, 2015, EUR J EPIDEMIOL, V30, P1165, DOI 10.1007/s10654-015-0044-3
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   WHO, 2007, WHO CHILD GROWTH STA
   Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854
NR 19
TC 29
Z9 30
U1 0
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 13
PY 2016
VL 354
AR i4721
DI 10.1136/bmj.i4721
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3NG
UT WOS:000383547700006
PM 27623840
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Thayer, A
AF Thayer, Ann
TI US funds work on two Zika vaccines
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD SEP 12
PY 2016
VL 94
IS 36
BP 15
EP 15
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DW4UX
UT WOS:000383639600027
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika's emerging threat for the Asia-Pacific region
SO LANCET
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD SEP 10
PY 2016
VL 388
IS 10049
BP 1026
EP 1026
DI 10.1016/S0140-6736(16)31585-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV0OD
UT WOS:000382616900004
PM 27628509
DA 2020-07-08
ER

PT J
AU Lipsitch, M
   Cowling, BJ
AF Lipsitch, Marc
   Cowling, Benjamin J.
TI Zika vaccine trials
SO SCIENCE
LA English
DT Editorial Material
ID EBOLA
C1 [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.
   [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Collaborating Ctr Infect Dis Epidemiol & Control, WHO,Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.
RP Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.
EM mlipsitc@hsph.harvard.edu
RI Cowling, Benjamin John/C-4263-2009
OI Cowling, Benjamin John/0000-0002-6297-7154
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9
   Cohen J, 2014, SCIENCE, V346, P289, DOI 10.1126/science.346.6207.289
   Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Johansson MA, 2016, NEW ENGL J MED, V375
   Lipsitch M, 2015, SCIENCE, V348, P46, DOI 10.1126/science.aaa3178
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Rid A, 2014, VACCINE, V32, P4708, DOI 10.1016/j.vaccine.2014.04.022
   World Health Organisation (WHO), 2013, CONS GUID US ANT DRU, P1, DOI DOI 10.1017/CBO9781107415324.004
   World Health Organization, 2016, REP COMM END CHILDH, P1
NR 15
TC 7
Z9 7
U1 1
U2 121
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 9
PY 2016
VL 353
IS 6304
BP 1094
EP 1095
DI 10.1126/science.aai8126
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0RN
UT WOS:000382626800028
PM 27609872
DA 2020-07-08
ER

PT J
AU Osterholm, MT
AF Osterholm, Michael T.
TI Ebola and Zika: Cautionary tales
SO SCIENCE
LA English
DT Editorial Material
C1 [Osterholm, Michael T.] Univ Minnesota, McKnight Endowed, Minneapolis, MN 55455 USA.
   [Osterholm, Michael T.] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA.
RP Osterholm, MT (corresponding author), Univ Minnesota, McKnight Endowed, Minneapolis, MN 55455 USA.; Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA.
EM mto@umn.edu
NR 0
TC 8
Z9 8
U1 0
U2 73
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 9
PY 2016
VL 353
IS 6304
BP 1073
EP 1073
DI 10.1126/science.aai9078
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0RN
UT WOS:000382626800001
PM 27609862
OA Bronze
DA 2020-07-08
ER

PT J
AU Abbink, P
   Larocca, RA
   De La Barrera, RA
   Bricault, CA
   Moseley, ET
   Boyd, M
   Kirilova, M
   Li, ZF
   Ng'ang'a, D
   Nanayakkara, O
   Nityanandam, R
   Mercado, NB
   Borducchi, EN
   Agarwal, A
   Brinkman, AL
   Cabral, C
   Chandrashekar, A
   Giglio, PB
   Jetton, D
   Jimenez, J
   Lee, BC
   Mojta, S
   Molloy, K
   Shetty, M
   Neubauer, GH
   Stephenson, KE
   Peron, JPS
   Zanotto, PMD
   Misamore, J
   Finneyfrock, B
   Lewis, MG
   Alter, G
   Modjarrad, K
   Jarman, RG
   Eckels, KH
   Michael, NL
   Thomas, SJ
   Barouch, DH
AF Abbink, Peter
   Larocca, Rafael A.
   De La Barrera, Rafael A.
   Bricault, Christine A.
   Moseley, Edward T.
   Boyd, Michael
   Kirilova, Marinela
   Li, Zhenfeng
   Ng'ang'a, David
   Nanayakkara, Ovini
   Nityanandam, Ramya
   Mercado, Noe B.
   Borducchi, Erica N.
   Agarwal, Arshi
   Brinkman, Amanda L.
   Cabral, Crystal
   Chandrashekar, Abishek
   Giglio, Patricia B.
   Jetton, David
   Jimenez, Jessica
   Lee, Benjamin C.
   Mojta, Shanell
   Molloy, Katherine
   Shetty, Mayuri
   Neubauer, George H.
   Stephenson, Kathryn E.
   Peron, Jean Pierre S.
   Zanotto, Paolo M. de A.
   Misamore, Johnathan
   Finneyfrock, Brad
   Lewis, Mark G.
   Alter, Galit
   Modjarrad, Kayvon
   Jarman, Richard G.
   Eckels, Kenneth H.
   Michael, Nelson L.
   Thomas, Stephen J.
   Barouch, Dan H.
TI Protective efficacy of multiple vaccine platforms against Zika virus
   challenge in rhesus monkeys
SO SCIENCE
LA English
DT Article
ID INFECTION; ANTIBODIES; MICE
AB Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Here we demonstrate that three different vaccine platforms protect against ZIKV challenge in rhesus monkeys. A purified inactivated virus vaccine induced ZIKV-specific neutralizing antibodies and completely protected monkeys against ZIKV strains from both Brazil and Puerto Rico. Purified immunoglobulin from vaccinated monkeys also conferred passive protection in adoptive transfer studies. A plasmid DNA vaccine and a single-shot recombinant rhesus adenovirus serotype 52 vector vaccine, both expressing ZIKV premembrane and envelope, also elicited neutralizing antibodies and completely protected monkeys against ZIKV challenge. These data support the rapid clinical development of ZIKV vaccines for humans.
C1 [Abbink, Peter; Larocca, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [De La Barrera, Rafael A.; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil.
   [Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA.
   [Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
   [Modjarrad, Kayvon] Henry M Jackson Fdn, Bethesda, MD 20817 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Peron, Jean Pierre S/F-9248-2012; de A. Zanotto, Paolo M./B-9286-2019;
   Chandrashekar, Abishek/P-2610-2019; Barouch, Dan/Y-3918-2019
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Chandrashekar,
   Abishek/0000-0001-7821-5552; Jetton, David/0000-0002-1615-9986; Peron,
   Jean Pierre/0000-0003-1638-8866; Stephenson, Kathryn/0000-0002-3440-4105
FU U.S. Military Research and Materiel Command; U.S. Military HIV Research
   Program; Henry M. Jackson Foundation [W81XWH-11-2-0174]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI095985, AI096040,
   AI100663, AI124377]; Ragon Institute of MGH; MIT; Harvard; Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2011/18703-2, 2014/17766-9]
FX We thank J. Mascola, B. Graham, H. Marston, P. Vasconcelos, N. Collins,
   R. Olson, K. Kabra, C. Springer, G. Ballarini, N. Botero, K. Chandrika,
   G. Donofrio, M. Robb, D. Weiss, A. Cook, J. Campbell, S. Hetzel, U.
   Reimer, H. Wenschuh, T. Suscovich, C. Linde, R. Lu, L. Peter, J. Le
   Suer, P. Gandhi, M. Iampietro, K. Visitsunthorn, A. Badamchi-Zadeh, L.
   Maxfield, and F. Stephens for generous advice, assistance, and reagents.
   The data from this study are tabulated in the main paper and in the
   supplementary materials. P. A., R. A. L., D. H. B., R. G. J., K.H.E.,
   and S. J. T. are co-inventors on pending patent applications related to
   ZIKV vaccines, antigens, and vectors, and licensure discussions with
   industry partners are currently ongoing. P. A. and D. H. B. are
   cofounders and equity holders in AVVI Biotech. ZIKV challenge stocks and
   vaccine constructs are available with appropriate material transfer
   agreements. We acknowledge support from the U.S. Military Research and
   Materiel Command and the U.S. Military HIV Research Program through its
   cooperative agreement with the Henry M. Jackson Foundation
   (W81XWH-11-2-0174); the National Institutes of Health (grants AI095985,
   AI096040, AI100663, and AI124377); the Ragon Institute of MGH, MIT, and
   Harvard; and the Sao Paulo Research Foundation (FAPESP; grants
   2011/18703-2 and 2014/17766-9). The views expressed in this manuscript
   are those of the authors and do not represent the official views of the
   Department of the Army or the Department of Defense.
CR Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Demicheli V., 2000, COCHRANE DB SYST REV, V2000
   Demicheli V., 2009, COCHRANE DB SYST REV, V2009
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stephenson KE, 2015, J IMMUNOL METHODS, V416, P105, DOI 10.1016/j.jim.2014.11.006
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 30
TC 271
Z9 282
U1 3
U2 133
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 9
PY 2016
VL 353
IS 6304
BP 1129
EP 1132
DI 10.1126/science.aah6157
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0RN
UT WOS:000382626800047
PM 27492477
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI Men and women should practise safe sex for six months to avoid Zika,
   says WHO
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR WHO, 2016, PREV SEX TRANSM ZIK
NR 1
TC 0
Z9 0
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 8
PY 2016
VL 354
AR i4897
DI 10.1136/bmj.i4897
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV7FI
UT WOS:000383101300012
PM 27609128
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU van der Eijk, AA
   van Genderen, PJ
   Verdijk, RM
   Reusken, CB
   Mogling, R
   van Kampen, JJA
   Widagdo, W
   Aron, GI
   GeurtsvanKessel, CH
   Pas, SD
   Raj, VS
   Haagmans, BL
   Koopmans, MPG
AF van der Eijk, Annemiek A.
   van Genderen, Perry J.
   Verdijk, Rob M.
   Reusken, Chantal B.
   Mogling, Ramona
   van Kampen, Jeroen J. A.
   Widagdo, Widagdo
   Aron, Georgina I.
   GeurtsvanKessel, Corine H.
   Pas, Suzan D.
   Raj, V. Stalin
   Haagmans, Bart L.
   Koopmans, Marion P. G.
TI Miscarriage Associated with Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID BRAIN
C1 [van der Eijk, Annemiek A.; Verdijk, Rob M.; Reusken, Chantal B.; Mogling, Ramona; van Kampen, Jeroen J. A.; Widagdo, Widagdo; Aron, Georgina I.; GeurtsvanKessel, Corine H.; Pas, Suzan D.; Raj, V. Stalin; Haagmans, Bart L.; Koopmans, Marion P. G.] Erasmus MC, Rotterdam, Netherlands.
   [van Genderen, Perry J.] Harbour Hosp, Rotterdam, Netherlands.
RP van der Eijk, AA (corresponding author), Erasmus MC, Rotterdam, Netherlands.
EM a.vandereijk@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019; Pas, Suzan D/M-9863-2013; Raj, Victor
   Stalin/E-9670-2016
OI Koopmans, Marion/0000-0002-5204-2312; Pas, Suzan D/0000-0003-1943-1217;
   Haagmans, Bart/0000-0001-6221-2015; Verdijk, Robert
   M/0000-0003-1437-214X; Raj, Victor Stalin/0000-0003-2250-8481
CR Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 3
TC 76
Z9 76
U1 0
U2 21
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 8
PY 2016
VL 375
IS 10
BP 1002
EP 1004
DI 10.1056/NEJMc1605898
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU9IG
UT WOS:000382529500024
PM 27463941
OA Bronze
DA 2020-07-08
ER

PT J
AU Yin, YX
   Xu, Y
   Su, L
   Zhu, X
   Chen, MX
   Zhu, WJ
   Xia, HM
   Huang, X
   Gong, ST
AF Yin, Yingxian
   Xu, Yi
   Su, Ling
   Zhu, Xun
   Chen, Minxia
   Zhu, Weijin
   Xia, Huimin
   Huang, Xi
   Gong, Sitang
TI Epidemiologic investigation of a family cluster of imported ZIKV cases
   in Guangdong, China: probable human-to-human transmission
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE arbovirus; flavivirus; molecular epidemiology; Guangdong; Zika virus
ID VIRUS; ALBOPICTUS; INFECTION; MOSQUITOS; OUTBREAK; VECTOR; PCR
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that can potentially threaten South China. A Chinese family of four returning from Venezuela to China was found to be positive for ZIKV when the youngest son's fever was first detected at an airport immigration inspection. They were isolated temporarily in a local hospital in Enping city, Guangdong province, where their clinical data were recorded and urine and saliva were collected to isolate ZIKV and to obtain viral sequences. All of them except the mother presented mild symptoms of rash and fever. Envelope gene sequences from the father, daughter and son were completely identical. Phylogenetic analysis demonstrated that this strain is similar to several imported strains reported in recent months, which are all clustered into a group isolated from 2015 ZIKA outbreaks in Brazil. Together with the climatic features in Venezuela, New York and Guangdong in February, it can be concluded that our subjects are imported cases from Venezuela. With the same viral sequence being shared between family members, neither direct human-to-human nor vector transmission can be ruled out in this study, but the former seems more likely. Although our subjects had mild illness, epidemiologists and public health officials should be aware of the risk of further expansion of ZIKV transmission by local competent vectors.
C1 [Yin, Yingxian; Su, Ling] Guangzhou Med Univ, Guangzhou Inst Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Xu, Yi; Chen, Minxia; Zhu, Weijin] Guangzhou Med Univ, Dept Infect Dis, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Zhu, Xun; Huang, Xi] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China.
   [Xia, Huimin] Guangzhou Med Univ, Dept Pediat Surg, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Gong, Sitang] Guangzhou Med Univ, Dept Gastroenterol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
RP Gong, ST (corresponding author), Guangzhou Med Univ, Dept Gastroenterol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
EM sitanggong@foxmail.com
OI Yin, Yingxian/0000-0002-8685-4378
FU Science and Technology Program of Guangzhou, China [2014Y2-00197]
FX We thank Dr De Wu (Guangdong Provincial Center for Disease Control and
   Prevention, China) for helpful discussions on Zika virus isolation. This
   work was supported by a grant (2014Y2-00197) from the Science and
   Technology Program of Guangzhou, China.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004390
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Meltzer E, 2016, AM J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shakir R, 2016, LANCET NEUROL, V15, P353, DOI 10.1016/S1474-4422(16)00072-7
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 38
TC 14
Z9 18
U1 0
U2 39
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 7
PY 2016
VL 5
AR e100
DI 10.1038/emi.2016.100
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1LG
UT WOS:000383404100002
PM 27599469
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saiz, JC
   Blazquez, AB
   De Oya, NJ
   Merino-Ramos, T
   Martin-Acebes, MA
   Escribano-Romero, E
   Vazquez-Calvo, A
AF Saiz, Juan-Carlos
   Blazquez, Ana B.
   De Oya, Nereida Jimenez
   Merino-Ramos, Teresa
   Martin-Acebes, Miguel A.
   Escribano-Romero, Estela
   Vazquez-Calvo, Angela
TI Response: Commentary: Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE Zika virus (ZIKV); Guillain-Barre syndrome; Flavivirus; surveillance;
   communicable diseases
C1 [Saiz, Juan-Carlos; Blazquez, Ana B.; De Oya, Nereida Jimenez; Merino-Ramos, Teresa; Martin-Acebes, Miguel A.; Escribano-Romero, Estela; Vazquez-Calvo, Angela] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; de Oya, Nereida
   Jimenez/T-6449-2019; Escribano-Romero, Estela/H-1495-2015; Blazquez,
   Ana/G-9791-2015; Jimenez de Oya, Nereida/K-8470-2016; Vazquez-Calvo,
   Angela/G-8795-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; de Oya, Nereida
   Jimenez/0000-0003-3129-813X; Escribano-Romero,
   Estela/0000-0002-5036-7607; Blazquez, Ana/0000-0002-0847-0977; Jimenez
   de Oya, Nereida/0000-0003-3129-813X; Vazquez-Calvo,
   Angela/0000-0003-3172-2762; Saiz, Juan-Carlos/0000-0001-8269-5544
CR Blazquez A. B., WORLD J VIR IN PRESS
   Craig AT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01028
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Winner J. B., 2001, MOL PATHOL, V54, P381, DOI [10.1136/mp.54.6.381, DOI 10.1136/MP.54.6.381]
NR 11
TC 3
Z9 3
U1 0
U2 73
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 7
PY 2016
VL 7
AR 1398
DI 10.3389/fmicb.2016.01398
PG 2
WC Microbiology
SC Microbiology
GA DU9GO
UT WOS:000382524700002
PM 27656170
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zumla, A
   Alagaili, AN
   Cotten, M
   Azhar, EI
AF Zumla, Alimuddin
   Alagaili, Abdulaziz N.
   Cotten, Matthew
   Azhar, Esam I.
TI Infectious diseases epidemic threats and mass gatherings: refocusing
   global attention on the continuing spread of the Middle East Respiratory
   syndrome coronavirus (MERS-CoV)
SO BMC MEDICINE
LA English
DT Editorial Material
DE MERS-CoV; Mass gathering; Hajj; Infectious diseases; Epidemic
   transmission; Control
ID SAUDI-ARABIA; PUBLIC-HEALTH; SOUTH-KOREA; SURVEILLANCE; OUTBREAK;
   EMERGENCE; GAMES; EBOLA
AB Media and World Health Organization (WHO) attention on Zika virus transmission at the 2016 Rio Olympic Games and the 2015 Ebola virus outbreak in West Africa diverted the attention of global public health authorities from other lethal infectious diseases with epidemic potential. Mass gatherings such as the annual Hajj pilgrimage hosted by Kingdom of Saudi Arabia attract huge crowds from all continents, creating high-risk conditions for the rapid global spread of infectious diseases. The highly lethal Middle Eastern respiratory syndrome coronavirus (MERS-CoV) remains in the WHO list of top emerging diseases likely to cause major epidemics. The 2015 MERS-CoV outbreak in South Korea, in which 184 MERS cases including 33 deaths occurred in 2 months, that was imported from the Middle East by a South Korean businessman was a wake-up call for the global community to refocus attention on MERS-CoV and other emerging and re-emerging infectious diseases with epidemic potential. The international donor community and Middle Eastern countries should make available resources for, and make a serious commitment to, taking forward a "One Health" global network for proactive surveillance, rapid detection, and prevention of MERS-CoV and other epidemic infectious diseases threats.
C1 [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Alagaili, Abdulaziz N.] King Saud Univ, Coll Sci, Dept Zool, KSU Mammals Res Chair, Riyadh, Saudi Arabia.
   [Cotten, Matthew] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
   [Azhar, Esam I.] King Abdulaziz Univ, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah, Saudi Arabia.
RP Zumla, A (corresponding author), UCL, Div Infect & Immun, London, England.; Zumla, A (corresponding author), UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
EM a.zumla@ucl.ac.uk
RI ; Alagaili, Abdulaziz/C-4278-2018
OI Cotten, Matthew/0000-0002-3361-3351; Alagaili,
   Abdulaziz/0000-0002-9733-4220; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735; Azhar, Esam/0000-0002-1736-181X
CR Al Arabiya, SAUDI ARABIA BANS HA
   Arabi YM, 2016, LANCET RESP MED, V4, P93, DOI 10.1016/S2213-2600(16)00007-2
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   CDC, 2016, MIDDL E RESP SYNDR M
   Cho SY, 2016, LANCET
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163
   Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176
   Hastings DL, 2016, EMERG INFECT DIS, V22, P794, DOI 10.3201/eid2205.151797
   Hui DS, 2015, LANCET RESP MED, V3, P509, DOI 10.1016/S2213-2600(15)00238-6
   Hui DS, 2014, J INFECT DIS, V209, P173, DOI 10.1093/infdis/jit591
   Hui DS, 2016, LANCET
   Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414
   McCloskey B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2014, INT J INFECT DIS, V23, P63, DOI 10.1016/j.ijid.2014.03.1372
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004
   PHE, MERS COV PUBL HLTH I
   Reusken CBEM, 2016, CURR OPIN VIROL, V16, P55, DOI 10.1016/j.coviro.2016.01.004
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   WHO, WORLD TRAV ADV MERS
   WHO, WHO DIR GEN SUMM OUT
   WHO, MIDDL E RESP SYNDR C
   WHO, 2013, PLOS CURR, V5
   WHO, 2013, MIDD E RESP SYNDR CO
   World Health Organization, 2016, WHO PUBL LIST TOP EM
   World Health Organization, 2016, ROADM RES PROD DEV M
   World Health Organization, SEV AC RESP SYNDR SA
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
   Zumla A, 2015, INT J INFECT DIS, V37, P77, DOI 10.1016/j.ijid.2015.06.020
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
   Zumla A, 2015, LANCET RESP MED, V3, P100, DOI 10.1016/S2213-2600(14)70316-9
NR 39
TC 12
Z9 12
U1 1
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD SEP 7
PY 2016
VL 14
AR 132
DI 10.1186/s12916-016-0686-3
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV2FO
UT WOS:000382736400001
PM 27604081
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Guo, XX
   Li, CX
   Deng, YQ
   Xing, D
   Liu, QM
   Wu, Q
   Sun, AJ
   Dong, YD
   Cao, WC
   Qin, CF
   Zhao, TY
AF Guo, Xiao-xia
   Li, Chun-xiao
   Deng, Yong-qiang
   Xing, Dan
   Liu, Qin-mei
   Wu, Qun
   Sun, Ai-juan
   Dong, Yan-de
   Cao, Wu-chun
   Qin, Cheng-feng
   Zhao, Tong-yan
TI Culex pipiens quinquefasciatus: a potential vector to transmit Zika
   virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Culex pipiens quinquefasciatus; transmission; vector competence; Zika
   virus (ZIKV)
ID JAPANESE ENCEPHALITIS-VIRUS; AEDES-AEGYPTI MOSQUITOS; CHINA;
   CHIKUNGUNYA; ISOLATIONS; ALBOPICTUS; CULICIDAE; SINGAPORE; OUTBREAK;
   DIPTERA
AB Zika virus (ZIKV) has become a threat to global health since the outbreak in Brazil in 2015. Although ZIKV is generally considered an Aedes-transmitted pathogen, new evidence has shown that parts of the virus closely resemble Culex-transmitted viruses. Therefore, it is important to evaluate the competence of Culex species for ZIKV to understand their potential as vectors. In this study, female Culex pipiens quinquefasciatus were orally exposed to ZIKV. Mosquito midguts, salivary glands and ovaries were tested for ZIKV to measure infection and dissemination at 2, 4, 6, 8, 12, 16 and 18 days post exposure (pe). In addition, saliva was collected from mosquitoes after infection and infant mice were bitten by infected mosquitoes to measure the transmission ability of Cx. p. quinquefasciatus. The results showed that the peak time of virus appearance in the salivary glands was day 8 pe, with 90% infection rate and an estimated virus titer of 3.92 +/- 0.49 lg RNA copies/mL. Eight of the nine infant mice had positive brains after being bitten by infected mosquitoes, which meant that Cx. p. quinquefasciatus could be infected with and transmit ZIKV following oral infection. These laboratory results clearly demonstrate the potential role of Cx. p. quinquefasciatus as a vector of ZIKV in China. Because there are quite different vector management strategies required to control Aedes (Stegomyia) species and Cx. p. quinquefasciatus, an integrated approach may be required should a Zika epidemic occur.
C1 [Guo, Xiao-xia; Li, Chun-xiao; Xing, Dan; Liu, Qin-mei; Wu, Qun; Sun, Ai-juan; Dong, Yan-de; Zhao, Tong-yan] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Vector Biol & Control, Beijing 100071, Peoples R China.
   [Deng, Yong-qiang; Qin, Cheng-feng] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Cao, Wu-chun] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Epidemiol, Beijing 100071, Peoples R China.
RP Zhao, TY (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Vector Biol & Control, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn; tongyanzhao@126.com
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU Infective Diseases Prevention and Cure Project of China
   [2012ZX10004219]; National Key Technology Support ProgramNational Key
   Technology R&D Program [2014BAI13B01]; National Key Research and
   Development Project of China [2016YFD0500304]; Zika Prevention and
   Control Project of China
FX This work was funded by grants from the Infective Diseases Prevention
   and Cure Project of China (NO 2012ZX10004219), the National Key
   Technology Support Program (NO 2014BAI13B01), the National Key Research
   and Development Project of China (NO 2016YFD0500304) and the Zika
   Prevention and Control Project of China.
CR Azmi SA, 2015, J VECTOR DIS, V52, P252
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   He Chang-hua, 2014, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V25, P15
   Jiang SF, 2010, J MED ENTOMOL, V47, P788, DOI 10.1603/ME08292
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Lu BL, 1999, MOSQUITO INTEGRATED
   Lu BL, 1997, FAUNA SINICA INSECT, P401
   Lu Run-ze, 2016, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V27, P107
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Samuel PP, 2004, J MED ENTOMOL, V41, P442, DOI 10.1603/0022-2585-41.3.442
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Tongyan Zhao, 1995, Entomologia Sinica, V2, P1
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   Wang Xiao-hua, 2015, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V26, P424
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 108
Z9 113
U1 1
U2 35
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 7
PY 2016
VL 5
AR e102
DI 10.1038/emi.2016.102
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1LG
UT WOS:000383404100001
PM 27599470
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Onorati, M
   Li, Z
   Liu, FC
   Sousa, AMM
   Nakagawa, N
   Li, MF
   Dell'Anno, MT
   Gulden, FO
   Pochareddy, S
   Tebbenkamp, ATN
   Han, WQ
   Pletikos, M
   Gao, TLY
   Zhu, Y
   Bichsel, C
   Varela, L
   Szigeti-Buck, K
   Lisgo, S
   Zhang, YL
   Testen, A
   Gao, XB
   Mlakar, J
   Popovic, M
   Flamand, M
   Strittmatter, SM
   Kaczmarek, LK
   Anton, ES
   Horvath, TL
   Lindenbach, BD
   Sestan, N
AF Onorati, Marco
   Li, Zhen
   Liu, Fuchen
   Sousa, Andre M. M.
   Nakagawa, Naoki
   Li, Mingfeng
   Dell'Anno, Maria Teresa
   Gulden, Forrest O.
   Pochareddy, Sirisha
   Tebbenkamp, Andrew T. N.
   Han, Wenqi
   Pletikos, Mihovil
   Gao, Tianliuyun
   Zhu, Ying
   Bichsel, Candace
   Varela, Luis
   Szigeti-Buck, Klara
   Lisgo, Steven
   Zhang, Yalan
   Testen, Anze
   Gao, Xiao-Bing
   Mlakar, Jernej
   Popovic, Mara
   Flamand, Marie
   Strittmatter, Stephen M.
   Kaczmarek, Leonard K.
   Anton, E. S.
   Horvath, Tamas L.
   Lindenbach, Brett D.
   Sestan, Nenad
TI Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human
   Neuroepithelial Stem Cells and Radial Glia
SO CELL REPORTS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; BINDING KINASE 1; HUMAN BRAIN; NEURAL
   PROGENITORS; INNATE IMMUNITY; LONG-TERM; INFECTION; MICE; ORGANOIDS;
   ADAPTER
AB The mechanisms underlying Zika virus (ZIKV)-related microcephaly and other neurodevelopment defects remain poorly understood. Here, we describe the derivation and characterization, including singlecell RNA-seq, of neocortical and spinal cord neuroepithelial stem (NES) cells to model early human neurodevelopment and ZIKV-related neuropathogenesis. By analyzing human NES cells, organotypic fetal brain slices, and a ZIKV-infected micrencephalic brain, we show that ZIKV infects both neocortical and spinal NES cells as well as their fetal homolog, radial glial cells (RGCs), causing disrupted mitoses, supernumerary centrosomes, structural disorganization, and cell death. ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial sequestration of phospho-TBK1 during mitosis. We also found that nucleoside analogs inhibit ZIKV replication in NES cells, protecting them from ZIKV-induced pTBK1 relocalization and cell death. We established a model system of human neural stem cells to reveal cellular and molecular mechanisms underlying neurodevelopmental defects associated with ZIKV infection and its potential treatment.
C1 [Onorati, Marco; Li, Zhen; Liu, Fuchen; Sousa, Andre M. M.; Li, Mingfeng; Gulden, Forrest O.; Pochareddy, Sirisha; Tebbenkamp, Andrew T. N.; Han, Wenqi; Pletikos, Mihovil; Gao, Tianliuyun; Zhu, Ying; Bichsel, Candace; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.
   [Onorati, Marco; Li, Zhen; Liu, Fuchen; Sousa, Andre M. M.; Li, Mingfeng; Gulden, Forrest O.; Pochareddy, Sirisha; Tebbenkamp, Andrew T. N.; Han, Wenqi; Pletikos, Mihovil; Gao, Tianliuyun; Zhu, Ying; Bichsel, Candace; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA.
   [Nakagawa, Naoki; Testen, Anze; Anton, E. S.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.
   [Nakagawa, Naoki; Testen, Anze; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.
   [Dell'Anno, Maria Teresa; Strittmatter, Stephen M.; Sestan, Nenad] Yale Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06510 USA.
   [Dell'Anno, Maria Teresa; Strittmatter, Stephen M.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.
   [Varela, Luis; Szigeti-Buck, Klara; Gao, Xiao-Bing; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA.
   [Lisgo, Steven] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Zhang, Yalan; Kaczmarek, Leonard K.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.
   [Mlakar, Jernej; Popovic, Mara] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana 1000, Slovenia.
   [Flamand, Marie] Inst Pasteur, Dept Virol, F-75724 Paris 15, France.
   [Kaczmarek, Leonard K.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.
   [Horvath, Tamas L.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.
   [Horvath, Tamas L.] Yale Sch Med, Yale Program Integrat Cell Signaling & Neurobiol, New Haven, CT 06510 USA.
   [Lindenbach, Brett D.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA.
   [Sestan, Nenad] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.
   [Sestan, Nenad] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.
RP Horvath, TL; Sestan, N (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.; Horvath, TL; Sestan, N (corresponding author), Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA.; Horvath, TL (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.; Horvath, TL (corresponding author), Yale Sch Med, Yale Program Integrat Cell Signaling & Neurobiol, New Haven, CT 06510 USA.; Lindenbach, BD (corresponding author), Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.
EM tamas.horvath@yale.edu; brett.lindenbach@yale.edu; nenad.sestan@yale.edu
RI Gao, Tianliuyun/AAA-1237-2020; Onorati, Marco/K-3919-2018; Li,
   Zhen/J-7456-2019; Gao, Xiao-Bing/C-3121-2011; Strittmatter,
   Stephen/F-5739-2011
OI Gao, Tianliuyun/0000-0002-6261-8303; Onorati, Marco/0000-0001-8517-930X;
   Li, Zhen/0000-0002-6418-9485; Gao, Xiao-Bing/0000-0002-2035-4936; Lisgo,
   Steven/0000-0001-5186-3971; Strittmatter, Stephen/0000-0001-8188-3092
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS076503, MH103339, MH105972,
   MH106934, MH060929, NS080388, AG034924, AG047270, DC01919, AI120113,
   AI089826, HD0008836]; Simons Foundation [SFARI 307705]; Connecticut
   Innovations' Regenerative Medicine Research Fund [15-RMA-YALE-31]; Joint
   MRC/Wellcome Trust [099175/Z/12/Z]; Kavli Foundation; Falk Medical
   Research Trust; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15004, G0700089]
FX We thank Carolyn Hain for assistance with tissue acquisition and
   processing and Brian G. Rash for technical advice. We also thank
   Angeliki Louvi and Flora Vaccarino for sharing equipment and providing
   reagents and tissue samples. We thank Alain Kohl (MRC Glasgow) for
   providing us with the Brazilian ZIKV strain PE243, Scott Terhune
   (Medical College of Wisconsin) and Felicia Goodrum (University of
   Arizona) for supplying HCMV-GFP, and Avinash Phadke (Achillion
   Pharmaceuticals) for supplying samples of Sofosbuvir and
   2'-C-methyladenosine. We also thank the other members of our
   laboratories for their comments. This work was supported by grants
   NS076503, MH103339, MH105972, MH106934, MH060929, NS080388, AG034924,
   AG047270, DC01919, AI120113, and AI089826 from the NIH, SFARI 307705
   from the Simons Foundation, and 15-RMA-YALE-31 from Connecticut
   Innovations' Regenerative Medicine Research Fund. The Laboratory of
   Developmental Biology at the University of Washington, Seattle, and
   Human Developmental Biology Resource were supported by NIH award number
   HD0008836 and the Joint MRC/Wellcome Trust grant 099175/Z/12/Z,
   respectively. Additional support was provided by the Kavli Foundation
   and the Falk Medical Research Trust.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066
   Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112
   Diaz AL, 2009, CLIN PERINATOL, V36, P503, DOI 10.1016/j.clp.2009.06.008
   Edri R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7500
   Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Farlik M, 2012, MOL CELL BIOL, V32, P1032, DOI 10.1128/MCB.06021-11
   FINE JD, 1985, J AM ACAD DERMATOL, V12, P697, DOI 10.1016/S0190-9622(85)70095-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059
   Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
   Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106
   KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Marin-Padilla M, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00038
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860
   Onorati M, 2011, CELL MOL LIFE SCI, V68, P1769, DOI 10.1007/s00018-010-0548-7
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Roberts MR, 2000, J NEUROSCI, V20, P2295
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Tailor J, 2013, J NEUROSCI, V33, P12407, DOI 10.1523/JNEUROSCI.0130-13.2013
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 64
TC 130
Z9 131
U1 1
U2 70
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 6
PY 2016
VL 16
IS 10
BP 2576
EP 2592
DI 10.1016/j.celrep.2016.08.038
PG 17
WC Cell Biology
SC Cell Biology
GA DW8CH
UT WOS:000383880400005
PM 27568284
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Swannell, C
AF Swannell, Cate
TI Zika virus tentacles reach further
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD SEP 5
PY 2016
VL 205
IS 5
BP 197
EP 197
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX0FQ
UT WOS:000384037600003
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI Continued spread of Zika raises many research questions, WHO says
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Collucci C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4439
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4740
NR 2
TC 2
Z9 2
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 5
PY 2016
VL 354
AR i4812
DI 10.1136/bmj.i4812
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV7EX
UT WOS:000383100200007
PM 27596253
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Thayer, A
AF Thayer, Ann
TI Zika is boon to device makers
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD SEP 5
PY 2016
VL 94
IS 35
BP 14
EP 14
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DU7XV
UT WOS:000382428800020
DA 2020-07-08
ER

PT J
AU Cristina, J
   Fajardo, A
   Sonora, M
   Moratorio, G
   Musto, H
AF Cristina, Juan
   Fajardo, Alvaro
   Sonora, Martin
   Moratorio, Gonzalo
   Musto, Hector
TI A detailed comparative analysis of codon usage bias in Zika virus
SO VIRUS RESEARCH
LA English
DT Article
DE Zika; Codon usage; Codon bias; Evolution
ID ADAPTATION INDEX; DEOPTIMIZATION; TRANSMISSION; INFECTION; SELECTION;
   EVOLUTION
AB Zika virus (ZIKV) is a member of the family Flaviviridae and its genome consists of a single-stranded positive sense RNA molecule with 10,794 nucleotides. Clinical manifestations of disease caused by ZIKV infection range from asymptomatic cases to an influenza-like syndrome. There is an increasing concern about the possible relation among microcephaly and ZIKV infection. To get insight into the relation of codon usage among viruses and their hosts is extremely important to understand virus survival, fitness, evasion from host's immune system and evolution. In this study, we performed a comprehensive analysis of codon usage and composition of ZIKV. The overall codon usage among ZIKV strains is similar and slightly biased. Different codon preferences in ZIKV genes in relation to codon usage of human, Aedes aegypti and Aedes albopictus genes were found. Most of the highly frequent codons are A-ending, which strongly suggests that mutational bias is the main force shaping codon usage in this virus. G+C compositional constraint as well as dinucleotide composition also influence the codon usage of ZIKV. The results of these studies suggest that the emergence of ZIKV outside Africa, in the Pacific and the Americas may also be reflected in ZIKV codon usage. No significant differences were found in codon usage among strains isolated from microcephaly cases and the rest of strains from the Asian cluster enrolled in these studies. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Cristina, Juan; Fajardo, Alvaro; Sonora, Martin; Moratorio, Gonzalo] Univ La Republ, Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
   [Moratorio, Gonzalo] Inst Pasteur, CNRS UMR 3569, Viral Populat & Pathogenesis Lab, Paris, France.
   [Musto, Hector] Univ La Republ, Fac Ciencias, Inst Biol, Lab Org & Evoluc Genoma, Igua 4225, Montevideo 11400, Uruguay.
RP Cristina, J (corresponding author), Univ La Republ, Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
EM cristina@cin.edu.uy
FU Agencia Nacional de Investigacion e Innovacion (ANII)
   [PE_ALI_2009_1_1603]; FondoMariaVinas; PEDECIBA, Uruguay; Fondo Clemente
   Estable [2007_722]; Comision Sectorial de Investigacion Cientifica
   (CSIC), Universidad de la Republica, UruguayConsejo Superior de
   Investigaciones Cientificas (CSIC)
FX Authors acknowledge support by Agencia Nacional de Investigacion e
   Innovacion (ANII) through project PE_ALI_2009_1_1603, FondoMariaVinas
   and PEDECIBA, Uruguay. We also thank the support of Fondo Clemente
   Estable, 2007_722 to HM. We acknowledge Comision Sectorial de
   Investigacion Cientifica (CSIC), Universidad de la Republica, Uruguay,
   for support through Grupos I+D program.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Driggers R.W., 2016, NEW ENGL J MED
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Greenacre M.J., 1984, THEORY APPL CORRES A
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tsai CT, 2007, VIRUS RES, V126, P196, DOI 10.1016/j.virusres.2007.03.001
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Wessa P., 2012, FREE STAT SOFTWARE O
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 42
TC 18
Z9 18
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD SEP 2
PY 2016
VL 223
BP 147
EP 152
DI 10.1016/j.virusres.2016.06.022
PG 6
WC Virology
SC Virology
GA DW7JI
UT WOS:000383826600019
PM 27449601
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Major, CG
   Mayshack, M
   Medina, N
   Matos, D
   Ryff, KR
   Torres-Aponte, J
   Alkis, R
   Munoz-Jordan, J
   Colon-Sanchez, C
   Salinas, JL
   Pastula, DM
   Garcia, M
   Segarra, MO
   Malave, G
   Thomas, DL
   Rodriguez-Vega, GM
   Luciano, CA
   Sejvar, J
   Sharp, TM
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Major, Chelsea G.
   Mayshack, Marrielle
   Medina, Nicole
   Matos, Desiree
   Ryff, Kyle R.
   Torres-Aponte, Jomil
   Alkis, Rebecca
   Munoz-Jordan, Jorge
   Colon-Sanchez, Candimar
   Salinas, Jorge L.
   Pastula, Daniel M.
   Garcia, Myriam
   Segarra, Marangely Olivero
   Malave, Graciela
   Thomas, Dana L.
   Rodriguez-Vega, Gloria M.
   Luciano, Carlos A.
   Sejvar, James
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Guillain-Barre Syndrome During Ongoing Zika Virus Transmission - Puerto
   Rico, January 1-July 31, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Dirlikov, Emilio; Mayshack, Marrielle; Ryff, Kyle R.; Torres-Aponte, Jomil; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00927 USA.
   [Dirlikov, Emilio; Salinas, Jorge L.] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Major, Chelsea G.; Medina, Nicole; Matos, Desiree; Munoz-Jordan, Jorge; Colon-Sanchez, Candimar; Pastula, Daniel M.; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Major, Chelsea G.; Mayshack, Marrielle] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Alkis, Rebecca] Emory Univ, Atlanta, GA 30322 USA.
   [Pastula, Daniel M.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA.
   [Pastula, Daniel M.] Univ Colorado, Div Infect Dis, Denver, CO 80202 USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Thomas, Dana L.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Rodriguez-Vega, Gloria M.] HIMA San Pablo, Caguas, PR USA.
   [Luciano, Carlos A.] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Sejvar, James] CDC, Off Infect Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Dirlikov, E (corresponding author), Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00927 USA.; Dirlikov, E (corresponding author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
EM GBS@salud.pr.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Dirlikov,
   Emilio/0000-0003-4631-2643
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Siu R, 2016, NEUROLOGY
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 10
TC 70
Z9 71
U1 1
U2 73
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 910
EP 914
DI 10.15585/mmwr.mm6534e1
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700006
PM 27584942
OA Bronze
DA 2020-07-08
ER

PT J
AU Brooks, RB
   Carlos, MP
   Myers, RA
   White, MG
   Bobo-Lenoci, T
   Aplan, D
   Blythe, D
   Feldman, KA
AF Brooks, Richard B.
   Carlos, Maria Paz
   Myers, Robert A.
   White, Mary Grace
   Bobo-Lenoci, Tanya
   Aplan, Debra
   Blythe, David
   Feldman, Katherine A.
TI Likely Sexual Transmission of Zika Virus from a Man with No Symptoms of
   Infection - Maryland, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; EPIDEMIC
C1 [Brooks, Richard B.] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Brooks, Richard B.; Blythe, David; Feldman, Katherine A.] Maryland Dept Hlth & Mental Hyg, Prevent & Hlth Promot Adm, Baltimore, MD 21201 USA.
   [Carlos, Maria Paz; Myers, Robert A.] Maryland Dept Hlth & Mental Hyg, Labs Adm, Baltimore, MD 21201 USA.
   [White, Mary Grace; Bobo-Lenoci, Tanya] Baltimore City Dept Hlth, Baltimore, MD USA.
   [Aplan, Debra] Montgomery Cty Dept Hlth & Human Serv, Rockville, MD USA.
RP Brooks, RB (corresponding author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.; Brooks, RB (corresponding author), Maryland Dept Hlth & Mental Hyg, Prevent & Hlth Promot Adm, Baltimore, MD 21201 USA.
EM richard.brooks@maryland.gov
OI Feldman, Katherine/0000-0003-4653-8802
CR Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
NR 6
TC 66
Z9 66
U1 0
U2 21
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 915
EP 916
DI 10.15585/mmwr.mm6534e2
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700007
PM 27585037
OA Bronze
DA 2020-07-08
ER

PT J
AU Leal, MC
   Muniz, LF
   Ferreira, TSA
   Santos, CM
   Almeida, LC
   Van der Linden, V
   Ramos, RCF
   Rodrigues, LC
   Neto, SSC
AF Leal, Mariana C.
   Muniz, Lilian F.
   Ferreira, Tamires S. A.
   Santos, Cristiane M.
   Almeida, Luciana C.
   Van der Linden, Vanessa
   Ramos, Regina C. F.
   Rodrigues, Laura C.
   Caldas Neto, Silvio S.
TI Hearing Loss in Infants with Microcephaly and Evidence of Congenital
   Zika Virus Infection - Brazil, November 2015-May 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Leal, Mariana C.; Ferreira, Tamires S. A.; Santos, Cristiane M.] Hosp Agamenon Magalhaes, Recife, PE, Brazil.
   [Leal, Mariana C.; Muniz, Lilian F.; Almeida, Luciana C.; Caldas Neto, Silvio S.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Van der Linden, Vanessa] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Ramos, Regina C. F.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Leal, MC (corresponding author), Hosp Agamenon Magalhaes, Recife, PE, Brazil.; Leal, MC (corresponding author), Univ Fed Pernambuco, Recife, PE, Brazil.
EM marianacleal@hotmail.com
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Brazilian Ministry of Health, PROT MON RESP MICR O
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 10
TC 80
Z9 82
U1 0
U2 31
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 917
EP 919
DI 10.15585/mmwr.mm6534e3
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700008
PM 27585248
OA Bronze
DA 2020-07-08
ER

PT J
AU Nascimento, OJM
   Andorinho, AC
   Passos, P
   Bittar, C
   Dib, JG
   Matta, A
   Hygino, C
   Pupe, C
   Rocha, I
AF Nascimento, O. J. M.
   Andorinho, A. C.
   Passos, P.
   Bittar, C.
   Dib, J. G.
   Matta, A.
   Hygino, C.
   Pupe, C.
   Rocha, I.
TI Central nervous system demyelination associated to Zika virus outbreaks
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the
   European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis
   (ECTRIMS)
CY SEP 14-17, 2016
CL London, ENGLAND
SP European Comm Treatment & Res Multiple Sclerosis
C1 [Nascimento, O. J. M.; Andorinho, A. C.; Passos, P.; Bittar, C.; Dib, J. G.; Matta, A.; Pupe, C.; Rocha, I.] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Hygino, C.] Hosp Amer, CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD SEP
PY 2016
VL 22
SU 3
MA P807
BP 404
EP 404
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DV9NJ
UT WOS:000383267202009
DA 2020-07-08
ER

PT J
AU Schwarz, MC
   Sourisseau, M
   Espino, MM
   Gray, ES
   Chambers, MT
   Tortorella, D
   Evans, MJ
AF Schwarz, Megan C.
   Sourisseau, Marion
   Espino, Michael M.
   Gray, Essanna S.
   Chambers, Matthew T.
   Tortorella, Domenico
   Evans, Matthew J.
TI Rescue of the 1947 Zika Virus Prototype Strain with a Cytomegalovirus
   Promoter-Driven cDNA Clone
SO MSPHERE
LA English
DT Article
DE Zika virus; cell culture; flavivirus; infectious clones
ID HEPATITIS-C VIRUS; WEST-NILE-VIRUS; ENTRY
AB The recent Zika virus (ZIKV) outbreak has been linked to severe pathogenesis. Here, we report the construction of a plasmid carrying a cytomegalovirus (CMV) promoter-expressed prototype 1947 Uganda MR766 ZIKV cDNA that can initiate infection following direct plasmid DNA transfection of mammalian cells. Incorporation of a synthetic intron in the nonstructural protein 1 (NS1) region of the ZIKV polyprotein reduced viral cDNA-associated toxicity in bacteria. High levels of infectious virus were produced following transfection of the plasmid bearing the wildtype MR766 ZIKV genome, but not one with a disruption to the viral nonstructural protein 5 (NS5) polymerase active site. Multicycle growth curve and plaque assay experiments indicated that the MR766 virus resulting from plasmid transfection exhibited growth characteristics that were more similar to its parental isolate than previously published 2010 Cambodia and 2015 Brazil cDNA-rescued ZIKV. This ZIKV infectious clone will be useful for investigating the genetic determinants of ZIKV infection and pathogenesis and should be amenable to construction of diverse infectious clones expressing reporter proteins and representing a range of ZIKV isolates.
   IMPORTANCE The study of ZIKV, which has become increasingly important with the recent association of this virus with microcephaly and Guillain-Barre syndrome, would benefit from an efficient strategy to genetically manipulate the virus. This work describes a model system to produce infectious virus in cell culture. We created a plasmid carrying the prototype 1947 Uganda MR766 ZIKV genome that both was stable in bacteria and could produce high levels of infectious virus in mammalian cells through direct delivery of this DNA. Furthermore, growth properties of this rescued virus closely resembled those of the viral isolate from which it was derived. This model system will provide a simple and effective means to study how ZIKV genetics impact viral replication and pathogenesis.
C1 [Schwarz, Megan C.; Sourisseau, Marion; Espino, Michael M.; Gray, Essanna S.; Chambers, Matthew T.; Tortorella, Domenico; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM matthew.evans@mssm.edu
OI Espino, Michael/0000-0002-4319-5333
FU HHS | NIH | National Institute of Allergy and Infectious Diseases
   (NIAID) [F31AI126863, AI07647]; HHS | NIH | National Institute of
   General Medical Sciences (NIGMS)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R25GM064118]; HHS | NIH |
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [R01DK095125]; Burroughs Wellcome Fund (BWF)Burroughs Wellcome Fund;
   American Cancer Society (ACS)American Cancer Society [RSG-12-176-01-MPC]
FX This work, including the efforts of Essanna S. Gray, was funded by HHS |
   NIH | National Institute of Allergy and Infectious Diseases (NIAID)
   (F31AI126863). This work, including the efforts of Marion Sourisseau,
   was funded by HHS | NIH | National Institute of Allergy and Infectious
   Diseases (NIAID) (AI07647). This work, including the efforts of Michael
   M. Espino, was funded by HHS | NIH | National Institute of General
   Medical Sciences (NIGMS) (R25GM064118). This work, including the efforts
   of Matthew J. Evans, was funded by HHS | NIH | National Institute of
   Diabetes and Digestive and Kidney Diseases (NIDDK) (R01DK095125). This
   work, including the efforts of Matthew J. Evans, was funded by Burroughs
   Wellcome Fund (BWF). This work, including the efforts of Matthew J.
   Evans, was funded by American Cancer Society (ACS) (RSG-12-176-01-MPC).
CR Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gonzalez JM, 2002, J VIROL, V76, P4655, DOI 10.1128/JVI.76.9.4655-4661.2002
   Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100
   Hopcraft SE, 2015, HEPATOLOGY, V62, P1059, DOI 10.1002/hep.27815
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sourisseau M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003244
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793
NR 20
TC 50
Z9 50
U1 1
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD SEP-OCT
PY 2016
VL 1
IS 5
AR e00246-16
DI 10.1128/mSphere.00246-16
PG 12
WC Microbiology
SC Microbiology
GA EI6EC
UT WOS:000392586800014
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Toresdahl, BG
   Asif, IM
AF Toresdahl, Brett G.
   Asif, Irfan M.
TI Update on Zika Virus: Considerations for the Traveling Athlete
SO SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH
LA English
DT Article
DE Zika virus; infectious disease; travel medicine; Olympic athletes;
   Paralympic athletes
ID TRANSMISSION; OUTBREAK; STATES; BRAZIL; WOMEN
AB As public health experts work to contain the outbreak of Zika virus in South America and minimize the devastating prenatal complications, the international sports community prepares for the 2016 Summer Olympic and Paralympic Games in Rio de Janeiro, Brazil. Athletes have publicly expressed concern regarding the health risks of competition in Zika-endemic areas. 33 Ensuring the safety of the athletes during training and competition is the primary role of the team physician. Special consideration is needed for sports teams preparing for travel to areas affected by Zika virus.
C1 [Toresdahl, Brett G.] Hosp Special Surg, Dept Med, Primary Care Sports Med Serv, 535 E 70th St, New York, NY 10021 USA.
   [Asif, Irfan M.] Univ South Carolina, Greenville Sch Med, Greenville Hlth Syst, Dept Family Med, Greenville, SC USA.
RP Toresdahl, BG (corresponding author), Hosp Special Surg, 535 East 70th St, New York, NY 10021 USA.
EM toresdahlb@hss.edu
CR Ahmed Azam, 2016, NY TIMES
   Atkinson L, 2016, MATERN CHILD HLTH J, V20, P88, DOI 10.1007/s10995-015-1806-y
   Bases D, EXCLUSIVE US ATHLETE
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Clarke J, WHO WILL WIN SEX OLY
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wahl G, SOLO NOW WOULDNT GO
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 2
Z9 2
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1941-7381
EI 1941-0921
J9 SPORTS HEALTH
JI Sports Health
PD SEP-OCT
PY 2016
VL 8
IS 5
BP 438
EP 443
DI 10.1177/1941738116659060
PG 6
WC Sport Sciences
SC Sport Sciences
GA EG8DE
UT WOS:000391285100006
PM 27436751
OA Green Published
DA 2020-07-08
ER

PT J
AU Battersby, T
   Chmura, A
   Hao, S
   Huang, H
   Kritikos, G
   Lal, A
   Malhotra, R
   Miller, A
   Monga, D
   Mosner, J
   Patel, A
   Wagner, C
AF Battersby, T.
   Chmura, A.
   Hao, S.
   Huang, H.
   Kritikos, G.
   Lal, A.
   Malhotra, R.
   Miller, A.
   Monga, D.
   Mosner, J.
   Patel, A.
   Wagner, C.
TI Analytical performance and method comparison of the VERSANT Zika RNA 1.0
   Assay (kPCR)
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Battersby, T.; Chmura, A.; Hao, S.; Huang, H.; Kritikos, G.; Lal, A.; Malhotra, R.; Miller, A.; Monga, D.; Mosner, J.; Patel, A.; Wagner, C.] Siemens Mol Diagnost, Berkeley, CA USA.
CR Versant Z., 2016, IKA RNA 1 0 IN PRESS
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 334
BP S58
EP S59
DI 10.1016/j.jcv.2016.08.115
PG 3
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800115
OA Bronze
DA 2020-07-08
ER

PT J
AU Burdino, E
   Allice, T
   Milia, MG
   Gregori, G
   Ruggiero, T
   Calleri, G
   Lipani, F
   Lucchini, A
   Venturi, G
   Ghisetti, V
AF Burdino, E.
   Allice, T.
   Milia, M. G.
   Gregori, G.
   Ruggiero, T.
   Calleri, G.
   Lipani, F.
   Lucchini, A.
   Venturi, G.
   Ghisetti, V.
TI Appropriate diagnosis of Zika virus infection: Italy North-West
   experience
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Burdino, E.; Allice, T.; Milia, M. G.; Gregori, G.; Ruggiero, T.; Ghisetti, V.] Amedeo di Savoia Hosp, Lab Microbiol & Virol, Turin, Italy.
   [Calleri, G.] Amedeo di Savoia Hosp, Unit Infect & Trop Dis A, Turin, Italy.
   [Lipani, F.; Lucchini, A.] Amedeo di Savoia Hosp, Dept Infect Dis, Turin, Italy.
   [Venturi, G.] Ist Super Sanita, Natl Reference Lab Arboviruses, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy.
RI VENTURI, GIULIETTA/O-8123-2015
OI VENTURI, GIULIETTA/0000-0002-9078-8350
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 142
BP S55
EP S55
DI 10.1016/j.jcv.2016.08.108
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800108
DA 2020-07-08
ER

PT J
AU Kastl, L
   Bruckner, J
AF Kastl, Lena
   Brueckner, Jessica
TI RIDA (R) GENE Zika Virus: A new commercial real-time RT-PCR assay for
   sensitive and reliable detection of zika virus in urine and serum
   samples
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Kastl, Lena; Brueckner, Jessica] R Biopharm AG, Darmstadt, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 173
BP S56
EP S56
DI 10.1016/j.jcv.2016.08.110
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800110
DA 2020-07-08
ER

PT J
AU Kempster, SL
   Santirso-Margaretto, C
   Doris, K
   Almond, N
   Anderson, R
AF Kempster, Sarah L.
   Santirso-Margaretto, Cristina
   Doris, Kathryn
   Almond, Neil
   Anderson, Rob
TI External in-run controls for gastro-intestinal, respiratory infections
   and Zika virus that will improve assay standardisation
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Kempster, Sarah L.; Santirso-Margaretto, Cristina; Doris, Kathryn; Almond, Neil; Anderson, Rob] NIBSC, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 138
BP S28
EP S28
DI 10.1016/j.jcv.2016.08.054
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800054
DA 2020-07-08
ER

PT J
AU Latz, A
   Pereira, ME
   Berlie, R
AF Latz, A.
   Pereira, M. E.
   Berlie, R.
TI Increasing blood safety by diagnosing Zika, Chikungunya and Dengue in
   times of massive outbreaks
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Latz, A.; Berlie, R.] NovaTec Immundiagnost GmbH, Dietzenbach, Germany.
   [Pereira, M. E.] Siemens Healthcare GmbH, Marburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 41
BP S45
EP S45
DI 10.1016/j.jcv.2016.08.089
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800089
DA 2020-07-08
ER

PT J
AU Ze-Ze, LMM
   Alves, MJ
AF Marques Ze-Ze, Libia Maria
   Alves, Maria Joao
TI Zika virus infections imported to Portugal, the National Reference
   Laboratory experience: The importance of sample collection time lapse in
   diagnosis
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Marques Ze-Ze, Libia Maria; Alves, Maria Joao] Inst Nacl Saude Dr Ricardo Jorge, Ctr Estudos Vectores & Doencas Infecciosas, Aguas De Moura, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 81
BP S21
EP S21
DI 10.1016/j.jcv.2016.08.040
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800040
DA 2020-07-08
ER

PT J
AU Plachot, C
   Huang, C
   Vemula, R
   Wu, J
   Lee, HJ
   Anekella, B
AF Plachot, C.
   Huang, C.
   Vemula, R.
   Wu, J.
   Lee, H. J.
   Anekella, B.
TI Use of recombinant virus technology to produce non-infectious, whole
   process controls for emerging viruses such as Ebola, Chikungunya,
   Dengue-2, Norovirus GII, MERS-CoV and Zika
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Plachot, C.; Huang, C.; Vemula, R.; Wu, J.; Lee, H. J.; Anekella, B.] SeraCare Life Sci, Polson, MT USA.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 65
BP S49
EP S49
DI 10.1016/j.jcv.2016.08.096
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800096
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Rovida, F
   Campanini, G
   Percivalle, E
   Zavattoni, M
   Sarasini, A
   Arossa, A
   Clerici, P
   Grossi, PA
   Bonfanti, P
   Baldanti, F
AF Rovida, Francesca
   Campanini, Giulia
   Percivalle, Elena
   Zavattoni, Maurizio
   Sarasini, Antonella
   Arossa, Alessia
   Clerici, Pierangelo
   Grossi, Paolo Antonio
   Bonfanti, Paolo
   Baldanti, Fausto
TI Zika virus infections in travellers and contacts in Lombardy, Northern
   Italy 2016
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Rovida, Francesca; Campanini, Giulia; Percivalle, Elena; Zavattoni, Maurizio; Sarasini, Antonella; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, I-27100 Pavia, Italy.
   [Arossa, Alessia] Fdn IRCCS Policlin San Matteo, Dept Obstet & Gynecol, I-27100 Pavia, Italy.
   [Clerici, Pierangelo] Hosp Legnano, Microbiol Unit, Milan, Italy.
   [Grossi, Paolo Antonio] Univ Insubria, Infect Dis Sect, Dept Surg & Morphol Sci Clin Med, Varese, Italy.
   [Bonfanti, Paolo] Manzoni Hosp, Infect Dis Unit, Lecce, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
RI Rovida, Francesca/K-7984-2016; Bonfanti, Paolo/AAK-9800-2020;
   percivalle, elena/K-7994-2016; Baldanti, Fausto/J-4924-2018
OI Rovida, Francesca/0000-0003-2345-2790; percivalle,
   elena/0000-0002-3355-1410; Baldanti, Fausto/0000-0002-3358-8969
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 87
BP S21
EP S21
DI 10.1016/j.jcv.2016.08.039
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800039
DA 2020-07-08
ER

PT J
AU Slavov, SN
   Matsuno, AK
   de Melo, FU
   Otaguiri, KK
   Balbao, VDP
   Covas, DT
   Kashima, S
AF Slavov, Svetoslav Nanev
   Matsuno, Alessandra Kimie
   de Melo, Fernanda Ursoli
   Otaguiri, Katia Kaori
   Pasti Balbao, Viviane da Mata
   Covas, Dimas Tadeu
   Kashima, Simone
TI Preadolescent patients with atypical course of Zika virus (ZIKV)
   infection: Clinical findings and quantitative viral detection in saliva
   and plasma
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Slavov, Svetoslav Nanev; de Melo, Fernanda Ursoli; Otaguiri, Katia Kaori; Covas, Dimas Tadeu; Kashima, Simone] Univ Sao Paulo, Fac Med Ribeirao Preto, Reg Blood Ctr Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Matsuno, Alessandra Kimie; Pasti Balbao, Viviane da Mata] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pediat, BR-05508 Sao Paulo, Brazil.
RI Covas, Dimas T/C-5431-2013; N, Svetoslav/M-5416-2017; Matsuno,
   Alessandra K/H-9507-2012
OI Covas, Dimas T/0000-0002-7364-2595; Matsuno, Alessandra
   K/0000-0002-3491-1641
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 104
BP S9
EP S9
DI 10.1016/j.jcv.2016.08.017
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800017
DA 2020-07-08
ER

PT J
AU Stiasny, K
   Medits, I
   Malafa, S
   Bradt, V
   Tsouchnikas, G
   Aberle, JH
   Aberle, SW
   Heinz, FX
AF Stiasny, Karin
   Medits, Iris
   Malafa, Stefan
   Bradt, Victoria
   Tsouchnikas, Georgios
   Aberle, Judith H.
   Aberle, Stephan W.
   Heinz, Franz X.
TI Structural basis of Zika virus cross-reactivity and cross-neutralization
   with flavivirus post-infection and post-vaccination sera
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Stiasny, Karin; Medits, Iris; Malafa, Stefan; Bradt, Victoria; Tsouchnikas, Georgios; Aberle, Judith H.; Aberle, Stephan W.; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Vienna, Austria.
OI Malafa, Stefan/0000-0002-0222-9832
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 350
BP S20
EP S20
DI 10.1016/j.jcv.2016.08.038
PG 1
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800038
DA 2020-07-08
ER

PT J
AU Tan, SK
   Soh, A
   Luo, R
   Lee, C
   Huang, W
   Michel, G
AF Tan, S. K.
   Soh, A.
   Luo, R.
   Lee, C.
   Huang, W.
   Michel, G.
TI Qualitative detection of Zika virus RNA with the Sentosa (R) SA ZIKV
   RT-PCR test
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the European-Society-for-Clinical-Virology
CY SEP 14-17, 2016
CL Lisbon, PORTUGAL
SP European Soc Clin Virol
C1 [Tan, S. K.; Soh, A.; Luo, R.; Lee, C.; Huang, W.; Michel, G.] Vela Res Pte Ltd, Singapore, Singapore.
RI tan, tskeat2008/A-3787-2011
OI tan, tskeat2008/0000-0003-1371-9586
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
SU S
MA 234
BP S36
EP S37
DI 10.1016/j.jcv.2016.08.072
PG 3
WC Virology
SC Virology
GA EF8NC
UT WOS:000390584800072
DA 2020-07-08
ER

PT J
AU Goo, L
   Dowd, KA
   Smith, ARY
   Pelc, RS
   DeMaso, CR
   Pierson, TC
AF Goo, Leslie
   Dowd, Kimberly A.
   Smith, Alexander R. Y.
   Pelc, Rebecca S.
   DeMaso, Christina R.
   Pierson, Theodore C.
TI Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared
   to Other Flaviviruses
SO MBIO
LA English
DT Article
ID TRANSMISSION; OUTBREAK; BRAZIL
AB Zika virus (ZIKV) is a flavivirus that has emerged as a global health threat due in part to its association with congenital abnormalities. Other globally relevant flaviviruses include dengue virus (DENV) and West Nile virus (WNV). High-resolution structures of ZIKV reveal many similarities to DENV and suggest some differences, including an extended glycan loop (D. Sirohi, Z. Chen, L. Sun, T. Klose, T. C. Pierson, et al., 352:467-470, 2016, http://dx.doi.org/10.1126/science.aaf5316) and unique interactions among envelope (E) protein residues that were proposed to confer increased virion stability and contribute mechanistically to the distinctive pathobiology of ZIKV (V. A. Kostyuchenko, E. X. Lim, S. Zhang, G. Fibriansah, T. S. Ng, et al., Nature 533: 425-428, 2016, http://dx.doi.org/10.1038/nature17994). However, in the latter study, virus stability was inferred by measuring the loss of infectivity following a short incubation period. Here, we rigorously assessed the relative stability of ZIKV, DENV, and WNV by measuring changes in infectivity following prolonged incubation at physiological temperatures. At 37 degrees C, the half-life of ZIKV was approximately twice as long as the half-life of DENV (11.8 and 5.2 h, respectively) but shorter than that of WNV (17.7 h). Incubation at 40 degrees C accelerated the loss of ZIKV infectivity. Increasing virion maturation efficiency modestly increased ZIKV stability, as observed previously with WNV and DENV. Finally, mutations at E residues predicted to confer increased stability to ZIKV did not affect virion half-life. Our results demonstrate that ZIKV is not uniquely stable relative to other flaviviruses, suggesting that its unique pathobiology is explained by an alternative mechanism.
   IMPORTANCE Zika virus (ZIKV) belongs to the Flavivirus genus, which includes other clinically relevant mosquito-borne pathogens such as dengue virus (DENV) and West Nile virus (WNV). Historically, ZIKV infection was characterized by a self-limiting, mild disease, but recent outbreaks have been associated with severe clinical complications, including Guillain-Barre syndrome and microcephaly, which are atypical of other flavivirus infections. Moreover, ZIKV has been detected in saliva, urine, and semen, and it may be sexually transmitted. Analysis of a high-resolution cryo-electron microscopic reconstruction of ZIKV hypothesized that the unusual stability of this virus contributes to its distinctive pathobiology. Here, we directly compared the stability of ZIKV to that of other flaviviruses following prolonged incubation in solution at physiological temperatures. We found that the stability of multiple ZIKV strains, including those from recent outbreaks, is intermediate between that of DENV and WNV, suggesting an alternative explanation for the unique clinical manifestations of ZIKV infection.
C1 [Goo, Leslie; Dowd, Kimberly A.; Smith, Alexander R. Y.; Pelc, Rebecca S.; DeMaso, Christina R.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
OI Pelc, Rebecca/0000-0001-5080-4945
FU Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases (DIR, NIAID)
FX This work, including the efforts of Leslie Goo, Kimberly A Dowd,
   Alexander R.Y. Smith, Rebecca S. Pelc, Christina R DeMaso, and Theodore
   C. Pierson, was funded by the Division of Intramural Research, National
   Institute of Allergy and Infectious Diseases (DIR, NIAID).
CR Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   MANNING JS, 1979, J CLIN MICROBIOL, V10, P235, DOI 10.1128/JCM.10.2.235-239.1979
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 25
TC 21
Z9 21
U1 1
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2016
VL 7
IS 5
AR e01396-16
DI 10.1128/mBio.01396-16
PG 4
WC Microbiology
SC Microbiology
GA EF2CU
UT WOS:000390132900022
PM 27601578
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pettersson, JHO
   Eldholm, V
   Seligman, SJ
   Lundkvist, A
   Falconar, AK
   Gaunt, MW
   Musso, D
   Nougairede, A
   Charrel, R
   Gould, EA
   de Lamballerie, X
AF Pettersson, John H. -O.
   Eldholm, Vegard
   Seligman, Stephen J.
   Lundkvist, Ake
   Falconar, Andrew K.
   Gaunt, Michael W.
   Musso, Didier
   Nougairede, Antoine
   Charrel, Remi
   Gould, Ernest A.
   de Lamballerie, Xavier
TI How Did Zika Virus Emerge in the Pacific Islands and Latin America?
SO MBIO
LA English
DT Article
ID DENGUE VIRUS; TRANSMISSION
AB The unexpected emergence of Zika virus (ZIKV) in the Pacific Islands and Latin America and its association with congenital Zika virus syndrome (CZVS) (which includes microcephaly) and Guillain-Barre syndrome (GBS) have stimulated wide-ranging research. High densities of susceptible Aedes spp., immunologically naive human populations, global population growth with increased urbanization, and escalation of global transportation of humans and commercial goods carrying vectors and ZIKV undoubtedly enhanced the emergence of ZIKV. However, flavivirus mutations accumulate with time, increasing the likelihood that genetic viral differences are determinants of change in viral phenotype. Based on comparative ZIKV complete genome phylogenetic analyses and temporal estimates, we identify amino acid substitutions that may be associated with increased viral epidemicity, CZVS, and GBS. Reverse genetics, vector competence, and seroepidemiological studies will test our hypothesis that these amino acid substitutions are determinants of epidemic and neurotropic ZIKV emergence.
C1 [Pettersson, John H. -O.; Eldholm, Vegard] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Infect Dis Epidemiol & Modelling Mol Biol, Oslo, Norway.
   [Pettersson, John H. -O.; Lundkvist, Ake] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
   [Seligman, Stephen J.] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Seligman, Stephen J.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilia, Colombia.
   [Gaunt, Michael W.] London Sch Hyg & Trop Med, London, England.
   [Musso, Didier] Inst Louis Malarde, Pole Rech Veilie Malad Infect Emergentes, Tahiti, France.
   [Nougairede, Antoine; Charrel, Remi; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, UMR Emergence Pathol Virales EPV, INSERM 1207, IRA 190,EHESP, Marseille, France.
   [Nougairede, Antoine; Charrel, Remi; de Lamballerie, Xavier] Inst Hosp Univ Mediterranee Infect, APHM Publ Hosp Marseille, Marseille, France.
RP Gould, EA (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales EPV, INSERM 1207, IRA 190,EHESP, Marseille, France.
EM eag@ceh.ac.uk
RI Musso, Didier/P-7809-2016; Eldholm, Vegard/I-4680-2019; Musso,
   Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Eldholm, Vegard/0000-0001-6721-3375;
   Musso, Didier/0000-0002-9226-0971; Pettersson, John
   H.-O./0000-0001-6665-7492
FU EU FP7 Project PREDEMICSEuropean Union (EU) [278433]; EU Horizon 2020
   Project EVAg [653316]
FX This study was partly funded under the EU FP7 Project PREDEMICS (grant
   agreement no. 278433) and the EU Horizon 2020 Project EVAg (grant
   agreement no. 653316).
CR Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erb SM, 2010, VIROLOGY, V406, P328, DOI 10.1016/j.virol.2010.07.024
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Ke RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003193
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Malakoutikhah M, 2011, ANGEW CHEM INT EDIT, V50, P7998, DOI 10.1002/anie.201006565
   Miller MA, 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 72
Z9 74
U1 1
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2016
VL 7
IS 5
AR e01239-16
DI 10.1128/mBio.01239-16
PG 6
WC Microbiology
SC Microbiology
GA EF2CU
UT WOS:000390132900056
PM 27729507
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Ebiasah, RP
   Sise, TK
   Wildman, M
AF Ebiasah, Ruth P.
   Sise, Thucuma K.
   Wildman, Michelle
TI Zika Virus and Its Effects in Pregnancy
SO US PHARMACIST
LA English
DT Article
AB Recently, a major outbreak of Zika virus occurred in several countries in South and Central America and the Caribbean. The World Health Organization estimated that more than 3 million cases of Zika infection would occur in the Americas in 2016, spurring the global community to develop preventive and supportive strategies. Recognizing the signs and symptoms of Zika infection, performing diagnostic tests based on current knowledge, successfully implementing preventive measures, and further evaluating the effects of Zika virus in pregnancy are of chief importance in response to the outbreak. The pharmacist's role in patient counseling and education and the pharmacy technician's role in symptom identification are essential for successfully managing the current outbreak and curbing further spread to the most vulnerable populations, including pregnant women.
C1 [Ebiasah, Ruth P.; Sise, Thucuma K.; Wildman, Michelle] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Ebiasah, RP (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD SEP
PY 2016
VL 41
IS 9
BP 48
EP 56
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EF1XF
UT WOS:000390117700020
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika Alerts Increasing Abortion Requests?
SO US PHARMACIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD SEP
PY 2016
VL 41
IS 9
BP HS12
EP HS12
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EF1XF
UT WOS:000390117700010
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Blood donation and Zika virus
SO Lancet Haematology
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-3026
J9 LANCET HAEMATOL
JI Lancet Haematol.
PD SEP
PY 2016
VL 3
IS 9
BP E398
EP E398
DI 10.1016/S2352-3026(16)30113-2
PG 1
WC Hematology
SC Hematology
GA ED7SJ
UT WOS:000389070200001
PM 27570082
DA 2020-07-08
ER

PT J
AU Ashfaq, UA
   Ahmed, B
AF Ashfaq, Usman Ali
   Ahmed, Bilal
TI De Novo Structural Modeling and Conserved Epitopes Prediction of Zika
   Virus Envelop Protein for Vaccine Development
SO VIRAL IMMUNOLOGY
LA English
DT Article
ID SERVER; IMMUNOINFORMATICS; TRANSMISSION
AB Zika virus (Zika V) is a positive single-stranded RNA virus that is transmitted by mosquito bites. Zika V Envelop protein is antigenic and is involved in fusion and entry of viral particles into the cell. Till date, there is no vaccine and antiviral drug available against Zika V. Thus, there is a need to develop a vaccine against Zika V. This study was designed for the prediction of B cell and T cell epitopes that can be helpful in diagnosis and vaccine designing against this emerging threat. For this purpose, several B cell and T cell epitopes were predicted that are conserved among Zika virus genomes taken from 12 different countries. Peptides QTLTPVGRL, in case of major histocompatibility complex (MHC) class I, and IRCIGVSNRDFV, in case ofMHC class II, are highly antigenic among T cell epitopes. Molecular docking was performed to study the interactions of B cell epitopes with HLA-B7. However, these predicted epitopes could play a constructive role in designing of a vaccine against Zika V.
C1 [Ashfaq, Usman Ali; Ahmed, Bilal] GCUF, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan.
RP Ashfaq, UA (corresponding author), GCUF, Dept Bioinformat & Biotechnol, Hlth Biotechnol Lab, Faisalabad 53600, Pakistan.
EM usmancemb@gmail.com
RI Ashfaq, Usman Ali/AAH-7649-2019
OI Ashfaq, Usman Ali/0000-0002-5495-805X
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gasteiger E., 2015, PROTEOMICS PROTOCOLS, P571
   Hasan MA, 2015, MOL IMMUNOL, V65, P189, DOI [10.1016/j.mol, 10.1016/j.molimm.2014.12.013]
   Idrees S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-113
   JACOB CO, 1985, EMBO J, V4, P3339, DOI 10.1002/j.1460-2075.1985.tb04086.x
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   M. Chemical Computing Group, 2008, MOL OPERATING ENV
   Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
   Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254
NR 22
TC 11
Z9 12
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD SEP
PY 2016
VL 29
IS 7
BP 436
EP 443
DI 10.1089/vim.2016.0033
PG 8
WC Immunology; Virology
SC Immunology; Virology
GA DW4GN
UT WOS:000383601100009
PM 27438351
DA 2020-07-08
ER

PT J
AU Sukumaran, D
AF Sukumaran, D.
TI A review on use of attractants and traps for host seeking Aedes aegypti
   mosquitoes
SO INDIAN JOURNAL OF NATURAL PRODUCTS AND RESOURCES
LA English
DT Review
DE Aedes; Attractants; Surveillance; Traps; Virus; Zika
ID HUMAN SKIN EMANATIONS; L-LACTIC ACID; YELLOW-FEVER MOSQUITO;
   TSETSE-FLIES DIPTERA; VECTOR ANOPHELES-GAMBIAE; PHLEBOTOMINE SAND FLIES;
   SENSU-STRICTO DIPTERA; ODOR-BAITED TARGETS; CARBON-DIOXIDE; ZIKA VIRUS
AB Arthropod vectors like mosquitoes and other blood sucking insects transmit diseases such as malaria, dengue, chikungunya, zika vius. Among the vectors, Aedes aegypti and Ae. albopictus are medically important since they cause huge numbers of morbidity and mortality to human beings. Many blood feeding arthropod vectors locate their hosts using vision and primarily through olfactory cues including carbon dioxide (CO2), lactic acid, ammonia, and carboxylic acids. Release of CO2 from commercial cylinders and dry ice enhances efficiency of the traps. Different traps have been developed to trap mosquitoes and other vectors. They were found effective when attractants were added to CO2. Understanding the cues and synergism of attractants on peripheral olfactory system of mosquitoes, may lead to identification of newer molecules with improved efficiency for host seeking mosquitoes and will be useful for natural control of vectors transmitting dengue and other diseases.
C1 [Sukumaran, D.] Def Res & Dev Estab, Vector Management Div, Jhansi Rd, Gwalior 474002, Madhya Pradesh, India.
RP Sukumaran, D (corresponding author), Def Res & Dev Estab, Vector Management Div, Jhansi Rd, Gwalior 474002, Madhya Pradesh, India.
EM sukumarand@drde.drdo.in
RI SUKUMARAN, DEVANATHAN/L-6343-2019
CR ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346
   AITKEN THG, 1959, AM J TROP MED HYG, V8, P41, DOI 10.4269/ajtmh.1959.8.41
   Alencar CHM, 2008, REV APS, V11, P459
   Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x
   ALLSOPP R, 1984, B ENTOMOL RES, V74, P1, DOI 10.1017/S0007485300009895
   [Anonymous], 2016, CURR BIOL, V26, pR41
   Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2
   Bernier UR, 2003, J MED ENTOMOL, V40, P653, DOI 10.1603/0022-2585-40.5.653
   Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v
   Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k
   Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042
   Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8
   Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748
   Braks MAH, 2001, PHYSIOL ENTOMOL, V26, P142, DOI 10.1046/j.1365-3032.2001.00227.x
   Burkett DA, 2001, J AM MOSQUITO CONTR, V17, P196
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834
   Clements AN, 1999, BIOL MOSQUITOES, VII
   Cooperband MF, 2006, MED VET ENTOMOL, V20, P1, DOI 10.1111/j.1365-2915.2006.00614.x
   Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x
   Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736
   Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EIRAS AE, 1994, B ENTOMOL RES, V84, P207, DOI 10.1017/S0007485300039705
   Empresa Brasil de Comunicacao S/A - EBC Agencia Brasil, 2015, PRIM CAS ZIK VIR CON
   Faiman R, 2009, J VECTOR ECOL, V34, P114, DOI 10.1111/j.1948-7134.2009.00014.x
   de Azara TMF, 2013, MEM I OSWALDO CRUZ, V108, P229, DOI 10.1590/0074-0276108022013016
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647
   Geier M, 1996, CIBA F SYMP, V200, P132
   GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811
   GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   GUBLER DJ, 1988, ARBOVIRUSES EPIDEMIO, V2, P223
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101
   Hiwat H, 2011, J MED ENTOMOL, V48, P1039, DOI 10.1603/ME10245
   HOY JB, 1970, J ECON ENTOMOL, V63, P792, DOI 10.1093/jee/63.3.792
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676
   JORDAN AM, 1995, J AM MOSQUITO CONTR, V11, P249
   Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2
   Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2
   Kline DL, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/11-6200R.1
   Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463
   Kline DL, 1998, J VECTOR ECOL, V23, P171
   Kline DL, 2002, J VECTOR ECOL, V27, P1
   Lacey ES, 2014, PHYSIOL ENTOMOL, V39, P60, DOI 10.1111/phen.12048
   Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0
   Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   Moncaz A, 2013, ACTA TROP, V126, P205, DOI 10.1016/j.actatropica.2013.02.024
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   MULHERN TD, 1985, J AM MOSQUITO CONTR, V1, P411
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Obenauer PJ, 2013, J MED ENTOMOL, V50, P863, DOI 10.1603/ME12174
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   Ortiz DI, 2008, J MED ENTOMOL, V45, P1117, DOI 10.1603/0022-2585(2008)45[1117:SOAADC]2.0.CO;2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Portal da Saude-Ministerio da Saude (Internet), 2015, CONF ZIK VIR BRAS
   Puri SN, 2006, J MED ENTOMOL, V43, P207, DOI 10.1603/0022-2585(2006)043[0207:EABROC]2.0.CO;2
   Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x
   Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2
   REEVES WC, 1951, P SOC EXP BIOL MED, V77, P64, DOI 10.3181/00379727-77-18679
   REEVES WC, 1953, AM J TROP MED HYG, V2, P325, DOI 10.4269/ajtmh.1953.2.325
   Revay EE, 2013, ACTA TROP, V127, P63, DOI 10.1016/j.actatropica.2013.03.011
   Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Rudolfs W, 1922, B N J AGR EXP STN, V367, P23
   Rupp H. R, 1969, Proc. New Jers. Mosq. Exterm. Ass., V56, P183
   Savioli L, 2014, E MEDITERR HEALTH J, V20, P217
   Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230
   SCHRECK CE, 1990, J AM MOSQUITO CONTR, V6, P406
   SCHRECK CE, 1982, J CHEM ECOL, V8, P429, DOI 10.1007/BF00987791
   Seenivasagan T, 2014, PARASITOL RES, V113, P1927, DOI 10.1007/s00436-014-3840-x
   Seenivasagan T, 2010, VITAM HORM, V83, P597, DOI 10.1016/S0083-6729(10)83024-9
   Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075
   Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010
   Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015
   Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7
   SMITH CN, 1970, ANN ENTOMOL SOC AM, V63, P760, DOI 10.1093/aesa/63.3.760
   Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523
   SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126
   Sukumaran D, 2016, PARASITOL RES, V115, P1453, DOI 10.1007/s00436-015-4879-z
   TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311
   TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747
   Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131
   Takken W, 2010, MALARIA J, V9, P116
   TORR SJ, 1994, J AM MOSQUITO CONTR, V10, P258
   VALE GA, 1993, J MED ENTOMOL, V30, P831, DOI 10.1093/jmedent/30.5.831
   VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059
   VALE GA, 1986, B ENTOMOL RES, V76, P179, DOI 10.1017/S000748530001467X
   van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28
   Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107
   WHO, 2011, WORLD MALARIA REPORT 2011, P1
   WHO, 2006, SEX HLTH DOC SER, P1, DOI DOI 10.1177/000331975400500201
   WHO, JOINT PUBL WHO WHO S
   WILLEMSE L, 1991, B ENTOMOL RES, V81, P351, DOI 10.1017/S0007485300033630
   Willey J.M., 2009, PRESCOTTS PRINCIPLES
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Helth Organization, GLOB STRAT DENG PREV
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 115
TC 6
Z9 6
U1 2
U2 22
PU NATL INST SCIENCE COMMUNICATION & INFORMATION RESOURCES-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI, 110 012, INDIA
SN 0976-0504
EI 0976-0512
J9 INDIAN J NAT PROD RE
JI Indian J. Nat. Prod. Resour.
PD SEP
PY 2016
VL 7
IS 3
BP 207
EP 214
PG 8
WC Plant Sciences
SC Plant Sciences
GA ED7MC
UT WOS:000389048600003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Knope, KE
   Muller, M
   Kurucz, N
   Doggett, SL
   Feldman, R
   Johansen, CA
   Hobby, M
   Bennett, S
   Lynch, S
   Sly, A
   Currie, BJ
AF Knope, Katrina E.
   Muller, Mike
   Kurucz, Nina
   Doggett, Stephen L.
   Feldman, Rebecca
   Johansen, Cheryl A.
   Hobby, Michaela
   Bennett, Sonya
   Lynch, Stacey
   Sly, Angus
   Currie, Bart J.
CA Natl Arbovirus Malaria Advisory Co
TI ARBOVIRAL DISEASES AND MALARIA IN AUSTRALIA, 2013-14: ANNUAL REPORT OF
   THE NATIONAL ARBOVIRUS AND MALARIA ADVISORY COMMITTEE
SO COMMUNICABLE DISEASES INTELLIGENCE
LA English
DT Article
DE arbovirus; Barmah Forest virus; chikungunya; dengue; disease
   surveillance; epidemiology; flavivirus; Kunjin virus; Japanese
   encephalitis; West Nile virus; malaria; mosquito-borne; mosquitoes;
   Murray Valley encephalitis virus; Ross River virus; yellow fever; West
   Nile virus
ID ZIKA VIRUS; DENGUE; OUTBREAK; BRAZIL; TRANSMISSION; ENCEPHALITIS;
   CHIKUNGUNYA; SALVADOR
AB This report describes the epidemiology of mosquito-borne diseases of public health importance in Australia during the 2013-14 season (1 July 2013 to 30 June 2014) and includes data from human notifications, sentinel chicken, vector and virus surveillance programs. The National Notifiable Diseases Surveillance System received notifications for 8,898 cases of disease transmitted by mosquitoes during the 2013-14 season. The Australasian alphaviruses Barmah Forest virus and Ross River virus accounted for 6,372 (72%) total notifications. However, over-diagnosis and possible false positive diagnostic test results for these 2 infections mean that the true burden of infection is likely overestimated, and as a consequence, the case definitions have been amended. There were 94 notifications of imported chikungunya virus infection and 13 cases of imported Zika virus infection. There were 212 notifications of dengue virus infection acquired in Australia and 1,795 cases acquired overseas, with an additional 14 cases for which the place of acquisition was unknown. Imported cases of dengue were most frequently acquired in Indonesia (51%). No cases of locally-acquired malaria were notified during the 2013-14 season, though there were 373 notifications of overseas-acquired malaria. In 2013-14, arbovirus and mosquito surveillance programs were conducted in most jurisdictions. Surveillance for exotic mosquitoes at international ports of entry continues to be a vital part of preventing the spread of vectors of mosquito-borne diseases such as dengue to new areas of Australia, with 13 detections of exotic mosquitoes at the ports of entry in 2013-14.
C1 [Knope, Katrina E.] Dept Hlth, Off Hlth Protect, Hlth Protect Policy Branch, Zoonoses Foodborne & Emerging Infect Dis Sect, Canberra, ACT, Australia.
   [Muller, Mike] Brisbane City Council Mosquito Management, Fortitude Valley, Qld, Australia.
   [Kurucz, Nina] Royal Darwin Hosp, Northern Terr Dept Hlth, Ctr Dis Control, Hlth Protect Div,Med Entomol, Casuarina, NT, Australia.
   [Doggett, Stephen L.] Westmead Hosp, Inst Clin Pathol & Med Res, Pathol West, Dept Med Entomol, Westmead, NSW, Australia.
   [Feldman, Rebecca] Dept Hlth, Commun Dis Prevent & Control, Melbourne, Vic, Australia.
   [Johansen, Cheryl A.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Pathol & Lab Med, Arbovirus Surveillance & Res Lab, Nedlands, WA, Australia.
   [Johansen, Cheryl A.] Western Australian Dept Hlth, QEII Med Ctr, PathWest Lab Med WA, Div Microbiol & Infect Dis, Nedlands, WA, Australia.
   [Hobby, Michaela] South Australian Dept Hlth, Hlth Protect, Publ Hlth, Adelaide, SA, Australia.
   [Bennett, Sonya] Queensland Hlth, Dept Hlth, Commun Dis Branch, Herston, Qld, Australia.
   [Lynch, Stacey] AgriBio Ctr, Dept Econ Dev, Bundoora, Vic, Australia.
   [Sly, Angus] Dept Agr & Water Resources, Compliance Div, Operat Sci Serv, Eagle Farm, Qld, Australia.
   [Currie, Bart J.] Royal Darwin Hosp Northern Terr, Darwin, NT, Australia.
   [Currie, Bart J.] Menzies Sch Hlth Res, Darwin, NT, Australia.
RP Knope, KE (corresponding author), Australian Govt Dept Hlth, Off Hlth Protect, Hlth Emergency Management Branch, Knope Zoonoses Foodborne & Emerging Infect Dis Se, MDP 14,GPO Box 9848, Canberra, ACT 2601, Australia.
EM Katrina.Knope@health.gov.au
RI Johansen, Cheryl A/A-2208-2009
CR [Anonymous], 2013, AUSTR IMM HDB
   Broom A K, 2001, Commun Dis Intell Q Rep, V25, P157
   Broom Annette K, 2003, Commun Dis Intell Q Rep, V27, P367
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Case Definitions Working Group, 2015, COMMUN DIS INTELL, V39, pE599
   CHIANG CL, 1962, AM J HYG, V75, P377, DOI 10.1093/oxfordjournals.aje.a120259
   Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888
   Doggett S, 2004, NEW S WALES ARBOVIRU
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FORBES JA, 1978, MURRAY VALLEY ENCEPH
   Gray TJ, 2011, AM J TROP MED HYG, V85, P952, DOI 10.4269/ajtmh.2011.11-0165
   HALL RA, 1995, J VIROL METHODS, V51, P201, DOI 10.1016/0166-0934(94)00105-P
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P198
   Hanna JN, 2004, MED J AUSTRALIA, V180, P24, DOI 10.5694/j.1326-5377.2004.tb05769.x
   Harrington S, 2009, CHRISTMAS ISLAND COC
   Heymann DL, 2008, CONTROL COMMUNICABLE
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Johansen C., 2013, U W AUSTR ARBOVIRUS
   Johansen C, 2013, U W AUSTR ARBOVIRUS
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lindsay MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004114
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Ministerio da Saude, 2015, CONF ZIK VIR BRAS
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NICHOLLS N, 1986, AUST J EXP BIOL MED, V64, P587, DOI 10.1038/icb.1986.62
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parida MM, 2008, FUTURE VIROL, V3, P179, DOI 10.2217/17460794.3.2.179
   Queensland Health, 2011, QUEENSL DENG MAN PLA
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rich G., 1993, Communicable Diseases Intelligence, V17, P208
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   SAMMELS LM, 1995, VIROLOGY, V212, P20, DOI 10.1006/viro.1995.1449
   Selvey LA, 2014, COMMUN DIS INTELL, V38, pE114
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Sloan-Gardner T, 2016, COMMUN DIS INTELL, V40, pE48
   Souares Y, 2000, Pac Health Dialog, V7, P11
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   World Health Organization, WORLD MAL REP 2015
NR 43
TC 8
Z9 8
U1 0
U2 7
PU AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING
PI CANBERRA
PA OFFICE HEALTH PROTECTION SURVEILLANCE BRANCH, GPO BOX 9848, CANBERRA,
   ACT 2601, AUSTRALIA
SN 0725-3141
EI 1445-4866
J9 COMMUN DIS INTELL
JI Commun. Dis. Intell.
PD SEP
PY 2016
VL 40
IS 3
BP E401
EP E436
PG 36
WC Infectious Diseases
SC Infectious Diseases
GA ED0NF
UT WOS:000388538500014
DA 2020-07-08
ER

PT J
AU Barzon, L
   Trevisan, M
   Sinigaglia, A
   Lavezzo, E
   Palu, G
AF Barzon, Luisa
   Trevisan, Marta
   Sinigaglia, Alessandro
   Lavezzo, Enrico
   Palu, Giorgio
TI Zika virus: from pathogenesis to disease control
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE Zika virus; pathogenesis; transmission; clinical features; diagnosis;
   vaccines; antiviral drugs
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; REVERSE
   TRANSCRIPTION-PCR; MALE SEXUAL TRANSMISSION; UPDATE INTERIM GUIDANCE;
   DENGUE VIRUS; FRENCH-POLYNESIA; VERTICAL TRANSMISSION; NEURAL
   PROGENITORS; CRYSTAL-STRUCTURE
AB Zika virus is a mosquito-borne flavivirus discovered in Uganda in 1947. The virus has emerged in recent years and spread in the Pacific Area and the Americas, where it has caused large human outbreaks. The factors involved in the virus's emergence are still unknown, but probably include its introduction in naive environments characterised by the presence of high densities of competent Aedes spp. mosquitoes and susceptible human hosts in urban areas. Unique features of Zika virus infection are sexual and transplacental transmission and associated neurological morbidities, i.e. Guillain-Barre syndrome and fetal microcephaly. Diagnosis relies on the detection of viral nucleic acids in biological samples, while detection of a specific antibody response may be inconclusive because of the broad cross-reactivity of antibodies among flaviviruses. Experimental studies have clarified some mechanisms of Zika virus pathogenesis and have identified potential targets for antiviral drugs. In animal models, the virus can infect and efficiently replicate in the placenta and in the brain, and induce fetal demise or neural damage, recapitulating human diseases. These animal models have been used to evaluate candidate vaccines and promising results have been obtained.
C1 [Barzon, Luisa; Trevisan, Marta; Sinigaglia, Alessandro; Lavezzo, Enrico; Palu, Giorgio] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016; Lavezzo, Enrico/K-7962-2016; TREVISAN,
   MARTA/K-6591-2016
OI Barzon, Luisa/0000-0003-0720-8456; Lavezzo, Enrico/0000-0002-3902-8356;
   TREVISAN, MARTA/0000-0002-3148-7240; sinigaglia,
   alessandro/0000-0002-2386-1757
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aliota MT, 2016, BIORXIV
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2012, CLIN MICROBIOL INFEC, V18, pE541, DOI 10.1111/1469-0691.12001
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P1373, DOI 10.1586/14787210.2015.1083859
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P866, DOI 10.1016/S1473-3099(16)30117-7
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet GA, 2015, BRAZIL J CLIN VIROL, V74, P1
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, ZIK VIR
   Center for Infectious Disease Research and Policy (CIDRAP), 2016, BRAZ CONF BLOOD TRAN
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centers for Disease Control and Prevention (CDC), 2016, HAN PRIOR PROF MED P
   Centers for Disease Control and Prevention (CDC), 2016, ZIK BLOOD TRANSF
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cohen J, 2016, SCIENCE, V353, P529, DOI 10.1126/science.353.6299.529
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corman VM, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.175950, DOI 10.2471/BLT.16.175950.]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   European Centre for Disease Prevention and Control (ECDC), 2016, ECDC PROSP CAS DEF S
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lavezzo E, 2016, EXPERT REV MOL DIAGN, V16, P1011, DOI 10.1080/14737159.2016.1217158
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, BRAZ J OTORHINOLAR, DOI [10.1016/j.bjorl.2016.06.001, DOI 10.1016/J.BJORL.2016.06.001.]
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Makhluf H, 2016, EXPERT OPIN DRUG DIS, V11, P921, DOI 10.1080/17460441.2016.1212013
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude (Brasil), 2015, MIN SAUD INV AUM CAS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nemesio H, 2012, BBA-BIOMEMBRANES, V1818, P2818, DOI 10.1016/j.bbamem.2012.06.022
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037.]
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pan American Health Organization (PAHO), 2016, EP DIS ZIK AM
   Pan American Health Organization (PAHO), 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization (PAHO), 2016, REG ZIK EP UPD AM
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Trevisan M, 2015, VIRUSES-BASEL, V7, P3835, DOI 10.3390/v7072800
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verstrepen BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112568
   Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   WHO, 2016, PREV SEX TRANSM ZIK
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Zambrano H, 2016, AM J TROP MED HYG, P16
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 209
TC 28
Z9 28
U1 1
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD SEP
PY 2016
VL 363
IS 18
AR fnw202
DI 10.1093/femsle/fnw202
PG 17
WC Microbiology
SC Microbiology
GA EC8GL
UT WOS:000388379400010
OA Bronze
DA 2020-07-08
ER

PT J
AU Deng, YQ
   Zhang, NN
   Li, CF
   Tian, M
   Hao, JN
   Xie, XP
   Shi, PY
   Qin, CF
AF Deng, Yong-Qiang
   Zhang, Na-Na
   Li, Chun-Feng
   Tian, Min
   Hao, Jia-Nan
   Xie, Xu-Ping
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE adenosine analog; antiviral; mouse model; Zika virus
AB The ongoing Zika virus (ZIKV) outbreaks have raised global concerns due to its unexpected clinical manifestations. Antiviral development is of high priority in response to the ZIKV emergency. In this study, we report that an adenosine analog NITD008 has potent in vitro and in vivo antiviral activity against ZIKV. The compound can effectively inhibit the historical and contemporary ZIKV strains in cultures as well as significantly reduce viremia and prevent mortality in A129 mice. Our results have demonstrated that NITD008 is potent inhibitor of ZIKV and can be used as reference inhibitor for future ZIKV antiviral drug screen and discovery.
C1 [Deng, Yong-Qiang; Zhang, Na-Na; Hao, Jia-Nan; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Deng, Yong-Qiang; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Nanning, Peoples R China.
   [Li, Chun-Feng] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.
   [Li, Chun-Feng] Peking Union Med Coll, Beijing, Peoples R China.
   [Li, Chun-Feng] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.
   [Tian, Min] Capital Med Univ, Beijing Tradit Med Chinese Hosp, Hefei, Peoples R China.
   [Hao, Jia-Nan; Qin, Cheng-Feng] Anhui Med Univ, Hefei, Peoples R China.
   [Xie, Xu-Ping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.; Qin, CF (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Qin, CF (corresponding author), Guangxi Med Univ, Nanning, Peoples R China.; Qin, CF (corresponding author), Anhui Med Univ, Hefei, Peoples R China.
EM qincf@bmi.ac.cn
RI Li, Chunfeng/S-3185-2019; Qin, Cheng-Feng/I-6839-2019; Xie,
   Xuping/AAD-7406-2019
OI Li, Chunfeng/0000-0001-8883-9078; Qin, Cheng-Feng/0000-0002-0632-2807; 
FU State Key Laboratory of Pathogen and Biosecurity [SKLPBS1601]; Guangzhou
   Science and Technology Program for Public Wellbeing [2014Y2-00185,
   2014Y2-00550]; National Natural Science Foundation (NSFC) of
   ChinaNational Natural Science Foundation of China [31470265]; NSFC of
   ChinaNational Natural Science Foundation of China [81522025,
   81661130162]; Academy of Medical Sciences, UK; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI087856]
FX This work was supported by the State Key Laboratory of Pathogen and
   Biosecurity (SKLPBS1601), the Guangzhou Science and Technology Program
   for Public Wellbeing (2014Y2-00185, No. 2014Y2-00550), and the National
   Natural Science Foundation (NSFC) of China (No. 31470265). C.-F. Q. was
   supported by the Excellent Young Scientist Program from the NSFC of
   China (No. 81522025) and the Newton Advanced Fellowship from the Academy
   of Medical Sciences, UK and the NSFC of China (No. 81661130162). PYS's
   group is supported by NIH grant (AI087856).
CR Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Qing J, 2016, ANTIVIR RES, V126, P43, DOI 10.1016/j.antiviral.2015.12.010
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 16
TC 74
Z9 77
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2016
VL 3
IS 4
DI 10.1093/ofid/ofw175
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0ZI
UT WOS:000388572800007
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Galliez, RM
   Spitz, M
   Rafful, PP
   Cagy, M
   Escosteguy, C
   Germano, CSB
   Sasse, E
   Goncalves, AL
   Silveira, PP
   Pezzuto, P
   Ornelas, AMD
   Tanuri, A
   Aguiar, RS
   Moll, FT
AF Galliez, Rafael Mello
   Spitz, Mariana
   Rafful, Patricia Piazza
   Cagy, Marcelo
   Escosteguy, Claudia
   Brito Germano, Caroline Sposito
   Sasse, Elisa
   Goncalves, Alessandro Luis
   Silveira, Paola Paz
   Pezzuto, Paula
   de Magalhaes Ornelas, Alice Maria
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Moll, Fernanda Tovar
TI Zika Virus Causing Encephalomyelitis Associated With Immunoactivation
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE encephalomyelitis; neurological manifestations; proinflammatory
   cytokines; Zika virus
ID JAPANESE ENCEPHALITIS
AB Brazil has experienced a Zika virus (ZIKV) outbreak with increased incidence of congenital malformations and neurological manifestations. We describe a case of a 26-year-old Brazilian Caucasian man infected with ZIKV and diagnosed with encephalomyelitis. Brain and spinal cord images showed hyperintense lesions on T2 and fluid-attenuated inversion recovery (FLAIR), and levels of proinflammatory cytokines in the cerebrospinal fluid showed a remarkable increase of interleukin (IL)-6 and IL-8. The observed pattern suggests immune activation during the acute phase, along with the neurological impairment, with normalization in the recovery phase. This is the first longitudinal report of ZIKV infection causing encephalomyelitis with documented immune activation.
C1 [Galliez, Rafael Mello] Inst Estadual Infectol Sao Sebastiao, Rio De Janeiro, Brazil.
   [Galliez, Rafael Mello] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Hosp Fed Servidores Estado, Neurol Serv, Rio De Janeiro, Brazil.
   [Escosteguy, Claudia] Hosp Fed Servidores Estado, Epidemiol Serv, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza; Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; Moll, Fernanda Tovar] Dor Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza] Univ Fed Rio de Janeiro, Radiol Dept, BR-21941 Rio De Janeiro, Brazil.
   [Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; de Magalhaes Ornelas, Alice Maria; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Genet Dept, Inst Biol, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, BR-21941 Rio De Janeiro, Brazil.
RP Moll, FT (corresponding author), Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Galliez, Rafael Mello/AAA-2724-2020; Escosteguy, Claudia
   Caminha/D-1043-2010; Aguiar, Renato S/G-3542-2015
OI Galliez, Rafael Mello/0000-0003-0348-8374; Escosteguy, Claudia
   Caminha/0000-0003-0273-6911; Aguiar, Renato S/0000-0001-5180-3717
FU Brazilian Council for Development of Science and Technology; CAPES
   FoundationCAPES; Brazilian Ministry of Education; Rio de Janeiro
   Foundation; D'Or Institute for Research and Education
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology, the CAPES Foundation, Brazilian
   Ministry of Education, the Rio de Janeiro Foundation for the Support of
   Science, and intramural grants from D'Or Institute for Research and
   Education.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A
   Kalita J, 2000, J NEUROL SCI, V174, P3, DOI 10.1016/S0022-510X(99)00318-4
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nandan VA, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/487659
   Thabet FI, 2013, PEDIATR NEUROL, V48, P393, DOI 10.1016/j.pediatrneurol.2012.12.017
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
NR 9
TC 15
Z9 16
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2016
VL 3
IS 4
DI 10.1093/ofid/ofw203
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0ZI
UT WOS:000388572800009
PM 28053996
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rizzo, C
   Napoli, C
   Venturi, G
   Pupella, S
   Lombardini, L
   Calistri, P
   Monaco, F
   Cagarelli, R
   Angelini, P
   Bellini, R
   Tamba, M
   Piatti, A
   Russo, F
   Palu, G
   Chiari, M
   Lavazza, A
   Bella, A
AF Rizzo, C.
   Napoli, C.
   Venturi, G.
   Pupella, S.
   Lombardini, L.
   Calistri, P.
   Monaco, F.
   Cagarelli, R.
   Angelini, P.
   Bellini, R.
   Tamba, M.
   Piatti, A.
   Russo, F.
   Palu, G.
   Chiari, M.
   Lavazza, A.
   Bella, A.
CA Italian WNV Surveillance Working G
TI West Nile virus transmission: results from the integrated surveillance
   system in Italy, 2008 to 2015
SO EUROSURVEILLANCE
LA English
DT Article
ID REGION; EUROPE; EPIDEMIC
AB In Italy a national Plan for the surveillance of imported and autochthonous human vector-borne diseases (chikungunya, dengue, Zika virus disease and West Nile virus (WNV) disease) that integrates human and veterinary (animals and vectors) surveillance, is issued and revised annually according with the observed epidemiological changes. Here we describe results of the WNV integrated veterinary and human surveillance systems in Italy from 2008 to 2015. A real time data exchange protocol is in place between the surveillance systems to rapidly identify occurrence of human and animal cases and to define and update the map of affected areas i.e. provinces during the vector activity period from June to October. WNV continues to cause severe illnesses in Italy during every transmission season, albeit cases are sporadic and the epidemiology varies by virus lineage and geographic area. The integration of surveillance activities and a multidisciplinary approach made it possible and have been fundamental in supporting implementation of and/or strengthening preventive measures aimed at reducing the risk of transmission of WNV trough blood, tissues and organ donation and to implementing further measures for vector control.
C1 [Rizzo, C.; Napoli, C.; Venturi, G.; Bella, A.] ISS, Natl Inst Hlth, Rome, Italy.
   [Pupella, S.] ISS, Natl Inst Hlth, Natl Blood Ctr, Rome, Italy.
   [Lombardini, L.] ISS, Natl Inst Hlth, Natl Transplant Ctr, Rome, Italy.
   [Calistri, P.; Monaco, F.] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, TE, Italy.
   [Cagarelli, R.; Angelini, P.] Reg Hlth Author Emilia Romagna, Bologna, Italy.
   [Bellini, R.] Ctr Agr Ambiente G Nicoli, Crevalcore, Italy.
   [Tamba, M.] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.
   [Piatti, A.] Reg Hlth Author Lombardy, Lombardy, Italy.
   [Russo, F.] Reg Hlth Author Veneto, Veneto, Italy.
   [Palu, G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Chiari, M.; Lavazza, A.] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.
RP Rizzo, C (corresponding author), ISS, Natl Inst Hlth, Rome, Italy.
EM caterina.rizzo@iss.it
RI VENTURI, GIULIETTA/O-8123-2015; Monaco, Federica/G-9282-2016; napoli,
   christian/H-1862-2012; Calistri, Paolo/E-4157-2015; Lelli,
   Davide/AAB-6996-2019; Tamba, Marco/J-5495-2016; napoli,
   christian/B-9924-2018; Rizzo, Caterina/H-4092-2012; Rovida,
   Francesca/K-7984-2016; Bella, Antonino/AAB-9943-2019; Gismondo, Maria
   Rita/I-3965-2017; Baldanti, Fausto/J-4924-2018
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Monaco,
   Federica/0000-0002-7827-2642; napoli, christian/0000-0002-5775-2276;
   Calistri, Paolo/0000-0001-6004-9373; Lelli, Davide/0000-0002-5775-6058;
   napoli, christian/0000-0002-5775-2276; Rizzo,
   Caterina/0000-0002-5583-7508; Rovida, Francesca/0000-0003-2345-2790;
   Remoli, Maria Elena/0000-0003-3565-383X; Gismondo, Maria
   Rita/0000-0001-6926-8660; Baldanti, Fausto/0000-0002-3358-8969; Tamba,
   Marco/0000-0002-5878-4595; Dottori, Michele/0000-0002-9975-0367
FU Italian Ministry of Health-CCM
FX The authors would like to thank all health professionals from local and
   regional health authorities for collaborating. The project was
   implemented with a financial support of the Italian Ministry of
   Health-CCM.
CR Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26
   Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234
   Bagnarelli P, 2011, EUROSURVEILLANCE, V16, P5
   Barzon L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.018
   Calistri P, 2010, VET ITAL, V46, P471
   Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915
   Chiari M, 2015, TRANSBOUND EMERG DIS, V62, P343, DOI 10.1111/tbed.12375
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Conte A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146024
   ECDC, 2012, EP SIT W NIL VIR INF
   European Center for Disease Prevention and Control (ECDC), 2014, HIST DAT
   European Centre for Disease Prevention and Control (ECDC), W NIL FEV MAPS
   European Centre for Disease Prevention Control (ECDC), 2016, ANN EP REP 2016 W NI
   Giese C, W NILE VIRUS CIRCULA
   Gobbi F, 2012, EMERG INFECT DIS, V18, P671, DOI 10.3201/eid1804.110753
   Italian National Institute of Statistics, STAT COD TERR ADM UN
   Kalaycioglu H, 2012, EUROSURVEILLANCE, V17, P12
   Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018
   Ministero della Salute, 2002, 4003324234 MIN SAL
   Ministero della Salute, 2008, GU SER GEN, V36
   Ministero della Salute. [Italian Ministry of Health.], 2010, SORV MAL W NIL IT
   Napoli C, 2015, BIOMED RES INT, V2015
   Papa A, 2010, EUROSURVEILLANCE, P15
   Pupella S, 2013, BLOOD TRANSFUS-ITALY, V11, P563, DOI 10.2450/2013.0077-13
   Ravagnan S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1031-y
   Rizzo C, 2012, EUROSURVEILLANCE, V17, P7
   Rizzo C, 2009, EUROSURVEILLANCE, V14, P5
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211
   The World Organisation for Animal Health (OIE), WORLD AN HLTH INF DA
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
NR 31
TC 36
Z9 36
U1 0
U2 8
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP
PY 2016
VL 21
IS 37
BP 10
EP 17
DI 10.2807/1560-7917.ES.2016.21.37.30340
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DW5GT
UT WOS:000383672200002
PM 27684046
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, YN
   Chen, CP
   Lin, CJ
   Chen, SW
AF Chen, Yen-Ni
   Chen, Chih-Ping
   Lin, Chen-Ju
   Chen, Shin-Wen
TI Prenatal Ultrasound Findings of Pregnancy Associated with Zika Virus
   Infection
SO JOURNAL OF MEDICAL ULTRASOUND
LA English
DT Review
DE microcephaly; prenatal ultrasound; Zika virus
ID INTERIM GUIDANCE; UNITED-STATES; TRANSMISSION; OUTBREAK; WOMEN; FETAL
AB The outbreak of Zika virus followed by an increase in cases of fetal microcephaly in Brazil in 2015 has raised the concern of the association of Zika virus infection with fetal microcephaly and other central nervous system (CNS) malformations. Most patients with Zika virus infection are asymptomatic. However, according to a previous report, the most common symptom in pregnant women with Zika virus infection and fetal microcephaly is rash. Reported prenatal ultrasound findings are microcephaly, lissencephaly, agenesis of corpus callosum, intracranial calcification, cerebellar atrophy, ventriculomegaly, brain hypoplasia, microophthalmia, abnormal amniotic fluid volume, abnormal cerebral blood flow, abnormal umbilical artery blood flow, hydrocephalus, intrauterine growth restriction, and arthrogryposis which are mostly CNS lesions. Pregnant women who have a traveling history in active infection areas should have serological testing for Zika virus infection. Targeted ultrasound examinations at 18-20 weeks of gestation and serial ultrasound follow-ups are also suggested. In the cases of fetal microcephaly, intracranial anatomy and extracranial abnormalities should be also carefully examined. Amniocentesis might be needed for suspected Zika virus infection, genetic abnormalities, or other congenital infection. (C) 2016, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Chen, Yen-Ni; Chen, Chih-Ping; Lin, Chen-Ju; Chen, Shin-Wen] Mackay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan North Rd, Taipei, Taiwan.
   [Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   [Chen, Chih-Ping] Asia Univ, Dept Biotechnol, Taichung, Taiwan.
   [Chen, Chih-Ping] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.
   [Chen, Chih-Ping] Natl Yang Ming Univ, Inst Clin & Community Hlth Nursing, Taipei, Taiwan.
   [Chen, Chih-Ping] Natl Yang Ming Univ, Dept Obstet & Gynecol, Sch Med, Taipei, Taiwan.
RP Chen, CP (corresponding author), Mackay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan North Rd, Taipei, Taiwan.
EM cpc_mmh@yahoo.com
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
NR 28
TC 2
Z9 2
U1 0
U2 6
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0929-6441
EI 2212-1552
J9 J MED ULTRASOUND
JI J. Med. Ultrasound
PD SEP
PY 2016
VL 24
IS 3
BP 89
EP 92
DI 10.1016/j.jmu.2016.08.007
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EC4PC
UT WOS:000388114300004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Esposito, DLA
   da Fonseca, BAL
AF Alves Esposito, Danillo Lucas
   Lopes da Fonseca, Benedito Antonio
TI Zika and chikungunya infections in Brazil: reviewing the epidemic and
   treatment options
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
ID VIRUS
C1 [Alves Esposito, Danillo Lucas; Lopes da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ministerio da Saude, 2016, MIN SAUD B EP, V47
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 6
TC 3
Z9 3
U1 0
U2 8
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 535
EP 536
DI 10.1590/0037-8682-0428-2016
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500001
PM 27812645
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Brito, CAA
   Cordeiro, MT
AF Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
TI One year after the Zika virus outbreak in Brazil: from hypotheses to
   evidence
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika; Microcephaly; Neurological cases; Epidemiology; Review
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; UNITED-STATES; EPIDEMIOLOGY;
   INFECTIONS; HISTORY
AB Zika virusis an arbovirus of the Flaviviridae family with two major strains, an Asian and an African strain. The main vectors involved in the transmission of Zika virus are the Aedes aegypti and Aedes albopictus mosquitoes. Despite its identification, discovered in 1947 in the Zika forest in Uganda, only isolated and sporadic occurrences of human infection were reported within a largely asymptomatic proportion of individuals. The first reported outbreak occurred in 2007 in the Yap Island, which belongs to the Federated States of Micronesia in the Pacific Ocean, and in French Polynesia, where high attack rates occurred and the first cases of associated Guillain-Barre syndrome were reported. From November 2014 to early 2015, the Northeast states of Brazil reported the first outbreaks of Zika virus infection, with laboratory confirmation of Zika virus circulation in April 2015. In the second quarter of 2015, the association between Zika virus infection and neurological symptoms was confirmed in adults. Moreover, in October 2015 a novel suspicion was raised based on clinical and epidemiological observations: that an association between Zika virus infection and neonatal microcephaly may exist. A year after the first reports on Zika virus in Brazil, many hypotheses and much evidence on the patterns of involvement of the disease and its complications have been produced, both in this country and others; other hypotheses still need to be clarified. This review is a synthesis of a new chapter in the history of medicine; it outlines the main results produced.
C1 [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick GWA, 1952, T R SOC TROP MED HYG, V46
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   European Union, 2014, REP CRIT RAW MAT EU, P1
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053.]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio Secretaria General de la Presidencia, 2015, PROT AT SAUD RESP OC, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD, P1
   Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUIDELINES USE ANTIR, P1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polynesie Francaise, 2014, SURV DENG ZIK POL FR, P6
   Public Health England, 2016, GUID ZIK VIR TRAV AD, P1
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Reuters News Agency, 2016, BRAZ REP ZIK INF BLO, P6
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Secretaria de Saude de Pernambuco, 2015, CIRC FEBR ZIK VIR PE, P1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization(WHO), 2016, SIK SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 21
Z9 21
U1 0
U2 15
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 537
EP 543
DI 10.1590/0037-8682-0328-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500002
PM 27812646
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Brito, CAA
   de Brito, CC
   Oliveira, AC
   Rocha, M
   Atanasio, C
   Asfora, C
   Matos, JD
   Lima, AS
   Albuquerque, MFM
AF Antunes de Brito, Carlos Alexandre
   Moraes de Brito, Cecilia Coelho
   Oliveira, Augusto Cesar
   Rocha, Marilia
   Atanasio, Caio
   Asfora, Carolina
   Matos, Julio Dourado
   Lima, Anton Saraiva
   Militao Albuquerque, Maria Fatima
TI Zika in Pernambuco: rewriting the first outbreak
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Zika; Dengue; Outbreak; Arbovirus; Surveillance
ID VIRUS OUTBREAK; STATES
AB Introduction: A Zika virus epidemic was registered in 2015 in Northeast Brazil. In the State of Pernambuco, thousands of classical cases transpired, and in the following months, neurological disturbances in adults and microcephaly in newborns emerged as complications. After the peak of the epidemic, the official system reported only four cases of Zika virus but over 100,000 cases of dengue virus. The vigilance system was unable to retrospectively estimate cases or to issue an alert to officially notified cases with possible inconsistence concerning specific arbovirosis diagnoses. Methods: To evaluate the frequency of different arbovirosis diagnoses based on clinical-epidemiologic criteria, from January to April 2015, we conducted a hospital-based cross-sectional study retrospectively analyzing suspected cases of arbovirosis. Results: Of 1,046 total suspected cases of arbovirus, 895 (86%) were classified as probable Zika virus cases, and 151 (14%) as probable dengue virus cases. The most frequent manifestations in probable Zika virus cases were exanthema (100%), pruritus (50.7%), fever (20.4%) and arthralgia (27.7%). Conclusions: In contrast to the official data, during the peak months of the arbovirosis epidemic of 2015, most cases were compatible with Zika virus infections. Hospital-based studies, although retrospective and based on secondary data from clinical files, might provide a better estimate of the number of cases relative to currently available data, if derived from several urgent care units of representative areas of a city or state. This would partially retrospectively correct some inconsistences regarding official notifications.
C1 [Antunes de Brito, Carlos Alexandre; Rocha, Marilia; Asfora, Carolina; Lima, Anton Saraiva] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Moraes de Brito, Cecilia Coelho; Oliveira, Augusto Cesar; Atanasio, Caio] Univ Fed Pernambuco, Programa Grad Med, Recife, PE, Brazil.
   [Matos, Julio Dourado] Fac Pernambucana Saude, Programa Grad Med, Recife, PE, Brazil.
   [Militao Albuquerque, Maria Fatima] Ctr Pesquisa Aggeu Magalhaes, Dept Saude Publ, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Brasil. Ministerio da Sande, 2005, GUIA VIGILANCIA EPID
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Deng L, 2015, COMPUT INTEL NEUROSC, DOI 10.1155/2015/896072
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Center for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR, P1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Ministerio da Saude, 2016, MIN SAUD B EP, V47
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   MINISTERIO DE AGRICULTURA PESCA Y ALIMENTACION, 2016, PROC SER AD VIG FEBR, P1
   Ministerio Secretaria General de la Presidencia, 2015, PROT AT SAUD RESP OC, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oregon Health Autrhority, 2016, ZIK VIR INV GUID, P1
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Pan American Health Organization (PAHO). PAHO, 2015, GUIA VIG ENF VIR ZIK, P1
   Persons TM, 2016, EMERG INFECT DIS, P1
   Polynesie Francaise, 2014, SURV DENG ZIK POL FR, P6
   Secretaria Estatual de Saude de Pernambuco, 2016, MICR EXP SES PE INV, P1
   Secretaria Estatual de Saude de Pernambuco, 2015, 2015 SECR EST SAUD P, P1
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 12
Z9 12
U1 0
U2 9
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 553
EP 558
DI 10.1590/0037-8682-0245-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500004
PM 27812648
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Khatami, R
   Wang, Q
   Kaplan, C
AF Khatami, Rokhsareh
   Wang, Qian
   Kaplan, Cynthia
TI Zika Virus Infection in Early Pregnancy, a Case Report
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Meeting Abstract
C1 [Khatami, Rokhsareh; Wang, Qian; Kaplan, Cynthia] Cynthia Kaplan Stony Brook Univ Hosp, Stony Brook, NY USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD SEP 1
PY 2016
VL 146
SU 1
MA 197
BP S87
EP S88
PG 2
WC Pathology
SC Pathology
GA EB1TZ
UT WOS:000387139400201
DA 2020-07-08
ER

PT J
AU Giugliano, E
   Balzano-Kane, J
   Poczter, H
   Hemmings, B
   Stein, MB
AF Giugliano, Edmund
   Balzano-Kane, Jeanne
   Poczter, Hannah
   Hemmings, Bryan
   Stein, Mary Beth
TI Team Zika: How Northwell Health Laboratories Expedited the Collection,
   Handling, and Transportation for Testing of Zika Virus Specimens
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Meeting Abstract
C1 [Giugliano, Edmund; Balzano-Kane, Jeanne; Poczter, Hannah; Hemmings, Bryan; Stein, Mary Beth] Northwell Hlth Labs, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD SEP 1
PY 2016
VL 146
SU 1
MA 97
PG 1
WC Pathology
SC Pathology
GA EB1TZ
UT WOS:000387139400100
DA 2020-07-08
ER

PT J
AU Sadarangani, SP
   Hsu, LY
AF Sadarangani, Sapna Pradip
   Hsu, Li Yang
TI The 2016 Outbreak of Zika in Singapore
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Editorial Material
C1 [Sadarangani, Sapna Pradip; Hsu, Li Yang] Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Infect Dis, Moulmein Rd, Singapore 308433, Singapore.
   [Hsu, Li Yang] Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
RP Sadarangani, SP (corresponding author), Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Infect Dis, Moulmein Rd, Singapore 308433, Singapore.
EM Sapna_Sadarangani@ttsh.com.sg
OI Sadarangani, Sapna/0000-0002-8781-0713; Hsu, Li Yang/0000-0002-0396-066X
CR Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Environment Agency, ZIK CLUST
   Retallack H, BIORXIV
   Thangamani S, 2016, AM J TROP MED HYG, P16
   WHO, WHO DIR GEN SUMM OUT
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 8
TC 5
Z9 5
U1 0
U2 0
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD SEP
PY 2016
VL 45
IS 9
BP 381
EP 382
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB3XE
UT WOS:000387301600001
PM 27748784
DA 2020-07-08
ER

PT J
AU Kessler, CM
   Busch, MP
AF Kessler, Craig M.
   Busch, Michael P.
TI Zika and the Safety of the US Blood Supply
SO CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY
LA English
DT Editorial Material
ID VIRUS
C1 [Busch, Michael P.] UCSF Sch Med, Dept Lab Med, San Francisco, CA USA.
   [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Musso D., 2014, EURO SURVEILL, V19
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 6
TC 3
Z9 3
U1 0
U2 1
PU MILLENNIUM MEDICAL PUBLISHING, INC
PI NEW YORK
PA 611 BROADWAY, STE 310, NEW YORK, NY 10012 USA
SN 1543-0790
J9 CLIN ADV HEMATOL ONC
JI Clin. Adv. Hematol. Oncol.
PD SEP
PY 2016
VL 14
IS 9
BP 677
EP 679
PG 3
WC Oncology
SC Oncology
GA EB4JZ
UT WOS:000387339000007
PM 27673286
DA 2020-07-08
ER

PT J
AU Kartzinel, MA
   Alto, BW
   Deblasio, MW
   Burkett-Cadena, ND
AF Kartzinel, Mark A.
   Alto, Barry W.
   Deblasio, Michael W., II
   Burkett-Cadena, Nathan D.
TI TESTING OF VISUAL AND CHEMICAL ATTRACTANTS IN CORRELATION WITH THE
   DEVELOPMENT AND FIELD EVALUATION OF AN AUTODISSEMINATION STATION FOR THE
   SUPPRESSION OF AEDES AEGYPTI AND AEDES ALBOPICTUS IN FLORIDA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; autodissemination; dengue virus;
   chikungunya virus; pyriproxyfen; Zika virus
ID INSECT GROWTH-REGULATORS; CHIKUNGUNYA VIRUS; ANOPHELES-GAMBIAE;
   POTENTIAL USE; MOSQUITO; PYRIPROXYFEN; CULICIDAE; DIPTERA; DENGUE;
   OVIPOSITION
AB Three exotic mosquito-borne pathogens dengue, chikungunya, and Zika viruses transmitted by Aedes albopictus and Ae. aegypti have undergone dramatic global expansion in recent years. The control of vector populations and minimizing bites from these vectors are the primary methods of reducing risk of transmission of these viruses to humans. However, Ae. albopictus and Ae. aegypti are notoriously challenging to control through conventional chemical means, due primarily to difficulties in applying pesticides to their cryptic larval habitats. A novel strategy for suppressing populations of these species is the autodissemination of insect growth regulators (IGRs), in which adult female mosquitoes are attracted to a treatment station where they are tainted with small amounts of potent IGR. When the adult females subsequently visit oviposition sites, they inadvertently disseminate the IGR to larval development sites, suppressing their own population. Implementing this technology to control natural vector populations presents substantial logistical challenges. The current manuscript describes laboratory bioassays and field evaluations to design a novel autodissemination station (ADS) and test the methodology at field locations in Florida where Ae. aegypti and Ae. albopictus are abundant and pose a risk for transmission of emerging pathogens. The prototype ADS is intended to attract host-seeking, resting site seeking, and oviposition site seeking females through a combination of visual and olfactory cues. The efficacy of this strategy was assessed through the use of sentinel ovicups at field locations in Indian River County and Martin County, FL. Greatest efficacy (45.3 7.7% mortality in treatment sentinel ovicups) was achieved at a field site with few competing natural ovisites, while much lower efficacy was observed in locations with numerous competing ovisites (0.0 to 29.0 8.2% mortality). The efficacy of the ADS is likely to be strongly affected by the abundance of competing ovisites, the population dynamics, and climatic conditions.
C1 [Kartzinel, Mark A.; Alto, Barry W.; Deblasio, Michael W., II; Burkett-Cadena, Nathan D.] Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Kartzinel, MA (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
OI Burkett-Cadena, Nathan/0000-0001-6168-1637
FU Florida Department of Agriculture and Consumer Services [021790]; NIFA
   [FLA-VME-005446]
FX The authors wish to thank Gene Lemire, Sherry Burroughs, Doug Carlson,
   Don Shroyer, and Michael Hudon for help with preliminary experiments and
   site selection. Three homeowners and one restaurant owner allowed
   unrestricted access to their properties for field research. Valent
   Biosciences generously supplied the IGR product used in this research
   (Esteem WP). This work was supported by Florida Department of
   Agriculture and Consumer Services project 021790 to NDBC and BWA and
   NIFA FLA-VME-005446.
CR ALI A, 1995, J AM MOSQUITO CONTR, V11, P72
   ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Bartlett-Healy K, 2011, J MED ENTOMOL, V48, P712, DOI 10.1603/ME10168
   Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k
   Braks MAH, 2001, PHYSIOL ENTOMOL, V26, P142, DOI 10.1046/j.1365-3032.2001.00227.x
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x
   GONZALEZ JP, 1995, AM J TROP MED HYG, V53, P1
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   Hirano M, 1998, REV TOXICOL, V2, P357
   Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Kamal Hany A., 2010, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V40, P565
   Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846
   KILHAM L, 1955, AM J HYG, V61, P45, DOI 10.1093/oxfordjournals.aje.a119737
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P776, DOI 10.1001/jama.2014.9916
   Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0
   Mbare O, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-280
   Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244
   OMeara GF, 1995, J VECTOR ECOL, V20, P216
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Russell BM, 2002, J MED ENTOMOL, V39, P143, DOI 10.1603/0022-2585-39.1.143
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P14, DOI 10.1179/2046904712Z.00000000046
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Van Emden HF, 2004, PEST VECTOR CONTROL
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Yanoviak SP, 2001, FLA ENTOMOL, V84, P265, DOI 10.2307/3496178
NR 36
TC 3
Z9 3
U1 1
U2 8
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2016
VL 32
IS 3
BP 194
EP 202
DI 10.2987/16-6555.1
PG 9
WC Entomology
SC Entomology
GA EB6YC
UT WOS:000387530500003
PM 27802398
DA 2020-07-08
ER

PT J
AU Harwood, JF
   Helmey, WL
   Turnwall, BB
   Justice, KD
   Farooq, M
   Richardson, AG
AF Harwood, James F.
   Helmey, Wendy L.
   Turnwall, Brent B.
   Justice, Kevin D.
   Farooq, Muhammed
   Richardson, Alec G.
TI CONTROLLING AEDES AEGYPTI IN CRYPTIC ENVIRONMENTS WITH MANUALLY CARRIED
   ULTRA-LOW VOLUME AND MIST BLOWER PESTICIDE APPLICATIONS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Adult mosquito control; cold fogger; indoor space spray; larviciding;
   thermal fogger; ultra-low volume
ID ADULTICIDE EFFICACY; DENGUE; CULICIDAE; DIPTERA; VECTOR; INSECTICIDE;
   BEHAVIOR; MOSQUITO; CITY
AB Because Aedes aegypti, a vector of dengue, chikungunya, and Zika viruses, exhibits resting and reproductive behaviors that present challenges to control them, pesticide application equipment available for vector control must be evaluated for their ability to control this species in a variety of cryptic environments. Five types of pesticide sprayers, representing 3 spray technologies (1 mister, 2 ultra-low volume [ULV] cold foggers, and 2 ULV thermal foggers), were evaluated for their ability to control adult and immature stages of Ae. aegypti in indoor and outdoor environments. Cages holding adult mosquitoes and larvae were placed in cryptic sites for indoor sprays and placed among dense vegetation for outdoor sprays. Adult and pupal mortality data were recorded following applications of a mixture of synergized pyrethrins and pyriproxyfen. We found that no single sprayer was best suited for controlling Ae. aegypti in indoor and outdoor environments, nor was one best for controlling adult and immature mosquitoes. Sprayers producing larger droplets (misters and cold foggers) were more effective in controlling immature mosquitoes indoors and outdoors. Thermal fogging was more effective in controlling adults indoors, whereas cold fogs and misters were more effective for outdoor control.
C1 [Harwood, James F.; Helmey, Wendy L.; Turnwall, Brent B.; Justice, Kevin D.; Farooq, Muhammed; Richardson, Alec G.] Navy Entomol Ctr Excellence, Box 43,Bldg 937,Naval Air Stn, Jacksonville, FL 32212 USA.
RP Harwood, JF (corresponding author), Navy Entomol Ctr Excellence, Box 43,Bldg 937,Naval Air Stn, Jacksonville, FL 32212 USA.
FU Deployed War-Fighter Protection research program (DWFP)
FX We thank J. Kerce, C. Clark, D. Spatola, S. Solache, and L. Santana for
   technical assistance during field trials and J. Cilek and H. Arimoto for
   additional editorial remarks on previous editions of the manuscript.
   This research was funded by the Deployed War-Fighter Protection research
   program (DWFP). The views expressed in this article are those of the
   authors and do not necessarily reflect the official policy or position
   of the Department of the Navy, Department of Defense, nor the US
   Government.
CR ASTM [American Society for Testing and Materials], 2015, E126003 ASTM
   Bache DH, 1992, MICROCLIMATE SPRAY D
   BARTLETT M. S., 1937, J. Roy. Statist. Soc., (Suppl.), V4, P137
   Chadee D. D., 1989, ENTOMOL END PARASITO, V23, P71
   Curtis GA, 1996, J AM MOSQUITO CONTR, V12, P368
   DUNCAN D. B., 1951, Virginia Journal of Science, V2, P171
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Farooq M, 2001, J AGR ENG RES, V78, P347, DOI 10.1006/jaer.2000.0660
   Fritz BK, 2010, J AM MOSQUITO CONTR, V26, P411, DOI 10.2987/10-6031.1
   Gibbons RV, 2012, EMERG INFECT DIS, V18, P623, DOI 10.3201/eid1804.110134
   Harwood JF, 2015, J MED ENTOMOL, V52, P663, DOI 10.1093/jme/tjv043
   Harwood JF, 2014, J MED ENTOMOL, V51, P845, DOI 10.1603/ME14056
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441
   MORRIS ON, 1977, CAN ENTOMOL, V109, P1319, DOI 10.4039/Ent1091319-10
   Newman D, 1939, BIOMETRIKA, V31, P20, DOI 10.1093/biomet/31.1-2.20
   Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2
   Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183
   Pages F, 2010, CLIN MICROBIOL INFEC, V16, P209, DOI 10.1111/j.1469-0691.2009.03132.x
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87
   Smirnov N.V., 1939, B MATH U MOSCOW    I, V2, P3
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   TUKEY JW, 1949, BIOMETRICS, V5, P232, DOI 10.2307/3001938
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organizations (WHO), 2003, SPAC SPRAY APPL INS
   Zar J. H., 1999, BIOSTATISTICAL ANAL
NR 30
TC 2
Z9 2
U1 1
U2 10
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2016
VL 32
IS 3
BP 217
EP 223
DI 10.2987/16-6553.1
PG 7
WC Entomology
SC Entomology
GA EB6YC
UT WOS:000387530500006
PM 27802406
DA 2020-07-08
ER

PT J
AU Kutateladze, T
   Zangaladze, E
   Dolidze, N
   Mamatsashvili, T
   Tskhvaradze, L
   Andrews, ES
   Haddow, AD
AF Kutateladze, Tamar
   Zangaladze, Ekaterine
   Dolidze, Nato
   Mamatsashvili, Tamar
   Tskhvaradze, Lamzira
   Andrews, Elizabeth S.
   Haddow, Andrew D.
TI FIRST RECORD OF AEDES ALBOPICTUS IN GEORGIA AND UPDATED CHECKLIST OF
   REPORTED SPECIES
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Black Sea; chikungunya virus; dengue virus; West Nile virus; Zika virus
ID MOSQUITOS
AB Mosquito surveillance was carried out in Batumi, Georgia, in August 2014. Aedes albopictus was detected for the first time, Which brought the number of reported mosquito species in Georgia to 32. An updated checklist of the mosquitoes of Georgia is provided.
C1 [Kutateladze, Tamar; Zangaladze, Ekaterine; Dolidze, Nato; Mamatsashvili, Tamar; Tskhvaradze, Lamzira] Natl Ctr Dis Control & Publ Hlth, 9 Mikheil Asatiani St, Tbilisi 380077, Georgia.
   [Andrews, Elizabeth S.; Haddow, Andrew D.] US Army, Div Virol, Med Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.
RP Kutateladze, T (corresponding author), Natl Ctr Dis Control & Publ Hlth, 9 Mikheil Asatiani St, Tbilisi 380077, Georgia.
RI Haddow, Andrew D/C-5902-2008
OI Haddow, Andrew D/0000-0002-8957-2608
FU Defense Threat Reduction Agency (DTRA) Cooperative Biological Engagement
   Program (CBEP)
FX This study was funded by the Defense Threat Reduction Agency (DTRA)
   Cooperative Biological Engagement Program (CBEP). The authors wish to
   thank Rik Obiso, Theresa Gallagher, and Magda Metreveli for their
   assistance in the coordination of logistical activities. The views
   expressed in this article are those of the authors and do not represent
   the official policy or position of the US Department of the Army,
   Department of Defense, or the US Government.
CR Azari-Hamidian S, 2009, ZOOTAXA, P1
   Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P247
   Favr VV, 1903, MALARIA RESPECT SANI
   Glick Jayson I., 1992, Mosquito Systematics, V24, P125
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   HARBACH R E, 1985, Mosquito Systematics, V17, P83
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   KALANDADZE L. P., 1938, Medical Parasitology, V7, P878
   Kalandadze LP, 1929, P TROP MED, V3, P218
   Kalandadze LP, 1930, P TROP MED, V1, P87
   Kanchaveli GI, 1955, THESIS
   Kandelaki SP, 1926, P TROP MED CENTRAL S, V1, P86
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   MASLOV AV, 1967, BLOOD SUCKING MOSQUI
   Mgeladze VM, 1991, B ACAD SCI GEORGIA, V143, P329
   Mgeladze VM, 1990, B ACAD SCI GEORGIA, V138, P621
   Oter K, 2013, VECTOR-BORNE ZOONOT, V13, P753, DOI 10.1089/vbz.2012.1093
   Riabova T E, 2005, Med Parazitol (Mosk), P3
   Rukhadze NP, 1926, P SCI SOC ABKHAZIA, V3, P87
   Rukhadze NP, 1925, J TROP MED, V1-3, P45
   Shakhov SD, 1925, P SCI SOC ABKHAZIA, V8, P34
   Sichinava SG, 1970, THESIS
   Sichinava SG, 1972, 21 SESS I MED PAR TR, P27
   Skorikov AS, 1906, RUSSIAN OBSERVER, V3-4, P225
   Yunicheva Yu. V., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P40
   Zabudco-Reingard TN, 1937, P RUKHADZE NP TROP I, V3, P26
NR 27
TC 1
Z9 3
U1 0
U2 2
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2016
VL 32
IS 3
BP 230
EP 233
DI 10.2987/16-6574.1
PG 4
WC Entomology
SC Entomology
GA EB6YC
UT WOS:000387530500008
PM 27802403
DA 2020-07-08
ER

PT J
AU Griffiths, P
AF Griffiths, Paul
TI Zika circumnavigates the globe to go for gold
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Editorial Material
ID VIRUS
EM p.griffiths@ucl.ac.uk
CR Butler D, 2016, NATURE, V535, P17, DOI 10.1038/535017a
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro MC, 2016, TRAVEL MED INFECT DI
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sehdev PS, 2002, CLIN INFECT DIS, V35, P1071, DOI 10.1086/344062
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Watson R, 2007, BRIT MED J, V335, P532, DOI 10.1136/bmj.39332.708738.DB
NR 14
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD SEP
PY 2016
VL 26
IS 5
BP 307
EP 308
DI 10.1002/rmv.1901
PG 2
WC Virology
SC Virology
GA EB4FH
UT WOS:000387324800001
PM 27573074
DA 2020-07-08
ER

PT J
AU Ahmed, QA
   Memish, ZA
AF Ahmed, Qanta A.
   Memish, Ziad A.
TI Hajj 2016: Required vaccinations, crowd control, novel wearable tech and
   the Zika threat
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
ID RESPIRATORY-TRACT INFECTIONS
C1 [Ahmed, Qanta A.] SUNY Stony Brook, Div Pulm Dis & Crit Care Med, Dept Med, Winthrop Univ Hosp, Stony Brook, NY 11794 USA.
   [Memish, Ziad A.] Alfaisal Univ, Minist Hlth, POB 54146, Riyadh 11514, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.
RP Memish, ZA (corresponding author), Alfaisal Univ, Minist Hlth, POB 54146, Riyadh 11514, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.
EM qanta.ahmed@gmail.com; zmemish@yahoo.com
CR Al-Tawfiq JA, 2014, TRAVEL MED INFECT DI, V12, P422, DOI 10.1016/j.tmaid.2014.06.007
   Al-Tawfiq JA, 2013, CURR OPIN PULM MED, V19, P192, DOI 10.1097/MCP.0b013e32835f1ae8
   Alaska YA, 2016, TRAVEL MED INFECT DI
   Algarni H, 2016, EPIDEMIOL GLOB HLTH, V6, P7
   [Anonymous], 2016, WKLY EPIDEMIOL REC, V91, P331
   Benkouiten S, 2014, TRAVEL MED INFECT DI, V12, P429, DOI 10.1016/j.tmaid.2014.06.005
   Elachola H, 2016, J HLTH SPECIALTIES, V4, P87
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
NR 8
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 429
EP 432
DI 10.1016/j.tmaid.2016.09.007
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300001
PM 27663284
DA 2020-07-08
ER

PT J
AU Calleri, G
   Burdino, E
   Bonora, S
   Raso, R
   Ghisetti, V
   Caramello, P
AF Calleri, Guido
   Burdino, Elisa
   Bonora, Stefano
   Raso, Roberto
   Ghisetti, Valeria
   Caramello, Pietro
TI Zika virus infection in two travelers returning from an epidemic area to
   Italy, 2016: Algorithm for diagnosis and recommendations
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
C1 [Calleri, Guido] Amedeo di Savoia Hosp, Travel Med Unit, Turin, Italy.
   [Burdino, Elisa; Ghisetti, Valeria] Amedeo di Savoia Hosp, Lab Microbiol & Virol, Turin, Italy.
   [Bonora, Stefano] Univ Turin, Dept Med Sci, Infect Dis Unit, Turin, Italy.
   [Raso, Roberto] Local Hlth Unit Alessandria, Reg Infect Dis Epidemiol Serv, Piedmont, Italy.
   [Caramello, Pietro] Amedeo di Savoia Hosp, Infect & Trop Dis Unit, Turin, Italy.
RP Calleri, G (corresponding author), Osp Amedeo di Savoia, Corso Svizzera 164, I-10149 Turin, Italy.
EM guido.calleri@aslto2.piemonte.it
RI bonora, stefano/AAC-2993-2019
OI bonora, stefano/0000-0002-7537-3341
CR Angelini R, 2007, Euro Surveill, V12
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Ministero della Salute Circolare del 30 giugno, 2014, ZIKA VIRUS W NILE DI, V2014, P2014
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   WHO EURO, ZIK VIR VECT RISK SP
   World Health Organization, 2016, ZIK VIR DIS INT CAS
NR 6
TC 3
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 506
EP 508
DI 10.1016/j.tmaid.2016.07.001
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300015
PM 27404665
DA 2020-07-08
ER

PT J
AU Gundacker, ND
   Rodriguez, JM
AF Gundacker, Nathan D.
   Rodriguez, J. Martin
TI Does the Zika virus outbreak provide an educational opportunity for STI
   prevention in the pre-travel setting?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
ID SYPHILIS; HIV; SEX
C1 [Gundacker, Nathan D.; Rodriguez, J. Martin] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35233 USA.
RP Gundacker, ND (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35233 USA.
EM ngundacker@uabmc.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI052069]
CR CDC, 2015, MMWR, V65, P55
   Klunge-de Luze C, 2014, BMC PUBLIC HEALTH, V14, P1199
   Matteelli A, 2014, TRAVEL MED INFECT DI, V12, P5, DOI 10.1016/j.tmaid.2013.11.006
   Salavec M, 2014, TRAVEL MED INFECT DI, V12, P84, DOI 10.1016/j.tmaid.2013.10.003
   Vivancos R, 2010, INT J INFECT DIS, V14, pE842, DOI 10.1016/j.ijid.2010.02.2251
NR 5
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 509
EP 509
DI 10.1016/j.tmaid.2016.08.008
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300016
PM 27586510
DA 2020-07-08
ER

PT J
AU Chiodini, J
AF Chiodini, Jane
TI ZIKA App - A great resource from the World Health Organization (WHO)
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
C1 [Chiodini, Jane] Clapham Rd Surg, Bedford, England.
RP Chiodini, J (corresponding author), Clapham Rd Surg, Bedford, England.
EM janechiodini@btinternet.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 539
EP 540
DI 10.1016/j.tmaid.2016.09.010
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300027
PM 27693616
DA 2020-07-08
ER

PT J
AU Fiorentino, DG
   Montero, FJ
AF Fiorentino, D. G.
   Montero, F. J.
TI The Zika Virus and Pregnancy
SO CURRENT OBSTETRICS AND GYNECOLOGY REPORTS
LA English
DT Article
DE Zika virus; Microcephaly; Congenital brain anomalies; Pregnancy
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; SEXUAL TRANSMISSION; PREVENTION;
   INFECTION
AB Purpose of Review Following the recent association of Zika virus with microcephaly in Brazil, there has been a multitude of studies attempting to elucidate the relationship between Zika virus infection in pregnancy and congenital anomalies. The American Congress of Obstetricians and Gynecologists (ACOG), the U.S. Centers for Disease Control and Prevention (CDC), and the Society for Maternal Fetal Medicine (SMFM) have all issued guidelines governing the screening and management of pregnant patients with Zika exposure. These guidelines have rapidly evolved as the scientific evidence supporting causation of microcephaly in cases of Zika Virus infection has continued to mount. The purpose of this article is to review the current guidelines and the available evidence on which they are based.
   Recent Findings A series of experiments on animals and human cell lines have demonstrated that Zika virus is neurotropic. Further, examinations of amniotic fluid, fetal tissues, and placenta have confirmed the ability of Zika virus to cross the placenta. With the currently available evidence, the CDC has recently concluded that Zika virus infection in pregnancy is a cause of microcephaly.
   Summary Recently, it has become clear that Zika virus infection during pregnancy is responsible for congenital brain anomalies and microcephaly in the offspring. What remains unclear is the rate of vertical transmission from mother to fetus, the risk of microcephaly, and other CNS anomalies in fetuses when maternal infection is proven and the time from exposure or infection to clinical manifestations including ultrasound anomalies. Further studies are needed to answer these important questions.
C1 [Fiorentino, D. G.; Montero, F. J.] Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Holtz Childrens Hosp 4070, 1611 NW 14 St, Miami, FL 33136 USA.
RP Montero, FJ (corresponding author), Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Holtz Childrens Hosp 4070, 1611 NW 14 St, Miami, FL 33136 USA.
EM freddyjmd@gmail.com
CR ACOG and SMFM Practice Advisory, 2016, UPD INT GUID CAR WOM
   [Anonymous], 2016, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6518e
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D., 2014, EURO SURVEILL, V19
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Society for Maternal Fetal Medicine Statement, 2016, AJOG
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
NR 21
TC 8
Z9 8
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2161-3303
J9 CURR OBSTET GYNECOL
JI CURR. OBSTET. GYNECOL. REP.
PD SEP
PY 2016
VL 5
IS 3
BP 234
EP 238
DI 10.1007/s13669-016-0171-1
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EA0DK
UT WOS:000386255500007
OA Bronze
DA 2020-07-08
ER

PT J
AU Fourcade, C
   Mansuy, JM
   Dutertre, M
   Delpech, M
   Marchou, B
   Delobel, P
   Izopet, J
   Martin-Blondel, G
AF Fourcade, Camille
   Mansuy, Jean-Michel
   Dutertre, Marine
   Delpech, Marie
   Marchou, Bruno
   Delobel, Pierre
   Izopet, Jacques
   Martin-Blondel, Guillaume
TI Viral load kinetics of Zika virus in plasma, urine and saliva in a
   couple returning from Martinique, French West Indies
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus infection; Kinetics; Plasma; Urine; RNA; Antibodies
ID INFECTION; TRANSMISSION; EPIDEMIC; BRAZIL
AB While the rapid spread of Zika virus (ZIKV) in South America has been declared a public health emergency few data are available on the kinetics of the virus load and the specific antibodies in individual patients. This report describes the kinetics of ZIKV decay in the body compartments and the kinetics of anti ZIKV IgG and IgM of two people returning from Martinique, French West Indies. ZIKV remained detectable in the plasma for roughly 2 weeks indicating that mosquito control measures should be prolonged accordingly. Remarkably, their urine samples consistently tested positive for even longer. The antibodies responses were different between the two patients but for both the rapid onset of IgM allowed a diagnosis from the end of the first week. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Fourcade, Camille; Mansuy, Jean-Michel; Dutertre, Marine; Marchou, Bruno; Delobel, Pierre; Izopet, Jacques; Martin-Blondel, Guillaume] Toulouse Univ Hosp, Toulouse, France.
   [Delpech, Marie] St Gaudens Hosp, St Gaudens, France.
   [Delobel, Pierre; Izopet, Jacques; Martin-Blondel, Guillaume] INSERM, UMR1043, Toulouse, France.
RP Martin-Blondel, G (corresponding author), Toulouse Univ Hosp, Dept Infect Dis, Pl Docteur Baylac TSA 40031, F-31059 Toulouse 9, France.
EM fourcade.c@chu-toulouse.fr; mansuy.jm@chu-toulouse.fr;
   dutertre.m@chu-toulouse.fr; marie.delpech@ch-saintgaudens.fr;
   marchou.b@chu-toulouse.fr; delobel.p@chu-toulouse.fr;
   izopet.j@chu-toulouse.fr; martin-blondel.g@chu-toulouse.fr
RI Martin-Blondel, Guillaume/K-6762-2014; Delobel, Pierre/Q-6028-2019
OI Martin-Blondel, Guillaume/0000-0002-8363-7028; Delobel,
   Pierre/0000-0002-2874-3581; IZOPET, JACQUES/0000-0002-8462-3234;
   MARCHOU, Bruno/0000-0002-0673-2945
CR Brasil P, 2016, N ENGL J MED
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huzly D, 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS
   Maria AT, 2016, EURO SURVEILL, V21
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Tappe D, 2013, EURO SURVEILL, V19
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P157, DOI 10.1016/S1473-3099(16)00023-2
NR 18
TC 25
Z9 26
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
BP 1
EP 4
DI 10.1016/j.jcv.2016.06.011
PG 4
WC Virology
SC Virology
GA DZ7DP
UT WOS:000386024900001
PM 27389909
OA Bronze
DA 2020-07-08
ER

PT J
AU Fernandes, RS
   Campos, SS
   Ferreira-de-Brito, A
   de Miranda, RM
   da Silva, KAB
   de Castro, MG
   Raphael, LMS
   Brasil, P
   Failloux, AB
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Ferreira-de-Brito, Anielly
   de Miranda, Rafaella Moraes
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   Raphael, Lidiane M. S.
   Brasil, Patricia
   Failloux, Anna-Bella
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Culex quinquefasciatus from Rio de Janeiro Is Not Competent to Transmit
   the Local Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI MOSQUITOS; POTENTIAL VECTOR; YELLOW-FEVER; DENGUE;
   ALBOPICTUS; BRAZIL; SPECIFICITY; CHIKUNGUNYA; ISOLATIONS; AMERICA
AB Background
   The Americas have suffered a dramatic epidemic of Zika since May in 2015, when Zika virus (ZIKV) was first detected in Brazil. Mosquitoes belonging to subgenus Stegomyia of Aedes, particularly Aedes aegypti, are considered the primary vectors of ZIKV. However, the rapid spread of the virus across the continent raised several concerns about the transmission dynamics, especially about potential mosquito vectors. The purpose of this work was to assess the vector competence of the house mosquito Culex quinquefasciatus from an epidemic Zika area, Rio de Janeiro, Brazil, for local circulating ZIKV isolates.
   Methodology/Principal Findings
   Culex quinquefasciatus and Ae. aegypti (positive control of ZIKV infection) from Rio de Janeiro were orally exposed to two ZIKV strains isolated from human cases from Rio de Janeiro (Rio-U1 and Rio-S1). Fully engorged mosquitoes were held in incubators at 26 +/- 1 degrees C, 12 h:12 h light: dark cycle and 70 +/- 10% humidity. For each combination mosquito population-ZIKV strain, 30 specimens were examined for infection, dissemination and transmission rates, at 7, 14 and 21 days after virus exposure by analyzing body (thorax plus abdomen), head and saliva respectively. Infection rates were minimal to completely absent in all Cx. quinquefasciatus-virus combinations and were significantly high for Ae. aegypti. Moreover, dissemination and transmission were not detected in any Cx. quinquefasciatus mosquitoes whatever the incubation period and the ZIKV isolate. In contrast, Ae. aegypti ensured high viral dissemination and moderate to very high transmission.
   Conclusions/Significance
   The southern house mosquito Cx. quinquefasciatus from Rio de Janeiro was not competent to transmit local strains of ZIKV. Thus, there is no experimental evidence that Cx. quinquefasciatus likely plays a role in the ZIKV transmission. Consequently, at least in Rio, mosquito control to reduce ZIKV transmission should remain focused on Ae. aegypti.
C1 [Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
RP Lourenco-de-Oliveira, R (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br
FU CAPES-COFECUB COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL
   SUPERIOR [799/14]; Institut Pasteur; French Government's Investissement
   d'Avenir program, aboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/102.351/2013]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309577/2013-6]; National Institut
   of Health [1UO1 AI115595-01]
FX This work was funded by CAPES-COFECUB COORDENACAO DE APERFEICOAMENTO DE
   PESSOAL DE NIVEL SUPERIOR (grant n. 799/14), the Institut Pasteur, the
   French Government's Investissement d'Avenir program, aboratoire
   d'Excellence "Integrative Biology of Emerging Infectious Diseases"(grant
   n. ANR-10-LABX-62-IBEID), Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (grant n. E-26/102.351/2013),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant n.
   309577/2013-6). National Institut of Health (grant n. 1UO1 AI115595-01).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2015, J INFECT DIS
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lourenco-De-Oliveira R, 2008, MEM I OSWALDO CRUZ, V103, P627, DOI 10.1590/S0074-02762008000700001
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL INFEC
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tognarelli J, 2015, ARCH VIROL
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, REV VECT ZIK AED
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 60
Z9 61
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004993
DI 10.1371/journal.pntd.0004993
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900048
PM 27598421
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lahon, A
   Arya, RP
   Kneubehl, AR
   Vogt, MB
   Garnes, NJMD
   Rico-Hesse, R
AF Lahon, Anismrita
   Arya, Ravi P.
   Kneubehl, Alexander R.
   Vogt, Megan B.
   Garnes, Natalie J. M. Dailey
   Rico-Hesse, Rebecca
TI Characterization of a Zika Virus Isolate from Colombia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; AEDES; CHIKUNGUNYA; INFECTIONS; MOSQUITOS; GENOTYPE; GENOMES;
   CELLS
AB Background
   Zika virus (Flavivirus genus) is the first mosquito-borne virus known to cause high rates of microcephaly and abortion in humans. Typically, Zika virus causes a self-limiting, systemic illness; however, the current outbreak of Zika virus in the Americas has been associated with increased rates of fetal malformations and Guillain-Barre syndrome. Very few Zika virus isolates have been described in the literature, and live viruses are needed to perform studies of pathogenesis and to develop vaccines and treatments.
   Methodology/Clinical findings
   We isolated Zika virus, strain FLR, directly from the serum of an individual infected in Barranquilla, Colombia (December, 2015). Here, we describe the patient's clinical course and characterize strain FLR by its growth characteristics in mosquito and mammalian cells and its partial resistance to UV-inactivation. The full genome sequence of FLR was also analyzed (including the 3'un-translated region), to determine its probable geographic origin, and to pinpoint structural differences from other Zika virus strains.
   Conclusions/Significance
   We anticipate that the study of this low passage, clinical isolate of Zika virus, which is available for worldwide distribution, will help uncover the mechanisms of viral replication and host immune responses contributing to the varied and sometimes severe clinical presentations seen during the current epidemic in the Americas.
C1 [Lahon, Anismrita; Arya, Ravi P.; Kneubehl, Alexander R.; Vogt, Megan B.; Rico-Hesse, Rebecca] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Vogt, Megan B.] Baylor Coll Med, Integrat Mol & Biol Sci Program, Houston, TX 77030 USA.
   [Garnes, Natalie J. M. Dailey] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Garnes, Natalie J. M. Dailey] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.
RP Rico-Hesse, R (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
EM rebecca.rico-hesse@bcm.edu
RI ARYA, RAVI/AAF-4108-2020
OI ARYA, RAVI/0000-0001-9255-610X; Dailey Garnes,
   Natalie/0000-0002-4016-4929
FU BCM internal funds; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI098715,
   R01AI099483]
FX Financial support was provided by BCM internal funds and NIH grants
   R01AI098715 and R01AI099483 (to RRH). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC NCID VBZID, 2016, ALL COUNTR TERR ACT
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120
   Instituto Nacional de Salud, 2015, B EP BOG
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Pfaender S, 2015, APPL ENVIRON MICROB, V81, P1616, DOI 10.1128/AEM.03580-14
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
NR 28
TC 10
Z9 10
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0005019
DI 10.1371/journal.pntd.0005019
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900063
PM 27654889
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Viennet, E
   Ritchie, SA
   Williams, CR
   Faddy, HM
   Harley, D
AF Viennet, Elvina
   Ritchie, Scott A.
   Williams, Craig R.
   Faddy, Helen M.
   Harley, David
TI Public Health Responses to and Challenges for the Control of Dengue
   Transmission in High-Income Countries: Four Case Studies
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID AEDES-AEGYPTI DIPTERA; FAR NORTH QUEENSLAND; LIFE TABLE MODEL;
   CLIMATE-CHANGE; ALBOPICTUS DIPTERA; HEMORRHAGIC-FEVER; KEY-WEST; HABITAT
   SEGREGATION; ECONOMIC-IMPACT; VECTOR CONTROL
AB Dengue has a negative impact in low-and lower middle-income countries, but also affects upper middle-and high-income countries. Despite the efforts at controlling this disease, it is unclear why dengue remains an issue in affluent countries. A better understanding of dengue epidemiology and its burden, and those of chikungunya virus and Zika virus which share vectors with dengue, is required to prevent the emergence of these diseases in high-income countries in the future. The purpose of this review was to assess the relative burden of dengue in four high-income countries and to appraise the similarities and differences in dengue transmission. We searched PubMed, ISI Web of Science, and Google Scholar using specific keywords for articles published up to 05 May 2016. We found that outbreaks rarely occur where only Aedes albopictus is present. The main similarities between countries uncovered by our review are the proximity to dengue-endemic countries, the presence of a competent mosquito vector, a largely nonimmune population, and a lack of citizens' engagement in control of mosquito breeding. We identified important epidemiological and environmental issues including the increase of local transmission despite control efforts, population growth, difficulty locating larval sites, and increased human mobility from neighboring endemic countries. Budget cuts in health and lack of practical vaccines contribute to an increased risk. To be successful, dengue-control programs for high-income countries must consider the epidemiology of dengue in other countries and use this information to minimize virus importation, improve the control of the cryptic larval habitat, and engage the community in reducing vector breeding. Finally, the presence of a communicable disease center is critical for managing and reducing future disease risks.
C1 [Viennet, Elvina; Harley, David] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
   [Viennet, Elvina; Faddy, Helen M.] Australian Red Cross Blood Serv, Res & Dev, Kelvin Grove, Qld, Australia.
   [Ritchie, Scott A.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia.
   [Williams, Craig R.] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia.
RP Viennet, E (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.; Viennet, E (corresponding author), Australian Red Cross Blood Serv, Res & Dev, Kelvin Grove, Qld, Australia.
EM eviennet@redcrossblood.org.au
RI Viennet, Elvina/M-5818-2019; Viennet, Elvina/D-9032-2017; Harley,
   David/B-4910-2017; Williams, Craig/A-1617-2011; Harley, David
   O/C-1326-2010
OI Viennet, Elvina/0000-0002-1418-1426; Viennet,
   Elvina/0000-0002-1418-1426; Harley, David/0000-0001-6691-5420; Williams,
   Craig/0000-0002-4758-1506; Faddy, Helen/0000-0002-3446-8248
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [APP1003371]
FX This work was financially supported by the National Health and Medical
   Research Council [Project Grant APP1003371] https://www.nhmrc.gov.au/
   Principal Investigator D. Harley. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Allen G., 2011, TROPICAL DIS BUZZES
   Anez G, 2013, BIOMED RES INT, V2013, P13, DOI 10.1155/2013/678645
   [Anonymous], 2016, S 200 FINE ALL HOMES
   [Anonymous], 2013, ENV ISSUES BROUGHT O
   [Anonymous], 2016, IMM VACC BIOL
   [Anonymous], 2016, SINGAPORE REPORTS DE
   [Anonymous], 2015, DENGUE SEASON DRAWS
   [Anonymous], 2015, CASES DENGUE FEVER M
   [Anonymous], 2016, ONLY DOZEN INSPECTOR
   [Anonymous], 2011, HLTH NEWS FLORIDA
   [Anonymous], 2010, WATSON WYATT HEA OCT
   [Anonymous], 2013, 46 JOBS AXED FEDERAL
   [Anonymous], 2015, IMM VACC BIOL
   [Anonymous], 2016, FLORIDAS MOSQUITO CO
   [Anonymous], 2016, S 200 FINE HOMES FOU
   [Anonymous], 2016, RESPONSES TAIWAN CAN
   [Anonymous], 2012, IMMIGRATION LAST 5 Y
   [Anonymous], 2013, AUSTR INDEPENDENT
   Arima Y, 2013, W PACIFIC SURVEILLAN, V4, DOI 10.5365/wpsar.2012.3.4.019
   Australian Bureau of Statistics, 2013, QUICKSTATS 2011 CENS
   Australian Bureau of Statistics, 2007, 2006 CENS QUICKSTATS
   Bannister-Tyrrell M, 2013, AM J TROP MED HYG, V88, P65, DOI 10.4269/ajtmh.2012.11-0451
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Bhatt S, 2013, NATURE LETT RES, P5, DOI 10.1038/nature12060
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Canyon Deon V., 2008, Journal of Vector Borne Diseases, V45, P245
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Centers for Disease Control and Prevention, 2010, MORB MORT WEEKL REP
   Centers for Disease Control ROCT, 2014, NAT NOT DIS SURV SYS
   Centers for Diseases Control Ministry of HEALTH and Welfare, 2014, 2013 2014 CTR DIS CO
   Chadee DD, 2004, B ENTOMOL RES, V94, P201, DOI 10.1079/BER2004297
   Chan R., 2015, RESIDENTS MUST TAKE
   Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001
   Changi Airport Group, 2012, REC 51 MILL PASS CHA
   Changi AirportSingapore, 2014, FACTS STAT
   Chiueh T-S, 2011, ISBT SCI SERIES, V6, P313, DOI 10.1111/j.1751-2824.2011.01535
   Church JA, 2006, AUST METEOROL MAG, V55, P253
   Constenla Dagna, 2015, Value Health Reg Issues, V8, P80, DOI 10.1016/j.vhri.2015.06.001
   Corporate Communications Division, 2013, ANN REPORT2013 CORP
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   Dale PE, 2008, J AM MOSQUITO CONTR, V24, P11
   Department of Statistics Singapore, 2014, LAT DAT
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dillon J, 2014, OFFICIAL J AUSTRALAS, V15
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Garcia-Ellin JC., 2013, INTERNAL MIGRATION P
   Gardner LM, 2012, J TROPICAL MED, V11, DOI 10.1155/2012/103679
   Giele C, 2013, INCREASING NOTIFICAT
   Goh K. T., 1997, Annals Academy of Medicine Singapore, V26, P664
   GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x
   Hanna Jeffrey N, 2003, Commun Dis Intell Q Rep, V27, P384
   Hanna JN, 1998, MED J AUSTRALIA, V168, P221, DOI 10.5694/j.1326-5377.1998.tb140134.x
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   Hanna JN, 2009, COMMUN DIS INTELL, V33, P1
   Hare FE, 1898, AUSTR MED GAZ, V17, P98
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hayden MH, 2015, AM J TROP MED HYG, V93, P397, DOI 10.4269/ajtmh.15-0128
   Health Florida, 2013, FLOR ARB SURV DEC 30
   Health Florida, 2014, FLOR ARB SURV WEEK 1
   Health Florida, 2015, FLOR ARB SURV WEEK 5
   Health Florida, 2014, MART COUNT DENG OUTB
   Health Queensland. Queensland, 2011, DENG FEV MAN PLAN DM
   HIA Economics Group Research Note, 2013, AUSTR POP GROWTH CUR
   Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hribar LG, 2013, LIFE EXCIT BIOL, V1
   Hsieh CJ, 2013, EUROPEAN J HLTH, V5
   Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   KAY BH, 1984, MED J AUSTRALIA, V140, P264, DOI 10.5694/j.1326-5377.1984.tb104033.x
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Key West Chamber of Commerce, 2009, KEY W STAT TOUR
   Khalik S., 2013, ASIAONE YOUR HLTH
   King Chwan-Chuen, 2000, Dengue Bulletin, V24, P1
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Kuan MM, 2010, INT J INFECT DIS, V14, pE693, DOI 10.1016/j.ijid.2009.12.010
   Kutsuna Satoshi, 2015, Kansenshogaku Zasshi, VSuppl 13, P34
   Lee AS., NEA LOOKING INFECT A
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Leggat PA, 2009, TRAVEL MED INFECT DI, V7, P212, DOI 10.1016/j.tmaid.2009.03.007
   Lei HuanYao, 2002, Dengue Bulletin, V26, P14
   Ler TS, 2011, WEST PAC SURVEILL RE, V2, P24, DOI [10.5365/WPSAR.2010.1.1.011, 10.5365/wpsar.2010.1.1.011]
   Lima-Camara TN, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/0074-0276130381
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   LIN H-M, 1986, Chinese Journal of Microbiology and Immunology (Taipei), V19, P218
   Liu YT, 2012, EPIDEMIOL B, V23, P193
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Mayurasakorn S, 2010, SE ASIAN J TROP MED, V41, P858
   McBride WJH, 2005, MED J AUSTRALIA, V183, P35, DOI 10.5694/j.1326-5377.2005.tb06889.x
   McBride WJH, 1998, EPIDEMIOLOGY INFECT, V121, P151, DOI [10.1017/S0950268898001058, DOI 10.1017/S0950268898001058]
   McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961
   McKerr C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003639
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, P6
   Medical Society of Victoria, 1873, AUSTR MED J
   *MIN HLTH SING, 2006, COMM DIS SURV SING 2
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Ministry of Health Singapore, 2016, WEEKL INF DIS B EP W
   Ministry of Health Singapore, 2012, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2002, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2013, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2007, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2014, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2005, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2015, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2001, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2011, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2010, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2008, COMM DIS SURV SING 2
   Ministry of Helath Singapore, 2009, COMM DIS SURV SING 2
   Ministry of Transportation ROC, 2014, BOLST CROSS STRAIT I
   Misra Y, 2011, EC PENALTY DENGUE
   Montgomery BL, 2004, J AM MOSQUITO CONTR, V20, P365
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   National Environment Agency, 2011, CLEAN SING SOC STUD
   National Environment Agency, 2014, LAT DENG DAT
   National Notifiable Diseases Surveillance System, 2016, NUMB NOT DENG VIR IN
   NNDSS Annual ReportWriting Group, 2012, AUSTR NOT DIS STAT 2
   O'Shea J., 2013, Advance Tropical Medicine and Public Health International, V3, P32
   [Office of the Assistant Secretary for Research and Technology Bureau of Transportation Statistics Transportation USDo], 2014, AIRL SYST PASS 0 8 P
   Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012
   Ong SGJ., 2015, EACH TIME NEA OFFICE
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Organization WH, 1997, DENG DENG HAEM FEV D, V84
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Publication of the Committee on Epidemic Diseases, 2003, EPIDEMIOLOGICAL NEWS, V29
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Russell BM, 2002, J MED ENTOMOL, V39, P143, DOI 10.1603/0022-2585-39.1.143
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Seet RCS, 2005, J CLIN VIROL, V33, P336, DOI 10.1016/j.jcv.2005.03.002
   Septfons A, 2014, REV EPIDEMIOLOGIE SA, V62, pS234
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Singapore DoS, 2015, POP POP STRUCT KEY D
   Sipe NG, 2011, 3 WORLD PLANN SCH C
   Stahl H-C, 2013, BMC PUBLIC HEALTH, V13, P1, DOI 10.1186/1471-2458-13-1048
   State of Queensland (Queensland Health), 2015, QUEENSL DENG MAN PLA
   Storr KA, 2014, SCI BITES BACK RELEA
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Teets F.D., 2013, VIROL REP, V1-2, P2, DOI DOI 10.1016/J.VIREP.2014.05.001.HTTP://WWW.SCIENCEDIRECT.C0M/SCIENCE/ARTICLE/PII/
   Teng HJ, 2007, JPN J INFECT DIS, V60, P271
   The World Bank, 2014, UPD INC CLASS
   Thein TunLinn, 2011, Dengue Bulletin, V35, P76
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tropical public health news, 2015, TROPICAL PUBLIC HLTH
   Tseng WC, 2009, CLIMATIC CHANGE, V92, P123, DOI 10.1007/s10584-008-9437-6
   U.S. Department of the Interior U.S. Geological Survey, 2014, DENG FEV LOC ACQ HUM
   U.S. Departmentof the Interior U.S. Geological Survey, 2014, DENG FEV IMP HUM
   United States Census Bureau, 2016, QUICKFACTS LEE COUNT
   Vannice KS, VACCINE
   Vazquez-Prokopec G, 2010, PLOS NEGL TROP DIS, V4
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422
   Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46
   Warrilow D, 2012, EMERG INFECT DIS, V18, P1850, DOI 10.3201/eid1811.120014
   Williams CR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-447
   Williams CR, 2012, T ROY SOC SOUTH AUST, V136, P128, DOI 10.1080/03721426.2012.10887167
   Williams CR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000922
   Williams N, 2010, CURR BIOL, V20, pR1004, DOI 10.1016/j.cub.2010.11.047
   World Health Organization, 2014, GLOB HLTH EST 2014 S
   World Health Organization, 1997, DENG HAEM FEV DIAGN, pviii
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
   Yang YY, 2010, J INSECT PHYSIOL, V56, P1219, DOI 10.1016/j.jinsphys.2010.03.028
   Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150
   Yu HL, 2011, STOCH ENV RES RISK A, V25, P485, DOI 10.1007/s00477-010-0417-9
NR 203
TC 11
Z9 12
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004943
DI 10.1371/journal.pntd.0004943
PG 33
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900019
PM 27643596
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Byler, KG
   Ogungbe, IV
   Setzer, WN
AF Byler, Kendall G.
   Ogungbe, Ifedayo Victor
   Setzer, William N.
TI In-silico screening for anti-Zika virus phytochemicals
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE Zika virus; Neglected tropical disease; Homology model; Molecular
   docking
ID WEST-NILE-VIRUS; RESISTANT STAPHYLOCOCCUS-AUREUS; MOLECULAR-FORCE FIELD;
   HAIRY ROOT CULTURES; SOPHORA-FLAVESCENS; GLYCYRRHIZA-GLABRA; DRUG
   DISCOVERY; ANTIBACTERIAL ACTIVITY; TRIBULUS-TERRESTRIS;
   CIMICIFUGA-RACEMOSA
AB Zika virus (ZIKV) is an arbovirus that has infected hundreds of thousands of people and is a rapidly expanding epidemic across Central and South America. ZIKV infection has caused serious, albeit rare, complications including Guillain Barre syndrome and congenital microcephaly. There are currently no vaccines or antiviral agents to treat or prevent ZIKV infection, but there are several ZIKV non-structural proteins that may serve as promising antiviral drug targets. In this work, we have carried out an insilico search for potential anti-Zika viral agents from natural sources. We have generated ZIKV protease, methyltransferase, and RNA-dependent RNA polymerase using homology modeling techniques and we have carried out molecular docking analyses of our in-house virtual library of phytochemicals with these protein targets as well as with ZIKV helicase. Overall, 2263 plant-derived secondary metabolites have been docked. Of these, 43 compounds that have drug-like properties have exhibited remarkable docking profiles to one or more of the ZIKV protein targets, and several of these are found in relatively common herbal medicines, suggesting promise for natural and inexpensive antiviral therapy for this emerging tropical disease. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Byler, Kendall G.; Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   [Ogungbe, Ifedayo Victor] Jackson State Univ, Dept Chem & Biochem, Jackson, MS 39217 USA.
RP Setzer, WN (corresponding author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
EM wsetzer@chemistry.uah.edu
RI Byler, Kendall/X-7084-2019
OI Setzer, William N./0000-0002-3639-0528
CR Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6
   Asada Y, 1999, PHYTOCHEMISTRY, V50, P1015, DOI 10.1016/S0031-9422(98)00623-2
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   BARRETT ML, 1986, EXPERIENTIA, V42, P452, DOI 10.1007/BF02118655
   BAUER RFX, 1985, HELV CHIM ACTA, V68, P2355, DOI 10.1002/hlca.19850680831
   Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7
   Bischoff TA, 2004, J ETHNOPHARMACOL, V95, P455, DOI 10.1016/j.jep.2004.06.031
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carta G, 2007, J CHEM INF MODEL, V47, P1564, DOI 10.1021/ci600471m
   Case D.A., 2008, AMBER 10, V10
   Cha JD, 2009, PHYTOTHER RES, V23, P1326, DOI 10.1002/ptr.2540
   Chan BCL, 2012, J CHROMATOGR B, V880, P157, DOI 10.1016/j.jchromb.2011.11.039
   Chanphen R, 1998, J NAT PROD, V61, P1146, DOI 10.1021/np980041x
   de Andrade-Neto VF, 2007, ANTIMICROB AGENTS CH, V51, P2346, DOI 10.1128/AAC.01344-06
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Falk SP, 2014, J BIOMOL SCREEN, V19, P1147, DOI 10.1177/1087057114533147
   Felippe LG, 2008, PHYTOCHEMISTRY, V69, P445, DOI 10.1016/j.phytochem.2007.08.012
   Fernandez LS, 2009, ORG LETT, V11, P329, DOI 10.1021/ol802506n
   FIEBIG M, 1984, PLANTA MED, V50, P310, DOI 10.1055/s-2007-969717
   Fukai T, 1998, PHYTOCHEMISTRY, V49, P2005, DOI 10.1016/S0031-9422(98)00389-6
   Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   HATAYAMA K, 1971, CHEM PHARM BULL, V19, P2126
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hu K, 1997, PHYTOCHEMISTRY, V44, P1339
   Inui S, 2012, J AGR FOOD CHEM, V60, P11765, DOI 10.1021/jf303516w
   Kim SJ, 2003, BIOL PHARM BULL, V26, P1348, DOI 10.1248/bpb.26.1348
   Kouam J, 2011, INT J CHEM, V3, P23
   Kruse SO, 1999, PLANTA MED, V65, P763, DOI 10.1055/s-2006-960862
   Kuete V, 2007, J ETHNOPHARMACOL, V112, P271, DOI 10.1016/j.jep.2007.03.008
   Kuroyanagi M, 1999, J NAT PROD, V62, P1595, DOI 10.1021/np990051d
   Kwon HJ, 2015, J PHARMACOL SCI, V128, P159, DOI 10.1016/j.jphs.2015.04.007
   Lavoie S, 2013, TETRAHEDRON LETT, V54, P1631, DOI 10.1016/j.tetlet.2012.12.012
   Lescar J, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P101
   Li W, 1998, PLANTA MED, V64, P746, DOI 10.1055/s-2006-957571
   Li W, 2000, PHYTOCHEMISTRY, V55, P447, DOI 10.1016/S0031-9422(00)00337-X
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MIKAYA GA, 1981, PLANTA MED, V43, P378, DOI 10.1055/s-2007-971527
   MITSCHER LA, 1985, PHYTOCHEMISTRY, V24, P2885, DOI 10.1016/0031-9422(85)80020-0
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Narender T, 2005, BIOORG MED CHEM LETT, V15, P2453, DOI 10.1016/j.bmcl.2005.03.081
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oshimi S, 2009, J NAT PROD, V72, P1899, DOI 10.1021/np9004213
   Pan YP, 2003, J CHEM INF COMP SCI, V43, P267, DOI 10.1021/ci020055f
   PARNHAM M J, 1985, Drugs of the Future, V10, P756
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Salem MM, 2011, PHYTOTHER RES, V25, P1246, DOI 10.1002/ptr.3404
   Schmidt TJ, 2012, PHYTOCHEM LETT, V5, P632, DOI 10.1016/j.phytol.2012.06.011
   Sendl A, 1996, J NAT PROD, V59, P808, DOI 10.1021/np9601871
   Smejkal K, 2008, J NAT PROD, V71, P706, DOI 10.1021/np070446u
   Smejkal K, 2010, J NAT PROD, V73, P568, DOI 10.1021/np900681y
   Steuber H, 2015, TOP MED CHEM SER, V15, P93, DOI 10.1007/7355_2014_46
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Stromeier S, 2005, PLANTA MED, V71, P495, DOI 10.1055/s-2005-864148
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   TILLEQUIN F, 1979, LLOYDIA, V42, P92
   Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   Wu TS, 1999, PHYTOCHEMISTRY, V50, P1411, DOI 10.1016/S0031-9422(97)01086-8
   Xu TH, 2009, FITOTERAPIA, V80, P354, DOI 10.1016/j.fitote.2009.05.002
   Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387
   Yin S, 2004, BIOORGAN MED CHEM, V12, P4387, DOI 10.1016/j.bmc.2004.06.014
   Yoshikawa M, 1997, CHEM PHARM BULL, V45, P81, DOI 10.1248/cpb.45.81
   YOSHIZAKI F, 1982, CHEM PHARM BULL, V30, P4407
   Zhang BB, 2010, FITOTERAPIA, V81, P948, DOI 10.1016/j.fitote.2010.06.015
NR 84
TC 27
Z9 29
U1 2
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD SEP
PY 2016
VL 69
BP 78
EP 91
DI 10.1016/j.jmgm.2016.08.011
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA DZ1KP
UT WOS:000385597600008
PM 27588363
OA Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Imported Thai patient with Zika virus to Taiwan: What else should be
   known and discussed?
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
ID INFECTION
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok 10160, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Sumatovacka, Nis, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Osun State, Nigeria.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 3
Z9 3
U1 0
U2 64
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD SEP
PY 2016
VL 115
IS 9
BP 822
EP 822
DI 10.1016/j.jfma.2016.06.003
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ4HH
UT WOS:000385818800020
PM 27364879
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Sheffield, J
   Segars, J
AF Sheffield, Jeanne
   Segars, James
TI Zika Virus: A Race to Prevent a Reproductive Crisis Preface
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Editorial Material
C1 [Sheffield, Jeanne] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.
   [Segars, James] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 624 Ross,720 Rutland, Baltimore, MD 21205 USA.
RP Segars, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 624 Ross,720 Rutland, Baltimore, MD 21205 USA.
EM jsegars2@jhmi.edu
CR Chaves-Carballo E, 2005, MIL MED, V170, P881, DOI 10.7205/MILMED.170.10.881
   Finlay C, 1937, Yale J Biol Med, V9, P589
   Pierce JR, 2005, YELLOW JACK YELLOW F
NR 3
TC 1
Z9 1
U1 0
U2 2
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 259
EP 260
DI 10.1055/s-0036-1592065
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400003
PM 27589583
OA Bronze
DA 2020-07-08
ER

PT J
AU Schirmer, DA
   Kawwass, JF
AF Schirmer, David A.
   Kawwass, Jennifer Fay
TI Epidemiology, Virology, and Pathogenesis of the Zika Virus: From
   Neglected Tropical Disease to a Focal Point of International Attention
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika virus; microcephaly; review; pregnancy; assisted reproductive
   technology (ART); in vitro fertilization
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; CHIKUNGUNYA VIRUS; INFECTION;
   TRANSMISSION; OUTBREAK; SPREADS; AMERICA; NIGERIA; BRAZIL
AB Over the past year, the Zika virus, an arthropod-borne Flavivirus, has transitioned from a relatively unknown tropical disease to the cause of a public health emergency. The Zika virus is transmitted by the Aedes species of mosquito as well as by sexual intercourse. Although the symptoms of acute Zika virus infection are usually mild and self-limited, it causes fetal microcephaly in pregnant women, and is associated with an increased risk of Guillain Barre syndrome. The risk of microcephaly from Zika virus infection is estimated to be highest in women who are infected during the first trimester of pregnancy. The Zika virus has been shown to have significant neurotrophism in vivo and in vitro, although further study is needed to characterize its mechanisms of pathogenesis. Zika virus has previously caused two known outbreaks in the Pacific region prior to the current epidemic in South and Central America, and the current epidemic has affected at least 440,000 to 1,300,000 people. The population of the vector for the current epidemic, Aedes aegypti, varies seasonally in the United States, however there have been few documented cases of local spread of the Zika infection in the United States and it is unclear whether epidemic spread of Zika will occur within the United States.
C1 [Schirmer, David A.; Kawwass, Jennifer Fay] Emory Reprod Ctr, Endocrinol & Infertil Div, Dept Gynecol & Obstet, 550 Peachtree St NE,MOT Bldg,Suite 1800, Atlanta, GA 30308 USA.
RP Kawwass, JF (corresponding author), Emory Reprod Ctr, Endocrinol & Infertil Div, Dept Gynecol & Obstet, 550 Peachtree St NE,MOT Bldg,Suite 1800, Atlanta, GA 30308 USA.
EM jennifer.kawwass@emory.edu
RI Schirmer, David A./Y-5182-2019
OI Schirmer, David A./0000-0003-4522-3446; Kawwass,
   Jennifer/0000-0001-7345-735X
CR Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P556
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P544
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 53
TC 2
Z9 2
U1 0
U2 19
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 261
EP 265
DI 10.1055/s-0036-1592069
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400004
PM 27618294
DA 2020-07-08
ER

PT J
AU Nayak, S
   Lei, J
   Pekosz, A
   Klein, S
   Burd, I
AF Nayak, Shriddha
   Lei, Jun
   Pekosz, Andrew
   Klein, Sabra
   Burd, Irina
TI Pathogenesis and Molecular Mechanisms of Zika Virus
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika; microcephaly; congenital malformations; pathogenicity; mouse
   models
ID NEURAL PROGENITORS; INFECTION; TRANSMISSION; BRAIN; BIOLOGY; BRAZIL;
   MODEL
AB Zika virus (ZIKV) is one of the most important emerging viruses of 2016. A developing outbreak in the Americas has demonstrated an association between the virus and serious clinical manifestations, such as Guillain Barre syndrome in adults and congenital malformations in infants born to infected mothers. Pathogenesis and mechanisms of neurologic or immune disease by ZIKV have not been clearly delineated. However, several pathways have been described to explain viral involvement in brain and immune system as well as other organ systems such as eye, skin, and male and female reproductive tracts. ZIKV activates toll-like receptor 3 and several pathways have been described to explain the mechanisms at a molecular level. The mechanism of microcephaly has been more difficult to demonstrate experimentally, likely due to the multifactorial and complex nature of the phenotype. This article provides an overview of existing literature on ZIKV pathogenicity and possible molecular mechanisms of disease as outlined to date.
C1 [Nayak, Shriddha; Lei, Jun; Burd, Irina] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, 600 North Wolfe st,Phipps 228, Baltimore, MD 21287 USA.
   [Pekosz, Andrew; Klein, Sabra] Johns Hopkins Univ Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.
RP Burd, I (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, 600 North Wolfe st,Phipps 228, Baltimore, MD 21287 USA.
EM iburd@jhmi.edu
OI Pekosz, Andrew/0000-0003-3248-1761
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC Health Alert Network, 2016, REC MAN REP ZIK VIR
   Centers for Disease Control and Prevention, 2016, OUTC PREGN LAB EV PO
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   International Committee on Taxonomy of Viruses, VIRUS TAXONOMY
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization/World Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization/World Health Organization, 2016, GUILLAIN BARRE SYNDR
   Pan American Health Organization/World Health Organization, 2016, REG ZIK EP UPD AM 2
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, CURR ZIK PROD PIP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 67
TC 10
Z9 11
U1 0
U2 144
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 266
EP 272
DI 10.1055/s-0036-1592071
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400005
PM 27612156
OA Bronze
DA 2020-07-08
ER

PT J
AU Eloundou, SN
   Sheffield, JS
AF Eloundou, Solange N.
   Sheffield, Jeanne S.
TI Prenatal Effects of Zika Virus and Management of the Pregnant Woman
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika virus; pregnancy; microcephaly; perinatal infection
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; SEXUAL TRANSMISSION;
   REPRODUCTIVE AGE; INFECTION; WOMEN; GUIDELINES; OUTBREAK; EXPOSURE
AB The identification of Zika virus as a significant teratogen has raised international concern, causing the World Health Organization to declare a Public Health Emergency of International Concern. This has allowed a global mobilization of experts in tropical infectious diseases, obstetrics, pediatrics, virology, public health policy, reproductive health, bioethics, and germ cell research to name just a few. This worldwide crisis has also raised awareness of health care disparities and concerns regarding the ability of families and societies to shoulder the long-term financial burden that the follow-up of affected children will require. There is now strong biologic evidence of causality between Zika virus and microcephaly and other neurologic abnormalities identified. Multiple national and international organizations have collaborated to develop guidelines for the management of pregnant women who reside in or who are exposed to Zika virus, whether from travel to affected areas or via sexual contact with an infected individual. These guidelines are updated frequently as data are made available. Testing algorithms are available and though testing is fraught with interpretation issues, the development of better diagnostic tests is ongoing.
C1 [Eloundou, Solange N.; Sheffield, Jeanne S.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Baltimore, MD 21205 USA.
RP Eloundou, SN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, 600 North Wolfe St,Phipps 228, Baltimore, MD 21287 USA.
EM selound1@jhmi.edu
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2016, INF FEED AR ACT ZIK
   [Anonymous], 2016, REC MAN REP ZIK VIR
   [Anonymous], 2016, PRACTICE ADVISORY UP
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, INS REP US SAF
   Centers for Disease Control and Prevention, US ZIK PREGN REG
   Centers for Disease Control and Prevention, 2016, PREC COUNS WOM MEN L
   Chibueze EC, 2016, B WHO
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Environmental Protection Agency, REP TREAT CLOTH
   Franca GV, 2016, LANCET
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization. World Health Organization, 2015, EPID AL NEUR SYNDR C
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 38
TC 0
Z9 0
U1 1
U2 86
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 280
EP 284
DI 10.1055/s-0036-1592073
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400007
PM 27612155
DA 2020-07-08
ER

PT J
AU Gornet, ME
   Bracero, NJ
   Segars, JH
AF Gornet, Megan E.
   Bracero, Nabal J.
   Segars, James H.
TI Zika Virus in Semen: What We Know and What We Need to Know
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika; semen; sexual transmission; male
ID UPDATE INTERIM GUIDANCE; MALE SEXUAL TRANSMISSION; UNITED-STATES;
   PREVENTION; INFECTION; GUIDELINES; EMERGENCE; DISEASE; BORNE; MODEL
AB The emergence of the Zika virus (ZIKV) epidemic in South and Central America has ascended to the forefront of international attention. While research regarding the effects and details surrounding ZIKV in pregnancy is well underway, especially related to blood-borne transmission, less attention has been devoted to ZIKV infection in semen and questions concerning implications of ZIKV infection in men. In this review, we present what is known and unknown, and the implications for localization of ZIKV to the male urogenital system. We examine the duration and viral load of ZIKV in semen, male and female transmission of ZIKV, the asymptomatic male carrier, and the consequences for assisted reproductive technology and sperm banking facilities. Furthermore, we discuss the potential for active ZIKV transmission in the United States as world travel continues to rise and the evolution and case history of ZIKV sexual transmission. We also review the current government-sponsored and reproductive society recommendations for managing sexual transmission of ZIKV and elucidate future research needs.
C1 [Gornet, Megan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Bracero, Nabal J.] Univ Puerto Rico, Sch Med, Dept Obstet & Gynecol, San Juan, PR 00936 USA.
   [Segars, James H.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624, Baltimore, MD 21205 USA.
RP Segars, JH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624, Baltimore, MD 21205 USA.
EM jsegars2@jhmi.edu
CR [Anonymous], 2016, TSA PREP MILL SPRING
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ball GD, 2016, GUIDANCE PROVIDERS C
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   CDC, 2016, ZIK VIR
   Center for Disease Control, 2014, CHIK VIR US
   Center for Disease Control, 2015, ZIK VIR DIS US
   Center for Disease Control, SURV CONTR AED ALB U
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Central Intelligence Agency, WORLD FACTB 2013 201
   Coelho FC, SEXUAL TRANSMISSION
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deen GF, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJMOA1511410]
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards MS, 2015, PEDIATR DEVEL PATHOL, V18, P155, DOI 10.2350/14-09-1548-CR.1
   Elder K, 2005, PLOS ONE
   Elder K, 2005, INFECTIONS INFER 2 3
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Food and Drug Administration, REC DON SCREEN DEF P
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Fourie JM, 2015, REPROD BIOMED ONLINE, V30, P296, DOI 10.1016/j.rbmo.2014.11.008
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EURO SURVEILL, V21
   Freour T, 2016, EURO SURVEIL, V21
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gardella B, 2011, CURR HIV RES, V9, P313, DOI 10.2174/157016211797636017
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Habu A, 1977, Uirusu, V27, P21
   Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569
   International Trade Administration. National Travel and Tourism Office, 2014, US TRAV TOUR STAT US
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Magli MC, 2008, HUM REPROD, V23, P1253, DOI 10.1093/humrep/den068
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Merino O, 2015, ANDROLOGIA, V47, P186, DOI 10.1111/and.12246
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization. World Health Organization, ZIK EPID UPD
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sifferlin Alexandria, TIME
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   VESTERGAARD BF, 1971, AM J PATHOL, V64, P541
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization Pan American Health Organization, 2016, BLOOMB SCH PUBL HLTH
NR 58
TC 16
Z9 16
U1 0
U2 31
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 285
EP 292
DI 10.1055/s-0036-1592312
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400008
PM 27627657
DA 2020-07-08
ER

PT J
AU Washington, CI
   Hague, S
   Segars, JH
   Bracero, N
   Rodriguez, F
   Ball, GD
   Davis, OK
AF Washington, Chantel I.
   Hague, Sara
   Segars, James H.
   Bracero, Nabal
   Rodriguez, Fernando
   Ball, G. David
   Davis, Owen K.
TI Keeping the Zika Virus Out of the Assisted Reproductive Technology
   Laboratory
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika virus; assisted reproductive technology; sexual transmission;
   laboratory
ID HEPATITIS-B; CULTURE-MEDIA; TRANSMISSION; INFECTION; EMBRYOS; WOMEN;
   SUSCEPTIBILITY; CONTAMINATION; OOCYTES; BRAIN
AB The Zika virus (ZIKV) epidemic spreading through South and Central America, as well as several U.S. territories has created worldwide concern as the linkage between ZIKV infection and microcephaly has been established. Both travel associated and sexually transmitted cases have put couples who live in nonendemic areas at risk of falling victim to effects of Zika. The presence of ZIKV within reproductive tissues may pose a significant threat to patients seeking fertility services and to safety of the tissues currently housed in assisted reproductive technology (ART) laboratories. There are still many unanswered questions regarding the mechanism of ZIKV sexual transmission. Just as strict guidelines have been set regarding the screening and handling of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus-positive patient tissues, similar recommendations are needed to prevent contamination and inadvertent transmission within the ART laboratory.
C1 [Washington, Chantel I.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Endocrinol & Infertil, Baltimore, MD 21205 USA.
   [Hague, Sara; Segars, James H.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, Baltimore, MD 21205 USA.
   [Bracero, Nabal] GENES Fertil Inst, San Juan, PR USA.
   [Rodriguez, Fernando] Univ Puerto Rico, Sch Med, GENES Fertil Inst, Dept Obstet & Gynecol, San Juan, PR 00936 USA.
   [Ball, G. David] Seattle Reprod Med, Seattle, WA USA.
   [Davis, Owen K.] Weill Cornell Med Coll, Ctr Reprod Med & Infertil, Dept Obstet & Gynecol & Reprod Med, 1305 York Ave, New York, NY 10021 USA.
RP Davis, OK (corresponding author), Weill Cornell Med Coll, Ctr Reprod Med & Infertil, Dept Obstet & Gynecol & Reprod Med, 1305 York Ave, New York, NY 10021 USA.
EM okdavis@med.cornell.edu
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS45, DOI 10.1016/j.fertnstert.2008.08.099
   ARANETA MRG, 1995, JAMA-J AM MED ASSOC, V273, P854, DOI 10.1001/jama.273.11.854
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BERRY WR, 1987, JAMA-J AM MED ASSOC, V257, P1079, DOI 10.1001/jama.257.8.1079
   Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227
   Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US
   CHAN PJ, 1995, GYNECOL ONCOL, V58, P194, DOI 10.1006/gyno.1995.1209
   CHAN PJ, 1992, J ASSIST REPROD GEN, V9, P531, DOI 10.1007/BF01204249
   Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Devaux A, 2003, HUM REPROD, V18, P2342, DOI 10.1093/humrep/deg431
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gimenes F, 2014, NAT REV UROL, V11, P672, DOI 10.1038/nrurol.2014.285
   Gornet M, 2006, SEMIN REPROD MED
   Ma MF, 2016, CLIN LAB, V62, P1, DOI 10.7754/Clin.Lab.2015.150706
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NEIGHBOUR PA, 1978, J REPROD FERTIL, V54, P15, DOI 10.1530/jrf.0.0540015
   Palermo GD, 2009, SEMIN REPROD MED, V27, P191, DOI 10.1055/s-0029-1202309
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebourbi L, 2002, HUM REPROD, V17, P760, DOI 10.1093/humrep/17.3.760
   TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X
   The Association of American Blood Banks, 2016, ZIK DENG CHIK VIR, V16-04
   Vanroose G, 1997, THERIOGENOLOGY, V47, P1389, DOI 10.1016/S0093-691X(97)00130-1
   Wong KM, 2014, FERTIL STERIL, V102, P19, DOI 10.1016/j.fertnstert.2014.05.027
NR 37
TC 7
Z9 7
U1 1
U2 8
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 293
EP 298
DI 10.1055/s-0036-1592067
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400009
PM 27618295
DA 2020-07-08
ER

PT J
AU Durbin, AP
AF Durbin, Anna P.
TI Vaccine Development for Zika Virus-Timelines and Strategies
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE Zika virus; vaccines; DNA vaccine
ID TETRAVALENT DENGUE VACCINE; I CLINICAL-TRIAL; UNITED-STATES; SEXUAL
   TRANSMISSION; HEMORRHAGIC-FEVER; ANTIBODY; ADULTS; INFECTION;
   ENHANCEMENT; ADOLESCENTS
AB Zika virus is a mosquito-borne Flavivirus that spread rapidly through South and Central America in 2015 to 2016. Microcephaly has been causally associated with Zika virus infection during pregnancy and the World Health Organization declared Zika virus as a Public Health Emergency of International Concern. To address this crisis, many groups have expressed their commitment to developing a Zika virus vaccine. Different strategies for Zika virus vaccine development are being considered including recombinant live attenuated vaccines, purified inactivated vaccines (PIVs), DNA vaccines, and viral vectored vaccines. Important to Zika virus vaccine development will be the target group chosen for vaccination and which end point(s) is chosen for efficacy determination. The first clinical trials of Zika virus vaccine candidates will begin in Q3/4 2016 but the pathway to licensure for a Zika virus vaccine is expected to take several years. Efforts are ongoing to accelerate Zika virus vaccine development and evaluation with the ultimate goal of reducing time to licensure.
C1 [Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA.
RP Durbin, AP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA.
EM adurbin1@jhu.edu
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, DOI [10.1038/nature18952, DOI 10.1038/NATUREL8952]
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Poo J, 2011, PEDIATR INFECT DIS J, V30, pE9, DOI 10.1097/INF.0b013e3181fe05af
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   WHO, 2016, WHO GLOB CONS RES RE
   World Health Organization, 2016, WHO EXP PRIOR VACC D
NR 43
TC 25
Z9 25
U1 0
U2 23
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 299
EP 304
DI 10.1055/s-0036-1592070
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400010
PM 27607566
OA Bronze
DA 2020-07-08
ER

PT J
AU Burke, A
   Moreau, C
AF Burke, Anne
   Moreau, Caroline
TI Family Planning and Zika Virus: The Power of Prevention
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE contraception; family planning; abortion; Zika
ID SEXUAL TRANSMISSION; UNITED-STATES; PUERTO-RICO; CONTRACEPTION; BRAZIL;
   PREGNANCY; WOMEN
AB The connection between infection with the Zika virus (ZKV) and congenital anomalies such as microcephaly has been generally accepted. Although efforts are underway to develop preventive interventions such as vaccines, these are not yet available. Family planning is an effective preventive approach that has been underemphasized in many lists of research priorities. In addition to acquisition of ZKV from mosquitoes, sexual transmission from males to females has been documented. Women at risk of ZKV need access to effective contraception if they want to avoid or postpone pregnancy, as well as access to safe abortion. There is often overlap between areas where risk of ZKV acquisition is highest, and areas where access to reproductive health services may be more limited. Data on the impact of ZKV on contraceptive use and abortion are sparse, but a few studies have begun to address these questions. ZKV highlights the need to provide at-risk women and couples with effective means to prevent or postpone childbearing. Contraception, prenatal care, and safe abortion should be available to all women.
C1 [Burke, Anne] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Johns Hopkins Bayview Med Ctr, 4940 Eastern Ave, Baltimore, MD 21224 USA.
   [Burke, Anne; Moreau, Caroline] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
RP Burke, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Johns Hopkins Bayview Med Ctr, 4940 Eastern Ave, Baltimore, MD 21224 USA.
EM aburke@jhmi.edu
RI Moreau, Caroline/A-8989-2019
OI Moreau, Caroline/0000-0002-8637-6249
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], 2016, Community Pract, V89, P6
   [Anonymous], 2016, BBC NEWS
   [Anonymous], 2016, ECONOMIST
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Belluck P., 2016, NY TIMES
   Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2016, INT CDC ZIK IN PRESS
   Centers for Disease Control and Prevention, 2016, CDC TEST ALG PREGN W
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daniels JP, 2015, LANCET, V385, P1495, DOI 10.1016/S0140-6736(15)60738-3
   Daniels Kimberly, 2014, NCHS Data Brief, P1
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Dreweke J, 2016, GUTTMACHER POLICY RE, V19
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Guttmacher Institute, 2014, INV SEX REPR HLTH LA
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   International Consortium for Emergency Contraception, STAT AV DAT
   Kost K., 2015, UNINTENDED PREGNANCY
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Machado-Alba JE, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30429-9
   McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3462
   Minowa E, 2015, VALUE HEALTH, V18, pA832, DOI 10.1016/j.jval.2015.09.327
   National Institutes of Health, 2016, NOT NICHD NINDS NIDC
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuck-Paim Cynthia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.7038a6813f734c1db547240c2a0ba291
   Singh S, 2012, ADDING IT COSTS BENE
   Tavares MP, 2016, CONTRACEPTION, V94, P109, DOI 10.1016/j.contraception.2016.04.006
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   United Nations Department of Economic and Social Affairs, 2014, AB POL REPR HLTH WOR
   United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD CONTR US 2015
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization, 2016, ZIK STRAT RESP PLAN
   World Health Organization, 2016, WHOZIKVMOC161
   Yaneer B-Y, 2016, IS ZIKA CAUSE MICROC
NR 43
TC 5
Z9 5
U1 0
U2 116
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 305
EP 311
DI 10.1055/s-0036-1592068
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400011
PM 27612157
DA 2020-07-08
ER

PT J
AU Sukkaromdee, P
   Wiwanikit, V
AF Sukkaromdee, Pathoom
   Wiwanikit, Viroj
TI Seasonal variation of Zika infection case reports in Thailand
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sukkaromdee, Pathoom] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanikit, Viroj] Hainan Med Univ, Dept Trop Med, Hainan, Peoples R China.
RP Sukkaromdee, P (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Dash AP, 2013, J VECTOR DIS, V50, P77
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
BP 357
EP 357
DI 10.4103/1755-6783.190200
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA DX3EK
UT WOS:000384256000016
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Zika virus infection, do medical personnel know about the situation?
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Chulalongkorn Univ, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
   Wiwanitkit V, 2015, ANN TROP MED PUBLIC, V8, P311, DOI 10.4103/1755-6783.162666
NR 4
TC 4
Z9 4
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
BP 361
EP U110
DI 10.4103/1755-6783.190206
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DX3EK
UT WOS:000384256000022
DA 2020-07-08
ER

PT J
AU Wiwanikwit, S
   Wiwanitkit, V
AF Wiwanikwit, Somsri
   Wiwanitkit, Viroj
TI Zika virus infection: No anemia
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
ID BIRD FLU; THAILAND
C1 [Wiwanikwit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Wiwanikwit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit S, 2015, INDIAN J HEMATOL BLO, V31, P320, DOI 10.1007/s12288-013-0306-8
   Wiwanitkit V, 2005, J INFECTION, V51, P259, DOI 10.1016/j.jinf.2005.05.024
   Wiwanitkit V, 2016, MED J DY PATIL U, V9, P287
NR 6
TC 0
Z9 0
U1 1
U2 20
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
BP 362
EP 362
DI 10.4103/1755-6783.190207
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA DX3EK
UT WOS:000384256000023
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Concurrent Zika virus and HIV infection: A new concern on the new
   concurrence
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surin Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Surin Rajabhat Univ, Surin, Thailand.
EM wviroj@yahoo.com
CR Calvet G., 2016, LANCET INFECT DIS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED
NR 5
TC 1
Z9 1
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
DI 10.4103/1755-6783.190197
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA DX3EK
UT WOS:000384256000013
DA 2020-07-08
ER

PT J
AU Mo, Y
   Salada, BMA
   Tambyah, PA
AF Mo, Yin
   Salada, Brenda Mae Alferez
   Tambyah, Paul Anantharajah
TI Zika virus-a review for clinicians
SO BRITISH MEDICAL BULLETIN
LA English
DT Review
DE Zika virus; microcephaly; Guillain-Barr; syndrome
ID FRENCH-POLYNESIA; YELLOW-FEVER; PERINATAL TRANSMISSION; VERTICAL
   TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; DECEMBER 2013;
   INFECTION; DENGUE; CHIKUNGUNYA
C1 [Mo, Yin] Natl Univ Hlth Syst, Univ Med Cluster, Minist Hlth Holdings, 1 Maritime Sq, Singapore 099253, Singapore.
   [Mo, Yin; Salada, Brenda Mae Alferez; Tambyah, Paul Anantharajah] Natl Univ Hlth Syst, Univ Med Cluster, Div Infect Dis, 1E Kent Ridge Rd,Level 10, Singapore 119228, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, 1E Kent Ridge Rd 119228,NUHS Tower Block, Singapore 117597, Singapore.
RP Mo, Y (corresponding author), Natl Univ Hlth Syst, Univ Med Cluster, NUHS Tower Block,1E Kent Ridge Rd,Level 10, Singapore 119228, Singapore.
EM yin_mo@nuhs.edu.sg
OI Mo, Yin/0000-0002-0216-9550
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2016, EP WEEK 47 2015
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bitan M, 2004, CLIN INFECT DIS, V39, P1076, DOI 10.1086/424015
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOTROS BAM, 1989, J MED VIROL, V29, P79, DOI 10.1002/jmv.1890290202
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Brasil Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, INF EP 11 SEM EP 04
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, ARB DIS DENG BRANCH
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Institut de Veille Sanitaire, 2016, B HEBD INT 5 11 MARS
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lunn M, 2011, CLIN INFECT DIS, V52, P845, DOI 10.1093/cid/cir082
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1042
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, NUMB REP CAS CHIK FE
   Pan American Health Organization, 2016, PREL GUID SURV MICR
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Saude Agencia, 2015, MICR MIN SAUD DIV B
   Soares de Araujo JS, 2016, B WHO
   Society of Maternal Fetal Medicine, 2016, PRACT ADV UPD INT GU
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thomas Emy Abi, 2010, Indian J Dermatol, V55, P79, DOI 10.4103/0019-5154.60359
   Thomas EA, 2007, INT J DERMATOL, V46, P715, DOI 10.1111/j.1365-4632.2007.03298.x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2016, NEUR SYNDR CONG AN Z
   WHO, 2015, DIS OUTBREAK NE 0208
   WHO SEARO, 2011, COMPR GUID PREV CONT
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2012, GLOB STRAT DENG CONT
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zylberkan M., 2015, THE NOW
NR 104
TC 7
Z9 8
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD SEP
PY 2016
VL 119
IS 1
BP 25
EP 36
DI 10.1093/bmb/ldw023
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX8VF
UT WOS:000384667500004
PM 27283145
OA Bronze
DA 2020-07-08
ER

PT J
AU Vanlandingham, DL
   Higgs, S
   Huang, YJS
AF Vanlandingham, Dana L.
   Higgs, Stephen
   Huang, Yan-Jang S.
TI Aedes albopictus (Diptera: Culicidae) and Mosquito-Borne Viruses in the
   United States
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; arbovirology; mosquito-borne
ID WEST-NILE-VIRUS; EQUINE ENCEPHALITIS-VIRUS; LA-CROSSE-VIRUS; CHIKUNGUNYA
   VIRUS; DENGUE-FEVER; AUTOCHTHONOUS TRANSMISSION; INDIAN-OCEAN; ZIKA
   VIRUS; OUTBREAK; ARBOVIRUSES
AB The Asian tiger mosquito Aedes albopictus (Skuse), is a highly invasive species that continues to expand its geographic distribution both in the United States and in countries on other continents. Studies have demonstrated its susceptibility to infection with at least 32 viruses, including 13 that are present in the United States. Despite this susceptibility, its role as a significant competent vector in natural transmission cycles of arboviruses, has been limited. However, with the recent introductions of chikungunya and Zika viruses into the Americas, for which Ae. albopictus is a recognized vector, it is possible that the species may contribute to the transmission of these viruses to humans and perhaps other susceptible vertebrates.
C1 [Vanlandingham, Dana L.; Higgs, Stephen; Huang, Yan-Jang S.] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Higgs, Stephen; Huang, Yan-Jang S.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
RP Higgs, S (corresponding author), Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.; Higgs, S (corresponding author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
EM dlvanlan@vet.ksu.edu; shiggs@k-state.edu; yshuang1985@ksu.edu
CR Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785
   Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Armstrong PM, 2013, J MED ENTOMOL, V50, P1310, DOI 10.1603/ME13099
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994
   Cassadou S., 2014, EUROSURVEILLANCE B E, V19
   COULANGES P, 1979, B SOC PATHOL EXOT, V72, P205
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOHM DJ, 1995, J MED ENTOMOL, V32, P818, DOI 10.1093/jmedent/32.6.818
   EADS RB, 1972, MOSQ NEWS, V32, P113
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Fortuna C, 2015, MED VET ENTOMOL, V29, P430, DOI 10.1111/mve.12133
   Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GRIMSTAD PR, 1989, J AM MOSQUITO CONTR, V5, P422
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0
   HOTTA S, 1953, J Trop Med Hyg, V56, P83
   Joy JE, 2003, J MED ENTOMOL, V40, P73, DOI 10.1603/0022-2585-40.1.73
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0
   Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442
   Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301
   METSELAAR D, 1980, B WORLD HEALTH ORGAN, V58, P937
   Mitchell C. J., 1995, Parassitologia (Rome), V37, P109
   MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44
   MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   Noden BH, 2015, J AM MOSQUITO CONTR, V31, P336, DOI 10.2987/moco-31-04-336-345.1
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Palmisano CT, 2005, J AM MOSQUITO CONTR, V21, P33, DOI 10.2987/8756-971X(2005)21[33:IOWNVO]2.0.CO;2
   PRATT J J Jr, 1946, Mil Surg, V99, P785
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Seki Naomi, 2015, Nihon Koshu Eisei Zasshi, V62, P238, DOI 10.11236/jph.62.5_238
   SHROYER DA, 1986, J AM MOSQUITO CONTR, V2, P424
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Tsai T F, 1991, Infect Dis Clin North Am, V5, P73
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576
   TURELL MJ, 1994, J MED ENTOMOL, V31, P287, DOI 10.1093/jmedent/31.2.287
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Yee DA, 2016, J MED ENTOMOL, V53, P989, DOI 10.1093/jme/tjw063
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 61
TC 21
Z9 22
U1 2
U2 14
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2016
VL 53
IS 5
BP 1024
EP 1028
DI 10.1093/jme/tjw025
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DW5SV
UT WOS:000383708100005
PM 27113107
DA 2020-07-08
ER

PT J
AU Hahn, MB
   Eisen, RJ
   Eisen, L
   Boegler, KA
   Moore, CG
   McAllister, J
   Savage, HM
   Mutebi, JP
AF Hahn, Micah B.
   Eisen, Rebecca J.
   Eisen, Lars
   Boegler, Karen A.
   Moore, Chester G.
   McAllister, Janet
   Savage, Harry M.
   Mutebi, John-Paul
TI Reported Distribution of Aedes (Stegomyia) aegypti and Aedes (Stegomyia)
   albopictus in the United States, 1995-2016 (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; surveillance; distribution; United
   States
ID YELLOW-FEVER; TEMPORAL PATTERNS; GEOGRAPHIC RANGE; DENGUE; FLORIDA;
   MOSQUITOS; AMERICA; DISEASE; SPREAD; VIRUS
AB Aedes (Stegomyia)aegypti (L.) andAedes (Stegomyia)albopictus (Skuse) transmit arboviruses that are increasing threats to human health in the Americas, particularly dengue, chikungunya, and Zika viruses. Epidemics of the associated arboviral diseases have been limited to South and Central America, Mexico, and the Caribbean in the Western Hemisphere, with only minor localized outbreaks in the United States. Nevertheless, accurate and up-to-date information for the geographical ranges ofAe. aegypti andAe. albopictus in the United States is urgently needed to guide surveillance and enhance control capacity for these mosquitoes. We compiled county records for presence ofAe. aegypti andAe. albopictus in the United States from 1995-2016, presented here in map format. Records were derived from the Centers for Disease Control and Prevention ArboNET database, VectorMap, the published literature, and a survey of mosquito control agencies, university researchers, and state and local health departments. Between January 1995 and March 2016, 183 counties from 26 states and the District of Columbia reported occurrence ofAe. aegypti, and 1,241 counties from 40 states and the District of Columbia reported occurrence ofAe. albopictus. During the same time period,Ae. aegypti was collected in 3 or more years from 94 counties from 14 states and the District of Columbia, andAe. albopictus was collected during 3 or more years from 514 counties in 34 states and the District of Columbia. Our findings underscore the need for systematic surveillance ofAe. aegypti andAe. albopictus in the United States and delineate areas with risk for the transmission of these introduced arboviruses.
C1 [Hahn, Micah B.; Eisen, Rebecca J.; Eisen, Lars; Boegler, Karen A.; McAllister, Janet; Savage, Harry M.; Mutebi, John-Paul] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Moore, Chester G.] Colorado State Univ, Dept Microbiol Immunol & Pathol, 3195 Rampart Rd, Ft Collins, CO 80523 USA.
RP Mutebi, JP (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM xht1@cdc.gov; dyn2@cdc.gov; hms1@cdc.gov; kje5@cdc.gov;
   Chester.Moore@ColoState.edu; evp4@cdc.gov; jvm6@cdc.gov; grv0@cdc.gov
OI Moore, Charity/0000-0002-0060-0124
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bennett JK, 2005, J AM MOSQUITO CONTR, V21, P341, DOI 10.2987/8756-971X(2006)21[341:NSRFTA]2.0.CO;2
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Centers for Disease Control and Prevention, 2014, ARBONET DAT
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Foley D., 2016, VECTORMAP
   Foy B. D., 2011, EMERG INFECT DIS, V17
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 2012, J MED ENTOMOL, V49, P1163, DOI 10.1603/ME12022
   Leisnham PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091655
   Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   MOORE CG, 1988, J AM MOSQUITO CONTR, V4, P356
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   MORLAN HB, 1965, AM J TROP MED HYG, V14, P892, DOI 10.4269/ajtmh.1965.14.892
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314
   Neitzel DF, 2009, J AM MOSQUITO CONTR, V25, P367, DOI 10.2987/09-0015.1
   Pan American Health Organization (PAHO)-CDC, 2011, PREP RESP CHIK VIR I
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   SLOSEK J, 1986, SOC SCI MED, V23, P249, DOI 10.1016/0277-9536(86)90345-X
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 45
TC 48
Z9 48
U1 0
U2 24
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2016
VL 53
IS 5
BP 1169
EP 1175
DI 10.1093/jme/tjw072
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DW5SV
UT WOS:000383708100020
PM 27282817
DA 2020-07-08
ER

PT J
AU Perkins, TA
   Siraj, AS
   Ruktanonchai, CW
   Kraemer, MUG
   Tatem, AJ
AF Perkins, T. Alex
   Siraj, Amir S.
   Ruktanonchai, Corrine W.
   Kraemer, Moritz U. G.
   Tatem, Andrew J.
TI Model-based projections of Zika virus infections in childbearing women
   in the Americas
SO NATURE MICROBIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; CHIKUNGUNYA VIRUS; FINAL SIZE; DENGUE; OUTBREAK;
   SEROPREVALENCE; EPIDEMIC; SURVIVAL; ISLAND; FEVER
AB Zika virus is a mosquito-borne pathogen that is rapidly spreading across the Americas. Due to associations between Zika virus infection and a range of fetal maladies(1,2), the epidemic trajectory of this viral infection poses a significant concern for the nearly 15 million children born in the Americas each year. Ascertaining the portion of this population that is truly at risk is an important priority. One recent estimate(3) suggested that 5.42 million childbearing women live in areas of the Americas that are suitable for Zika occurrence. To improve on that estimate, which did not take into account the protective effects of herd immunity, we developed a new approach that combines classic results from epidemiological theory with seroprevalence data and highly spatially resolved data about drivers of transmission to make location-specific projections of epidemic attack rates. Our results suggest that 1.65 (1.45-2.06) million childbearing women and 93.4 (81.6-117.1) million people in total could become infected before the first wave of the epidemic concludes. Based on current estimates of rates of adverse fetal outcomes among infected women(2,4,5), these results suggest that tens of thousands of pregnancies could be negatively impacted by the first wave of the epidemic. These projections constitute a revised upper limit of populations at risk in the current Zika epidemic, and our approach offers a new way to make rapid assessments of the threat posed by emerging infectious diseases more generally.
C1 [Perkins, T. Alex; Siraj, Amir S.] Univ Notre Dame, Dept Biol Sci, 100 Galvin Hall, Notre Dame, IN 46556 USA.
   [Perkins, T. Alex; Siraj, Amir S.] Univ Notre Dame, Eck Inst Global Hlth, 100 Galvin Hall, Notre Dame, IN 46556 USA.
   [Ruktanonchai, Corrine W.; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, WorldPop Project, Southampton SO17 1BJ, Hants, England.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England.
   [Tatem, Andrew J.] Flowminder Fdn, SE-11355 Stockholm, Sweden.
RP Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, 100 Galvin Hall, Notre Dame, IN 46556 USA.; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, 100 Galvin Hall, Notre Dame, IN 46556 USA.
EM taperkins@nd.edu
RI Ruktanonchai, Corrine/M-3979-2016
OI Ruktanonchai, Corrine/0000-0002-7889-3473
FU National Science FoundationNational Science Foundation (NSF) [DEB
   1641130]; University of Southampton's Economic and Social Research
   Council's Doctoral Training Centre; International Research Consortium on
   Dengue Risk Assessment Management and Surveillance (IDAMS; European
   Commission 7th Framework Programme) [21893]; NIH/NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI089674]; BMGF [OPP1106427, 1032350]; NORAD; Wellcome Trust
   Sustaining Health GrantWellcome Trust [106866/Z/15/Z]; WorldPop;
   Flowminder Foundation; Notre Dame Center for Research Computing
FX The authors thank three anonymous reviewers, as well as J. Ashander,
   C.M. Barker, M.A. Johansson, R.C. Reiner, S.T. Stoddard, J.C. Miller and
   members of the Perkins Lab for discussions. The authors thank O.J. Brady
   for sharing code for calculating mosquito mortality as a function of
   temperature. T.A.P., A.S.S. and A.J.T. are supported by funding from the
   National Science Foundation (DEB 1641130). C.W.R. is supported by
   funding through the University of Southampton's Economic and Social
   Research Council's Doctoral Training Centre. M.U.G.K. receives funding
   from the International Research Consortium on Dengue Risk Assessment
   Management and Surveillance (IDAMS; European Commission 7th Framework
   Programme, 21893). A.J.T. is supported by funding from NIH/NIAID
   (U19AI089674), the BMGF (OPP1106427, 1032350), NORAD and a Wellcome
   Trust Sustaining Health Grant (106866/Z/15/Z). A.J.T. and C.W.R.
   acknowledge the support of the WorldPop (www.worldpop.org) and
   Flowminder Foundation (www.flowminder.org) teams in demographic data set
   production, and T.A.P. and A.S.S. acknowledge support from the Notre
   Dame Center for Research Computing.
CR Andreasen V, 2011, B MATH BIOL, V73, P2305, DOI 10.1007/s11538-010-9623-3
   [Anonymous], 2016, NATURE, V530, P5, DOI 10.1038/530005a
   [Anonymous], 2016, ZIK EP UPD
   [Anonymous], 2016, WORLD FACTBOOK
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P., 2016, NEW ENG J MED
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dwibedi B, 2011, INDIAN J MED RES, V133, P316
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Feldstein LR, 2015, T ROY SOC TROP MED H, V109, P303, DOI 10.1093/trstmh/trv012
   Funk S., 2016, COMP ANAL DENGUE ZIK
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Johansson M. A., 2016, RISK ESTIMATES MICRO
   Keeling M.J., 2007, MODELING INFECT DIS
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lessler J., 2016, TIMES KEY EVENTS COU
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103
   Pya N, 2015, STAT COMPUT, V25, P543, DOI 10.1007/s11222-013-9448-7
   R Core Team, 2014, R LANG STAT COMP
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042
   Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2
   Tatem AJ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-11
   Taylor B. P., 2016, STOCHASTICITY LIMITS
   UNFPA, 2014, STAT WORLDS MIDW 201
   United Nation, 2015, WORLD POP PROSP 2015
   Weiss DJ, 2014, ISPRS J PHOTOGRAMM, V98, P106, DOI 10.1016/j.isprsjprs.2014.10.001
   WRIGHT DH, 1991, J BIOGEOGR, V18, P463, DOI 10.2307/2845487
NR 53
TC 69
Z9 69
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD SEP
PY 2016
VL 1
IS 9
AR 16126
DI 10.1038/NMICROBIOL.2016.126
PG 7
WC Microbiology
SC Microbiology
GA DW4KB
UT WOS:000383610500004
PM 27562260
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Chan, S
   Playford, G
   Siebert, D
   Fahim, M
   Cho, Y
   Vaneps, C
   Isbel, N
AF Chan, S.
   Playford, G.
   Siebert, D.
   Fahim, M.
   Cho, Y.
   Vaneps, C.
   Isbel, N.
TI COEXISTING ZIKA VIRUS, DENGUE AND INFLUENZA A IN THE IMMUNOSUPPRESSED
   TRAVELLER
SO NEPHROLOGY
LA English
DT Meeting Abstract
C1 [Chan, S.; Fahim, M.; Cho, Y.; Vaneps, C.; Isbel, N.] Princess Alexandra Hosp, Woolloongabba, Qld, Australia.
   [Chan, S.; Fahim, M.; Cho, Y.; Vaneps, C.; Isbel, N.] Princess Alexandra Hosp, Queensland Renal Transplant Serv, Woolloongabba, Qld, Australia.
   [Chan, S.; Playford, G.; Fahim, M.; Cho, Y.; Vaneps, C.; Isbel, N.] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia.
   [Playford, G.] Princess Alexandra Hosp, Dept Infect Dis, Woolloongabba, Qld, Australia.
   [Siebert, D.] Princess Alexandra Hosp, Queensland Hlth Pathol Serv, Clin Virol, Woolloongabba, Qld, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-5358
EI 1440-1797
J9 NEPHROLOGY
JI Nephrology
PD SEP
PY 2016
VL 21
SU 2
MA 228
BP 245
EP 246
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA DW4CV
UT WOS:000383590600458
DA 2020-07-08
ER

PT J
AU Kandel, N
   Lamichhane, J
   Tangermann, RH
   Rodier, GRM
AF Kandel, Nirmal
   Lamichhane, Jaya
   Tangermann, Rudolf H.
   Rodier, Guenael R. M.
TI Detecting Guillain-Barre syndrome caused by Zika virus using systems
   developed for polio surveillance
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Editorial Material
C1 [Kandel, Nirmal; Rodier, Guenael R. M.] WHO, Dept Global Capac Alert & Response, Appia 20, CH-1211 Geneva 27, Switzerland.
   [Tangermann, Rudolf H.] WHO, Dept Polio Operat & Res, CH-1211 Geneva, Switzerland.
RP Kandel, N (corresponding author), WHO, Dept Global Capac Alert & Response, Appia 20, CH-1211 Geneva 27, Switzerland.
EM kandeln@who.int
FU World Health OrganizationWorld Health Organization [001]
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P169
   [Anonymous], 2016, COUNTR SURV SYST
   [Anonymous], 2016, POL ER ENDG STRAT PL
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Olive JA, 1997, J INFECT DIS, V175, pS160, DOI 10.1093/infdis/175.Supplement_1.S160
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Rapid Risk Assessment, 2016, ZIK VIR DIS EP POT A
NR 12
TC 6
Z9 6
U1 0
U2 5
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD SEP
PY 2016
VL 94
IS 9
BP 705
EP 708
DI 10.2471/BLT.16.171504
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX8HX
UT WOS:000384629800018
PM 27708476
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Oliveira, ERA
   de Alencastro, RB
   Horta, BAC
AF Oliveira, Edson R. A.
   de Alencastro, Ricardo B.
   Horta, Bruno A. C.
TI The mechanism by which P250L mutation impairs flavivirus-NS1
   dimerization: an investigation based on molecular dynamics simulations
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE Flavivirus; Molecular dynamics simulation; NS1; Virology; Vaccine;
   Antivirals
ID NONSTRUCTURAL PROTEIN NS1; NUCLEOTIDE-SEQUENCE; VIRUS; VACCINES;
   REPLICATION; POTENTIALS; OUTBREAK; BIOLOGY; REVEAL; ZIKA
AB The flavivirus non-structural protein 1 (NS1) is a conserved glycoprotein with as yet undefined biological function. This protein dimerizes when inside infected cells or associated to cell membranes but also forms lipid-associated hexamers when secreted to the extracellular space. A single amino acid substitution (P250L) is capable of preventing the dimerization of NS1 resulting in lower virulence and slower virus replication. In this work, based on molecular dynamics simulations of the dengue-2 virus NS1 beta-ladder monomer as a core model, we found that this mutation can induce several conformational changes that importantly affect critical monomer-monomer interactions. Based on additional simulations, we suggest a mechanism by which a highly orchestrated sequence of events propagate the local perturbations around the mutation site towards the dimer interface. The elucidation of such a mechanism could potentially support new strategies for rational production of live-attenuated vaccines and highlights a step forward in the development of novel anti-flavivirus measures.
C1 [Oliveira, Edson R. A.; de Alencastro, Ricardo B.; Horta, Bruno A. C.] Univ Fed Rio de Janeiro, Inst Quim, Ave Athos da Silveira Ramos,149 Ctr Tecnol, BR-21941909 Rio De Janeiro, RJ, Brazil.
RP Horta, BAC (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Ave Athos da Silveira Ramos,149 Ctr Tecnol, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM bruno.horta@gmail.com
RI Horta, Bruno AC/L-5079-2013
OI Horta, Bruno AC/0000-0002-3952-1474; Oliveira, Edson
   RA/0000-0002-8606-7454
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   DEUBEL V, 1988, VIROLOGY, V165, P234, DOI 10.1016/0042-6822(88)90677-0
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hall RA, 1999, VIROLOGY, V264, P66, DOI 10.1006/viro.1999.9956
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hockney R. W., 1970, Methods in computational physics. IX. Plasma physics, P135
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MACKOW E, 1987, VIROLOGY, V159, P217, DOI 10.1016/0042-6822(87)90458-2
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Modhiran N, 2015, SCI TRANSL MED, V7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003
   PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   WRIGHT PJ, 1989, VIROLOGY, V171, P61, DOI 10.1016/0042-6822(89)90510-2
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
NR 38
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD SEP
PY 2016
VL 45
IS 6
BP 573
EP 580
DI 10.1007/s00249-016-1147-9
PG 8
WC Biophysics
SC Biophysics
GA DX9NN
UT WOS:000384722500008
PM 27324799
OA Bronze
DA 2020-07-08
ER

PT J
AU Raposo-Amaral, CE
AF Raposo-Amaral, Cassio Eduardo
TI Microcephaly: Consequence of the Zika Virus Global Outbreak
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Editorial Material
ID BRAZIL
C1 [Raposo-Amaral, Cassio Eduardo] SOBRAPAR Hosp, Inst Plast & Craniofacial Surg, Ave Adolpho Lutz 100,Caixa Postal 6028, BR-13084880 Campinas, SP, Brazil.
RP Raposo-Amaral, CE (corresponding author), SOBRAPAR Hosp, Inst Plast & Craniofacial Surg, Ave Adolpho Lutz 100,Caixa Postal 6028, BR-13084880 Campinas, SP, Brazil.
EM cassioraposo@hotmail.com
RI Raposo-Amaral, Cassio/D-1397-2013
OI Raposo-Amaral, Cassio/0000-0001-6201-0827
CR [Anonymous], 2015, B EP
   [Anonymous], 2016, 24 MIN SAUD
   [Anonymous], 2016, 1 MIN SAUD
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Johansson MA, 2016, NEW ENGL J MED, V375
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Raposo-Amaral CE, 2012, J CRANIOFAC SURG, V23, P1104, DOI 10.1097/SCS.0b013e318258814a
   Raposo-Amaral CE, 2014, PLAST RECONSTR SURG, V133, p182e
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 14
TC 3
Z9 3
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD SEP
PY 2016
VL 27
IS 6
BP 1383
EP 1384
DI 10.1097/SCS.0000000000002997
PG 2
WC Surgery
SC Surgery
GA DX3KD
UT WOS:000384271100037
PM 27526251
DA 2020-07-08
ER

PT J
AU Hajra, A
   Bandyopadhyay, D
   Hajra, SK
AF Hajra, Adrija
   Bandyopadhyay, Dhrubajyoti
   Hajra, Shyamal Kumar
TI Zika virus: New interest in neurology
SO NEUROLOGY INDIA
LA English
DT Letter
C1 [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
   [Bandyopadhyay, Dhrubajyoti] Lady Hardinge Med Coll & Hosp, Dept Accid & Emergency, New Delhi, India.
   [Hajra, Shyamal Kumar] NMB Diagnost Ctr, Cardiol Soc India, Assoc Phys India, Serampore, W Bengal, India.
RP Hajra, A (corresponding author), IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
EM adrija847@gmail.com
RI Hajra, Adrija/AAM-5736-2020; Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cordeiro MT, LANCET
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Guo J, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0096-4
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Nielsen KK, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30254-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian X., 2016, CELL
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Santos C N D, TRENDS PARASITOLOGY
   Thiery G, 2016, INTENS CARE MED, V42, P1485, DOI 10.1007/s00134-016-4364-x
NR 14
TC 7
Z9 7
U1 0
U2 72
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD SEP-OCT
PY 2016
VL 64
IS 5
BP 1102
EP +
DI 10.4103/0028-3886.190249
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA DX6WW
UT WOS:000384527500074
PM 27625288
DA 2020-07-08
ER

PT J
AU Moskosky, SB
AF Moskosky, Susan B.
TI Pregnancy Intention-More Important Than Ever
SO PUBLIC HEALTH REPORTS
LA English
DT Editorial Material
ID UNITED-STATES; ZIKA VIRUS; INTERIM GUIDELINES; COST SAVINGS;
   CONTRACEPTION; SERVICES; CARE
C1 [Moskosky, Susan B.] US Dept HHS, Off Populat Affairs, 200 Independence Ave SW, Washington, DC 20201 USA.
RP Moskosky, SB (corresponding author), US Dept HHS, Off Populat Affairs, 200 Independence Ave SW, Washington, DC 20201 USA.
EM susan.moskosky@hhs.gov
CR *AL GUTTM I, 2000, FULF PROM PUBL POL U
   American College of Obstetricians and Gynecologists, 2011, PRACT B, V121
   Brasil P, 2016, N ENGL J MED
   Centers for Disease Control and Prevention (US), 6 18 IN EV SUMM PROP
   Centers for Disease Control and Prevention (US), 2016, ADV PEOPL LIV TRAV W
   Centers for Medicare & Medicaid Services (US), MAT INF HLTH CAR QUA
   Cleland K, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1104373
   COPEN CE, 2015, NATL VITAL STAT REP, V64, P1
   Curtis KM, 2013, MMWR RECOMM REP, V62, P1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dehlendorf C, 2015, CONTRACEPTION, V91, P433, DOI 10.1016/j.contraception.2015.02.002
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Foster DG, 2013, WOMEN HEALTH ISS, V23, P265
   Frost JJ, 2008, J HEALTH CARE POOR U, V19, P778, DOI 10.1353/hpu.0.0060
   Frost JJ, 2014, MILBANK Q, V92, P696, DOI 10.1111/1468-0009.12080
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Gemmill A, 2013, OBSTET GYNECOL, V122, P64, DOI 10.1097/AOG.0b013e3182955e58
   Hamilton BE, 2014, NATL VITAL STAT REP, V63, P1
   Hathaway M, 2014, CLIN OBSTET GYNECOL, V57, P718, DOI 10.1097/GRF.0000000000000071
   Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3
   Karch Debra L., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Moniz MH, 2015, CONTRACEPTION, V92, P523, DOI 10.1016/j.contraception.2015.09.014
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Ott MA, 2014, PEDIATRICS, V134, pE1244, DOI 10.1542/peds.2014-2299
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sonfield A, 2015, PUBLIC COSTS UNINTEN
   The National Campaign to Prevent Teen and Unplanned Pregnancy, 2010, COUNT IT PUBL COSTS
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Uberoi N, 2016, HLTH INSURANCE COVER
   US Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
NR 31
TC 0
Z9 1
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD SEP-OCT
PY 2016
VL 131
IS 5
BP 658
EP 660
DI 10.1177/0033354916662638
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX3LT
UT WOS:000384275300002
PM 28123204
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pate, LL
   Williamson, P
   Latoni, G
   Busch, M
   Dyer, NH
   Bertuzis, R
   Huynh, N
   Hooks, RT
   Duncan, J
   Galel, SA
AF Pate, L. L.
   Williamson, P.
   Latoni, G.
   Busch, M.
   Dyer, N. H.
   Bertuzis, R.
   Huynh, N.
   Hooks, R. T.
   Duncan, J.
   Galel, S. A.
TI Detection of Zika Virus in Puerto Rico Blood Donations
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Pate, L. L.; Dyer, N. H.; Bertuzis, R.; Huynh, N.; Hooks, R. T.; Duncan, J.; Galel, S. A.] Roche Mol Syst, Pleasanton, CA USA.
   [Latoni, G.] Banco Sangre Serv Mutuos, San Juan, PR USA.
   [Williamson, P.] Creat Testing Solut, Tempe, AZ USA.
   [Busch, M.] Blood Syst Res Inst, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S13-010C
BP 10A
EP 11A
PG 2
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400020
DA 2020-07-08
ER

PT J
AU Germain, M
   Delage, G
   O'Brien, S
   Gregoire, Y
   Devine, D
AF Germain, M.
   Delage, G.
   O'Brien, S.
   Gregoire, Y.
   Devine, D.
TI The Risk of Transfusion-transmitted Zika in a Non-endemic Country: A
   Monte Carlo Simulation to Evaluate this Risk and the Efficacy of Travel
   Deferral Scenarios
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Germain, M.; Delage, G.; Gregoire, Y.] Hema Quebec, Med Affairs, Quebec City, PQ, Canada.
   [O'Brien, S.; Devine, D.] Canadian Blood Serv, Ottawa, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S14-010C
BP 11A
EP 11A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400021
DA 2020-07-08
ER

PT J
AU Maria, FS
   Laughhunn, A
   Lenhoff, R
   Stassinopoulos, A
AF Maria, F. Santa
   Laughhunn, A.
   Lenhoff, R.
   Stassinopoulos, A.
TI Effective Inactivation of Zika Virus by Nucleic Acid Targeted Adducts
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Maria, F. Santa; Laughhunn, A.; Lenhoff, R.; Stassinopoulos, A.] Cerus Corp, Concord, CA USA.
NR 0
TC 2
Z9 2
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S16-010C
BP 11A
EP 12A
PG 2
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400023
DA 2020-07-08
ER

PT J
AU Kelley, JM
   Tholpady, A
   Lichtiger, B
AF Kelley, J. M.
   Tholpady, A.
   Lichtiger, B.
TI Impact of Enhanced Screening for Zika Virus on Blood Donor Deferrals
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Kelley, J. M.; Tholpady, A.; Lichtiger, B.] Univ Texas MD Anderson Canc Ctr, Lab Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S18-010C
BP 12A
EP 12A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400025
DA 2020-07-08
ER

PT J
AU O'Brien, SF
   Fearon, MA
   Devine, D
   Goldman, MR
   Germain, M
   Delage, G
AF O'Brien, S. F.
   Fearon, M. A.
   Devine, D.
   Goldman, M. R.
   Germain, M.
   Delage, G.
TI Estimated Risk to the Canadian Blood Supply from Sexually Transmitted
   Zika Virus
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [O'Brien, S. F.] Canadian Blood Serv, Epidemiol & Surveillance, Ottawa, ON, Canada.
   [Devine, D.; Goldman, M. R.] Canadian Blood Serv, Donor & Clin Serv, Ottawa, ON, Canada.
   [Fearon, M. A.] Canadian Blood Serv, Med Microbiol, Toronto, ON, Canada.
   [Germain, M.] Hema Quebec, Med Affairs, St Laurent, PQ, Canada.
   [Delage, G.] Hema Quebec, Microbiol, Quebec City, PQ, Canada.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S17-010C
BP 12A
EP 12A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400024
DA 2020-07-08
ER

PT J
AU Leparc, G
   Reik, R
   Zielinski, T
AF Leparc, G.
   Reik, R.
   Zielinski, T.
TI Rapid Assessment of Donor Loss Rates Associated with Past and Future
   Travel from Areas with Zika Virus Activity in the Donor Population
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Leparc, G.; Reik, R.; Zielinski, T.] OneBlood, Tampa, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP141
BP 94A
EP 94A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400245
DA 2020-07-08
ER

PT J
AU Albrecht, P
   Dyer, NH
   Hoppler, M
   Lamont, J
   Schlag, P
   Kuehler, A
   VanDerMark, D
   Pate, LL
   Galel, SA
   Niemiec, J
AF Albrecht, P.
   Dyer, N. H.
   Hoppler, M.
   Lamont, J.
   Schlag, P.
   Kuehler, A.
   VanDerMark, D.
   Pate, L. L.
   Galel, S. A.
   Niemiec, J.
TI Assay Performance of a Zika Nucleic Acid Test for Screening of Blood
   Donations
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Dyer, N. H.; Hoppler, M.; Lamont, J.; Schlag, P.; VanDerMark, D.; Pate, L. L.; Galel, S. A.; Niemiec, J.] Roche Mol Syst, Pleasanton, CA USA.
   [Albrecht, P.; Kuehler, A.] Roche Mol Diagnost, Rotkreuz, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP452
BP 200A
EP 200A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400556
DA 2020-07-08
ER

PT J
AU Christenson, C
   Galloway-Haskins, R
   Martone, J
   Nikolis, NM
   Logdberg, L
   Chhibber, V
   Indrikovs, AJ
AF Christenson, C.
   Galloway-Haskins, R.
   Martone, J.
   Nikolis, N. M.
   Logdberg, L.
   Chhibber, V.
   Indrikovs, A. J.
TI Zika Virus Deferral Rates in Donors Within a Multiple Hospital Health
   System
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Christenson, C.; Galloway-Haskins, R.; Martone, J.; Nikolis, N. M.; Logdberg, L.; Chhibber, V.; Indrikovs, A. J.] North Shore Univ Hosp, Transfus Med Donor Serv, Manhasset, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP456
BP 201A
EP 202A
PG 2
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400560
DA 2020-07-08
ER

PT J
AU Kashima, S
   Slavov, SN
   Rodrigues, ES
   Otaguiri, KK
   Melo, FU
   Romagnoli, AC
   Ubiali, EM
   Covas, DT
AF Kashima, S.
   Slavov, S. N.
   Rodrigues, E. S.
   Otaguiri, K. K.
   Melo, F. U.
   Romagnoli, A. C.
   Ubiali, E. M.
   Covas, D. T.
TI Reducing the Transfusion Transmission Risk of Zika Virus in an Area with
   Active Viral Circulation, Brazil
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Kashima, S.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, Brazil.
   [Kashima, S.; Slavov, S. N.; Rodrigues, E. S.; Otaguiri, K. K.; Melo, F. U.; Romagnoli, A. C.; Ubiali, E. M.; Covas, D. T.] Univ Sao Paulo, Reg Blood Ctr Ribeirao Preto, Ctr Cell Based Therapy, Ribeirao Preto, Brazil.
   [Covas, D. T.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
RI Covas, Dimas T/C-5431-2013; N, Svetoslav/M-5416-2017; Rodrigues,
   Evandra/L-6094-2017
OI Covas, Dimas T/0000-0002-7364-2595; Rodrigues,
   Evandra/0000-0003-0964-9554
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP455
BP 201A
EP 201A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400559
DA 2020-07-08
ER

PT J
AU Weiner, E
   Velez, E
   Alsina, JO
   Chrebtow, V
AF Weiner, E.
   Velez, E.
   Alsina, J. O.
   Chrebtow, V.
TI Implementation of the INTERCEPT Blood System for Platelets in Puerto
   Rico to Help Safeguard Against Zika
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Weiner, E.; Chrebtow, V.] Cerus Corp, Concord, CA USA.
   [Velez, E.; Alsina, J. O.] Banco Sangre Serv Mutuos, San Juan, PR USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP454
BP 201A
EP 201A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400558
DA 2020-07-08
ER

PT J
AU Bakkour, S
   Lee, T
   Stone, M
   Deng, X
   Busch, M
AF Bakkour, S.
   Lee, T.
   Stone, M.
   Deng, X.
   Busch, M.
TI Analytical Performance of PCR Assays for Detection of Zika Virus RNA
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Bakkour, S.; Lee, T.; Stone, M.; Deng, X.; Busch, M.] Blood Syst Res Inst, San Francisco, CA USA.
   [Busch, M.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP459
BP 202A
EP 203A
PG 2
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400563
DA 2020-07-08
ER

PT J
AU Gao, K
   James, A
   Green, T
   Le, T
   Do, D
   Knight, J
   Peling, T
   Vang, L
   Stone, M
   Linnen, JM
AF Gao, K.
   James, A.
   Green, T.
   Le, T.
   Do, D.
   Knight, J.
   Peling, T.
   Vang, L.
   Stone, M.
   Linnen, J. M.
TI Procleix Zika Virus Assay on the Fully Automated Panther System
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Gao, K.; James, A.; Green, T.; Le, T.; Do, D.; Knight, J.; Peling, T.; Vang, L.; Linnen, J. M.] Hologic, San Diego, CA USA.
   [Stone, M.] Blood Syst Res Inst, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP458
BP 202A
EP 202A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400562
DA 2020-07-08
ER

PT J
AU Townsend, M
   Bravo, M
   Kamel, H
   Vassallo, R
AF Townsend, M.
   Bravo, M.
   Kamel, H.
   Vassallo, R.
TI Implementation of Measures to Reduce the Risk of Transfusion
   Transmission of Zika Virus
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Townsend, M.; Bravo, M.; Kamel, H.; Vassallo, R.] Blood Syst, Scottsdale, AZ USA.
RI Townsend, Mary/AAF-2566-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP457
BP 202A
EP 202A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400561
DA 2020-07-08
ER

PT J
AU Chancey, C
   Fares, RC
   Grinev, A
   Volkova, E
   Rios, M
AF Chancey, C.
   Fares, R. C.
   Grinev, A.
   Volkova, E.
   Rios, M.
TI Zika Virus Outbreak in the Americas: Development of Tools to Assist
   Responses
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Chancey, C.; Fares, R. C.; Grinev, A.; Volkova, E.; Rios, M.] US FDA, CBER, DETTD, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA SP461
BP 203A
EP 203A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400565
DA 2020-07-08
ER

PT J
AU Layon, A
   Hodghead, K
   Giulvezan, D
   Eisberg, L
   Pituley, W
   Wawrzyczek, N
   Garcia, A
   Spinale, A
   Bonaga, DU
   Oh, D
   Driscoll, R
AF Layon, A.
   Hodghead, K.
   Giulvezan, D.
   Eisberg, L.
   Pituley, W.
   Wawrzyczek, N.
   Garcia, A.
   Spinale, A.
   Bonaga, D. U.
   Oh, D.
   Driscoll, R.
TI Challenges in Creating a Process to Use the Centers for Disease Control
   and Prevention (CDC) Zika Virus Website in Donor Eligibility Screening
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Layon, A.; Hodghead, K.; Giulvezan, D.; Eisberg, L.; Pituley, W.; Wawrzyczek, N.; Garcia, A.; Spinale, A.; Bonaga, D. U.; Oh, D.; Driscoll, R.] Stanford Blood Ctr, Campbell, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA AP35
BP 231A
EP 232A
PG 2
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400636
DA 2020-07-08
ER

PT J
AU Thiery, G
   Valentino, R
   Meddhaoui, H
AF Thiery, Guillaume
   Valentino, Ruddy
   Meddhaoui, Hossein
TI Zika virus-associated Guillain-Barr, syndrome: a warning for critical
   care physicians
SO INTENSIVE CARE MEDICINE
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Thiery, Guillaume] Univ Hosp Pointe A Pitre Abymes, Intens Care Unit, Pointe A Pitre, Guadeloupe, France.
   [Thiery, Guillaume] Univ Antilles, Univ French West Indies, Pointe A Pitre, Guadeloupe, France.
   [Valentino, Ruddy; Meddhaoui, Hossein] Univ Hosp Ft France, Intens Care Unit, Fort De France, Martinique, France.
RP Thiery, G (corresponding author), Univ Hosp Pointe A Pitre Abymes, Intens Care Unit, Pointe A Pitre, Guadeloupe, France.; Thiery, G (corresponding author), Univ Antilles, Univ French West Indies, Pointe A Pitre, Guadeloupe, France.
EM guillaume.thiery.bih@gmail.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charrel RN, 2016, STATE KNOWLEDGE ZIKA
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Mallet HP, 2015, BILAN EPIDEMIE VIRUS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Oehler E, 2014, EURO SURVEILL, V19
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 17
TC 8
Z9 8
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD SEP
PY 2016
VL 42
IS 9
BP 1485
EP +
DI 10.1007/s00134-016-4364-x
PG 2
WC Critical Care Medicine
SC General & Internal Medicine
GA DU2IJ
UT WOS:000382034200025
PM 27118575
OA Bronze
DA 2020-07-08
ER

PT J
AU Bozza, FA
   Grinsztejn, B
AF Bozza, Fernando A.
   Grinsztejn, Beatriz
TI Key points on Zika infection for the intensivist
SO INTENSIVE CARE MEDICINE
LA English
DT Editorial Material
ID VIRUS-INFECTION; BRAZIL; OUTBREAK; STATES
C1 [Bozza, Fernando A.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Intens Care Lab, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Grinsztejn, Beatriz] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, HIV Lab, Rio De Janeiro, Brazil.
RP Bozza, FA (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Intens Care Lab, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM fernando.bozza@ini.fiocruz.br
RI Bozza, Fernando A/A-2618-2013
OI Bozza, Fernando A/0000-0003-4878-0256
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Roth A, 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 15
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD SEP
PY 2016
VL 42
IS 9
BP 1490
EP 1492
DI 10.1007/s00134-016-4378-4
PG 3
WC Critical Care Medicine
SC General & Internal Medicine
GA DU2IJ
UT WOS:000382034200027
PM 27172823
OA Bronze
DA 2020-07-08
ER

PT J
AU Bozza, FA
   Grinsztejn, B
AF Bozza, Fernando A.
   Grinsztejn, Beatriz
TI Key points on Zika infection for the intensivist (vol 42, pg 1490, 2016)
SO INTENSIVE CARE MEDICINE
LA English
DT Correction
C1 [Bozza, Fernando A.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Intens Care Lab, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Grinsztejn, Beatriz] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, HIV Lab, Rio De Janeiro, Brazil.
RP Bozza, FA (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Intens Care Lab, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM fernando.bozza@ini.fiocruz.br
OI Bozza, Fernando Augusto/0000-0003-4878-0256
CR Bozza FA, 2016, INTENS CARE MED, V42, P1490, DOI 10.1007/s00134-016-4378-4
NR 1
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD SEP
PY 2016
VL 42
IS 9
BP 1522
EP 1522
DI 10.1007/s00134-016-4408-2
PG 1
WC Critical Care Medicine
SC General & Internal Medicine
GA DU2IJ
UT WOS:000382034200042
PM 27299353
OA Bronze
DA 2020-07-08
ER

PT J
AU Davies, SE
   Bennett, B
AF Davies, Sara E.
   Bennett, Belinda
TI A gendered human rights analysis of Ebola and Zika: locating gender in
   global health emergencies
SO INTERNATIONAL AFFAIRS
LA English
DT Article
ID VIRUS-DISEASE EPIDEMIC; WOMEN; VIOLENCE; HIV; MORTALITY; OUTBREAK;
   ACCESS; CRISIS; LEGACY
AB Globally gender remains a key factor in differing health outcomes for men and women. This article analyses the particular relevance of gender for debates about global health and the role for international human rights law in supporting improved health outcomes during public health emergencies. Looking specifically at the recent Ebola and Zika outbreaks, what we find particularly troubling in both cases is the paucity of engagement with human rights language and the diverse backgrounds of women in these locations of crisis, when women-specific advice was being issued. We find the lessons that should have been learnt from the Ebola experience have not been applied in the Zika outbreak and there remains a disconnect between the international public health advice being issued and the experience of pervasive structural gender inequalities among those experiencing the crises. In both cases we find that responses at the outbreak of the crisis presume that women have economic, social or regulatory options to exercise the autonomy contained in international advice. The problem in the case of both Ebola and Zika has been that leaving structural gender inequalities out of the crisis response has further compounded those inequalities. The article argues for a contextual human rights analysis that takes into account gender as a social and economic determinant of health.
C1 [Davies, Sara E.] Griffith Univ, ARC, Nathan, Qld 4111, Australia.
   [Davies, Sara E.] Griffith Univ, Sch Govt & Int Relat, Ctr Governance & Publ Policy, Nathan, Qld 4111, Australia.
   [Davies, Sara E.] Griffith Univ, Sch Govt & Int Relat, Griffith Asia Inst, Nathan, Qld 4111, Australia.
   [Davies, Sara E.] Monash Univ, Sch Social Sci, Gender Peace & Secur Initiat, Clayton, Vic 3800, Australia.
   [Bennett, Belinda] Queensland Univ Technol, Australian Ctr Hlth Law Res, Hlth Law, Brisbane, Qld, Australia.
RP Davies, SE (corresponding author), Griffith Univ, ARC, Nathan, Qld 4111, Australia.; Davies, SE (corresponding author), Griffith Univ, Sch Govt & Int Relat, Ctr Governance & Publ Policy, Nathan, Qld 4111, Australia.; Davies, SE (corresponding author), Griffith Univ, Sch Govt & Int Relat, Griffith Asia Inst, Nathan, Qld 4111, Australia.
OI Bennett, Belinda/0000-0003-0912-5662; Davies, Sara
   E./0000-0002-7637-2252
FU Australian Research CouncilAustralian Research Council [FT130101040]
FX Sara Davies is the recipient of an Australian Research Council Future
   Fellowship (FT130101040). An earlier version of this article was
   presented at the Oxford Global Health and Bioethics International
   Conference in September 2015 and the Oceanic Conference on International
   Studies (OCIS) in June 2016. The authors thank the attendees for their
   comments and feedback. The authors also thank Lawrence O. Gostin for his
   comments and feedback on an earlier draft.
CR Anderson EL, 2012, INT FEM J POLIT, V14, P267, DOI 10.1080/14616742.2012.659850
   [Anonymous], 2016, UPH WOM HUM RIGHTS E
   [Anonymous], 2016, BBC NEWS
   [Anonymous], 2015, COUNTR PROF
   [Anonymous], 2016, GUARDIAN
   [Anonymous], 2015, UN HIGH LEV POL FOR
   Aolain F. N, 2011, MICHIGAN J GENDER LA, V18, P1
   Bennett Belinda, 2015, GLOBAL HLTH GOVERNAN, V9, p[149, 150]
   Bigaton Ulisses Lacava, 2016, UNFPA NEWS      0226
   Blanchet N., 2013, GLOBAL COLLECTIVE AC
   Charlesworth Hilary, 2014, EUROPEAN HUMAN RIGHT, V6, p[560, 560]
   Cook RJ, 2002, INT J GYNECOL OBSTET, V76, P225, DOI 10.1016/S0020-7292(01)00568-9
   Cooper B, 2015, REPROD HEALTH MATTER, V23, P56, DOI 10.1016/j.rhm.2015.11.001
   Davies SE, 2016, THIRD WORLD Q, V37, P419, DOI 10.1080/01436597.2015.1110015
   Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   Dias TZ, 2015, INT J GYNECOL OBSTET, V128, P224, DOI 10.1016/j.ijgo.2014.09.031
   Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0
   Felten-Biermann C., 2006, DEVELOPMENT, V49, P82, DOI DOI 10.1057/PALGRAVE.DEVELOPMENT.1100276
   Fisher S, 2010, VIOLENCE AGAINST WOM, V16, P902, DOI 10.1177/1077801210377649
   Fried S., 2016, OPEN DEMOCRACY
   Fried Susana T., 2016, LANCET GLOBAL H 0216
   Froio Nicole, 2016, GUARDIAN
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gostin Lawrence O., 2016, TIME
   Gruskin S, 2014, REPROD HEALTH MATTER, V22, P174, DOI 10.1016/S0968-8080(14)44810-9
   Guttmacher Institute, 2016, BRIEF FACTS AB LAT A
   Guttmacher Institute, 2014, INV SEX REPR HLTH LA
   Hamel MJ, 2015, LANCET INFECT DIS, V15, P75, DOI 10.1016/S1473-3099(15)70167-2
   Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029
   Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827
   Harman S, 2011, GLOBALIZATIONS, V8, P213, DOI 10.1080/14747731.2010.493023
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6
   Hayden EC, 2015, NATURE, V519, P24, DOI 10.1038/519024a
   Henry Jazmyn, 2016, COMPREHENSIVE APPROA
   Hodge JG, 2015, DISASTER MED PUBLIC, V9, P47, DOI 10.1017/dmp.2014.96
   Hoffman S., 2009, UC DAVIS LAW REV, V42, P1491
   Hunt P, 2007, LANCET, V370, P369, DOI 10.1016/S0140-6736(07)61173-8
   International Crisis Group, 2014, STAT EB CONFL W AFR
   Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P230, DOI 10.2471/BLT.06.039222
   Kirby Michael, 2010, AUSTR YB INT LAW, V29, p[17, 25]
   Kitching A, 2015, BJOG-INT J OBSTET GY, V122, P287, DOI 10.1111/1471-0528.13286
   Labonte R, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-14
   Leyser-Whalen O, 2011, J WOMENS HEALTH, V20, P1861, DOI 10.1089/jwh.2010.2613
   Machado-Alba JE, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30429-9
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   McInnes C, 2015, INT AFF, V91, P1299, DOI 10.1111/1468-2346.12454
   Menendez C, 2015, LANCET GLOB HEALTH, V3, pE130, DOI 10.1016/S2214-109X(15)70009-4
   Moon Suerie, 2013, CTR GLOBAL HLTH SECU, P7
   Mullan Zoe, 2015, LANCET GLOBAL HLTH
   O'Manique C, 2010, CAN J AFR STUDIES, V44, P457, DOI 10.1080/00083968.2010.9707541
   OECD, 2014, SOC I GEND IND GUIN
   Osotimehin B, 2014, REPROD HEALTH MATTER, V22, P163, DOI 10.1016/S0968-8080(14)44820-1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plucinski MM, 2015, LANCET INFECT DIS, V15, P1017, DOI 10.1016/S1473-3099(15)00061-4
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Schmidt Rachel, 2016, OPEN DEMOCRACY
   Seckinelgin H, 2011, CONFL SECUR DEV, V11, P55, DOI 10.1080/14678802.2011.552247
   Sridhar D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001312
   UN, 2015, 3 INT C FIN DEV OUTC, P6
   UN, 2016, REP HIGH LEV PAN GLO, P21
   UN Committee on Economic, 2000, EC1220004 UN COMM EC
   UN Office for the Coordination of Humanitarian Affairs (OCHA), 1999, UN OCHA OR HDB COMPL
   UN Population Fund (UNFPA), 2014, ACC PROGR MDG 5 3, V5, P3
   UN Security Council, 2014, 28 PROGR REP SEC GEN
   UN Sustainable Development Knowledge Platform, 2015, UN AD NEW GLOB GOALS
   UN Women, 2014, LIB MOB BANK HELP EB
   UN Women Inter-Agency Standing Committee Reference Group for Gender in Humanitarian Action, HUM CRIS W AFR EB GE
   UNDP, 2015, REC EB CRIS UNPUB, P12
   UNDP, 2015, SOC IMP EB VIR DIS W
   UNDP, 2015, GETT ZER EARL REC RE, P5
   United Nations Populations Fund (UNFPA), 2016, UN ACC REPR HLTH PRO
   Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
   Watson AD, 2015, INT FEM J POLIT, V17, P573, DOI 10.1080/14616742.2015.1080908
   WHO, 2015, HLTH CAR WORK EB INF
   World Bank, 2015, POV HEADC RAT 90 DAY
   World Health Organization, 2002, GEND HLTH DIS
   World Health Organization, 2012, POLICY BRIEF
   Yamin AE, 2014, J HUM DEV CAPABIL, V15, P218, DOI 10.1080/19452829.2014.896322
   YOUDE J, 2016, GLOBAL SECURITY STUD, V1, P157, DOI DOI 10.1093/JOGSS/OGW001
NR 83
TC 16
Z9 16
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-5850
EI 1468-2346
J9 INT AFF
JI Int. Aff.
PD SEP
PY 2016
VL 92
IS 5
BP 1041
EP 1060
DI 10.1111/1468-2346.12704
PG 20
WC International Relations
SC International Relations
GA DW9LM
UT WOS:000383981000001
OA Bronze
DA 2020-07-08
ER

PT J
AU Carvalho, FHC
   Cordeiro, KM
   Peixoto, AB
   Tonni, G
   Moron, AF
   Feitosa, FEL
   Feitosa, HN
   Araujo, E
AF Costa Carvalho, Francisco Herlanio
   Cordeiro, Karita Melo
   Peixoto, Alberto Borges
   Tonni, Gabriele
   Moron, Antonio Fernandes
   Lucena Feitosa, Francisco Edson
   Feitosa, Helvecio Neves
   Araujo Junior, Edward
TI Associated ultrasonographic findings in fetuses with microcephaly
   because of suspected Zika virus (ZIKV) infection during pregnancy
SO PRENATAL DIAGNOSIS
LA English
DT Article
AB ObjectiveTo describe fetal ultrasonographic findings and outcomes in a series of cases of fetal microcephaly associated with Zika virus infection.
   MethodsRetrospective case series of microcephaly with definite (laboratory evidence) or highly probable (specific neuroimaging findings and negative laboratory results) maternal Zika virus infection. Microcephaly was graded as mild if the head circumference was between 2 and 3 standard deviation (SD) below the mean, and severe if 3 or more SD below the mean. Associated central nervous system (CNS) and extracranial malformations are described.
   ResultsNineteen singleton pregnancies fulfilling the inclusion criteria were identified. Severe microcephaly and mild microcephaly were identified in 14 and 5 fetuses, respectively. Additional CNS malformations were present in 17 cases and 7 had extracranial congenital anomalies. Symptoms were reported in 13/19 cases at a gestational age between 5 and 16weeks. Mean (SD) gestational age at ultrasound diagnosis was 32.35.1weeks. Amniocentesis was performed in five cases at a median gestational age of 31weeks (range 28-38) and was positive for Zika virus RT-PCR in two cases. There were three neonatal deaths and one stillbirth.
   ConclusionIn the presence of fetal microcephaly associated with Zika virus infection, CNS malformations are frequently detected. (c) 2016 John Wiley & Sons, Ltd.
C1 [Costa Carvalho, Francisco Herlanio; Cordeiro, Karita Melo; Lucena Feitosa, Francisco Edson; Feitosa, Helvecio Neves] Fed Univ Ceara UFC, Sch Med, Dept Maternal & Child Hlth, Fortaleza, CE, Brazil.
   [Peixoto, Alberto Borges] Univ Uberaba UNIUBE, Mario Palmerio Univ Hosp, Uberaba, MG, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, Dept Obstet & Gynecol, Prenatal Diagnost Ctr, Reggio Emilia, Italy.
   [Peixoto, Alberto Borges; Moron, Antonio Fernandes; Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Peixoto, Alberto/L-6074-2016; Junior, Edward Araujo/E-1228-2012; Tonni,
   Gabriele/AAM-9842-2020; MORON, ANTONIO F./H-4987-2013
OI Peixoto, Alberto/0000-0002-1655-3609; Junior, Edward
   Araujo/0000-0002-6145-2532; MORON, ANTONIO F./0000-0002-7963-1758
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Brasil P, 2016, N ENGL J MED
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE TR, 1990, AM J OBSTET GYNECOL, V162, P1168, DOI 10.1016/0002-9378(90)90009-V
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 20
TC 38
Z9 38
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD SEP
PY 2016
VL 36
IS 9
BP 882
EP 887
DI 10.1002/pd.4882
PG 6
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA DX1AB
UT WOS:000384096800011
PM 27491635
DA 2020-07-08
ER

PT J
AU Bailey, MD
AF Bailey, Michael D.
TI Religion, the Supernatural, and Visual Culture in Early Modern Europe:
   An Album Amicorum for Charles Zika
SO RENAISSANCE QUARTERLY
LA English
DT Book Review
C1 [Bailey, Michael D.] Iowa State Univ, Ames, IA 50011 USA.
RP Bailey, MD (corresponding author), Iowa State Univ, Ames, IA 50011 USA.
CR Spinks Jennifer, 2015, RELIG SUPERNATURAL V
NR 1
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0034-4338
EI 1935-0236
J9 RENAISSANCE QUART
JI Renaiss. Q.
PD FAL
PY 2016
VL 69
IS 3
BP 1048
EP 1049
PG 2
WC Medieval & Renaissance Studies
SC Arts & Humanities - Other Topics
GA DX0MF
UT WOS:000384056000029
DA 2020-07-08
ER

PT J
AU Lavezzo, E
   Barzon, L
   Toppo, S
   Palu, G
AF Lavezzo, Enrico
   Barzon, Luisa
   Toppo, Stefano
   Palu, Giorgio
TI Third generation sequencing technologies applied to diagnostic
   microbiology: benefits and challenges in applications and data analysis
SO EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
LA English
DT Review
DE Metagenomics; metatranscriptomics; third generation sequencing
   technologies; next generation sequencing technologies; single-molecule
   sequencing; diagnostics of infectious diseases; outbreak monitoring;
   nucleotide modification detection; host; pathogen interaction; pathogen
   discovery
ID DUAL RNA-SEQ; DOUBLE-STRANDED DNA; SINGLE-MOLECULE; REAL-TIME; FUNCTION
   PREDICTION; GENOME ASSEMBLIES; POPULATION GENOMICS; PROTEIN FAMILIES;
   GENE PREDICTION; ZIKA VIRUS
AB Introduction: The diagnosis of infectious diseases is among the most successful areas of application of new generation sequencing technologies. The field has seen the development of numerous experimental and analytical approaches for the detection and the fine description of pathogenic and non-pathogenic microorganisms.Areas covered: Without claiming to be exhaustive with respect to all applications and methods developed over the years, this review focuses on the advantages and the issues brought by the new technologies, with an eye in particular to third generation sequencing methods. Both experimental procedures and algorithmic strategies are presented, following the most relevant publications which have led to progress in our ability of detecting infectious agents.Expert commentary: The technical advance brought by third generation sequencing platforms has the potential to significantly expand the range of diagnostic tools that will be available to clinicians. Nonetheless, the implementation of these technologies in clinical practice is still far from being actionable and will temporally follow the path undertaken by second generation methods, which still require the setup of standardized pipelines in both wet and dry laboratory procedures.
C1 [Lavezzo, Enrico; Barzon, Luisa; Toppo, Stefano; Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy.
RP Lavezzo, E (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.
EM enrico.lavezzo@unipd.it
RI Barzon, Luisa/K-7961-2016; Lavezzo, Enrico/K-7962-2016; Toppo,
   Stefano/Z-5479-2019
OI Barzon, Luisa/0000-0003-0720-8456; Lavezzo, Enrico/0000-0002-3902-8356;
   Toppo, Stefano/0000-0002-0246-3119
CR Abrams AJ, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01052-15
   Ackelsberg J, 2015, CELL SYST, V1, P4, DOI 10.1016/j.cels.2015.07.008
   Afiahayati, 2015, DNA RES, V22, P69, DOI 10.1093/dnares/dsu041
   Afshinnekoo E, 2015, CELL SYST, V1, P97, DOI 10.1016/j.cels.2015.07.006
   Allam A, 2015, BIOINFORMATICS, V31, P3421, DOI 10.1093/bioinformatics/btv415
   Ambulos Nicholas P Jr, 2016, J Biomol Tech, V27, P46, DOI 10.7171/jbt.16-2702-004
   Ammar Ron, 2015, F1000Res, V4, P17, DOI 10.12688/f1000research.6037.2
   Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861
   Barzona L, 2011, J CLIN VIROL, V52, P93, DOI 10.1016/j.jcv.2011.07.006
   Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63
   Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288
   Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238
   Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211
   Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367
   Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495
   Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940
   Brown SD, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-40
   Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553
   Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103
   Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]
   Ching PKG, 2015, EMERG INFECT DIS, V21, P328, DOI 10.3201/eid2102.141433
   Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106
   Choi YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002905
   Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]
   Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107
   Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duo D, 2008, MOL MED REP, V1, P673, DOI 10.3892/mmr_00000011
   Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Falda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S14
   Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004
   Fang G, 2013, NAT BIOTECHNOL, V31, P566, DOI 10.1038/nbt0613-565f
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
   Feng YX, 2015, GENOM PROTEOM BIOINF, V13, P4, DOI 10.1016/j.gpb.2015.01.009
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Finotello F, 2012, BRIEF BIOINFORM, V13, P269, DOI 10.1093/bib/bbr063
   Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113
   Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455
   Gregori J, 2016, VIROLOGY, V493, P227, DOI 10.1016/j.virol.2016.03.017
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392
   Haider B, 2014, BIOINFORMATICS, V30, P2717, DOI 10.1093/bioinformatics/btu395
   Haque F, 2015, BIOMATERIALS, V53, P744, DOI 10.1016/j.biomaterials.2015.02.104
   Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2
   Heng JB, 2004, BIOPHYS J, V87, P2905, DOI 10.1529/biophysj.104.041814
   Hodkinson BP, 2015, ADV WOUND CARE, V4, P50, DOI 10.1089/wound.2014.0542
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327
   Hong LZ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0517-9
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Ip Camilla L C, 2015, F1000Res, V4, P1075, DOI 10.12688/f1000research.7201.1
   Judge K, 2015, J ANTIMICROB CHEMOTH, V70, P2775, DOI 10.1093/jac/dkv206
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910
   Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014
   Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101
   Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Kumar S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00684
   Kuzmina NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082348
   Lagier JC, 2015, CLIN MICROBIOL REV, V28, P208, DOI 10.1128/CMR.00110-14
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Laver TW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21746
   Lavezzo E, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030079
   Lavezzo E, 2016, METHODS, V93, P15, DOI 10.1016/j.ymeth.2015.08.021
   Lavezzo E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-554
   Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Leung HCM, 2015, J COMPUT BIOL, V22, P367, DOI 10.1089/cmb.2014.0139
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747
   Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848
   Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4
   Liu S, 2013, ADV MATER, V25, P4549, DOI 10.1002/adma.201301336
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Luo RB, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0069-2
   Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171
   Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723
   Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164
   Menestrina J, 2014, J PHYS CHEM C, V118, P2391, DOI 10.1021/jp412135v
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Micalessi MI, 2013, J VIROL METHODS, V187, P166, DOI 10.1016/j.jviromet.2012.09.013
   Militello V, 2013, CLIN MICROBIOL INFEC, V19, pE428, DOI 10.1111/1469-0691.12219
   Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001
   Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mou KT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00782
   Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723
   Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Pal M, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00356-15
   Patel A, 2014, GENOME RES, V24, P318, DOI 10.1101/gr.161497.113
   Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581
   Piccirillo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149529
   Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006
   Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]
   Poh WT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-355
   Powers JG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-675
   Prosperi MCF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02837
   Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/nmeth.2340, 10.1038/NMETH.2340]
   Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747
   Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002
   Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112
   Ritz A, 2014, BIOINFORMATICS, V30, P3458, DOI 10.1093/bioinformatics/btu714
   Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643
   Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Schirmer M, 2014, BRIEF BIOINFORM, V15, P431, DOI 10.1093/bib/bbs081
   Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]
   Schulz MH, 2014, BIOINFORMATICS, V30, pI356, DOI 10.1093/bioinformatics/btu440
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075
   Shim J, 2015, ACS NANO, V9, P290, DOI 10.1021/nn5045596
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Streicker DG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002720
   Taira CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-406
   Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543
   Vahidnia A, 2015, J MICROBIOL METH, V113, P38, DOI 10.1016/j.mimet.2015.03.024
   Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108
   Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/nnano.2011.129, 10.1038/NNANO.2011.129]
   Vergnaud G, 2009, METHODS MOL BIOL, V551, P141, DOI 10.1007/978-1-60327-999-4_12
   Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
   Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]
   Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547
   Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wirawan A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-131
   WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576
   Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhang XJ, 2012, BIOTECHNIQUES, V53, P61, DOI 10.2144/0000113891
   Zhou YJ, 2014, J CLIN MICROBIOL, V52, P4260, DOI 10.1128/JCM.02115-14
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
NR 172
TC 9
Z9 11
U1 4
U2 56
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 1473-7159
EI 1744-8352
J9 EXPERT REV MOL DIAGN
JI Expert Rev. Mol. Diagn.
PD SEP
PY 2016
VL 16
IS 9
BP 1011
EP 1023
DI 10.1080/14737159.2016.1217158
PG 13
WC Pathology
SC Pathology
GA DV9HO
UT WOS:000383251600010
PM 27453996
DA 2020-07-08
ER

PT J
AU Su, S
   Qiu, XG
   Zhou, JY
AF Su, Shuo
   Qiu, Xiangguo
   Zhou, Jiyong
TI Spread of ZIKV and YFV to China: Potential implications
SO JOURNAL OF INFECTION
LA English
DT Letter
ID YELLOW-FEVER; VIRUS; OUTBREAK; DISEASES; USA
C1 [Su, Shuo; Zhou, Jiyong] Nanjing Agr Univ, Jiangsu Engn Lab Anim Immunol, Inst Immunol, Nanjing, Jiangsu, Peoples R China.
   [Su, Shuo; Zhou, Jiyong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.
   [Qiu, Xiangguo] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
   [Qiu, Xiangguo] Univ Manitoba, Dept Med Microbiol, Coll Med, Winnipeg, MB, Canada.
   Nanjing Agr Univ, Nanjing, Peoples R China.
   [Zhou, Jiyong] Zhejiang Univ, Coll Anim Sci, Minist Agr, Key Lab Anim Virol, Hangzhou, Zhejiang, Peoples R China.
   [Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr, Hangzhou, Zhejiang, Peoples R China.
   [Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.
RP Zhou, JY (corresponding author), Nanjing Agr Univ, Jiangsu Engn Lab Anim Immunol, Inst Immunol, Nanjing, Jiangsu, Peoples R China.; Zhou, JY (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.; Qiu, XG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
EM xiangguo.qiu@phac-aspc.gc.ca; jyzhou@njau.edu.cn
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   ASEFFA A, 1993, E AFR MED J, V70, P624
   Awate P, 2016, J INFECTION, V72, P759, DOI 10.1016/j.jinf.2016.03.006
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buckingham SC, 2015, J INFECTION, V71, pS88, DOI 10.1016/j.jinf.2015.04.009
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Jin LQ, 2008, MED VET ENTOMOL, V22, P359, DOI 10.1111/j.1365-2915.2008.00758.x
   McNeill JR, 2004, OAH MAGAZINE HIST, V18, P9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
NR 16
TC 3
Z9 3
U1 0
U2 46
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD SEP
PY 2016
VL 73
IS 3
BP 289
EP 291
DI 10.1016/j.jinf.2016.06.004
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DW1CN
UT WOS:000383380500012
PM 27321115
OA Bronze
DA 2020-07-08
ER

PT J
AU Wu, D
   Sun, JF
   Zhong, HJ
   Guan, DW
   Zhang, H
   Tan, QQ
   Zhou, HQ
   Ning, D
   Ke, CW
   Song, T
   Lin, JY
   Zhang, YH
   Koopmans, M
   Gao, GF
AF Wu, De
   Sun, Jiufeng
   Zhong, Haojie
   Guan, Dawei
   Zhang, Huan
   Tan, Qiqi
   Zhou, Huiqiong
   Ning, Dan
   Ke, Changwen
   Song, Tie
   Lin, Jinyan
   Zhang, Yonghui
   Koopmans, Marion
   Gao, George F.
TI A family cluster of imported ZIKV cases: Viremia period may be longer
   than previously reported
SO JOURNAL OF INFECTION
LA English
DT Letter
ID VIRUS; STATES
C1 [Wu, De; Sun, Jiufeng; Zhong, Haojie; Guan, Dawei; Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Ning, Dan; Ke, Changwen; Song, Tie; Lin, Jinyan; Zhang, Yonghui] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510430, Guangdong, Peoples R China.
   [Wu, De; Sun, Jiufeng; Zhong, Haojie; Guan, Dawei; Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Ning, Dan; Ke, Changwen; Song, Tie; Lin, Jinyan; Zhang, Yonghui] WHO Collaborating Ctr Surveillance Res & Training, Guangzhou, Guangdong, Peoples R China.
   [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510430, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
RI Zhou, Huiqiong/S-1276-2016; Koopmans, Marion/Y-9170-2019
OI Zhou, Huiqiong/0000-0003-2124-6563; Koopmans,
   Marion/0000-0002-5204-2312; sun, jiufeng/0000-0003-1047-929X
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
NR 10
TC 10
Z9 11
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD SEP
PY 2016
VL 73
IS 3
BP 300
EP 303
DI 10.1016/j.jinf.2016.06.008
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DW1CN
UT WOS:000383380500017
PM 27373766
OA Bronze
DA 2020-07-08
ER

PT J
AU Barreira, AA
   Marques, W
   Marreco, A
   Aquino-Cruz, C
   Esposito, D
   Klein, T
   Jacobs, BC
   Hughes, RAC
   Cornblath, DR
   van Doorn, P
   Gorson, KC
   Hartung, HP
   Willison, HJ
   Kusunoki, S
   Fonseca, B
AF Barreira, A. A.
   Marques, W., Jr.
   Marreco, A.
   Aquino-Cruz, C.
   Esposito, D.
   Klein, T.
   Jacobs, B. C.
   Hughes, R. A. C.
   Cornblath, D. R.
   van Doorn, P.
   Gorson, K. C.
   Hartung, H-P
   Willison, H. J.
   Kusunoki, S.
   Fonseca, B.
TI GUILLAIN-BARRE SYNDROME RELATED TO ZIKA VIRUS INFECTION IN BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Barreira, A. A.] Univ Sao Paulo, Med Sch Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Univ Hosp Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Jacobs, B. C.; van Doorn, P.] Erasmus MC, Rotterdam, Netherlands.
   [Hughes, R. A. C.] UCL, Inst Neurol, London, England.
   [Cornblath, D. R.] Johns Hopkins Univ, Baltimore, MD USA.
   [Gorson, K. C.] Tufts Univ, Sch Med, Boston, MA 02111 USA.
   [Hartung, H-P] Univ Dusseldorf, Dusseldorf, Germany.
   [Willison, H. J.] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Kusunoki, S.] Univ Sch Med, Osaka, Japan.
RI Esposito, Danillo L.A./N-9261-2017; Marques, Wilson/G-4240-2012; Gorson,
   Kenneth/K-7778-2019
OI Esposito, Danillo L.A./0000-0002-2755-4471; Marques,
   Wilson/0000-0002-4589-2749; 
NR 0
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 162
EP 162
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200020
DA 2020-07-08
ER

PT J
AU Ferreira, ACAF
   Cruz, LCH
   Santos, PP
   Fontes, CAP
   Neves, DG
   Cavaliere, MG
   Prado, HIP
   Herculano, FGN
   Silva, IRF
   Nascimento, OJM
AF Ferreira, A. C. A. F.
   Cruz Jr, L. C. H.
   Santos, P. P.
   Fontes, C. A. P.
   Neves, D. G.
   Cavaliere, M. G.
   Prado, H. I. P.
   Herculano, F. G. N.
   Silva, I. R. F.
   Nascimento, O. J. M.
TI MRI FINDINGS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM IN PATIENTS
   WITH ZIKA VIRUS INFECTION
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Ferreira, A. C. A. F.; Santos, P. P.; Fontes, C. A. P.; Neves, D. G.; Cavaliere, M. G.; Prado, H. I. P.; Herculano, F. G. N.; Silva, I. R. F.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
   [Cruz Jr, L. C. H.] Hosp Amer, CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 173
EP 173
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200049
DA 2020-07-08
ER

PT J
AU Ferreira, MLB
   Brito, PFR
   Albuquerque, LBB
   Coutinho, MCR
   Moreira, AJP
   Machado, MIM
AF Ferreira, M. L. B.
   Brito, P. F. R.
   Albuquerque, L. B. B.
   Coutinho, M. C. R.
   Moreira, A. J. P.
   Machado, M. I. M.
TI GUILLAIN-BARRE SYNDROME ASSOCIATED TO ZIKA VIRUS OUTBREAK IN RECIFE,
   NORTHEAST BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Ferreira, M. L. B.; Moreira, A. J. P.; Machado, M. I. M.] Hosp Restauracao, Recife, PE, Brazil.
   [Brito, P. F. R.] Fac Pernambucana Saude, Med, Recife, PE, Brazil.
   [Albuquerque, L. B. B.] Univ Fed Pernambuco, Fac Med, Recife, PE, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 173
EP 173
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200050
DA 2020-07-08
ER

PT J
AU Santos, PP
   Nogueira, CB
   Cruz, LCH
   Vianna, FSL
   Ferreira, ACA
   Carvalho, ML
   Filho, PFM
   Matta, AP
   Silva, IRF
   Nascimento, OJM
AF Santos, P. P.
   Nogueira, C. B.
   Cruz Jr, L. C. H.
   Vianna, F. S. L.
   Ferreira, A. C. A.
   Carvalho, M. L.
   Filho, P. F. M.
   Matta, A. P.
   Silva, I. R. F.
   Nascimento, O. J. M.
TI CNS AND PNS FINDINGS DURING THE ZIKA VIRUS OUTBREAK
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Santos, P. P.; Nogueira, C. B.; Vianna, F. S. L.; Ferreira, A. C. A.; Carvalho, M. L.; Filho, P. F. M.; Matta, A. P.; Silva, I. R. F.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
   [Cruz Jr, L. C. H.] Hosp Amer, CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 207
EP 207
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200142
DA 2020-07-08
ER

PT J
AU Silva, IRF
   Araujo, LM
   Santos, PP
   Ferreira, ACA
   Almeida, IM
   Pagliarini, LFD
   Magalhaes, TN
   Pupe, CCB
   Guedes, V
   Costa, HVM
   Nascimento, OJM
AF Silva, I. R. F.
   Araujo, L. M.
   Santos, P. P.
   Ferreira, A. C. A.
   Almeida, I. M.
   Pagliarini, L. F. D.
   Magalhaes, T. N.
   Pupe, C. C. B.
   Guedes, V
   Costa, H. V. M.
   Nascimento, O. J. M.
TI INCREASED INCIDENCE OF GBS CASES DURING ZIKA EPIDEMIC IN BRAZIL: A
   POPULATION STUDY ZIKA VIRUS OUTBREAK
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Silva, I. R. F.; Araujo, L. M.; Santos, P. P.; Ferreira, A. C. A.; Almeida, I. M.; Pagliarini, L. F. D.; Magalhaes, T. N.; Pupe, C. C. B.; Guedes, V; Costa, H. V. M.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 211
EP 211
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200155
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI Will Zika return to the 'Old World'?
SO MICROBES AND INFECTION
LA English
DT Editorial Material
C1 [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Sabin Vaccine Inst, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Texas Childrens Hosp Ctr Vaccine Dev, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Houston, TX 77030 USA.
   [Hotez, Peter J.] Rice Univ, James A Baker Inst Publ Policy 3, Houston, TX USA.
   [Hotez, Peter J.] 1 Baylor Plaza, Houston, TX USA.
RP Hotez, PJ (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Sabin Vaccine Inst, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Coll Med, Natl Sch Trop Med, Texas Childrens Hosp Ctr Vaccine Dev, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Rice Univ, James A Baker Inst Publ Policy 3, Houston, TX USA.; Hotez, PJ (corresponding author), 1 Baylor Plaza, Houston, TX USA.
EM hotez@bcm.edu
OI Hotez, Peter/0000-0001-8770-1042
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alikhan M, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.69
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   El-Kafrawy SA, 2016, VECTOR-BORNE ZOONOT, V16, P391, DOI 10.1089/vbz.2015.1911
   Hotez PJ, 2016, PLOS NEGL T IN PRESS
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
NR 10
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD SEP
PY 2016
VL 18
IS 9
BP 527
EP 528
DI 10.1016/j.micinf.2016.05.003
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DW0EN
UT WOS:000383313800002
PM 27242327
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Association Between Zika Virus and Microcephaly in French Polynesia,
   2013-2015: A Retrospective Study EDITORIAL COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD SEP
PY 2016
VL 71
IS 9
BP 512
EP 514
DI 10.1097/01.ogx.0000491260.72445.aa
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DW9RT
UT WOS:000384000500005
DA 2020-07-08
ER

PT J
AU Dorit, RL
AF Dorit, Robert L.
TI Zika Goes Viral While the Zika virus has its moment, few people are
   discussing the problems underlying the worldwide increase in emerging
   infectious diseases
SO AMERICAN SCIENTIST
LA English
DT Editorial Material
C1 [Dorit, Robert L.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.
RP Dorit, RL (corresponding author), Ford Hall 114,100 Green St, Northampton, MA 01063 USA.
EM rdorit@smith.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SIGMA XI-SCI RES SOC
PI RES TRIANGLE PK
PA PO BOX 13975, RES TRIANGLE PK, NC 27709 USA
SN 0003-0996
EI 1545-2786
J9 AM SCI
JI Am. Scientist
PD SEP-OCT
PY 2016
VL 104
IS 5
BP 274
EP 277
DI 10.1511/2016.122.274
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4JU
UT WOS:000381446800013
DA 2020-07-08
ER

PT J
AU Leandro, CG
AF Leandro, Carol Gois
TI Nutritional status and gross motor function in children with cerebral
   palsy, and implications for Zika virus infection
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Editorial Material
ID BIRTH-WEIGHT; PERFORMANCE
AB This commentary is on the original article by Herrera-Anaya etal. on pages 936-941 of this issue.
C1 [Leandro, Carol Gois] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Recife, PE, Brazil.
RP Leandro, CG (corresponding author), Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Recife, PE, Brazil.
CR Herrera-Anaya E, 2016, DEV MED CHILD NEUROL, V58, P936, DOI 10.1111/dmcn.13108
   Moura-Dos-Santos M, 2013, AM J HUM BIOL, V25, P58, DOI 10.1002/ajhb.22341
   Moura-Dos-Santos MA, 2015, DEV MED CHILD NEUROL, V57, P470, DOI 10.1111/dmcn.12664
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100
NR 5
TC 5
Z9 5
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD SEP
PY 2016
VL 58
IS 9
BP 893
EP 894
DI 10.1111/dmcn.13134
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DV3VJ
UT WOS:000382852000004
PM 27060691
OA Bronze
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Vijayan, P
   Kadaikunnan, S
   Alharbi, NS
   Benelli, G
AF Govindarajan, Marimuthu
   Vijayan, Periasamy
   Kadaikunnan, Shine
   Alharbi, Naiyf S.
   Benelli, Giovanni
TI One-pot biogenic fabrication of silver nanocrystals using Quisqualis
   indica: Effectiveness on malaria and Zika virus mosquito vectors, and
   impact on non-target aquatic organisms
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Arbovirus; Mosquito-borne diseases; Green synthesis; Nanobiotechnology;
   AFM
ID CULEX-QUINQUEFASCIATUS; GREEN SYNTHESIS; AEDES-AEGYPTI; LEAF EXTRACT;
   ANOPHELES-STEPHENSI; PREDATION EFFICIENCY; VETERINARY IMPORTANCE;
   LARVICIDAL ACTIVITY; AQUEOUS EXTRACT; ACUTE TOXICITY
AB Currently, mosquito vector control is facing a number of key challenges, including the rapid development of resistance to synthetic pesticides and the recent spread of aggressive arbovirus outbreaks. The biosynthesis of silver nanoparticles (AgNPs) is currently considered an environmental friendly alternative to the employ of pyrethroids, carbamates and microbial agents (e.g. Bacillus thuringiensis var. israelensis), since AgNPs are easy to produce, effective and stable in the aquatic environment. However, their biophysical features showed wide variations according to the botanical agent using for the green synthesis, outlining the importance of screening local floral resources used as reducing and stabilizing agents. In this study, we focused on the biophysical properties and the mosquitocidal action of Quisqualis indica-fabricated AgNPs. AgNPs were characterized using spectroscopic (UV, FTIR, XRD) and microscopic (AFM, SEM, TEM and EDX) techniques. AFM, SEM and TEM confirmed the synthesis of poly-dispersed AgNPs with spherical shape and size ranging from 1 to 30 nm. XRD shed light on the crystalline structure of these AgNPs. The acute toxicity of Quisqualis indica extract and AgNPs was evaluated against malaria, arbovirus, and filariasis vectors, Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus, as well as on three important non-target aquatic organisms. The Q. indica leaf extract showed moderate larvicidal effectiveness on Cx. quinquefasciatus (LC50 = 220.42), Ae. aegypti (LC50 = 203.63) and An. stephensi (LC50 = 185.98). Q indica-fabricated AgNPs showed high toxicity against Cx. quinquefasciatus (LC50 = 14.63), Ae. aegypti (LC50 = 13.55) and An. stephensi (LC50 = 1252), respectively. Notably, Q indica-synthesized AgNPs were moderately toxic to non-target aquatic mosquito predators Anisops bouvieri (LC50 = 653.05 mu g/mL), Diplonychus indicus (LC50 = 860.94 mu g/mL) and Gambusia affinis (LC50 = 2183.16 mu g/mL), if compared to the targeted mosquitoes. Overall, the proposed one-pot biogenic fabrication of AgNPs using Q. indica is a low-cost and eco-friendly tool in the fight against Zika virus, malaria and filariasis vectors, with little impact against non-target aquatic mosquito predators. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Govindarajan, Marimuthu; Vijayan, Periasamy] Annamalai Univ, Unit Vector Control Phytochem & Nanotechnol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
   [Kadaikunnan, Shine; Alharbi, Naiyf S.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (corresponding author), Annamalai Univ, Unit Vector Biol Phytochem & Nanotechnol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI Alharbi, Naiyf S/B-9402-2019; /L-2836-2013; Benelli,
   Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI /0000-0001-7018-5379; Benelli, Giovanni/0000-0001-8971-6010;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]; PROAPI
   (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. Matyus and three anonymous reviewers improved an earlier version
   of our manuscript. The authors extend their sincere appreciations to the
   Deanship of Scientific Research at King Saud University for its funding
   this Prolific Research Group (PRG-1437-36). G. Benelli is supported by
   PROAPI (PRAF 2015) and University of Pisa, Department of Agriculture,
   Food and Environment (grant ID: COFIN2015_22). Funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bar H, 2009, COLLOID SURFACE A, V348, P212, DOI 10.1016/j.colsurfa.2009.07.021
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G., 2016, PARASITOL RES MONOGR, P155
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   DEO P G, 1988, International Pest Control, V30, P118
   Efferth T, 2008, MOL CANCER THER, V7, P152, DOI 10.1158/1535-7163.MCT-07-0073
   Finney D.T., 1971, PROBIT ANAL
   Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i
   Govindarajan M, 2011, EUR REV MED PHARMACO, V15, P787
   Govindarajan M., 2016, NAT PROD RES
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M., 2016, ENZYME MICROB TECHNO
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Jahan Fatima N, 2008, Oriental Pharmacy and Experimental Medicine, V8, P53
   Kannan P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085602
   Kumar VP, 2006, J ETHNOPHARMACOL, V107, P182, DOI 10.1016/j.jep.2006.03.013
   Luo LB, 2005, J AM CHEM SOC, V127, P2822, DOI 10.1021/ja0428154
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P4385, DOI 10.1007/s00436-015-4677-7
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nair PMG, 2011, AQUAT TOXICOL, V101, P31, DOI 10.1016/j.aquatox.2010.08.013
   Nitu S., 2011, INT J RES PHARM SCI, V1, P88
   Pavela R., 2016, J PEST SCI
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Siddiqui BS, 2000, PHYTOCHEMISTRY, V53, P371, DOI 10.1016/S0031-9422(99)00548-8
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Subramaniam J., 2016, ENV SCI POLLUT RES
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Tavakoli F, 2015, MATER RES BULL, V63, P51, DOI 10.1016/j.materresbull.2014.11.045
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Tripathy A, 2010, J NANOPART RES, V12, P237, DOI 10.1007/s11051-009-9602-5
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   Vincent S., 2016, J CLUST SCI
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   Whiteman S C, 2008, Ther Adv Respir Dis, V2, P23, DOI 10.1177/1753465807087972
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Yugandhar P, 2016, APPL NANOSCI, V6, P223, DOI 10.1007/s13204-015-0428-4
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
   Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031
NR 74
TC 11
Z9 11
U1 0
U2 77
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD SEP
PY 2016
VL 162
BP 646
EP 655
DI 10.1016/j.jphotobiol.2016.07.036
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DV5XK
UT WOS:000383003800076
PM 27491031
DA 2020-07-08
ER

PT J
AU Zhang, JW
   Jin, X
   Zhu, ZY
   Huang, L
   Liang, SJ
   Xu, Y
   Liao, RY
   Zhou, LC
   Zhang, Y
   Wilder-Smith, A
AF Zhang, Jiwen
   Jin, Xia
   Zhu, Zhaoyin
   Huang, Li
   Liang, Shaojun
   Xu, Yuan
   Liao, Ruyan
   Zhou, Licheng
   Zhang, Yan
   Wilder-Smith, Annelies
TI Early detection of Zika virus infection among travellers from areas of
   ongoing transmission in China
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika virus; detection; imported case
AB Nine imported Zika virus (ZIKV) infections (four through temperature monitoring and epidemiological investigation at entry and five by active surveillance tracking of index case contacts during follow-up; from Venezuela [n = 5], Samoa [n = 3] and both Samoa and Fiji [n = 1]) were detected in mainland China from February 1 to 29, 2016. The minimal incubation period lasted 5.2 days, with mean lag time to diagnosis of 2.6 days. Diagnosis relied on positive real-time reverse transcriptase polymerase chain reaction for ZIKV RNA in serum (n = 7), urine (n = 4) or saliva (n = 3), respectively. All cases recovered rapidly without serious complications.
C1 [Zhang, Jiwen; Jin, Xia; Zhu, Zhaoyin] Gen Adm Qual Supervis Inspect & Quarantine PRC, Beijing, Peoples R China.
   [Huang, Li] Guangdong Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
   [Liang, Shaojun] Guangdong Int Travel Hlth Care Ctr, Guangzhou, Guangdong, Peoples R China.
   [Xu, Yuan] Shenzhen Int Travel Hlth Care Ctr, Shenzhen, Guangdong, Peoples R China.
   [Liao, Ruyan] Guangzhou Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
   [Zhou, Licheng] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen, Guangdong, Peoples R China.
   [Zhang, Yan] Zhejiang Entry & Exit Inspect & Quarantine Bur, Hangzhou, Zhejiang, Peoples R China.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Huang, L (corresponding author), Guangdong Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
EM 997843156@qq.com
RI Wilder-Smith, Annelies/F-8751-2015
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Jiamu C, 2015, PORT HLTH CONTROL, V20, P14
   Kui Z, 2016, CHIN FRONT HLTH QUAR, V39, P1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Qiyong L., 2016, CHIN J VECTOR BIOL C, V27, P93
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   WHO, WHO DIR GEN SUMM OUT
NR 8
TC 11
Z9 11
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD SEP
PY 2016
VL 23
IS 5
AR taw047
DI 10.1093/jtm/taw047
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA DV9MN
UT WOS:000383264700003
PM 27378370
OA Bronze
DA 2020-07-08
ER

PT J
AU de Sa, TH
   Reis-Santos, B
   Rodrigues, LC
AF de Sa, Thiago Herick
   Reis-Santos, Barbara
   Rodrigues, Laura C.
TI Zika outbreak, mega-events, and urban reform
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID VIRUS
C1 [de Sa, Thiago Herick] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.
   [Reis-Santos, Barbara] Univ Espirito Santo, LabEpi Lab Epidemiol, BR-29040091 Vitoria, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Reis-Santos, B (corresponding author), Univ Espirito Santo, LabEpi Lab Epidemiol, BR-29040091 Vitoria, Brazil.
EM reissantos.barbara@gmail.com
RI Sa, Thiago Herick de/N-1952-2015; Reis-Santos, Barbara/A-3149-2014
OI Sa, Thiago Herick de/0000-0002-9348-4483; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU Brazilian Science without Borders Scheme [200358/2014-6]; Sao Paulo
   Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2012/08565-4]; International Clinical, Operational and Health
   Services Research Training Award (ICOHRTA grant) from the National
   Institutes of Health (Bethesda, Maryland, United States) [5 U2R
   TW006883-02]
FX We declare no competing interests. THdS was supported by the Brazilian
   Science without Borders Scheme (process number: 200358/2014-6) and the
   Sao Paulo Research Foundation (process number: 2012/08565-4). BR-S was
   supported by International Clinical, Operational and Health Services
   Research Training Award (ICOHRTA grant: 5 U2R TW006883-02) from the
   National Institutes of Health (Bethesda, Maryland, United States).
CR Comite Popular Rio Copa e Olimpiadas, 2013, MEG VIOL DIR HUM RIO
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Paula MD, 2014, COPA QUEM QUE OLHAR
   The LGH, 2016, LANCET GLOB HLTH, V4, pe427
NR 5
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD SEP
PY 2016
VL 4
IS 9
BP E603
EP E603
DI 10.1016/S2214-109X(16)30174-7
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU4VV
UT WOS:000382211700013
PM 27539802
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Samy, AM
   Thomas, SM
   Abd El Wahed, A
   Cohoon, KP
   Peterson, AT
AF Samy, Abdallah M.
   Thomas, Stephanie Margarete
   Abd El Wahed, Ahmed
   Cohoon, Kevin P.
   Peterson, A. Townsend
TI Mapping the global geographic potential of Zika virus spread
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; global distribution; risk; Aedes; Brazil; climate;
   socioeconomic; accessibility
AB The Americas are presently experiencing the most serious known outbreak of Zika virus (ZIKV). Here, we present a novel set of analyses using environmental characteristics, vector mosquito distributions, and socioeconomic risk factors to develop the first map to detail global ZIKV transmission risk in multiple dimensions based on ecological niche models. Our model predictions were tested against independent evaluation data sets, and all models had predictive ability significantly better than random expectations. The study addresses urgent knowledge gaps regarding (1) the potential geographic scope of the current ZIKV epidemic, (2) the global potential for spread of ZIKV, and (3) drivers of ZIKV transmission. Our analysis of potential drivers of ZIKV distributions globally identified areas vulnerable in terms of some drivers, but not for others. The results of these analyses can guide regional education and preparedness efforts, such that medical personnel will be better prepared for diagnosis of potential ZIKV cases as they appear.
C1 [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Cairo, Egypt.
   [Samy, Abdallah M.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.
   [Thomas, Stephanie Margarete] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany.
   [Abd El Wahed, Ahmed] Univ Gottingen, Div Microbiol & Anim Hyg, Gottingen, Germany.
   [Cohoon, Kevin P.] Mayo Clin, Rochester, MN USA.
RP Samy, AM (corresponding author), Ain Shams Univ, Fac Sci, Cairo, Egypt.; Samy, AM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.
EM asamy.ku@hotmail.com
RI Samy, Abdallah/B-4375-2010
OI Samy, Abdallah/0000-0003-3978-1134; Thomas, Stephanie
   Margarete/0000-0003-0507-2006
FU Research and Training Center on Vectors of Diseases; Department of
   Entomology of Ain Shams UniversityAin Shams University; Egyptian
   Fulbright Mission Program (EFMP)
FX To the Egyptian Fulbright Mission Program (EFMP), for supporting AMS,
   Ian Mackay who provided enormously useful discussion and suggestions on
   the manuscript, KU ENM group and the Research and Training Center on
   Vectors of Diseases and the Department of Entomology of Ain Shams
   University for their support, Abdelghafar Alkishe and Katie Allen, for
   their continuous support during the study, and Omama Ali, for her
   support during the whole work.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Koenig KL, 2016, DISASTER MED PUBLIC, V1, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 9
TC 39
Z9 39
U1 4
U2 42
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2016
VL 111
IS 9
BP 559
EP 560
DI 10.1590/0074-02760160149
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DW0NC
UT WOS:000383336100004
PM 27653360
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Safadi, MAP
AF Palazzi Safadi, Marco Aurelio
TI Zika Virus: What Have We Learned?
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Editorial Material
ID BRAZIL; INFECTION; OUTBREAK
C1 [Palazzi Safadi, Marco Aurelio] Santa Casa de Sao Paulo Sch Med Sci, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, Brazil.
RP Safadi, MAP (corresponding author), Alameda Indigenas 228, BR-04059060 Sao Paulo, Brazil.
EM masafadi@uol.com.br
RI safadi, marco aurelio palazzi/B-7157-2015
OI safadi, marco aurelio palazzi/0000-0002-4401-9446
CR Brasil P, 2016, NEW ENGL J MED, V16, P742
   Brazilian Ministry of Health, B EPIDEMIOLOGICO
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, DIAGN TEST
   Delvecchio R, 2016, BIORXIV, DOI [10.1101/051268, DOI 10.1101/051268]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization, GUILL BARR SYNDR COL
   World Health Organization, GUILL BARR SYNDR BRA
   World Health Organization (WHO), ZIK SIT REP
NR 25
TC 1
Z9 1
U1 0
U2 97
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD SEP
PY 2016
VL 33
IS 11
BP 1029
EP 1031
DI 10.1055/s-0036-1586116
PG 3
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DU7TZ
UT WOS:000382418800001
PM 27603528
OA Bronze
DA 2020-07-08
ER

PT J
AU Dar, H
   Zaheer, T
   Rehman, MT
   Ali, A
   Javed, A
   Khan, GA
   Babar, MM
   Waheed, Y
AF Dar, Hamza
   Zaheer, Tahreem
   Rehman, Muhammad Talha
   Ali, Amjad
   Javed, Aneela
   Khan, Gohar Ayub
   Babar, Mustafeez Mujtaba
   Waheed, Yasir
TI Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein:
   An in silico approach
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika Virus; B-Cell Epitopes; T-Cell Epitopes; Vaccine; Antigenicity
ID VACCINATION; DATABASE; TOOL
AB Objective: To predict immunogenic promiscuous T-cell epitopes from the polyprotein of the Zika virus using a range of bioinformatics tools. To date, no epitope data are available for the Zika virus in the IEDB database. Methods: We retrieved nearly 54 full length polyprotein sequences of the Zika virus from the NCBI database belonging to different outbreaks. A consensus sequence was then used to predict the promiscuous T-cell epitopes that bind MHC 1 and MHC II alleles using Propred1 and Propred immunoinformatic algorithms respectively. The antigencity predicted score was also calculated for each predicted epitope using the VaxiJen 2.0 tool. Results: By using ProPred1, 23 antigenic epitopes for HLA class I and 48 antigenic epitopes for HLA class II were predicted from the consensus polyprotein sequence of Zika virus. The greatest number of MHC class I binding epitopes were projected within the NS5 (21%), followed by Envelope (17%). For MHC class II, greatest number of predicted epitopes were in NS5 (19%) followed by the Envelope, NS1 and NS2 (17% each). A variety of epitopes with good binding affinity, promiscuity and antigenicity were predicted for both the HLA classes. Conclusion: The predicted conserved promiscuous T-cell epitopes examined in this study were reported for the first time and will contribute to the imminent design of Zika virus vaccine candidates, which will be able to induce a broad range of immune responses in a heterogeneous HLA population. However, our results can be verified and employed in future efficacious vaccine formulations only after successful experimental studies.
C1 [Dar, Hamza; Zaheer, Tahreem; Rehman, Muhammad Talha; Ali, Amjad; Javed, Aneela; Khan, Gohar Ayub] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan.
   [Babar, Mustafeez Mujtaba] Shifa Tameer e Millat Univ, Shifa Coll Pharmaceut Sci, Islamabad, Pakistan.
   [Waheed, Yasir] Fdn Univ Islamabad, DHA I, Fdn Univ Med Coll, Islamabad 44000, Pakistan.
RP Waheed, Y (corresponding author), Fdn Univ Islamabad, DHA I, Fdn Univ Med Coll, Islamabad 44000, Pakistan.
EM darhamza000@gmail.com; javedaneela@gmail.com;
   yasir_waheed_199@hotmail.com
RI Waheed, Yasir/AAC-3896-2019; Waheed, Yasir/F-6390-2015
OI Waheed, Yasir/0000-0002-5789-4215; Waheed, Yasir/0000-0002-5789-4215;
   Dar, Hamza Arshad/0000-0002-0667-5653
CR Adhisivam B, 2013, RECENT ADV PEDIAT, V22
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Almanzar G, 2007, WIEN MED WOCHENSCHR, V157, P116, DOI 10.1007/s10354-007-0393-y
   Amin N, 2013, ISRN VIROL, V2013
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, P61, DOI DOI 10.4172/JAA.1000E130
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hafner C, 2005, J INVEST DERMATOL, V124, P125, DOI 10.1111/j.0022-202X.2004.23515.x
   Hari A, 2015, EUR J IMMUNOL, V45, P383, DOI 10.1002/eji.201445156
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1983, VIROLOGY, V126, P525, DOI 10.1016/S0042-6822(83)80010-5
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucchese G, 2016, AUTOIMMUN REV, V16, P53
   Macstrc AM, 2016, EBIO MED, V5, P2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Olsen AW, 2000, EUR J IMMUNOL, V30, P1724
   Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595
   Oyarzun P, 2015, VACCINE, V33, P1267, DOI 10.1016/j.vaccine.2015.01.040
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Saxena SK, 2016, VIRUS DIS, P1
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Slifka MK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00195
   Steward MW, 2001, BIOLOGICALS, V29, P215, DOI 10.1006/biol.2001.0291
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
NR 43
TC 15
Z9 16
U1 0
U2 59
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD SEP
PY 2016
VL 9
IS 9
BP 822
EP 828
DI 10.1016/j.apjtm.2016.07.004
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DU1HD
UT WOS:000381957900004
PM 27633296
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Schmidt, CW
AF Schmidt, Charles W.
TI Zika in the United States How Are We Preparing?
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Editorial Material
ID VIRUS TRANSMISSION; EXPOSURE; DENGUE; BRAZIL
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   [Anonymous], 2016, DENGUE
   ATSDR, 2003, PUBL HLTH STAT PYR P
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE NEWS     0321
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, TRAV HLTH NOT CURR N
   CDC, 2016, ZIK SEX TRANSM BAS Z
   CDC, 2016, ADV PEOPL LIV TRAV W
   CDC, 2016, SPEC BIRTH DEF MICR
   CDC, MOSQ LIF CYCL AED AE
   CDC, 2016, TRAV HLTH ZIK VIR PU
   CDC, 2016, AR ZIK CAS COUNTS US
   CDC, 2016, INT CDC ZIK IN PRESS
   CDC, 2016, CLIN GUID HEALTHC PR
   Coelho FC, 2016, BIORXIV, DOI 10.1101/055459
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Ferguson N, 2016, COUNTERING ZIKA LATI, DOI [10.1126/science.aag0219, DOI 10.1126/SCIENCE.AAG0219]
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Florida Health, ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Griffin S, 2016, LIVE UPDATES WHAT YO
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Gunier RB, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP504
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kathy Keatley Garvey, 2016, AR CUL MOSQ POT VECT
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Mallet HP, 2015, BISES B INFORM SANIT
   Mississippi State Department of Health, 2016, ZIK VIR
   Monaghan AJ, 2016, PLOS CURRENTS OUTBRE, DOI [10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.0UTBREAKS.50DFC7F467]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   National Birth Defect Prevention Network, 2013, BIRTH DEFECTS RES A, V97
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO/WHO, 2016, ZIK EP UPD
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sena BF, 2016, WAR ZIKA PERSISTENT
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   WHO, 2016, HIST ZIK VIR
   WHO, 2016, PREV SEX TRANSM ZIK
   Zettel C., YELLOW FEVER MOSQUIT
NR 49
TC 7
Z9 7
U1 0
U2 14
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD SEP
PY 2016
VL 124
IS 9
BP A157
EP A165
DI 10.1289/ehp.124-A157
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DU9IM
UT WOS:000382530200004
PM 27581255
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tripp, RA
   Ross, TM
AF Tripp, Ralph A.
   Ross, Ted M.
TI Development of a Zika vaccine
SO EXPERT REVIEW OF VACCINES
LA English
DT Editorial Material
DE Zika; vaccine; virus; countermeasures; immunity
ID UNITED-STATES; VIRUS; TRANSMISSION; OUTBREAK
C1 [Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Anim Hlth Res Ctr, Athens, GA 30602 USA.
   [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
RP Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
EM tedross@uga.edu
OI Ross, Ted/0000-0003-1947-7469
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Durbin AP, 2016, J INFECT DIS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 20
TC 21
Z9 22
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD SEP
PY 2016
VL 15
IS 9
SI SI
BP 1083
EP 1085
DI 10.1080/14760584.2016.1192474
PG 3
WC Immunology
SC Immunology
GA DV2TX
UT WOS:000382775700003
PM 27212079
OA Bronze
DA 2020-07-08
ER

PT J
AU De Groot, AS
   Moise, L
   Olive, D
   Einck, L
   Martin, W
AF De Groot, Anne S.
   Moise, Leonard
   Olive, David
   Einck, Leo
   Martin, William
TI Agility in adversity: Vaccines on Demand
SO EXPERT REVIEW OF VACCINES
LA English
DT Article
DE Vaccine; biodefense; Zika virus; smallpox; anthrax; influenza; avian
   influenza; pandemic; bioterror; cancer vaccine; computational
   vaccinology; immunoinformatics; genome; personalized vaccine; FDA; IND;
   BLA; platform; T cell; T-cell assay; iVAX system; genome-to-vaccine;
   epitope-driven vaccine
ID DESIGN; FEVER
AB Is the US ready for a biological attack using Ebola virus or Anthrax? Will vaccine developers be able to produce a Zika virus vaccine, before the epidemic spreads around the world? A recent report by The Blue Ribbon Study Panel on Biodefense argues that the US is not ready for these challenges, however, technologies and capabilities that could address these deficiencies are within reach. Vaccine technologies have advanced and readiness has improved in recent years, due to advances in sequencing technology and computational power making the vaccines on demand' concept a reality. Building a robust strategy to design effective biodefense vaccines from genome sequences harvested by real-time biosurveillance will benefit from technologies that are being brought to bear on the cancer cure moonshot'. When combined with flexible vaccine production platforms, vaccines on demand will relegate expensive and, in some cases, insufficiently effective vaccine stockpiles to the dust heap of history.
C1 [De Groot, Anne S.; Moise, Leonard; Martin, William] EpiVax Inc, Providence, RI 02903 USA.
   [De Groot, Anne S.; Moise, Leonard] Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
   [Olive, David] Catalyst Partners, Washington, DC USA.
   [Einck, Leo] Sequella, Rockville, MD USA.
RP De Groot, AS (corresponding author), EpiVax Inc, Providence, RI 02903 USA.; De Groot, AS (corresponding author), Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
EM annied@epivax.com
RI Moise, Lenny/AAE-7448-2019; De Groot, Annie/B-6221-2013
OI Moise, Lenny/0000-0002-4410-865X; De Groot, Annie/0000-0001-5911-1459
CR [Anonymous], 2015, BIPARTISAN REPORT BL
   Bresciani A, 2016, IMMUNOLOGY, V148, P34, DOI 10.1111/imm.12585
   De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P1877, DOI 10.4161/hv.25611
   De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939
   Gardner Shea N, 2015, BMC Res Notes, V8, P682, DOI 10.1186/s13104-015-1530-0
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gilchrist CA, 2015, CLIN MICROBIOL REV, V28, P541, DOI 10.1128/CMR.00075-13
   Graham B., 2010, PREVENTION WMD PROLI
   Graham B., 2008, WORLD RISK REPORT CO
   Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19, DOI 10.1177/026119290903701S05
   Katoski SE, 2015, J MED VIROL, V87, P1616, DOI 10.1002/jmv.24196
   Leblanc P, 2014, HUM VACC IMMUNOTHER, V10, P3022, DOI 10.4161/hv.34413
   Liu R, 2015, HUM VACC IMMUNOTHER, V11, P2241, DOI 10.1080/21645515.2015.1052197
   Losikoff PT, 2015, J HEPATOL, V62, P48, DOI 10.1016/j.jhep.2014.08.026
   Moise L, 2015, HUM VACC IMMUNOTHER, V11, P2312, DOI 10.1080/21645515.2015.1061159
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Reardon S, 2014, NATURE, V509, P16, DOI 10.1038/509016a
   Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348
   Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Wullner D, 2010, CLIN IMMUNOL, V137, P5, DOI 10.1016/j.clim.2010.06.018
NR 21
TC 3
Z9 3
U1 0
U2 48
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD SEP
PY 2016
VL 15
IS 9
SI SI
BP 1087
EP 1091
DI 10.1080/14760584.2016.1205951
PG 5
WC Immunology
SC Immunology
GA DV2TX
UT WOS:000382775700004
PM 27389971
DA 2020-07-08
ER

PT J
AU Maya, WDC
   Du Plessis, SS
   Velilla, PA
AF Cardona Maya, Walter D.
   Du Plessis, Stefan S.
   Velilla, Paula A.
TI Semen as virus reservoir?
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Letter
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ZIKA VIRUS; EBOLA-VIRUS; SEXUAL
   TRANSMISSION; MANNOSE RECEPTOR; HIV-1; SPERMATOZOA; INFECTION; SPERM;
   DNA
C1 [Cardona Maya, Walter D.] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Reproducc, Medellin, Colombia.
   [Du Plessis, Stefan S.] Univ Stellenbosch, Div Med Physiol, Fac Med & Hlth Sci, Tygerberg, South Africa.
   [Velilla, Paula A.] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Inmunovirol, Medellin, Colombia.
RP Maya, WDC (corresponding author), Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Reproducc, Medellin, Colombia.
EM wdario.cardona@udea.edu.co
OI Velilla, Paula A/0000-0003-0885-1320; Cardona Maya, Walter
   D/0000-0003-0062-6444; Du Plessis, Stefan/0000-0003-4617-4367
CR BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903
   BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Maya WC, 2009, ACTAS UROL ESP, V33, P223
   Cardona-Maya W, 2006, AM J REPROD IMMUNOL, V55, P241, DOI 10.1111/j.1600-0897.2005.00340.x
   Cardona-Maya W, 2011, J REPROD IMMUNOL, V92, P1, DOI 10.1016/j.jri.2011.09.002
   Cardona-Maya W, 2009, CURR HIV RES, V7, P418, DOI 10.2174/157016209788680570
   Cardona-Maya WD, 2014, REPROD SCI
   Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579
   Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004
   Deen GF, 2015, NEW ENGLAND J MED
   EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328
   Mate SE, 2015, NEW ENGLAND J MED
   McCarthy M, 2016, BMJ CLIN RES ED, V352, pi1813
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NUOVO GJ, 1994, AM J PATHOL, V144, P1142
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Sánchez Jurany Andrea, 2013, Rev Cubana Obstet Ginecol, V39, P249
   Sturmer M, 2008, ANTIVIR THER, V13, P729
   Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7
   Zea-Mazo JW, 2010, ACTAS UROL ESP, V34, P845, DOI 10.1016/j.acuro.2010.07.002
NR 25
TC 3
Z9 3
U1 0
U2 44
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD SEP
PY 2016
VL 33
IS 9
BP 1255
EP +
DI 10.1007/s10815-016-0747-8
PG 2
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DV1LD
UT WOS:000382681700019
PM 27241530
OA Green Published
DA 2020-07-08
ER

PT J
AU Faccini-Martinez, AA
   Botero-Garcia, CA
   Benitez-Baracaldo, FC
   Perez-Diaz, CE
AF Faccini-Martinez, Alvaro A.
   Botero-Garcia, Carlos A.
   Benitez-Baracaldo, Fabian C.
   Perez-Diaz, Carlos E.
TI With regard about the case of Dengue, Chikungunya and Zika co-infection
   in a patient from Colombia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
ID OUTBREAK
C1 [Faccini-Martinez, Alvaro A.; Benitez-Baracaldo, Fabian C.; Perez-Diaz, Carlos E.] Serv & Asesorias Infectol, Bogota, Colombia.
   [Botero-Garcia, Carlos A.] Univ Militar Nueva Granada, Sch Med, Bogota, Colombia.
   [Perez-Diaz, Carlos E.] Clin Marly, Dept Infect Dis, Bogota, Colombia.
RP Faccini-Martinez, AA (corresponding author), Serv & Asesorias Infectol, Bogota, Colombia.
EM afaccini@gmail.com
OI Faccini-Martinez, Alvaro A./0000-0002-1127-0132
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Bhat Vivek G, 2015, Open Microbiol J, V9, P33, DOI 10.2174/1874285801509010033
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   [Direccion de vigilanciay Analisis del Riesgo en Salud Publica Instituto Nacional de Salud de Colombia], 2015, B EP SEM SEM EP
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Kohl A, 2015, J GEN VIROL IN PRESS
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 10
TC 5
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
BP 687
EP 688
DI 10.1016/j.jiph.2016.01.001
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DT3ML
UT WOS:000381385200023
PM 26837723
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Benign bacteria reduces Zika transmission
SO LAB ANIMAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0093-7355
EI 1548-4475
J9 LAB ANIMAL
JI Lab Anim.
PD SEP
PY 2016
VL 45
IS 9
BP 317
EP 317
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA DU4LO
UT WOS:000382184300007
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI ZIKA VACCINES
SO CHEMICAL & ENGINEERING NEWS
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD SEP
PY 2016
SU S
BP 5
EP 6
PG 2
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DU7XY
UT WOS:000382429100003
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika imbalance
SO NATURE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 1
PY 2016
VL 537
IS 7618
BP 7
EP 7
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DU7XC
UT WOS:000382426900001
DA 2020-07-08
ER

PT J
AU Taylor, TJ
   Diaz, F
   Colgrove, RC
   Bernard, KA
   DeLuca, NA
   Whelan, SPJ
   Knipe, DM
AF Taylor, Travis J.
   Diaz, Fernando
   Colgrove, Robert C.
   Bernard, Kristen A.
   DeLuca, Neal A.
   Whelan, Sean P. J.
   Knipe, David M.
TI Production of immunogenic West Nile virus-like particles using a herpes
   simplex virus 1 recombinant vector
SO VIROLOGY
LA English
DT Article
DE West Nile virus; Vaccine vector; Flavivirus; Zika virus; HSV recombinant
   vector
ID REPLICATION-DEFECTIVE MUTANT; CD8(+) T-CELLS; IMMUNE-RESPONSES;
   DISSEMINATED INFECTION; JAPANESE ENCEPHALITIS; PROTECTIVE EFFICACY;
   GENITAL HERPES; DNA VACCINE; NEW-YORK; B-CELLS
AB West Nile virus (WNV) is a flavivirus that swept rapidly across North America in 1999, declined in prevalence, and then resurged in 2012. To date, no vaccine is available to prevent infection in the human population. Herpes simplex virus (HSV) replication-defective vaccine vectors induce a durable immunity characterized by strong antibody and CD8(+) T cell responses even in HSV-immune animals. In this study, a WNV protein expression cassette was optimized for virus-like. particle (VLP) production in transfection studies, and the cassette was recombined into an HSV-1 d106-WNV virus vector, which produced extracellular VLPs, as confirmed by immunoelectron microscopy. Immunization of mice with the d106-WNV recombinant vector elicited a specific anti-WNV IgG response. This study highlights the flavivirus coding sequences needed for efficient assembly of virus-like particles. This information will facilitate generation of additional vaccine vectors against other flaviviruses including the recently emerged Zika virus. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Taylor, Travis J.; Diaz, Fernando; Colgrove, Robert C.; Whelan, Sean P. J.; Knipe, David M.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, POB 509, Albany, NY 12201 USA.
   [DeLuca, Neal A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 523 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15261 USA.
   [Diaz, Fernando] Sanofi Pasteur, Cambridge, MA USA.
   [Colgrove, Robert C.] Mt Auburn Hosp, Cambridge, MA USA.
   [Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.
RP Knipe, DM (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM david_knipe@hms.harvard.edu
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U54-AI057159, U54-AI057158, R01 AI057552,
   U19-AI109740]
FX We thank Kim Appler for her technical assistance with the antibody
   analysis, Maria Ericsson for her assistance with electron microscopy,
   Gus Kousoulis for plasmids, and Patrick T. Waters for assistance with
   preparation of the manuscript. This research was supported by NIAID
   grants U54-AI057159 (New England Regional Center for Excellence in
   Biodefense and Emerging Infections) and U54-AI057158 (Northeast
   Biodefense Center) and R01 AI057552 to DMK and U19-AI109740 to SPJW.
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P513
   Brehm M, 1999, VIROLOGY, V256, P258, DOI 10.1006/viro.1999.9653
   Brehm MA, 1997, J VIROL, V71, P3534, DOI 10.1128/JVI.71.5.3534-3544.1997
   Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Brubaker JO, 1996, J IMMUNOL, V157, P1598
   Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699
   Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08
   Cruz L, 2005, AM J TROP MED HYG, V72, P612, DOI 10.4269/ajtmh.2005.72.612
   Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000
   Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994
   DaCosta XJ, 1997, VIROLOGY, V232, P1, DOI 10.1006/viro.1997.8564
   Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020
   Estrada-Franco JG, 2003, EMERG INFECT DIS, V9, P1604, DOI 10.3201/eid0912.030564
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022
   Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837
   Ishikawa T, 2007, MICROBES INFECT, V9, P1089, DOI 10.1016/j.micinf.2007.05.013
   Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628
   Kaur A., UNPUB
   Kaur A, 2007, VIROLOGY, V357, P199, DOI 10.1016/j.virol.2006.08.007
   Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005
   Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028
   Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047
   Morrison LA, 1997, VIROLOGY, V239, P315, DOI 10.1006/viro.1997.8884
   MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279
   Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000
   NGUYEN L, 1994, J IMMUNOL, V152, P478
   Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933
   Raja P, 2016, MBIO, V7, DOI [10.1128/mBio.00633-16, 10.1128/mBio.02007-15]
   Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077
   RICE SA, 1989, J VIROL, V63, P3399, DOI 10.1128/JVI.63.8.3399-3407.1989
   Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998
   Samina I, 2005, VACCINE, V23, P4955, DOI 10.1016/j.vaccine.2005.03.052
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Siger L, 2006, VET THER, V7, P249
   Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175
   Takahashi H, 2009, MICROBES INFECT, V11, P1019, DOI 10.1016/j.micinf.2009.07.009
   Volz A, 2016, VACCINE, V34, P1915, DOI 10.1016/j.vaccine.2016.02.042
   WALBOOMERS JMM, 1976, VIROLOGY, V74, P256, DOI 10.1016/0042-6822(76)90151-3
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watanabe D, 2007, VIROLOGY, V357, P186, DOI 10.1016/j.virol.2006.08.015
   Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008
   Yang JS, 2001, J INFECT DIS, V184, P809, DOI 10.1086/323395
   Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109
NR 66
TC 12
Z9 13
U1 0
U2 61
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2016
VL 496
BP 186
EP 193
DI 10.1016/j.virol.2016.06.006
PG 8
WC Virology
SC Virology
GA DT1IU
UT WOS:000381235700021
PM 27336950
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Muller, JA
   Harms, M
   Schubert, A
   Jansen, S
   Michel, D
   Mertens, T
   Schmidt-Chanasit, J
   Munch, J
AF Mueller, Janis A.
   Harms, Mirja
   Schubert, Axel
   Jansen, Stephanie
   Michel, Detlef
   Mertens, Thomas
   Schmidt-Chanasit, Jonas
   Muench, Jan
TI Inactivation and Environmental Stability of Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mueller, Janis A.; Harms, Mirja; Schubert, Axel; Michel, Detlef; Mertens, Thomas; Muench, Jan] Univ Ulm, Med Ctr, Ulm, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, World Hlth Org Collaborating Ctr Arbovirus & Hemo, Hamburg, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] German Ctr Infect Res Partner Sites, Hamburg Luebeck Borstel, Germany.
RP Munch, J (corresponding author), Univ Ulm, Med Ctr, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.
EM jan.muench@uni-ulm.de
OI Jan, Munch/0000-0001-7316-7141
CR Charrel RN, B WHO
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Zammarchi L, 2015, EURO SURVEILL, V20
NR 10
TC 21
Z9 22
U1 0
U2 77
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2016
VL 22
IS 9
BP 1685
EP 1687
DI 10.3201/eid2209.160664
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DU1GJ
UT WOS:000381955900039
PM 27367466
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matheus, S
   Boukhari, R
   Labeau, B
   Ernault, V
   Bremand, L
   Kazanji, M
   Rousset, D
AF Matheus, Severine
   Boukhari, Rachida
   Labeau, Bhety
   Ernault, Valerie
   Bremand, Laetitia
   Kazanji, Mirdad
   Rousset, Dominique
TI Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue
   and Zika Virus Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Matheus, Severine; Labeau, Bhety; Bremand, Laetitia; Kazanji, Mirdad; Rousset, Dominique] Inst Pasteur, Cayenne, French Guiana.
   [Boukhari, Rachida; Ernault, Valerie] Ctr Hosp Ouest Guyanais, St Laurent Du Maroni, French Guiana.
RP Matheus, S (corresponding author), Inst Pasteur, Ctr Natl Reference Arbovirus, Lab Associe, 23 Ave Pasteur,BP 6010-97306, Cayenne, French Guiana.
EM smatheus@pasteur-cayenne.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
CR Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
NR 7
TC 18
Z9 20
U1 0
U2 27
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2016
VL 22
IS 9
BP 1691
EP 1693
DI 10.3201/eid2209.160725
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DU1GJ
UT WOS:000381955900042
PM 27347853
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tang, BL
AF Tang, Bor Luen
TI Zika virus as a causative agent for primary microencephaly: the evidence
   so far
SO ARCHIVES OF MICROBIOLOGY
LA English
DT Review
DE Microcephaly; Neuroprogenitor cells; Zika virus
ID CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; CEREBRAL-CORTEX; BRAIN;
   INFECTION; BRAZIL; FLAVIVIRUS; BIOLOGY; UPDATE; MODEL
AB Zika virus (ZIKV) infection has been associated with congenital microcephaly and peripheral neuropathy. The ongoing epidemic has triggered swift responses in the scientific community, and a number of recent reports have now confirmed a causal relationship between ZIKV infection and birth defect. In particular, ZIKV has been shown to be capable of compromising and crossing the placental barrier and infect the developing fetal brain, resulting in the demise and functional impairment of neuroprogenitor cells critical for fetal cortex development. Here, the evidence for ZIKV as a teratogenic agent that causes microcephaly is reviewed, and its association with other disorders is discussed.
C1 [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117597, Singapore.
   [Tang, Bor Luen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, 28 Med Dr, Singapore 117456, Singapore.
RP Tang, BL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117597, Singapore.; Tang, BL (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, 28 Med Dr, Singapore 117456, Singapore.
EM bchtbl@nus.edu.sg
RI Tang, Bor Luen/E-4548-2012
OI Tang, Bor Luen/0000-0002-1925-636X
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chae Teresa H, 2007, Novartis Found Symp, V288, P79
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corno C, 2016, CURR MED CHEM, V23, P1496, DOI 10.2174/0929867323666160405112954
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010
   Rao Sachin, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-008229
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040
   Tang BL, 2016, J CELL PHYSIOL, V231, P1417, DOI 10.1002/jcp.25261
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Tyler KL, 2014, CURR OPIN NEUROL, V27, P342, DOI 10.1097/WCO.0000000000000088
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 68
TC 14
Z9 14
U1 1
U2 213
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-8933
EI 1432-072X
J9 ARCH MICROBIOL
JI Arch. Microbiol.
PD SEP
PY 2016
VL 198
IS 7
BP 595
EP 601
DI 10.1007/s00203-016-1268-7
PG 7
WC Microbiology
SC Microbiology
GA DS3FI
UT WOS:000380668100001
PM 27412681
OA Bronze
DA 2020-07-08
ER

PT J
AU Goubert, C
   Minard, G
   Vieira, C
   Boulesteix, M
AF Goubert, C.
   Minard, G.
   Vieira, C.
   Boulesteix, M.
TI Population genetics of the Asian tiger mosquito Aedes albopictus, an
   invasive vector of human diseases
SO HEREDITY
LA English
DT Review
ID YELLOW-FEVER MOSQUITO; DIPTERA-CULICIDAE; UNITED-STATES;
   MITOCHONDRIAL-DNA; REUNION ISLAND; 1ST RECORD; INSECTICIDE RESISTANCE;
   MICROSATELLITE MARKERS; ADAPTIVE EVOLUTION; BREEDING STRUCTURE
AB The Asian tiger mosquito Aedes albopictus is currently one of the most threatening invasive species in the world. Native to Southeast Asia, the species has spread throughout the world in the past 30 years and is now present in every continent but Antarctica. Because it was the main vector of recent Dengue and Chikungunya outbreaks, and because of its competency for numerous other viruses and pathogens such as the Zika virus, A. albopictus stands out as a model species for invasive diseases vector studies. A synthesis of the current knowledge about the genetic diversity of A. albopictus is needed, knowing the interplays between the vector, the pathogens, the environment and their epidemiological consequences. Such resources are also valuable for assessing the role of genetic diversity in the invasive success. We review here the large but sometimes dispersed literature about the population genetics of A. albopictus. We first debate about the experimental design of these studies and present an up-to-date assessment of the available molecular markers. We then summarize the main genetic characteristics of natural populations and synthesize the available data regarding the worldwide structuring of the vector. Finally, we pinpoint the gaps that remain to be addressed and suggest possible research directions.
C1 [Goubert, C.; Vieira, C.; Boulesteix, M.] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, Villeurbanne, France.
   [Minard, G.] Univ Lyon 1, Microbial Ecol, UMR CNRS 5557, UMR INRA 1418,VetAgro Sup,BioEnvironm & Hlth FR41, Villeurbanne, France.
   [Minard, G.] Univ Helsinki, Metapopulat Res Ctr, Dept Biosci, Helsinki, Finland.
RP Boulesteix, M (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.
EM matthieu.boulesteix@univ-lyon1.fr
RI Vieira, Cristina/Q-3137-2017; Goubert, Clement/AAG-6228-2019
OI Vieira, Cristina/0000-0003-3414-3993; Goubert,
   Clement/0000-0001-8034-5559; Minard, Guillaume/0000-0002-2079-8844
FU French Ministry of Superior Education
FX We are grateful to Marie Fablet, who provided insightful comments, as
   well as three anonymous referees who contributed to improve the
   manuscript. We also thank Celine Toty (MIVEGEC Montpellier) for
   providing the A. albopictus individuals from La Reunion Island used in
   the pilot RAD-seq experiment and Helene Henri for the libraries
   construction. CG received a grant from the French Ministry of Superior
   Education.
CR ADHAMI J, 1987, REV MJEKESORE, V1, P13
   Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276
   Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x
   Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022
   Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Behura SK, 2014, FUNCT INTEGR GENOMIC, V14, P581, DOI 10.1007/s10142-014-0376-1
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   BLACK WC, 1988, HEREDITY, V60, P173, DOI 10.1038/hdy.1988.29
   BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136
   Bock DG, 2015, MOL ECOL, V24, P2277, DOI 10.1111/mec.13032
   Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boulesteix M, 2007, MOL ECOL, V16, P441, DOI 10.1111/j.1365-294X.2006.03150.x
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611
   Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240
   Chareonviriyaphap T, 2004, J MED ENTOMOL, V41, P657, DOI 10.1603/0022-2585-41.4.657
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088
   Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1
   Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   Damal K, 2013, AM J TROP MED HYG, V89, P482, DOI 10.4269/ajtmh.13-0102
   Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084
   de Albuquerque AL, 2011, MEM I OSWALDO CRUZ, V106, P773, DOI 10.1590/S0074-02762011000600021
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Diallo M, 2010, TROP MED INT HEALTH, V15, P1185, DOI 10.1111/j.1365-3156.2010.02594.x
   Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968
   Excoffier L, 2004, HDB STAT GENETICS
   Fernandez Z, 2004, J MED ENTOMOL, V41, P961, DOI 10.1603/0022-2585-41.5.961
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x
   Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089
   Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gupta S, 2014, PARASITOL RES, V113, P2137, DOI 10.1007/s00436-014-3864-2
   Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300
   Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2
   Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Henri H, 2015, GENETICA, V143, P139, DOI 10.1007/s10709-015-9828-3
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Huber K, 2001, MOL ECOL NOTES, V1, P219, DOI 10.1046/j.1471-8278.2001.00077.x
   Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056
   Isabel N, 1999, MOL ECOL, V8, P477, DOI 10.1046/j.1365-294X.1999.00597.x
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   Jones CJ, 1997, MOL BREEDING, V3, P381, DOI 10.1023/A:1009612517139
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   KAMBHAMPATI S, 1990, HEREDITY, V64, P281, DOI 10.1038/hdy.1990.34
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519
   Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685
   Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x
   LOWE A, 2004, ECOLOGICAL GENETICS
   Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Mccoy KD, 2008, PARASITE, V15, P444, DOI 10.1051/parasite/2008153444
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Mutebi JP, 1997, J HERED, V88, P489, DOI 10.1093/oxfordjournals.jhered.a023142
   O'Donnell D, 2010, INFECT GENET EVOL, V10, P669, DOI 10.1016/j.meegid.2010.03.011
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x
   Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135
   Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249
   Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x
   Shaikevich E, 2013, ISRN ENTOMOL, V2013, P1, DOI DOI 10.1155/2013/157426
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116
   van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x
   Vargas REM, 2013, INFECT GENET EVOL, V13, P242, DOI 10.1016/j.meegid.2012.08.008
   Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491
   WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117
   White VL, 2015, INSECT SCI, V22, P409, DOI 10.1111/1744-7917.12145
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
   Zitko T, 2011, EUR J ENTOMOL, V108, P501, DOI 10.14411/eje.2011.065
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
NR 114
TC 36
Z9 37
U1 0
U2 109
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0018-067X
EI 1365-2540
J9 HEREDITY
JI Heredity
PD SEP
PY 2016
VL 117
IS 3
BP 125
EP 134
DI 10.1038/hdy.2016.35
PG 10
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA DT2LR
UT WOS:000381312300001
PM 27273325
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Panchaud, A
   Vouga, M
   Musso, D
   Baud, D
AF Panchaud, Alice
   Vouga, Manon
   Musso, Didier
   Baud, David
TI An international registry for women exposed to Zika virus during
   pregnancy: time for answers
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID BRAZIL
C1 [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Sch Pharmaceut Sci, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vouga, Manon; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Baud, David] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Baud, David] CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
RP Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Hosp, Lausanne, Switzerland.; Baud, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.; Baud, D (corresponding author), CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Panchaud, Alice/S-6535-2019; Musso, Didier/AAO-8178-2020; Musso,
   Didier/P-7809-2016
OI Panchaud, Alice/0000-0001-6086-2401; Musso, Didier/0000-0002-9226-0971;
   Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 9
TC 9
Z9 9
U1 0
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 995
EP 996
DI 10.1016/S1473-3099(16)30255-9
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200011
PM 27684333
OA Bronze
DA 2020-07-08
ER

PT J
AU McConnell, J
   de Ambrogi, M
   Cleghorn, S
   Sekkides, O
AF McConnell, John
   de Ambrogi, Marco
   Cleghorn, Sean
   Sekkides, Onisillos
TI Zika virus and the 2016 Olympic Games reply
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID RIO-DE-JANEIRO
C1 [McConnell, John; de Ambrogi, Marco; Cleghorn, Sean; Sekkides, Onisillos] Lancet Infect Dis, 125 London Wall, London EC2Y 5AS, England.
RP McConnell, J (corresponding author), Lancet Infect Dis, 125 London Wall, London EC2Y 5AS, England.
OI Sekkides, Onisillos/0000-0002-4531-4404; McConnell,
   John/0000-0002-9928-6568
CR Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Grills A, 2016, MMWR MORB MORTAL WKL
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Ministerio da Saude Brazil, MIN SAUD CONF 1 656
   THE LANCET Infectious Diseases, 2017, LANCET INFECT DIS
NR 5
TC 0
Z9 0
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1003
EP 1004
DI 10.1016/S1473-3099(16)30266-3
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200019
PM 27460686
OA Bronze
DA 2020-07-08
ER

PT J
AU Sukkaromdee, P
   Wiwanikti, V
AF Sukkaromdee, Pathoom
   Wiwanikti, Viroj
TI Zika virus infection in Thailand: Common in coastal province
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Sukkaromdee, Pathoom] TWS Med Ctr, Bangkok, Thailand.
   [Wiwanikti, Viroj] Hainan Med Univ, Dept Tropcial Med, Haikou, Peoples R China.
RP Sukkaromdee, P (corresponding author), TWS Med Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Dash AP, 2013, J VECTOR DIS, V50, P77
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
DI 10.4103/1755-6783.190201
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DX3EK
UT WOS:000384256000017
DA 2020-07-08
ER

PT J
AU Kindhauser, MK
   Allen, T
   Frank, V
   Santhana, RS
   Dye, C
AF Kindhauser, Mary Kay
   Allen, Tomas
   Frank, Veronika
   Santhana, Ravi Shankar
   Dye, Christopher
TI Zika: the origin and spread of a mosquito-borne virus
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID YELLOW-FEVER; SEROLOGICAL SURVEY; ARBOVIRUS INFECTIONS;
   FRENCH-POLYNESIA; TRANSMISSION; ANTIBODIES; NIGERIA; SERA; EPIDEMIC;
   UGANDA
AB Objective To describe the temporal and geographical distribution of Zika virus infection and associated neurological disorders, from 1947 to 1 February 2016, when Zika became a Public Health Emergency of International Concern (PHEIC).
   Methods We did a literature search using the terms"Zika"and"ZIKV"in PubMed, cross-checked the findings for completeness against other published reviews and added formal notifications to WHO submitted under the International Health Regulations.
   Findings From the discovery of Zika virus in Uganda in 1947 to the declaration of a PHEIC by the World Health Organization (WHO) on 1 February 2016, a total of 74 countries and territories had reported human Zika virus infections. The timeline in this paper charts the discovery of the virus (1947), its isolation from mosquitos (1948), the first human infection (1952), the initial spread of infection from Asia to a Pacific island (2007), the first known instance of sexual transmission (2008), reports of Guillain-Barre syndrome (2014) and microcephaly (2015) linked to Zika infections and the first appearance of Zika in the Americas (from 2015).
   Conclusion Zika virus infection in humans appears to have changed in character as its geographical range has expanded from equatorial Africa and Asia.The change is from an endemic, mosquito-borne infection causing mild illness to one that can cause large outbreaks linked with neurological sequelae and congenital abnormalities.
C1 [Kindhauser, Mary Kay; Allen, Tomas; Frank, Veronika; Santhana, Ravi Shankar; Dye, Christopher] WHO, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Dye, C (corresponding author), WHO, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM dyec@who.int
FU World Health OrganizationWorld Health Organization [001]
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, EPIDEMIOLOGICAL ALER
   [Anonymous], 2016, REC MAN REP ZIK VIR
   [Anonymous], 2005, INT HLTH
   [Anonymous], 2016, HLTH ADV SEX TRANSM, Patent No. Dallas Country Health and Human Services (DCHHS)
   Aubry A, 2015, 64TH ANNUAL MEETING
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Casals J, 1966, 9 INT C MICR MOSC, P441
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P787
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   ROBIN Y, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P833
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Robin Y, 1967, 7 C TECHN ORG COORD
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 90
TC 164
Z9 171
U1 4
U2 62
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD SEP
PY 2016
VL 94
IS 9
BP 675
EP 686
DI 10.2471/BLT.16.171082
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DX8HX
UT WOS:000384629800015
PM 27708473
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Herrera, K
   Bernasko, J
   Garry, D
   Vahanian, S
   Kaplan, C
AF Herrera, Kimberly
   Bernasko, James
   Garry, David
   Vahanian, Sevan
   Kaplan, Cynthia
TI Vertical transmission of Zika virus (ZIKV) in early pregnancy: two
   cases, two different courses
SO CASE REPORTS IN PERINATAL MEDICINE
LA English
DT Article
DE Pregnancy; Zika virus (ZIKV)
AB Background: Vertical Zika virus (ZIKV) transmission is actively being studied. Prior cases of ZIKV in pregnancy have suggested an association with infection and adverse fetal outcomes. We describe two cases of maternal illness and their respective pregnancy courses.
   - Case 1: A 30-year-old Hispanic female presented with rash, fatigue, and chills after noticing mosquito bites in Honduras. Fetal anatomy appeared normal on ultrasound at 16 and 17 weeks. ZIKV RNA reverse-transcriptase-polymerase-chain-reaction (RT-PCR) was identified in her serum and amniotic fluid. She opted for pregnancy termination. Fetal serum and tissue analysis confirmed ZIKV infection.
   - Case 2: A 28-year-old Hispanic female presented with rash, fever, and fatigue after sexual intercourse. Her ZIKV serum RNA RT-PCR was positive and amniotic fluid was negative. Fetal anatomy appeared normal at 20 and 22 weeks and her pregnancy remains ongoing.
   Conclusion: The effects of maternal ZIKV infection in early pregnancy can vary.
C1 [Herrera, Kimberly; Bernasko, James; Garry, David; Vahanian, Sevan] Stony Brook Med Obstet Gynecol & Reprod Med, Hlth Sci Tower Level 9,Room 030, Stony Brook, NY 11794 USA.
   [Kaplan, Cynthia] Stony Brook Med, Dept Pathol, Stony Brook, NY USA.
RP Herrera, K (corresponding author), Stony Brook Med Obstet Gynecol & Reprod Med, Hlth Sci Tower Level 9,Room 030, Stony Brook, NY 11794 USA.
EM kimberly.herrera@stonybrookmedicine.edu
CR Centers for Disease Control and Prevention, ZIK VIR TRANSM
   Centers for Disease Control and Prevention, CDC NEWSR CDC ADDS C
   Centers for Disease Control and Prevention (CDC), 2016, INT GUID PREGN WOM Z
   Dallas County Health and Human Services, DCHHS REP 1 ZIK VIR
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
NR 9
TC 1
Z9 1
U1 0
U2 0
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2192-8959
J9 CASE REP PERINAT MED
JI Case Rep. Perinat. Med.
PD SEP
PY 2016
VL 5
IS 2
BP 131
EP 133
DI 10.1515/crpm-2016-0027
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FE3DM
UT WOS:000408096600014
DA 2020-07-08
ER

PT J
AU Landry, ML
   Ko, AI
   Kramer, LD
   Vasilakis, N
AF Landry, Marie Louise
   Ko, Albert I.
   Kramer, Laura D.
   Vasilakis, Nikolaos
TI Zika Virus: From Obscurity to Potentially Devastating International
   Threat
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Landry, Marie Louise] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale Univ, Sch Med, Dept Med Infect Dis, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale New Haven Med Ctr, Clin Virol Lab, 20 York St, New Haven, CT 06504 USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Med Infect Dis, New Haven, CT USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Arbovirus Lab, New York State Dept Hlth,Wadsworth Ctr, Albany, NY 12222 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Biomed Sci, Albany, NY 12222 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (corresponding author), Yale Univ, Sch Med, POB 208035, New Haven, CT 06520 USA.
EM marie.landry@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI121207]
NR 0
TC 0
Z9 0
U1 0
U2 62
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD SEP
PY 2016
VL 62
IS 9
BP 1175
EP 1180
DI 10.1373/clinchem.2016.261917
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DU7VH
UT WOS:000382422200003
PM 27551005
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Yung, CF
   Thoon, KC
AF Yung, Chee Fu
   Thoon, Koh Cheng
TI Guillain-Barre Syndrome and Zika Virus: Estimating Attributable Risk to
   Inform Intensive Care Capacity Preparedness
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
C1 [Yung, Chee Fu; Thoon, Koh Cheng] KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, Singapore, Singapore.
RP Yung, CF (corresponding author), KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, Singapore, Singapore.
EM cheefu.yung@gmail.com
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Porta M, 2008, DICT EPIDEMIOLOGY
   WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG
   Yung CF, 2016, ANN ACAD MED SINGAP, V45, P148
NR 6
TC 3
Z9 3
U1 0
U2 52
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2016
VL 63
IS 5
BP 708
EP +
DI 10.1093/cid/ciw355
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DW7TZ
UT WOS:000383856300025
PM 27225243
OA Bronze
DA 2020-07-08
ER

PT J
AU Liuzzi, G
   Nicastri, E
   Puro, V
   Zumla, A
   Ippolito, G
AF Liuzzi, Giuseppina
   Nicastri, Emanuele
   Puro, Vincenzo
   Zumla, Alimuddin
   Ippolito, Giuseppe
TI Zika virus in saliva-New challenges for prevention of human to human
   transmission
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
DE Zika virus; Saliva; Sexual transmission
C1 [Liuzzi, Giuseppina; Nicastri, Emanuele; Puro, Vincenzo; Ippolito, Giuseppe] Lazzaro Spallanzani Natl Inst Infect Dis IRCCS, Rome, Italy.
   [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp Natl Hlth Serv Fdn Trust, UK Natl Inst Hlth Res, Biomed Res Ctr, London, England.
RP Liuzzi, G (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis IRCCS, Rome, Italy.
EM giuseppina.liuzzi@inmi.it; emanuele.nicastri@inmi.it;
   Vincenzo.Puro@inmi.it; a.zumla@ucl.ac.uk; giuseppe.ippolito@inmi.it
RI nicastri, emanuele/K-7780-2016; Ippolito, Giuseppe/J-7207-2017
OI nicastri, emanuele/0000-0002-5606-8712; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735; Ippolito, Giuseppe/0000-0002-1076-2979
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen E, 2016, INT J INFECT DIS
NR 5
TC 5
Z9 5
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD SEP
PY 2016
VL 33
BP E20
EP E21
DI 10.1016/j.ejim.2016.04.022
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX9QQ
UT WOS:000384730600010
PM 27179414
DA 2020-07-08
ER

PT J
AU Amraoui, F
   Atyame-Nten, C
   Vega-Rua, A
   Lourenco-de-Oliveira, R
   Vazeille, M
   Failloux, AB
AF Amraoui, F.
   Atyame-Nten, C.
   Vega-Rua, A.
   Lourenco-de-Oliveira, R.
   Vazeille, M.
   Failloux, A. B.
TI Culex mosquitoes are experimentally unable to transmit Zika virus
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST NILE VIRUS; AEDES-AEGYPTI
AB We report that two laboratory colonies of Culex quinquefasciatus and Culex pipiens mosquitoes were experimentally unable to transmit ZIKV either up to 21 days post an infectious blood meal or up to 14 days post intrathoracic inoculation. Infectious viral particles were detected in bodies, heads or saliva by a plaque forming unit assay on Vero cells. We therefore consider it unlikely that Culex mosquitoes are involved in the rapid spread of ZIKV.
C1 [Amraoui, F.; Atyame-Nten, C.; Vazeille, M.; Failloux, A. B.] Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
   [Vega-Rua, A.] Inst Pasteur Guadeloupe, Lab Med Entomol, Environm & Hlth Unit, Les Abymes, Guadeloupe, France.
   [Lourenco-de-Oliveira, R.] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
RP Failloux, AB (corresponding author), Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
EM anna-bella.failloux@pasteur.fr
FU FP7 Health grant 'Dengue research Framework for resisting epidemics in
   Europe' (DENFREE); PTR grant [528]; Institut Pasteur; AXA Research Fund
FX The authors thank Myrielle Dupont-Rouzeyrol for providing the ZIKV
   strain and Mylene Weill for the Cx. quinquefasciatus SLab strain. We
   warmly thank Richard Paul for correcting the manuscript. The study is
   funded by a FP7 Health 2011 grant 'Dengue research Framework for
   resisting epidemics in Europe' (DENFREE) and the PTR grant no. 528 'Risk
   of reemergence of urban yellow fever in Brazil: role of the invasive
   mosquito Aedes albopictus'. FA was supported by the Institut Pasteur and
   CAN by the AXA Research Fund.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fall G, 2014, AM J TROP MED HYG, V90, P747, DOI 10.4269/ajtmh.13-0405
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Georghiou G P, 1966, Proc Pap Annu Conf Calif Mosq Control Assoc, V34, P71
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Huang YS, 2016, VECTOR BORNE ZOONOTI
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Krida G, 2015, MED VET ENTOMOL, V29, P124, DOI 10.1111/mve.12107
   Krida Ghazi, 1997, Bulletin de la Societe Entomologique de France, V102, P143
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855
   RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0
   TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635
   United States Centers for Disease Control and Prevention (CDC), ALL COUNTR TERR ACT
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 27
TC 40
Z9 40
U1 1
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP
PY 2016
VL 21
IS 35
BP 2
EP 5
AR 30333
DI 10.2807/1560-7917.ES.2016.21.35.30333
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DW5GL
UT WOS:000383671200001
PM 27605159
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boccolini, D
   Toma, L
   Di Luca, M
   Severini, F
   Romi, R
   Remoli, ME
   Sabbatucci, M
   Venturi, G
   Rezza, G
   Fortuna, C
AF Boccolini, D.
   Toma, L.
   Di Luca, M.
   Severini, F.
   Romi, R.
   Remoli, M. E.
   Sabbatucci, M.
   Venturi, G.
   Rezza, G.
   Fortuna, C.
TI Experimental investigation of the susceptibility of Italian Culex
   pipiens mosquitoes to Zika virus infection
SO EUROSURVEILLANCE
LA English
DT Article
ID POPULATIONS; COMPLEX; AREAS
AB We investigated the susceptibility of an Italian population of Culex pipiens mosquitoes to Zika virus (ZIKV) infection, tested in parallel with Aedes aegypti, as a positive control. We analysed mosquitoes at 0, 3, 7, 10, 14, 20 and 24 days after an infectious blood meal. Viral RNA was detected in the body of Cx. pipiens up to three days post-infection, but not at later time points. Our results indicate that Cx. pipiens is not susceptible to ZIKV infection.
C1 [Boccolini, D.; Toma, L.; Di Luca, M.; Severini, F.; Romi, R.; Remoli, M. E.; Sabbatucci, M.; Venturi, G.; Rezza, G.; Fortuna, C.] Ist Super Sanita, Dept Infect Dis, Rome, Italy.
   [Sabbatucci, M.] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden.
RP Fortuna, C (corresponding author), Ist Super Sanita, Dept Infect Dis, Rome, Italy.
EM claudia.fortuna@iss.it
RI FORTUNA, CLAUDIA/O-9446-2015; VENTURI, GIULIETTA/O-8123-2015; rezza,
   giovanni/D-4393-2016; Sabbatucci, Michela/M-9642-2017
OI FORTUNA, CLAUDIA/0000-0001-8878-4505; VENTURI,
   GIULIETTA/0000-0002-9078-8350; rezza, giovanni/0000-0003-0268-6790;
   Sabbatucci, Michela/0000-0001-5889-1780; Remoli, Maria
   Elena/0000-0003-3565-383X
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Di Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146476
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Fundacao Oswaldo Cruz (Fiocruz), 2016, FIOCR ID CUL REC COM
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   United States Centers for Disease Control and Prevention (CDC), COUNTR TERR ACT LOC
NR 19
TC 28
Z9 28
U1 0
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD SEP
PY 2016
VL 21
IS 35
BP 6
EP 8
AR 30328
DI 10.2807/1560-7917.ES.2016.21.35.30328
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DW5GL
UT WOS:000383671200002
PM 27605056
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Madrid, L
   Varo, R
   Sitoe, A
   Bassat, Q
AF Madrid, Lola
   Varo, Rosauro
   Sitoe, Antonio
   Bassat, Quique
TI Congenital and perinatally-acquired infections in resource-constrained
   settings
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE TORCH; congenital infections; congenital toxoplasmosis; rubella;
   cytomegalovirus; neonatal herpes; congenital syphilis; hepatitis B;
   congenital varicella syndrome; parvovirus B19
ID HERPES-SIMPLEX-VIRUS; HEPATITIS-B-VIRUS; PARVOVIRUS B19 INFECTION;
   VARICELLA-ZOSTER-VIRUS; CYTOMEGALOVIRUS-INFECTION; ZIKA VIRUS;
   PREGNANT-WOMEN; CHAGAS-DISEASE; INFANTS BORN; VERTICAL TRANSMISSION
AB Introduction: Congenital and perinatal infections are a leading cause of neonatal and infant morbidity and mortality. Maternal screening, vaccines or treatment where available, constitute effective prevention strategies to reduce the burden of these diseases. Data on the burden of congenital and perinatal infections are very limited for low and middle-income regions.Areas covered: This review aims to summarize the burden of congenital and perinatal infections and the main challenges for their control in resource-limited settings. Articles were identified through the main electronic databases and cover the period 1971-2016.Expert commentary: Estimates from low and middle-income countries indicate that the burden of congenital infections may be higher in these regions than in industrialized countries. As preventive and curative strategies are available to tackle some of these infections, efforts at the international and national levels must be made to implement those and thus reduce their burden in resource-limited countries.
C1 [Madrid, Lola; Varo, Rosauro; Sitoe, Antonio; Bassat, Quique] CISM, Rua 12, Maputo 1929, Mozambique.
   [Madrid, Lola; Varo, Rosauro; Bassat, Quique] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
RP Madrid, L (corresponding author), CISM, Rua 12, Maputo 1929, Mozambique.
EM lola.madrid@isglobal.org
RI Bassat, Quique/P-2341-2016
OI Bassat, Quique/0000-0003-0875-7596; Madrid, Lola/0000-0003-4034-6033
CR Adler SP, 1996, PEDIATR INFECT DIS J, V15, P240, DOI 10.1097/00006454-199603000-00013
   Adler SP, 2013, BRIT MED BULL, V107, P57, DOI 10.1093/bmb/ldt023
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301
   [Anonymous], 2014, Wkly Epidemiol Rec, V89, P265
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P180
   [Anonymous], 2015, GUID START ANT THER
   Ansbro EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127728
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Baquero-Artigao F, 2009, AN PEDIATR, V71, P535, DOI 10.1016/j.anpedi.2009.07.029
   Baquero-Artigao F, 2013, AN PEDIAT BARC, V79
   Basnayake SK, 2016, J VIRAL HEPATITIS, V23, P545, DOI 10.1111/jvh.12519
   BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366
   Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447
   Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204
   Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bollen LJM, 2008, AIDS, V22, P1169, DOI 10.1097/QAD.0b013e3282fec42a
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Botelho CAO, 2008, REV PATOL TROP, V37, P341
   Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Brown Zane, 2004, Herpes, V11 Suppl 3, p175A
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0
   Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI [10.1590/0074-02760140405, 10.1590/0074-02760140410]
   Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250
   (CDC) CfDCaP, 2009, MMWR-MORBID MORTAL W, V2014, P983
   Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013
   Chotun N, 2015, VACCINE, V33, P4618, DOI 10.1016/j.vaccine.2015.06.076
   Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Cowan FA, 2008, AIDS, V22, P193, DOI 10.1097/QAD.0b013e3282f2a939
   Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55
   Dabbagh AJ, 2013, MMWR-MORBID MORTAL W, V62, P983
   de Haan TR, 2008, BJOG-INT J OBSTET GY, V115, P76, DOI 10.1111/j.1471-0528.2007.01555.x
   De Paschale M, 2014, TROP MED INT HEALTH, V19, P743, DOI 10.1111/tmi.12296
   Del Pizzo J, 2011, PEDIATR REV, V32, P537, DOI 10.1542/pir.32-12-537
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765
   Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832
   Duryea EL, 2010, PEDIATR INFECT DIS J, V29, P915, DOI 10.1097/INF.0b013e3181e0ce05
   El-Magrahe H, 2010, J INFECT DEV COUNTR, V4, P168, DOI 10.3855/jidc.609
   El-Shabrawi MH, 2013, WORLD J GASTROENTERO, V19, P7880, DOI 10.3748/wjg.v19.i44.7880
   FAIRLEY CK, 1995, LANCET, V346, P1335, DOI 10.1016/S0140-6736(95)92346-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FORDJONES EL, 1995, PEDIATR INFECT DIS J, V14, P638, DOI 10.1097/00006454-199507000-00028
   Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74
   Gentile I, 2014, IN J WOMENS HEALTH, V6, P605, DOI 10.2147/IJWH.S51138
   Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gous NM, 2016, JAIDS-J ACQ IMM DEF, V71, pE34, DOI 10.1097/QAI.0000000000000872
   Grant G, 2014, GLOBAL RUBELLA UPDAT
   GRATACOS E, 1995, J INFECT DIS, V171, P1360, DOI 10.1093/infdis/171.5.1360
   Guibert G, 2009, CLIN INFECT DIS, V48, P1516, DOI 10.1086/598934
   Gulaid LA, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17390
   Gumbo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114870
   Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012
   Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4
   Jhaveri R, 2014, J PEDIAT INF DIS SOC, V3, pS13, DOI 10.1093/jpids/piu045
   Jones JL, 2014, AM J TROP MED HYG, V90, P1135, DOI 10.4269/ajtmh.14-0013
   Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798
   Kang GD, 2015, VACCINE, V33, P4093, DOI 10.1016/j.vaccine.2015.06.081
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   KORNAI J, 1979, ECONOMETRICA, V47, P801, DOI 10.2307/1914132
   Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796
   Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203
   Kravetz J., 2013, BMJ CLIN EVID, V2013, P1
   Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015
   Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778
   Kuznik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127379
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128
   Loto OM, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/379271
   Mack CL, 2012, J PEDIATR GASTR NUTR, V54, P838, DOI 10.1097/MPG.0b013e318258328d
   Manicklal S, 2014, CLIN INFECT DIS, V58, P1467, DOI 10.1093/cid/ciu096
   Mareri A, 2016, J MATERN-FETAL NEO M, V29, P1657, DOI 10.3109/14767058.2015.1058774
   Marin M, 2013, MMWR-MORBID MORTAL W, V63, P732
   Martinez-Quintana E, 2015, REV PANAM SALUD PUBL, V37, P179
   Martins-Melo FR, 2014, TROP MED INT HEALTH, V19, P943, DOI 10.1111/tmi.12328
   Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934
   Menendez C, 2007, SEMIN FETAL NEONAT M, V12, P207, DOI 10.1016/j.siny.2007.01.018
   Menendez C, 2015, LANCET GLOB HEALTH, V3, pE433, DOI 10.1016/S2214-109X(15)00041-8
   MENSON E, 2005, CURR PEDIAT, V15, P163
   MRI, 2014, THE MEASLES AND RUBE
   Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882
   Mussi-Pinhata MM, 2004, J PEDIATR-US, V145, P685, DOI 10.1016/j.jpeds.2004.07.025
   Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9
   Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396
   Nigro G, 1996, AIDS, V10, P1127, DOI 10.1097/00002030-199609000-00011
   Nigro G, 2013, CLIN INFECT DIS, V57, pS193, DOI 10.1093/cid/cit586
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okeke T C, 2012, Niger J Med, V21, P57
   OMS/OPS, 2006, EST CUANT ENF CHAG A
   Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   PAHO/WHO, 2016, ZIK VIR INF
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850
   Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881
   Phiske Meghana Madhukar, 2014, Indian J Sex Transm Dis AIDS, V35, P12, DOI 10.4103/0253-7184.132404
   Pinninti SG, 2014, CLIN PERINATOL, V41, P945, DOI 10.1016/j.clp.2014.08.012
   Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Rodriguez MDM, 2002, AIDS, V16, P451
   Lopes-Mori FMR, 2011, REV ASSOC MED BRAS, V57, P594, DOI 10.1590/S0104-42302011000500021
   Saloojee H, 2004, B WORLD HEALTH ORGAN, V82, P424
   Schillie S, 2015, PEDIATRICS, V135, pE1141, DOI 10.1542/peds.2014-3213
   Schleiss MR, 2009, AIDS, V23, P2215, DOI 10.1097/QAD.0b013e328331919c
   Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SCHULZ KF, 1987, GENITOURIN MED, V63, P320
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shet A, 2011, INDIAN J PEDIATR, V78, P88, DOI 10.1007/s12098-010-0254-3
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sokal EM, 2000, ANTIMICROB AGENTS CH, V44, P590, DOI 10.1128/AAC.44.3.590-597.2000
   Stanaway JD, 2015, GLOB HEART, V10, P139, DOI 10.1016/j.gheart.2015.06.001
   Strick LB, 2006, CLIN INFECT DIS, V43, P347, DOI 10.1086/505496
   Talukder YS, 2007, EPIDEMIOL INFECT, V135, P1344, DOI 10.1017/S0950268807008497
   Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Thiebaut R, 2007, LANCET, V369, P115
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Uhanova J, 2012, J HEPATOL, V57, P736, DOI 10.1016/j.jhep.2012.05.018
   UNAIDS, 2015, AIDS NUMB
   UNAIDS, 2014, CHILDR PREGN WOM LIV
   UNICEF, 2012, OPT B B KEY CONS COU
   Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032
   Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085
   Waters A, 2014, J CLIN VIROL, V59, P156, DOI 10.1016/j.jcv.2013.12.007
   Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951
   WHO, 2014, PROGR REP GLOB PLAN
   WHO, 2010, STRENGTH HLTH SERV F
   WHO, 2015, GLOB IMM DAT
   WHO, 2015, HEP B SURV DOCD RESP
   WHO Publication, 2010, Vaccine, V28, P589, DOI 10.1016/j.vaccine.2009.10.110
   WHO U UNAIDS, 2010, SCAL HIV SERV WOM CH
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Williams EJ, 2013, J PEDIATR-US, V163, P424, DOI 10.1016/j.jpeds.2013.02.004
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2007, GLOB EL CONG SYPH RA
   World Health Organization (WHO), 1999, GUID SEX TRANSM INF
   Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456
   Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75
   Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640
   Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840
   Zhang H, 2014, HEPATOLOGY, V60, P468, DOI 10.1002/hep.27034
   Zhang XW, 2007, J CLIN VIROL, V40, P180, DOI 10.1016/j.jcv.2007.08.018
NR 168
TC 3
Z9 4
U1 0
U2 29
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD SEP
PY 2016
VL 14
IS 9
BP 845
EP 861
DI 10.1080/14787210.2016.1215913
PG 17
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA DV7TJ
UT WOS:000383140000008
PM 27442227
OA Green Accepted
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI GIS Technology to Tackle Zika Virus
SO GIM INTERNATIONAL-THE WORLDWIDE MAGAZINE FOR GEOMATICS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS-GEO
PI LEMMER
PA PO BOX 112, LEMMER, 8530 AC, NETHERLANDS
SN 1566-9076
J9 GIM INT
JI GIM Int.
PD SEP
PY 2016
VL 30
IS 9
BP 7
EP 7
PG 1
WC Remote Sensing
SC Remote Sensing
GA FO0XT
UT WOS:000416480000003
DA 2020-07-08
ER

PT J
AU Na, YE
   Jung, JW
   Kwon, HW
AF Na, Young-Eun
   Jung, Je Won
   Kwon, Hyung Wook
TI Identification and expression patterns of two TRPV channel genes in
   antennae and Johnston's organ of the dengue and Zika virus vector
   mosquito, Aedes aegypti
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE TRPV channels; Mosquito; Dengue; Zika; Sensory; Aedes aegypti
ID DIPTERA-CULICIDAE; FINE-STRUCTURE; PUNGENT COMPOUNDS; GROOVED PEGS;
   DROSOPHILA; ACTIVATION; RECEPTORS; ELEGANS; HEARING; FAMILY
AB Transient Receptor Potential (TRP) channels respond to diverse stimuli and function as primary regulators of sensory information such as olfaction and auditory. TRP proteins are activated by several chemicals and secondary messengers to modulate communications between cell to cell as well as to recognize some environmental changes. Here we report on the identification and localization of the Aedes aegypti homolog of the TRPV channel proteins that is conserved to other insect species based on comparison of amino acids sequences similarities. Transcripts of two TRPV proteins homologous to Drosophila TRPV proteins (Nan and Iav) were ubiquitously expressed in the whole tissues such as antennae, maxillary palps, proboscis, legs, and body of the mosquito. Indeed, TRPV channel family members were localized in sensilla chaetica and sensilla basiconica on the antennae as well as ciliary segment of Johnston's organs. Taken together, we infer that TRPV channels of Aedes aegypti may function as both a sound sensor involved in detection of sound signals and as a chemical sensor responding attractants or repellent compounds allowing them to respond to the appearance of predators or other environmental chemical cues at a distance with behaviors crucial for survival. (C) 2016 Published by Elsevier B.V. on behalf of Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society.
C1 [Na, Young-Eun] RDA, Natl Inst Agr Sci, Climate Change & Agroecol Div, 300 Nongsaengmyeong Ro, Jeonju Si 54875, Jeollabuk Do, South Korea.
   [Jung, Je Won; Kwon, Hyung Wook] Incheon Natl Univ, Div Life Sci, 119 Acad Ro, Inchon 22012, South Korea.
   [Jung, Je Won; Kwon, Hyung Wook] Incheon Natl Univ, Coll Life Sci & Bioengn, Bioresource & Environm Ctr, 119 Acad Ro, Inchon 22012, South Korea.
RP Kwon, HW (corresponding author), Incheon Natl Univ, Div Life Sci, 119 Acad Ro, Inchon 22012, South Korea.; Kwon, HW (corresponding author), Incheon Natl Univ, Coll Life Sci & Bioengn, Bioresource & Environm Ctr, 119 Acad Ro, Inchon 22012, South Korea.
EM hwkwon@inu.ac.kr
FU Next-Generation BioGreen 21 Program of Rural Development Administration,
   Republic of Korea [PJ011170022016]; Incheon National University
   (International Cooperative) Research Grant
FX This work was supported by a grant from the Next-Generation BioGreen 21
   Program (Project No. PJ011170022016) of Rural Development
   Administration, Republic of Korea and by Incheon National University
   2016 (International Cooperative) Research Grant in 2016 to HWK.
CR Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3
   BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2
   BOO KS, 1976, CAN J ZOOL, V54, P235, DOI 10.1139/z76-026
   Chentsova NA, 2002, J COMP PHYSIOL B, V172, P643, DOI 10.1007/s00360-002-0293-9
   Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149
   CRIBB BW, 1995, TISSUE CELL, V27, P47, DOI 10.1016/S0040-8166(95)80008-5
   Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063
   DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052
   DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2
   Early C., 1999, VANILLOID CAPSAICIN, P51
   Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048
   Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035
   Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200
   Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735
   Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004
   Jung JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13444
   Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715
   KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4
   Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733
   Kim SH, 2013, INTERDISCIP BIOL CEN, P6
   Kim SI, 2012, J MED ENTOMOL, V49, P876, DOI 10.1603/ME11127
   Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016
   Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010
   Lee J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011012
   Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030
   Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223
   Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018
   Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228
   MCIVER S, 1978, J INSECT PHYSIOL, V24, P383, DOI 10.1016/0022-1910(78)90079-3
   MCIVER SB, 1972, CAN J ZOOLOG, V50, P571, DOI 10.1139/z72-078
   Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041
   Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2
   Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3
   Nilius B., 2014, HDB EXPT PHARM
   O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4
   Reegan AD, 2014, J ASIA-PAC ENTOMOL, V17, P327, DOI 10.1016/j.aspen.2014.02.008
   Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056
   Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043
   Spletter ML, 2009, CELL, V136, P23, DOI 10.1016/j.cell.2008.12.031
   Sun Y., 2009, TRPA CHANNELS DISTIN, V106, P1
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2
   Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819
   Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85
   Yang YoungCheol, 2004, Journal of Asia-Pacific Entomology, V7, P227, DOI 10.1016/S1226-8615(08)60220-4
NR 45
TC 1
Z9 1
U1 1
U2 28
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD SEP
PY 2016
VL 19
IS 3
BP 563
EP 569
DI 10.1016/j.aspen.2016.06.009
PG 7
WC Entomology
SC Entomology
GA DX6SY
UT WOS:000384514600001
DA 2020-07-08
ER

PT J
AU Sardi, SI
   Somasekar, S
   Naccache, SN
   Bandeira, AC
   Tauro, LB
   Campos, GS
   Chiu, CY
AF Sardi, Silvia I.
   Somasekar, Sneha
   Naccache, Samia N.
   Bandeira, Antonio C.
   Tauro, Laura B.
   Campos, Gubio S.
   Chiu, Charles Y.
TI Coinfections of Zika and Chikungunya Viruses in Bahia, Brazil,
   Identified by Metagenomic Next-Generation Sequencing
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID CLINICAL-SAMPLES; DENGUE VIRUSES; REAL-TIME; OUTBREAK; AMERICA; GENOME
AB Metagenomic next-generation sequencing (mNGS) of samples from 15 patients with documented Zika virus (ZIKV) infection in Bahia, Brazil, from April 2015 to January 2016 identified coinfections with chikungunya virus (CHIKV) in 2 of 15 ZIKV-positive cases by PCR (13.3%). While generally nonspecific, the clinical presentation corresponding to these two CHIKV/ZIKV coinfections reflected infection by the virus present at a higher titer. Aside from CHIKV and ZIKV, coinfections of other viral pathogens were not detected. The mNGS approach is promising for differential diagnosis of acute febrile illness and identification of coinfections, although targeted arbovirus screening may be sufficient in the current ZIKV outbreak setting.
C1 [Sardi, Silvia I.; Campos, Gubio S.] Univ Fed Bahia, Hlth Inst Sci, Virol Lab, Salvador, BA, Brazil.
   [Somasekar, Sneha; Naccache, Samia N.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, Sneha; Naccache, Samia N.; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.
   [Bandeira, Antonio C.] Alianca Hosp, Salvador, BA, Brazil.
   [Tauro, Laura B.] Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA.
EM charles.chiu@ucsf.edu
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
FU HHS \ National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01-HL105704, R21-AI120977]; Abbott LaboratoriesAbbott Laboratories
FX This work, including the efforts of Charles Y. Chiu, was funded by HHS
   vertical bar National Institutes of Health (NIH) (R01-HL105704 and
   R21-AI120977). This work, including the efforts of Charles Y. Chiu, was
   funded by Abbott Laboratories.
CR Baishya R, 2010, UROL ANNALS, V2, P110, DOI 10.4103/0974-7796.68859
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0235-2
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Naccache SN, 2016, EMERG INFECT DIS
   Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
NR 29
TC 52
Z9 53
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2016
VL 54
IS 9
BP 2348
EP 2353
DI 10.1128/JCM.00877-16
PG 6
WC Microbiology
SC Microbiology
GA DX3CT
UT WOS:000384251300024
PM 27413190
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Cabral-Castro, MJ
   Cavalcanti, MG
   Peralta, RHS
   Peralta, JM
AF Cabral-Castro, Mauro Jorge
   Cavalcanti, Marta Guimaraes
   Saramago Peralta, Regina Helena
   Peralta, Jose Mauro
TI Molecular and serological techniques to detect co-circulation of DENV,
   ZIKV and CHIKV in suspected dengue-like syndrome patients
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Differential diagnosis; Dengue virus; Zika virus; Chikungunya virus;
   Arboviruses; Viral RNA
ID CHIKUNGUNYA-VIRUS; OUTBREAK
AB Background: Arboviruses are important emerging viruses worldwide. The signs and symptoms of Zika virus (ZIKV) infection are similar to those presented by infections with dengue virus (DENV) and chikungunya virus (CHIKV). Furthermore, diagnosis of ZIKV infection is particularly challenging in dengue endemic regions and with co-circulation of DENV, CHIKV, and ZIKV, making diagnosis based solely on clinical and epidemiological data unreliable. As these three viral infections share similar clinical manifestations, differential diagnosis is crucial.
   Objectives: In this study, diagnoses of ZIKV, CHIKV and DENV infections were investigated in 30 patients with suspected dengue fever residing in the area of co-circulation of these three arboviruses.
   Study design: The study included whole blood and/or serum samples obtained from 30 patients with suspected dengue fever. All patients were tested for DENV infection as well as for CHIKV and ZIKV infections. Assays for detecting anti-DENV IgM and DENV RNA by semi-nested RT-PCR and ZIKV and CHIKV RNA by real-time RT-PCR were performed.
   Results: DENV RNA was not detectable in any of the clinical samples, whereas ZIKV RNA was detectable in 17 samples (56.7%). Co-infection by ZIKV and CHIKV was documented in one case. Of the 17 ZIKV-positive individuals, 8 showed reactivity for anti-DENV IgM, which suggested recent DENV infection, cross-reactivity or co-infection.
   Conclusion: Our findings confirm that accurate laboratory testing is of paramount importance for differential diagnosis in areas of simultaneous transmission of different arboviruses with similar clinical presentations. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Cabral-Castro, Mauro Jorge; Peralta, Jose Mauro] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Cavalcanti, Marta Guimaraes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Doencas Infecciosas & Parasitorias, Rio De Janeiro, RJ, Brazil.
   [Saramago Peralta, Regina Helena] Univ Fed Fluminense, Fac Med, Dept Patol, Niteroi, RJ, Brazil.
RP Peralta, JM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM peralta@micro.ufrj.br
RI Cabral-Castro, Mauro Jorge/L-8868-2016
OI Cabral-Castro, Mauro Jorge/0000-0002-1755-999X
FU FAPERJ, BrazilCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPES, BrazilCAPES; CNPq,
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX FAPERJ, CAPES and CNPq, Brazil.
CR Brasil P, 2016, N ENGL J MED
   Brazil Ministry of Health, 2015, MON CAS DENG CHIK FE, V52
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kelser E.A., 2015, MICROBES INFECT, P1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues Faria N., 2016, PLOS CURR
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villamil-Gomez W.E., 2015, J INFECT PUBLIC HLTH
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 20
TC 22
Z9 23
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2016
VL 82
BP 108
EP 111
DI 10.1016/j.jcv.2016.07.017
PG 4
WC Virology
SC Virology
GA DZ7DP
UT WOS:000386024900020
PM 27479173
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Gonzalez-Camargo, O
   Rodriguez-Ayubi, J
   Zapata-Serpa, D
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Gonzalez-Camargo, Orfy
   Rodriguez-Ayubi, Jose
   Zapata-Serpa, Diana
   Rodriguez-Morales, Alfonso J.
TI Dengue, chikungunya and Zika co-infection in a patient from Colombia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
ID INFECTION; AMERICA; TRAVEL
C1 [Villamil-Gomez, Wilmer E.; Zapata-Serpa, Diana] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Cartagena, Programa Doctorado Med Trop, Cartagena, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer E.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Gonzalez-Camargo, Orfy] Hosp Univ Sincelejo, Div Epidemiol, Sincelejo, Sucre, Colombia.
   [Rodriguez-Ayubi, Jose] Corp Univ Antonio Jose de Sucre, Grp Invest, Corposucre, Sincelejo, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Comm Zoonoses & Haemorrhag, Fevers, Colombia.
   [Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Martinez-Pulgarin D.F., 2015, TRAVEL MED INFECT DI
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rodriguez-Morales A.J., 2015, ARCH MED, V11, P3, DOI [10.3823/1245., DOI 10.3823/1245]
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
NR 10
TC 69
Z9 72
U1 0
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD SEP-OCT
PY 2016
VL 9
IS 5
BP 684
EP 686
DI 10.1016/j.jiph.2015.12.002
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DT3ML
UT WOS:000381385200022
PM 26754201
OA Bronze
DA 2020-07-08
ER

PT J
AU Eyer, L
   Nencka, R
   Huvarova, I
   Palus, M
   Alves, MJ
   Gould, EA
   De Clercq, E
   Ruzek, D
AF Eyer, Ludek
   Nencka, Radim
   Huvarova, Ivana
   Palus, Martin
   Alves, Maria Joao
   Gould, Ernest A.
   De Clercq, Erik
   Ruzek, Daniel
TI Nucleoside Inhibitors of Zika Virus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; flavivirus; nucleoside analogue; antiviral; therapy
ID FLAVIVIRUS DRUG DISCOVERY
AB There is growing evidence that Zika virus (ZIKV) can cause devastating infant brain defects and other neurological disorders in humans. However, no specific antiviral therapy is available at present. We tested a series of 2'-C- or 2'-O-methyl-substituted nucleosides, 2'-C-fluoro-2'-C-methyl-substituted nucleosides, 3'-O-methyl-substituted nucleosides, 3'-deoxynucleosides, derivatives with 4'-C-azido substitution, heterobase-modified nucleosides, and neplanocins for their ability to inhibit ZIKV replication in cell culture. Antiviral activity was identified when 2'-C-methylated nucleosides were tested, suggesting that these compounds might represent promising lead candidates for further development of specific antivirals against ZIKV.
C1 [Eyer, Ludek; Huvarova, Ivana; Palus, Martin; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno, Czech Republic.
   [Nencka, Radim] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.
   [Palus, Martin; Ruzek, Daniel] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Prague, Czech Republic.
   [Palus, Martin; Ruzek, Daniel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.
   [Alves, Maria Joao] Natl Inst Hlth Dr Ricardo Jorge CEVDI INSA, Aguas De Moura, Portugal.
   [Gould, Ernest A.] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France.
   [De Clercq, Erik] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.
RP Ruzek, D (corresponding author), Vet Res Inst, Hudcova 70, CZ-62100 Brno, Czech Republic.
EM ruzekd@paru.cas.cz
RI Ruzek, Daniel/G-9275-2014; Nencka, Radim/G-5296-2014; Palus,
   Martin/N-1263-2017; Eyer, Ludek/U-4883-2018
OI Ruzek, Daniel/0000-0003-4655-2380; Palus, Martin/0000-0002-4279-7092;
   Eyer, Ludek/0000-0001-7761-0702; Alves, Maria Joao/0000-0003-0065-9000;
   De Clercq, Erik/0000-0002-2985-8890
FU Czech Science FoundationGrant Agency of the Czech Republic
   [GA14-29256S]; Ministry of Education, Youth, and Sports of the Czech
   Republic, under the NPU I program [LO1218]; National Subvention for the
   Development of Research Organizations [RVO:61388963]; European Virus
   Archive Goes Global project - European Union [653316]
FX This work was supported by the Czech Science Foundation
   (grantGA14-29256S); the Ministry of Education, Youth, and Sports of the
   Czech Republic, under the NPU I program (grant LO1218); the National
   Subvention for the Development of Research Organizations (grant
   RVO:61388963); the European Virus Archive Goes Global project, which has
   received funding from the European Union's Horizon 2020 research and
   innovation program (grant 653316).
CR Botting C, 2012, EXPERT OPIN DRUG DIS, V7, P417, DOI 10.1517/17460441.2012.673579
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Eldrup AB, 2004, J MED CHEM, V47, P2283, DOI 10.1021/jm030424e
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Roth A, 2014, EURO SURVEILL, V19
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 14
TC 97
Z9 102
U1 1
U2 35
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2016
VL 214
IS 5
BP 707
EP 711
DI 10.1093/infdis/jiw226
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DY7YY
UT WOS:000385346400008
PM 27234417
OA Bronze
DA 2020-07-08
ER

PT J
AU Faraji, A
   Unlu, I
AF Faraji, Ary
   Unlu, Isik
TI The Eye of the Tiger, the Thrill of the Fight: Effective Larval and
   Adult Control Measures Against the Asian Tiger Mosquito, Aedes
   albopictus (Diptera: Culicidae), in North America
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Review
DE mosquito control; integrated mosquito management; larvicide; adulticide;
   vector surveillance
ID BACILLUS-THURINGIENSIS-ISRAELENSIS; INSECT-GROWTH-REGULATOR; TOXIC SUGAR
   BAITS; CONTAINER-BREEDING MOSQUITOS; LIFE-SHORTENING WOLBACHIA;
   ENGINEERED MALE MOSQUITOS; AUTOCIDAL GRAVID OVITRAP; DENGUE VECTOR
   CONTROL; MASS TRAPPING SCHEME; BG-SENTINEL TRAP
AB The Asian tiger mosquito, Aedes albopictus (Skuse), is a highly invasive container-inhabiting species with a global distribution. This mosquito, similar to other Stegomyia species such as Aedes aegypti (L.), is highly adapted to urban and suburban areas, and commonly oviposits in artificial containers, which are ubiquitous in these peridomestic environments. The increase in speed and amount of international travel and commerce, coupled with global climate change, have aided in the resurgence and expansion of Stegomyia species into new areas of North America. In many parts of their range, both species are implicated as significant vectors of emerging and re-emerging arboviruses such as dengue, chikungunya, and now Zika. Although rapid and major advances have been made in the field of biology, ecology, genetics, taxonomy, and virology, relatively little has changed in the field of mosquito control in recent decades. This is particularly discouraging in regards to container-inhabiting mosquitoes, because traditional integrated mosquito management (IMM) approaches have not been effective against these species. Many mosquito control programs simply do not possess the man-power or necessary financial resources needed to suppress Ae. albopictus effectively. Therefore, control of mosquito larvae, which is the foundation of IMM approaches, is exceptionally difficult over large areas. This review paper addresses larval habitats, use of geographic information systems for habitat preference detection, door-to-door control efforts, source reduction, direct application of larvicides, biological control agents, area-wide low-volume application of larvicides, hot spot treatments, autodissemination stations, public education, adult traps, attractive-toxic sugar bait methods, lethal ovitraps, barrier-residual adulticides, hand-held ultra-low-volume adulticides, area-wide adulticides applied by ground or air, and genetic control methods. The review concludes with future recommendations for practitioners, researchers, private industry, and policy makers.
C1 [Faraji, Ary; Unlu, Isik] Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08901 USA.
   [Unlu, Isik] Mercer Cty Mosquito Control, West Trenton, NJ 08628 USA.
RP Faraji, A (corresponding author), Rutgers State Univ, Dept Entomol, Ctr Vector Biol, New Brunswick, NJ 08901 USA.
EM ary@slcmad.org; iunlu@mercercounty.org
FU USDAUnited States Department of Agriculture (USDA)
   [USDA-ARS-58-6615-8-105]; Rutgers University [USDA-ARS-58-6615-8-105]
FX It is nearly impossible to include all relevant control measures and
   historical perspectives in a review paper, and we apologize in advance
   to any organizations or researchers whose work was omitted. Any
   oversight was not intentional. The vast majority of the control efforts
   provided within this document were obtained as a result of funding
   through a Cooperative Agreement between the USDA and Rutgers University
   (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for
   the Asian Tiger Mosquito in New Jersey". We thank the various
   individuals who played a key role in those investigations, including
   Dina Fonseca, Randy Gaugler, Sean Healy, Taryn Crepeau, Kristen
   Bartlett-Healy, George Hamilton, Greg Williams, Scott Crans, Mark
   Nelder, Banu Kesavaraju, Peter DeChant, Don Shepard, Yara Halasa,
   Sebastian Marcombe, Jiawu Xu, Nick Indelicato, Dan Strickman, Gary
   Clark, Dan Kline, Roger Nasci, Dawn Wesson, George O'Meara, Emily
   Zielinski-Gutierrez, Rui-De Xue, James McNelly, Ilia Rochlin, Jack
   Peterson, Karl Malamud-Roam, Doug Burkett, and Graham White. In
   addition, we owe gratitude to various industry partners, additional
   mosquito control collaborators in New Jersey, New York, Pennsylvania,
   Florida, Louisiana, and California. We are also grateful for the
   valuable discussions and data provided by Chris Lesser, Mark Latham,
   Roberto Barrera, Mike Doyle, Kenn Fujioka, Derric Nimmo, and Scott
   Ritchie. Last, but certainly not least, is our gratitude and
   appreciation for the numerous mosquito control personnel and seasonal
   employees whose dedication and drive left no dipper dry, no tire
   unrecycled, no bucket overturned, and no discarded container picked up.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Andreadis TG, 2007, J AM MOSQUITO CONTR, V23, P3, DOI 10.2987/8756-971X(2007)23[3:MPOM]2.0.CO;2
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Bartlett-Healy K, 2011, J MED ENTOMOL, V48, P712, DOI 10.1603/ME10168
   Baxter IH, 2008, J STORED PROD RES, V44, P152, DOI 10.1016/j.jspr.2007.08.004
   Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256
   Becnel JJ, 2007, J AM MOSQUITO CONTR, V23, P36, DOI 10.2987/8756-971X(2007)23[36:MPVLY]2.0.CO;2
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Caputo B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0734-4
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313
   Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   (CDC) Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU, P69
   Chadee D., 1990, PAN AM SANITARY BURE, V109, P350
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Abramides GC, 2011, T ROY SOC TROP MED H, V105, P281, DOI 10.1016/j.trstmh.2011.01.003
   Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Cilek JE, 2008, J AM MOSQUITO CONTR, V24, P172, DOI 10.2987/8756-971X(2008)24[172:AOITVA]2.0.CO;2
   Clements A.N, 2000, BIOL MOSQUITOES DEV, V1
   Crepeau TN, 2013, J AM MOSQUITO CONTR, V29, P177, DOI 10.2987/12-6277r.1
   Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Dobson SL, 2004, EVOLUTION, V58, P2156, DOI 10.1111/j.0014-3820.2004.tb01594.x
   Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Edillo FE, 2012, SE ASIAN J TROP MED, V43, P1365
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847
   Englbrecht C, 2015, J AM MOSQUITO CONTR, V31, P16, DOI 10.2987/14-6444.1
   Estrada-Franco J. G., 1995, BIOL DIS RELATIONSHI
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Faraji A., 2014, THESIS
   Faraji A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152069
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P385, DOI 10.2987/13-6332.1
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Ferwerda C., 2009, THESIS
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   FOCKS DA, 1987, AM J TROP MED HYG, V36, P639, DOI 10.4269/ajtmh.1987.36.639
   Focks DA, 2007, J AM MOSQUITO CONTR, V23, P118, DOI 10.2987/8756-971X(2007)23[118:TABA]2.0.CO;2
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Fulcher A, 2014, J MED ENTOMOL, V51, P896, DOI 10.1603/ME13243
   FURLONG MJ, 1995, B ENTOMOL RES, V85, P331, DOI 10.1017/S0007485300036051
   Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x
   Geden CJ, 2012, J MED ENTOMOL, V49, P606, DOI 10.1603/ME11226
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gu WD, 2006, J VECTOR ECOL, V31, P107, DOI 10.3376/1081-1710(2006)31[107:SEODDO]2.0.CO;2
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Gubler D. J., 2002, Dengue Bulletin, V26, P96
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   HAILE DG, 1982, MOSQ NEWS, V42, P576
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Higa Yukiko, 2000, Medical Entomology and Zoology, V51, P205
   Hoel DF, 2009, J AM MOSQUITO CONTR, V25, P47, DOI 10.2987/08-5800.1
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   Jackson MJ, 2012, J AM MOSQUITO CONTR, V28, P292, DOI 10.2987/12-6241R.1
   Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385
   JATANASEN S, 1967, B WORLD HEALTH ORGAN, V36, P636
   Joseph S. R., 1970, Proceedings. New Jersey Mosquito Extermination Association, V57, P125
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kawada H, 2010, JPN J INFECT DIS, V63, P19
   Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40
   Khallaayoune K, 2013, ENVIRON ENTOMOL, V42, P1040, DOI 10.1603/EN13119
   Khatchikian CE, 2009, J VECTOR ECOL, V34, P119, DOI [10.3376/038.034.0115, 10.1111/j.1948-7134.2009.00015.x]
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2
   Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lacroix R, 2009, MED VET ENTOMOL, V23, P160, DOI 10.1111/j.1365-2915.2009.00806.x
   Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601
   Li CX, 2010, J AM MOSQUITO CONTR, V26, P346, DOI 10.2987/10-6007.1
   Linthicum KJ, 2003, J AM MOSQUITO CONTR, V19, P301
   LOWE RE, 1980, AM J TROP MED HYG, V29, P695, DOI 10.4269/ajtmh.1980.29.695
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Mains JW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003406
   Manrique-Saide P, 2008, J AM MOSQUITO CONTR, V24, P289, DOI 10.2987/5578.1
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marshall JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-291
   Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Mogi M, 2007, J AM MOSQUITO CONTR, V23, P93, DOI 10.2987/8756-971X(2007)23[93:IAOIP]2.0.CO;2
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison N. I., 2012, Outlooks on Pest Management, V23, P65, DOI 10.1564/23apr05
   Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305
   Muller GC, 2010, MED VET ENTOMOL, V24, P346, DOI 10.1111/j.1365-2915.2010.00876.x
   Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108
   Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008
   Muller GC, 2008, J AM MOSQUITO CONTR, V24, P147, DOI 10.2987/8756-971X(2008)24[147:DOASAA]2.0.CO;2
   Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009
   MULLA MS, 1994, J AM MOSQUITO CONTR, V10, P574
   Muller GC, 2008, T ROY SOC TROP MED H, V102, P480, DOI 10.1016/j.trstmh.2008.01.008
   Naranjo DP, 2013, PARASITOL RES, V112, P1583, DOI 10.1007/s00436-013-3312-8
   Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546
   Norzahira R, 2011, TROP BIOMED, V28, P48
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Obenauer PJ, 2010, ENVIRON ENTOMOL, V39, P1608, DOI 10.1603/EN09322
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   Patterson Gordon M, 2009, MOSQUITO CRUSADES HI
   PATTERSON RS, 1970, SCIENCE, V168, P1368, DOI 10.1126/science.168.3937.1368
   PERICH MJ, 1990, J AM MOSQUITO CONTR, V6, P1
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Phanthumachinda B., 1985, Mosquito-Borne Diseases Bulletin, V2, P1
   Edward EG, 2007, J AM MOSQUITO CONTR, V23, P58, DOI 10.2987/8756-971X(2007)23[58:MN]2.0.CO;2
   Preechaporn W., 2006, Dengue Bulletin, V30, P204
   Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004
   Qualls WA, 2012, ACTA TROP, V124, P158, DOI 10.1016/j.actatropica.2012.07.004
   Rao BB, 2010, J VECTOR DIS, V47, P175
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Ratigan CW, 1999, ASIAN TIGER MOSQUITO
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter P., 1997, SURVEILLANCE CONTROL, P425
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2
   Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Rochlin I, 2016, J MED ENTOMOL, V53, P454, DOI 10.1093/jme/tjv171
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776
   SCHAFFNER FP, 2009, DEV AEDES ALBOPICTUS
   Seleena P., 1998, Israel Journal of Entomology, V32, P25
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025
   SOEDARMO SP, 1994, TROP MED, V35, P315
   Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   Sunahara T, 1997, RES POPUL ECOL, V39, P173, DOI 10.1007/BF02765263
   Suter TT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004315
   Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Trout RT, 2007, J MED ENTOMOL, V44, P470, DOI 10.1603/0022-2585(2007)44[470:EOTPIA]2.0.CO;2
   Tseng M, 2007, J AM MOSQUITO CONTR, V23, P30, DOI 10.2987/8756-971X(2007)23[30:APAPBA]2.0.CO;2
   Unlu I, 2016, PEST MANAG SCI, V72, P1427, DOI 10.1002/ps.4174
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   Unlu I, 2014, ACTA TROP, V137, P201, DOI 10.1016/j.actatropica.2014.05.009
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walton WE, 2007, J AM MOSQUITO CONTR, V23, P184, DOI 10.2987/8756-971X(2007)23[184:LFIG]2.0.CO;2
   Wang Y, 2014, PEST MANAG SCI, V70, P1299, DOI 10.1002/ps.3702
   Warner DG, 2005, J MED LIBR ASSOC, V93, P243
   Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1
   Williams CR, 2007, J MED ENTOMOL, V44, P256, DOI 10.1603/0022-2585(2007)44[256:IOABLO]2.0.CO;2
   Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035
   WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342
   Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xue RD, 2011, J AM MOSQUITO CONTR, V27, P56, DOI 10.2987/10-6069.1
   YEE WL, 1992, J MED ENTOMOL, V29, P784, DOI 10.1093/jmedent/29.5.784
   Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150
   Zeichner Brian C, 2011, US Army Med Dep J, P4
   [周毅彬 ZHOU Yi-bin], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P3
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 214
TC 25
Z9 26
U1 1
U2 53
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2016
VL 53
IS 5
BP 1029
EP 1047
DI 10.1093/jme/tjw096
PG 19
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DW5SV
UT WOS:000383708100006
PM 27354440
OA Bronze
DA 2020-07-08
ER

PT J
AU Boete, C
AF Boete, Christophe
TI Yellow Fever Outbreak: O Vector Control, Where Art Thou?
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Letter
ID ZIKA; VACCINE
C1 [Boete, Christophe] Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, Inserm 1207,EHESP, 27 Bd Jean Moulin, F-13385 Marseille 5, France.
RP Boete, C (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, Inserm 1207,EHESP, 27 Bd Jean Moulin, F-13385 Marseille 5, France.
EM cboete@gmail.com
RI BOETE, Christophe/A-7926-2010
OI BOETE, Christophe/0000-0001-9043-8652
CR Cope S., 2005, EMERG INFECT DIS, V11, P1652
   Faerstein E, 2010, EPIDEMIOLOGY, V21, P158, DOI 10.1097/EDE.0b013e3181c308e0
   Finlay C. J., 1882, ANALES REAL ACAD CIE, V18
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gorgas W. C., 1905, MED RET, V67, P162
   Gorgas WC, 1902, LANCET, V2, P667
   Gorgas William, 1915, SANITATION IN PANAMA
   Leonard J, 1991, Bull Pan Am Health Organ, V25, P166
   Lima E. P., 2015, BMC PUBLIC HEALTH, V15, P1
   Matas R., 1881, YALE J BIOL MED, V9, P589
   Maurice J, 2016, LANCET, V387, P733, DOI 10.1016/S0140-6736(16)00390-1
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Mullan Z, 2016, LANCET GLOB HEALTH, V4, pE137, DOI 10.1016/S2214-109X(16)00051-6
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   The Lancet, 2016, LANCET, V387, P1348
   WHO, 2013, YELLOW FEVER VACCINA
   World Health Organization, 2016, ANG GRAPPL WORST YEL
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 20
TC 0
Z9 0
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2016
VL 53
IS 5
BP 1048
EP 1049
DI 10.1093/jme/tjw087
PG 2
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DW5SV
UT WOS:000383708100007
PM 27330101
DA 2020-07-08
ER

PT J
AU Valentine, G
   Marquez, L
   Pammi, M
AF Valentine, Gregory
   Marquez, Lucila
   Pammi, Mohan
TI Zika Virus-Associated Microcephaly and Eye Lesions in the Newborn
SO JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
LA English
DT Review
DE global health; microcephaly; neonate; Zika virus
ID FRENCH-POLYNESIA; BRAZIL; TRANSMISSION; INFECTION; ENVIRONMENT; AMERICA;
   INFANTS
AB On February 1, 2016, Zika virus (ZIKV) was designated as a Public Health Emergency of International Concern by the director of the World Health Organization. Zika virus has spread to numerous countries throughout the Americas, affecting up to an estimated 1.3 million people since the first reports from Brazil in early 2015. Although ZIKV infections are self-limiting, fetal microcephaly and ophthalmic anomalies have been associated with ZIKV infection as a possible result of perinatal transmission. The causal link between maternal ZIKV infection and newborn microcephaly and eye lesions has not been proven beyond doubt and is currently debated. We discuss the possibility of causality by ZIKV using Koch's postulates and the more appropriate Bradford Hill criteria. In this review, we summarize and consolidate the current literature on newborn microcephaly and eye lesions associated with ZIKV infection and discuss current perspectives and controversies.
C1 [Valentine, Gregory] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Marquez, Lucila] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.
   [Pammi, Mohan] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.
RP Valentine, G (corresponding author), Dept Pediat, One Baylor Plaza,MC BCM320, Houston, TX 77030 USA.
EM gvalenti@bcm.edu
OI Valentine, Gregory/0000-0002-3055-2987
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Coats DK, 2000, J AAPOS, V4, P110, DOI 10.1067/mpa.2000.103870
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durkin M, 2004, INFECT ETIOLOGY CHRO
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   ECDC, ZIK VIR EP AM POT AS
   ECDC: European Centre for Disease Prevention and Control, RAP RISK ASS MICR BR
   EUROCAT, PREV TABL
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Koch R, 1891, 10 INT C MED BERL
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organisation, NEUR SYNDR CONG MALF
   Pan American Health Organization World Health Organization; Regional Office for the Americas, EP AL INCR MICR NE B
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, WHO SPEC EV PUBL HLT
   WILLIAMSON WD, 1992, PEDIATRICS, V90, P862
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2011, GUID DRINK WAT QUAL, P439
   World Health Organization, 2010, PYR DRINK WAT BACKGR
   Wren SME, 2004, EYE, V18, P389, DOI 10.1038/sj.eye.6700696
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 61
TC 19
Z9 19
U1 0
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-7193
EI 2048-7207
J9 J PEDIAT INF DIS SOC
JI J. Pediatr. Infect. Dis. Soc.
PD SEP
PY 2016
VL 5
IS 3
BP 323
EP 328
DI 10.1093/jpids/piw037
PG 6
WC Infectious Diseases; Pediatrics
SC Infectious Diseases; Pediatrics
GA DZ8RH
UT WOS:000386138100015
PM 27405738
OA Bronze
DA 2020-07-08
ER

PT J
AU Prisant, N
   Bujan, L
   Benichou, H
   Hayot, PH
   Pavili, L
   Lurel, S
   Herrmann, C
   Janky, E
   Joguet, G
AF Prisant, Nadia
   Bujan, Louis
   Benichou, Helene
   Hayot, Pierre-Humbert
   Pavili, Lynda
   Lurel, Sylvia
   Herrmann, Cecile
   Janky, Eustase
   Joguet, Guillaume
TI Zika virus in the female genital tract
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Prisant, Nadia; Benichou, Helene; Hayot, Pierre-Humbert; Pavili, Lynda; Lurel, Sylvia; Janky, Eustase; Joguet, Guillaume] Ctr Hosp Univ Pointe A Pitre, Pole Parents Enfant, Ctr Caribeen Med Reprod, CECOS Caraibes, Pointe A Pitre 97159, Guadeloupe, France.
   [Bujan, Louis] Univ Toulouse 3, Human Fertil Res Grp, Toulouse, France.
   [Bujan, Louis] Ctr Hosp Univ Paule de Viguier, CECOS, Toulouse, France.
   [Herrmann, Cecile] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre, Guadeloupe, France.
RP Prisant, N (corresponding author), Ctr Hosp Univ Pointe A Pitre, Pole Parents Enfant, Ctr Caribeen Med Reprod, CECOS Caraibes, Pointe A Pitre 97159, Guadeloupe, France.
EM nadia.mutaftschiev@chu-guadeloupe.fr
OI Bujan, Louis/0000-0003-1540-0536
CR Agence de la Biomedecine, 2016, REC PROF PRIS CHARG
   Calvet G., 2016, LANCET INFECT DIS
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
NR 5
TC 87
Z9 87
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1000
EP +
DI 10.1016/S1473-3099(16)30193-1
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200017
PM 27427201
OA Bronze
DA 2020-07-08
ER

PT J
AU Attaran, A
AF Attaran, Amir
TI Zika virus and the 2016 Olympic Games
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Attaran, Amir] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.
   [Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
RP Attaran, A (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.; Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
EM aattaran@uottawa.ca
CR Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grills A, 2016, MMWR MORB MORTAL WKL
   International Research Institute for Climate and Society, IRI MULT PROB FOR TE
   Ministerio da Saude, 2016, MON CAS DENG FEBR CH, V21
   The Lancet Infectious, 2016, LANCET INFECT DIS, V16, P619
   WHO, 1947, MAP COUNTR TERR SHOW
   WHO, 2016, ZIK VIR OL PAR GAM R
NR 7
TC 5
Z9 5
U1 0
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1001
EP 1003
DI 10.1016/S1473-3099(16)30230-4
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200018
PM 27460685
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Atkinson, B
   Graham, V
   Miles, RW
   Lewandowski, K
   Dowall, SD
   Pullan, ST
   Hewson, R
AF Atkinson, Barry
   Graham, Victoria
   Miles, Rory W.
   Lewandowski, Kuiama
   Dowall, Stuart D.
   Pullan, Steven T.
   Hewson, Roger
TI Complete Genome Sequence of Zika Virus Isolated from Semen
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Zika virus (ZIKV) is an emerging pathogenic flavivirus currently circulating in numerous countries in South America, the Caribbean, and the Western Pacific Region. Using an unbiased metagenomic sequencing approach, we report here the first complete genome sequence of ZIKV isolated from a clinical semen sample.
C1 [Atkinson, Barry; Graham, Victoria; Miles, Rory W.; Lewandowski, Kuiama; Dowall, Stuart D.; Pullan, Steven T.; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England.
   [Hewson, Roger] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
RP Atkinson, B (corresponding author), Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England.
EM barry.atkinson@phe.gov.uk
OI Pullan, Steven/0000-0002-8983-599X; Miles, Rory/0000-0002-6055-4166;
   Atkinson, Barry/0000-0002-1348-7204
FU Public Health England (PHE)
FX This work, including the efforts of Barry Atkinson, was funded by Public
   Health England (PHE).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89
   Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Miles RW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00480-16
   WHO, 2016, WHO ZIK SIT REP
   WHO/PAHO, 2016, EP DIS ZIK AM
NR 11
TC 8
Z9 8
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD SEP-OCT
PY 2016
VL 4
IS 5
AR e01116-16
DI 10.1128/genomeA.01116-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DS
UT WOS:000460668900195
PM 27738033
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Trosemeier, JH
   Musso, D
   Blumel, J
   Theze, J
   Pybus, OG
   Baylis, SA
AF Troesemeier, Jan-Hendrik
   Musso, Didier
   Bluemel, Johannes
   Theze, Julien
   Pybus, Oliver G.
   Baylis, Sally A.
TI Genome Sequence of a Candidate World Health Organization Reference
   Strain of Zika Virus for Nucleic Acid Testing
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report here the sequence of a candidate reference strain of Zika virus (ZIKV) developed on behalf of the World Health Organization (WHO). The ZIKV reference strain is intended for use in nucleic acid amplification (NAT)-based assays for the detection and quantification of ZIKV RNA.
C1 [Troesemeier, Jan-Hendrik; Bluemel, Johannes; Baylis, Sally A.] Paul Ehrlich Inst, Langen, Germany.
   [Troesemeier, Jan-Hendrik] Goethe Univ Frankfurt, Mol Bioinformat, Frankfurt, Germany.
   [Musso, Didier] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
RP Baylis, SA (corresponding author), Paul Ehrlich Inst, Langen, Germany.
EM sally.baylis@pei.de
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020; Pybus, Oliver
   g/B-2640-2012
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Pybus, Oliver g/0000-0002-8797-2667
FU grant "Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren" from the German Ministry of Health; U.S.
   Agency for International Development (USAID)United States Agency for
   International Development (USAID) [AID-OAA-A-14-00102]
FX This work was supported by the grant "Sicherheit von Blut(produkten) und
   Geweben hinsichtlich der Abwesenheit von Zikaviren" from the German
   Ministry of Health (S. A. Baylis, J.-H. Trosemeier, J. Blumel). This
   study was made possible by the generous support of the American people
   through the U.S. Agency for International Development (USAID) Emerging
   Pandemic Threats Program-2 PREDICT-2 (cooperative agreement no.
   AID-OAA-A-14-00102; J. Theze, O. Pybus). The contents are the
   responsibility of the authors and do not necessarily reflect the views
   of USAID or the U.S. government.
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baylis SA, 2015, TRANSFUS MED HEMOTH, V42, P211, DOI 10.1159/000435872
   Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
NR 14
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD SEP-OCT
PY 2016
VL 4
IS 5
AR e00917-16
DI 10.1128/genomeA.00917-16
PG 2
WC Microbiology
SC Microbiology
GA VI1DS
UT WOS:000460668900045
PM 27587826
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Bennett, KL
   Shija, F
   Linton, YM
   Misinzo, G
   Kaddumukasa, M
   Djouaka, R
   Anyaele, O
   Harris, A
   Irish, S
   Hlaing, T
   Prakash, A
   Lutwama, J
   Walton, C
AF Bennett, Kelly Louise
   Shija, Fortunate
   Linton, Yvonne-Marie
   Misinzo, Gerald
   Kaddumukasa, Martha
   Djouaka, Rousseau
   Anyaele, Okorie
   Harris, Angela
   Irish, Seth
   Hlaing, Thaung
   Prakash, Anil
   Lutwama, Julius
   Walton, Catherine
TI Historical environmental change in Africa drives divergence and
   admixture of Aedes aegypti mosquitoes: a precursor to successful
   worldwide colonization?
SO MOLECULAR ECOLOGY
LA English
DT Article
DE approximate Bayesian computation; arbovirus; domestication; forest
   fragmentation; invasive species; Pleistocene climatic change
ID RIFT-VALLEY COMPLEX; GENETIC-STRUCTURE; YELLOW-FEVER; COMPARATIVE
   PHYLOGEOGRAPHY; EVOLUTIONARY HISTORY; POPULATION-GENETICS; BIOLOGICAL
   INVASION; CHIKUNGUNYA VIRUS; ANOPHELES-GAMBIAE; MITOCHONDRIAL
   PSEUDOGENES
AB Increasing globalization has promoted the spread of exotic species, including disease vectors. Understanding the evolutionary processes involved in such colonizations is both of intrinsic biological interest and important to predict and mitigate future disease risks. The Aedes aegypti mosquito is a major vector of dengue, chikungunya and Zika, the worldwide spread of which has been facilitated by Ae. aegypti's adaption to human-modified environments. Understanding the evolutionary processes involved in this invasion requires characterization of the genetic make-up of the source population (s). The application of approximate Bayesian computation (ABC) to sequence data from four nuclear and one mitochondrial marker revealed that African populations of Ae. aegypti best fit a demographic model of lineage diversification, historical admixture and recent population structuring. As ancestral Ae. aegypti were dependent on forests, this population history is consistent with the effects of forest fragmentation and expansion driven by Pleistocene climatic change. Alternatively, or additionally, historical human movement across the continent may have facilitated their recent spread and mixing. ABC analysis and haplotype networks support earlier inferences of a single out-of-Africa colonization event, while a cline of decreasing genetic diversity indicates that Ae. aegypti moved first from Africa to the Americas and then to Asia. ABC analysis was unable to verify this colonization route, possibly because the genetic signal of admixture obscures the true colonization pathway. By increasing genetic diversity and forming novel allelic combinations, divergence and historical admixture within Africa could have provided the adaptive potential needed for the successful worldwide spread of Ae. aegypti.
C1 [Bennett, Kelly Louise; Shija, Fortunate; Walton, Catherine] Univ Manchester, Computat Evolutionary Biol Grp, Fac Life Sci, Manchester, Lancs, England.
   [Shija, Fortunate; Misinzo, Gerald] Sokoine Univ Agr, Dept Vet Microbiol & Parasitol, Morogoro, Tanzania.
   [Linton, Yvonne-Marie] Smithsonian Inst, Walter Reed Biosystemat Unit, Museum Support Ctr, Suitland, MD USA.
   [Linton, Yvonne-Marie] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Linton, Yvonne-Marie] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Linton, Yvonne-Marie] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, NHB 169, Washington, DC 20560 USA.
   [Kaddumukasa, Martha; Lutwama, Julius] Uganda Virus Res Inst, Dept Arbovirol Emerging & Reemerging Infect, Entebbe, Uganda.
   [Djouaka, Rousseau] Int Inst Trop Agr, Agroecohlth Platform West & Cent Africa, Cotonou, Benin.
   [Anyaele, Okorie] Univ Ibadan, Dept Zool, Entomol Unit, Ibadan, Nigeria.
   [Harris, Angela] Cayman Islands Govt, Mosquito Res & Control Unit, Grand Cayman, Cayman Islands.
   [Irish, Seth] London Sch Hyg & Trop Med, London, England.
   [Hlaing, Thaung] Minist Hlth, Med Entomol Res Div, Dept Med Res Lower Myanmar, Yangon, Myanmar.
   [Prakash, Anil] Minist H & FW Govt India, Natl Inst Res Environm Hlth, Bhopal, India.
RP Walton, C (corresponding author), Univ Manchester, Computat Evolutionary Biol Grp, Fac Life Sci, Manchester, Lancs, England.
EM Catherine.walton@manchester.ac.uk
RI Linton, Yvonne/AAG-2353-2019
OI Misinzo, Gerald/0000-0003-1827-6403; Bennett, Kelly/0000-0003-0330-5275
FU Natural Environment Research CouncilNERC Natural Environment Research
   Council [NE/H525170/1, NE/1528134/1, NE/J500057/1]; Royal SocietyRoyal
   Society of London; Leverhulme Trust AfricaLeverhulme Trust [AA110092];
   Natural Environment Research CouncilNERC Natural Environment Research
   Council [1097371]
FX The authors are grateful to field teams at the Uganda Virus Research
   Institute, International Institute for Tropical Agriculture, Vector
   Control Program for the Ministry of Health in Jamaica, Manatee County
   Mosquito District, Public Works Division in Miami-Dade County, The
   Florida Keys Mosquito District, Key West, and Dengue Branch of CDC in
   Puerto Rico and to Miriam Richards, Luke B. Mitchell and John Morgan for
   assistance with collection of mosquito samples. This work was supported
   by the Natural Environment Research Council (NE/H525170/1, NE/1528134/1,
   NE/J500057/1) and a Royal Society and Leverhulme Trust Africa Award
   (AA110092). This manuscript was prepared while YML held a National
   Research Council (NRC) Research Associateship Award at the Walter Reed
   Army Institute of Research. The material to be published reflects the
   views of the authors and should not be construed to represent those of
   the Department of the Army or the Department of Defense. The funders had
   no role in study design, data collection and analysis, decision to
   publish or preparation of the manuscript.
CR Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x
   Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x
   Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105
   Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70
   Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Braginets OP, 2003, AM J TROP MED HYG, V69, P303, DOI 10.4269/ajtmh.2003.69.303
   BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106
   Cathey JT, 2014, T ROY SOC TROP MED H, V108, P252, DOI 10.1093/trstmh/tru043
   Chadee DD, 1998, J AM MOSQUITO CONTR, V14, P5
   Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003
   Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401
   Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514
   Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54
   CRANDALL KA, 1993, GENETICS, V134, P959
   Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024
   Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128
   DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53
   DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   DIAMOND AW, 1980, J ZOOL, V191, P379
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x
   Eltis D, 2007, BRIEF OVERVIEW TRANS
   Eltis D, 1997, SLAVERY ABOLIT, V18, P16
   Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012
   Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x
   Fjeldsa J, 2007, J ORNITHOL, V148, pS359, DOI 10.1007/s10336-007-0179-4
   Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Fountain T, 2014, MOL ECOL, V23, P1071, DOI 10.1111/mec.12673
   Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118
   Giraldez Arturo, 2015, AGE TRADE MANILA GAL
   Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200
   GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680
   Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92
   HAMILTON AC, 1981, AFR J ECOL, V19, P1, DOI 10.1111/j.1365-2028.1981.tb00647.x
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hassanin A, 2015, CR BIOL, V338, P197, DOI 10.1016/j.crvi.2014.12.003
   Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388
   Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x
   Hewitt Godfrey M, 2004, Front Zool, V1, P4
   Hlaing T, 2010, EVOL APPL, V3, P319, DOI 10.1111/j.1752-4571.2009.00113.x
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Huang YM, 2004, ZOOTAXA, P1
   Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9
   Huhndorf MH, 2007, MOL ECOL, V16, P663, DOI 10.1111/j.1365-294X.2007.03153.x
   Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101
   Johnson MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-244
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Kadu CAC, 2013, ANN BOT-LONDON, V111, P47, DOI 10.1093/aob/mcs235
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x
   Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x
   Koffi KG, 2011, AM J BOT, V98, P254, DOI 10.3732/ajb.1000220
   Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205
   Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807
   Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104
   Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5
   Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613
   Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024
   Lehmann T, 2000, J HERED, V91, P165, DOI 10.1093/jhered/91.2.165
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   LIVAK KJ, 1984, GENETICS, V107, P611
   Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743
   Lorenzen ED, 2006, J HERED, V97, P119, DOI 10.1093/jhered/esj012
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lowe A. J., 2010, Tropical Plant Biology, V3, P50, DOI 10.1007/s12042-010-9045-2
   Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x
   MALEY J, 1991, CLIMATIC CHANGE, V19, P79, DOI 10.1007/BF00142216
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY PF, 1967, B WORLD HEALTH ORGAN, V36, P552
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   MCDONALD PT, 1977, J MED ENTOMOL, V14, P42, DOI 10.1093/jmedent/14.1.42
   Measey GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026606
   MESSING J, 1983, METHOD ENZYMOL, V101, P20
   Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   MORIYAMA EN, 1992, GENETICS, V130, P855
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Ngoagouni C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-175
   Nicolas V, 2008, MOL ECOL, V17, P5118, DOI 10.1111/j.1365-294X.2008.03974.x
   Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x
   Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032
   Olago DO, 2001, CLIMATE RES, V17, P105, DOI 10.3354/cr017105
   Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2
   Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Paupy C, 2008, J MED ENTOMOL, V45, P391, DOI 10.1603/0022-2585(2008)45[391:GFBDAS]2.0.CO;2
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016
   Petersen JL, 1977, BEHAV DIFFERENCES 2
   Plana V, 2004, MOL PHYLOGENET EVOL, V31, P449, DOI 10.1016/j.ympev.2003.08.023
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Qu YH, 2012, MOL ECOL, V21, P6117, DOI 10.1111/mec.12080
   Qu YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-174
   R Core Team, 2015, R LANG ENV STAT COMP
   RAY N, 2001, INTERNET ARCHAEOLOGY, V11
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003
   Roy MS, 1997, P ROY SOC B-BIOL SCI, V264, P1337, DOI 10.1098/rspb.1997.0185
   Sang R C, 2001, East Afr Med J, V78, P655
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Schurz WL, 1917, SW HIST Q, V21, P107
   Schurz WL, 1918, HISPANIC AM HIST REV, V1, P389, DOI 10.2307/2505890
   Sezonlin M, 2006, MOL ECOL, V15, P407, DOI 10.1111/j.1365-294X.2005.02761.x
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Smith TB, 2011, BIOL J LINN SOC, V103, P821, DOI 10.1111/j.1095-8312.2011.01674.x
   Sonsthagen SA, 2012, ECOL EVOL, V2, P1278, DOI 10.1002/ece3.240
   Sowilem MM, 2013, TROP BIOMED, V30, P301
   Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501
   Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x
   Surendran SN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-304
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI 10.1111/j.1558-5646.1979.tb04682.x
   TABACHNICK WJ, 1978, NATURE, V272, P535, DOI 10.1038/272535a0
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wagner P, 2008, J BIOGEOGR, V35, P1349, DOI 10.1111/j.1365-2699.2008.01883.x
   WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121
   Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   White VL, 2015, INSECT SCI, V22, P409, DOI 10.1111/1744-7917.12145
   Wilcox B. A., 2006, Unasylva (English ed.), V57, P11
   Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007
NR 147
TC 20
Z9 20
U1 0
U2 58
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD SEP
PY 2016
VL 25
IS 17
BP 4337
EP 4354
DI 10.1111/mec.13762
PG 18
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA DW0PS
UT WOS:000383343800016
PM 27439067
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Harrison, SC
AF Harrison, Stephen C.
TI Immunogenic cross-talk between dengue and Zika viruses
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
ID ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION
AB At least five recent papers have shown an unexpected antigenic relationship between Zika and dengue viruses, with potential implications for vaccines and therapeutics.
C1 [Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.
   [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA.
RP Harrison, SC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.; Harrison, SC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.
EM harrison@crystal.harvard.edu
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 14
TC 21
Z9 23
U1 0
U2 50
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2016
VL 17
IS 9
BP 1010
EP 1012
DI 10.1038/ni.3539
PG 3
WC Immunology
SC Immunology
GA DT9OO
UT WOS:000381832000003
PM 27540984
DA 2020-07-08
ER

PT J
AU Dejnirattisai, W
   Supasa, P
   Wongwiwat, W
   Rouvinski, A
   Barba-Spaeth, G
   Duangchinda, T
   Sakuntabhai, A
   Cao-Lormeau, VM
   Malasit, P
   Rey, FA
   Mongkolsapaya, J
   Screaton, GR
AF Dejnirattisai, Wanwisa
   Supasa, Piyada
   Wongwiwat, Wiyada
   Rouvinski, Alexander
   Barba-Spaeth, Giovanna
   Duangchinda, Thaneeya
   Sakuntabhai, Anavaj
   Cao-Lormeau, Van-Mai
   Malasit, Prida
   Rey, Felix A.
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
TI Dengue virus sero-cross-reactivity drives antibody-dependent enhancement
   of infection with zika virus
SO NATURE IMMUNOLOGY
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; CHIKUNGUNYA VIRUS; OUTBREAK; BRAZIL; BRAIN
AB Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The recent explosive outbreak of ZIKV in South America has led to widespread concern, with reports of neurological sequelae ranging from Guillain Barre syndrome to microcephaly. ZIKV infection has occurred in areas previously exposed to dengue virus (DENV), a flavivirus closely related to ZIKV. Here we investigated the serological cross-reaction between the two viruses. Plasma immune to DENV showed substantial cross-reaction to ZIKV and was able to drive antibody-dependent enhancement (ADE) of ZIKV infection. Using a panel of human monoclonal antibodies (mAbs) to DENV, we showed that most antibodies that reacted to DENV envelope protein also reacted to ZIKV. Antibodies to linear epitopes, including the immunodominant fusion-loop epitope, were able to bind ZIKV but were unable to neutralize the virus and instead promoted ADE. Our data indicate that immunity to DENV might drive greater ZIKV replication and have clear implications for disease pathogenesis and future vaccine programs for ZIKV and DENV.
C1 [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.
   [Supasa, Piyada; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
   [Supasa, Piyada] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med,Grad Program Immunol, Bangkok, Thailand.
   [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France.
   [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] CNRS UMR 3569 Virol, Paris, France.
   [Duangchinda, Thaneeya; Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand.
   [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
   [Sakuntabhai, Anavaj] CNRS URA3012, Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, France.
RP Mongkolsapaya, J; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
EM j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk
RI Rey, Felix/B-6497-2012; Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Rey,
   Felix/0000-0002-9953-7988; Barba Spaeth, Giovanna/0000-0003-2069-9501;
   Screaton, Gavin/0000-0002-3549-4309
FU Medical Research Council, UKMedical Research Council UK (MRC); Wellcome
   Trust, UKWellcome Trust; National Institute for Health Research
   Biomedical Research CentreNational Institute for Health Research (NIHR);
   European CommissionEuropean Commission Joint Research Centre [282 378];
   Laboratory of Excellence Integrative Biology of Emerging Infectious
   Diseases [ANR-10-LABX-62-IBEID]; Agence Nationale de la RechercheFrench
   National Research Agency (ANR) [FlaviStem/I1378]; Thailand Research Fund
   through the Royal Golden Jubilee PhD; Medical Research CouncilMedical
   Research Council UK (MRC) [G0600000, G0801508, G0400720]
FX We thank Armed Forces Research Institute of Medical Sciences, Thailand
   for Vero cells, C6/36 cells, mAb 4G2 to DENV envelope protein, and
   viruses DENV-1, DENV-2 and DENV-3; and M. Nguyen-De Bernon for technical
   assistance. Supported by the Medical Research Council, UK, the Wellcome
   Trust, UK (G.R.S.), the National Institute for Health Research
   Biomedical Research Centre, Funding Scheme, European Commission Seventh
   Framework Programme (FP7/2007-2013) for the DENFREE project (under grant
   agreement 282 378), Laboratory of Excellence Integrative Biology of
   Emerging Infectious Diseases (ANR-10-LABX-62-IBEID to F.A.R.), Agence
   Nationale de la Recherche (FlaviStem/I1378 to F.A.R.) and the Thailand
   Research Fund through the Royal Golden Jubilee PhD (P.S. and J.M.).
CR Barba-Spaeth G., NATURE IN PRESS
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRANDT WE, 1982, INFECT IMMUN, V36, P1036, DOI 10.1128/IAI.36.3.1036-1041.1982
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J., 2016, CELL STEM CELL, DOI [10.1016/jstem.2016.04.014, DOI 10.1016/JSTEM.2016.04.014]
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2016, ZIK EM
   World Health Organization (WHO), 2016, DENG VACC
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 47
TC 457
Z9 469
U1 14
U2 126
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2016
VL 17
IS 9
BP 1102
EP 1108
DI 10.1038/ni.3515
PG 7
WC Immunology
SC Immunology
GA DT9OO
UT WOS:000381832000014
PM 27339099
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Riley, S
AF Riley, Steven
TI Making high-res Zika maps
SO NATURE MICROBIOLOGY
LA English
DT News Item
C1 [Riley, Steven] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
RP Riley, S (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
EM s.riley@imperial.ac.uk
OI Riley, Steven/0000-0001-7904-4804
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K010174/1B, MR/K010174/1, 1109359]; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/J008761/1]
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Ferguson N. M., 2016, SCIENCE
   Franca G. V. A., 2016, LANCET
   Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kucharski A. J, 2016, PLOS NEGL TROP DIS, V10
   Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mordecai E., 2016, PREPRINT
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
NR 13
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD SEP
PY 2016
VL 1
IS 9
AR 16157
DI 10.1038/NMICROBIOL.2016.157
PG 2
WC Microbiology
SC Microbiology
GA DW4KB
UT WOS:000383610500011
PM 27562269
OA Bronze
DA 2020-07-08
ER

PT J
AU Brown, WC
   Akey, DL
   Konwerski, JR
   Tarrasch, JT
   Skiniotis, G
   Kuhn, RJ
   Smith, JL
AF Brown, W. Clay
   Akey, David L.
   Konwerski, Jamie R.
   Tarrasch, Jeffrey T.
   Skiniotis, Georgios
   Kuhn, Richard J.
   Smith, Janet L.
TI Extended surface for membrane association in Zika virus NS1 structure
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
AB The Zika virus, which has been implicated in an increase in neonatal microcephaly and Guillain-Barre syndrome, has spread rapidly through tropical regions of the world. The virulence protein NS1 functions in genome replication and host immune-system modulation. Here, we report the crystal structure of full-length Zika virus NS1, revealing an elongated hydrophobic surface for membrane association and a polar surface that varies substantially among flaviviruses.
C1 [Brown, W. Clay; Akey, David L.; Konwerski, Jamie R.; Tarrasch, Jeffrey T.; Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.
   [Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Smith, JL (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.
EM janetsmith@umich.edu
FU Margaret J. Hunter Collegiate Professorship in the Life Sciences;
   University of Michigan Life Sciences Institute; NIH National Institute
   of General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [AGM-12006]; National Cancer
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [ACB-12002];  [DE-AC02-06CH11357]
FX The work described in this report was supported by a Margaret J. Hunter
   Collegiate Professorship in the Life Sciences to J.L.S. and by the
   University of Michigan Life Sciences Institute. GM/CA@APS is supported
   by the NIH National Institute of General Medical Sciences (AGM-12006)
   and the National Cancer Institute (ACB-12002). The Advanced Photon
   Source is a US Department of Energy (DOE) Office of Science User
   Facility operated by Argonne National Laboratory under contract no.
   DE-AC02-06CH11357.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
NR 20
TC 69
Z9 74
U1 1
U2 31
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD SEP
PY 2016
VL 23
IS 9
BP 865
EP 867
DI 10.1038/nsmb.3268
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DV1WL
UT WOS:000382712700016
PM 27455458
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Hall-Mendelin, S
   Pyke, AT
   Moore, PR
   Mackay, IM
   McMahon, JL
   Ritchie, SA
   Taylor, CT
   Moore, FAJ
   van den Hurk, AF
AF Hall-Mendelin, Sonja
   Pyke, Alyssa T.
   Moore, Peter R.
   Mackay, Ian M.
   McMahon, Jamie L.
   Ritchie, Scott A.
   Taylor, Carmel T.
   Moore, Frederick A. J.
   van den Hurk, Andrew F.
TI Assessment of Local Mosquito Species Incriminates Aedes aegypti as the
   Potential Vector of Zika Virus in Australia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID YELLOW-FEVER VIRUS; DIPTERA-CULICIDAE; ORAL INFECTION; DENGUE VIRUS;
   TRANSMISSION; SUSCEPTIBILITY; COMPETENCE; IDENTIFICATION; QUEENSLAND;
   ISOLATIONS
AB Background
   Within the last 10 years Zika virus (ZIKV) has caused unprecedented epidemics of human disease in the nations and territories of the western Pacific and South America, and continues to escalate in both endemic and non-endemic regions. We evaluated the vector competence of Australian mosquitoes for ZIKV to assess their potential role in virus transmission.
   Methodology/Principal Findings
   Mosquitoes were exposed to infectious blood meals containing the prototype African ZIKV strain. After 14 days incubation at 28 degrees C and high relative humidity, infection, dissemination and transmission rates were assessed. Infection in Culex annulirostris and Cx. sitiens could not be detected. 8% of Cx. quinquefasciatus were infected, but the virus did not disseminate in this species. Despite having infection rates >50%, Aedes notoscriptus and Ae. vigilax did not transmit ZIKV. In contrast, Ae. aegypti had infection and transmission rates of 57% and 27%, respectively. In susceptibility trials, the virus dose required to infect 50% (ID50) of Ae. aegypti was 10(6.4) tissue culture infectious dose(50) (TCID50)/mL. Additionally, a threshold viral load within the mosquito of at least 10(5.1) TCID50 equivalents/mL had to be reached before virus transmission occurred.
   Conclusions/Significance
   We confirmed Ae. aegypti to be the most likely mosquito vector of ZIKV in Australia, although the restricted distribution of this species will limit the receptive zone to northern Queensland where this species occurs. Importantly, the role in ZIKV transmission of Culex and other Aedes spp. tested will be negligible. Despite being the implicated vector, the relatively high ID50 and need for a high titer disseminated infection in Ae. aegypti suggest that high mosquito population densities will be required to facilitate epidemic ZIKV transmission among the currently immunologically naive human population in Australia.
C1 [Hall-Mendelin, Sonja; Pyke, Alyssa T.; Moore, Peter R.; Mackay, Ian M.; McMahon, Jamie L.; Taylor, Carmel T.; Moore, Frederick A. J.; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Australia.
   [Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.
RP van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Australia.
EM andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019; Mackay, Ian M./B-2537-2010
OI van den Hurk, Andrew/0000-0001-6262-831X; Taylor,
   Carmel/0000-0001-6283-2695; Pyke, Alyssa/0000-0003-3512-4321; Mackay,
   Ian M./0000-0003-3598-2350; McMahon, Jamie/0000-0002-9304-1500
FU internal Forensic and Scientific Services research and development
   project grant [RSS15-003]; National Health and Medical Research Council
   Senior Research FellowshipNational Health and Medical Research Council
   of Australia [1044698]
FX This study was funded by an internal Forensic and Scientific Services
   research and development project grant (number RSS15-003). S. Ritchie is
   funded by National Health and Medical Research Council Senior Research
   Fellowship 1044698. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Department of Health Australian Government, 2016, SITREP 32 ZIK, DOI [10.1177/136345931561902126621264, DOI 10.1177/1363459315619021]
   Department of Health Queensland Government, 2015, QUEENSLAND DENGUE MA
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frances SP, 2009, J AM MOSQUITO CONTR, V25, P511, DOI 10.2987/Moco-09-5938.1
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prada P, 2016, RES INDICATES ANOTHE
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith G, 2006, J VIROL METHODS, V135, P229, DOI 10.1016/j.jviromet.2006.03.007
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061
   van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, SITUATION REPORT ZIK
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
NR 44
TC 49
Z9 50
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004959
DI 10.1371/journal.pntd.0004959
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900027
PM 27643685
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Richard, V
   Paoaafaite, T
   Cao-Lormeau, VM
AF Richard, Vaea
   Paoaafaite, Tuterarii
   Cao-Lormeau, Van-Mai
TI Vector Competence of French Polynesian Aedes aegypti and Aedes
   polynesiensis for Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOSQUITOS DIPTERA; TRANSMISSION; CHIKUNGUNYA; DENGUE; CULICIDAE
AB Background
   In 2013-2014, French Polynesia experienced for the first time a Zika outbreak. Two Aedes mosquitoes may have contributed to Zika virus (ZIKV) transmission in French Polynesia: the worldwide distributed Ae. aegypti and the Polynesian islands-endemic Ae. polynesiensis mosquito.
   Methodology/Principal Findings
   To evaluate their vector competence for ZIKV, mosquitoes were infected per os at viral titers of 7 logs tissue culture infectious dose 50%. At several days post-infection (dpi), saliva was collected from each mosquito and inoculated onto C6/36 mosquito cells to check for the presence of ZIKV infectious particles. Legs and body of each mosquito were also collected and submitted separately to RNA extraction and ZIKV RT-PCR. In Ae. aegypti the infection rate was high as early as 6 dpi and the dissemination efficiency get substantial from 9 dpi while the both rates remained quite low in Ae. polynesiensis. The transmission efficiency was poor in Ae. aegypti until 14 dpi and no infectious saliva was found in Ae. polynesiensis at the time points studied.
   Conclusions/Significance
   In our experimental conditions, the late ability of the French Polynesian Ae. aegypti to transmit ZIKV added by the poor competence of Ae. polynesiensis for this virus suggest the possible contribution of another vector for the propagation of ZIKV during the outbreak, in particular in remote islands where Ae. polynesiensis is predominating.
C1 [Richard, Vaea; Paoaafaite, Tuterarii; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, France.
RP Richard, V (corresponding author), Inst Louis Malarde, Papeete, France.
EM vrichard@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Richard,
   Vaea/0000-0001-8132-0740
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doggett S.L., 2001, Arbovirus Research in Australia, V8, P126
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379, DOI 10.1093/oxfordjournals.aje.a120748
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1303, DOI 10.4269/ajtmh.1981.30.1303
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2007, REV MED VIROL, V17, P327, DOI 10.1002/rmv.545
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marie J, 2013, J MED ENTOMOL, V50, P37, DOI 10.1603/ME12170
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   ROSEN L, 1954, AM J TROP MED HYG, V3, P878, DOI 10.4269/ajtmh.1954.3.878
   Van den Hurk AF, 2007, J MED ENTOMOL, V44, P845, DOI 10.1603/0022-2585(2007)44[845:EOFDSF]2.0.CO;2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, ZIK VIR FACT SHEET
NR 27
TC 46
Z9 48
U1 2
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0005024
DI 10.1371/journal.pntd.0005024
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900064
PM 27654962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sironi, M
   Forni, D
   Clerici, M
   Cagliani, R
AF Sironi, Manuela
   Forni, Diego
   Clerici, Mario
   Cagliani, Rachele
TI Nonstructural Proteins Are Preferential Positive Selection Targets in
   Zika Virus and Related Flaviviruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; NS1 PROTEIN;
   SUBSTITUTION SATURATION; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; VIRAL
   REPLICATION; NS4B PROTEIN; MOUSE MODEL
AB The Flavivirus genus comprises several human pathogens such as dengue virus (DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV). Although ZIKV usually causes mild symptoms, growing evidence is linking it to congenital birth defects and to increased risk of Guillain-Barre syndrome. ZIKV encodes a polyprotein that is processed to produce three structural and seven nonstructural (NS) proteins. We investigated the evolution of the viral polyprotein in ZIKV and in related flaviviruses (DENV, Spondweni virus, and Kedougou virus). After accounting for saturation issues, alignment uncertainties, and recombination, we found evidence of episodic positive selection on the branch that separates DENV from the other flaviviruses. NS1 emerged as the major selection target, and selected sites were located in immune epitopes or in functionally important protein regions. Three of these sites are located in an NS1 region that interacts with structural proteins and is essential for virion biogenesis. Analysis of the more recent evolutionary history of ZIKV lineages indicated that positive selection acted on NS5 and NS4B, this latter representing the preferential target. All selected sites were located in the N-terminal portion of NS4B, which inhibits interferon response. One of the positively selected sites (26M/I/T/V) in ZIKV also represents a selection target in sylvatic DENV2 isolates, and a nearby residue evolves adaptively in JEV. Two additional positively selected sites are within a protein region that interacts with host (e.g. STING) and viral (i.e. NS1, NS4A) proteins. Notably, mutations in the NS4B region of other flaviviruses modulate neurovirulence and/or neuroinvasiveness. These results suggest that the positively selected sites we identified modulate viral replication and contribute to immune evasion. These sites should be prioritized in future experimental studies. However, analyses herein detected no selective events associated to the spread of the Asian/American ZIKV lineage.
C1 [Sironi, Manuela; Forni, Diego; Cagliani, Rachele] Sci Inst IRCCS E MEDEA, Bioinformat, Bosisio Parini, Italy.
   [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, Milan, Italy.
   [Clerici, Mario] Don C Gnocchi Fdn ONLUS, IRCCS, Milan, Italy.
RP Cagliani, R (corresponding author), Sci Inst IRCCS E MEDEA, Bioinformat, Bosisio Parini, Italy.
EM rachele.cagliani@bp.lnf.it
RI Forni, Diego/K-5643-2016; Forni, Diego/AAA-1648-2020; Cagliani,
   Rachele/K-4545-2016; sironi, manuela/AAH-5456-2019
OI Forni, Diego/0000-0001-9291-5352; Forni, Diego/0000-0001-9291-5352;
   Cagliani, Rachele/0000-0003-2670-3532; sironi,
   manuela/0000-0002-2267-5266
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Anisimova M, 2003, GENETICS, V164, P1229
   Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Brasil P, 2016, N ENGL J MED
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Calvet G., 2016, LANCET INFECT DIS
   Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009
   Cao-Lormeau V. M., 2016, LANCET
   Carney J, 2012, ARCH VIROL, V157, P75, DOI 10.1007/s00705-011-1143-4
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dash PK, 2013, BIOCHEM BIOPH RES CO, V436, P478, DOI 10.1016/j.bbrc.2013.05.130
   Faria NR, 2016, SCIENCE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062
   Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63
   Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Lee TH, 2012, J GEN VIROL, V93, P20, DOI 10.1099/vir.0.036640-0
   Li YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-135
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102
   Maringer K, 2014, CYTOKINE GROWTH F R, V25, P669, DOI 10.1016/j.cytogfr.2014.08.004
   Mathew A, 2014, FUTURE MICROBIOL, V9, P411, DOI 10.2217/fmb.13.171
   Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison CR, 2014, VIROLOGY, V456, P96, DOI 10.1016/j.virol.2014.03.017
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Murphy BR, 2004, LANCET, V364, P499, DOI 10.1016/S0140-6736(04)16801-3
   Murrell B., 2015, MOL BIOL EVOL
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Petersen L.R., 2016, N ENGL J MED
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Theze J, 2015, GENOME BIOL EVOL, V7, P2996, DOI 10.1093/gbe/evv202
   Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weaver SC, 2016, ANTIVIRAL RES
   Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565
   Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3
   Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 75
TC 25
Z9 25
U1 1
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004978
DI 10.1371/journal.pntd.0004978
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900037
PM 27588756
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU May, M
   Relich, RF
AF May, Meghan
   Relich, Ryan F.
TI A Comprehensive Systems Biology Approach to Studying Zika Virus
SO PLOS ONE
LA English
DT Article
ID WEST-NILE-VIRUS; INFECTION; TRANSMISSION; SERVER; FLAVIVIRUSES;
   MOSQUITOS; SELECTON; AMERICA; STRAINS; VECTOR
AB Zika virus (ZIKV) is responsible for an ongoing and intensifying epidemic in the Western Hemisphere. We examined the complete predicted proteomes, glycomes, and selectomes of 33 ZIKV strains representing temporally diverse members of the African lineage, the Asian lineage, and the current outbreak in the Americas. Derivation of the complete selectome is an 'omics' approach to identify distinct evolutionary pressures acting on different features of an organism. Employment of the M8 model did not show evidence of global diversifying selection acting on the ZIKV polyprotein; however, a mixed effect model of evolution showed strong evidence (P<0.05) for episodic diversifying selection acting on specific sites. Single nucleotide polymorphisms (SNPs) were predictably frequent across strains relative to the derived consensus sequence. None of the 9 published detection procedures utilize targets that share 100% identity across the 33 strains examined, indicating that ZIKV escape from molecular detection is predictable. The predicted O-linked glycome showed marked diversity across strains; however, the N-linked glycome was highly stable. All Asian and American strains examined were predicted to include glycosylation of E protein ASN(154), a modification proposed to mediate neurotropism, whereas the modification was not predicted for African strains. SNP diversity, episodic diversifying selection, and differential glycosylation, particularly of ASN(154), may have major biological implications for ZIKV disease. Taken together, the systems biology perspective of ZIKV indicates: a.) The recently emergent Asian/American N-glycotype is mediating the new and emerging neuropathogenic potential of ZIKV; and b.) further divergence at specific sites is predictable as endemnicity is established in the Americas.
C1 [May, Meghan] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.
   [May, Meghan] Seacoast Biomed Sci Inst, York, ME 03911 USA.
   [Relich, Ryan F.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.
RP May, M (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.; May, M (corresponding author), Seacoast Biomed Sci Inst, York, ME 03911 USA.
EM mmay3@une.edu
FU sbsi-innovation-fund/parny
FX This work was supported by the following source of funding:
   http://www.seacoastbiomedicalscience.org/#!sbsi-innovation-fund/parny
   (MM). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Ayres CFJ, 2016, LANCET, V16
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2013, GENOME ANNOUNC, V2
   Beasley DWC, 2005, CURR MOL MED, V5, P835, DOI 10.2174/156652405774962272
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI 10.1093/nar/gkt1030
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Cauchemez S, 2016, LANCET
   Chauhan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067008
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR MORB MORTAL WKL
   Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, 1 DETECTION IN PRESS
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Gardner LM, 2016, LANCET INFECT DIS
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   May M, 2008, MICROB PATHOGENESIS, V45, P38, DOI 10.1016/j.micpath.2008.02.002
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029
   Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rasmussen SA, 2016, N ENGL J MED
   Robinson O, 2016, MOL BIOL EVOLUTION
   Roze B, 2016, EURO SURVEILL, P21
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang H, 2016, CELL STEM CELL
   Tappe D, 2013, EURO SURVEILL, V19
   Thiery G, 2016, INTENSIVE CARE MED
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WOLFE MS, 1982, LANCET, V2, P1306
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, ZIK VIR FACT SHEET
   Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 68
TC 8
Z9 8
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 1
PY 2016
VL 11
IS 9
AR e0161355
DI 10.1371/journal.pone.0161355
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV3WN
UT WOS:000382855600023
PM 27584813
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vouga, M
   Baud, D
AF Vouga, Manon
   Baud, David
TI Imaging of congenital Zika virus infection: the route to identification
   of prognostic factors
SO PRENATAL DIAGNOSIS
LA English
DT Review
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOMEGALOVIRUS-INFECTION;
   PRENATAL-DIAGNOSIS; HEAD CIRCUMFERENCE; FETAL ULTRASOUND; PREGNANCY;
   TRANSMISSION; OUTBREAK; WOMEN; RISK
AB Zika virus (ZIKV) has recently emerged as a novel teratogenic agent associated with severe neurological complications. The risk associated with maternal infection remains to be exactly defined but appears to be significant. Like other TORCH agents (toxoplasmosis, other agents, rubella, cytomegalovirus and herpes simplex), it is unlikely that all affected fetuses will be symptomatic at birth. It is therefore urgent to better define the spectrum of anomalies observed in infected fetuses to provide adequate parental counseling. In this review, we provide a comprehensive analysis of major cases described to date and highlight specific prenatal and postnatal radiological findings of congenital ZIKV infection. A total of 19 reports were included in our analysis. ZIKV seemed to harbor a specific tropism for the central nervous system, and anomalies were mostly limited to the brain. Major radiological findings were ventriculomegaly, diffuse calcifications and signs of abnormal gyration as well as cortical development. In addition, a significant number of fetuses suffered from intra uterine growth restriction. Based on these findings, we provide recommendations for adequate radiological monitoring of at-risk pregnancies. (c) 2016 John Wiley & Sons, Ltd.
C1 [Vouga, Manon] Univ Hosp, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, Matern, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
RP Baud, D (corresponding author), Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne Hosp, Lausanne, Switzerland.
EM david.baud@chuv.ch
OI Baud, David/0000-0001-9914-6496
FU 'Fondation Leenaards' through the 'Bourse pour la releve academique';
   Divesa Foundation; Swiss National Science Foundation (SNSF)Swiss
   National Science Foundation (SNSF) [310030-156169]; MD-PhD grant by the
   Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [323530_158123]
FX David Baud is supported by the 'Fondation Leenaards' through the 'Bourse
   pour la releve academique', the Divesa Foundation and the Swiss National
   Science Foundation (SNSF n310030-156169). Manon Vouga is funded through
   the MD-PhD grant by the Swiss National Science Foundation (SNSF) (no.
   323530_158123).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Beke A, 2011, PRENATAL DIAG, V31, P945, DOI 10.1002/pd.2762
   Benoist G, 2008, ULTRASOUND OBST GYN, V32, P900, DOI 10.1002/uog.6129
   BERREBI A, 1994, LANCET, V344, P36, DOI 10.1016/S0140-6736(94)91054-5
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention, 2016, ZIK TRAV INF
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cuiller F, CASE WEEK 168
   Culjat M, 2016, CLIN INFECT DIS
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Denis D, 2001, FETAL DIAGN THER, V16, P354, DOI 10.1159/000053940
   Dhombres F, 2017, FETAL DIAGN THER, V41, P8, DOI 10.1159/000445113
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Engels AC, 2016, PRENATAL DIAG, V36, P266, DOI 10.1002/pd.4770
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Jaenisch T, 2016, B WORLD HEALTH ORGAN, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Lim J, 2013, PRENATAL DIAG, V33, P863, DOI 10.1002/pd.4145
   Liuzzi G, 2016, EUR J INTERN MED, V33, pE20, DOI 10.1016/j.ejim.2016.04.022
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P447, DOI 10.1046/j.1469-0705.2002.00840.x
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Panchaud A, 2016, LANCET INFE IN PRESS
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Razek AAKA, 2009, AM J NEURORADIOL, V30, P4, DOI 10.3174/ajnr.A1223
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rubod C, 2005, PRENATAL DIAG, V25, P1181, DOI 10.1002/pd.1133
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scala C, 2017, ULTRASOUND OBST GYN, V49, P450, DOI 10.1002/uog.15943
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Van Mieghem T, 2015, CURR OPIN OBSTET GYN, V27, P143, DOI 10.1097/GCO.0000000000000161
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4
NR 86
TC 34
Z9 34
U1 0
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD SEP
PY 2016
VL 36
IS 9
BP 799
EP 811
DI 10.1002/pd.4880
PG 13
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA DX1AB
UT WOS:000384096800001
PM 27481629
DA 2020-07-08
ER

PT J
AU Munoz, LS
   Barreras, P
   Pardo, CA
AF Munoz, Laura S.
   Barreras, Paula
   Pardo, Carlos A.
TI Zika Virus-Associated Neurological Disease in the Adult: Guillain-Barre
   Syndrome, Encephalitis, and Myelitis
SO SEMINARS IN REPRODUCTIVE MEDICINE
LA English
DT Article
DE ZIKV; GBS; encephalitis; myelitis; adult
ID CASE DEFINITIONS; INFECTION; OUTBREAK; MICE; AUTOIMMUNITY; PREGNANCY;
   ORGANOIDS; BRAZIL
AB Zika virus (ZIKV) has caused a major infection outbreak in the Americas since 2015. In parallel with the ZIKV epidemic, an increase in cases of neurological disorders which include Guillain-Barre syndrome (GBS), encephalitis, and myelitis have been linked to the infection. We reviewed the evidence suggesting a relationship between ZIKV and neurological disorders in adults. A search of the literature supporting such link included databases such as PubMed and the World Health Organization (WHO) surveillance system. Through June 1, 2016, 761 publications were available on PubMed using the search word "Zika." Among those publications as well as surveillance reports released by the WHO and other health organizations, 20 articles linked ZIKV with neurological complications other than microcephaly. They corresponded to population and surveillance studies (n = 7), case reports (n = 9), case series (n = 3), and case-control studies (n = 1). Articles were also included if they provided information related to possible mechanisms of ZIKV neuropathogenesis. Evidence based on epidemiological and virological information supports the hypothesis that ZIKV infection is associated with GBS. Although cases of encephalopathy and myelitis have also been linked to ZIKV infection, the evidence is scarce and there is a need for virological, epidemiological, and controlled studies to better characterize such relationship.
C1 [Munoz, Laura S.; Barreras, Paula; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, 600 North Wolfe St,627 Pathol Bldg, Baltimore, MD 21287 USA.
RP Pardo, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 North Wolfe St,627 Pathol Bldg, Baltimore, MD 21287 USA.
EM cpardovl@jhmi.edu
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335; Munoz Arcos, Laura
   Sofia/0000-0002-0229-9056
FU Bart McLean Fund for Neuroimmunology Research; Johns Hopkins Project
   Restore 20
FX We would like to thank the Bart McLean Fund for Neuroimmunology Research
   and Johns Hopkins Project Restore 20 for their support.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Craig AT, 2016, B WHO
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2015, INFECTION, DOI [DOI 10.1007/S15010-016-0906-Y, 10.1007/s15010-016-0906-y]
   ECDC, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Knipe D.M., 2013, FIELDS VIROLOGY
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization (PAHO)/ World Health Organization (WHO), 2016, ZIK EP UPD
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   Roze B, 2016, EURO SURVEILL, P21
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   Correa ARV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143391
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison HJ, 2016, LANCET
NR 47
TC 33
Z9 35
U1 2
U2 38
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1526-8004
EI 1526-4564
J9 SEMIN REPROD MED
JI Semin. Reprod. Med.
PD SEP
PY 2016
VL 34
IS 5
BP 273
EP 279
DI 10.1055/s-0036-1592066
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DZ2SB
UT WOS:000385690400006
PM 27612158
OA Bronze
DA 2020-07-08
ER

PT J
AU Quwaider, M
   Jararweh, Y
AF Quwaider, Muhannad
   Jararweh, Yaser
TI Multi-tier cloud infrastructure support for reliable global health
   awareness system
SO SIMULATION MODELLING PRACTICE AND THEORY
LA English
DT Article
DE Global health awareness system; Cloud computing; Multi-tier cloud;
   MapReduce; Processing delay
ID DATA-COLLECTION
AB The exceptional outbreaks of a number of epidemic diseases such as Ebola, SARS, Zika and H1N1 and their wide distribution over multiple regions calls for a reliable global health awareness system. This system is needed to achieve early detection of such emergencies. Furthermore, such health awareness system should be capable of predicting the outbreaks patterns to facilitate future countermeasure planning. This health awareness system should cover large scale regions that can be extended to multiple countries, continents and ultimately the globe. Many advanced and industrial countries are still struggling in building such system effectively even with the availability of resources and domain experts. The realization of a reliable health awareness system is accompanied with multiple challenges such as the availability of resources and experts, the global agreements about the system from the legislative and control point of view and the availability of the infrastructure that will support the system functionality with a reasonable cost. This paper presents a novel global health awareness system that overcomes the aforementioned challenges. The system is exploiting the emerging cloud computing services availability over the globe. To handle the large scale requirements, we introduce a multi-tier based cloud system that spans over four tiers starting from the monitored subjects to a centralized global cloud system. Also, we present a mixed integer optimization formulation to tackle the issues related to the latency of detecting outbreaks. Our results show that processing the data in multi-tier health awareness system will reduce the overall delay significantly and enable efficient health data sharing. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Quwaider, Muhannad; Jararweh, Yaser] Jordan Univ Sci & Technol, Irbid, Jordan.
RP Quwaider, M (corresponding author), Jordan Univ Sci & Technol, Irbid, Jordan.
EM mqquwaider@just.edu.jo
OI Jararweh, Yaser/0000-0002-4403-3846
FU Research Deanship at Jordan University of Science and Technology
   [20130179, 20150050]
FX This Project is supported by Research Deanship at Jordan University of
   Science and Technology, Grant nos. 20130179 and 20150050.
CR Balani R., 2007, ENERGY CONSUMPTION A
   Bernstein D, 2009, 2009 FOURTH INTERNATIONAL CONFERENCE ON INTERNET AND WEB APPLICATIONS AND SERVICES, P328, DOI 10.1109/ICIW.2009.55
   Biswas S., 2008, P 2 IEEE INT C BIOM, P1
   Bonomi F., 2012, P 1 ED MCC WORKSH MO, P13, DOI [10.1145/2342509.2342513, DOI 10.1145/2342509.2342513]
   Bonomi F., 2014, BIG DATA INTERNET TH, P169, DOI DOI 10.1007/978-3-319-05029-4_7
   Buyya R, 2008, HPCC 2008: 10TH IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, PROCEEDINGS, P5, DOI 10.1109/HPCC.2008.172
   Buyya R, 2010, LECT NOTES COMPUT SC, V6081, P13
   Calain P, 2007, HEALTH POLICY PLANN, V22, P2, DOI 10.1093/heapol/czl034
   Cecchine G, 2006, INFECT DIS NATL SECU
   Celesti Antonio, 2010, 2010 IEEE 3rd International Conference on Cloud Computing (CLOUD 2010), P337, DOI 10.1109/CLOUD.2010.46
   Cenciarelli O., 2015, INT J MICROBIOL, V2015
   Dementyev A, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON RFID (RFID), P1, DOI 10.1109/RFID.2013.6548128
   Fan XB, 2007, CONF PROC INT SYMP C, P13, DOI 10.1145/1273440.1250665
   Fernandez-Cardenosa G, 2012, J MED SYST, V36, P3777, DOI 10.1007/s10916-012-9850-2
   Ferrer AJ, 2012, FUTURE GENER COMP SY, V28, P66, DOI 10.1016/j.future.2011.05.022
   Grozev N, 2014, SOFTWARE PRACT EXPER, V44, P369, DOI 10.1002/spe.2168
   Gubbi J, 2013, FUTURE GENER COMP SY, V29, P1645, DOI 10.1016/j.future.2013.01.010
   Hu.gov, H5N1 AV FLU H5N1 BIR
   Jackson KR, 2010, CLOUD COMP TECHN SCI, P159, DOI [10. 1109/CloudCom. 2010. 69, DOI 10.1109/CLOUDCOM.2010.69]
   Jararweh Y, 2014, SIMUL MODEL PRACT TH, V49, P180, DOI 10.1016/j.simpat.2014.09.003
   Jin C, 2009, LECT NOTES COMPUT SC, V5704, P417
   JOSEPH DA, 2004, P 2 ACM INT WORKSH W, P127
   Jovanov E, 2005, P ANN INT IEEE EMBS, P3810, DOI 10.1109/IEMBS.2005.1615290
   Kossmann D., 2010, P 2010 ACM SIGMOD IN, P579, DOI DOI 10.1145/1807167.1807231
   Lee KH, 2011, SIGMOD REC, V40, P11, DOI 10.1145/2094114.2094118
   Li A., 2010, P 10 ACM SIGC C INT, P1, DOI DOI 10.1145/1879141.1879143
   Nagakura H, 2011, FUJITSU SCI TECH J, V47, P263
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Quwaider M, 2014, 2014 5 INT C INF COM, P1
   QUWAIDER M, 2015, BMC BIOINFORMATICS, V52, P1147
   Quwaider M., 2013, P 8 INT C BOD AR NET, P148
   Quwaider M, 2013, INT CONF INTERNET, P137, DOI 10.1109/ICIST.2013.6747527
   Quwaider M, 2016, PERVASIVE MOB COMPUT, V28, P35, DOI 10.1016/j.pmcj.2015.07.012
   Quwaider M, 2015, SIMUL MODEL PRACT TH, V50, P57, DOI 10.1016/j.simpat.2014.06.015
   Rallapalli S, 2016, SMART INNOV SYST TEC, V43, P143, DOI 10.1007/978-81-322-2538-6_15
   Rochwerger B, 2009, IBM J RES DEV, V53, DOI 10.1147/JRD.2009.5429058
   Rolim CO, 2010, SECOND INTERNATIONAL CONFERENCE ON EHEALTH, TELEMEDICINE, AND SOCIAL MEDICINE: ETELEMED 2010, PROCEEDINGS, P95, DOI 10.1109/eTELEMED.2010.19
   Shiratori T, 2011, FUJITSU SCI TECH J, V47, P311
   Soror AA, 2010, ACM T DATABASE SYST, V35, DOI 10.1145/1670243.1670250
   St Louis Michael, 2012, MMWR Suppl, V61, P15
   STURGUL J, 2000, MINE DESIGN EXAMPLES
   Wagener J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-279
NR 42
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-190X
EI 1878-1462
J9 SIMUL MODEL PRACT TH
JI Simul. Model. Pract. Theory
PD SEP
PY 2016
VL 67
BP 44
EP 58
DI 10.1016/j.simpat.2016.06.005
PG 15
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering
SC Computer Science
GA DU6EP
UT WOS:000382307100004
PM 32518536
OA Green Published
DA 2020-07-08
ER

PT J
AU Bakkour, S
   Gao, K
   Lu, K
   Deng, X
   Simmons, G
   Stone, M
   Lanteri, MC
   Sabino, EC
   Linnen, JM
   Busch, M
AF Bakkour, S.
   Gao, K.
   Lu, K.
   Deng, X.
   Simmons, G.
   Stone, M.
   Lanteri, M. C.
   Sabino, E. C.
   Linnen, J. M.
   Busch, M.
TI Clinical Performance of Hologic/Grifols NAT and CDC Real-Time PCR Assays
   for Detection of Zika Virus
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 22-25, 2016
CL Orlando, FL
SP AABB
C1 [Bakkour, S.; Lu, K.; Deng, X.; Simmons, G.; Stone, M.; Lanteri, M. C.; Busch, M.] Blood Syst Res Inst, San Francisco, CA USA.
   [Gao, K.; Linnen, J. M.] Hologic Inc, San Francisco, CA USA.
   [Simmons, G.; Lanteri, M. C.; Busch, M.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Sabino, E. C.] Univ Sao Paulo, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2016
VL 56
SU 4
SI SI
MA S15-010C
BP 11A
EP 11A
PG 1
WC Hematology
SC Hematology
GA DX8NS
UT WOS:000384646400022
DA 2020-07-08
ER

PT J
AU de Magalhaes-Barbosa, MC
   Prata-Barbosa, A
   Robaina, JR
   Raymundo, CE
   Lima-Setta, F
   da Cunha, AJLA
AF de Magalhaes-Barbosa, Maria Clara
   Prata-Barbosa, Arnaldo
   Robaina, Jaqueline Rodrigues
   Raymundo, Carlos Eduardo
   Lima-Setta, Fernanda
   Ledo Alves da Cunha, Antonio Jose
TI Trends of the microcephaly and Zika virus outbreak in Brazil,
   January-July 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Zika virus; Microcephaly; Congenital abnormalities; Outbreak
AB In the last two months, there have been indications that the Zika virus epidemic is on the decline in Brazil. We reviewed the surveillance data published by the Brazilian Ministry of Health to assess trends of microcephaly and neurological abnormalities suggestive of congenital infection, as well as Zika virus disease in Brazil as a whole and its various regions. From November 2015 to July 2016, 8301 cases of microcephaly were reported in Brazil, mainly in the Northeast region. The number of newly reported cases is declining throughout the country, except in the Southeast region. The numbers of cases that remain under investigation still represent 37.7% of all reported cases in early July. Meanwhile, from January to June, 2016, 165,241 cases of Zika virus disease were reported in Brazil. The state of Rio de Janeiro (South. east) experienced the third highest incidence, lagging behind only the states of Bahia (Northeast) and Mato Grosso (Midwest). In early June, the number of new Zika virus cases showed a marked decline in all of the regions, except the North. Although the Zika epidemic seems to be diminishing, continued monitoring and surveillance of reported microcephaly and neurological abnormality cases is essential, and investigation efforts need to be vastly improved, as some states still reported high incidences of Zika disease in the first half of 2016. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [de Magalhaes-Barbosa, Maria Clara; Prata-Barbosa, Arnaldo; Robaina, Jaqueline Rodrigues; Raymundo, Carlos Eduardo; Lima-Setta, Fernanda] Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rua Bruno Lobo 50, BR-21941612 Rio De Janeiro, RJ, Brazil.
RP de Magalhaes-Barbosa, MC (corresponding author), Inst DOr Pesquisa & Ensino IDOR, Dept Pediat, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
EM mariaclaramb@globo.com; arnaldoprata@globo.com; jaque.robaina@gmail.com;
   caducer@gmail.com; felimasetta@gmail.com; acunha@hucff.ufrj.br
RI da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Prata-Barbosa,
   Arnaldo/B-2212-2009
OI da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; de Magalhaes-Barbosa, Maria
   Clara/0000-0003-0959-0775
CR Brasil. Ministerio da Saade, 012015 MIN SAUD SECR
   Brasil. Ministerio da Saiide, 2016, 332016 MIN SAUD CTR
   Brasil. Ministerio da SaOcle, MIN SAUD B EP
   Brasil. Ministerio da SaOde, 2016, 012015 MIN SAUD CTR
   Brasil. Ministerio da SaOde, 2016, PROT VIG RESP OC MIC
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha AJLA, 2015, B WHO, V16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 9
TC 19
Z9 19
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2016
VL 14
IS 5
BP 458
EP 463
DI 10.1016/j.tmaid.2016.09.006
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EA8BW
UT WOS:000386861300007
PM 27702683
DA 2020-07-08
ER

PT J
AU Singh, RK
   Dhama, K
   Malik, YS
   Ramakrishnan, MA
   Karthik, K
   Tiwari, R
   Saurabh, S
   Sachan, S
   Joshi, SK
AF Singh, Raj Kumar
   Dhama, Kuldeep
   Malik, Yashpal Singh
   Ramakrishnan, Muthannan Andavar
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Saurabh, Sharad
   Sachan, Swati
   Joshi, Sunil Kumar
TI Zika virus - emergence, evolution, pathology, diagnosis, and control:
   current global scenario and future perspectives - a comprehensive review
SO VETERINARY QUARTERLY
LA English
DT Review
DE Zika virus; flavivirus; global warming; zoonosis; review
ID MOSQUITOS DIPTERA-CULICIDAE; PUBLIC-HEALTH PREPAREDNESS; AEDES-AEGYPTI
   MOSQUITOS; YELLOW-FEVER; INTERIM GUIDELINES; FRENCH-POLYNESIA;
   UNITED-STATES; WEST NILE; SEROLOGICAL SURVEY; ARBOVIRUS INFECTIONS
AB This review converses the Zika virus which has attained global concern due to its rapid pandemic potential and impact on humans. Though Zika virus was first isolated in 1947, till the recent large-scale outbreak which occurred in Micronesia, in 2007, the virus was placed into the innocuous pathogen category. The World Health Organization on 1 February 2016 declared it as a Public Health Emergency of International Concern.' Of the note, American as well as Pacific Island strains/isolates is relatively closer to Asian lineage strains. The African and American strains share more than 87.5% and 95% homologies with Asian strains/isolates, respectively. Asian strains form independent clusters, except those isolated from China, suggesting relatively more diversity than African strains. Prevention and control are mainly aimed at the vector population (mosquitoes) with Aedes aegypti being the main species. Surveys in Africa and Asia indicated seropositivity in various animal species. However, so far its natural reservoir is unknown. There is an urgent need to understand why Zika virus has shifted from being a virus that caused mild illness to unforeseen birth defects as well as autoimmune-neurological problems. Unfortunately, an effective vaccine is not available yet. Availability of cryo-electron microscopy based on 3.8 angstrom resolution revealing mature Zika virus structure and the probable virus attachment site to host cell would provide critical insights into the development of antiviral treatments and vaccines.
C1 [Singh, Raj Kumar] ICAR Indian Vet Res Inst, Bareilly, Uttar Pradesh, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Malik, Yashpal Singh; Saurabh, Sharad] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Ramakrishnan, Muthannan Andavar] ICAR Indian Vet Res Inst, Div Virol, Mukteswar Campus, Bareilly, Uttarakhand, India.
   [Karthik, Kumaragurubaran] ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India.
   [Tiwari, Ruchi] Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwa, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Sachan, Swati] ICAR Indian Vet Res Inst, Immunol Sect, Bareilly, Uttar Pradesh, India.
   [Joshi, Sunil Kumar] Old Dominion Univ, Cellular Immunol Lab, Sch Med Diagnost & Translat Sci, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA.
RP Malik, YS (corresponding author), ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
EM malikyps@ivri.res.in
RI Malik, Yashpal Singh/AAI-2259-2019; Ramakrishnan, Muthannan
   Andavar/Y-3338-2019; Dhama, Kuldeep/B-7852-2015
OI Dhama, Kuldeep/0000-0001-7469-4752; Ramakrishnan, Muthannan
   Andavar/0000-0001-7789-328X; Malik, Yashpal/0000-0002-2832-4854; Tiwari,
   Ruchi/0000-0001-7763-5547
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barrera-Cruz Antonio, 2016, Rev Med Inst Mex Seguro Soc, V54, P211
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bergquist R, 2011, MEM I OSWALDO CRUZ, V106, P892, DOI 10.1590/S0074-02762011000700016
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brelsfoard C.L., 2009, ASIA PAC J MOL BIOL, V17, P55
   Brown C, 2015, CMAJ, V188, P1
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   CDC, 2016, MED STAT CDC ADDS 4
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chastel C, 2012, Bull Soc Pathol Exot, V105, P251, DOI 10.1007/s13149-012-0255-8
   Chattopadhyay S, 2010, BIOINFORMATION, V4, P448, DOI 10.6026/97320630004448
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Chong L, 2013, BIOMED CHROMATOGR, V27, P825, DOI 10.1002/bmc.2866
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Citrome L, 2016, INT J CLIN PRACT, V70, P181, DOI 10.1111/ijcp.12793
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Dhama K, 2008, VET RES COMMUN, V32, P341, DOI 10.1007/s11259-008-9040-3
   Dhama K., 2013, INT J CURR RES, V5, P1942
   Dhama K, 2013, PAKISTAN J BIOL SCI, V16, P1
   Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290
   Dhama K, 2015, J INFECT DEV COUNTR, V9, P441, DOI 10.3855/jidc.6197
   Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166
   Dhama K, 2013, J EXP BIOL AGRIC SCI, V1, P1
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   European CDC, 2014, RAP RISK ASS ZIK VIR
   Faccini-Martinez AA, 2016, J INFECT PUBLIC HEAL, V9, P687, DOI 10.1016/j.jiph.2016.01.001
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Finco O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00012
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Goeijenbier M, 2016, NETH J MED, V74, P104
   GOMA LKH, 1965, B ENTOMOL RES, V56, P17, DOI 10.1017/S0007485300057011
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P1097, DOI 10.1001/jama.2016.1219
   Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Junquera Elena C, 2014, Recent Pat Antiinfect Drug Discov, V9, P14
   Kant R, 2013, J VECTOR DIS, V50, P1
   Kapoor S, 2014, INSIGHT INFLUENZA VI
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kawadkar J, 2011, J PHARM CLIN RES, V4, P23
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kim MG, 2014, ASIAN J PHARM SCI, V9, P227, DOI 10.1016/j.ajps.2014.06.002
   Kindhauser MK, 2016, B WHO
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuldeep Dhama, 2014, Research Opinions in Animal and Veterinary Sciences, V4, P353
   Kumar S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00147
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucchese G, 2016, AUTOIMMUN REV
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MacNamara F., 1952, ANN REPORT, P1951
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahima, 2012, Pak J Biol Sci, V15, P754, DOI 10.3923/pjbs.2012.754.774
   Malik Y. S., 2013, South Asian Journal of Experimental Biology, V3, P207
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez MJ, 2015, INFECT DIS THER, V4, P365, DOI 10.1007/s40121-015-0079-5
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1042
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i306
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V352, pi855
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624, DOI 10.4269/ajtmh.1980.29.624
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nunes-Alves C, 2016, NAT REV MICROBIOL, V14, P130, DOI 10.1038/nrmicro.2016.16
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i875
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ong KC, 2015, BRAIN PATHOL, V25, P605, DOI 10.1111/bpa.12278
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Pany SS, 2015, ADV ANIMAL VET SCI, V3, P1
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0377
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Perkasa A, 2016, EMERG INFECT DIS, P22
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x
   Picard-Jean F, 2013, CURRENT ISSUES MOL V
   Pierre DYS, 2014, J VECTOR DIS, V51, P216
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rafiei N, 2016, MED J AUSTRALIA, V204, P186, DOI 10.5694/mja15.01275
   Ramkumar G, 2015, PARASITOL RES, V114, P167, DOI 10.1007/s00436-014-4173-5
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Reis-Castro L, 2012, CROAT MED J, V53, P635, DOI 10.3325/cmj.2012.53.635
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Ryan MD, 1998, J GEN VIROL, V79, P947, DOI 10.1099/0022-1317-79-5-947
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39
   Simkiss D, 2016, J TROP PEDIATRICS, V62, P1, DOI 10.1093/tropej/fmw006
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh R.K., 2015, CURRENT TRENDS FUTUR, P1, DOI DOI 10.2118/175057-MS
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   Tiwari Ruchi, 2014, Pak J Biol Sci, V17, P316, DOI 10.3923/pjbs.2014.316.328
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Ulmer JB, 2015, EXPERT OPIN DRUG DIS, V10, P101, DOI 10.1517/17460441.2015.996128
   Valero N, 2015, INVEST CLIN, V56, P241
   van den Hurk R, 2015, SENSORS-BASEL, V15, P14045, DOI 10.3390/s150614045
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vest KG, 2016, DISASTER MED PUBLIC, V29, P1
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, DIS OUTBR NEWS ZIK V
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Xiao XW, 2013, J ASIAN NAT PROD RES, V15, P809, DOI 10.1080/10286020.2013.803473
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhou Yan, 2014, Medicinal Plant, V5, P57
NR 293
TC 40
Z9 43
U1 3
U2 147
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0165-2176
EI 1875-5941
J9 VET QUART
JI Vet. Q.
PD SEP
PY 2016
VL 36
IS 3
BP 150
EP 175
DI 10.1080/01652176.2016.1188333
PG 26
WC Veterinary Sciences
SC Veterinary Sciences
GA DT5HK
UT WOS:000381512700006
PM 27158761
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carneiro, BM
   Batista, MN
   Braga, ACS
   Nogueira, ML
   Rahal, P
AF Carneiro, Bruno M.
   Batista, Mariana N.
   Braga, Ana Claudia S.
   Nogueira, Mauricio L.
   Rahal, Paula
TI The green tea molecule EGCG inhibits Zika virus entry
SO VIROLOGY
LA English
DT Article
DE Zika virus; (-)-Epigallocatechin gallate; Antiviral; Green-tea
ID EPIGALLOCATECHIN GALLATE; HIV-1 THERAPY; POLYPHENOL; CATECHINS; AMERICA;
   SAFETY; RATS
AB During ZIKV the outbreak in Brazil it was observed an increase of almost 20 times the number of reported cases of microcephaly in newborn babies. There is no vaccine or approved drug available for the treatment and prevention of infections by this virus. EGCG, a polyphenol present in green tea has been shown to have an antiviral activity for many viruses. In view of the need for the development of a drug against a Brazilian strain of ZIKV, we assessed the effect of EGCG on ZIKV entry in Vero E6 cells. The drug was capable of inhibiting the virus entry by at least 1-log ( > 90%) at higher concentrations ( > 100 mu M). The pre-treatment of cells with EGCG did not show any effect on virus attachment. This is the first study to demonstrate the effect of EGCG on ZIKV indicating that this drug might be possibility to be used for prevention of Zika virus infections. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Carneiro, Bruno M.; Batista, Mariana N.; Braga, Ana Claudia S.; Rahal, Paula] Sao Paulo State Univ UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil.
   [Nogueira, Mauricio L.] FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Carneiro, BM (corresponding author), Sao Paulo State Univ UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil.
EM brunocopo@yahoo.com.br
RI Rahal, Paula/D-3871-2012; Carneiro, Bruno/P-2415-2019; Nogueira,
   Mauricio L/B-7599-2012
OI Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio
   L/0000-0003-1102-2419; Carneiro, Bruno/0000-0002-2355-7907
FU Sao Paulo Research Foundation (FAPESP), BrazilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3, 2014/22199-6,
   2014/22198-0]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP),
   Brazil. Grant numbers 2013/21719-3, 2014/22199-6 and 2014/22198-0.
CR Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fangueiro JF, 2016, INT J PHARMACEUT, V502, P161, DOI 10.1016/j.ijpharm.2016.02.039
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002
   Lambert JD, 2006, DRUG METAB DISPOS, V34, P2111, DOI 10.1124/dmd.106.011460
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Weisburg JH, 2004, BASIC CLIN PHARMACOL, V95, P191, DOI 10.1111/j.1742-7843.2004.pto_950407.x
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 68
Z9 69
U1 2
U2 91
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2016
VL 496
BP 215
EP 218
DI 10.1016/j.virol.2016.06.012
PG 4
WC Virology
SC Virology
GA DT1IU
UT WOS:000381235700024
PM 27344138
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ye, Q
   Liu, ZY
   Han, JF
   Jiang, T
   Li, XF
   Qin, CF
AF Ye, Qing
   Liu, Zhong-Yu
   Han, Jian-Feng
   Jiang, Tao
   Li, Xiao-Feng
   Qin, Cheng-Feng
TI Genomic characterization and phylogenetic analysis of Zika virus
   circulating in the Americas
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Zika virus; Genomic characterization; Phylogenetics; Flavivirus
ID JAPANESE ENCEPHALITIS-VIRUS; VACCINE STRAIN SA14-14-2; RNA SECONDARY
   STRUCTURES; DENGUE VIRUS; WEST-NILE; ATTENUATED VACCINE; GLYCOSYLATION
   SITE; ENVELOPE PROTEIN; N-GLYCOSYLATION; FLAVIVIRUS RNA
AB The rapid spread and potential link with birth defects have made Zika virus (ZIKV) a global public health problem. The virus was discovered 70 years ago, yet the knowledge about its genomic structure and the genetic variations associated with current ZIKV explosive epidemics remains not fully understood. In this review, the genome organization, especially conserved terminal structures of ZIKV genome were characterized and compared with other mosquito-borne flaviviruses. It is suggested that major viral proteins of ZIKV share high structural and functional similarity with other known flaviviruses as shown by sequence comparison and prediction of functional motifs in viral proteins. Phylogenetic analysis demonstrated that all ZIKV strains circulating in the America form a unique clade within the Asian lineage. Furthermore, we identified a series of conserved amino acid residues that differentiate the Asian strains including the current circulating American strains from the ancient African strains. Overall, our findings provide an overview of ZIKV genome characterization and evolutionary dynamics in the Americas and point out critical clues for future virological and epidemiological studies. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ye, Qing; Liu, Zhong-Yu; Han, Jian-Feng; Jiang, Tao; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Jiang, Tao; Li, Xiao-Feng; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926;
   Liu, Zhong-Yu/0000-0001-7385-5681
FU State Key Laboratory of Pathogen and Biosecurity, China; National Basic
   Research ProjectNational Basic Research Program of China [2012CB518904];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31270974, 81522025]; National Major Special Program
   of Science and Technology of China [2013ZX10004001]; Newton Advanced
   Fellowship from the Academy of Medical Sciences, UK; NSFC of
   ChinaNational Natural Science Foundation of China [81661130162]
FX This work was supported by the State Key Laboratory of Pathogen and
   Biosecurity, China, the National Basic Research Project (No.
   2012CB518904), the National Natural Science Foundation of China (No.
   31270974) and the National Major Special Program of Science and
   Technology of China (2013ZX10004001). C.F. Qin was supported by the
   National Natural Science Foundation of China (81522025) and the Newton
   Advanced Fellowship from the Academy of Medical Sciences, UK and the
   NSFC of China (No. 81661130162).
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, N ENGL J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Li XF, 2013, J GEN VIROL, V94, P2700, DOI 10.1099/vir.0.059436-0
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Torresi J, 2010, VACCINE, V28, P7993, DOI 10.1016/j.vaccine.2010.09.035
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Wang HJ, 2014, VACCINE, V32, P949, DOI 10.1016/j.vaccine.2013.12.050
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Waugh A, 2002, RNA, V8, P707, DOI 10.1017/S1355838202028017
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 60
TC 57
Z9 59
U1 1
U2 284
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2016
VL 43
BP 43
EP 49
DI 10.1016/j.meegid.2016.05.004
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DR1YP
UT WOS:000379701100007
PM 27156653
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Outbreak of Zika in Singapore sparks warnings in neighbouring countries
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Thangamani S, 2016, AM J TROP MED HYG, P16, DOI [10.4269/ajtmh.16-0448.Yjrn, DOI 10.4269/AJTMH.16-0448.YJRN]
NR 1
TC 7
Z9 7
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 31
PY 2016
VL 354
AR i4740
DI 10.1136/bmj.i4740
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV3AD
UT WOS:000382792500021
PM 27581052
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hodak, H
AF Hodak, Helene
TI Down to the Molecular Mechanisms of Host-Pathogen Interactions
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Editorial Material
ID EBOLA-VIRUS DISEASE; ZIKA VIRUS
C1 [Hodak, Helene] Elsevier Inc, Journal Mol Biol, 50 Hampshire St, Cambridge, MA 02139 USA.
RP Hodak, H (corresponding author), Elsevier Inc, Journal Mol Biol, 50 Hampshire St, Cambridge, MA 02139 USA.
EM h.hodak@elsevier.com
CR [Anonymous], 2016, B WHO
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bajaj S, 2016, J MOL BIOL, V428, P3540, DOI 10.1016/j.jmb.2016.06.006
   Banadyga L, 2016, J MOL BIOL, V428, P3449, DOI 10.1016/j.jmb.2016.05.008
   Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227
   Blevins SM, 2010, INT J INFECT DIS, V14, pE744, DOI 10.1016/j.ijid.2009.12.003
   Bouzidi MS, 2016, J MOL BIOL, V428, P3514, DOI 10.1016/j.jmb.2016.05.022
   Brogden KA, 2004, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)17745-9
   Brown CS, 2014, J MOL BIOL, V426, P2045, DOI 10.1016/j.jmb.2014.01.010
   Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chatterjee S, 2016, J MOL BIOL, V428, P3467, DOI 10.1016/j.jmb.2016.07.017
   Choby JE, 2016, J MOL BIOL, V428, P3408, DOI 10.1016/j.jmb.2016.03.018
   Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Furniss RCD, 2016, J MOL BIOL, V428, P3399, DOI 10.1016/j.jmb.2016.05.023
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Johnson B, 2016, J MOL BIOL, V428, P3483, DOI 10.1016/j.jmb.2016.07.020
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Koch R, 1987, ESSAYS R KOCH, P83
   Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841
   Miller C, 2016, J MOL BIOL, V428, P3387, DOI 10.1016/j.jmb.2016.07.007
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Patrick KL, 2016, J MOL BIOL, V428, P3372, DOI 10.1016/j.jmb.2016.04.030
   Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   RAZUMOV A. S., 1932, MIKROBIOLOGIIA [MICROBIOLOGY], V1, P131
   Rivers TM, 1937, J BACTERIOL, V33, P1
   Tay WH, 2016, J MOL BIOL, V428, P3355, DOI 10.1016/j.jmb.2016.05.006
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turner T, 2016, J MOL BIOL, V428, P3529, DOI 10.1016/j.jmb.2016.05.029
   Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
NR 39
TC 0
Z9 0
U1 0
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 28
PY 2016
VL 428
IS 17
SI SI
BP 3353
EP 3354
DI 10.1016/j.jmb.2016.07.019
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DW0FD
UT WOS:000383315400001
PM 27484029
DA 2020-07-08
ER

PT J
AU Olagnier, D
   Amatore, D
   Castiello, L
   Ferrari, M
   Palermo, E
   Diamond, MS
   Palamara, AT
   Hiscott, J
AF Olagnier, David
   Amatore, Donatella
   Castiello, Luciano
   Ferrari, Matteo
   Palermo, Enrico
   Diamond, Michael S.
   Palamara, Anna Teresa
   Hiscott, John
TI Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of
   Zika Virus
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Review
DE dengue; Zika; innate immunity; oxidative stress; pathogenesis
ID ANTIBODY-DEPENDENT ENHANCEMENT; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B;
   INTERFERON ANTIVIRAL RESPONSE; HUMAN DENDRITIC CELLS; OXIDATIVE STRESS;
   RIG-I; DC-SIGN; CYTOKINE PRODUCTION; IMMUNE ACTIVATION
AB Dengue is the leading mosquito-transmitted viral infection in the world. There are more than 390 million new infections annually; while the majority of infected individuals are asymptomatic or develop a self-limited dengue fever, up to 1 million clinical cases develop severe manifestations, including dengue hemorrhagic fever and shock syndrome, resulting in similar to 25,000 deaths annually, mainly in children. Gaps in our understanding of the mechanisms that contribute to dengue infection and immunopathogenesis have hampered the development of vaccines and antiviral agents. Some of these limitations are highlighted by the explosive re-emergence of another arthropod-borne flavivirus Zika virus spread by the same vector, the Aedes aegypti mosquito, that also carries dengue, yellow fever and chikungunya viruses. This review will discuss the early virus-host interactions in dengue infection, with emphasis on the interrelationship between oxidative stress and innate immune pathways, and will provide insight as to how lessons learned from dengue research may expedite therapeutic strategies for Zika virus. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Olagnier, David] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.
   [Amatore, Donatella; Palamara, Anna Teresa] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Castiello, Luciano; Ferrari, Matteo; Palermo, Enrico; Palamara, Anna Teresa; Hiscott, John] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy.
   [Diamond, Michael S.] Washington Univ, Dept Med, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Dept Pathol, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Dept Immunol, St Louis, MO USA.
RP Hiscott, J (corresponding author), Ist Pasteur Fdn Cenci Bolognetti, Lab Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
EM john.hiscott@istitutopasteur.it
RI Diamond, Michael/AAH-1733-2019; Castiello, Luciano/Z-3150-2019
OI Diamond, Michael/0000-0002-8791-3165; Castiello,
   Luciano/0000-0001-7146-3158; AMATORE, DONATELLA/0000-0001-5701-9683;
   Ferrari, Matteo/0000-0002-4224-8835; Palermo,
   Enrico/0000-0002-9595-6931; Olagnier, David/0000-0001-6912-0674;
   PALAMARA, ANNA TERESA/0000-0001-8330-4381
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI108861]; Italian
   Association for Cancer ResearchAssociazione Italiana per la Ricerca sul
   Cancro (AIRC); Pasteur GPF Vaccinologie program; PRIN MIURMinistry of
   Education, Universities and Research (MIUR)Research Projects of National
   Relevance (PRIN); Burroughs Wellcome FundBurroughs Wellcome Fund;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755]; Peter Quinlan McGill
   postdoctoral fellowship
FX This research was supported by grants from the National Institutes of
   Health (AI108861), the Italian Association for Cancer Research and the
   Pasteur GPF Vaccinologie program to J.H.; by grants from PRIN MIUR to
   A.T.P.; and grants from the Burroughs Wellcome Fund and NIH (R01
   AI073755) to M.S.D. David Olagnier was supported by a Peter Quinlan
   McGill postdoctoral fellowship. The authors would like to acknowledge
   all the contributions in the field that could not be included in the
   review. The figures of the review were illustrated by David Olagnier
   with the Servier Medical Art software
   http://www.servier.fr/smart/banque-dimages-powerpoint.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448
   Al-alimi AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002711
   Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6
   Amatore D, 2015, CELL MICROBIOL, V17, P131, DOI 10.1111/cmi.12343
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012
   Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   Beljanski V, 2015, J VIROL, V89, P10612, DOI 10.1128/JVI.01526-15
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brien JD, 2013, J VIROL, V87, P7747, DOI 10.1128/JVI.00327-13
   Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016
   Butthep P, 2006, PEDIATR INFECT DIS J, V25, P894, DOI 10.1097/01.inf.0000237918.85330.b9
   Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6
   Callaway JB, 2015, J BIOL CHEM, V290, P17306, DOI 10.1074/jbc.M115.664136
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cardier JE, 2006, CYTOKINE, V34, P155, DOI 10.1016/j.cyto.2006.04.002
   Castro R, 2015, COLOMB MEDICA, V46, P135
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Driggers RW, 2016, N ENGL J MED
   Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118
   Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   GARACI E, 1992, BIOCHEM BIOPH RES CO, V188, P1090, DOI 10.1016/0006-291X(92)91343-O
   Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54
   Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172
   Ghezzi P, 2013, BBA-GEN SUBJECTS, V1830, P3165, DOI 10.1016/j.bbagen.2013.02.009
   Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652
   Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011
   Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858
   Gutteridge J M, 1989, Baillieres Clin Haematol, V2, P195, DOI 10.1016/S0950-3536(89)80017-4
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002
   Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x
   Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251
   Kelser E.A., 2015, MICROBES INFECT
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   Lazear HM, 2016, CELL HOST MICROBE
   Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   MCCORD JM, 1968, J BIOL CHEM, V243, P5753
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Mlakar J, 2016, N ENGL J MED
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178
   Mufson S., 1 8 BILLION FIGHT ZI
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje
   Neves-Souza PCF, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-64
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6
   Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1373, DOI 10.1089/aid.1996.12.1373
   PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Richards AL, 2013, J VIROL, V87, P9966, DOI 10.1128/JVI.00460-13
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Rossi SL, 2016, AM J TROP MED HYG
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Sgarbanti R, 2011, ANTIOXID REDOX SIGN, V15, P593, DOI 10.1089/ars.2010.3512
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Silva RLA, 2008, VIRUS RES, V135, P320, DOI 10.1016/j.virusres.2008.03.007
   Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284
   Soundravally R, 2014, INT J INFECT DIS, V18, P68, DOI 10.1016/j.ijid.2013.09.022
   Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013
   Sun PF, 2013, SCI WORLD J, DOI 10.1155/2013/843469
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, MED MICROBIOL IMMUNO
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Teets F.D., 2013, VIROL REP, V1-2, P2, DOI DOI 10.1016/J.VIREP.2014.05.001.HTTP://WWW.SCIENCEDIRECT.C0M/SCIENCE/ARTICLE/PII/
   Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001
   Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wu MF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-36
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhou Y, 2006, J GEN VIROL, V87, P2595, DOI 10.1099/vir.0.81994-0
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 182
TC 22
Z9 22
U1 0
U2 29
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 28
PY 2016
VL 428
IS 17
SI SI
BP 3429
EP 3448
DI 10.1016/j.jmb.2016.04.024
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DW0FD
UT WOS:000383315400007
PM 27130436
DA 2020-07-08
ER

PT J
AU Heukelbach, J
   Werneck, GL
AF Heukelbach, Joerg
   Werneck, Guilherme Loureiro
TI Surveillance of Zika virus infection and microcephaly in Brazil
SO LANCET
LA English
DT Editorial Material
C1 [Heukelbach, Joerg] Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil.
   [Heukelbach, Joerg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.
   [Heukelbach, Joerg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
RP Heukelbach, J (corresponding author), Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil.; Heukelbach, J (corresponding author), James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.; Heukelbach, J (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
EM heukelbach@web.de
RI Werneck, Guilherme/A-2841-2013
OI Werneck, Guilherme/0000-0003-1169-1436; Heukelbach,
   Jorg/0000-0002-7845-5510
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 8
TC 11
Z9 11
U1 0
U2 44
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 846
EP 847
DI 10.1016/S0140-6736(16)30931-X
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800006
PM 27372396
OA Other Gold
DA 2020-07-08
ER

PT J
AU Roberts, DJ
   Frosch, MP
AF Roberts, Drucilla J.
   Frosch, Matthew P.
TI Zika and histopathology in first trimester infections
SO LANCET
LA English
DT Editorial Material
ID CRANIOSYNOSTOSIS; INTERVILLOSITIS; PREGNANCY; PLACENTA; VIRUS
C1 [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA.
   [Frosch, Matthew P.] Harvard Med Sch, Boston, MA 02115 USA.
RP Roberts, DJ (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
EM djroberts@mgh.harvard.edu
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Boyd TK, 2000, HUM PATHOL, V31, P1389, DOI 10.1016/S0046-8177(00)80009-X
   Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295
   Flaherty K, 2016, WIRES DEV BIOL, V5, P429, DOI 10.1002/wdev.227
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hyde SR, 1997, MODERN PATHOL, V10, P602
   Martines R. B., 2016, LANCET
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011
   Raam MS, 2010, AM J MED GENET C, V154C, P176, DOI 10.1002/ajmg.c.30234
   Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Centers for Disease Control and Prevention, 2016, CDC CONCL ZIK CAUS M
NR 15
TC 7
Z9 7
U1 0
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 847
EP 849
DI 10.1016/S0140-6736(16)30930-8
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800007
PM 27372399
OA Bronze
DA 2020-07-08
ER

PT J
AU de Laval, F
   Matheus, S
   Maquart, M
   Yvrard, E
   Barthes, N
   Combes, C
   Rousset, D
   Leparc-Goffart, I
   Briolant, S
AF de laval, Franck
   Matheus, Severine
   Maquart, Marianne
   Yvrard, Emmanuel
   Barthes, Nicolas
   Combes, Cedric
   Rousset, Dominique
   Leparc-Goffart, Isabelle
   Briolant, Sebastien
TI Prospective Zika virus disease cohort: systematic screening
SO LANCET
LA English
DT Letter
ID MICRONESIA; EPIDEMIC; URINE
C1 [de laval, Franck] Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [de laval, Franck; Barthes, Nicolas; Combes, Cedric; Briolant, Sebastien] French Armed Forces Hlth Serv French Guiana, BP 6019, Cayenne 97306, French Guiana.
   [Rousset, Dominique; Briolant, Sebastien] Natl Reference Ctr Arboviruses, Inst Pasteur French Guiana, Virol Lab, Cayenne, French Guiana.
   [Briolant, Sebastien] Unit Med Entomol, Cayenne, French Guiana.
   [Maquart, Marianne; Yvrard, Emmanuel; Leparc-Goffart, Isabelle] Natl Reference Ctr Arboviruses, French Armed Forces Biomed Res Inst, Marseille, France.
   [Briolant, Sebastien] Hop Instruct Armees Laveran, Unit Parasitol & Med Entomol, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, Fac Med La Timone, Res Unit Emerging Infect & Trop Dis, UM 63,CNRS 7278,IRD 198, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, Fac Med La Timone, INSERM 1095, Marseille, France.
RP Briolant, S (corresponding author), French Armed Forces Hlth Serv French Guiana, BP 6019, Cayenne 97306, French Guiana.; Briolant, S (corresponding author), Natl Reference Ctr Arboviruses, Inst Pasteur French Guiana, Virol Lab, Cayenne, French Guiana.; Briolant, S (corresponding author), Unit Med Entomol, Cayenne, French Guiana.; Briolant, S (corresponding author), Hop Instruct Armees Laveran, Unit Parasitol & Med Entomol, Marseille, France.; Briolant, S (corresponding author), Aix Marseille Univ, Fac Med La Timone, Res Unit Emerging Infect & Trop Dis, UM 63,CNRS 7278,IRD 198, Marseille, France.; Briolant, S (corresponding author), Aix Marseille Univ, Fac Med La Timone, INSERM 1095, Marseille, France.
EM sbriolant@wanadoo.fr
RI Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 5
TC 17
Z9 20
U1 0
U2 51
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 868
EP 868
DI 10.1016/S0140-6736(16)31429-5
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800021
PM 27597462
OA Bronze
DA 2020-07-08
ER

PT J
AU Franca, GVA
   Schuler-Faccini, L
   Oliveira, WK
   Henriques, CMP
   Carmo, EH
   Pedi, VD
   Nunes, ML
   Castro, MC
   Serruya, S
   Silveira, MF
   Barros, FC
   Victora, CG
AF Franca, Giovanny V. A.
   Schuler-Faccini, Lavinia
   Oliveira, Wanderson K.
   Henriques, Claudio M. P.
   Carmo, Eduardo H.
   Pedi, Vaneide D.
   Nunes, Marilia L.
   Castro, Marcia C.
   Serruya, Suzanne
   Silveira, Mariangela F.
   Barros, Fernando C.
   Victora, Cesar G.
TI Congenital Zika virus syndrome in Brazil: a case series of the first
   1501 livebirths with complete investigation
SO LANCET
LA English
DT Article
ID INFECTION; OUTBREAK
AB Background In November, 2015, an epidemic of microcephaly was reported in Brazil, which was later attributed to congenital Zika virus infection. 7830 suspected cases had been reported to the Brazilian Ministry of Health by June 4, 2016, but little is known about their characteristics. We aimed to describe these newborn babies in terms of clinical findings, anthropometry, and survival.
   Methods We reviewed all 1501 liveborn infants for whom investigation by medical teams at State level had been completed as of Feb 27, 2016, and classified suspected cases into five categories based on neuroimaging and laboratory results for Zika virus and other relevant infections. Definite cases had laboratory evidence of Zika virus infection; highly probable cases presented specific neuroimaging findings, and negative laboratory results for other congenital infections; moderately probable cases had specific imaging findings but other infections could not be ruled out; somewhat probable cases had imaging findings, but these were not reported in detail by the local teams; all other newborn babies were classified as discarded cases. Head circumference by gestational age was assessed with InterGrowth standards. First week mortality and history of rash were provided by the State medical teams.
   Findings Between Nov 19, 2015, and Feb 27, 2015, investigations were completed for 1501 suspected cases reported to the Brazilian Ministry of Health, of whom 899 were discarded. Of the remainder 602 cases, 76 were definite, 54 highly probable, 181 moderately probable, and 291 somewhat probable of congenital Zika virus syndrome. Clinical, anthropometric, and survival differences were small among the four groups. Compared with these four groups, the 899 discarded cases had larger head circumferences (mean Z scores -1.54 vs -3.13, difference 1.58 [95% CI 1.45-1.72]); lower first-week mortality (14 per 1000 vs 51 per 1000; rate ratio 0.28 [95% CI 0.14-0.56]); and were less likely to have a history of rash during pregnancy (20.7% vs 61.4%, ratio 0.34 [95% CI 0.27-0.42]). Rashes in the third trimester of pregnancy were associated with brain abnormalities despite normal sized heads. One in five definite or probable cases presented head circumferences in the normal range (above -2 SD below the median of the InterGrowth standard) and for one third of definite and probable cases there was no history of a rash during pregnancy. The peak of the epidemic occurred in late November, 2015.
   Interpretation Zika virus congenital syndrome is a new teratogenic disease. Because many definite or probable cases present normal head circumference values and their mothers do not report having a rash, screening criteria must be revised in order to detect all affected newborn babies. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
C1 [Franca, Giovanny V. A.; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.] Secretariat Hlth Surveillance Minist Hlth, Brasilia, DF, Brazil.
   [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Castro, Marcia C.] Harvard T H Chan Sch Publ Hlth, Boston, MA USA.
   [Serruya, Suzanne] Latin Amer Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay.
   [Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.
   [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, RS, Brazil.
RP Victora, CG (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.
EM cvictora@equidade.org
RI Castro, Marcia/S-2681-2019; Victora, Cesar Gomes/Y-2455-2019; Victora,
   Cesar G/D-4476-2013; SCHULER-FACCINI, LAVINIA/C-8309-2013; de Franca,
   Giovanny Vinicius Araujo/L-7385-2018; Oliveira, Wanderson/AAF-5182-2019
OI Castro, Marcia/0000-0003-4606-2795; Victora, Cesar
   Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180;
   SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; de Franca, Giovanny
   Vinicius Araujo/0000-0002-7530-2017; Oliveira,
   Wanderson/0000-0002-9662-1930
FU Wellcome TrustWellcome Trust
FX CGV holds a Wellcome Trust Senior Investigator Award. We thank the
   Health Secretaries of the Brazilian states and municipalities; the state
   Central Laboratories Network National Reference Laboratories; the
   General Coordination of National Dengue Control Program (CGPNCD/MS); the
   General Coordination of Surveillance and Response (CGVR/MS); the General
   Coordination of Public Health Laboratories (CGLAB/MS); the General
   Coordination of Information and Epidemiological Analysis (CGIAE/MS); the
   Brazilian Society of Medical Genetics; the Latin American Center for
   Perinatology, Women and Reproductive Health (CLAP/WR-PAHO/WHO); and the
   Pan American Health Organization in Washington and the national office
   in Brazil. Pablo Duran and Andres de Francisco provided inputs in an
   earlier version of the manuscript; Jose Villar and Eric Ohuma provided
   advice on the calculations of head circumference Z scores; Dacio de Lyra
   Rabello Neto, Roberto Carlos Reyes Lecca, Marli Montenegro Silva, and
   Anthony Stevens carried out the linkage between the microcephaly
   surveillance system and the National Birth Registration System (SINASC);
   and Aluisio J D Barros provided statistical analysis advice. The views
   and opinions expressed herein are those of the authors and do not
   necessarily reflect those of the Brazilian Ministry of Health or of the
   Pan American Health Organization.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Brasil. Ministerio da Saude, 2016, REG EV SAUD PUBL RES
   BRASIL. Ministerio da Saude, 2016, PROT VIG RESP OC MIC
   Brasil Ministerio da Saude, 2016, INF EP 25
   Brasil Ministerio da Saude, 2016, SIST NAC NASC VIV
   Brasil. Ministerio da Saude, 2016, INF EP 15
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   [DATASUS Brasil. Ministerio da Saude], IND MORT TEX MORT NE
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Matijasevich A, 2013, EPIDEMIOL SERV SAUDE, V22, P557, DOI 10.5123/S1679-49742013000400002
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 26
TC 263
Z9 265
U1 2
U2 57
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 891
EP 897
DI 10.1016/S0140-6736(16)30902-3
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800027
PM 27372398
OA Other Gold
DA 2020-07-08
ER

PT J
AU Martines, RB
   Bhatnagar, J
   Ramos, AMD
   Davi, HPF
   Iglezias, SD
   Kanamura, CT
   Keating, MK
   Hale, G
   Silva-Flannery, L
   Muehlenbachs, A
   Ritter, J
   Gary, J
   Rollin, D
   Goldsmith, CS
   Reagan-Steiner, S
   Ermias, Y
   Suzuki, T
   Luz, KG
   de Oliveira, WK
   Lanciotti, R
   Lambert, A
   Shieh, WJ
   Zaki, SR
AF Martines, Roosecelis Brasil
   Bhatnagar, Julu
   de Oliveira Ramos, Ana Maria
   Freire Davi, Helaine Pompeia
   Iglezias, Silvia D'Andretta
   Kanamura, Cristina Takami
   Keating, M. Kelly
   Hale, Gillian
   Silva-Flannery, Luciana
   Muehlenbachs, Atis
   Ritter, Jana
   Gary, Joy
   Rollin, Dominique
   Goldsmith, Cynthia S.
   Reagan-Steiner, Sarah
   Ermias, Yokabed
   Suzuki, Tadaki
   Luz, Kleber G.
   de Oliveira, Wanderson Kleber
   Lanciotti, Robert
   Lambert, Amy
   Shieh, Wun-Ju
   Zaki, Sherif R.
TI Pathology of congenital Zika syndrome in Brazil: a case series
SO LANCET
LA English
DT Article
ID VIRUS-INFECTION; ARTHROGRYPOSIS; ETIOLOGY; TISSUES; UPDATE; STATES;
   BRAIN; PCR
AB Background Zika virus is an arthropod-borne virus that is a member of the family Flaviviridae transmitted mainly by mosquitoes of the genus Aedes. Although usually asymptomatic, infection can result in a mild and self-limiting illness characterised by fever, rash, arthralgia, and conjunctivitis. An increase in the number of children born with microcephaly was noted in 2015 in regions of Brazil with high transmission of Zika virus. More recently, evidence has been accumulating supporting a link between Zika virus and microcephaly. Here, we describe findings from three fatal cases and two spontaneous abortions associated with Zika virus infection.
   Methods In this case series, formalin-fixed paraffin-embedded tissue samples from five cases, including two newborn babies with microcephaly and severe arthrogryposis who died shortly after birth, one 2-month-old baby, and two placentas from spontaneous abortions, from Brazil were submitted to the Infectious Diseases Pathology Branch at the US Centers for Disease Control and Prevention (Atlanta, GA, USA) between December, 2015, and March, 2016. Specimens were assessed by histopathological examination, immunohistochemical assays using a mouse anti-Zika virus antibody, and RT-PCR assays targeting the NS5 and envelope genes. Amplicons of RT-PCR positive cases were sequenced for characterisation of strains.
   Findings Viral antigens were localised to glial cells and neurons and associated with microcalcifications in all three fatal cases with microcephaly. Antigens were also seen in chorionic villi of one of the first trimester placentas. Tissues from all five cases were positive for Zika virus RNA by RT-PCR, and sequence analyses showed highest identities with Zika virus strains isolated from Brazil during 2015.
   Interpretation These findings provide strong evidence of a link between Zika virus infection and different congenital central nervous system malformations, including microcephaly as well as arthrogryposis and spontaneous abortions.
C1 [Martines, Roosecelis Brasil; Bhatnagar, Julu; Keating, M. Kelly; Hale, Gillian; Silva-Flannery, Luciana; Muehlenbachs, Atis; Ritter, Jana; Gary, Joy; Rollin, Dominique; Goldsmith, Cynthia S.; Ermias, Yokabed; Shieh, Wun-Ju; Zaki, Sherif R.] NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA USA.
   [Reagan-Steiner, Sarah] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA USA.
   [de Oliveira Ramos, Ana Maria] Univ Fed Rio Grande do Norte, Dept Pathol, Natal, RN, Brazil.
   [de Oliveira Ramos, Ana Maria; Freire Davi, Helaine Pompeia] Serv Ascertaining Death State Rio Grande Norte SV, Natal, RN, Brazil.
   [Iglezias, Silvia D'Andretta; Kanamura, Cristina Takami] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.
   [Luz, Kleber G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [de Oliveira, Wanderson Kleber] Minist Hlth, Brasilia, DF, Brazil.
   [Lanciotti, Robert; Lambert, Amy] Ctr Dis Control & Prevent, NCEZID, Div Vector Borne Dis, Arboviral Dis Branch, Ft Collins, CO USA.
RP Zaki, SR (corresponding author), Ctr Dis Control & Prevent, NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA 30329 USA.
EM szaki@cdc.gov
RI Oliveira, Wanderson/AAF-5182-2019
OI Oliveira, Wanderson/0000-0002-9662-1930; Ramos, Ana
   Maria/0000-0001-7542-4973
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2016, 32 CLIN VIR S
   Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GV, 2016, LANCET
   FRASER SH, 1994, J PAEDIATR CHILD H, V30, P450, DOI 10.1111/j.1440-1754.1994.tb00701.x
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 29
TC 164
Z9 168
U1 0
U2 94
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 898
EP 904
DI 10.1016/S0140-6736(16)30883-2
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800028
PM 27372395
OA Bronze
DA 2020-07-08
ER

PT J
AU Russell, K
   Oliver, SE
   Lewis, L
   Barfield, WD
   Cragan, J
   Meaney-Delman, D
   Staples, JE
   Fischer, M
   Peacock, G
   Oduyebo, T
   Petersen, EE
   Zaki, S
   Moore, CA
   Rasmussen, SA
AF Russell, Kate
   Oliver, Sara E.
   Lewis, Lillianne
   Barfield, Wanda D.
   Cragan, Janet
   Meaney-Delman, Dana
   Staples, J. Erin
   Fischer, Marc
   Peacock, Georgina
   Oduyebo, Titilope
   Petersen, Emily E.
   Zaki, Sherif
   Moore, Cynthia A.
   Rasmussen, Sonja A.
TI Update: Interim Guidance for the Evaluation and Management of Infants
   with Possible Congenital Zika Virus Infection - United States, August
   2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID TRANSMISSION; CHILDREN; BRAZIL; LABOR
C1 [Russell, Kate; Oliver, Sara E.; Lewis, Lillianne] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Oliver, Sara E.] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Lewis, Lillianne] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Barfield, Wanda D.; Oduyebo, Titilope; Petersen, Emily E.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Cragan, Janet; Moore, Cynthia A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Staples, J. Erin; Fischer, Marc] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Peacock, Georgina] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Zaki, Sherif] CDC, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Russell, K; Oliver, SE (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Russell, K (corresponding author), CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.; Oliver, SE (corresponding author), CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM kerussell@cdc.gov; seoliver@cdc.gov
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Trevathan,
   Edwin/0000-0003-2370-5970; Lewis, Lillianne/0000-0002-0957-2190
CR American Academy of Pediatrics, 2016, HLTH CHILDR
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Birkebaek NH, 2003, J CLIN ENDOCR METAB, V88, P5281, DOI 10.1210/jc.2003-030527
   Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Duffee JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0339
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Kuo DZ, 2012, MATERN CHILD HLTH J, V16, P297, DOI 10.1007/s10995-011-0751-7
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marcin JP, 2016, PEDIATR RES, V79, P169, DOI 10.1038/pr.2015.192
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAWLS WE, 1967, ARCH OPHTHALMOL-CHIC, V77, P430
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 30
TC 77
Z9 77
U1 0
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 26
PY 2016
VL 65
IS 33
BP 870
EP 878
DI 10.15585/mmwr.mm6533e2
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3TO
UT WOS:000382135300007
PM 27559830
OA Bronze
DA 2020-07-08
ER

PT J
AU Collucci, C
AF Collucci, Claudia
TI Brazilian attorneys demand abortion rights for women infected with Zika
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS IN
   Guttmacher Institute, AB LAT AM CAR FACT S
   Instituto Datafolha, OP VIR ZIK FEV 2016
NR 4
TC 3
Z9 3
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 25
PY 2016
VL 354
AR i4657
DI 10.1136/bmj.i4657
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV3AA
UT WOS:000382792200008
PM 27562089
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Valadao, ALC
   Aguiar, RS
   de Arruda, LB
AF Valadao, Ana L. C.
   Aguiar, Renato S.
   de Arruda, Luciana B.
TI Interplay between Inflammation and Cellular Stress Triggered by
   Flaviviridae Viruses
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus; innate immune response; ER stress; reactive oxygen species;
   stress granules
ID HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN
   RESPONSE; PATTERN-RECOGNITION RECEPTORS; IRF3 TRANSCRIPTION FACTOR;
   INNATE IMMUNE-RESPONSES; BETA GENE-EXPRESSION; TOLL-LIKE RECEPTOR-3;
   SPECK-LIKE PROTEIN; FACTOR-KAPPA-B
AB The Flaviviridae family comprises several human pathogens, including Dengue, Zika, Yellow Fever, West Nile, Japanese Encephalitis viruses, and Hepatitis C Virus. Those are enveloped, single-stranded positive sense RNA viruses, which replicate mostly in intracellular compartments associated to endoplasmic reticulum (ER) and Golgi complex. Virus replication results in abundant viral RNAs and proteins, which are recognized by cellular mechanisms evolved to prevent virus infection, resulting in inflammation and stress responses. Virus RNA molecules are sensed by Toll-like receptors (TLRs), RIG-I-like receptors (RIG-I and MDA5) and RNA-dependent protein kinases (PKR), inducing the production of inflammatory mediators and interferons. Simultaneously, the synthesis of virus RNA and proteins are distinguished in different compartments such as mitochondria, ER and cytoplasmic granules, triggering intracellular stress pathways, including oxidative stress, unfolded protein response pathway, and stress granules assembly. Here, we review the new findings that connect the inflammatory pathways to cellular stress sensors and the strategies of Flaviviridae members to counteract these cellular mechanisms and escape immune response.
C1 [Valadao, Ana L. C.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
RP de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
EM arruda@micro.ufrj.br
RI Arruda, Luciana B/N-9086-2013; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, and FAPERJ.
   AV is the recipient of a FAPERJ fellowship.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Asdonk T, 2012, BIOCHEM BIOPH RES CO, V420, P66, DOI 10.1016/j.bbrc.2012.02.116
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888
   Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005
   Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004
   Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673
   Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Chakrabarti A, 2012, J VIROL, V86, P11311, DOI 10.1128/JVI.00270-12
   Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082
   Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50
   Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953
   Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Daito T, 2014, GASTROENTEROLOGY, V147, P463, DOI 10.1053/j.gastro.2014.04.035
   Dang SS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-424
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004
   Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948
   Eksioglu EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021186
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Finnen RL, 2012, J VIROL, V86, P8119, DOI 10.1128/JVI.00313-12
   Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004
   Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019
   Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010
   Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652
   Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352
   He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833
   He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926
   Iglesias NG, 2009, VIRAL GENOME REPLICATION, P41, DOI 10.1007/b135974_3
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Ishikawa H, 2008, NATURE, V456, P274, DOI 10.1038/nature07432
   Ivanov AV, 2015, VIRUSES-BASEL, V7, P2745, DOI 10.3390/v7062745
   Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Jain B, 2014, MICROB PATHOGENESIS, V69-70, P45, DOI 10.1016/j.micpath.2014.03.004
   Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006
   Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251
   Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221
   Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kim HJ, 2015, AM J RESP CELL MOL, V53, P525, DOI 10.1165/rcmb.2014-0334OC
   Kim SK, 2015, PUBLIC MANAG REV, V17, P328, DOI 10.1080/14719037.2013.822530
   Klassen P, 2004, NUTRITION, V20, P542, DOI 10.1016/j.nut.2004.03.016
   Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2
   Langereis MA, 2013, J VIROL, V87, P6314, DOI 10.1128/JVI.03213-12
   Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527
   Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390
   Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7
   Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690
   Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008
   Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7
   Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007
   Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108
   Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210
   Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782
   Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007
   Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328
   Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823
   Mottola G, 2002, VIROLOGY, V293, P31, DOI 10.1006/viro.2001.1229
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Nazmi A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00347
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031
   Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008
   Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7
   Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x
   Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pesne V, 2015, J VIROL, V89, P5462, DOI 10.1128/JVI.03197-14
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415
   Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09
   Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Qin CF, 2011, MOL BIOL REP, V38, P3867, DOI 10.1007/s11033-010-0502-7
   Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11
   Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017
   Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0
   SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Sen D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00250
   Seronello S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027436
   Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Sou SN, 2012, BIOCHEM BIOPH RES CO, V420, P473, DOI 10.1016/j.bbrc.2012.03.030
   Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930
   Soundravally R, 2008, ACTA TROP, V106, P156, DOI 10.1016/j.actatropica.2008.03.001
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054
   Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520
   Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492
   Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078
   Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002
   Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372
   Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387
   Tsai WC, 2014, ANNU REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819
   Valiente-Echeverria F, 2012, VIRUS RES, V169, P430, DOI 10.1016/j.virusres.2012.06.004
   Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009
   Vasallo C, 2015, VIRUS RES, V209, P100, DOI 10.1016/j.virusres.2015.03.013
   von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x
   White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001
   Williams KL, 2009, ANN NY ACAD SCI, V1171, pE12, DOI 10.1111/j.1749-6632.2009.05057.x
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291
   Xu Z, 1998, J INTERF CYTOK RES, V18, P609, DOI 10.1089/jir.1998.18.609
   Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1
   Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552
   Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012
   Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09
   Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2
   Zhou RB, 2011, NATURE, V475, DOI 10.1038/nature10156
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
   Zou J, 2013, IMMUNITY, V38, P717, DOI 10.1016/j.immuni.2012.12.007
NR 209
TC 23
Z9 24
U1 0
U2 23
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 25
PY 2016
VL 7
AR 1233
DI 10.3389/fmicb.2016.01233
PG 19
WC Microbiology
SC Microbiology
GA DT9VS
UT WOS:000381851000001
PM 27610098
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yockey, LJ
   Varela, L
   Rakib, T
   Khoury-Hanold, W
   Fink, SL
   Stutz, B
   Szigeti-Buck, K
   Van den Pol, A
   Lindenbach, BD
   Horvath, TL
   Iwasaki, A
AF Yockey, Laura J.
   Varela, Luis
   Rakib, Tasfia
   Khoury-Hanold, William
   Fink, Susan L.
   Stutz, Bernardo
   Szigeti-Buck, Klara
   Van den Pol, Anthony
   Lindenbach, Brett D.
   Horvath, Tamas L.
   Iwasaki, Akiko
TI Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain
   Infection
SO CELL
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; TOLL-LIKE RECEPTORS; INNATE IMMUNITY;
   UNITED-STATES; MOUSE MODEL; RIG-I; CELLS; ENCEPHALITIS; RECOGNITION;
   INDUCTION
AB Zika virus (ZIKV) can be transmitted sexually between humans. However, it is unknown whether ZIKV replicates in the vagina and impacts the unborn fetus. Here, we establish a mouse model of vaginal ZIKV infection and demonstrate that, unlike other routes, ZIKV replicates within the genital mucosa even in wild-type (WT) mice. Mice lacking RNA sensors or transcription factors IRF3 and IRF7 resulted in higher levels of local viral replication. Furthermore, mice lacking the type I interferon (IFN) receptor (IFNAR) became viremic and died of infection after a high-dose vaginal ZIKV challenge. Notably, vaginal infection of pregnant dams during early pregnancy led to fetal growth restriction and infection of the fetal brain in WT mice. This was exacerbated in mice deficient in IFN pathways, leading to abortion. Our study highlights the vaginal tract as a highly susceptible site of ZIKV replication and illustrates the dire disease consequences during pregnancy.
C1 [Yockey, Laura J.; Rakib, Tasfia; Khoury-Hanold, William; Fink, Susan L.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.
   [Varela, Luis; Stutz, Bernardo; Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.
   [Fink, Susan L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA.
   [Van den Pol, Anthony] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.
   [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.
   [Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.
RP Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856; Stutz, Bernardo/0000-0001-5282-6400;
   Fink, Susan/0000-0003-1705-0103
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute; National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI054359]; NIH
   Medical Scientist Training Program Training GrantUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [T32 GM007205];  [K08 AI119142]
FX We thank Huiping Dong for technical support and the members of the Erol
   Fikrig laboratory for helpful discussions. We thank Dr. Marie Flamand at
   the Institut Pasteur in Paris for providing us the antibody to NS1. This
   work was supported by the Howard Hughes Medical Institute, and National
   Institutes of Health (NIH) grants R01 AI054359 (A.I.). L.J.Y. is
   supported by NIH Medical Scientist Training Program Training Grant T32
   GM007205. S.L.F. is supported by K08 AI119142.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   PARR MB, 1994, LAB INVEST, V70, P369
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926
   Prisant N., 2016, LANCET INFECT DIS
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Venturi G, 2016, EURO SURVEILL, V21
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 53
TC 211
Z9 216
U1 1
U2 74
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 25
PY 2016
VL 166
IS 5
BP 1247
EP +
DI 10.1016/j.cell.2016.08.004
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DU5NW
UT WOS:000382259500020
PM 27565347
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Larocca, RA
   Abbink, P
   Peron, JPS
   Zanotto, PMD
   Iampietro, MJ
   Badamchi-Zadeh, A
   Boyd, M
   Ng'ang'a, D
   Kirilova, M
   Nityanandam, R
   Mercado, NB
   Li, ZF
   Moseley, ET
   Bricault, CA
   Borducchi, EN
   Giglio, PB
   Jetton, D
   Neubauer, G
   Nkolola, JP
   Maxfield, LF
   De La Barrera, RA
   Jarman, RG
   Eckels, KH
   Michael, NL
   Thomas, SJ
   Barouch, DH
AF Larocca, Rafael A.
   Abbink, Peter
   Peron, Jean Pierre S.
   Zanotto, Paolo M. de A.
   Iampietro, M. Justin
   Badamchi-Zadeh, Alexander
   Boyd, Michael
   Ng'ang'a, David
   Kirilova, Marinela
   Nityanandam, Ramya
   Mercado, Noe B.
   Li, Zhenfeng
   Moseley, Edward T.
   Bricault, Christine A.
   Borducchi, Erica N.
   Giglio, Patricia B.
   Jetton, David
   Neubauer, George
   Nkolola, Joseph P.
   Maxfield, Lori F.
   De La Barrera, Rafael A.
   Jarman, Richard G.
   Eckels, Kenneth H.
   Michael, Nelson L.
   Thomas, Stephen J.
   Barouch, Dan H.
TI Vaccine protection against Zika virus from Brazil
SO NATURE
LA English
DT Article
ID NEUTRALIZING ANTIBODY; HEALTHY-ADULTS; CHALLENGE; IMMUNOGENICITY;
   INFECTION; AMERICA; SAFETY; MODEL; MICE
AB Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans(3-8) and mice(9-11). The rapid development of a safe and effective ZIKV vaccine is a global health priority(1,2), but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization with a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a strain of ZIKV involved in the outbreak in northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice(11). We produced DNA vaccines expressing ZIKV pre-membrane and envelope (prM-Env), as well as a series of deletion mutants. The prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV, as measured by absence of detectable viraemia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and depletion of CD4 and CD8 T lymphocytes in vaccinated mice did not abrogate this protection. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans is likely to be achievable.
C1 [Larocca, Rafael A.; Abbink, Peter; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil.
   [De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Peron, Jean Pierre S/F-9248-2012; Barouch, Dan/Y-3918-2019; de A.
   Zanotto, Paolo M./B-9286-2019
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Jetton,
   David/0000-0002-1615-9986; Maxfield, Lori/0000-0002-7595-6205; Peron,
   Jean Pierre/0000-0003-1638-8866
FU Ragon Institute of MGH, MIT, and Harvard; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI095985, AI096040, AI100663,
   AI124377]; Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [FAPESP 2011/18703-2, 2014/17766-9]
FX We thank P. Vasconcelos, K. Modjarrad, R. Olson, K. Kabra, C. Kannadka,
   C. Springer, G. Ballarini, G. Alter, K. Stephenson, F. Stephens, B. Lee,
   J. Jimenez, A. Chandrashekar, P. Penaloza and C. Cabral for generous
   advice, assistance and reagents. We acknowledge support from the Ragon
   Institute of MGH, MIT, and Harvard, the National Institutes of Health
   (AI095985, AI096040, AI100663, AI124377), and the Sao Paulo Research
   Foundation (FAPESP 2011/18703-2, 2014/17766-9). The views expressed in
   this manuscript are those of the authors and do not represent the
   official views of the Department of the Army or the Department of
   Defense.
CR Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DEMICHELI V, 2000, COCHRANE DB SYST REV
   Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
NR 30
TC 277
Z9 292
U1 10
U2 114
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 25
PY 2016
VL 536
IS 7617
BP 474
EP +
DI 10.1038/nature18952
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0YL
UT WOS:000382646600045
PM 27355570
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Acharya, D
   Bastola, P
   Le, LD
   Paul, AM
   Fernandez, E
   Diamond, MS
   Miao, WJ
   Bai, FW
AF Acharya, Dhiraj
   Bastola, Pradip
   Le, Linda
   Paul, Amber M.
   Fernandez, Estefania
   Diamond, Michael S.
   Miao, Wujian
   Bai, Fengwei
TI An ultrasensitive electrogenerated chemiluminescence-based immunoassay
   for specific detection of Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SENSITIVE DETERMINATION; CAPILLARY-ELECTROPHORESIS; HIGH AMPLIFICATION;
   HUMAN SERUM; INFECTION; DENGUE; TRANSMISSION; EXPLOSIVES; BIOSENSOR;
   DISEASE
AB Zika virus (ZIKV) is a globally emerging mosquito-transmitted flavivirus that can cause severe fetal abnormalities, including microcephaly. As such, highly sensitive, specific, and cost-effective diagnostic methods are urgently needed. Here, we report a novel electrogenerated chemiluminescence (ECL)-based immunoassay for ultrasensitive and specific detection of ZIKV in human biological fluids. We loaded polystyrene beads (PSB) with a large number of ECL labels and conjugated them with anti-ZIKV monoclonal antibodies to generate anti-ZIKV-PSBs. These anti-ZIKV-PSBs efficiently captured ZIKV in solution forming ZIKV-anti-ZIKV-PSB complexes, which were subjected to measurement of ECL intensity after further magnetic beads separation. Our results show that the anti-ZIKV-PSBs can capture as little as 1 PFU of ZIKV in 100 mu l of saline, human plasma, or human urine. This platform has the potential for development as a cost-effective, rapid and ultrasensitive assay for the detection of ZIKV and possibly other viruses in clinical diagnosis, epidemiologic and vector surveillance, and laboratory research.
C1 [Acharya, Dhiraj; Le, Linda; Paul, Amber M.; Bai, Fengwei] Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
   [Bastola, Pradip; Miao, Wujian] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Bai, FW (corresponding author), Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.; Miao, WJ (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
EM wujian.miao@usm.edu; fengwei.bai@usm.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Paul, Amber/0000-0002-1657-3618
FU National Science Foundation CAREER awardNational Science Foundation
   (NSF) [CHE-0955878]; National Institute of Allergy and Infectious
   Diseases of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R15AI113706, R01 AI073755]
FX We thank Dr. Barbara W. Johnson (CDC Arbovirus Branch, Fort Collins CO)
   for providing ZIKV, Dr. Robert B. Tesh (University of Texas Medical
   Branch) for providing CHIKV, and Dr. John F. Anderson at the Connecticut
   Agricultural Experiment Station for providing WNV and dengue viruses. We
   thank Dr. Jennifer Givero and Derek Platt for technical help with
   generating antibodies. We also thank Mississippi-IDeA Network of
   Biomedical Research Excellence (MS-INBRE) for the use of research
   facility. This work was supported in part by financial support from the
   National Science Foundation CAREER award (CHE-0955878, W.M.) and
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (R15AI113706 to F.B. and R01 AI073755 to M.S.D.).
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Doeven EH, 2014, ANAL CHEM, V86, P2727, DOI 10.1021/ac404135f
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hao N, 2016, ANAL BIOANAL CHEM, V408, P7035, DOI 10.1007/s00216-016-9548-2
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li Y, 2008, ELECTROCHEM COMMUN, V10, P1322, DOI 10.1016/j.elecom.2008.06.027
   Liu X, 2008, ANAL CHEM, V80, P5377, DOI 10.1021/ac8003715
   Liu YM, 2008, ELECTROPHORESIS, V29, P3207, DOI 10.1002/elps.200800048
   Liu YM, 2008, J SEP SCI, V31, P2463, DOI 10.1002/jssc.200800034
   Ma F, 2012, BIOSENS BIOELECTRON, V32, P37, DOI 10.1016/j.bios.2011.11.011
   McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1914
   Miao WJ, 2004, ANAL CHEM, V76, P7109, DOI 10.1021/ac048782s
   Miao WJ, 2004, ANAL CHEM, V76, P5379, DOI 10.1021/ac0495236
   Miao WJ, 2004, MG ELEC CH, P213
   Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Parajuli S, 2013, ANAL CHEM, V85, P8008, DOI 10.1021/ac401962b
   Parajuli S, 2009, ANAL CHEM, V81, P5267, DOI 10.1021/ac900489a
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pittman TL, 2009, ANAL CHIM ACTA, V632, P197, DOI 10.1016/j.aca.2008.11.032
   Rabenau HF, 2007, J CLIN VIROL, V40, P93, DOI 10.1016/j.jcv.2007.07.009
   Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Sun B, 2010, ANAL CHEM, V82, P5046, DOI 10.1021/ac9029289
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Toedter G, 2008, CLIN VACCINE IMMUNOL, V15, P42, DOI 10.1128/CVI.00211-07
   Wang SJ, 2010, PHYS CHEM CHEM PHYS, V12, P10073, DOI 10.1039/c0cp00545b
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Xu SJ, 2010, ANAL CHEM, V82, P9566, DOI 10.1021/ac102296g
NR 59
TC 19
Z9 19
U1 2
U2 114
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 24
PY 2016
VL 6
AR 32227
DI 10.1038/srep32227
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT9WC
UT WOS:000381852000001
PM 27554037
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Yip, CCY
   Tsang, JOL
   Tee, KM
   Cai, JP
   Chik, KKH
   Zhu, Z
   Chan, CCS
   Choi, GKY
   Sridhar, S
   Zhang, AJ
   Lu, G
   Chiu, K
   Lo, ACY
   Tsao, SW
   Kok, KH
   Jin, DY
   Chan, KH
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Yip, Cyril Chik-Yan
   Tsang, Jessica Oi-Ling
   Tee, Kah-Meng
   Cai, Jian-Piao
   Chik, Kenn Ka-Heng
   Zhu, Zheng
   Chan, Chris Chung-Sing
   Choi, Garnet Kwan-Yue
   Sridhar, Siddharth
   Zhang, Anna Jinxia
   Lu, Gang
   Chiu, Kin
   Lo, Amy Cheuk-Yin
   Tsao, Sai-Wah
   Kok, Kin-Hang
   Jin, Dong-Yan
   Chan, Kwok-Hung
   Yuen, Kwok-Yung
TI Differential cell line susceptibility to the emerging Zika virus:
   implications for disease pathogenesis, non-vector-borne human
   transmission and animal reservoirs
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE animal; cell line; flavivirus; placenta; transmission; tropism; virus;
   Zika
ID SEXUAL TRANSMISSION; INFECTION; EPIDEMIC; DENGUE; EMERGENCE; URINE;
   MOUSE; MODEL; RNA
AB Zika virus (ZIKV) is unique among human-pathogenic flaviviruses by its association with congenital anomalies and trans-placental and sexual human-to-human transmission. Although the pathogenesis of ZIKV-associated neurological complications has been reported in recent studies, key questions on the pathogenesis of the other clinical manifestations, non-vector-borne transmission and potential animal reservoirs of ZIKV remain unanswered. We systematically characterized the differential cell line susceptibility of 18 human and 15 nonhuman cell lines to two ZIKV isolates (human and primate) and dengue virus type 2 (DENV-2). Productive ZIKV replication (>= 2 log increase in viral load, ZIKV nonstructural protein-1 (NS1) protein expression and cytopathic effects (CPE)) was found in the placental (JEG-3), neuronal (SF268), muscle (RD), retinal (ARPE19), pulmonary (Hep-2 and HFL), colonic (Caco-2), and hepatic (Huh-7) cell lines. These findings helped to explain the trans-placental transmission and other clinical manifestations of ZIKV. Notably, the prostatic (LNCaP), testicular (833KE) and renal (HEK) cell lines showed increased ZIKV load and/or NS1 protein expression without inducing CPE, suggesting their potential roles in sexual transmission with persistent viral replication at these anatomical sites. Comparatively, none of the placental and genital tract cell lines allowed efficient DENV-2 replication. Among the nonhuman cell lines, nonhuman primate (Vero and LLC-MK2), pig (PK-15), rabbit (RK-13), hamster (BHK21) and chicken (DF-1) cell lines supported productive ZIKV replication. These animal species may be important reservoirs and/or potential animal models for ZIKV. The findings in our study help to explain the viral shedding pattern, transmission and pathogenesis of the rapidly disseminating ZIKV, and are useful for optimizing laboratory diagnostics and studies on the pathogenesis and counter-measures of ZIKV.
C1 [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yip, Cyril Chik-Yan; Tsang, Jessica Oi-Ling; Tee, Kah-Meng; Cai, Jian-Piao; Chik, Kenn Ka-Heng; Zhu, Zheng; Chan, Chris Chung-Sing; Choi, Garnet Kwan-Yue; Sridhar, Siddharth; Zhang, Anna Jinxia; Kok, Kin-Hang; Chan, Kwok-Hung; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
   [Lu, Gang] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Chiu, Kin; Lo, Amy Cheuk-Yin] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.
   [Chiu, Kin; Lo, Amy Cheuk-Yin] Univ Hong Kong, Resarch Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.
   [Chiu, Kin] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.
   [Tsao, Sai-Wah; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013; ZHU, ZHENG/P-2173-2016; Kok,
   Kin-Hang/C-4184-2009; Sridhar, Siddharth/J-4061-2019; Lo, Amy Cheuk
   Yin/C-1195-2009
OI Chan, Jasper F. W./0000-0001-6336-6657; ZHU, ZHENG/0000-0002-2035-0804;
   Sridhar, Siddharth/0000-0002-2022-8307; Yuen,
   Kwok-yung/0000-0002-2083-1552; Lo, Amy Cheuk Yin/0000-0003-4239-6851;
   /0000-0003-3426-332X
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region; Seed Funding Programme for Basic Research, the
   University Research Committee, The University of Hong Kong;
   Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, the Ministry of Education of ChinaMinistry of
   Education, China; European UnionEuropean Union (EU) [653316]
FX We thank Tony Schountz (Colorado State University, Fort Collins, CO,
   USA), Kwok-Fai So (The University of Hong Kong, Hong Kong Special
   Administrative Region, China), Stephen Yuen-Wing Shiu (The University of
   Hong Kong, Hong Kong Special Administrative Region, China) and Annie
   Nga-Yin Cheung (The University of Hong Kong, Hong Kong Special
   Administrative Region, China) for facilitation of the study. This work
   was partly supported by the donations of Larry Chi-Kin Yung, and Hui Hoy
   and Chow Sin Lan Charity Fund Limited; and funding from the Consultancy
   Service for Enhancing Laboratory Surveillance of Emerging Infectious
   Diseases of the Department of Health, Hong Kong Special Administrative
   Region; the Seed Funding Programme for Basic Research, the University
   Research Committee, The University of Hong Kong; the Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of China; and the European Virus Archive goes
   Global (EVAg) project that has received funding from the European
   Union's Horizon 2020 research and innovation programme under grant
   agreement NO 653316.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2015, J CLIN MICROBIOL, V53, P2722, DOI 10.1128/JCM.01224-15
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Regina T, 2016, J MED VIROL, V88, P1711, DOI 10.1002/jmv.24533
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS S, VS1473-3099, P30006
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, EM ZIK SIT REP WHO
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yip CCY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-222
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 54
TC 70
Z9 71
U1 0
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 24
PY 2016
VL 5
AR e93
DI 10.1038/emi.2016.99
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1KK
UT WOS:000383401900001
PM 27553173
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Collucci, C
AF Collucci, Claudia
TI Joint research projects will focus on social impact of Zika in Brazil
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 23
PY 2016
VL 354
AR i4624
DI 10.1136/bmj.i4624
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV2ZY
UT WOS:000382792000019
PM 27553292
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Abbasi, J
AF Abbasi, Jennifer
TI HHS Moves to Accelerate Zika Vaccine Development
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD AUG 23
PY 2016
VL 316
IS 8
BP 808
EP 808
DI 10.1001/jama.2016.10817
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT8JL
UT WOS:000381736200003
DA 2020-07-08
ER

PT J
AU Abbasi, J
AF Abbasi, Jennifer
TI HHS Moves to Accelerate Zika Vaccine Development
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD AUG 23
PY 2016
VL 316
IS 8
BP 809
EP 809
DI 10.1001/jama.2016.10817
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL9WG
UT WOS:000394970200001
DA 2020-07-08
ER

PT J
AU Sterkel, M
   Perdomo, HD
   Guizzo, MG
   Barletta, ABF
   Nunes, RD
   Dias, FA
   Sorgine, MHF
   Oliveira, PL
AF Sterkel, Marcos
   Perdomo, Hugo D.
   Guizzo, Melina G.
   Barletta, Ana Beatriz F.
   Nunes, Rodrigo D.
   Dias, Felipe A.
   Sorgine, Marcos H. F.
   Oliveira, Pedro L.
TI Tyrosine Detoxification Is an Essential Trait in the Life History of
   Blood-Feeding Arthropods
SO CURRENT BIOLOGY
LA English
DT Article
ID 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-CYCLOHEXANE-1,3-DIONE NTBC;
   MESOTRIONE; RESISTANCE; INHIBITORS; RESPONSES; IMMUNITY; VECTORS;
   INSECT; ALGAE
AB Blood-feeding arthropods are vectors of infectious diseases such as dengue, Zika, Chagas disease, and malaria [1], and vector control is essential to limiting disease spread. Because these arthropods ingest very large amounts of blood, a protein-rich meal, huge amounts of amino acids are produced during digestion. Previous work on Rhodnius prolixus, a vector of Chagas disease, showed that, among all amino acids, only tyrosine degradation enzymes were overexpressed in the midgut compared to other tissues [2]. Here we demonstrate that tyrosine detoxification is an essential trait in the life history of blood-sucking arthropods. We found that silencing Rhodnius tyrosine aminotransferase (TAT) and 4-hydroxyphenylpyruvate dioxygenase (HPPD), the first two enzymes of the phenylalanine/tyrosine degradation pathway, caused the death of insects after a blood meal. This was confirmed by using the HPPD inhibitor mesotrione, which selectively killed hematophagous arthropods but did not affect non-hematophagous insects. In addition, mosquitoes and kissing bugs died after feeding on mice that had previously received a therapeutic effective oral dose (1 mg/kg) of nitisinone, another HPPD inhibitor used in humans for the treatment of tyrosinemia type I [3]. These findings indicate that HPPD (and TAT) can be a target for the selective control of blood-sucking disease vector populations. Because HPPD inhibitors are extensively used as herbicides and in medicine, these compounds may provide an alternative less toxic to humans and more environmentally friendly than the conventional neurotoxic insecticides that are currently used, with the ability to affect only hematophagous arthropods.
C1 [Sterkel, Marcos; Perdomo, Hugo D.; Guizzo, Melina G.; Barletta, Ana Beatriz F.; Nunes, Rodrigo D.; Dias, Felipe A.; Sorgine, Marcos H. F.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Sorgine, Marcos H. F.; Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
RP Sterkel, M; Oliveira, PL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.; Oliveira, PL (corresponding author), Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
EM msterkel29@gmail.com; pedro@bioqmed.ufrj.br
RI Perdomo, Hugo D./S-2723-2019; Nunes, Rodrigo/J-6859-2012
OI Perdomo, Hugo D./0000-0002-8783-1557; Nunes,
   Rodrigo/0000-0003-1346-291X; Barletta Ferreira, Ana
   Beatriz/0000-0001-9913-3775
CR Beaudegnies R, 2009, BIOORGAN MED CHEM, V17, P4134, DOI 10.1016/j.bmc.2009.03.015
   Cedergreen N, 2005, PEST MANAG SCI, V61, P1152, DOI 10.1002/ps.1117
   Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009
   Ferguson AA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004020
   Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S
   Fuchs S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084865
   GOLDSMITH LA, 1976, BIOCHEM J, V158, P17, DOI 10.1042/bj1580017
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Gurevitz JM, 2012, J MED ENTOMOL, V49, P1379, DOI 10.1603/ME11157
   Hall MG, 2001, BRIT J CLIN PHARMACO, V52, P169, DOI 10.1046/j.0306-5251.2001.01421.x
   Holme E, 2000, Clin Liver Dis, V4, P805, DOI 10.1016/S1089-3261(05)70142-2
   Kawanaka M, 2015, HEPATIC MED-EVID RES, V7, P29, DOI 10.2147/HMER.S79100
   Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614
   Lehane MJ, 2005, BIOL BLOOD SUCKING I
   Lock EA, 2000, TOXICOLOGY, V144, P179, DOI 10.1016/S0300-483X(99)00205-X
   Lock EA, 2006, TOXICOL APPL PHARM, V215, P9, DOI 10.1016/j.taap.2006.01.015
   Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112
   Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E
   Mougabure-Cueto G, 2015, ACTA TROP, V149, P70, DOI 10.1016/j.actatropica.2015.05.014
   Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014
   Ni Y, 2014, ENVIRON SCI-PROC IMP, V16, P2288, DOI [10.1039/c4em00254g, 10.1039/C4EM00254G]
   Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594
   Schwarzenbach GA, 2006, EVOLUTION, V60, P1612, DOI 10.1111/j.0014-3820.2006.tb00506.x
   Scott CR, 2006, AM J MED GENET C, V142C, P121, DOI 10.1002/ajmg.c.30092
   STOERNER JW, 1980, AM J DIS CHILD, V134, P492, DOI 10.1001/archpedi.1980.02130170042014
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   Thimm E, 2011, MOL GENET METAB, V102, P122, DOI 10.1016/j.ymgme.2010.11.003
   Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619
   Vavricka C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016124
   VENCILL WK, 2002, HERBICIDE HDB
   Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895
NR 33
TC 14
Z9 14
U1 0
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD AUG 22
PY 2016
VL 26
IS 16
BP 2188
EP 2193
DI 10.1016/j.cub.2016.06.025
PG 6
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA DU3FO
UT WOS:000382096400030
PM 27476595
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhong, YB
   Liu, XQ
   Deng, YC
   Xu, PH
   Zhong, GR
   Zhang, W
AF Zhong, Yuan-Bin
   Liu, Xiao-Qing
   Deng, Yi-Chu
   Xu, Ping-Hua
   Zhong, Gong-Rong
   Zhang, Wei
TI First Case of Laboratory-confirmed Zika Virus Infection Imported into
   China
SO CHINESE MEDICAL JOURNAL
LA English
DT Letter
ID STATES
C1 [Zhong, Yuan-Bin; Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Dept Infect Dis, 17 Yong Wai Zheng, Nanchang 330006, Jiangxi, Peoples R China.
   [Zhong, Yuan-Bin; Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Dept Resp Med, 17 Yong Wai Zheng, Nanchang 330006, Jiangxi, Peoples R China.
   [Liu, Xiao-Qing] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang 330029, Jiangxi, Peoples R China.
   [Deng, Yi-Chu; Xu, Ping-Hua; Zhong, Gong-Rong] Ganxian Peoples Hosp Ganzhou, Dept Infect Dis, Ganxian 341100, Jiangxi, Peoples R China.
RP Zhang, W (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Infect Dis, 17 Yong Wai Zheng, Nanchang 330006, Jiangxi, Peoples R China.; Zhang, W (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Resp Med, 17 Yong Wai Zheng, Nanchang 330006, Jiangxi, Peoples R China.
EM zhangwei8869@126.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Liuzzi G, 2016, EUR J INTERN MED, V33, pE20, DOI 10.1016/j.ejim.2016.04.022
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 5
TC 9
Z9 12
U1 0
U2 5
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD AUG 20
PY 2016
VL 129
IS 16
BP 2013
EP 2014
DI 10.4103/0366-6999.187864
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV9DG
UT WOS:000383239400023
PM 27503033
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krause, S
AF Krause, Steven
TI Proven vector control methods to reduce the risk of dengue: Lessons for
   Zika
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Krause, Steven] Valent BioSci Corp, Libertyville, IL USA.
EM steve.krause@valent.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 319
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TU
UT WOS:000431460200668
DA 2020-07-08
ER

PT J
AU Alvarado-Socarras, JL
   Sepulveda-Arias, JC
   Zambrano, LI
   Rodriguez-Morales, AJ
AF Alvarado-Socarras, Jorge L.
   Sepulveda-Arias, Juan C.
   Zambrano, Lysien I.
   Rodriguez-Morales, Alfonso J.
TI Relevance of laboratory diagnosis of Zika during pregnancy and its
   possible association with Guillain-Barre syndrome
SO MEDICINA CLINICA
LA English
DT Letter
ID POLYMORPHISMS; VIRUS
C1 [Alvarado-Socarras, Jorge L.; Sepulveda-Arias, Juan C.; Zambrano, Lysien I.; Rodriguez-Morales, Alfonso J.] Red Colombiana Colaborac Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Alvarado-Socarras, Jorge L.; Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, Dept Pediat, Unidad Neonatol, Floridablanca, Santander, Colombia.
   [Sepulveda-Arias, Juan C.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Infecc & Inmunidad, Pereira, Risaralda, Colombia.
   [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Fac Ciencias Med, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med EPM, Sao Paulo, Brazil.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Red Colombiana Colaborac Zika RECOLZIKA, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), OLFIS, Bucaramanga, Santander, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Infecc & Inmunidad, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Zambrano, Lysien/R-5628-2019; Zambrano, Lysien/N-8843-2015; AJ,
   Rodriguez-Morales/R-9765-2016; Sepulveda-Arias, Juan Carlos/F-3969-2010
OI Zambrano, Lysien/0000-0001-9002-5807; Zambrano,
   Lysien/0000-0001-9002-5807; AJ, Rodriguez-Morales/0000-0001-9773-2192;
   Sepulveda-Arias, Juan Carlos/0000-0002-5410-5997
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fekih-Mrissa N, 2014, CLIN NEUROL NEUROSUR, V121, P19, DOI 10.1016/j.clineuro.2014.03.014
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Wu LY, 2012, J NEUROIMMUNOL, V243, P18, DOI 10.1016/j.jneuroim.2011.12.003
   Zafar Mir Sadaqat Hassan, 2013, J Family Med Prim Care, V2, P90, DOI 10.4103/2249-4863.109965
NR 6
TC 0
Z9 0
U1 0
U2 12
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD AUG 19
PY 2016
VL 147
IS 4
BP 182
EP 183
DI 10.1016/j.medcli.2016.03.044
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU9CA
UT WOS:000382512600011
PM 27236614
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AROUND THE WORLD White House diverts funds to Zika
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 19
PY 2016
VL 353
IS 6301
BP 732
EP 732
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZE
UT WOS:000381561400003
DA 2020-07-08
ER

PT J
AU Speer, SD
   Pierson, TC
AF Speer, Scott D.
   Pierson, Theodore C.
TI Diagnostics for Zika virus on the horizon
SO SCIENCE
LA English
DT Editorial Material
ID WEST-NILE-VIRUS; INFECTION; ANTIBODY
C1 [Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Watterson D., 2016, ANTIVIRAL RES, V130
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 15
TC 17
Z9 17
U1 0
U2 89
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 19
PY 2016
VL 353
IS 6301
BP 750
EP 751
DI 10.1126/science.aah6187
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZE
UT WOS:000381561400020
PM 27540152
OA Bronze
DA 2020-07-08
ER

PT J
AU Parry, GJ
   Peacey, M
   Buenz, EJ
AF Parry, Gareth J.
   Peacey, Matthew
   Buenz, Eric J.
TI Little risk of severe complications associated with Zika infection in
   New Zealand
SO NEW ZEALAND MEDICAL JOURNAL
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; UNITED-STATES; TRANSMISSION;
   BRAZIL
AB Zika virus infection has raised considerable concern in New Zealand, but the risks faced by most New Zealanders, while real, are quite small as New Zealand does not harbor the primary mosquito vector. Furthermore, in individuals with a competent immune system, the acute illness caused by Zika virus infection is generally mild. Serious complication associated with Zika virus infections include microcephaly and Guillain-Barre Syndrome. Pacific Island countries have reported cases of Zika virus infection and these climates support the mosquito vector. Thus, travelers to these areas are at risk of infection. New Zealand travelers returning from endemic areas have developed the illness associated with the virus, but the probability of autochthonous transmission in New Zealand is very small.
C1 [Parry, Gareth J.; Peacey, Matthew; Buenz, Eric J.] Nelson Marlborough Inst Technol, 322 Hardy St, Nelson, New Zealand.
RP Parry, GJ (corresponding author), Nelson Marlborough Inst Technol, 322 Hardy St, Nelson, New Zealand.
EM gareth.parry@nmit.ac.nz
OI Peacey, Matthew/0000-0002-4312-8085
CR Baker MG, 2012, EMERG INFECT DIS, V18, P226, DOI 10.3201/eid1802.111126
   Besnard M, 2014, EUROSURVEILLANCE B E, V19
   de Melo Freire CC, BIORXIV
   Fauci AS, 2016, NEW ENGLAND J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   HEYMANN D.L., 2016, LANCET
   Holder P, 2010, J MED ENTOMOL, V47, P600, DOI 10.1603/ME09111
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5
   Lamb RA, 2001, FIELDS VIROLOGY, P1
   Ministry of Health, 2016, ZIK VIR
   Mlakar J, 2016, NEW ENGLAND J MED
   Musso D, 2014, EUROSURVEILLANCE B E, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira Melo AS, ULTRASOUND OBSTET GY
   PARRY GJ, 1993, GUILLAIN BARRE SYNDR
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2
   Rubin EJ, 2016, NEW ENGLAND J MED
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sears A, 2011, EMERG INFECT DIS, V17, P1007, DOI [10.3201/eid1706.101272, 10.3201/eid/1706.101272]
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yang JY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1123-2
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
NR 31
TC 0
Z9 0
U1 0
U2 1
PU NEW ZEALAND MEDICAL ASSOC
PI CHRISTCHURCH
PA C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345,
   CHRISTCHURCH, 00000, NEW ZEALAND
SN 0028-8446
EI 1175-8716
J9 NEW ZEAL MED J
JI N. Z. Med. J.
PD AUG 19
PY 2016
VL 129
IS 1440
BP 108
EP 113
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE3NP
UT WOS:000408123000012
PM 27538044
DA 2020-07-08
ER

PT J
AU Stettler, K
   Beltramello, M
   Espinosa, DA
   Graham, V
   Cassotta, A
   Bianchi, S
   Vanzetta, F
   Minola, A
   Jaconi, S
   Mele, F
   Foglierini, M
   Pedotti, M
   Simonelli, L
   Dowall, S
   Atkinson, B
   Percivalle, E
   Simmons, CP
   Varani, L
   Blum, J
   Baldanti, F
   Cameroni, E
   Hewson, R
   Harris, E
   Lanzavecchia, A
   Sallusto, F
   Corti, D
AF Stettler, Karin
   Beltramello, Martina
   Espinosa, Diego A.
   Graham, Victoria
   Cassotta, Antonino
   Bianchi, Siro
   Vanzetta, Fabrizia
   Minola, Andrea
   Jaconi, Stefano
   Mele, Federico
   Foglierini, Mathilde
   Pedotti, Mattia
   Simonelli, Luca
   Dowall, Stuart
   Atkinson, Barry
   Percivalle, Elena
   Simmons, Cameron P.
   Varani, Luca
   Blum, Johannes
   Baldanti, Fausto
   Cameroni, Elisabetta
   Hewson, Roger
   Harris, Eva
   Lanzavecchia, Antonio
   Sallusto, Federica
   Corti, Davide
TI Specificity, cross-reactivity, and function of antibodies elicited by
   Zika virus infection
SO SCIENCE
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN;
   DETERMINANTS; PATHOGENESIS; ENHANCEMENT; EPITOPES; RECEPTOR; BINDING;
   FEVER
AB Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a public health emergency. By characterizing memory lymphocytes from ZIKV-infected patients, we dissected ZIKV-specific and DENV-cross-reactive immune responses. Antibodies to nonstructural protein 1 (NS1) were largely ZIKV-specific and were used to develop a serological diagnostic tool. In contrast, antibodies against E protein domain I/II (EDI/II) were cross-reactive and, although poorly neutralizing, potently enhanced ZIKV and DENV infection in vitro and lethally enhanced DENV disease in mice. Memory T cells against NS1 or E proteins were poorly cross-reactive, even in donors preexposed to DENV. The most potent neutralizing antibodies were ZIKV-specific and targeted EDIII or quaternary epitopes on infectious virus. An EDIII-specific antibody protected mice from lethal ZIKV infection, illustrating the potential for antibody-based therapy.
C1 [Stettler, Karin; Beltramello, Martina; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Jaconi, Stefano; Cameroni, Elisabetta; Corti, Davide] Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.
   [Espinosa, Diego A.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA USA.
   [Graham, Victoria; Dowall, Stuart; Atkinson, Barry] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Cassotta, Antonino; Foglierini, Mathilde; Pedotti, Mattia; Simonelli, Luca; Varani, Luca; Lanzavecchia, Antonio; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
   [Cassotta, Antonino; Lanzavecchia, Antonio] ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
   [Percivalle, Elena; Baldanti, Fausto] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy.
   [Simmons, Cameron P.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX1 2JD, England.
   [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ctr Trop Med, Ho Chi Minh City, Vietnam.
   [Simmons, Cameron P.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Blum, Johannes] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland.
   [Blum, Johannes] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
RP Corti, D (corresponding author), Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.; Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
EM federica.sallusto@irb.usi.ch; davide.corti@humabs.ch
RI percivalle, elena/K-7994-2016; Baldanti, Fausto/J-4924-2018
OI percivalle, elena/0000-0002-3355-1410; Baldanti,
   Fausto/0000-0002-3358-8969; Atkinson, Barry/0000-0002-1348-7204; varani,
   luca/0000-0002-0963-0987; Cassotta, Antonino/0000-0001-8674-4294;
   Simonelli, Luca/0000-0001-6331-7716; Simmons, Cameron
   P./0000-0002-9039-7392; Bianchi, Siro/0000-0002-5100-8905; Espinosa,
   Diego A./0000-0002-4364-5031
FU European UnionEuropean Union (EU) [HEALTH-F3-2011-281803]; European
   Research CouncilEuropean Research Council (ERC) [323183 PREDICT]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [160279]; U.S. National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI24493]; Ministero della Salute, Fondazione IRCCS Policlinico San
   Matteo, Ricerca CorrenteMinistry of Health, Italy [8020615]; Helmut
   Horten Foundation; SNF [310030_166445]; Lions Club Monteceneri
FX The data presented in this manuscript are tabulated in the main paper
   and in the supplementary materials. The views expressed are those of the
   authors and not necessarily those of the funding bodies. This work was
   supported by grants from the European Union
   (HEALTH-F3-2011-281803-Project IDAMS, "International Research Consortium
   on Dengue Risk Assessment, Management, and Surveillance" to F.S.), the
   European Research Council (grant 323183 PREDICT to F.S.), the Swiss
   National Science Foundation (grant 160279 to A.L.), the U.S. National
   Institutes of Health (grant R01 AI24493 to E.H.), and the Ministero
   della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente
   grant 8020615 (to E.P. and F.B.). A.L. is supported by the Helmut Horten
   Foundation. A.L. is the scientific founder of Humabs BioMed. D.C., A.L.,
   and F.S. hold shares in Humabs BioMed. F.S. and F.B. are a scientific
   advisor and a consultant at Humabs BioMed, respectively. The MAbs
   described in this study are available under a materials transfer
   agreement with Humabs BioMed SA. L.V. is grateful for financial support
   by SNF grant 310030_166445 and Lions Club Monteceneri. A.L. is an
   inventor on a patent related to DENV mAbs described in this study:
   PCT/IB2009/007372 (Dengue virus neutralizing antibodies and uses
   thereof). D.C. is an inventor on a patent application held by Humabs
   BioMed SA related to ZIKV mAbs described in this study:
   PCT/EP2016/066684 (Novel antibodies specifically binding to Zika virus
   epitopes and uses thereof). Antibody nucleotide and amino acid sequences
   for the 68 mAbs described in table S2 have been deposited in GenBank
   (accession nos. KX496807 to KX496874).
CR Aliota M. T., 2016, PLOS NEGLECT TROP D, V10
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowall S. D., 2016, PLOS NEGLECT TROP D, V10
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MONATH TP, 1984, AM J TROP MED HYG, V33, P695, DOI 10.4269/ajtmh.1984.33.695
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ohana B., 2000, CLIN DIAGN LAB IMMUN, V7, P904
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teoh E. P., 2012, SCI TRANSL MED, V4
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
NR 38
TC 353
Z9 367
U1 3
U2 99
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 19
PY 2016
VL 353
IS 6301
BP 823
EP 826
DI 10.1126/science.aaf8505
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZE
UT WOS:000381561400046
PM 27417494
OA Bronze
DA 2020-07-08
ER

PT J
AU Reardon, S
AF Reardon, Sara
TI Cuba's epic battle with Zika
SO NATURE
LA English
DT News Item
NR 0
TC 5
Z9 5
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 18
PY 2016
VL 536
IS 7616
BP 257
EP 258
DI 10.1038/536257a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT9GN
UT WOS:000381804900004
PM 27535512
OA Bronze
DA 2020-07-08
ER

PT J
AU Jurado, KA
   Simoni, MK
   Tang, Z
   Uraki, R
   Hwang, J
   Householder, S
   Wu, MJ
   Lindenbach, BD
   Abrahams, VM
   Guller, S
   Fikrig, E
AF Jurado, Kellie Ann
   Simoni, Michael K.
   Tang, Zhonghua
   Uraki, Ryuta
   Hwang, Jesse
   Householder, Sarah
   Wu, Mingjie
   Lindenbach, Brett D.
   Abrahams, Vikki M.
   Guller, Seth
   Fikrig, Erol
TI Zika virus productively infects primary human placenta-specific
   macrophages
SO JCI INSIGHT
LA English
DT Article
ID CELLS
AB The strong association of Zika virus infection with congenital defects has led to questions of how a flavivirus is capable of crossing the placental barrier to reach the fetal brain. Here, we demonstrate permissive Zika virus infection of primary human placental macrophages, commonly referred to as Hofbauer cells, and placental villous fibroblasts. We also demonstrate Zika virus infection of Hofbauer cells within the context of the tissue ex vivo using term placental villous explants. In addition to amplifying infectious virus within a usually inaccessible area, the putative migratory activities of Hofbauer cells may aid in dissemination of Zika virus to the fetal brain. Understanding the susceptibility of placenta-specific cell types will aid future work around and understanding of Zika virus-associated pregnancy complications.
C1 [Jurado, Kellie Ann; Uraki, Ryuta; Hwang, Jesse; Householder, Sarah; Wu, Mingjie; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Simoni, Michael K.; Tang, Zhonghua; Abrahams, Vikki M.; Guller, Seth] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
   [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA.
RP Fikrig, E (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med,Anlyan Ctr Med Res & Educ, 300 Cedar St, New Haven, CT 06520 USA.
EM erol.fikrig@yale.edu
OI Simoni, Michael/0000-0002-4514-4804
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   DODEUR M, 1990, REPROD NUTR DEV, V30, P183, DOI 10.1051/rnd:19900204
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richardson SJ, 2010, J CLIN VIROL, V49, P180, DOI 10.1016/j.jcv.2010.07.015
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x
   Wang YS Z, 2010, VASCULAR BIOL PLACEN
NR 19
TC 73
Z9 73
U1 0
U2 18
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD AUG 18
PY 2016
VL 1
IS 13
DI 10.1172/jci.insight.88461
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EB1NO
UT WOS:000387119700009
OA Bronze, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Robert, MA
   Christofferson, RC
   Silva, NJB
   Vasquez, C
   Mores, CN
   Wearing, HJ
AF Robert, Michael A.
   Christofferson, Rebecca C.
   Silva, Noah J. B.
   Vasquez, Chalmers
   Mores, Christopher N.
   Wearing, Helen J.
TI Modeling Mosquito-Borne Disease Spread in US Urbanized Areas: The Case
   of Dengue in Miami
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; HUMAN MOVEMENT; HABITAT SEGREGATION; AIR-TRAVEL;
   VIRUS; CULICIDAE; ALBOPICTUS; DISPERSAL; TRANSMISSION; DYNAMICS
AB Expansion of mosquito-borne pathogens into more temperate regions of the world necessitates tools such as mathematical models for understanding the factors that contribute to the introduction and emergence of a disease in populations naive to the disease. Often, these models are not developed and analyzed until after a pathogen is detected in a population. In this study, we develop a spatially explicit stochastic model parameterized with publicly available U.S. Census data for studying the potential for disease spread in Urbanized Areas of the United States. To illustrate the utility of the model, we specifically study the potential for introductions of dengue to lead to autochthonous transmission and outbreaks in a population representative of the Miami Urbanized Area, where introductions of dengue have occurred frequently in recent years. We describe seasonal fluctuations in mosquito populations by fitting a population model to trap data provided by the Miami-Dade Mosquito Control Division. We show that the timing and location of introduced cases could play an important role in determining both the probability that local transmission occurs as well as the total number of cases throughout the entire region following introduction. We show that at low rates of clinical presentation, small outbreaks of dengue could go completely undetected during a season, which may confound mitigation efforts that rely upon detection. We discuss the sensitivity of the model to several critical parameter values that are currently poorly characterized and motivate the collection of additional data to strengthen the predictive power of this and similar models. Finally, we emphasize the utility of the general structure of this model in studying mosquito-borne diseases such as chikungunya and Zika virus in other regions.
C1 [Robert, Michael A.; Silva, Noah J. B.; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.
   [Robert, Michael A.; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.
   [Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
   [Vasquez, Chalmers] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Robert, MA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Robert, MA (corresponding author), Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.
EM marobert@unm.edu
FU National Institutes of Health/NIGMS program for Models of Infectious
   Disease Agent Study (MIDAS) [U01GM097661]
FX This project was supported by the National Institutes of Health/NIGMS
   program for Models of Infectious Disease Agent Study (MIDAS) grant
   U01GM097661. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   ANDERSON R M, 1991
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282
   de Jong M.C.M., 1995, EPIDEMIC MODELS THEI, P84
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056
   Erlander S., 1990, GRAVITY MODEL TRANSP
   Feldstein LR, 2015, T ROY SOC TROP MED H, P1
   Florida Department of Health, 2015, WEEKL SURV INF MOSQ
   Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2
   Guagliardo SA, 2015, J MED ENTOMOL, V52, P726, DOI 10.1093/jme/tjv048
   Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Miami-Dade Aviation Department, 2013, 2013 ANN REP MIAM IN
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0
   Ross R, 1910, PREVENTION MALARIA
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   The Bureau of Transportation Statistics, 2015, STATE TRANSPORTATION
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   U. S. Census Bureau, 2010, 2010 CENS POP HOUS T
   U. S. Census Bureau, 2010, TIG LIN SHAP TIG LIN
   U. S. Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   U. S. Centers for Disease Control and Prevention, 2014, CHIK VIR US 2014
   U. S. Department of Transportation Bureau of Transportation Statistics, 2012, CRUIS SHIP STAT
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   World Health Organization, 2015, DENG SEV DENG FACT S
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
NR 78
TC 14
Z9 14
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2016
VL 11
IS 8
AR e0161365
DI 10.1371/journal.pone.0161365
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4YN
UT WOS:000381487600088
PM 27532496
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paz-Soldan, VA
   Yukich, J
   Soonthorndhada, A
   Giron, M
   Apperson, CS
   Ponnusamy, L
   Schal, C
   Morrison, AC
   Keating, J
   Wesson, DM
AF Paz-Soldan, Valerie A.
   Yukich, Josh
   Soonthorndhada, Amara
   Giron, Maziel
   Apperson, Charles S.
   Ponnusamy, Loganathan
   Schal, Coby
   Morrison, Amy C.
   Keating, Joseph
   Wesson, Dawn M.
TI Design and Testing of Novel Lethal Ovitrap to Reduce Populations of
   Aedes Mosquitoes: Community-Based Participatory Research between
   Industry, Academia and Communities in Peru and Thailand
SO PLOS ONE
LA English
DT Article
ID TREATED-BED NETS; AEGYPTI DIPTERA; CONTROL STRATEGIES; MALARIA CONTROL;
   PUERTO-RICO; ZIKA VIRUS; CHIKUNGUNYA; CULICIDAE; DENGUE; PREFERENCES
AB Background
   Dengue virus (and Chikungunya and Zika viruses) is transmitted by Aedes aegypti and Aedes albopictus mosquitoes and causes considerable human morbidity and mortality. As there is currently no vaccine or chemoprophylaxis to protect people from dengue virus infection, vector control is the only viable option for disease prevention. The purpose of this paper is to illustrate the design and placement process for an attractive lethal ovitrap to reduce vector populations and to describe lessons learned in the development of the trap.
   Methods
   This study was conducted in 2010 in Iquitos, Peru and Lopburi Province, Thailand and used an iterative community-based participatory approach to adjust design specifications of the trap, based on community members' perceptions and feedback, entomological findings in the lab, and design and research team observations. Multiple focus group discussions (FGD) were held over a 6 month period, stratified by age, sex and motherhood status, to inform the design process. Trap testing transitioned from the lab to within households.
   Results
   Through an iterative process of working with specifications from the research team, findings from the laboratory testing, and feedback from FGD, the design team narrowed trap design options from 22 to 6. Comments from the FGD centered on safety for children and pets interacting with traps, durability, maintenance issues, and aesthetics. Testing in the laboratory involved releasing groups of 50 gravid Ae. aegypti in walk-in rooms and assessing what percentage were caught in traps of different colors, with different trap cover sizes, and placed under lighter or darker locations. Two final trap models were mocked up and tested in homes for a week; one model was the top choice in both Iquitos and Lopburi.
   Discussion
   The community-based participatory process was essential for the development of novel traps that provided effective vector control, but also met the needs and concerns of community members.
C1 [Paz-Soldan, Valerie A.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.
   [Paz-Soldan, Valerie A.] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru.
   [Paz-Soldan, Valerie A.; Yukich, Josh; Keating, Joseph] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA.
   [Yukich, Josh; Keating, Joseph; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, 1440 Canal St, New Orleans, LA 70112 USA.
   [Soonthorndhada, Amara] Mahidol Univ, Inst Populat & Social Res, Phuthamontol 73170, Nakornpathom, Thailand.
   [Giron, Maziel] San Jose State Univ, Dept Hlth Sci & Recreat, 1 Washington Sq, San Jose, CA 95192 USA.
   [Apperson, Charles S.; Ponnusamy, Loganathan; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.
   [Morrison, Amy C.] Univ Calif Davis, Dept Entomol & Nematol, One Shields Ave, Davis, CA 95616 USA.
   [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, 1440 Canal St, New Orleans, LA 70112 USA.
RP Paz-Soldan, VA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.; Paz-Soldan, VA (corresponding author), Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru.; Paz-Soldan, VA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA.
EM vpazsold@tulane.edu
RI Schal, Coby/A-8717-2010
OI Schal, Coby/0000-0001-7195-6358; Ponnusamy,
   Loganathan/0000-0002-0700-4472; Paz-Soldan, Valerie/0000-0002-1065-4919
FU Bill and Melinda Gates FoundationGates Foundation [50025]; National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5
   U01 AI 58303-05]; National Institutes of Health Fogarty International
   CenterUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [K01TW008414-01A1]
FX This study was made possible by the generous support of Bill and Melinda
   Gates Foundation Grant #50025 (PI: DMW), the National Institute of
   Allergy and Infectious Diseases (NIAID) Grant # 5 U01 AI 58303-05, and
   the National Institutes of Health Fogarty International Center Grant
   K01TW008414-01A1 (to VPS). The contents are the responsibility of the
   authors and do not necessarily reflect the views of either institution.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   AIKINS MK, 1994, J TROP MED HYG, V97, P81
   ALLAN SA, 1994, J AM MOSQUITO CONTR, V10, P266
   ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O
   Apperson C, 2007, AM J TROP MED HYG, V77, P254
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bernard H.R., 2006, RES METHODS ANTHR QU
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377
   D'Alessandro U, 2001, BRIT MED J, V322, P249, DOI 10.1136/bmj.322.7281.249
   Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gyapong M, 1996, TROP MED INT HEALTH, V1, P328, DOI 10.1046/j.1365-3156.1996.d01-41.x
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Instituto Nacional de Estadistica e Informatica Peru, 2009, EST PROYECC POBL TOT
   Lengeler C, 2004, COCHRANE DB SYST REV, pCD000363
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199
   MACCORMACK CP, 1986, J TROP MED HYG, V89, P295
   Maketa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084314
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   National Statistical Office, 2010, 2010 POP HOUS CENS
   Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Ponnusamy L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1068-y
   Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2
   Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wesson DM, 2013, AM J TROP MED HYG  S, V89
   Wiseman V, 2007, AM J TROP MED HYG, V76, P830, DOI 10.4269/ajtmh.2007.76.830
   World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P450
NR 41
TC 7
Z9 7
U1 0
U2 61
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2016
VL 11
IS 8
AR e0160386
DI 10.1371/journal.pone.0160386
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4YN
UT WOS:000381487600028
PM 27532497
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI More Insights Into Zika Virus Infection and Birth Outcomes
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
CR Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
NR 2
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD AUG 16
PY 2016
VL 316
IS 7
BP 702
EP 702
DI 10.1001/jama.2016.10895
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT5IA
UT WOS:000381514800006
DA 2020-07-08
ER

PT J
AU Zhang, Y
   Zhao, B
   Roy, S
   Saha, TT
   Kokoza, VA
   Li, M
   Raikhel, AS
AF Zhang, Yang
   Zhao, Bo
   Roy, Sourav
   Saha, Tusar T.
   Kokoza, Vladimir A.
   Li, Ming
   Raikhel, Alexander S.
TI microRNA-309 targets the Homeobox gene SIX4 and controls ovarian
   development in the mosquito Aedes aegypti
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Homeobox protein gene; microRNA; CRISPR/Cas9; ovary; fast evolution
ID FAT-BODY; WOLBACHIA USES; ZIKA VIRUS; VECTOR; DRIVE; TRANSMISSION;
   CRISPR-CAS9; EXPRESSION; PREDICTION; MANIPULATE
AB Obligatory blood-triggered reproductive strategy is an evolutionary adaptation of mosquitoes for rapid egg development. It contributes to the vectorial capacity of these insects. Therefore, understanding the molecular mechanisms underlying reproductive processes is of particular importance. Here, we report that microRNA-309 (miR-309) plays a critical role in mosquito reproduction. A spatiotemporal expression profile of miR-309 displayed its blood feeding-dependent onset and ovary-specific manifestation in female Aedes aegypti mosquitoes. Antagomir silencing of miR-309 impaired ovarian development and resulted in nonsynchronized follicle growth. Furthermore, the genetic disruption of miR-309 by CRISPR/Cas9 system led to the developmental failure of primary follicle formation. Examination of genomic responses to miR-309 depletion revealed that several pathways associated with ovarian development are down-regulated. Comparative analysis of genes obtained from the high-throughput RNA sequencing of ovarian tissue from the miR-309 antagomirsilenced mosquitoes with those from the in silico computation target prediction identified that the gene-encoding SIX homeobox 4 protein (SIX4) is a putative target of miR-309. Reporter assay and RNA immunoprecipitation confirmed that SIX4 is a direct target of miR-309. RNA interference of SIX4 was able to rescue phenotypic manifestations caused by miR-309 depletion. Thus, miR-309 plays a critical role in mosquito reproduction by targeting SIX4 in the ovary and serves as a regulatory switch permitting a stage-specific degradation of the ovarian SIX4 mRNA. In turn, this microRNA (miRNA)targeted degradation is required for appropriate initiation of a blood feeding-triggered phase of ovarian development, highlighting involvement of this miRNA in mosquito reproduction.
C1 [Zhang, Yang; Zhao, Bo; Roy, Sourav; Saha, Tusar T.; Kokoza, Vladimir A.; Li, Ming; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Zhang, Yang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
   [Zhao, Bo; Roy, Sourav; Saha, Tusar T.; Kokoza, Vladimir A.; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
RP Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (corresponding author), Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu
OI Zhang, Yang/0000-0002-0789-4938
FU NIH GrantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI113729]; China Scholarship
   Council of Chinese Ministry of Education Scholar Fellowship
   [201408440009]
FX This work was supported by NIH Grant R01 AI113729 (to A.S.R.) and China
   Scholarship Council of Chinese Ministry of Education Scholar Fellowship
   201408440009.
CR Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932
   Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Berry S J, 1985, Dev Biol (N Y 1985), V1, P351
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031
   Clark IBN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-52
   Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163
   Enright AJ, 2004, GENOME BIOL, V5
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fujimoto Y, 2013, DEV CELL, V26, P416, DOI 10.1016/j.devcel.2013.06.018
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Huynh JR, 2000, DEVELOPMENT, V127, P2785
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Lucas KJ, 2015, CURR OPIN INSECT SCI, V11, P1, DOI 10.1016/j.cois.2015.06.004
   Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113
   RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245
   Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111
   Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021
   Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014
   Ziegler R, 1997, EUR J ENTOMOL, V94, P385
NR 46
TC 38
Z9 42
U1 4
U2 100
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 16
PY 2016
VL 113
IS 33
BP E4828
EP E4836
DI 10.1073/pnas.1609792113
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3RS
UT WOS:000381399200012
PM 27489347
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lewnard, JA
   Gonsalves, G
   Ko, AI
AF Lewnard, Joseph A.
   Gonsalves, Gregg
   Ko, Albert I.
TI Low Risk of International Zika Virus Spread due to the 2016 Olympics in
   Brazil
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID RIO-DE-JANEIRO; GAMES
C1 Global Hlth Justice Partnership, Yale Sch Publ Hlth, New Haven, CT USA.
   Yale Univ, Yale Law Sch, New Haven, CT USA.
   Minist Saude, Salvador, BA, Brazil.
   [Lewnard, Joseph A.; Ko, Albert I.] Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
   [Gonsalves, Gregg] Yale Global Hlth Justice Partnership, POB 208215, New Haven, CT 06520 USA.
RP Lewnard, JA (corresponding author), Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
EM joseph.lewnard@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW009504]; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI121207]
CR Attaran A, COMMUNICATION
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   Lessler J, 2016, B WORLD HEALTH ORGAN, P1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Secretaria de Vigilancia em Saude-Ministerio da Saude, PROT VIG RESP OC MIC
   Secretaria Nacional de Politicas de Turismo, 2015, AN EST TUR 2015
NR 9
TC 11
Z9 11
U1 0
U2 19
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD AUG 16
PY 2016
VL 165
IS 4
BP 286
EP +
DI 10.7326/M16-1628
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UI
UT WOS:000381267200019
PM 27454521
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Traynor, K
AF Traynor, Kate
TI As Zika cases mount, patients seek advice from healthcare teams
SO AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 USA
SN 1079-2082
EI 1535-2900
J9 AM J HEALTH-SYST PH
JI Am. J. Health-Syst. Pharm.
PD AUG 15
PY 2016
VL 73
IS 16
BP 1200
EP 1204
DI 10.2146/news160049
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DT6IL
UT WOS:000381587800002
PM 27496830
DA 2020-07-08
ER

PT J
AU Suryamohan, K
   Hanson, C
   Andrews, E
   Sinha, S
   Scheel, MD
   Halfon, MS
AF Suryamohan, Kushal
   Hanson, Casey
   Andrews, Emily
   Sinha, Saurabh
   Scheel, Molly Duman
   Halfon, Marc S.
TI Redeployment of a conserved gene regulatory network during Aedes aegypti
   development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Enhancer discovery; Gene regulatory networks; GRN; Drosophila
   melanogaster; Zika vector mosquito; Aedes aegypti; Ventral midline;
   Central Nervous System (CNS) development; Evolution of regulatory
   networks; Developmental system drift; Neofunctionalization
ID SINGLE-MINDED GENE; YELLOW-FEVER MOSQUITO; GROWTH CONE GUIDANCE; CNS
   MIDLINE; FUNCTIONAL-ANALYSIS; COMMISSURAL AXONS; VENTRAL MIDLINE;
   DROSOPHILA; EVOLUTION; EXPRESSION
AB Changes in gene regulatory networks (GRNs) underlie the evolution of morphological novelty and developmental system drift. The fruitfly Drosophila melanogaster and the dengue and Zika vector mosquito Aedes aegypti have substantially similar nervous system morphology. Nevertheless, they show significant divergence in a set of genes co-expressed in the midline of the Drosophila central nervous system, including the master regulator single minded and downstream genes including short gastrulation, Star, and NetrinA. In contrast to Drosophila, we find that midline expression of these genes is either absent or severely diminished in A. aegypti. Instead, they are co-expressed in the lateral nervous system. This suggests that in A. aegypti this "midline GRN" has been redeployed to a new location while lost from its previous site of activity. In order to characterize the relevant GRNs, we employed the SCRMshaw method we previously developed to identify transcriptional cis-regulatory modules in both species. Analysis of these regulatory sequences in transgenic Drosophila suggests that the altered gene expression observed in A. aegypti is the result of trans-dependent redeployment of the GRN, potentially stemming from cis mediated changes in the expression of sim and other as-yet unidentified regulators. Our results illustrate a novel "repeal, replace, and redeploy" mode of evolution in which a conserved GRN acquires a different function at a new site while its original function is co-opted by a different GRN. This represents a striking example of developmental system drift in which the dramatic shift in gene expression does not result in gross morphological changes, but in more subtle differences in development and function of the late embryonic nervous system. (C) 2016 Elsevier Inc. All rights
C1 [Suryamohan, Kushal; Halfon, Marc S.] Univ Buffalo State Univ New York, Dept Biochem, 701 Ellicott St, Buffalo, NY 14203 USA.
   [Suryamohan, Kushal; Halfon, Marc S.] NY State Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA.
   [Hanson, Casey; Sinha, Saurabh] Univ Illinois, Dept Comp Sci, Champaign, IL USA.
   [Andrews, Emily; Scheel, Molly Duman] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN USA.
   [Scheel, Molly Duman] Univ Notre Dame, Eck Inst Global Hlth, South Bend, IN USA.
   [Scheel, Molly Duman] Univ Notre Dame, Dept Biol Sci, South Bend, IN USA.
   [Halfon, Marc S.] Univ Buffalo State Univ New York, Dept Biol Sci, Buffalo, NY USA.
   [Halfon, Marc S.] Univ Buffalo State Univ New York, Dept Biomed Informat, Buffalo, NY USA.
   [Halfon, Marc S.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY USA.
   [Halfon, Marc S.] Roswell Pk Canc Inst, Program Canc Genet, Buffalo, NY USA.
RP Halfon, MS (corresponding author), Univ Buffalo State Univ New York, Dept Biochem, 701 Ellicott St, Buffalo, NY 14203 USA.
EM mshalfon@buffalo.edu
RI Halfon, Marc S./H-3447-2019; Suryamohan, Kushal/L-3502-2014
OI Halfon, Marc S./0000-0002-4149-2705; Suryamohan,
   Kushal/0000-0002-6614-7182
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 GM85233, R01 AI081795]; USDAUnited
   States Department of Agriculture (USDA) [2012-67013-19361]
FX We thank Steve Crews for Sim antiserum and for helpful comments on the
   manuscript, Yoshi Tomoyasu and Gene Robinson for generously providing
   T.cas and A. mellifera embryos, respectively, Jeremy Lynch for sharing
   N.vit sim in situs, and Jack Leatherbarrow for support for fly genetics.
   Stocks obtained from the Bloomington Drosophila Stock Center (NIH
   P40OD018537) were used in this study. Funding for this work came from
   NIH grants R01 GM85233 (SS and MSH) and R01 AI081795 (MDS), and USDA
   grant 2012-67013-19361 (MSH and SS).
CR Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Biffar L, 2014, DEV BIOL, V388, P103, DOI 10.1016/j.ydbio.2014.01.028
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625
   Cande J, 2009, P NATL ACAD SCI USA, V106, P14414, DOI 10.1073/pnas.0905754106
   CARROLL SB, 2005, DNA DIVERSITY MOL GE
   Clark-Hachtel CM, 2013, P NATL ACAD SCI USA, V110, P16951, DOI 10.1073/pnas.1304332110
   Clemons A, 2010, COLD SPRING HARB PRO
   Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7
   Davidson E.H., 2006, REGULATORY GENOME GE
   Dearden P. K., 2009, COLD SPRING HARB PRO, V225
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327
   Estes P, 2001, DEV BIOL, V232, P157, DOI 10.1006/dbio.2001.0174
   FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602
   Freer SM, 2011, GENE EXPR PATTERNS, V11, P533, DOI 10.1016/j.gep.2011.09.002
   Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999
   Georgiou M, 2002, DEVELOPMENT, V129, P2947
   Glassford WJ, 2015, DEV CELL, V34, P520, DOI 10.1016/j.devcel.2015.08.005
   Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235
   Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3
   Haugen M., 2010, COLD SPRING HARB PRO, V2010
   Haugen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021694
   Hong JW, 2013, DEV BIOL, V380, P335, DOI 10.1016/j.ydbio.2013.05.015
   Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Kantorovitz MR, 2009, DEV CELL, V17, P568, DOI 10.1016/j.devcel.2009.09.002
   KASAI Y, 1992, P NATL ACAD SCI USA, V89, P3414, DOI 10.1073/pnas.89.8.3414
   Kazemian M., 2011, NUCL ACIDS RES
   Kazemian M., 2014, GENOME BIOL EVOL
   Kazemian M, 2014, GENOME BIOL EVOL, V6, P2301, DOI 10.1093/gbe/evu184
   Kazemian M, 2011, NUCLEIC ACIDS RES, V39, P9463, DOI 10.1093/nar/gkr621
   Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z
   Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0
   LEWIS JO, 1994, MECH DEVELOP, V48, P81, DOI 10.1016/0925-4773(94)90018-3
   Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970
   Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124
   McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020
   Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1
   Monteiro A, 2015, ANNU REV ENTOMOL, V60, P253, DOI 10.1146/annurev-ento-010814-020942
   MURALIDHAR MG, 1993, MECH DEVELOP, V41, P129, DOI 10.1016/0925-4773(93)90043-W
   NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7
   NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287
   Ordway AJ, 2014, DEV BIOL, V392, P431, DOI 10.1016/j.ydbio.2014.05.023
   Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028
   Patel Nipam H., 1996, P357
   Pearson JC, 2014, DEV BIOL, V392, P466, DOI 10.1016/j.ydbio.2014.05.011
   Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017
   Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597
   Prud'homme B, 2011, NATURE, V473, P83, DOI 10.1038/nature09977
   Rebeiz M, 2015, ANNU REV GENOM HUM G, V16, P103, DOI 10.1146/annurev-genom-091212-153423
   Rebeiz M, 2011, P NATL ACAD SCI USA, V108, P10036, DOI 10.1073/pnas.1105937108
   Sarro J, 2013, DEV DYNAM, V242, P1466, DOI 10.1002/dvdy.24059
   Schinko J., 2009, COLD SPRING HARB PRO
   Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x
   Sonnenfeld M, 2005, DEV GENES EVOL, V215, P221, DOI 10.1007/s00427-004-0462-9
   Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x
   Weiss KM, 2000, THEOR POPUL BIOL, V57, P187, DOI 10.1006/tpbi.2000.1460
   WHARTON KA, 1994, DEVELOPMENT, V120, P3563
   Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343
   Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016
   Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052
   Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2
   Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X
   Zinzen RP, 2006, DEV CELL, V11, P895, DOI 10.1016/j.devcel.2006.10.012
NR 75
TC 5
Z9 5
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD AUG 15
PY 2016
VL 416
IS 2
BP 402
EP 413
DI 10.1016/j.ydbio.2016.06.031
PG 12
WC Developmental Biology
SC Developmental Biology
GA DT9QE
UT WOS:000381836600013
PM 27341759
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Attaran, A
   Caplan, A
   Igel, L
AF Attaran, Amir
   Caplan, Arthur
   Igel, Lee
TI The olympically mismeasured risk of Zika virus in Rio de Janeiro
SO LANCET
LA English
DT Letter
ID VISITORS
C1 [Attaran, Amir] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.
   [Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
   [Igel, Lee] NYU, Tisch Inst, Sports & Soc Program, New York, NY USA.
   [Caplan, Arthur] NYU, Div Med Eth, Langone Med Ctr, New York, NY USA.
RP Attaran, A (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.; Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
EM aattaran@uottawa.ca
OI Caplan, Art/0000-0002-4061-8011
CR Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   International Research Institute for Climate and Society, 2016, IRI MULT PROB FOR TE
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Watts J., 2016, GUARDIAN
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 6
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 13
PY 2016
VL 388
IS 10045
BP 657
EP 658
DI 10.1016/S0140-6736(16)31227-2
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UX
UT WOS:000381268700022
PM 27480044
OA Bronze
DA 2020-07-08
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI The olympically mismeasured risk of Zika virus in Rio de Janeiro Reply
SO LANCET
LA English
DT Letter
ID VISITORS; DENGUE; GAMES
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.
EM edmassad@usp.br
RI Coutinho, Francisco A B/H-5644-2011; Massad, Eduardo/B-1169-2012;
   Wilder-Smith, Annelies/F-8751-2015
OI Coutinho, Francisco A B/0000-0003-3127-3071; Massad,
   Eduardo/0000-0002-7200-2916; 
CR Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 7
TC 3
Z9 3
U1 0
U2 76
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 13
PY 2016
VL 388
IS 10045
BP 658
EP 659
DI 10.1016/S0140-6736(16)31228-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UX
UT WOS:000381268700023
PM 27480043
OA Bronze
DA 2020-07-08
ER

PT J
AU Manrique, PD
   Xu, C
   Hui, PM
   Johnson, NF
AF Manrique, Pedro D.
   Xu, Chen
   Hui, Pak Ming
   Johnson, Neil F.
TI Atypical viral dynamics from transport through popular places
SO PHYSICAL REVIEW E
LA English
DT Article
ID EPIDEMICS; DISEASE
AB The flux of visitors through popular places undoubtedly influences viral spreading-from H1N1 and Zika viruses spreading through physical spaces such as airports, to rumors and ideas spreading through online spaces such as chat rooms and social media. However, there is a lack of understanding of the types of viral dynamics that can result. Here we present a minimal dynamical model that focuses on the time-dependent interplay between the mobility through and the occupancy of such spaces. Our generic model permits analytic analysis while producing a rich diversity of infection profiles in terms of their shapes, durations, and intensities. The general features of these theoretical profiles compare well to real-world data of recent social contagion phenomena.
C1 [Manrique, Pedro D.; Johnson, Neil F.] Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
   [Xu, Chen] Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China.
   [Hui, Pak Ming] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China.
RP Manrique, PD (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
RI Hui, Pak Ming/S-2586-2017
OI Hui, Pak Ming/0000-0002-5201-8689
FU National Science Foundation (NSF)National Science Foundation (NSF)
   [CNS1522693]; Air Force (AFOSR) [16RT0367]
FX N.F.J. is grateful to the National Science Foundation (NSF) for funding
   under Grant No. CNS1522693 and to the Air Force (AFOSR) for Grant No.
   16RT0367.
CR *AAP, 2007, PAND INFL WARN CHILD
   Zuzek LGA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12151
   Aoki T, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.040301
   Bajardi P, 2009, Emerg Health Threats J, V2, pe11, DOI 10.3134/ehtj.09.011
   Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289
   Ball F, 1997, ANN APPL PROBAB, V7, P46
   Barrat A, 2008, DYNAMICAL PROCESSES
   Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701
   Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105
   Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701
   Estrada E., 2011, STRUCTURE COMPLEX NE
   Feng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126090
   Fernandez-Gracia J, 2017, LECT NOTES COMPUT SC, V10354, P271, DOI 10.1007/978-3-319-60240-0_33
   Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701
   Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001
   Jo HH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011041
   Johnson NF, 2003, FINANCIAL MARKET COM
   JOHNSON NF, 2008, MANAGING COMPLEXITY, P303
   Karsai M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04001
   Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397
   Keeling M.J., 2007, MODELING INFECT DIS
   KOOPMAN JS, 2007, BIOL NETWORKS
   Liu SY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032805
   Lyall S., 2009, NY TIMES
   Manore CA, 2015, J BIOL DYNAM, V9, P52, DOI 10.1080/17513758.2015.1005698
   Manrique P, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P169, DOI 10.1109/ISI.2013.6578812
   Matheny J, 2013, TEST EVALUATION ACE
   May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112
   McNeil Donald G., 2009, NY TIMES
   Murase Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052810
   Murray J. D., 2007, MATH BIOL
   Palchykov V, 2014, CONDENS MATTER PHYS, V17, DOI 10.5488/CMP.17.33802
   Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084
   Scholtes I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6024
   Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701
   Shaw LB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066101
   Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701
   Stepanova Ekaterina, 2011, 159 PONARS EUR
   Stopczynski A., ARXIV150906530V1
   Tomasello MV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05679
   Valdano E, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021005
   Valdez LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12172
   Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102
   Zhao ZY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056107
NR 46
TC 4
Z9 4
U1 0
U2 5
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0045
EI 2470-0053
J9 PHYS REV E
JI Phys. Rev. E
PD AUG 12
PY 2016
VL 94
IS 2
AR UNSP 022304
DI 10.1103/PhysRevE.94.022304
PG 13
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA DT3YW
UT WOS:000381418100007
PM 27627314
OA Bronze
DA 2020-07-08
ER

PT J
AU Lessler, J
   Chaisson, LH
   Kucirka, LM
   Bi, QF
   Grantz, K
   Salje, H
   Carcelen, AC
   Ott, CT
   Sheffield, JS
   Ferguson, NM
   Cummings, DAT
   Metcalf, CJE
   Rodriguez-Barraquer, I
AF Lessler, Justin
   Chaisson, Lelia H.
   Kucirka, Lauren M.
   Bi, Qifang
   Grantz, Kyra
   Salje, Henrik
   Carcelen, Andrea C.
   Ott, Cassandra T.
   Sheffield, Jeanne S.
   Ferguson, Neil M.
   Cummings, Derek A. T.
   Metcalf, C. Jessica E.
   Rodriguez-Barraquer, Isabel
TI Assessing the global threat from Zika virus
SO SCIENCE
LA English
DT Review
ID YELLOW-FEVER; ARBOVIRUS INFECTIONS; SEXUAL TRANSMISSION;
   FRENCH-POLYNESIA; AEDES-AEGYPTI; DENGUE VIRUS; WEST-NILE; JAPANESE
   ENCEPHALITIS; VECTOR CONTROL; BORNE VIRUSES
AB First discovered in 1947, Zika virus (ZIKV) infection remained a little-known tropical disease until 2015, when its apparent association with a considerable increase in the incidence of microcephaly in Brazil raised alarms worldwide. There is limited information on the key factors that determine the extent of the global threat from ZIKV infection and resulting complications. Here, we review what is known about the epidemiology, natural history, and public health effects of ZIKV infection, the empirical basis for this knowledge, and the critical knowledge gaps that need to be filled.
C1 [Lessler, Justin; Chaisson, Lelia H.; Kucirka, Lauren M.; Bi, Qifang; Salje, Henrik; Ott, Cassandra T.; Rodriguez-Barraquer, Isabel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Kucirka, Lauren M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.
   [Grantz, Kyra; Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Dept Biol, Gainesville, FL USA.
   [Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Carcelen, Andrea C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Sheffield, Jeanne S.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA.
   [Ferguson, Neil M.] Imperial Coll London, Sch Publ Hlth, Dept Med, London, England.
   [Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Metcalf, C. Jessica E.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
RP Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
EM justin@jhu.edu
RI Ferguson, Neil/B-8578-2008
OI Ferguson, Neil/0000-0002-1154-8093; Rodriguez-Barraquer,
   Isabel/0000-0001-6784-1021; Salje, Henrik/0000-0003-3626-4254; Lessler,
   Justin/0000-0002-9741-8109
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15091,
   MR/K010174/1]; NICHD NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [P2C HD047879]; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [T32 GM007309, U01 GM110721, U54
   GM088491]; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K010174/1B]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4
   Althouse B., 2016, POTENTIAL ZIKA VIRUS
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   ANDERSON R M, 1991
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bastos L., 2016, ZIKA RIO DE JANEIRO
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carlson C., 2016, ECOLOGICAL ASSESSMEN
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, ALL COUNTR TERR ACT
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Climate Prediction Center, ENSO DIAGN DISC
   Cornet M., 1979, ORSTOM SERIE ENTOMOL, V17, P47
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Melo Freire C. C., 2015, SPREAD PANDEMIC ZIKA
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz M. E., 2016, NY TIMES
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Barbeiro FMD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005568
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Funk S., 2016, COMP ANAL DENGUE ZIK
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Hill AVS, 2012, PHILOS T R SOC B, V367, P840, DOI 10.1098/rstb.2011.0275
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kliegman R.M, 2015, NELSON TXB PEDIAT
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Lessler J., 2016, BIORXIV
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan AJ, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks, DOI 10.1371/CURRENTS.OUTBREAKS]
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moreno-Mayar JV, 2014, CURR BIOL, V24, P2518, DOI 10.1016/j.cub.2014.09.057
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PATTERSON R, 1989, CAN MED ASSOC J, V141, P596
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Perkins A., 2016, MODEL BASED PROJECTI
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   R. Editorial, 2016, REUTERS
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rojas D. P., 2016, EPIDEMIOLOGY TRANSMI
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 1995, MAT ANTHR PREGN OUTC
   World Health Organization, 2016, CURR ZIK PROD PIP
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 161
TC 166
Z9 174
U1 3
U2 52
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 12
PY 2016
VL 353
IS 6300
AR aaf8160
DI 10.1126/science.aaf8160
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZC
UT WOS:000381561200031
PM 27417495
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Collucci, C
AF Collucci, Claudia
TI Brazil to investigate if other factors act with Zika to cause congenital
   defects
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, BRAZ EP MICR REC
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1362
NR 4
TC 2
Z9 2
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 11
PY 2016
VL 354
AR i4439
DI 10.1136/bmj.i4439
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT4UB
UT WOS:000381475500011
PM 27515384
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Barzon, L
   Pacenti, M
   Franchin, E
   Lavezzo, E
   Trevisan, M
   Sgarabotto, D
   Palu, G
AF Barzon, L.
   Pacenti, M.
   Franchin, E.
   Lavezzo, E.
   Trevisan, M.
   Sgarabotto, D.
   Palu, G.
TI Infection dynamics in a traveller with persistent shedding of Zika virus
   RNA in semen for six months after returning from Haiti to Italy, January
   2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB We describe the dynamics of Zika virus (ZIKV) infection in a man in his early 40s who developed fever and rash after returning from Haiti to Italy, in January 2016. Follow-up laboratory testing demonstrated detectable ZIKV RNA in plasma up to day 9 after symptom onset and in urine and saliva up to days 15 and 47, respectively. Notably, persistent shedding of ZIKV RNA was demonstrated in semen, still detectable at 181 days after onset.
C1 [Barzon, L.; Franchin, E.; Lavezzo, E.; Trevisan, M.; Palu, G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Barzon, L.; Pacenti, M.; Franchin, E.; Palu, G.] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Sgarabotto, D.] Padova Univ Hosp, Transplant Infect Dis Unit, Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.; Barzon, L (corresponding author), Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016; Lavezzo, Enrico/K-7962-2016; TREVISAN,
   MARTA/K-6591-2016
OI Barzon, Luisa/0000-0003-0720-8456; Lavezzo, Enrico/0000-0002-3902-8356;
   Sgarabotto, Dino/0000-0002-4962-0804; TREVISAN,
   MARTA/0000-0002-3148-7240
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, WHOZIKVMOC161
   2016, Wkly Epidemiol Rec, V91, P73
NR 17
TC 62
Z9 62
U1 0
U2 23
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 2
EP 5
AR 30316
DI 10.2807/1560-7917.ES.2016.21.32.30316
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800001
PM 27542178
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Septfons, A
   Leparc-Goffart, I
   Couturier, E
   Franke, F
   Deniau, J
   Balestier, A
   Guinard, A
   Heuze, G
   Liebert, AH
   Mailles, A
   Ndong, J
   Poujol, I
   Raguet, S
   Rousseau, C
   Saidouni-Oulebsir, A
   Six, C
   Subiros, M
   Servas, V
   Terrien, E
   Tillaut, H
   Viriot, D
   Watrin, M
   Wyndels, K
   Noel, H
   Paty, M
   De Valk, H
AF Septfons, A.
   Leparc-Goffart, I.
   Couturier, E.
   Franke, F.
   Deniau, J.
   Balestier, A.
   Guinard, A.
   Heuze, G.
   Liebert, A. H.
   Mailles, A.
   Ndong, J.
   Poujol, I.
   Raguet, S.
   Rousseau, C.
   Saidouni-Oulebsir, A.
   Six, C.
   Subiros, M.
   Servas, V.
   Terrien, E.
   Tillaut, H.
   Viriot, D.
   Watrin, M.
   Wyndels, K.
   Noel, H.
   Paty, M.
   De Valk, H.
CA Zika Surveillance Working Grp
TI Travel-associated and autochthonous Zika virus infection in mainland
   France, 1 January to 15 July 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB During summer 2016, all the conditions for local mosquito-borne transmission of Zika virus (ZIKV) are met in mainland France: a competent vector, Aedes albopictus, a large number of travellers returning from ZIKV-affected areas, and an immunologically naive population. From 1 January to 15 July 2016, 625 persons with evidence of recent ZIKV infection were reported in mainland France. We describe the surveillance system in place and control measures implemented to reduce the risk of infection.
C1 [Septfons, A.; Couturier, E.; Balestier, A.; Mailles, A.; Subiros, M.; Viriot, D.; Noel, H.; Paty, M.; De Valk, H.] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
   [Septfons, A.] ECDC, European Ctr Dis Prevent & Control, EPIET, Stockholm, Sweden.
   [Leparc-Goffart, I.] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Franke, F.; Deniau, J.; Heuze, G.; Six, C.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Provence Alpes Cotes dAzur, St Maurice, France.
   [Guinard, A.; Rousseau, C.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Languedoc Roussillon Midi Pyrenees, St Maurice, France.
   [Liebert, A. H.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Pays de la Loire, St Maurice, France.
   [Ndong, J.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Ctr Val de Loire, St Maurice, France.
   [Poujol, I.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Auvergne Rhone Alpes, St Maurice, France.
   [Raguet, S.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Alsace Lorraine Champagne Ardenne, St Maurice, France.
   [Saidouni-Oulebsir, A.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Ile de France, St Maurice, France.
   [Servas, V.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Aquitaine Limousin Poitou Charenes, St Maurice, France.
   [Terrien, E.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Bourgogne Franche Comte, St Maurice, France.
   [Tillaut, H.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Bretagne, St Maurice, France.
   [Watrin, M.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Normandie, St Maurice, France.
   [Wyndels, K.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Nord Pas de Calais, St Maurice, France.
RP Septfons, A (corresponding author), French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.; Septfons, A (corresponding author), ECDC, European Ctr Dis Prevent & Control, EPIET, Stockholm, Sweden.
EM alexandra.septfons@santepubliquefrance.fr
RI ; Subissi, Lorenzo/A-6553-2017
OI Noel, Harold/0000-0003-3011-9267; Mailles,
   Alexandra/0000-0002-8739-1168; Subissi, Lorenzo/0000-0001-5147-575X
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Codego Coelho F, 2016, SEXUAL TRANSMISSION
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, CURR ZIK TRANSM
   Flusin O, 2013, EURO SURVEILL, V18
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Jupille H, 2016, BIORXIV
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Ministere de l'Environnement de l'Energie et de la mer, 2016, B STAT TRAFF AER COM
   Ministere des Affaires Sociales et de la Sante, 2014, GUID REL MOD MIS OEU
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization World Health Organization., 2016, GEOGR DISTR CONF CAS, P2015
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO, 2005, SAF PYR PUBL HLTH US
   World Health Organization, 2016, ZIK SIT REP
NR 27
TC 9
Z9 9
U1 0
U2 61
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 10
EP 16
AR 30315
DI 10.2807/1560-7917.ES.2016.21.32.30315
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800003
PM 27542120
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, HY
   Fernandez, E
   Dowd, KA
   Speer, SD
   Platt, DJ
   Gorman, MJ
   Govero, J
   Nelson, CA
   Pierson, TC
   Diamond, MS
   Fremont, DH
AF Zhao, Haiyan
   Fernandez, Estefania
   Dowd, Kimberly A.
   Speer, Scott D.
   Platt, Derek J.
   Gorman, Matthew J.
   Govero, Jennifer
   Nelson, Christopher A.
   Pierson, Theodore C.
   Diamond, Michael S.
   Fremont, Daved H.
TI Structural Basis of Zika Virus-Specific Antibody Protection
SO CELL
LA English
DT Article
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS; DOMAIN-III;
   MONOCLONAL-ANTIBODY; FUSION-LOOP; NEUTRALIZATION; RECOGNITION;
   INFECTION; MOUSE
AB Zika virus (ZIKV) infection during pregnancy has emerged as a global public health problem because of its ability to cause severe congenital disease. Here, we developed six mouse monoclonal antibodies (mAbs) against ZIKV including four (ZV-48, ZV-54, ZV-64, and ZV-67) that were ZIKV specific and neutralized infection of African, Asian, and American strains to varying degrees. X-ray crystallographic and competition binding analyses of Fab fragments and scFvs defined three spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-54 and ZV-67), C-C' loop (ZV-48 and ZV-64), and ABDE sheet (ZV-2) regions. In vivo passive transfer studies revealed protective activity of DIII-lateral ridge specific neutralizing mAbs in a mouse model of ZIKV infection. Our results suggest that DIII is targeted by multiple type-specific antibodies with distinct neutralizing activity, which provides a path for developing prophylactic antibodies for use in pregnancy or designing epitope-specific vaccines against ZIKV.
C1 [Zhao, Haiyan; Gorman, Matthew J.; Nelson, Christopher A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Platt, Derek J.; Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
   [Nelson, Christopher A.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Dowd, Kimberly A.; Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu; fremont@wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Platt, Derek/0000-0003-0766-4590
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, T32
   AI007163]; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201400018C,
   HHSN272201200026C]; NIH Research Education Program [R25 HG006687];
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX This work was supported by NIH grants R01 AI073755 (to M.S.D. and D.H.F)
   and R01 AI104972 (to M.S.D.), and NIAID contracts HHSN272201400018C (to
   D.H.F. and M.S.D) and HHSN272201200026C (CSGID; to D.H.F.). E.F. and
   D.J.P. were supported by an NIH Pre-doctoral training grant award (T32
   AI007163) and the NIH Research Education Program (R25 HG006687),
   respectively. K.A.D., S.D.S., and T.C.P. were funded by the intramural
   program of NIAID. We acknowledge Jay Nix (MBC 4.2.2 beamline at ALS
   Berkeley) for aid in remote data collection. M.S.D. consults for Inbios,
   Visterra, Sanofi, and Takeda Pharmaceuticals, is on the Scientific
   Advisory Boards of Moderna and OraGene, and has received research grants
   from Moderna, Sanofi, and Visterra.
CR Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith S.A., 2013, MBIO, V4, pe13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
NR 53
TC 191
Z9 200
U1 1
U2 50
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 11
PY 2016
VL 166
IS 4
BP 1016
EP 1027
DI 10.1016/j.cell.2016.07.020
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DU5NO
UT WOS:000382258700022
PM 27475895
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Nicastri, E
   Castilletti, C
   Liuzzi, G
   Iannetta, M
   Capobianchi, MR
   Ippolito, G
AF Nicastri, E.
   Castilletti, C.
   Liuzzi, G.
   Iannetta, M.
   Capobianchi, M. R.
   Ippolito, G.
TI Persistent detection of Zika virus RNA in semen for six months after
   symptom onset in a traveller returning from Haiti to Italy, February
   2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB A man in his early 30s reported in January 2016 a history of fever, asthenia and erythematous rash during a stay in Haiti. On his return to Italy, ZIKV RNA was detected in his urine and saliva 91 days after symptom onset, and in his semen on day 188, six months after symptom onset. Our findings support the possibility of sexual transmission of ZIKV and highlight the importance of continuing to investigate non-vector-borne ZIKV infection.
C1 [Nicastri, E.; Castilletti, C.; Liuzzi, G.; Iannetta, M.; Capobianchi, M. R.; Ippolito, G.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
RP Castilletti, C (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM concetta.castilletti@inmi.it
RI Castilletti, Concetta/B-6545-2016; Castilletti, Concetta/AAA-8408-2019;
   Iannetta, Marco/M-4619-2019; Ippolito, Giuseppe/J-7207-2017; Iannetta,
   Marco/B-5596-2017; nicastri, emanuele/K-7780-2016
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; Iannetta, Marco/0000-0002-6938-8627;
   Iannetta, Marco/0000-0002-6938-8627; nicastri,
   emanuele/0000-0002-5606-8712; Ippolito, Giuseppe/0000-0002-1076-2979
FU Ricerca Corrente of the Italian Ministry of Health
FX This study was funded by Ricerca Corrente of the Italian Ministry of
   Health.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V9
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Huits R.M.H.G., 2016, B WHO
   Liuzzi G, 2016, EUR J INTERN MED
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Papa A, 2010, VECTOR-BORNE ZOONOT, V10, P655, DOI 10.1089/vbz.2010.0042
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Turmel JM, 2016, LANCET, V18, P387
   World Health Organization, 2016, WHOZIKVMOC161
NR 20
TC 137
Z9 137
U1 0
U2 29
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 6
EP 9
AR 30314
DI 10.2807/1560-7917.ES.2016.21.32.30314
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800002
PM 27541989
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mounce, BC
   Poirier, EZ
   Passoni, G
   Simon-Loriere, E
   Cesaro, T
   Prot, M
   Stapleford, KA
   Moratorio, G
   Sakuntabhai, A
   Levraud, JP
   Vignuzzi, M
AF Mounce, Bryan C.
   Poirier, Enzo Z.
   Passoni, Gabriella
   Simon-Loriere, Etienne
   Cesaro, Teresa
   Prot, Matthieu
   Stapleford, Kenneth A.
   Moratorio, Gonzalo
   Sakuntabhai, Anavaj
   Levraud, Jean-Pierre
   Vignuzzi, Marco
TI Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine
   Depletion Restrict Zika and Chikungunya Viruses
SO CELL HOST & MICROBE
LA English
DT Article
ID SEMLIKI-FOREST-VIRUS; ORNITHINE-DECARBOXYLASE; CELLS;
   DIFLUOROMETHYLORNITHINE; TRANSLATION; ANTIZYME; RECEPTOR; PROTEIN;
   GROWTH; CANCER
AB Polyamines are small, positively charged molecules derived from ornithine and synthesized through an intricately regulated enzymatic pathway. Within cells, they are abundant and play several roles in diverse processes. We find that polyamines are required for the life cycle of the RNA viruses chikungunya virus (CHIKV) and Zika virus (ZIKV). Depletion of spermidine and spermine via type I interferon signaling-mediated induction of spermidine/spermine N1-ace-tyltransferase (SAT1), a key catabolic enzyme in the polyamine pathway, restricts CHIKV and ZIKV replication. Polyamine depletion restricts these viruses in vitro and in vivo, due to impairment of viral translation and RNA replication. The restriction is released by exogenous replenishment of polyamines, further supporting a role for these molecules in virus replication. Thus, SAT1 and, more broadly, polyamine depletion restrict viral replication and suggest promising avenues for antiviral therapies.
C1 [Mounce, Bryan C.; Poirier, Enzo Z.; Cesaro, Teresa; Stapleford, Kenneth A.; Moratorio, Gonzalo; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
   [Poirier, Enzo Z.] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, F-75013 Paris, France.
   [Passoni, Gabriella] INRA, Virol & Immunol Mol, F-78352 Jouy En Josas, France.
   [Passoni, Gabriella; Levraud, Jean-Pierre] Inst Pasteur, Macrophages & Dev Immun, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
   [Passoni, Gabriella; Levraud, Jean-Pierre] CNRS, URA2578, F-75724 Paris 15, France.
   [Simon-Loriere, Etienne; Prot, Matthieu; Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
RP Vignuzzi, M (corresponding author), Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
EM marco.vignuzzi@pasteur.fr
OI , Etienne/0000-0001-8420-7743; Vignuzzi, Marco/0000-0002-4400-771X;
   Mounce, Bryan/0000-0003-1710-5362; Poirier, Enzo/0000-0001-9795-2144
FU French Government's Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]; French Fondation
   pour la Recherche MedicaleFondation pour la Recherche Medicale [Equipe
   FRM DEQ20150331759]; DENFREE program; Defeat Dengue Program; Marie-Curie
   Initial Training Network FishForPharmaEuropean Union (EU)
   [PITN-GA-2011-289209]; Erasmus+ Unipharma-Graduates Program
FX This work was supported by the French Government's Investissement
   d'Avenir program, Laboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases'' (grant noANR-10-LABX-62-IBEID) (B.C.M.
   and M.V.), the grant "Equipe FRM DEQ20150331759'' from the French
   Fondation pour la Recherche Medicale (M.V.), the DENFREE program
   (E.S.-L., M.P., and A.S.), the Defeat Dengue Program (B.C.M. and M.V.),
   PITN-GA-2011-289209 (G.P.) from Marie-Curie Initial Training Network
   FishForPharma, and the Erasmus+ Unipharma-Graduates Program (T.C.). We
   thank Benjamin tenOever, Britt Glaunsinger, Vera Tarakanova, and Carla
   Saleh for scientific discussions.
CR BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372
   BARDOCZ S, 1995, TRENDS FOOD SCI TECH, V6, P341, DOI 10.1016/S0924-2244(00)89169-4
   de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667
   Fabian CJ, 2002, CLIN CANCER RES, V8, P3105
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456, DOI 10.1016/0304-4165(76)90054-4
   FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784
   FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647
   FUKUMA I, 1975, J VIROL, V16, P222, DOI 10.1128/JVI.16.2.222-227.1975
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818
   GIBSON W, 1984, J VIROL, V50, P145, DOI 10.1128/JVI.50.1.145-154.1984
   Goyal L, 2013, CANCER CHEMOTH PHARM, V72, P1305, DOI 10.1007/s00280-013-2293-8
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Henig N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062366
   HODGSON J, 1975, BIOCHEM BIOPH RES CO, V63, P308, DOI 10.1016/S0006-291X(75)80044-1
   Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601
   Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363
   Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122
   ISOM HC, 1979, J GEN VIROL, V42, P265, DOI 10.1099/0022-1317-42-2-265
   Iwata M, 2000, BIOORGAN MED CHEM, V8, P2185, DOI 10.1016/S0968-0896(00)00156-5
   Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822
   Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419
   LANZER W, 1975, J VIROL, V16, P1254, DOI 10.1128/JVI.16.5.1254-1264.1975
   Law GL, 2001, J BIOL CHEM, V276, P38036
   Lee SB, 2010, J BIOL CHEM, V285, P15548, DOI 10.1074/jbc.M109.092007
   Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837
   Madhubala R, 1998, Methods Mol Biol, V79, P131
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6
   METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050
   MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   MOUSSATCHE N, 1985, BIOCHIM BIOPHYS ACTA, V826, P113, DOI 10.1016/0167-4781(85)90116-2
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133
   PEPIN J, 1987, LANCET, V2, P1431, DOI 10.1016/S0140-6736(87)91131-7
   POHJANPELTO P, 1988, LIFE SCI, V42, P2011, DOI 10.1016/0024-3205(88)90501-2
   RAINA A, 1981, MED BIOL, V59, P428
   Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308
   Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658
   Svoboda KR, 2001, DEVELOPMENT, V128, P3511
   THOMAS T, 1995, J STEROID BIOCHEM, V54, P89, DOI 10.1016/0960-0760(95)00126-K
   TUOMI K, 1983, MED BIOL, V61, P199
   TUOMI K, 1982, BIOCHEM J, V206, P113, DOI 10.1042/bj2060113
   Uimari A, 2009, BIOCHEM J, V422, P101, DOI 10.1042/BJ20090411
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289
   Wolff JC, 2003, CLIN CANCER RES, V9, P5922
   Yordanova MM, 2015, J BIOL CHEM, V290, P17863, DOI 10.1074/jbc.M115.647065
NR 52
TC 40
Z9 41
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 167
EP 177
DI 10.1016/j.chom.2016.06.011
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500009
PM 27427208
OA Bronze
DA 2020-07-08
ER

PT J
AU Tabata, T
   Petitt, M
   Puerta-Guardo, H
   Michlmayr, D
   Wang, C
   Fang-Hoover, J
   Harris, E
   Pereira, L
AF Tabata, Takako
   Petitt, Matthew
   Puerta-Guardo, Henry
   Michlmayr, Daniela
   Wang, Chunling
   Fang-Hoover, June
   Harris, Eva
   Pereira, Lenore
TI Zika Virus Targets Different Primary Human Placental Cells, Suggesting
   Two Routes for Vertical Transmission
SO CELL HOST & MICROBE
LA English
DT Article
ID HUMAN CYTOMEGALOVIRUS-INFECTION; TROPHOBLAST PROGENITOR CELLS; DENGUE
   VIRUS; LANGERHANS CELLS; PHOSPHATIDYLSERINE RECEPTORS; CYTOTROPHOBLASTS;
   ANTIBODIES; PATTERNS; IMMUNOGLOBULIN; INNATE
AB Zika virus (ZIKV) infection during pregnancy is linked to severe birth defects, but mother-to-fetus transmission routes are unknown. We infected different primary cell types from mid- and late-gestation placentas and explants from first-trimester chorionic villi with the prototype Ugandan and a recently isolated Nicaraguan ZIKV strain. ZIKV infects primary human placental cells and explants-cytotropho-blasts, endothelial cells, fibroblasts, and Hofbauer cells in chorionic villi and amniotic epithelial cells and trophoblast progenitors in amniochorionic membranes-that express Axl, Tyro3, and/or TIM1 viral entry cofactors. ZIKV produced NS3 and E proteins and generated higher viral titers in amniotic epithelial cells from mid-gestation compared to late-gestation placentas. Duramycin, a peptide that binds phosphatidylethanolamine in enveloped virions and precludes TIM1 binding, reduced ZIKV infection in placental cells and explants. Our results suggest that ZIKV spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that targeting TIM1 could suppress infection at the uterine-placental interface.
C1 [Tabata, Takako; Petitt, Matthew; Fang-Hoover, June; Pereira, Lenore] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
   [Puerta-Guardo, Henry; Michlmayr, Daniela; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Pereira, L (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu; lenore.pereira@ucsf.edu
RI Michlmayr, Daniela/Q-1216-2018
FU NIH Institute for Allergy and Infectious Diseases [R01AI046657,
   P01AI106695, R01AI124493]
FX We thank Saira Saborio and Dr. Angel Balmaseda at the National Virology
   Laboratory of the Nicaraguan Ministry of Health and the entire study
   team of the Nicaraguan Pediatric Dengue Cohort Study. We are grateful to
   Magelda Montoya and Alejandro Ramirez for their technical assistance.
   This work was supported by grants from the NIH Institute for Allergy and
   Infectious Diseases: R01AI046657 (L.P.), P01AI106695 (E.H.), and
   R01AI124493 (E.H.).
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BENIRSCHKE K, 2000, PATHOLOGY HUMAN PLAC
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   FUJITA M, 1991, J INVEST DERMATOL, V97, P65, DOI 10.1111/1523-1747.ep12478115
   Gao PS, 2005, J ALLERGY CLIN IMMUN, V115, P982, DOI 10.1016/j.jaci.2005.01.035
   Genbacev O, 2015, PLACENTA, V36, P716, DOI 10.1016/j.placenta.2015.05.002
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Kim HY, 2011, J CLIN INVEST, V121, P1111, DOI 10.1172/JCI44182
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   McDonagh S, 2006, J CLIN VIROL, V35, P210, DOI 10.1016/j.jcv.2005.08.011
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
   Zydek M, 2014, VIRUSES-BASEL, V6, P1346, DOI 10.3390/v6031346
NR 51
TC 197
Z9 202
U1 2
U2 101
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 155
EP 166
DI 10.1016/j.chom.2016.07.002
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500008
PM 27443522
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Barrows, NJ
   Campos, RK
   Powell, ST
   Prasanth, KR
   Schott-Lerner, G
   Soto-Acosta, R
   Galarza-Munoz, G
   McGrath, EL
   Urrabaz-Garza, R
   Gao, JL
   Wu, P
   Menon, R
   Saade, G
   Fernandez-Salas, I
   Rossi, SL
   Vasilakis, N
   Routh, A
   Bradrick, SS
   Garcia-Blanco, MA
AF Barrows, Nicholas J.
   Campos, Rafael K.
   Powell, Steven T.
   Prasanth, K. Reddisiva
   Schott-Lerner, Geraldine
   Soto-Acosta, Ruben
   Galarza-Munoz, Gaddiel
   McGrath, Erica L.
   Urrabaz-Garza, Rheanna
   Gao, Junling
   Wu, Ping
   Menon, Ramkumar
   Saade, George
   Fernandez-Salas, Ildefonso
   Rossi, Shannan L.
   Vasilakis, Nikos
   Routh, Andrew
   Bradrick, Shelton S.
   Garcia-Blanco, Mariano A.
TI A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID CLINICAL PHARMACOKINETICS; FLAVIVIRUS REPLICATION; MYCOPHENOLIC-ACID;
   NUCLEAR IMPORT; LONG-TERM; DENGUE; IVERMECTIN; DISCOVERY; CELLS;
   TOLERABILITY
AB Currently there are no approved vaccines or specific therapies to prevent or treat Zika virus (ZIKV) infection. We interrogated a library of FDA-approved drugs for their ability to block infection of human HuH-7 cells by a newly isolated ZIKV strain (ZIKV MEX_I_7). More than 20 out of 774 tested compounds decreased ZIKV infection in our in vitro screening assay. Selected compounds were further validated for inhibition of ZIKV infection in human cervical, placental, and neural stem cell lines, as well as primary human amnion cells. Established anti-flaviviral drugs (e.g., bortezomib and mycophenolic acid) and others that had no previously known antiviral activity (e.g., daptomycin) were identified as inhibitors of ZIKV infection. Several drugs reduced ZIKV infection across multiple cell types. This study identifies drugs that could be tested in clinical studies of ZIKV infection and provides a resource of small molecules to study ZIKV pathogenesis.
C1 [Barrows, Nicholas J.; Campos, Rafael K.; Powell, Steven T.; Prasanth, K. Reddisiva; Schott-Lerner, Geraldine; Soto-Acosta, Ruben; Galarza-Munoz, Gaddiel; Routh, Andrew; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Barrows, Nicholas J.; Campos, Rafael K.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [McGrath, Erica L.; Gao, Junling; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Urrabaz-Garza, Rheanna; Menon, Ramkumar; Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso] Ctr Reg Invest Salud Publ INSP, 19 Poniente Esquina 4a Norte S-N, Tapachula 30700, Chiapas, Mexico.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Routh, Andrew] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
RP Bradrick, SS; Garcia-Blanco, MA (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.; Garcia-Blanco, MA (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
EM ssbradri@utmb.edu; maragarc@utmb.edu
RI Campos, Rafael Kroon/AAB-5135-2020; Routh, Andrew/J-7486-2019
OI Campos, Rafael Kroon/0000-0002-4852-0449; Routh,
   Andrew/0000-0002-2874-5990
FU University of Texas Medical Branch; University of Texas System Faculty
   STARs Award; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-AI089526,
   R01-AI101431, R24-AI120942]; NIH-NINDS postdoctoral fellowship
   [F32-NS087899]; Chief Research Office at the University of Texas Medical
   Branch; John S. Dunn Foundation
FX This work was supported by start-up funds from the University of Texas
   Medical Branch (S.S.B and M.A.G.-B.), University of Texas System Faculty
   STARs Award (M.A.G.-B.), and NIH grants R01-AI089526 and R01-AI101431
   (M.A.G.-B.) and R24-AI120942 (N.V.). G.G.M was funded by NIH-NINDS
   postdoctoral fellowship F32-NS087899. P.W. was funded by the Chief
   Research Office at the University of Texas Medical Branch and the John
   S. Dunn Foundation. R.K. Campos, S. Powell, K. R. Prasanth, G.
   Schott-Lerner, and R. Soto-Acosta are listed in alphabetical order.
CR Adams J, 1999, CANCER RES, V59, P2615
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullingham RES, 1998, CLIN PHARMACOKINET, V34, P429, DOI 10.2165/00003088-199834060-00002
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontes C. A., 2016, NEURORADIOLOGY
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048
   Guerbois M., 2016, J INFECT DIS
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   HERTEL LW, 1990, CANCER RES, V50, P4417
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   KARBWANG J, 1990, CLIN PHARMACOKINET, V19, P264, DOI 10.2165/00003088-199019040-00002
   KOE BK, 1983, J PHARMACOL EXP THER, V226, P686
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Navari RM, 2015, BBA-BIOMEMBRANES, V1848, P2738, DOI 10.1016/j.bbamem.2015.03.020
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665
   Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EURO SURVEILL, V19
   SCHWEITZER BI, 1990, FASEB J, V4, P2441
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328
   Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 73
TC 193
Z9 198
U1 3
U2 68
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 259
EP 270
DI 10.1016/j.chom.2016.07.004
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500017
PM 27476412
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Kumar, A
   Singh, HN
   Pareek, V
   Raza, K
   Dantham, S
   Kumar, P
   Mochan, S
   Faiq, MA
AF Kumar, Ashutosh
   Singh, Himanshu N.
   Pareek, Vikas
   Raza, Khursheed
   Dantham, Subrahamanyam
   Kumar, Pavan
   Mochan, Sankat
   Faiq, Muneeb A.
TI A Possible Mechanism of Zika Virus Associated Microcephaly: Imperative
   Role of Retinoic Acid Response Element (RARE) Consensus Sequence Repeats
   in the Viral Genome
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article
DE fetal brain malformation; microcephaly; neurotropism; retinoic acid
   response element (RARE); zika virus (ZIKV)
ID CENTRAL-NERVOUS-SYSTEM; EXPRESSION; INFECTION; BRAIN; NEUROTROPISM;
   RECEPTOR; FEVER; CELL; MALFORMATIONS; CORONAVIRUS
AB Owing to the reports of microcephaly as a consistent outcome in the fetuses of pregnant women infected with ZIKV in Brazil, Zika virus (ZIKV) microcephaly etiomechanistic relationship has recently been implicated. Researchers, however, are still struggling to establish an embryological basis for this interesting causal handcuff. The present study reveals robust evidence in favor of a plausible ZIKV-microcephaly cause-effect liaison. The rationale is based on: (1) sequence homology between ZIKV genome and the response element of an early neural tube developmental marker "retinoic acid" in human DNA and (2) comprehensive similarities between the details of brain defects in ZIKV-microcephaly and retinoic acid embryopathy. Retinoic acid is considered as the earliest factor for regulating anteroposterior axis of neural tube and positioning of structures in developing brain through retinoic acid response elements (RARE) consensus sequence (5'-AGGTCA-3') in promoter regions of retinoic acid-dependent genes. We screened genomic sequences of already reported virulent ZIKV strains (including those linked to microcephaly) and other viruses available in National Institute of Health genetic sequence database (GenBank) for the RARE consensus repeats and obtained results strongly bolstering our hypothesis that ZIKV strains associated with microcephaly may act through precipitation of dysregulation in retinoic acid-dependent genes by introducing extra stretches of RARE consensus sequence repeats in the genome of developing brain cells. Additional support to our hypothesis comes from our findings that screening of other viruses for RARE consensus sequence repeats is positive only for those known to display neurotropism and cause fetal brain defects (for which maternal-fetal transmission during developing stage may be required). The numbers of RARE sequence repeats appeared to match with the virulence of screened positive viruses. Although, bioinformatic evidence and embryological features are in favor of our hypothesis, additional studies including animal models are warranted to validate our proposition. Such studies are likely to unfold ZIKV-microcephaly association and may help in devising methods to combat it.
C1 [Kumar, Ashutosh; Raza, Khursheed; Kumar, Pavan; Mochan, Sankat] All India Inst Med Sci, Dept Anat, New Delhi, India.
   [Singh, Himanshu N.; Dantham, Subrahamanyam] All India Inst Med Sci, Dept Biochem, New Delhi, India.
   [Pareek, Vikas] Natl Brain Res Ctr, Computat Neurosci & Neuroimaging Div, Manesar, India.
   [Faiq, Muneeb A.] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Faiq, Muneeb A.] All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.
   [Faiq, Muneeb A.] Univ Delhi, Dr BP Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.
RP Faiq, MA (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.; Faiq, MA (corresponding author), All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.; Faiq, MA (corresponding author), Univ Delhi, Dr BP Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.
EM muneeb1983@gmail.com
RI Singh, Himanshu N/K-1760-2016; Awasthi, Y K/A-1578-2010
OI Singh, Himanshu N/0000-0003-4111-5165; Awasthi, Y K/0000-0001-8860-2329;
   Kumar, Ashutosh/0000-0003-1589-9568; Pareek, Vikas/0000-0001-8985-4982
CR Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carty M, 2014, TRENDS IMMUNOL, V35, P79, DOI 10.1016/j.it.2013.10.012
   Cipriano R, 2016, REV EPIDEMIOL CONTRO, V6, P37, DOI 10.17058/reci.v6i1.6959
   CIVITELLO LA, 1992, PEDIATR NEUROSURG, V17, P104, DOI 10.1159/000120576
   Crandall JE, 2011, J NEUROCHEM, V119, P723, DOI 10.1111/j.1471-4159.2011.07471.x
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0
   Findlay GM, 1935, J PATHOL BACTERIOL, V41, P431, DOI 10.1002/path.1700410307
   Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Grapin-Botton A, 1998, DEVELOPMENT, V125, P1173
   Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x
   Guimard T, 2009, AM J TROP MED HYG, V81, P1141, DOI 10.4269/ajtmh.2009.09-0295
   Gupta S, 2015, DEVELOPMENT, V142, P1293, DOI 10.1242/dev.122390
   Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021
   Harrison-Uy SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058219
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702
   IRVING DW, 1986, TERATOLOGY, V34, P141, DOI 10.1002/tera.1420340203
   Salazar MI, 2013, SCI WORLD J, DOI 10.1155/2013/904067
   Jain S, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-11
   Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11
   KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676
   Konig R, 2012, J CHEM NEUROANAT, V43, P120, DOI 10.1016/j.jchemneu.2012.01.002
   Kot-Leibovich H, 2009, DIS MODEL MECH, V2, P295, DOI 10.1242/dmm.001420
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05
   Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Martinez-Morales PL, 2011, J CELL BIOL, V194, P489, DOI 10.1083/jcb.201011077
   Mic FA, 2004, DEV DYNAM, V231, P270, DOI 10.1002/dvdy.20128
   Micucci JA, 2014, HUM MOL GENET, V23, P434, DOI 10.1093/hmg/ddt435
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289
   Okuda Darin T, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.05.2009.1908
   Paganelli A, 2010, CHEM RES TOXICOL, V23, P1586, DOI 10.1021/tx1001749
   Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Rubin SA, 2003, J VIROL, V77, P11616, DOI 10.1128/JVI.77.21.11616-11624.2003
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457
   SCHEFFER IE, 1991, DEV MED CHILD NEUROL, V33, P916
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037
   Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004
   Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178
   Straface Gianluca, 2012, Infect Dis Obstet Gynecol, V2012, P385697, DOI 10.1155/2012/385697
   Takano T, 1999, NEUROREPORT, V10, P2215, DOI 10.1097/00001756-199908020-00001
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   TSIANG H, 1983, J NEUROPATH EXP NEUR, V42, P439, DOI 10.1097/00005072-198307000-00006
   Tuiskunen A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-398
   VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wilson LJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-138
   Wood BR, 2012, AIDS PATIENT CARE ST, V26, P383, DOI 10.1089/apc.2012.0048
   World Health Organization, 2016, ZIK SIT REP
   Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461
   Yamamoto M, 2003, MECH DEVELOP, V120, P701, DOI 10.1016/S0925-4773(03)00047-9
   Yazigi A, 2017, J MATERN-FETAL NEO M, V30, P274, DOI 10.3109/14767058.2016.1169526
NR 72
TC 10
Z9 11
U1 3
U2 209
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD AUG 9
PY 2016
VL 10
AR 403
DI 10.3389/fnhum.2016.00403
PG 11
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA DS7YT
UT WOS:000381000000001
PM 27555815
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU van der Linden, V
   Rolim, EL
   Lins, OG
   van der Linden, A
   Aragao, MDVV
   Brainer-Lima, AM
   Cruz, DDS
   Rocha, MAW
   da Silva, PFS
   Carvalho, MDCG
   do Amaral, FJ
   Gomes, JA
   de Medeiros, ICR
   Ventura, CV
   Ramos, RC
AF van der Linden, Vanessa
   Rolim Filho, Epitacio Leite
   Lins, Otavio Gomes
   van der Linden, Ana
   Viana Vasco Aragao, Maria de Fatima
   Brainer-Lima, Alessandra Mertens
   Sousa Cruz, Danielle Di Cavalcanti
   Wanderley Rocha, Maria Angela
   Sobral da Silva, Paula Fabiana
   Costa Gomes Carvalho, Maria Durce
   do Amaral, Fernando Jose
   Gomes, Joelma Arruda
   Ribeiro de Medeiros, Igor Colaco
   Ventura, Camila V.
   Ramos, Regina Coeli
TI Congenital Zika syndrome with arthrogryposis: retrospective case series
   study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID MULTIPLEX-CONGENITA; VIRUS OUTBREAK
AB OBJECTIVE
   To describe the clinical, radiological, and electromyographic features in a series of children with joint contractures (arthrogryposis) associated with congenital infection presumably caused by Zika virus.
   DESIGN
   Retrospective case series study.
   SETTING
   Association for Assistance of Disabled Children, Pernambuco state, Brazil.
   PARTICIPANTS
   Seven children with arthrogryposis and a diagnosis of congenital infection presumably caused by Zika virus during the Brazilian microcephaly epidemic.
   MAIN OUTCOME MEASURES
   Main clinical, radiological, and electromyographic findings, and likely correlation between clinical and primary neurological abnormalities.
   RESULTS
   The brain images of all seven children were characteristic of congenital infection and arthrogryposis. Two children tested positive for IgM to Zika virus in the cerebrospinal fluid. Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%). Hip radiographs showed bilateral dislocation in seven children, subluxation of the knee associated with genu valgus in three children (43%), which was bilateral in two (29%). All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities. Moderate signs of remodeling of the motor units and a reduced recruitment pattern were found on needle electromyography (monopolar). Five of the children underwent brain computed tomography (CT) and magnetic resonance imaging (MRI) and the remaining two CT only. All presented malformations of cortical development, calcifications predominantly in the cortex and subcortical white matter (especially in the junction between the cortex and white matter), reduction in brain volume, ventriculomegaly, and hypoplasia of the brainstem and cerebellum. MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots.
   CONCLUSIONS
   Congenital Zika syndrome should be added to the differential diagnosis of congenital infections and arthrogryposis. The arthrogryposis was unrelated to the abnormalities of the joints themselves, but was possibly of neurogenic origin, with chronic involvement of central and peripheral motor neurones leading to deformities as a result of fixed postures in utero. Based on the neurophysiological observations, we suggest two possible mechanisms: tropism of neurones, with involvement of peripheral and central motor neurones, or a relation with vascular disorders.
C1 [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil.
   [van der Linden, Vanessa; do Amaral, Fernando Jose; Gomes, Joelma Arruda] HBL, Recife, PE, Brazil.
   [Rolim Filho, Epitacio Leite; Lins, Otavio Gomes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Materno Infantil Pernambuco, Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens] Mauricio de Nassau Univ, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil.
   [Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; Ramos, Regina Coeli] HUOC, Recife, PE, Brazil.
   [Ribeiro de Medeiros, Igor Colaco] Hosp Infantil Jorge de Medeiros, Recife, PE, Brazil.
   [Ventura, Camila V.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.] Pernambucos Eye Hosp, Recife, PE, Brazil.
RP van der Linden, V (corresponding author), AACD, Recife, PE, Brazil.; van der Linden, V (corresponding author), HBL, Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Silva, Paula/0000-0001-9475-4732
CR Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller-Madsen B, 2015, THESIS, V9, P425
   Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2
   Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15
   Poduri A, 2010, BRAIN DEV-JPN, V32, P550, DOI 10.1016/j.braindev.2009.08.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tavernise S, 2016, ZIKA VIRUS GLOBAL HL
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Volpe JJ, 2008, NEUROLOGY NEWBORN
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 97
Z9 98
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 9
PY 2016
VL 354
AR i3899
DI 10.1136/bmj.i3899
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT4TU
UT WOS:000381474800002
PM 27509902
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Dowd, KA
   DeMaso, CR
   Pelc, RS
   Speer, SD
   Smith, ARY
   Goo, L
   Platt, DJ
   Mascola, JR
   Graham, BS
   Mulligan, MJ
   Diamond, MS
   Ledgerwood, JE
   Pierson, TC
AF Dowd, Kimberly A.
   DeMaso, Christina R.
   Pelc, Rebecca S.
   Speer, Scott D.
   Smith, Alexander R. Y.
   Goo, Leslie
   Platt, Derek J.
   Mascola, John R.
   Graham, Barney S.
   Mulligan, Mark J.
   Diamond, Michael S.
   Ledgerwood, Julie E.
   Pierson, Theodore C.
TI Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a
   Single Viral Serotype
SO CELL REPORTS
LA English
DT Article
ID ANTIBODY-MEDIATED NEUTRALIZATION; DENGUE VIRUS; CLINICAL-TRIAL;
   DOUBLE-BLIND; PHASE-III; INFECTION; FLAVIVIRUSES; VACCINES;
   IMMUNOGENICITY; ENHANCEMENT
AB Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barre syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.
C1 [Dowd, Kimberly A.; DeMaso, Christina R.; Pelc, Rebecca S.; Speer, Scott D.; Smith, Alexander R. Y.; Goo, Leslie; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
   [Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30030 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
RI Graham, Barney S./AAC-5898-2019; Mulligan, Mark/V-9275-2019; Diamond,
   Michael/AAH-1733-2019
OI Graham, Barney S./0000-0001-8112-0853; Diamond,
   Michael/0000-0002-8791-3165; Platt, Derek/0000-0003-0766-4590; Pelc,
   Rebecca/0000-0001-5080-4945
FU National Institute of Allergy and Infectious DiseaseUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   Emory University School of Medicine; Georgia Research Alliance; Moderna;
   SanofiSanofi-Aventis; Visterra;  [R01AI073755]
FX This work was funded by the intramural program of the National Institute
   of Allergy and Infectious Disease to the Division of Intramural Research
   and the Vaccine Research Center and extramural grant R01AI073755 to
   M.S.D. M.J.M. was supported by funds from the Emory University School of
   Medicine and the Georgia Research Alliance. We thank X. de Lamballerie
   (Emergence des Pathologies Virales, Aix-Marseille Universite) and the
   European Virus Archive Goes Global (EVAg) for providing the H/PF/2013
   ZIKV strain and Stephen S. Whitehead (NIAID) for the Brazil Paraiba/2015
   virus. We are grateful to the subjects for providing research samples
   and to Ingelise Gordon (VRC), Pamela Costner (VRC), Adam Dezure (VRC),
   Lilin Lai (Emory), Natalie Thornburg (Emory), Henry Wu (Emory), Srilatha
   Edupuganti (Emory), Allison Beck, (Emory), Sree Aramgam (Emory), and
   Pamela Lankford-Turner (Emory) for assistance with ZIKV patients and the
   collection of samples. We also thank Amanda Feldpausch (Georgia
   Department of Health), Jennifer Govero (Washington University), and
   Estefania Fernandez (Washington University) for their help with these
   studies. M.S.D. is a consultant for Inbios, Visterra, Sanofi, and Takeda
   Pharmaceuticals, is on the Scientific Advisory Boards of Moderna and
   OraGene, and is a recipient of research grants from Moderna, Sanofi, and
   Visterra.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang CL, 2016, J INFECT DIS, V213, P975, DOI 10.1093/infdis/jiv536
NR 39
TC 112
Z9 117
U1 0
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD AUG 9
PY 2016
VL 16
IS 6
BP 1485
EP 1491
DI 10.1016/j.celrep.2016.07.049
PG 7
WC Cell Biology
SC Cell Biology
GA DT3ID
UT WOS:000381373400001
PM 27481466
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Kao, JH
   Chen, CD
   Li, ZRT
   Chan, TC
   Tung, TH
   Chu, YH
   Cheng, HY
   Liu, JW
   Shih, FY
   Shu, PY
   Lin, CC
   Tsai, WH
   Ku, CC
   Ho, CK
   King, CC
AF Kao, Jui-Hung
   Chen, Chaur-Dong
   Li, Zheng-Rong Tiger
   Chan, Ta-Chien
   Tung, Tsung-Hwa
   Chu, Yin-Hsia
   Cheng, Hau-Yuan
   Liu, Jien-Wei
   Shih, Fuh-Yuan
   Shu, Pei-Yun
   Lin, Chien-Chou
   Tsai, Wu-Hsiung
   Ku, Chia-Chi
   Ho, Chi-Kung
   King, Chwan-Chuen
TI The Critical Role of Early Dengue Surveillance and Limitations of
   Clinical Reporting - Implications for Non-Endemic Countries
SO PLOS ONE
LA English
DT Article
ID GLOBAL DISTRIBUTION; DIFFUSION PATTERNS; TAIWAN; POPULATION; DISEASE;
   ADULTS; KAOHSIUNG; OUTBREAKS; CHILDREN; VIRUSES
AB The increasing dengue burden and epidemic severity worldwide have highlighted the need to improve surveillance. In non-endemic areas such as Taiwan, where outbreaks start mostly with imported cases from Southeast Asia, a closer examination of surveillance dynamics to detect cases early is necessary. To evaluate problems with dengue surveillance and investigate the involvement of different factors at various epidemic stages, we investigated 632 laboratory-confirmed indigenous dengue cases in Kaohsiung City, Taiwan during 2009-2010. The estimated sensitivity of clinical surveillance was 82.4% (521/632). Initially, the modified serological surveillance (targeting only the contacts of laboratory-confirmed dengue cases) identified clinically unrecognized afebrile cases in younger patients who visited private clinics and accounted for 30.4% (35/115) of the early-stage cases. Multivariate regression indicated that hospital/medical center visits [Adjusted Odds Ratio (aOR): 11.6, 95% confidence interval (CI): 6.3-21.4], middle epidemic stage [aOR: 2.4 (1.2-4.7)], fever [aOR: 2.3 (2.3-12.9)], and musculo-articular pain [aOR: 1.9 (1.05-3.3)] were significantly associated with clinical reporting. However, cases with pruritus/rash [aOR: 0.47 (0.26-0.83)] and diarrhea [aOR: 0.47 (0.26-0.85)] were underreported. In conclusion, multiple factors contributed to dengue surveillance problems. To prevent a large-scale epidemic and minimize severe dengue cases, there is a need for integrated surveillance incorporating entomological, clinical, serological, and virological surveillance systems to detect early cases, followed by immediate prevention and control measures and continuous evaluation to ensure effectiveness. This effort will be particularly important for an arbovirus, such as Zika virus, with a high asymptomatic infection ratio. For dengue-non-endemic countries, we recommend serological surveillance be implemented in areas with high Aedes mosquito indices or many breeding sites. Syndromic surveillance, spatial analysis and monitoring changes in epidemiological characteristics using a geographical information system, as well as epidemic prediction models involving epidemiological, meteorological and environmental variables will be helpful for early risk communication to increase awareness.
C1 [Kao, Jui-Hung] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 100, Taiwan.
   [Chen, Chaur-Dong; Tsai, Wu-Hsiung; Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan.
   [Li, Zheng-Rong Tiger; Tung, Tsung-Hwa; King, Chwan-Chuen] NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
   [Chan, Ta-Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.
   [Cheng, Hau-Yuan] NTU Hosp, Dept Pediat, Taipei 100, Taiwan.
   [Liu, Jien-Wei] Chang Gung Univ Med Coll, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan.
   [Shih, Fuh-Yuan] NTU Hosp, Dept Emergency Med, Taipei 100, Taiwan.
   [Shu, Pei-Yun; Lin, Chien-Chou] Taiwan Ctr Dis Control, Dept Hlth, Taipei 100, Taiwan.
   [Ho, Chi-Kung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan.
   [Ho, Chi-Kung] Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan.
   [Ku, Chia-Chi] NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan.
RP Ho, CK (corresponding author), Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan.; King, CC (corresponding author), NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.; Ho, CK (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan.; Ho, CK (corresponding author), Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan.; Ku, CC (corresponding author), NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan.
EM chiachiku@ntu.edu.tw; hochikung@yahoo.com; chwanchuen@gmail.com
RI Chu, Ying-Hsia/J-4738-2019
OI Chu, Ying-Hsia/0000-0002-8289-7418; SHIH, FUH-YUAN/0000-0002-7755-0110;
   Ho, Chi-Kung/0000-0001-8001-0601
FU Ministry of Science and Technology (MOST) in TaiwanMinistry of Science
   and Technology, Taiwan [MOST104-2314-B002-025, NSC102-2621-M002-002,
   101-2923-B-002-006-MY3, 102-2815-C-002-183-B]
FX The authors greatly appreciate financial support from the Ministry of
   Science and Technology (MOST) in Taiwan [formerly the National Science
   Council] Grant numbers MOST104-2314-B002-025, NSC102-2621-M002-002,
   101-2923-B-002-006-MY3, and 102-2815-C-002-183-B. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Anez G, 2013, BIOMED RES INT, DOI 10.1155/2013/678645
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carvalho A, 2016, EXPERT REV VACCINES, V15, P539, DOI 10.1586/14760584.2016.1152187
   Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Chu HJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-42
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x
   Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903
   Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666
   Jelinek T, 2009, EUROSURVEILLANCE B E, V14
   Kan CC, 2008, AM J TROP MED HYG, V79, P344, DOI 10.4269/ajtmh.2008.79.344
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Li Z-RT, 2012, IMPACT ENV FACTORS M
   Lin CH, 2012, EMERG INFECT DIS, V18, P1603, DOI 10.3201/eid1810.111929
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775
   Shu PY, 2001, VACCINE, V19, P1753, DOI 10.1016/S0264-410X(00)00391-1
   Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420
   Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11
   Wen TH, 2012, ANN ASSOC AM GEOGR, V102, P1026, DOI 10.1080/00045608.2012.671130
   Wen TH, 2010, INT J INFECT DIS, V14, pE334, DOI 10.1016/j.ijid.2009.06.006
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Wu HH, 2013, J MED ENTOMOL, V50, P261, DOI 10.1603/ME11263
   Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150
NR 36
TC 7
Z9 7
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2016
VL 11
IS 8
AR e0160230
DI 10.1371/journal.pone.0160230
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3IE
UT WOS:000381373500015
PM 27501302
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Halford, B
AF Halford, Bethany
TI Vaccine candidates protect monkeys from Zika
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD AUG 8
PY 2016
VL 94
IS 32
BP 8
EP 9
PG 2
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DT1HZ
UT WOS:000381233600010
DA 2020-07-08
ER

PT J
AU Boulet, SL
   D'Angelo, DV
   Morrow, B
   Zapata, L
   Berry-Bibee, E
   Rivera, M
   Ellington, S
   Romero, L
   Lathrop, E
   Frey, M
   Williams, T
   Goldberg, H
   Warner, L
   Harrison, L
   Cox, S
   Pazol, K
   Barfield, W
   Jamieson, DJ
   Honein, MA
   Kroelinger, CD
AF Boulet, Sheree L.
   D'Angelo, Denise V.
   Morrow, Brian
   Zapata, Lauren
   Berry-Bibee, Erin
   Rivera, Maria
   Ellington, Sascha
   Romero, Lisa
   Lathrop, Eva
   Frey, Meghan
   Williams, Tanya
   Goldberg, Howard
   Warner, Lee
   Harrison, Leslie
   Cox, Shanna
   Pazol, Karen
   Barfield, Wanda
   Jamieson, Denise J.
   Honein, Margaret A.
   Kroelinger, Charlan D.
TI Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for
   Unintended Pregnancy, and Female High School Students, in the Context of
   Zika Preparedness - United States, 2011-2013 and 2015
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
AB What is already known on this topic?
   Zika virus is transmitted through the bite of an Aedes species mosquito, sex with an infected partner, or from a pregnant woman to her fetus. Zika virus infection during pregnancy is a cause of congenital microcephaly and other severe fetal brain defects. It has also been associated with eye defects, hearing loss, and impaired growth. Nearly half of all pregnancies in the United States are unintended. Among nonpermanent contraceptive methods, long-acting reversible contraception (LARC) is the most effective contraceptive option for preventing unintended pregnancy.
   What is added by this report?
   State-based estimates of contraception use are provided for nonpregnant and postpartum women at risk for unintended pregnancy and sexually active female high school students. Among these populations, use of moderate and less effective contraception was most common; use of no contraceptive method and use of LARC varied by state, age group, and race/ethnicity.
   What are the implications for public health practice?
   State and local strategies are needed to increase access to contraceptive methods and related services, reduce the risk for unintended pregnancy, and minimize the number of pregnancies affected by Zika infection. Potentially effective strategies include addressing policies on high device costs and provider reimbursement, comprehensive provider training on insertion and removal of LARC, provision of youth-friendly services, support to resource-challenged jurisdictions, client-centered counseling and assessment of patient satisfaction, and increased consumer awareness of the full range of contraceptive methods to delay or avoid pregnancy.
C1 [Boulet, Sheree L.; D'Angelo, Denise V.; Morrow, Brian; Zapata, Lauren; Berry-Bibee, Erin; Ellington, Sascha; Romero, Lisa; Williams, Tanya; Goldberg, Howard; Warner, Lee; Harrison, Leslie; Cox, Shanna; Pazol, Karen; Barfield, Wanda; Jamieson, Denise J.; Kroelinger, Charlan D.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Frey, Meghan; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Rivera, Maria] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Lathrop, Eva] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Kroelinger, CD (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ckroelinger@cdc.gov
OI Boulet, Sheree/0000-0002-7638-7374; Jamieson, Denise/0000-0003-2597-1201
CR Bearak JM, 2016, CONTRACEPTION, V93, P139, DOI 10.1016/j.contraception.2015.08.018
   Brasil P, 2016, N ENGL J MED
   CDC, 2016, DRAFT INT CDC ZIK RE
   CDC, 2016, EST RANG AED ALB AED
   CDC, 2016, ZIK VIR
   Curtis KM, 2016, MMWR RECOMM REP, V65
   Daniels Kimberly, 2015, Natl Health Stat Report, P1
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fox J, 2016, JAMA-J AM MED ASSOC, V316, P815, DOI 10.1001/jama.2016.8800
   Frost J. J., 2015, CONTRACEPTIVE NEEDS
   Kost K., 2015, UNINTENDED PREGNANCY
   Kumar N, 2016, J ADOLESC HLTH, V2016
   Parks C, 2016, AM J OBSTET GYNECOL, V214, P681, DOI 10.1016/j.ajog.2016.02.017
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
NR 15
TC 27
Z9 27
U1 0
U2 11
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 5
PY 2016
VL 65
IS 30
BP 780
EP 787
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5XZ
UT WOS:000386699800006
PM 27490117
OA Bronze
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI INFECTIOUS DISEASE Zika vaccine has a good shot
SO SCIENCE
LA English
DT News Item
NR 0
TC 3
Z9 3
U1 0
U2 18
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 5
PY 2016
VL 353
IS 6299
BP 529
EP +
DI 10.1126/science.353.6299.529
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5YZ
UT WOS:000381560900010
PM 27493161
OA Bronze
DA 2020-07-08
ER

PT J
AU Adams, L
   Bello-Pagan, M
   Lozier, M
   Ryff, KR
   Espinet, C
   Torres, J
   Perez-Padilla, J
   Febo, MF
   Dirlikov, E
   Martinez, A
   Munoz-Jordan, J
   Garcia, M
   Segarra, MO
   Malave, G
   Rivera, A
   Shapiro-Mendoza, C
   Rosinger, A
   Kuehnert, MJ
   Chung, KW
   Pate, LL
   Harris, A
   Hemme, RR
   Lenhart, A
   Aquino, G
   Zaki, S
   Read, JS
   Waterman, SH
   Alvarado, LI
   Alvarado-Ramy, F
   Valencia-Prado, M
   Thomas, D
   Sharp, TM
   Rivera-Garcia, B
AF Adams, Laura
   Bello-Pagan, Melissa
   Lozier, Matthew
   Ryff, Kyle R.
   Espinet, Carla
   Torres, Jomil
   Perez-Padilla, Janice
   Febo, Mitchelle Flores
   Dirlikov, Emilio
   Martinez, Alma
   Munoz-Jordan, Jorge
   Garcia, Myriam
   Segarra, Marangely Olivero
   Malave, Graciela
   Rivera, Aidsa
   Shapiro-Mendoza, Carrie
   Rosinger, Asher
   Kuehnert, Matthew J.
   Chung, Koo-Whang
   Pate, Lisa L.
   Harris, Angela
   Hemme, Ryan R.
   Lenhart, Audrey
   Aquino, Gustavo
   Zaki, Sherif
   Read, Jennifer S.
   Waterman, Stephen H.
   Alvarado, Luisa I.
   Alvarado-Ramy, Francisco
   Valencia-Prado, Miguel
   Thomas, Dana
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1,
   2015-July 7, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INFECTION; EPIDEMIC; OUTBREAK; DISEASE; STATES
AB What is already known about this topic?
   Zika virus transmission in Puerto Rico has been increasing since it was first detected in November 2015. Zika virus infection is a cause of microcephaly and other severe birth defects and has been associated with Guillain-Barre syndrome and severe thrombocytopenia.
   What is added by this report?
   During November 1, 2015-July 7, 2016, specimens from 16,522 patients with suspected Zika virus disease in Puerto Rico were evaluated and 5,351 (32%) had laboratory evidence of current or recent Zika virus infection. The percentage of persons with confirmed or presumptive Zika virus infection among symptomatic pregnant females increased from 8% in February 2016 to 41% in June 2016; during the same time, the percentage of persons with confirmed or presumptive Zika virus infection among symptomatic males and nonpregnant females increased from 14% to 64%. The public health response includes increased surveillance for Zika virus infection, preventing infection in pregnant women, monitoring infected pregnant women and their fetuses for adverse outcomes, controlling mosquitoes, assuring the safety of blood products, and expanding access to the full range of voluntary contraceptive options for women and men.
   What are the implications for public health practice?
   The Zika virus outbreak in Puerto Rico continues to expand in geographic extent and number of infected persons. Residents of and travelers to Puerto Rico should continue to employ mosquito bite avoidance behaviors, take precautions to reduce the risk for sexual transmission, and seek medical care for any acute illness with rash or fever. Intensified vector control measures, including an integrated vector management strategy, are needed to help reduce disease spread. Clinicians who suspect Zika virus disease in patients who reside in or have recently returned from areas with ongoing Zika virus transmission should consider testing for Zika virus and report cases to public health officials.
C1 [Adams, Laura; Lozier, Matthew; Perez-Padilla, Janice; Febo, Mitchelle Flores; Munoz-Jordan, Jorge; Rivera, Aidsa; Harris, Angela; Hemme, Ryan R.; Read, Jennifer S.; Waterman, Stephen H.; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Bello-Pagan, Melissa; Ryff, Kyle R.; Espinet, Carla; Torres, Jomil; Febo, Mitchelle Flores; Dirlikov, Emilio; Thomas, Dana; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Dirlikov, Emilio] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Martinez, Alma; Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Prevent, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Shapiro-Mendoza, Carrie] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Rosinger, Asher] Natl Ctr Hlth Stat, Div Hlth & Nutr Examinat Surveys, Atlanta, GA USA.
   [Kuehnert, Matthew J.; Chung, Koo-Whang] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Pate, Lisa L.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Lenhart, Audrey] CDC, Entomol Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Aquino, Gustavo] CDC, Off Director, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Zaki, Sherif] CDC, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Alvarado, Luisa I.] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp Consortium, Ponce, PR USA.
   [Alvarado-Ramy, Francisco] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Thomas, Dana] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Adams, L (corresponding author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM leadams@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Dirlikov,
   Emilio/0000-0003-4631-2643
CR Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Brogdon W, 2010, GUIDELINES EVALUATIN
   Brooks JT, 2016, MMWR MORB MORTAL WKL, P65
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Pacheco O, 2016, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sharp TM, 2016, CLIN INFECT DIS
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
NR 20
TC 48
Z9 48
U1 0
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 5
PY 2016
VL 65
IS 30
BP 774
EP 779
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5XZ
UT WOS:000386699800005
PM 27490087
OA Bronze
DA 2020-07-08
ER

PT J
AU Mysorekar, IU
   Diamond, MS
AF Mysorekar, Indira U.
   Diamond, Michael S.
TI Modeling Zika Virus Infection in Pregnancy
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID TRANSMISSION; MICE
C1 [Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Mysorekar, IU; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073755]
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Li C, 2016, CELL STEM CELL
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Quicke KM, 2016, CELL HOST MICROBE
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 14
TC 63
Z9 65
U1 0
U2 35
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 4
PY 2016
VL 375
IS 5
BP 481
EP 484
DI 10.1056/NEJMcibr1605445
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS7AN
UT WOS:000380934900015
PM 27433842
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Johansson, MA
AF Johansson, Michael A.
TI Zika and the Risk of Microcephaly (vol 375, pg 1, 2016)
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Correction
CR Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
NR 1
TC 12
Z9 12
U1 0
U2 10
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 4
PY 2016
VL 375
IS 5
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS7AN
UT WOS:000380934900035
DA 2020-07-08
ER

PT J
AU Dang, J
   Tiwari, SK
   Lichinchi, G
   Qin, Y
   Patil, VS
   Eroshkin, AM
   Rana, TM
AF Dang, Jason
   Tiwari, Shashi Kant
   Lichinchi, Gianluigi
   Qin, Yue
   Patil, Veena S.
   Eroshkin, Alexey M.
   Rana, Tariq M.
TI Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids
   through Activation of the Innate Immune Receptor TLR3
SO CELL STEM CELL
LA English
DT Article
ID TOLL-LIKE RECEPTOR-3; HIPPOCAMPAL NEUROGENESIS; NEGATIVE REGULATOR;
   CELL-PROLIFERATION; HUMAN BRAIN; NETRIN-1
AB Emerging evidence from the current outbreak of Zika virus (ZIKV) indicates a strong causal link between Zika and microcephaly. To investigate how ZIKV infection leads to microcephaly, we used human embryonic stem cell-derived cerebral organoids to recapitulate early stage, first trimester fetal brain development. Here we show that a prototype strain of ZIKV, MR766, efficiently infects organoids and causes a decrease in overall organoid size that correlates with the kinetics of viral copy number. The innate immune receptor Toll-like-Receptor 3 (TLR3) was upregulated after ZIKV infection of human organoids and mouse neurospheres and TLR3 inhibition reduced the phenotypic effects of ZIKV infection. Pathway analysis of gene expression changes during TLR3 activation highlighted 41 genes also related to neuronal development, suggesting a mechanistic connection to disrupted neurogenesis. Together, therefore, our findings identify a link between ZIKV-mediated TLR3 activation, perturbed cell fate, and a reduction in organoid volume reminiscent of microcephaly.
C1 [Dang, Jason; Tiwari, Shashi Kant; Lichinchi, Gianluigi; Qin, Yue; Patil, Veena S.; Rana, Tariq M.] Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Dang, Jason] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Lichinchi, Gianluigi] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Eroshkin, Alexey M.] Sanford Burnham Prebys Med Discovery Inst, Bioinformat Core, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
RP Rana, TM (corresponding author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
RI Tiwari, Shashi Kant/R-8533-2018
OI Tiwari, Shashi Kant/0000-0002-6121-6249
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX We thank Steve Head and the staff of the Next Generation Sequencing core
   facility at The Scripps Research Institute for help with the HT-seq and
   data analysis, and we thank members of the Rana laboratory for helpful
   discussions and advice. This work was supported in part by grants from
   the NIH.
CR Bin JM, 2015, CELL REP, V12, P1099, DOI 10.1016/j.celrep.2015.07.028
   Calvet G., 2016, LANCET INFE IN PRESS
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007
   De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
   Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060
   Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lazear H.M., 2016, CELL HOST M IN PRESS
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107
   Ozmadenci D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8398
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poliak S, 2015, ELIFE, V4, DOI 10.7554/eLife.10841
   Rossi S.L., 2016, AM J TROP M IN PRESS
   Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
NR 32
TC 293
Z9 299
U1 6
U2 109
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD AUG 4
PY 2016
VL 19
IS 2
BP 258
EP 265
DI 10.1016/j.stem.2016.04.014
PG 8
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6VG
UT WOS:000381622000018
PM 27162029
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Barba-Spaeth, G
   Dejnirattisai, W
   Rouvinski, A
   Vaney, MC
   Medits, I
   Sharma, A
   Simon-Loriere, E
   Sakuntabhai, A
   Cao-Lormeau, VM
   Haouz, A
   England, P
   Stiasny, K
   Mongkolsapaya, J
   Heinz, FX
   Screaton, GR
   Rey, FA
AF Barba-Spaeth, Giovanna
   Dejnirattisai, Wanwisa
   Rouvinski, Alexander
   Vaney, Marie-Christine
   Medits, Iris
   Sharma, Arvind
   Simon-Loriere, Etienne
   Sakuntabhai, Anavaj
   Cao-Lormeau, Van-Mai
   Haouz, Ahmed
   England, Patrick
   Stiasny, Karin
   Mongkolsapaya, Juthathip
   Heinz, Franz X.
   Screaton, Gavin R.
   Rey, Felix A.
TI Structural basis of potent Zika-dengue virus antibody
   cross-neutralization
SO NATURE
LA English
DT Article
ID REACTIVE ANTIBODIES; FUSION-LOOP; IN-VIVO; FLAVIVIRUSES; MATURATION;
   INFECTION; ENHANCEMENT; RECOGNITION; DYNAMICS; RECEPTOR
AB Zika virus is a member of the Flavivirus genus that had not been associated with severe disease in humans until the recent outbreaks, when it was linked to microcephaly in newborns in Brazil and to Guillain-Barre syndrome in adults in French Polynesia. Zika virus is related to dengue virus, and here we report that a subset of antibodies targeting a conformational epitope isolated from patients with dengue virus also potently neutralize Zika virus. The crystal structure of two of these antibodies in complex with the envelope protein of Zika virus reveals the details of a conserved epitope, which is also the site of interaction of the envelope protein dimer with the precursor membrane (prM) protein during virus maturation. Comparison of the Zika and dengue virus immunocomplexes provides a lead for rational, epitope-focused design of a universal vaccine capable of eliciting potent cross-neutralizing antibodies to protect simultaneously against both Zika and dengue virus infections.
C1 [Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France.
   [Barba-Spaeth, Giovanna; Rouvinski, Alexander; Vaney, Marie-Christine; Sharma, Arvind; Rey, Felix A.] CNRS, UMR Virol 3569, F-75724 Paris 15, France.
   [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England.
   [Medits, Iris; Stiasny, Karin; Heinz, Franz X.] Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria.
   [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, Dept Genomes & Genet, F-75724 Paris 15, France.
   [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] CNRS, URA 3012, F-75724 Paris 15, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Papeete, Tahiti, France.
   [Haouz, Ahmed] Inst Pasteur, Plateforme Cristallog CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France.
   [Haouz, Ahmed; England, Patrick] CNRS, UMR 3528, F-75724 Paris 15, France.
   [England, Patrick] Inst Pasteur, Plateforme Biophys Macromol & Leurs Interact, CiTech, Dept Biol Struct & Chim, F-75724 Paris 15, France.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok 10700, Thailand.
RP Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris 15, France.; Rey, FA (corresponding author), CNRS, UMR Virol 3569, F-75724 Paris 15, France.; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England.; Heinz, FX (corresponding author), Med Univ Vienna, Dept Virol, Kinderspitalgasse 15, A-1095 Vienna, Austria.
EM franz.x.heinz@meduniwien.ac.at; g.screaton@imperial.ac.uk;
   felix.rey@pasteur.fr
RI Cao-Lormeau, Van-Mai/H-4879-2018; Rey, Felix/B-6497-2012
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; HAOUZ,
   Ahmed/0000-0003-1196-1635; Sharma, Arvind/0000-0002-7029-9867; Barba
   Spaeth, Giovanna/0000-0003-2069-9501; , Etienne/0000-0001-8420-7743;
   Screaton, Gavin/0000-0002-3549-4309; Rey, Felix/0000-0002-9953-7988;
   Stiasny, Karin/0000-0002-1902-8674
FU European CommissionEuropean Commission Joint Research Centre [282
   378FP7]; "Integrative Biology of Emerging Infectious Diseases" Labex
   (Laboratoire d'Excellence (French Government's "Investissements
   d'Avenir" program)French National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; transnational ANR/FWF grantFrench National
   Research Agency (ANR) [FlaviStem/I1378]; Medical Research Council,
   UKMedical Research Council UK (MRC); National Institute for Health
   Research Biomedical Research Centre, Funding Scheme, UK; NEUTRAVIR grant
   from Region ile-de-France (DIM-Maladies Infectieuses); Medical Research
   CouncilMedical Research Council UK (MRC) [G0600000, G0801508, G0400720]
FX We thank M. van Kerkhove, the 'working group ZIKA' and our colleagues in
   the Unite de Virologie Structurale at Institut Pasteur for help and
   discussions; the staff at the crystallogenesis platform and the
   recombinant proteins platform of the Institut Pasteur; P. Sylvestre and
   the Risk Prevention Unit of the Institut Pasteur for their biosafety
   expertise; W. Shepard and P. Legrand for help during data collection and
   for discussions; the staff at beamlines PX1 and PX2 at SOLEIL
   synchrotron (Saclay, France), at beamline ID23-2 of the European
   Synchrotron Radiation Facility (Grenoble, France) and at beamline PX1 of
   the Swiss Light Source synchrotron (Villigen, Switzerland); G. Bricogne
   for suggestions on processing anisotropic diffraction data; A. Reiter
   and H. Prechler for help in recombinant sE production. G.R.S. is a
   Wellcome Trust Senior Investigator. We acknowledge support from the
   European Commission FP7 Programme for the DENFREE project under Grant
   Agreement number 282 378FP7 (F.A.R., J.M., G.R.S. and A. Sa.); the
   "Integrative Biology of Emerging Infectious Diseases" Labex (Laboratoire
   d'Excellence) grant number ANR-10-LABX-62-IBEID (French Government's
   "Investissements d'Avenir" program) (F.A.R.); the transnational ANR/FWF
   grant FlaviStem/I1378 (F.A.R. and K.S.), the Medical Research Council,
   UK (J.M.); the National Institute for Health Research Biomedical
   Research Centre, Funding Scheme, UK (G.R.S.); and the NEUTRAVIR grant
   from Region ile-de-France (DIM-Maladies Infectieuses) (P.E., A. H. and
   F.A.R.)
CR Backovic M, 2010, PROTEIN ENG DES SEL, V23, P169, DOI 10.1093/protein/gzp088
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bricogne G, 2016, BUSTER VERSION 2 10
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Gilmartin AA, 2012, PROTEIN ENG DES SEL, V25, P59, DOI 10.1093/protein/gzr058
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lee PD, 2013, J VIROL, V87, P13729, DOI 10.1128/JVI.02340-13
   Lindenbach B., 2013, FLAVIVIRIDAE VIRUSES, V1, P1101
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 45
TC 256
Z9 261
U1 1
U2 63
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 4
PY 2016
VL 536
IS 7614
BP 48
EP +
DI 10.1038/nature18938
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS7YM
UT WOS:000380999200027
PM 27338953
OA Bronze
DA 2020-07-08
ER

PT J
AU Boeuf, P
   Drummer, HE
   Richards, JS
   Scoullar, MJL
   Beeson, JG
AF Boeuf, Phillipe
   Drummer, Heidi E.
   Richards, Jack S.
   Scoullar, Michelle J. L.
   Beeson, James G.
TI The global threat of Zika virus to pregnancy: epidemiology, clinical
   perspectives, mechanisms, and impact
SO BMC MEDICINE
LA English
DT Review
DE Biology; Pregnancy; Microcephaly; Placenta; Epidemiology; Economic cost;
   Pathogenesis; Public health
ID SEXUAL TRANSMISSION; BIRTH-DEFECTS; DENGUE VIRUS; INFECTION; BRAZIL;
   DIAGNOSTICS; OUTBREAK; EXPOSURE; STATES; FEVER
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has newly emerged as a significant global threat, especially to pregnancy. Recent major outbreaks in the Pacific and in Central and South America have been associated with an increased incidence of microcephaly and other abnormalities of the central nervous system in neonates. The causal link between ZIKV infection during pregnancy and microcephaly is now strongly supported. Over 2 billion people live in regions conducive to ZIKV transmission, with similar to 4 million infections in the Americas predicted for 2016. Given the scale of the current pandemic and the serious and long-term consequences of infection during pregnancy, the impact of ZIKV on health services and affected communities could be enormous. This further highlights the need for a rapid global public health and research response to ZIKV to limit and prevent its impact through the development of therapeutics, vaccines, and improved diagnostics. Here we review the epidemiology of ZIKV; the threat to pregnancy; the clinical consequences and broader impact of ZIKV infections; and the virus biology underpinning new interventions, diagnostics, and insights into the mechanisms of disease.
C1 [Boeuf, Phillipe; Drummer, Heidi E.; Richards, Jack S.; Scoullar, Michelle J. L.; Beeson, James G.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.
   [Boeuf, Phillipe; Richards, Jack S.; Scoullar, Michelle J. L.; Beeson, James G.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Drummer, Heidi E.; Richards, Jack S.; Beeson, James G.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
   [Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
RP Boeuf, P; Beeson, JG (corresponding author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.; Boeuf, P; Beeson, JG (corresponding author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.; Beeson, JG (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
EM philippe.boeuf@burnet.edu.au; beeson@burnet.edu.au
RI Scoullar, Michelle/F-6605-2017
OI Scoullar, Michelle/0000-0003-1417-1524; Drummer,
   Heidi/0000-0002-0042-6277
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia;
   NHMRC Independent Research Institutes Infrastructure Support Scheme;
   Victoria State Government Operational Infrastructure Support grant
FX Funding was provided by the National Health and Medical Research Council
   (NHMRC) of Australia (Early Career Fellowship to JSR, Senior Research
   Fellowships and Project Grants to JGB and HED). The Burnet Institute is
   supported by the NHMRC Independent Research Institutes Infrastructure
   Support Scheme, and a Victoria State Government Operational
   Infrastructure Support grant. Funding bodies had no role in the design
   of the study or collection, analysis, and interpretation of data or in
   writing the manuscript.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva SR, 2016, J MED VIROL
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558
   Dick GW, 1953, T R SOC TROP MED HYG, V47, P1348
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Feldman DM, 2016, CLIN LAB MED, V36, P407, DOI 10.1016/j.cll.2016.01.011
   Feldman HS, 2012, ALCOHOL CLIN EXP RES, V36, P670, DOI 10.1111/j.1530-0277.2011.01664.x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kliegman R, 2016, NELSON TXB PEDIAT
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcdante K, 2014, NELSON ESSENTIALS PE
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624, DOI 10.4269/ajtmh.1980.29.624
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rios A, 1996, Pediatr Rev, V17, P386
   Roth A, 2014, EURO SURVEILL, V19
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watts J, 2016, LANCET, V387, P1603, DOI 10.1016/S0140-6736(16)30249-5
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5
   Yazigi A, 2016, J MATERN FETAL NEONA
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 82
TC 54
Z9 55
U1 0
U2 227
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD AUG 3
PY 2016
VL 14
AR 112
DI 10.1186/s12916-016-0660-0
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS5NT
UT WOS:000380829700001
PM 27487767
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US officials issue travel alert for Miami area as Zika cases rise to 15
SO BMJ-British Medical Journal
LA English
DT News Item
C1 [McCarthy, Michael] No Org, Seattle, WA USA.
CR US Centers for Disease Control and Prevention, 2016, ADV PEOPL LIV TRAV W
NR 1
TC 3
Z9 3
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 3
PY 2016
VL 354
AR i4298
DI 10.1136/bmj.i4298
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS9CS
UT WOS:000381080600006
PM 27488825
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Anderson, KB
   Thomas, SJ
   Endy, TP
AF Anderson, Kathryn B.
   Thomas, Stephen J.
   Endy, Timothy P.
TI The Emergence of Zika Virus A Narrative Review
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; ENROLLING PREGNANT-WOMEN; SEXUAL TRANSMISSION;
   CLINICAL-RESEARCH; POTENTIAL VECTOR; UNITED-STATES; DENGUE-FEVER;
   INFECTION; BRAZIL; MOSQUITOS
AB Zika virus (ZIKV) is yet another arbovirus that is rapidly emerging on a global scale, on the heels of a chikungunya epidemic in the Americas that began in 2013. A ZIKV epidemic that began in Brazil in 2015 has now spread rapidly to more than 30 countries in the Americas and the Caribbean, infecting more than 2 million inhabitants. This epidemic currently continues unabated. The explosive nature of recent outbreaks and concerning links to Guillain-Barre syndrome and microcephaly are incompletely understood. Also unknown is the relative importance of sexual transmission of ZIKV and asymptomatic ZIKV infections to the overall burden of transmission. The limited understanding of ZIKV presents an enormous challenge for responses to this rapidly emerging threat to human health. This article reviews the existing literature on ZIKV and proposes critical questions for vaccine development and other areas of needed research.
C1 Univ Minnesota, Minneapolis, MN USA.
   Walter Reed Army Inst Res, US Army Med Directorate, Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Thomas, Stephen J.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Anderson, Kathryn B.] Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA.
   [Endy, Timothy P.] SUNY Upstate Med Univ, Div Infect Dis, 750 East Adams St,CPOB Suite 304, Syracuse, NY 13210 USA.
RP Anderson, KB (corresponding author), Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA.
EM ande7622@umn.edu
RI amsalu, ribka/G-8780-2019
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Afifi A K, 1994, J Family Community Med, V1, P30
   Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EURO SURVEILL, V19
   Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, TRAV HLTH CDC ISS IN
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P769
   Cornblath DR, 2009, ANN NEUROL, V66, P569, DOI 10.1002/ana.21816
   Dallas County Department of Health and Human Services, 2016, HLTH ADV SEX TRANSM
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   EPPS RE, 1995, SEMIN DERMATOL, V14, P179, DOI 10.1016/S1085-5629(05)80016-1
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foulkes MA, 2011, J WOMENS HEALTH, V20, P1429, DOI 10.1089/jwh.2011.3118
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1155
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, EP UPD ZIK VIR INF
   Pan American Health Organization, 2016, EP AL REP INCR CONG
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Roth A, 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 76
TC 30
Z9 31
U1 0
U2 81
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD AUG 2
PY 2016
VL 165
IS 3
BP 175
EP +
DI 10.7326/M16-0617
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2HA
UT WOS:000380583300006
PM 27135717
DA 2020-07-08
ER

PT J
AU Maestre, AM
   Fernandez-Sesma, A
AF Maestre, Ana M.
   Fernandez-Sesma, Ana
TI Finding Clues for Congenital Zika Syndrome: Zika Virus Selective
   Infection of Immature Neurons
SO EBIOMEDICINE
LA English
DT Editorial Material
DE Zika
ID ORGANOIDS
C1 [Maestre, Ana M.; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
RP Fernandez-Sesma, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM ana.sesma@mssm.edu
RI Merens, Ana Maestre/I-2445-2019
OI Merens, Ana Maestre/0000-0002-2494-0879; Fernandez-Sesma,
   Ana/0000-0002-3405-6702
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073450]
CR Dang J., 2016, CELL STEM CELL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 8
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG
PY 2016
VL 10
BP 7
EP +
DI 10.1016/j.ebiom.2016.07.026
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IE
UT WOS:000386877700004
PM 27475896
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hughes, BW
   Addanki, KC
   Sriskanda, AN
   McLean, E
   Bagasra, O
AF Hughes, Brandon W.
   Addanki, Krishna C.
   Sriskanda, Ahila N.
   McLean, Ewen
   Bagasra, Omar
TI Infectivity of Immature Neurons to Zika Virus: A Link to Congenital Zika
   Syndrome
SO EBIOMEDICINE
LA English
DT Article
DE Microcephaly; Neurogenesis; Neuroblastoma; Terminally differentiated;
   Undifferentiated; Zika virus
ID PHOSPHATIDYLSERINE; NEUROBLASTOMA
AB Background: Epidemiological data strongly suggest that microcephaly cases in Brazil are associated with the ongoing epidemic of Zika virus (ZIKV). In order to further solidify the possible link, we investigated the infectivity of ZIKV using various neuroblastoma (NB) cell lines.
   Methods: Six undifferentiated, two terminally differentiated and two retinoic acid (RA) -induced, partially differentiated cell lines were exposed to ZIKV strain PRVABC59, which is genetically similar to the French Polynesia strain, with 97-100% genetic homology to the current ZIKV strain found in Brazil. All infections were confirmed by real-time PCR (RT-qPCR), immunofluorescence assay (IFA) probing with anti-flavivirus E antibody, and evaluation of cytopathic effects.
   Findings: ZIKV infected all six undifferentiated NB cell lines. In five out of six NB cell lines, between 90 and 70% cells were positive by IFA whereas for one cell line, CCL-127, similar to 80% of cells were positive for ZIKV as determined by IFA but showed persistent infection. Two differentiated cell lines, JFEN and T-268, were highly resistant to ZIKV with <1% of the cells being susceptible, as determined by IFA and confirmed by qRT-PCR. Two retinoic acid (RA)-induced NB partially differentiated cell lines showed no difference in permissiveness as compared to their undifferentiated mother cell lines.
   Interpretation: These findings strengthen the reported association between high incidences of microcephaly and ZIKV infection in newborns in Brazil. Our results suggest that the undifferentiated neurons are highly permissive to ZIKV infection, as one would expect during the early stages of neurogenesis in fetal brains; whereas differentiated neurons, representative of adult brain neurons, are relatively resistant to the virus, which explains the rare occurrence of neurological complications in adults infected with ZIKV. Our studies confirm the neurotropism of the ZIKV strain closely related to the current epidemic in Latin America. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Hughes, Brandon W.; Addanki, Krishna C.; Sriskanda, Ahila N.; McLean, Ewen; Bagasra, Omar] Claflin Univ, South Carolina Ctr Biotechnol, 400 Magnolia St, Orangeburg, SC 29115 USA.
RP Bagasra, O (corresponding author), Claflin Univ, South Carolina Ctr Biotechnol, 400 Magnolia St, Orangeburg, SC 29115 USA.
EM obagasra@claflin.edu
RI McLean, Ewen/AAO-6863-2020
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936
   Carneiro LA, 2016, MICROBES INFECT
   Cauchemez S, 2016, LANCET
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS E ZIK V
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Kaddumukasa A. M., 2015, AFR J BIOTECHNOL, V14, P1418, DOI DOI 10.5897/AJB2015.14474
   Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Muller HD, 2003, ACTA NEUROPATHOL, V106, P509, DOI 10.1007/s00401-003-0768-0
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, N ENGL J MED
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001
   Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sorensen PHB, 1996, P NATL ACAD SCI USA, V93, P1038, DOI 10.1073/pnas.93.3.1038
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 39
TC 20
Z9 20
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG
PY 2016
VL 10
BP 65
EP 70
DI 10.1016/j.ebiom.2016.06.026
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IE
UT WOS:000386877700017
PM 27364784
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Davila, MG
   Polanco, VP
   Santaella, J
AF Davila, Mila Gonzalez
   Polanco, Victor Puac
   Santaella, Julian
TI "Convicting Zika"
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT News Item
C1 [Davila, Mila Gonzalez; Polanco, Victor Puac; Santaella, Julian] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.
RP Davila, MG (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD AUG
PY 2016
VL 106
IS 8
BP 1350
EP 1350
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DY3HK
UT WOS:000384981200009
DA 2020-07-08
ER

PT J
AU Diniz, D
AF Diniz, Debora
TI THE PROTECTION TO WOMEN'S FUNDAMENTAL RIGHTS VIOLATED BY THE ZIKA VIRUS
   EPIDEMIC
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
C1 [Diniz, Debora] Univ Brasilia, Fac Law, Brasilia, DF, Brazil.
   [Diniz, Debora] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Diniz, D (corresponding author), Caixa Postal 8011, BR-70673970 Brasilia, DE, Brazil.
EM d.diniz@anis.org.br
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
NR 1
TC 2
Z9 3
U1 0
U2 3
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD AUG
PY 2016
VL 106
IS 8
BP E9
EP E9
DI 10.2105/AJPH.2016.303246
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DY3HK
UT WOS:000384981200002
PM 27400363
OA Green Published
DA 2020-07-08
ER

PT J
AU Teixeira, MG
   Rodrigues, LC
AF Teixeira, Maria G.
   Rodrigues, Laura C.
TI THE PROTECTION TO WOMEN'S FUNDAMENTAL RIGHTS VIOLATED BY THE ZIKA VIRUS
   EPIDEMIC RESPONSE
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
C1 [Teixeira, Maria G.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
RI Teixeira, Maria Gloria/G-4808-2012
OI Teixeira, Maria Gloria/0000-0003-3318-3408
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD AUG
PY 2016
VL 106
IS 8
BP E9
EP E9
DI 10.2105/AJPH.2016.303249
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DY3HK
UT WOS:000384981200003
PM 27400362
OA Green Published
DA 2020-07-08
ER

PT J
AU Meltzer, E
   Lustig, Y
   Leshem, E
   Levy, R
   Gottesman, G
   Weissmann, R
   Rabi, DH
   Hindiyeh, M
   Koren, R
   Mendelson, E
   Schwartz, E
AF Meltzer, Eyal
   Lustig, Yaniv
   Leshem, Eyal
   Levy, Ran
   Gottesman, Giora
   Weissmann, Rotem
   Rabi, Duha Hejleh
   Hindiyeh, Musa
   Koren, Ravit
   Mendelson, Ella
   Schwartz, Eli
TI Zika Virus Disease in Traveler Returning from Vietnam to Israel
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INFECTION
C1 [Meltzer, Eyal; Lustig, Yaniv; Leshem, Eyal; Hindiyeh, Musa; Koren, Ravit; Mendelson, Ella; Schwartz, Eli] Sheba Med Ctr, Tel Hashomer, Israel.
   [Meltzer, Eyal; Leshem, Eyal; Gottesman, Giora; Hindiyeh, Musa; Mendelson, Ella; Schwartz, Eli] Tel Aviv Univ, Tel Aviv, Israel.
   [Levy, Ran] Maccabi Hlth Serv, Kfar Yona, Israel.
   [Gottesman, Giora; Weissmann, Rotem; Rabi, Duha Hejleh] Meir Med Ctr, Kefar Sava, Israel.
RP Mendelson, E; Schwartz, E (corresponding author), Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.; Mendelson, E; Schwartz, E (corresponding author), Chaim Sheba Med Ctr, Dept Med, IL-52621 Tel Hashomer, Israel.
EM meltzere@zahav.net.il; elischwa@post.tau.ac.il
OI Leshem, Eyal/0000-0003-1267-6131
CR [Anonymous], REUTERS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huzly D, 2016, EURO SURVEILL, V21
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   ProMED-mail, 2016, ZIK VIR AUSTR EXV NA
   World Health Organization. WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG
NR 9
TC 33
Z9 36
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2016
VL 22
IS 8
BP 1521
EP 1522
DI 10.3201/eid2208.160480
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DY2PM
UT WOS:000384934500042
PM 27331627
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Belfort, R
   Freitas, BD
   Dias, JRD
AF Belfort, Rubens, Jr.
   Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
TI Zika Virus, Microcephaly, and Ocular Findings Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Belfort, Rubens, Jr.; de Oliveira Dias, Joao Rafael] Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 2
TC 2
Z9 2
U1 0
U2 32
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 947
DI 10.1001/jamaophthalmol.2016.1305
PG 2
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200026
PM 27253365
DA 2020-07-08
ER

PT J
AU Vasconcelos-Santos, DV
   Andrade, GMQ
   Caiaffa, WT
AF Vasconcelos-Santos, Daniel Vitor
   Queiroz Andrade, Glaucia Manzan
   Caiaffa, Waleska Teixeira
TI Zika Virus, Microcephaly, and Ocular Findings
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Vasconcelos-Santos, Daniel Vitor] Univ Fed Minas Gerais, Sch Med, Dept Ophthalmol, Av Alfredo Balena 190,Sala 199, BR-30130100 Belo Horizonte, MG, Brazil.
   [Vasconcelos-Santos, Daniel Vitor; Queiroz Andrade, Glaucia Manzan; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Sch Med, Nucleo Acoes Pesquisa & Apoio Diagnost, Belo Horizonte, MG, Brazil.
   [Queiroz Andrade, Glaucia Manzan] Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Sch Med, Dept Prevent & Social Med Observ Urban Hlth, Belo Horizonte, MG, Brazil.
RP Vasconcelos-Santos, DV (corresponding author), Univ Fed Minas Gerais, Sch Med, Dept Ophthalmol, Av Alfredo Balena 190,Sala 199, BR-30130100 Belo Horizonte, MG, Brazil.
EM dvitorvs@gmail.com
RI Vasconcelos-Santos, Daniel V/D-3576-2013
OI Vasconcelos-Santos, Daniel V/0000-0002-6747-2024
CR de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Peyron F, 2016, INFECT DIS FETUS NEW, P949
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
NR 5
TC 3
Z9 3
U1 0
U2 50
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 946
DI 10.1001/jamaophthalmol.2016.1313
PG 1
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200025
PM 27253205
DA 2020-07-08
ER

PT J
AU Gerdts, C
   Fuentes, L
   Wahlin, B
   Blanchard, K
AF Gerdts, Caitlin
   Fuentes, Liza
   Wahlin, Britt
   Blanchard, Kelly
TI Zika Virus and Pregnancy: What Obstetric Health Care Providers Need to
   Know
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Gerdts, Caitlin; Fuentes, Liza] Ibis Reprod Hlth, Oakland, CA 94612 USA.
   [Wahlin, Britt; Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA.
RP Gerdts, C (corresponding author), Ibis Reprod Hlth, Oakland, CA 94612 USA.
OI Fuentes, Liza/0000-0003-2990-6933
CR Asplin N, 2013, SEX REPROD HEALTHC, V4, P79, DOI 10.1016/j.srhc.2013.02.001
   Center for Reproductive Rights, 2015, WORLDS ABORTION LAWS
   Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Winikoff B, 2012, INT PERSPECT SEX R H, V38, P164, DOI 10.1363/3816412
NR 5
TC 1
Z9 1
U1 0
U2 47
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD AUG
PY 2016
VL 128
IS 2
BP 405
EP 405
DI 10.1097/AOG.0000000000001540
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DS6UO
UT WOS:000380918500033
PM 27454712
DA 2020-07-08
ER

PT J
AU Phillips, JA
   Neyland, A
AF Phillips, Jennan A.
   Neyland, Anavernyel
TI Zika Virus
SO WORKPLACE HEALTH & SAFETY
LA English
DT Editorial Material
DE disease prevention; communicable diseases; global occupational health;
   women's health; emergency response
AB Zika virus (ZIKV) infections are the latest global public health emergency. Occupational health nurses can protect society by educating workers, women of childbearing age, and others traveling in ZIKV-infected areas about prevention strategies.
C1 [Phillips, Jennan A.; Neyland, Anavernyel] Univ Alabama Birmingham, Birmingham, AL USA.
RP Phillips, JA (corresponding author), Univ Alabama Birmingham, Occupat Hlth Nursing Specialty, 1701 Univ Blvd,NB 316, Birmingham, AL 35244 USA.
EM japhil@uab.edu
CR Pan American Health Organization, ZIK VIR INF
   World Health Organization, 2016, ZIK VIR COMPL
NR 2
TC 3
Z9 3
U1 0
U2 49
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2165-0799
EI 2165-0969
J9 WORKPLACE HEALTH SAF
JI Workplace Health Saf.
PD AUG
PY 2016
VL 64
IS 8
BP 396
EP 396
DI 10.1177/2165079916657109
PG 1
WC Nursing
SC Nursing
GA DS7KC
UT WOS:000380961400007
PM 27411846
OA Bronze
DA 2020-07-08
ER

PT J
AU Smith, HE
   Allen, K
AF Smith, Heather E.
   Allen, Kimberly
TI ZIKA VIRUS AND THE NEONATAL INTENSIVE CARE UNIT
SO ADVANCES IN NEONATAL CARE
LA English
DT News Item
C1 [Smith, Heather E.] QOL Med LLC, 505 Oberlin Rd,Ste 148, Raleigh, NC 27605 USA.
   [Allen, Kimberly] Univ Illinois, Chicago, IL USA.
RP Smith, HE (corresponding author), QOL Med LLC, 505 Oberlin Rd,Ste 148, Raleigh, NC 27605 USA.
EM helser@qolmed.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1536-0903
EI 1536-0911
J9 ADV NEONAT CARE
JI Adv. Neonatal Care
PD AUG
PY 2016
VL 16
IS 4
BP 249
EP 250
PG 2
WC Nursing
SC Nursing
GA DX2MA
UT WOS:000384202900004
DA 2020-07-08
ER

PT J
AU Bennett, R
AF Bennett, Rachel
TI NANN Provides Education About Neonatal Abstinence Syndrome and Zika
   Virus Infection and Prepares Neonatal Nurses to Be Advocates for Their
   Profession and Their Patients
SO ADVANCES IN NEONATAL CARE
LA English
DT Editorial Material
C1 [Bennett, Rachel] Natl Assoc Neonatal Nurses, 8735 W Higgins Rd,Ste 300, Chicago, IL 60631 USA.
RP Bennett, R (corresponding author), Natl Assoc Neonatal Nurses, 8735 W Higgins Rd,Ste 300, Chicago, IL 60631 USA.
EM rbennett@connect2amc.com
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1536-0903
EI 1536-0911
J9 ADV NEONAT CARE
JI Adv. Neonatal Care
PD AUG
PY 2016
VL 16
IS 4
BP 252
EP 253
DI 10.1097/ANC.0000000000000321
PG 2
WC Nursing
SC Nursing
GA DX2MA
UT WOS:000384202900006
PM 27391568
DA 2020-07-08
ER

PT J
AU Kalil, J
   Ho, P
   Precioso, AR
AF Kalil, J.
   Ho, P.
   Precioso, A. R.
TI Zika Virus Program at Butantan Institute
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT International Congress of Immunology (ICI)
CY AUG 21-26, 2016
CL Melbourne, AUSTRALIA
C1 [Kalil, J.; Ho, P.; Precioso, A. R.] Inst Butantan, Sao Paulo, Brazil.
RI KALIL, JORGE/C-8029-2012; Precioso, Alexander Roberto/A-9712-2013
OI KALIL, JORGE/0000-0001-8415-4274; Precioso, Alexander
   Roberto/0000-0001-8657-9292
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2016
VL 46
SU 1
SI SI
BP 998
EP 998
PG 1
WC Immunology
SC Immunology
GA DW4KA
UT WOS:000383610402402
DA 2020-07-08
ER

PT J
AU Wahid, B
   Ali, A
   Rafique, S
   Idrees, M
AF Wahid, Braira
   Ali, Amjad
   Rafique, Shazia
   Idrees, Muhammad
TI Zika: As an emergent epidemic
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE ZIKV; Neurological complications; Pathogenesis; Future prospects
ID VIRUS-INFECTION; YELLOW-FEVER; AEDES-ALBOPICTUS; 1ST REPORT; BRAZIL;
   TRANSMISSION; CULICIDAE; MOSQUITOS; OUTBREAK; AMERICA
AB Zika virus is a new global threat for 2016 that has been swept to almost all Americas and is now posing serious threats to the entire globe. This deadly virus is playing havoc to unborn lives because of its reported association with upsurge of fetal deformation called microcephaly and neuropathic disorders including Guillain-Barre syndrome. Till today, there is no vaccine prospect, antiviral therapy or licensed medical countermeasures to curb the teratogenic outcomes of this destructive viral infection. Diagnosis, treatment, chronicity and pathogenesis are still vague and unsettled. Therefore, this review article addresses all the aspects related to this disease to mitigate the explosive rise in Zika virus infection.
C1 [Wahid, Braira; Ali, Amjad; Rafique, Shazia; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
RP Idrees, M (corresponding author), Univ Punjab, Ctr Appl Mol Biol, Div Mol Virol, Lahore 53700, Pakistan.
EM idrees.khan96@yahoo.com
RI Idrees, Muhammad/K-6032-2012
OI Idrees, Muhammad/0000-0002-3081-7631
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2016, Nurs Stand, V30, P17, DOI 10.7748/ns.30.24.17.s20
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Cadu R, 2015, HEALTH, V386, P243
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Centers for Disease Control and Prevention, ZIK VIR SYMPT DIAGN
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Dibo MR, 2011, REV SOC BRAS MED TRO, V44, P496, DOI 10.1590/S0037-86822011000400019
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Getachew D, 2015, INTERDISCIP PERSPECT, V2015
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joshi V, 2006, J MED ENTOMOL, V43, P330, DOI 10.1603/0022-2585(2006)043[0330:IOSSAT]2.0.CO;2
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Muller GA, 2010, ENTOMOL NEWS, V121, P102, DOI 10.3157/021.121.0102
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shayama G, 2016, ZIKA LINK BIRTH DEFE
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Talan J., 2016, NEUROL TODAY, V16, P1
   Tappe D, 2013, EURO SURVEILL, V19
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   von Eije Karin J, 2015, Ned Tijdschr Geneeskd, V160, pD153
   Wang S, 2014, PROTEINS, V82, P2620, DOI 10.1002/prot.24626
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 73
TC 6
Z9 6
U1 0
U2 83
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD AUG
PY 2016
VL 9
IS 8
BP 723
EP 729
DI 10.1016/j.apjtm.2016.06.019
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV9EH
UT WOS:000383242400001
PM 27569879
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Al-Abdely, HM
AF Al-Abdely, Hail M.
TI Zika An emerging teratogenic virus
SO SAUDI MEDICAL JOURNAL
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
C1 [Al-Abdely, Hail M.] Minist Hlth, Gen Directorate Infect Prevent & Control, Riyadh, Saudi Arabia.
RP Al-Abdely, HM (corresponding author), Minist Hlth, Gen Directorate Infect Prevent & Control, Riyadh, Saudi Arabia.
EM halabdely@moh.gov.sa
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 12
TC 3
Z9 3
U1 0
U2 1
PU SAUDI MED J
PI RIYADH
PA ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA
SN 0379-5284
J9 SAUDI MED J
JI Saudi Med. J.
PD AUG
PY 2016
VL 37
IS 8
BP 831
EP 833
DI 10.15537/smj.2016.8.15676
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW6SR
UT WOS:000383782000001
PM 27464857
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kincaid, E
AF Kincaid, Ellie
TI A second look: Efforts to repurpose old drugs against Zika cast a wide
   net
SO NATURE MEDICINE
LA English
DT News Item
CR 2012, PLOS ONE, V7
   2016, PLOS NEGL TROP DIS, V10
   2013, MEM I O CRUZ, V108, P596
NR 3
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2016
VL 22
IS 8
BP 824
EP 825
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DS7YV
UT WOS:000381000200002
PM 27490430
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhou, HD
   Eaton, B
   Hu, ZH
   Arif, B
AF Zhou, Hedi
   Eaton, Bryan
   Hu, Zhihong
   Arif, Basil
TI Accidental discovery and isolation of Zika virus in Uganda and the
   relentless epidemiologist behind the investigations
SO VIROLOGICA SINICA
LA English
DT Editorial Material
ID CHIKUNGUNYA; INFECTION; OUTBREAK; SPECIFICITY; BRAZIL
C1 [Zhou, Hedi; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China.
   [Eaton, Bryan] 6 Belvedere Terrace, Ocean Grove, Vic 3226, Australia.
   [Arif, Basil] GLFC, Mol Virol Lab, Sault Ste Marie, ON P6A 2E5, Canada.
RP Arif, B (corresponding author), GLFC, Mol Virol Lab, Sault Ste Marie, ON P6A 2E5, Canada.
EM basil.arif@canada.ca
RI Hu, Zhihong/AAS-2215-2020
OI Hu, Zhihong/0000-0002-1560-0928
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Angusti A, 2008, CHEM PHARM BULL, V56, P423, DOI 10.1248/cpb.56.423
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chastel Claude, 2005, Bull Acad Natl Med, V189, P1827
   Citterio P, 2007, EXPERT OPIN INV DRUG, V16, P11, DOI 10.1517/13543784.16.1.11
   Cooke J, 2016, LANCET INFECT DIS, V16, P406, DOI 10.1016/S1473-3099(16)00123-7
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enserink M, 2006, SCIENCE, V311, P1085, DOI 10.1126/science.311.5764.1085a
   Haddow A. J., 1965, Transactions of the Royal Entomological Society of London, V117, P215
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009
   Lopes R J., 2016, NATURE NEWS, DOI [10.1038/nature.2016.19804, DOI 10.1038/NATURE.2016.19804]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P1
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
NR 39
TC 3
Z9 4
U1 0
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD AUG
PY 2016
VL 31
IS 4
BP 357
EP 361
DI 10.1007/s12250-016-3821-6
PG 5
WC Virology
SC Virology
GA DU1YN
UT WOS:000382007000013
PM 27438084
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Guillain-Barre syndrome and Zika virus infection
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 7
Z9 7
U1 0
U2 54
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD AUG
PY 2016
VL 74
IS 8
BP 692
EP 692
DI 10.1590/0004-282X20160089
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DU7UJ
UT WOS:000382419800017
PM 27556383
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Muller, M
   Terry, SF
AF Muller, Marion
   Terry, Sharon F.
TI Rising Concern Regarding Pregnant Women and Zika Virus
SO GENETIC TESTING AND MOLECULAR BIOMARKERS
LA English
DT Editorial Material
C1 [Muller, Marion] Emory Univ, Atlanta, GA 30322 USA.
   [Terry, Sharon F.] Genet Alliance, 4301 Connecticut Ave,NW Suite 404, Washington, DC 20008 USA.
RP Terry, SF (corresponding author), Genet Alliance, 4301 Connecticut Ave,NW Suite 404, Washington, DC 20008 USA.
EM sterry@geneticalliance.org
CR Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Herszenhorn David M, 2016, NY TIMES
   Jernej M, 2016, NEW ENGL J MED, V374, P951
   Ordonez Franco, 2016, LACK ZIKA SPECIFIC T
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   WHO, 2016, HIST ZIK VIR
NR 7
TC 0
Z9 0
U1 0
U2 52
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1945-0265
EI 1945-0257
J9 GENET TEST MOL BIOMA
JI Genet. Test. Mol. Biomark.
PD AUG
PY 2016
VL 20
IS 8
BP 411
EP 412
DI 10.1089/gtmb.2016.29018.sjt
PG 2
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DT2AL
UT WOS:000381283100001
PM 27414192
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dara
TI Zika vaccines effective in mice
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2016
VL 16
IS 8
BP 902
EP 902
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DU4XH
UT WOS:000382215700045
DA 2020-07-08
ER

PT J
AU Morrison, C
AF Morrison, Chris
TI DNA vaccines against Zika virus speed into clinical trials
SO NATURE REVIEWS DRUG DISCOVERY
LA English
DT News Item
AB Less than 6 months after Zika infection was declared a public health emergency, the first clinical trials of DNA vaccines against the virus are beginning.
NR 0
TC 25
Z9 25
U1 0
U2 39
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1776
EI 1474-1784
J9 NAT REV DRUG DISCOV
JI Nat. Rev. Drug Discov.
PD AUG
PY 2016
VL 15
IS 8
BP 521
EP 522
DI 10.1038/nrd.2016.159
PG 2
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA DU9IT
UT WOS:000382531000003
PM 27469223
OA Bronze
DA 2020-07-08
ER

PT J
AU Norton, ME
AF Norton, Mary E.
TI Guillain-Barre Syndrome Outbreak Associated With Zika Virus Infection in
   French Polynesia: A Case- Control Study EDITORIAL COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD AUG
PY 2016
VL 71
IS 8
BP 451
EP 452
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DT2KK
UT WOS:000381309000003
DA 2020-07-08
ER

PT J
AU Tian, HL
   Ji, XY
   Yang, XY
   Zhang, ZX
   Lu, ZK
   Yang, KL
   Chen, C
   Zhao, Q
   Chi, H
   Mu, ZY
   Xie, W
   Wang, ZF
   Lou, HQ
   Yang, HT
   Rao, ZH
AF Tian, Hongliang
   Ji, Xiaoyun
   Yang, Xiaoyun
   Zhang, Zhongxin
   Lu, Zuokun
   Yang, Kailin
   Chen, Cheng
   Zhao, Qi
   Chi, Heng
   Mu, Zhongyu
   Xie, Wei
   Wang, Zefang
   Lou, Huiqiang
   Yang, Haitao
   Rao, Zihe
TI Structural basis of Zika virus helicase in recognizing its substrates
SO PROTEIN & CELL
LA English
DT Article
DE Zika virus; helicase; ATP; crystal structure; flavivirus
ID SOFTWARE; PROTEIN
AB The recent explosive outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly associated with ZIKV infection has already caused a public health emergency of international concern. No specific vaccines or drugs are currently available to treat ZIKV infection. The ZIKV helicase, which plays a pivotal role in viral RNA replication, is an attractive target for therapy. We determined the crystal structures of ZIKV helicase-ATP-Mn2+ and ZIKV helicase-RNA. This is the first structure of any flavivirus helicase bound to ATP. Comparisons with related flavivirus helicases have shown that although the critical P-loop in the active site has variable conformations among different species, it adopts an identical mode to recognize ATP/Mn2+. The structure of ZIKV helicase-RNA has revealed that upon RNA binding, rotations of the motor domains can cause significant conformational changes. Strikingly, although ZIKV and dengue virus (DENV) apo-helicases share conserved residues for RNA binding, their different manners of motor domain rotations result in distinct individual modes for RNA recognition. It suggests that flavivirus helicases could have evolved a conserved engine to convert chemical energy from nucleoside triphosphate to mechanical energy for RNA unwinding, but different motor domain rotations result in variable RNA recognition modes to adapt to individual viral replication.
C1 [Tian, Hongliang; Yang, Xiaoyun; Chen, Cheng; Chi, Heng; Mu, Zhongyu; Xie, Wei; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Tian, Hongliang; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, Zhongxin; Lou, Huiqiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
   [Lu, Zuokun; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA.
   [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
RP Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM yanght@tju.edu.cn
RI Lou, Huiqiang/B-6287-2012; Yang, Kailin/L-2205-2013
OI Lou, Huiqiang/0000-0003-4465-6186; Yang, Kailin/0000-0001-5968-6738; Ji,
   Xiaoyun/0000-0002-0801-8825
FU National Basic Research program of China (973 program)National Basic
   Research Program of China [2015CB859800, 2014CB542800]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31528006, 31271331]
FX We would like to thank the staff at beamLine BL18U1 and BL19U1 of the
   Shanghai Synchrotron Radiation Facility (SSRF) for data collection;
   Henry C. Nguyen and Lanfeng Wang for discussion and advice. This work
   was supported by the National Basic Research program of China (973
   program) (Nos. 2015CB859800 and 2014CB542800) and the National Natural
   Science Foundation of China (Grant Nos. 31528006 and 31271331).
CR Brasil P, 2016, N ENGL J MED
   Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LINDENBACH BD, 2001, FUNDAMENTAL VIROLOGY
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson T.C., 2013, FLAVIVIRUSES, V2
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 22
TC 40
Z9 42
U1 0
U2 67
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD AUG
PY 2016
VL 7
IS 8
BP 562
EP 570
DI 10.1007/s13238-016-0293-2
PG 9
WC Cell Biology
SC Cell Biology
GA DT6GZ
UT WOS:000381583800003
PM 27430951
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hickman, HD
   Pierson, TC
AF Hickman, Heather D.
   Pierson, Theodore C.
TI Zika in the Brain: New Models Shed Light on Viral Infection
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
AB The current Zika virus (ZIKV) outbreak is associated with high numbers of human congenital birth defects, yet it has been unclear how ZIKV infection during pregnancy causes these abnormalities. Three new mouse models now show that ZIKV crosses the placenta and replicates in the brains of fetal mice.
C1 [Hickman, Heather D.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
OI Hickman, Heather/0000-0003-4168-4894
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 AI999999]
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Chastain EML, 2015, MBIO, V6, DOI 10.1128/mBio.01175-15
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Hsu TH, 2012, MBIO, V3, DOI 10.1128/mBio.00131-12
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 10
TC 5
Z9 5
U1 0
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG
PY 2016
VL 22
IS 8
BP 639
EP 641
DI 10.1016/j.molmed.2016.06.004
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DT5NR
UT WOS:000381530400005
PM 27345865
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus, autoimmunity and microcephaly: Other things for
   consideration
SO AUTOIMMUNITY REVIEWS
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Wiwanitkit V, 2005, CLIN APPL THROMB-HEM, V11, P112, DOI 10.1177/107602960501100116
   Wiwanitkit V, 2005, NANOMED-NANOTECHNOL, V1, P239, DOI 10.1016/j.nano.2005.06.002
   Wiwanitkit Viroj, 2006, J Ayub Med Coll Abbottabad, V18, P13
NR 4
TC 3
Z9 3
U1 1
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 855
EP 855
DI 10.1016/j.autrev.2016.04.002
PG 1
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300011
PM 27060381
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Global response to Zika
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD AUG
PY 2016
VL 94
IS 8
BP 560
EP 560
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3HM
UT WOS:000382101400004
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika and breastfeeding
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD AUG
PY 2016
VL 94
IS 8
BP 560
EP 560
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3HM
UT WOS:000382101400005
DA 2020-07-08
ER

PT J
AU Barr, KL
   Anderson, BD
   Prakoso, D
   Long, MT
AF Barr, Kelli L.
   Anderson, Benjamin D.
   Prakoso, Dhani
   Long, Maureen T.
TI Working with Zika and Usutu Viruses In Vitro
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; AEDES-ALBOPICTUS DIPTERA; BLOOD-FEEDING PATTERNS;
   CULEX-PIPIENS DIPTERA; SENTINEL CHICKENS; YELLOW-FEVER; CULICIDAE;
   TRANSMISSION; AEGYPTI; HOSTS
AB Usutu (USUV) and Zika (ZIKV) viruses are emerging arboviruses of significant medical and veterinary importance. These viruses have not been studied as well as other medically important arboviruses such as West Nile (WNV), dengue (DENV), or chikungunya (CHIKV) viruses. As such, information regarding the behavior of ZIKV and USUV viruses in the laboratory is dated. Usutu virus re-emerged in Austria in 2001 and has since spread throughout the European and Asian continents causing significant mortality among birds. Zika virus has recently appeared in the Western Hemisphere and has exhibited high rates of birth defects and sexual transmission. Information about the characteristics of USUV and ZIKV viruses are needed to better understand the transmission, dispersal, and adaptation of these viruses in new environments. Since their initial characterization in the middle of last century, technologies and reagents have been developed that could enhance our abilities to study these pathogens. Currently, standard laboratory methods for these viruses are limited to 2-3 cell lines and many assays take several days to generate meaningful data. The goal of this study was to characterize these viruses in cells from multiple diverse species. Cell lines from 17 species were permissive to both ZIKV and USUV. These viruses were able to replicate to significant titers in most of the cell lines tested. Moreover, cytopathic effects were observed in 8 of the cell lines tested. These data indicate that a variety of cell lines can be used to study ZIKV and USUV infection and may provide an updated foundation for the study of host-pathogen interactions, model development, and the development of therapeutics.
C1 [Barr, Kelli L.; Prakoso, Dhani; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.
   [Anderson, Benjamin D.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC USA.
   [Anderson, Benjamin D.] Duke Univ, Global Hlth Inst, Durham, NC USA.
RP Barr, KL (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.
EM kellilbarr@ufl.edu
RI Barr, Kelli L./I-7508-2019
OI Barr, Kelli L./0000-0001-7943-7181
CR Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P298, DOI 10.3201/eid1102.041016
   Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Barr KL, 2013, VIRUS ADAPTATION TRE, V5, P1
   Barr KL, 2012, VIRUS ADAPTATION TRE, V4, P65
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   Burke DS, 2001, FIELDS VIROLOGY, VI, P1043
   Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Cavrini F., 2009, EUROSURVEILLANCE, V14, P50
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005
   Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MCINTOSH BM, 1985, INT CATALOGUE ARBOVI, V3, P1059
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   PAHO, 2015, NEUR SYNDR CONG MALF
   PECORARI M, 2009, EURO SURVEILL, V14
   Peletto S, 2012, NEW MICROBIOL, V35, P167
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   SCHECHTER EM, 1988, J GEN VIROL, V69, P1591, DOI 10.1099/0022-1317-69-7-1591
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1
   Thaisomboonsuk BK, 2005, AM J TROP MED HYG, V72, P375, DOI 10.4269/ajtmh.2005.72.375
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 15
Z9 16
U1 1
U2 50
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004931
DI 10.1371/journal.pntd.0004931
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800066
PM 27541001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carlson, CJ
   Dougherty, ER
   Getz, W
AF Carlson, Colin J.
   Dougherty, Eric R.
   Getz, Wayne
TI An Ecological Assessment of the Pandemic Threat of Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SAMPLE-SIZE; VECTOR; DENGUE; TRANSMISSION; PERFORMANCE; EMERGENCE;
   AEGYPTI; ORIGIN
AB The current outbreak of Zika virus poses a severe threat to human health. While the range of the virus has been cataloged growing slowly over the last 50 years, the recent explosive expansion in the Americas indicates that the full potential distribution of Zika remains uncertain. Moreover, many studies rely on its similarity to dengue fever, a phylogenetically closely related disease of unknown ecological comparability. Here we compile a comprehensive spatially-explicit occurrence dataset from Zika viral surveillance and serological surveys based in its native range, and construct ecological niche models to test basic hypotheses about its spread and potential establishment. The hypothesis that the outbreak of cases in Mexico and North America are anomalous and outside the native ecological niche of the disease, and may be linked to either genetic shifts between strains, or El Nino or similar climatic events, remains plausible at this time. Comparison of the Zika niche against the known distribution of dengue fever suggests that Zika is more constrained by the seasonality of precipitation and diurnal temperature fluctuations, likely confining autochthonous nonsexual transmission to the tropics without significant evolutionary change. Projecting the range of the diseases in conjunction with three major vector species (Aedes africanus, Ae. aegypti, and Ae. albopictus) that transmit the pathogens, under climate change, suggests that Zika has potential for northward expansion; but, based on current knowledge, our models indicate Zika is unlikely to fill the full range its vectors occupy, and public fear of a vector-borne Zika epidemic in the mainland United States is potentially informed by biased or limited scientific knowledge. With recent sexual transmission of the virus globally, we caution that our results only apply to the vector-borne transmission route of the pathogen, and while the threat of a mosquito-carried Zika pandemic may be overstated in the media, other transmission modes of the virus may emerge and facilitate naturalization worldwide.
C1 [Carlson, Colin J.; Dougherty, Eric R.; Getz, Wayne] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
   [Getz, Wayne] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa.
RP Carlson, CJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
EM cjcarlson@berkeley.edu
RI Carlson, Colin/I-2736-2019
OI Carlson, Colin/0000-0001-6960-8434
CR Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Broenniman O, 2014, ECOSPAT SPATIAL ECOL
   Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254
   Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peterson AT, 2006, EMERG INFECT DIS, V12, P1822
   Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Ritchie SA, 2001, EMERG INFECT DIS, V7, P900
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Shapshak P, GLOBAL VIROLOGY, DOI [10.1007/978-1-4939-2410-3_18, DOI 10.1007/978-1-4939-2410-3_18]
   Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 48
TC 45
Z9 45
U1 2
U2 121
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004968
DI 10.1371/journal.pntd.0004968
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800081
PM 27564232
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jupille, H
   Seixas, G
   Mousson, L
   Sousa, CA
   Failloux, AB
AF Jupille, Henri
   Seixas, Goncalo
   Mousson, Laurence
   Sousa, Carla A.
   Failloux, Anna-Bella
TI Zika Virus, a New Threat for Europe?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK; DENGUE
AB Background
   Since its emergence in 2007 in Micronesia and Polynesia, the arthropod-borne flavivirus Zika virus) ZIKV) has spread in the Americas and the Caribbean, following first detection in Brazil in May 2015. The risk of ZIKV emergence in Europe increases as imported cases are repeatedly reported. Together with chikungunya virus) CHIKV) and dengue virus) DENV), ZIKV is transmitted by Aedes mosquitoes. Any countries where these mosquitoes are present could be potential sites for future ZIKV outbreak. We assessed the vector competence of European Aedes mosquitoes)Aedes aegypti and Aedes albopictus) for the currently circulating Asian genotype of ZIKV.
   Methodology/Principal Findings
   Two populations of Ae. aegypti from the island of Madeira) Funchal and Paul do Mar) and two populations of Ae. albopictus from France) Nice and Bar-sur-Loup) were challenged with an Asian genotype of ZIKV isolated from a patient in April 2014 in New Caledonia. Fully engorged mosquitoes were then maintained in insectary conditions (28 degrees +/- 1 degrees C, 16h:8h light: dark cycle and 80% humidity). 16-24 mosquitoes from each population were examined at 3, 6, 9 and 14 days post-infection to estimate the infection rate, disseminated infection rate and transmission efficiency. Based on these experimental infections, we demonstrated that Ae. albopictus from France were not very susceptible to ZIKV.
   Conclusions/Significance
   In combination with the restricted distribution of European Ae. albopictus, our results on vector competence corroborate the low risk for ZIKV to expand into most parts of Europe with the possible exception of the warmest regions bordering the Mediterranean coastline.
C1 [Jupille, Henri; Mousson, Laurence; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
   [Seixas, Goncalo; Sousa, Carla A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal.
   [Seixas, Goncalo; Sousa, Carla A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, P-1200 Lisbon, Portugal.
RP Failloux, AB (corresponding author), Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
EM anna-bella.failloux@pasteur.fr
RI Sousa, Carla/G-6531-2012; Seixas, Goncalo/F-9282-2014; Seixas,
   Goncalo/L-7932-2019
OI Sousa, Carla/0000-0002-2386-7577; Seixas, Goncalo/0000-0001-5745-2153; 
FU FP7-HEALTH "Dengue research Framework for resisting epidemics in Europe"
   (DENFREE) [HEALTH.2011.2.3.3-2, 282378]; Institut Pasteur (ACIP grant)
   [A15-2014]
FX The work was supported by a grant FP7-HEALTH HEALTH.2011.2.3.3-2 (grant
   number: 282378) "Dengue research Framework for resisting epidemics in
   Europe" (DENFREE) and the Institut Pasteur (ACIP grant A15-2014). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Antoine Enfissi JC, 2015, LANCET
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Levre E, 2002, Ann Ig, V14, P153
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642, DOI 10.4269/ajtmh.1986.35.642
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Tappe D, 2014, EURO SURVEILL, V19
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 47
Z9 49
U1 0
U2 50
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004901
DI 10.1371/journal.pntd.0004901
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800043
PM 27505002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Klase, ZA
   Khakhina, S
   Schneider, AD
   Callahan, MV
   Glasspool-Malone, J
   Malone, R
AF Klase, Zachary A.
   Khakhina, Svetlana
   Schneider, Adriano De Bernardi
   Callahan, Michael V.
   Glasspool-Malone, Jill
   Malone, Robert
TI Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID HUMAN DENDRITIC CELLS; HEPATITIS-C VIRUS; HUMAN
   CYTOMEGALOVIRUS-INFECTION; ANTIBODY-DEPENDENT ENHANCEMENT;
   CONGENITAL-RUBELLA SYNDROME; RECEPTOR TYROSINE KINASES;
   EPIDERMAL-GROWTH-FACTOR; RNA-BINDING PROTEINS; DENGUE-VIRUS;
   HERPES-SIMPLEX
AB The ongoing Zika virus epidemic in the Americas and the observed association with both fetal abnormalities (primary microcephaly) and adult autoimmune pathology (Guillain-Barre syndrome) has brought attention to this neglected pathogen. While initial case studies generated significant interest in the Zika virus outbreak, larger prospective epidemiology and basic virology studies examining the mechanisms of Zika viral infection and associated pathophysiology are only now starting to be published. In this review, we analyze Zika fetal neuropathogenesis from a comparative pathology perspective, using the historic metaphor of "TORCH" viral pathogenesis to provide context. By drawing parallels to other viral infections of the fetus, we identify common themes and mechanisms that may illuminate the observed pathology. The existing data on the susceptibility of various cells to both Zika and other flavivirus infections are summarized. Finally, we highlight relevant aspects of the known molecular mechanisms of flavivirus replication.
C1 [Klase, Zachary A.; Khakhina, Svetlana] Univ Sci, Dept Biol Sci, Philadelphia, PA USA.
   [Schneider, Adriano De Bernardi] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA.
   [Callahan, Michael V.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.
   [Callahan, Michael V.] Zika Fdn, College Stn, TX USA.
   [Glasspool-Malone, Jill; Malone, Robert] Ather Pharmaceut, Scottsville, VA 24590 USA.
   [Glasspool-Malone, Jill; Malone, Robert] Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA 02115 USA.
RP Malone, R (corresponding author), Ather Pharmaceut, Scottsville, VA 24590 USA.; Malone, R (corresponding author), Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA 02115 USA.
EM RWMaloneMD@gmail.com
RI de Bernardi Schneider, Adriano/E-6252-2017
OI de Bernardi Schneider, Adriano/0000-0001-7487-266X; Malone, Jill
   Glasspool/0000-0002-1463-6873; Malone, Robert W./0000-0003-0340-7490
FU UNC Research Opportunities Initiative grant
FX The authors received no specific funding for this work. Research
   reported in this publication was supported by a UNC Research
   Opportunities Initiative grant to UNC Charlotte, NC State University,
   and UNC-Chapel Hill. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ahn HM, 2012, NEONATOLOGY, V102, P259, DOI 10.1159/000339577
   ALFORD CA, 1990, REV INFECT DIS, V12, pS745
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Atreya CD, 2004, ARCH VIROL, V149, P779, DOI 10.1007/s00705-003-0267-6
   Baldwin C, 2016, CLIN EXP RHEUMATOL, V34, P172
   BANATVALA JE, 1971, J GEN VIROL, V13, P193, DOI 10.1099/0022-1317-13-2-193
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   Barefoot Katharine H, 2002, J Perinatol, V22, P86, DOI 10.1038/sj.jp.7210584
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Barrett PN, 1996, J MED VIROL, V49, P1, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt;1::AID-JMV1&gt;3.0.CO;2-A
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bobryshev YV, 2010, DIS ESOPHAGUS, V23, P580, DOI 10.1111/j.1442-2050.2010.01061.x
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buers I, 2016, CYTOKINE GROWTH F R, V29, P101, DOI 10.1016/j.cytogfr.2016.03.005
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carpenter JE, 2016, J VIROL, V90, P379, DOI 10.1128/JVI.02389-15
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754
   Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112
   Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803
   Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123
   Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009
   COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192
   Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11
   Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coutinho R., CULEX DEVE MODIFICAR
   Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Cunha SS, 2015, REV INST MED TROP SP, V57, P481, DOI 10.1590/S0036-46652015000600004
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Delvecchio R, 2016, BIORXIV, DOI [10.1101/051268, DOI 10.1101/051268]
   Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Doerrbecker J, 2011, J INFECT DIS, V204, P1830, DOI 10.1093/infdis/jir535
   Dollner H, 2002, BJOG-INT J OBSTET GY, V109, P534, DOI 10.1111/j.1471-0528.2002.01028.x
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dube M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004530
   DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741
   DUDGEON JA, 1967, ARCH DIS CHILD, V42, P110, DOI 10.1136/adc.42.222.110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   ENDERS AC, 1989, AM J ANAT, V186, P85, DOI 10.1002/aja.1001860107
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Finger-Jardim F, 2014, J MED VIROL, V86, P519, DOI 10.1002/jmv.23817
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129
   Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Huerta P, 2016, BRAIN RES, V1649, P173, DOI 10.1016/j.brainres.2016.02.052
   George IO, 2009, WORLD J PEDIATR, V5, P287, DOI 10.1007/s12519-009-0054-x
   GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109
   Gitlin D, 1971, IMMUNOLOGIC INCOMPET, P3
   Glass RBJ, 2004, RADIOGRAPHICS, V24, P507, DOI 10.1148/rg.242035105
   Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Homan J., 2016, BIORXIV, DOI [10.1101/044834, DOI 10.1101/044834]
   Ishikawa T, 2015, INT J MOL MED, V35, P1273, DOI 10.3892/ijmm.2015.2141
   ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665
   Johnson EL, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19385
   Kabra NS, 2004, OBSTET GYNECOL, V103, P1004, DOI 10.1097/01.AOG.0000126180.25221.c5
   Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915
   Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6
   Kayama M, 2010, OPHTHALMIC RES, V43, P79, DOI 10.1159/000247592
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Kopp SJ, 2009, P NATL ACAD SCI USA, V106, P17916, DOI 10.1073/pnas.0908892106
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kylat RI, 2006, EUR J PEDIATR, V165, P773, DOI 10.1007/s00431-006-0172-6
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledger WJ, 2008, CURR OPIN OBSTET GYN, V20, P120, DOI 10.1097/GCO.0b013e3282f734db
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Vianna FSL, 2015, REPROD TOXICOL, V53, P63, DOI 10.1016/j.reprotox.2015.03.007
   Luo SS, 2012, J R SOC INTERFACE, V9, P2603, DOI 10.1098/rsif.2012.0180
   Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mackenzie JM, 1996, J VIROL METHODS, V56, P67, DOI 10.1016/0166-0934(95)01916-2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388
   Madani TA, 2014, ARCH VIROL, V159, P2687, DOI 10.1007/s00705-014-2134-z
   Magro-Checa C, 2016, DRUGS, V76, P459, DOI 10.1007/s40265-015-0534-3
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Maidji E, 2002, VIROLOGY, V304, P53, DOI 10.1006/viro.2002.1661
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MASTROMARINO P, 1990, MED MICROBIOL IMMUN, V179, P105
   McAdams RM, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/561494
   Mejia C, 2015, FASEB J S, V29
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mis MSC, 2016, MOL CELL NEUROSCI, V72, P84, DOI 10.1016/j.mcn.2016.01.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moffitt KB, 2016, BIRTH DEFECTS RES A, V106, P155, DOI 10.1002/bdra.23470
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Musso D., 2014, EURO SURVEILL, V19
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   PAHO, 2016, ZIK EP UPD, P10
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   PORTERFIELD JS, 1986, ADV VIRUS RES, V31, P335, DOI 10.1016/S0065-3527(08)60268-7
   Prada P, 2016, REUTERS
   Prasad VM, 2013, P NATL ACAD SCI USA, V110, P20105, DOI 10.1073/pnas.1316681110
   Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047
   Prieto AL, 2000, J COMP NEUROL, V425, P295
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Reveiz L, 2009, REV PANAM SALUD PUBL, V26, P341, DOI 10.1590/S1020-49892009001000009
   Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417
   Rojas DP, 2016, PREPRINT, DOI [10.1101/049957, DOI 10.1101/049957]
   Paumgartten FJR, 2013, CIENC SAUDE COLETIVA, V18, P3401, DOI 10.1590/S1413-81232013001100029
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Scollard DM, 2015, AM J TROP MED HYG, V92, P108, DOI 10.4269/ajtmh.13-0221
   Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384
   Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635
   SELLER MJ, 1975, ARCH DIS CHILD, V50, P484, DOI 10.1136/adc.50.6.484
   Shet A, 2011, INDIAN J PEDIATR, V78, P88, DOI 10.1007/s12098-010-0254-3
   Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40
   Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steinlin MI, 1996, PEDIATR NEUROL, V15, P249, DOI 10.1016/S0887-8994(96)00170-1
   Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Nyuyen TV, 2015, EBIOMEDICINE, V2, P59, DOI 10.1016/j.ebiom.2014.10.021
   Thorbinson C, 2016, PEDIATR DRUGS, V18, P181, DOI 10.1007/s40272-016-0170-8
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tonduti D, 2016, EUR J PAEDIATR NEURO, V20, P604, DOI 10.1016/j.ejpn.2016.03.009
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Ueda K, 2016, VACCINE, V34, P1971, DOI 10.1016/j.vaccine.2015.10.010
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vianna FSL, 2013, CLIN DYSMORPHOL, V22, P59, DOI 10.1097/MCD.0b013e32835ffc58
   Vogel G., 2016, SCIENCE, DOI [10.1126/science.aaf5757, DOI 10.1126/SCIENCE.AAF5757]
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818
   Ward C, 2016, BBA-MOL CELL BIOL L, V1861, P269, DOI 10.1016/j.bbalip.2016.01.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   WHO, 2016, ON YEAR ZIK OUTBR OB
   Woo SJ, 2012, GRAEF ARCH CLIN EXP, V250, P915, DOI 10.1007/s00417-011-1648-2
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   YONEDA T, 1986, J CLIN INVEST, V77, P1613, DOI 10.1172/JCI112477
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
   Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 234
TC 39
Z9 39
U1 0
U2 128
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004877
DI 10.1371/journal.pntd.0004877
PG 32
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800024
PM 27560129
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sung, C
   Wei, Y
   Watanabe, S
   Lee, HS
   Khoo, YM
   Fan, L
   Rathore, APS
   Chan, KWK
   Choy, MM
   Kamaraj, US
   Sessions, OM
   Aw, P
   de Sessions, PF
   Lee, B
   Connolly, JE
   Hibberd, ML
   Vijaykrishna, D
   Wijaya, L
   Ooi, EE
   Low, JGH
   Vasudevan, SG
AF Sung, Cynthia
   Wei, Yuan
   Watanabe, Satoru
   Lee, How Sung
   Khoo, Yok Moi
   Fan, Lu
   Rathore, Abhay P. S.
   Chan, Kitti Wing-Ki
   Choy, Milly M.
   Kamaraj, Uma S.
   Sessions, October M.
   Aw, Pauline
   de Sessions, Paola F.
   Lee, Bernett
   Connolly, John E.
   Hibberd, Martin L.
   Vijaykrishna, Dhanasekaran
   Wijaya, Limin
   Ooi, Eng Eong
   Low, Jenny Guek-Hong
   Vasudevan, Subhash G.
TI Extended Evaluation of Virological, Immunological and Pharmacokinetic
   Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of
   Celgosivir in Dengue Fever Patients
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS-INFECTION; DOUBLE-BLIND; MOUSE MODEL; EFFICACY; INHIBITOR;
   VIREMIA; DIVERSITY; ALIGNMENT; SEVERITY; SEROTYPE
AB CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5 days. Replication competent virus was measured by plaque assay and compared to reverse transcription quantitative PCR (qPCR) of viral RNA. Pharmacokinetics (PK) correlations with viremia, immunological profiling, next generation sequence (NGS) analysis and hematological data were evaluated as exploratory endpoints here to identify possible signals of pharmacological activity. Viremia by plaque assay strongly correlated with qPCR during the first four days. Immunological profiling demonstrated a qualitative shift in T helper cell profile during the course of infection. NGS analysis did not reveal any prominent signature that could be associated with drug treatment; however the phylogenetic spread of patients' isolates underlines the importance of strain variability that may potentially confound interpretation of dengue drug trials conducted during different outbreaks and in different countries. Celgosivir rapidly converted to castanospermine (Cast) with mean peak and trough concentrations of 5727 ng/mL (30.2 mu M) and 430 ng/mL (2.3 mu M), respectively and cleared with a half-life of 2.5 (+/- 0.6) hr. Mean viral log reduction between day 2 and 4 (VLR2-4) was significantly greater in secondary dengue than primary dengue (p = 0.002). VLR2-4 did not correlate with drug AUC but showed a trend of greater response with increasing Cmin. PK modeling identified dosing regimens predicted to achieve 2.4 to 4.5 times higher Cmin. than in the CELADEN trial for only 13% to 33% increase in overall dose. A small, non-statistical trend towards better outcome on platelet nadir and difference between maximum and minimum hematocrit was observed in celgosivir-treated patients with secondary dengue infection. Optimization of the dosing regimen and patient stratification may enhance the ability of a clinical trial to demonstrate celgosivir activity in treating dengue fever based on hematological endpoints. A new clinical trial with a revised dosing regimen is slated to start in 2016 (NCT02569827). Furthermore celgosivir's potential value for treatment of other flaviruses such as Zika virus should be investigated urgently.
C1 [Sung, Cynthia; Watanabe, Satoru; Rathore, Abhay P. S.; Chan, Kitti Wing-Ki; Kamaraj, Uma S.; Sessions, October M.; Vijaykrishna, Dhanasekaran; Ooi, Eng Eong; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Sung, Cynthia] Hlth Sci Author, Vigilance & Compliance Branch, Singapore, Singapore.
   [Wei, Yuan] Singapore Clin Res Inst, Singapore, Singapore.
   [Lee, How Sung; Khoo, Yok Moi; Fan, Lu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore.
   [Choy, Milly M.; Aw, Pauline; de Sessions, Paola F.; Hibberd, Martin L.] ASTAR, Biopolis, Genome Inst Singapore, Singapore, Singapore.
   [Lee, Bernett; Connolly, John E.] ASTAR, Inst Mol & Cellular Biol, Biopolis, Singapore, Singapore.
   [Wijaya, Limin; Low, Jenny Guek-Hong] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.
RP Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
EM subhash.vasudevan@duke-nus.edu.sg
RI Dhanasekaran, Vijaykrishna/D-1011-2010; Vijaykrishna,
   Dhanasekaran/AAG-2077-2020; Sung, Cynthia/R-7654-2019
OI Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Vijaykrishna,
   Dhanasekaran/0000-0003-3293-6279; Sung, Cynthia/0000-0001-8603-4022;
   Hibberd, Martin/0000-0001-8587-1849; Ooi, Eng Eong/0000-0002-0520-1544;
   /0000-0003-2039-2964
FU National Medical Research Council STOP Dengue TCR; Duke-NUS Start-up
   funds; National Medical Research Council Industry Alliance grant
   [NMRC/MOHIAFCat1/0008/2014]
FX CELADEN clinical trial was funded by "National Medical Research Council
   STOP Dengue TCR, Duke-NUS Start-up funds and National Medical Research
   Council Industry Alliance grant NMRC/MOHIAFCat1/0008/2014. The funders
   had no role in role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], 2010, PHARMACOKIN IN PRESS
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Durantel D, 2009, CURR OPIN INVEST DR, V10, P860
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Kang WZ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-102
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Keller Thomas H, 2006, Novartis Found Symp, V277, P102, DOI 10.1002/0470058005.ch8
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu P S, 1991, [No title captured], Patent No. [5,017,563, 5017563, US5017563]
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Manokaran G, 2016, MICROBIOLOGY AUSTR
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Sorbera LA, 2005, DRUG FUTURE, V30, P545, DOI 10.1358/dof.2005.030.06.914820
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 43
TC 25
Z9 25
U1 0
U2 51
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004851
DI 10.1371/journal.pntd.0004851
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800012
PM 27509020
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Garcia, GD
   dos Santos, LMB
   Villela, DAM
   Maciel-de-Freitas, R
AF Garcia, Gabriela de Azambuja
   Barbosa dos Santos, Lilha Maria
   Maciel Villela, Daniel Antunes
   Maciel-de-Freitas, Rafael
TI Using Wolbachia Releases to Estimate Aedes aegypti (Diptera: Culicidae)
   Population Size and Survival
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; ZIKA VIRUS; CONTAINER PRODUCTIVITY; FIELD-EVALUATION;
   BG-SENTINEL; DENGUE; RATES; DISPERSAL; RECAPTURE; MOSQUITOS
AB Mosquitoes carrying the endosymbiont bacterium Wolbachia have been deployed in field trials as a biological control intervention due to Wolbachia effects on reducing transmission of arboviruses. We performed mark, release and recapture (MRR) experiments using Wolbachia as an internal marker with daily collections with BG-Traps during the first two weeks of releases in Rio de Janeiro, Brazil. The MRR design allowed us to investigate two critical parameters that determine whether Wolbachia would successful invade a field population: the probability of daily survival (PDS) of Wolbachia-infected Aedes aegypti females, and the wild population density during releases. Released females had a PDS of 0.82 and 0.89 in the first and second weeks, respectively, immediately after releases, which is well within the range of previous estimates of survivorship of wild mosquitoes in Rio de Janeiro. Abundance estimation of wild population varied up to 10-fold higher depending on the estimation method used (634-3565 females on the average-difference model to 6365-16188 females according to Lincoln-Petersen). Wolbachia-released mosquitoes were lower than the density estimation of their wild counterparts, irrespectively of the model used. Individually screening mosquitoes for the presence of Wolbachia reduced uncertainty on abundance estimations due to fluctuation in capturing per week. A successful invasion into local population requires Ae. aegypti fitness is unaffected by Wolbachia presence, but also reliable estimates on the population size of wild mosquitoes.
C1 [Garcia, Gabriela de Azambuja; Barbosa dos Santos, Lilha Maria; Maciel-de-Freitas, Rafael] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil.
   [Maciel Villela, Daniel Antunes] Fundacao Oswaldo Cruz PROCC, Programa Computacao Cient, Rio De Janeiro, Brazil.
RP Maciel-de-Freitas, R (corresponding author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
RI Villela, Daniel/AAG-6445-2019
OI Villela, Daniel/0000-0001-8371-2959; Maciel-de-Freitas,
   Rafael/0000-0002-2198-6492
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/110.168/2014]; CNPqNational Council for
   Scientific and Technological Development (CNPq); Brazilian Ministry of
   Health (DECIT/SVS); Foundation for the National Institutes of Health
   through the Vector-Based Transmission of Control: Discovery Research
   (VCTR) program of the Grand Challenges in Global Health Initiatives of
   the Bill and Melinda Gates Foundation
FX This work was partially supported by FAPERJ (E-26/110.168/2014), CNPq,
   the Brazilian Ministry of Health (DECIT/SVS) as well as a grant to
   Monash University from the Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) program of the Grand Challenges in Global Health
   Initiatives of the Bill and Melinda Gates Foundation. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Cattand P, 2006, DIS CONTROL PRIORITI
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   PAHO/WHO, 2016, NUMB REP CAS DENG SE
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   SHEPPARD PM, 1969, B WORLD HEALTH ORGAN, V40, P467
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 54
TC 6
Z9 6
U1 0
U2 78
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2016
VL 11
IS 8
AR e0160196
DI 10.1371/journal.pone.0160196
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS9NO
UT WOS:000381110300031
PM 27479050
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jayakumar, P
   Bache, K
   Lippmann, S
AF Jayakumar, Priyanga
   Bache, Kendall
   Lippmann, Steven
TI How Is Zika Transmitted?
SO SOUTHERN MEDICAL JOURNAL
LA English
DT Letter
ID VIRUS; TRANSMISSION
C1 [Jayakumar, Priyanga; Bache, Kendall; Lippmann, Steven] Univ Louisville, Sch Med, Louisville, KY 40292 USA.
RP Jayakumar, P (corresponding author), Univ Louisville, Sch Med, Louisville, KY 40292 USA.
CR Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
NR 5
TC 0
Z9 0
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0038-4348
EI 1541-8243
J9 SOUTH MED J
JI South.Med.J.
PD AUG
PY 2016
VL 109
IS 8
BP 492
EP 492
DI 10.14423/SMJ.0000000000000494
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU8RD
UT WOS:000382480500014
PM 27490661
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Neonatal neuroradiological aspects in Zika virus infection
SO CHILDS NERVOUS SYSTEM
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Surin, Thailand.
EM wviroj@yahoo.com
CR Cavalheiro S, 2016, CHILDS NERV SYST
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 2
TC 1
Z9 1
U1 0
U2 49
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD AUG
PY 2016
VL 32
IS 8
BP 1349
EP 1349
DI 10.1007/s00381-016-3102-6
PG 1
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA DS3FB
UT WOS:000380667400002
PM 27138556
OA Bronze
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, P. J.
TI What does Zika virus mean for the children of the Americas? (vol 170, pg
   787, 2016)
SO JAMA PEDIATRICS
LA English
DT Correction
CR Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
NR 1
TC 0
Z9 0
U1 0
U2 35
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD AUG
PY 2016
VL 170
IS 8
BP 811
EP 811
DI 10.1001/jamapediatrics.2016.2193
PG 1
WC Pediatrics
SC Pediatrics
GA DS9XW
UT WOS:000381137800030
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Rajeswary, M
   Muthukumaran, U
   Hoti, SL
   Khater, HF
   Benelli, G
AF Govindarajan, Marimuthu
   Rajeswary, Mohan
   Muthukumaran, Udaiyan
   Hoti, S. L.
   Khater, Hanem F.
   Benelli, Giovanni
TI Single-step biosynthesis and characterization of silver nanoparticles
   using Zornia diphylla leaves: A potent eco-friendly tool against malaria
   and arbovirus vectors
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Aedes albopictus; Anopheles subpictus; Culex tritaeniorhynchus;
   Nanomosquitocidals; Plant-borne larvicides; Non-target effects
ID AEGYPTI DIPTERA-CULICIDAE; AEDES-AEGYPTI; ANOPHELES-STEPHENSI;
   CULEX-QUINQUEFASCIATUS; GOLD NANOPARTICLES; LEAF EXTRACT; ENGINEERED
   NANOPARTICLES; INTRODUCED MOSQUITOFISH; PREDATION EFFICIENCY; LARVICIDAL
   ACTIVITY
AB Mosquitoes (Diptera: Culicidae) are vectors of important pathogens and parasites, including malaria, dengue, chikungunya, Japanese encephalitis, lymphatic filariasis and Zika virus. The application of synthetic insecticides causes development of resistance, biological magnification of toxic substances through the food chain, and adverse effects on the environment and human health. In this scenario, eco-friendly control tools of mosquito vectors are a priority. Here single-step fabrication of silver nanoparticles (AgNP) using a cheap aqueous leaf extract of Zornia diphylla as reducing and capping agent pf Ag+ ions has been carried out. Biosynthesized AgNP were characterized by UV visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy-dispersive spectroscopy (EDX) and X-ray diffraction analysis (XRD). The acute toxicity of Z. diphylla leaf extract and biosynthesized AgNP was evaluated against larvae of the malaria vector Anopheles subpictus, the dengue vector Aedes albopictus and the Japanese encephalitis vector Culex tritaeniorhynchus. Both the Z. diphylla leaf extract and Ag NP showed dose dependent larvicidal effect against all tested mosquito species. Compared to the leaf aqueous extract, biosynthesized Ag NP showed higher toxicity against An. subpictus, Ae. albopictus, and C chi. tritaeniorhynchus with LC50 values of 12.53, 13.42 and 14.61 mu g/ml, respectively. Biosynthesized AgNP were found safer to non-target organisms Chironomus circumdatus, Anisops bouvieri and Gambusia affinis, with the respective LC50 values ranging from 613.11 to 6903.93 mu g/ml, if compared to target mosquitoes. Overall, our results highlight that Z. diphylla-fabricated Ag NP are a promising and eco-friendly tool against larval populations of mosquito vectors of medical and veterinary importance, with negligible toxicity against other non-target organisms. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan; Muthukumaran, Udaiyan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Hoti, S. L.] Reg Med Res Ctr, Belgaum 590010, Karnataka, India.
   [Khater, Hanem F.] Benha Univ, Fac Vet Med, Dept Parasitol, Moshtohor 13736, Toukh, Egypt.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Khater, Hanem/I-3635-2019; GOVINDARAJAN,
   MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931; Khater, Hanem/0000-0002-1591-2534
CR Ankamwar B, 2005, SYNTH REACT INORG M, V35, P19, DOI 10.1081/SIM-200047527
   Ankanna S, 2010, DIG J NANOMATER BIOS, V5, P369
   Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y
   Benelli G., 2015, NANOPARTICL IN PRESS, P2192
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   DEO P G, 1988, International Pest Control, V30, P118
   Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Feynman R, 1991, SCIENCE, V254, P1300, DOI DOI 10.1126/SCIENCE.254.5036.1300
   Finney D.T., 1971, PROBIT ANAL
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Gillespie GR, 2001, BIOL CONSERV, V100, P187, DOI 10.1016/S0006-3207(01)00021-0
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gong P., 2007, NANOTECHNOLOGY, V18, P285
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Jayaseelan C, 2012, PARASITOL RES, V111, P921, DOI 10.1007/s00436-011-2473-6
   Juvekar M., 2009, PLANTA MED, V75, P168
   Kasthuri J, 2009, J NANOPART RES, V11, P1075, DOI 10.1007/s11051-008-9494-9
   Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x
   Kavitha R, 2011, J CHEM PHARM RES, V3, P115
   KHARE C, 2004, INDIAN MED PLANTS IL
   Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Morgan L. A., 1996, Australian Zoologist, V30, P143
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Murugan K., 2015, NAT PROD RES
   Murugan K., 2015, ENV SCI POLLUT RES
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Oberdorster E, 2006, CARBON, V44, P1112, DOI 10.1016/j.carbon.2005.11.008
   Park J, 2014, MAR POLLUT BULL, V85, P526, DOI 10.1016/j.marpolbul.2014.04.038
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Raghavendra K, 2008, INDIAN J MED RES, V128, P22
   Rai A, 2006, LANGMUIR, V22, P736, DOI 10.1021/la052055q
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Siddiqui BS, 2000, PHYTOCHEMISTRY, V53, P371, DOI 10.1016/S0031-9422(99)00548-8
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Webb Cameron, 1997, Australian Zoologist, V30, P316
   World Health Organization, 2005, WHOCDSWHOPESGCDPP201
NR 65
TC 47
Z9 49
U1 1
U2 24
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD AUG
PY 2016
VL 161
BP 482
EP 489
DI 10.1016/j.jphotobiol.2016.06.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DT7FZ
UT WOS:000381653800057
PM 27318605
DA 2020-07-08
ER

PT J
AU Martinez-Palomo, A
AF Martinez-Palomo, Adolfo
TI Revisiting Zika (and Rubella)
SO JOURNAL OF PUBLIC HEALTH POLICY
LA English
DT Article
DE Zika virus; dengue; chikungunya; rubella vaccine; microcephaly
AB Three months after the World Health Organization declared the epidemic of Zika virus infections to be a Public Health Emergency of International Concern, we can look back at what we have learned and prospects for controlling the disease. Although Zika virus infections may explain many cases of brain damage in newborns, it may not be the only cause. We need a clear association between confirmed cases of Zika infections in pregnant women and microcephaly in newborns. Until we reach a firm conclusion, past experience with another virus that causes damage to newborns offers some hope. The development and almost universal use of rubella vaccine has all but eliminated the congenital rubella syndrome in the world. Rapid development of Zika virus vaccine might well do the same for this epidemic.
C1 [Martinez-Palomo, Adolfo] Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
RP Martinez-Palomo, A (corresponding author), Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
EM amartine@cinvestav.mx
RI amsalu, ribka/G-8780-2019
CR Brasil P., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoax6oz412, DOI 10.1056/NEJMOA16OZ412]
   Martinez-Palomo A, 2016, J PUBLIC HLTH POLICY, V2016, P133, DOI [10.ioj7/jphp.2016.11, DOI 10.1057/JPHP.2016.11]
NR 2
TC 1
Z9 1
U1 0
U2 62
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 0197-5897
EI 1745-655X
J9 J PUBLIC HEALTH POL
JI J. Public Health Policy
PD AUG
PY 2016
VL 37
IS 3
BP 273
EP 276
DI 10.1057/s41271-016-0001-8
PG 4
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DT9SH
UT WOS:000381842100001
PM 28615701
OA Bronze
DA 2020-07-08
ER

PT J
AU Werner, H
   Sodre, D
   Hygino, C
   Guedes, B
   Fazecas, T
   Nogueira, R
   Daltro, P
   Tonni, G
   Lopes, J
   Araujo, E
AF Werner, Heron
   Sodre, Danielle
   Hygino, Celso
   Guedes, Bianca
   Fazecas, Tatiana
   Nogueira, Renata
   Daltro, Pedro
   Tonni, Gabriele
   Lopes, Jorge
   Araujo Junior, Edward
TI First-trimester intrauterine Zika virus infection and brain pathology:
   prenatal and postnatal neuroimaging findings
SO PRENATAL DIAGNOSIS
LA English
DT Article
C1 [Werner, Heron; Hygino, Celso; Guedes, Bianca; Fazecas, Tatiana; Nogueira, Renata; Daltro, Pedro] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Sodre, Danielle] Rio de Janeiro State Univ UERJ, Dept Obstet & Gynecol, Rio De Janeiro, RJ, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, Dept Obstet & Gynecol, AUSL Reggio Emilia, Reggio Emilia, Italy.
   [Lopes, Jorge] Pontificia Univ Catolica PUC Rio, Dept Arts & Design, Rio De Janeiro, RJ, Brazil.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Tonni, Gabriele/AAM-9842-2020; Junior, Edward Araujo/E-1228-2012;
   Werner, Heron/W-1578-2019
OI Junior, Edward Araujo/0000-0002-6145-2532; 
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Araujo E, 2014, J ULTRAS MED, V33, P1185, DOI 10.7863/ultra.33.7.1185
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
NR 12
TC 18
Z9 21
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD AUG
PY 2016
VL 36
IS 8
BP 785
EP 789
DI 10.1002/pd.4860
PG 5
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA DS9LO
UT WOS:000381104800013
PM 27316349
DA 2020-07-08
ER

PT J
AU Lucchese, G
   Kanduc, D
AF Lucchese, Guglielmo
   Kanduc, Darja
TI Reply concerning the article "Zika virus and autoimmunity: From
   microcephaly to Guillain-Barre syndrome, and beyond"
SO AUTOIMMUNITY REVIEWS
LA English
DT Letter
C1 [Lucchese, Guglielmo] Free Univ Berlin, Brain & Language Lab, D-14195 Berlin, Germany.
   [Kanduc, Darja] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
RP Kanduc, D (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
EM dkanduc@gmail.com
RI Lucchese, Guglielmo/AAL-9860-2020
OI Lucchese, Guglielmo/0000-0002-1809-6376
CR Kanduc D, 2012, J PEPT SCI, V18, P487, DOI 10.1002/psc.2419
NR 1
TC 2
Z9 2
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 854
EP 854
DI 10.1016/j.autrev.2016.04.003
PG 1
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300010
PM 27060380
DA 2020-07-08
ER

PT J
AU Barreto-Vieira, DF
   Barth, OM
   da Silva, MAN
   Santos, CC
   Santos, ADS
   Batista, FJ
   de Filippis, AMB
AF Barreto-Vieira, Debora Ferreira
   Barth, Ortrud Monika
   da Silva, Marcos Alexandre Nunes
   Santos, Carolina Cardoso
   Santos, Aline da Silva
   Joaquim Batista, F. Filho
   Bispo de Filippis, Ana Maria
TI Ultrastructure of Zika virus particles in cell cultures
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; virus particles; cell culture; transmission electron
   microscopy
AB Zika virus (ZIKV) has infected thousands of Brazilian people and spread to other American countries since 2015. The introduction of ZIKV brought a strong impact to public health in Brazil. It is of utmost importance to identify a susceptible cell line that will enable the isolation and identification of the virus from patient samples, viral mass production, and testing of drug and vaccine candidates. Besides real-time reverse transcriptase polymerase chain reaction diagnosis for detecting the viral genome, virus isolation in cell lines was useful in order to study the structure of the viral particle and its behaviour inside cells. Analysis of ZIKV infected cell lines was achieved using transmission electron microscopy (TEM). Blood was obtained from a Brazilian patient during the first days after presenting with signs of the disease, and ZIKV from the patient's blood was isolated in the C6/36 mosquito cell line. Afterwards, Vero cells were inoculated with the viral suspension, fixed six days after inoculation, embedded in polymers, and ultra-thin cut. Like dengue viruses, this flavivirus showed numerous virus particles present inside cellular vesicles thereby confirming the susceptibility of the Vero cell line to ZIKV replication. TEM is a unique technique available to make the virus visible.
C1 [Barreto-Vieira, Debora Ferreira; Barth, Ortrud Monika; da Silva, Marcos Alexandre Nunes] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
   [Santos, Carolina Cardoso; Santos, Aline da Silva; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Havivirus, Rio De Janeiro, RJ, Brazil.
   [Joaquim Batista, F. Filho] Lab Cent Saude Publ Espirito Santo Virol, Vitoria, ES, Spain.
RP Barreto-Vieira, DF (corresponding author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
EM barreto@ioc.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [304067/2012-0]
FX CNPq (304067/2012-0).
CR Barreto-Vieira DF, 2010, MODELO ANIMAL EXPT E
   BARRETOVIEIRA DF, 2015, INDIAN J APPL RES, V5, P44
   Barth OM, 2000, ATLAS DENGUE VIRUSES
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MS - Ministerio da Saude. Dengue chikungunya e Zika, 2016, DENG CHIK ZIK INF EP
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Schatzmayr HG, 2009, PESQUISA VET BRASIL, V29, P509, DOI 10.1590/S0100-736X2009000700004
   Sesso A, 2007, MANUAL TECNICAS BASI, VI, P13
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   TAKATA CS, 1994, REV SAUDE PUBL, V28, P209, DOI 10.1590/S0034-89101994000300008
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 7
Z9 8
U1 0
U2 70
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2016
VL 111
IS 8
BP 532
EP 534
DI 10.1590/0074-02760160104
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DS5OM
UT WOS:000380831600008
PM 27581122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection and Surgery: What Should We Be Concerned About?
SO SURGICAL INFECTIONS
LA English
DT Letter
ID DENGUE-FEVER
C1 [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
   [Wiwanitkit, Viroj] Chulalongkorn Univ, Bangkok 10330, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Fry DE, 2016, SURG INFECT, V17, P123, DOI 10.1089/sur.2016.29004.df
   Shamim M, 2010, ASIAN J SURG, V33, P107, DOI 10.1016/S1015-9584(10)60019-X
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2010, EXPERT REV ANTI-INFE, V8, P841, DOI [10.1586/eri.10.53, 10.1586/ERI.10.53]
   Wiwanitkit V, 2010, J INFECT DEV COUNTR, V4, P51, DOI 10.3855/jidc.145
NR 6
TC 2
Z9 2
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD AUG
PY 2016
VL 17
IS 4
BP 498
EP 498
DI 10.1089/sur.2016.060
PG 1
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA DS5FH
UT WOS:000380806200018
PM 27249094
DA 2020-07-08
ER

PT J
AU Shuaib, W
   Stanazai, H
   Abazid, AG
   Mattar, AA
AF Shuaib, Waqas
   Stanazai, Hashim
   Abazid, Ahmad G.
   Mattar, Ahmed A.
TI Re-Emergence of Zika Virus: A Review on Pathogenesis, Clinical
   Manifestations, Diagnosis, Treatment, and Prevention
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Review
DE Brazil; Chikungunya; Dengue; Microcephaly; Zika
ID TRANSMISSION; OUTBREAK; STATES; BRAZIL
AB Zika virus (ZKV) is an arbovirus of the Flaviviridae family, which includes West Nile, dengue fever, yellow fever, and Japanese encephalitis virus. It is transmitted by the Aedes genus of mosquitoes. Before 2015, ZKV outbreaks occurred in areas of Africa, the Pacific Islands, and Southeast Asia. The current large outbreak, which began in Brazil, has also emerged throughout a large part of South/Central America, a number of islands in the Caribbean, including Puerto Rico, the Virgin Islands, and Mexico. A sudden rise in the numbers of infants reported born with microcephaly in Brazil, and the detection of the single-stranded positive RNA virus in the amniotic fluid of affected newborns, has captured medical, mainstream media, and global political attention, causing considerable concern in a post-Ebola global community considerably more focused on the threat of internationally transmissible diseases. The goal of this article is to provide an overview of ZKV for clinicians, with the emphasis on pathogenesis, clinical manifestations, diagnosis, and treatment/preventive measures. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Shuaib, Waqas] Auburn Community Hosp, Dept Med, 17 Lansing St, Auburn, NY 13021 USA.
   [Stanazai, Hashim; Abazid, Ahmad G.; Mattar, Ahmed A.] Wichita Falls Family Practice Residency Program, Witchita Falls, TX USA.
RP Shuaib, W (corresponding author), Auburn Community Hosp, Dept Med, 17 Lansing St, Auburn, NY 13021 USA.
EM waqas1184@hotmail.com
CR Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grenoble R, 2016, WHO DECLARES PUBLIC
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marcondes CB, 2015, REV SOC BRA IN PRESS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Royal College of Obstetricians and Gynaecologists, 2016, INT ALG ASS PREGN WO
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 20
TC 30
Z9 31
U1 0
U2 118
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD AUG
PY 2016
VL 129
IS 8
AR 879.e7
DI 10.1016/j.amjmed.2016.02.027
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR9YU
UT WOS:000380253000047
PM 26994509
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Placenta, Zika Virus Infection and Fetal Brain Abnormality
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
ID TRANSMISSION
C1 [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Maharashtra, India.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeki Arakeji, Niger.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wiwanitkit V, 2005, AUST NZ J OBSTET GYN, V45, P539, DOI 10.1111/j.1479-828X.2005.00500.x
NR 10
TC 14
Z9 14
U1 1
U2 103
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD AUG
PY 2016
VL 76
IS 2
BP 97
EP 98
DI 10.1111/aji.12521
PG 2
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA DR6TH
UT WOS:000380033700001
PM 27207189
DA 2020-07-08
ER

PT J
AU Vasquez, AM
   Sapiano, MRP
   Basavaraju, SV
   Kuehnert, MJ
   Rivera-Garcia, B
AF Vasquez, Amber M.
   Sapiano, Mathew R. P.
   Basavaraju, Sridhar V.
   Kuehnert, Matthew J.
   Rivera-Garcia, Brenda
TI Survey of Blood Collection Centers and Implementation of Guidance for
   Prevention of Transfusion-Transmitted Zika Virus Infection Puerto Rico,
   2016
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
AB This report details current guidance for managing blood donation in Puerto Rico, where Zika has been identified and there is the potential for transmission from asymptomatic blood donors.
C1 [Vasquez, Amber M.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vasquez, Amber M.; Sapiano, Mathew R. P.; Basavaraju, Sridhar V.; Kuehnert, Matthew J.] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
RP Vasquez, AM (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
EM avasquez@cdc.gov
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR TRANSM RISKS
   Chung KW, 2016, TRANSFUSION, V56, P2184, DOI 10.1111/trf.13644
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Department of Health and Human Services, 2016, HHS SHIPS BLOOD PROD
NR 9
TC 6
Z9 6
U1 0
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD AUG
PY 2016
VL 16
IS 8
BP 2487
EP 2490
DI 10.1111/ajt.13941
PG 4
WC Surgery; Transplantation
SC Surgery; Transplantation
GA DR6QR
UT WOS:000380026900033
PM 27441778
OA Bronze
DA 2020-07-08
ER

PT J
AU Diniz, D
AF Diniz, Debora
TI Zika virus, women and ethics
SO DEVELOPING WORLD BIOETHICS
LA English
DT Editorial Material
ID ABORTION
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Ballantyne A, 2009, AM J BIOETHICS, V9, P48, DOI 10.1080/15265160902984996
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, INF EP 19 SEM EP SE
   Broutet N, 2016, NEW ENGL J MED, P1
   Diniz D, 2016, NY TIMES MAGAZINE, P23
   Editorial, 2016, NAT MICROBIOL, P1
   Francis C. R., 2016, EMBO MOL MED, P1
   Jesudason S, 2011, CONTRACEPTION, V84, P541, DOI 10.1016/j.contraception.2011.08.022
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P2016
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 10
TC 8
Z9 8
U1 0
U2 67
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-8731
EI 1471-8847
J9 DEV WORLD BIOETH
JI Dev. World Bioeth.
PD AUG
PY 2016
VL 16
IS 2
BP 62
EP 63
DI 10.1111/dewb.12119
PG 2
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA DR5HY
UT WOS:000379935300001
PM 27378033
DA 2020-07-08
ER

PT J
AU Pavela, R
   Benelli, G
AF Pavela, Roman
   Benelli, Giovanni
TI Ethnobotanical knowledge on botanical repellents employed in the African
   region against mosquito vectors - A review
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Review
DE Aedes; Anopheles; Culex; Arbovirus; Dengue; Filariasis; Malaria; Zika
   virus; Mosquito-borne diseases; Insect repellents
ID STERILE INSECT TECHNIQUE; ESSENTIAL OILS; VETERINARY IMPORTANCE;
   ANOPHELES-ARABIENSIS; MALARIA VECTOR; USAGE CUSTOM; ZIKA VIRUS; PLANTS;
   AEDES; CULICIDAE
AB Mosquitoes (Diptera: Culicidae) represent a huge threat for millions of humans and animals worldwide, since they act as vectors for important parasites and pathogens, including malaria, filariasis and important arboviruses, such as dengue, West Nile and Zika virus. No vaccines or other specific treatments are available against the arboviruses transmitted by mosquitoes, and avoidance of mosquito bites remains the best strategy. African regions are usually hit most whose inhabitants are poor, and the use of repellent plants is the only efficient protection against vectors they have. Ethnobotanical knowledge of such plants and their use is usually passed on orally from one generation to another. However, it is also important to preserve this information in a written form, as well. Ethnobotanical research projects carried out in the regions of today's Ethiopia, South Africa, Nigeria, Kenya, and Tanzania indicate that the native inhabitants of the African study regions traditionally use 64 plant species, belonging to 30 families. Aromatic plants (i.e., Citrus spp., Eucalyptus spp., Lantana camara, Ocimum spp. and Lippia javanica) the most commonly used in all the study regions. Native people know three major methods of using repellent plants: (i) production of repellent smoke from burning plants, (ii) hanging plants inside the house or sprinkling leaves on the floor, (iii) the use of plant oils, juices from crushed fresh parts of the plants, or various prepared extracts applied on uncovered body parts. Overall, this review covers studies conducted only in a limited part of the African continent, highlighting the importance to undertake further research efforts to preserve the unique knowledge and traditions of the native tribes. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Benelli, Giovanni] Univ Pisa, Insect Behav Grp, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Insect Behav Grp, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Pavela, Roman/Q-8647-2016; Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Pavela, Roman/0000-0001-7866-4278
FU Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [MZE RO0415]; PROAPI (PRAF); University of Pisa,
   Department of Agriculture, Food and Environment [COFIN2015_22]
FX R. Pavela would like to thank the Ministry of Agriculture of the Czech
   Republic for its financial support of botanical pesticide research
   (Project No. MZE RO0415). G. Benelli is supported by PROAPI (PRAF 2015)
   and University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006
   Dugassa S, 2009, ACTA TROP, V112, P38, DOI 10.1016/j.actatropica.2009.06.002
   Edwin-Wosu N. L., 2013, Journal of Biopesticides, V6, P104
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   HWANG YS, 1985, J CHEM ECOL, V11, P1297, DOI 10.1007/BF01024117
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Karunamoorthi K, 2008, PARASITOL RES, V103, P529, DOI 10.1007/s00436-008-1001-9
   Karunamoorthi K, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-22
   Karunamoorthi K, 2009, J ETHNOPHARMACOL, V125, P224, DOI 10.1016/j.jep.2009.07.008
   Karunamoorthi K, 2009, J ETHNOPHARMACOL, V121, P49, DOI 10.1016/j.jep.2008.09.027
   Kidane D, 2013, SCI RES ESSAYS, V8, P1139, DOI DOI 10.5897/SRE11.1216
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Mavundza EJ, 2011, J ETHNOPHARMACOL, V137, P1516, DOI 10.1016/j.jep.2011.08.040
   Mehlhorn H., 2016, PARASITOL RES MONOGR, V8
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   MIKOLAJCZAK KL, 1988, J NAT PROD, V51, P606, DOI 10.1021/np50057a033
   MULHOLLAND DA, 1980, PHYTOCHEMISTRY, V19, P2421, DOI 10.1016/S0031-9422(00)91040-9
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, IND CROP PROD, V60, P247, DOI 10.1016/j.indcrop.2014.06.030
   Pavela R, 2011, PARASITOL RES, V109, P1547, DOI 10.1007/s00436-011-2395-3
   Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   SCHMUTTERER H, 1990, ANNU REV ENTOMOL, V35, P271, DOI 10.1146/annurev.en.35.010190.001415
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   WEISS EA, 1979, ECON BOT, V33, P35, DOI 10.1007/BF02858210
NR 50
TC 83
Z9 86
U1 1
U2 80
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD AUG
PY 2016
VL 167
BP 103
EP 108
DI 10.1016/j.exppara.2016.05.010
PG 6
WC Parasitology
SC Parasitology
GA DR3IS
UT WOS:000379797500014
PM 27260568
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus transmission: What should we be concerned about apart from
   mosquito control
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
ID INFECTION
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Coll Med, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 7
TC 4
Z9 4
U1 0
U2 54
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD AUG
PY 2016
VL 115
IS 8
BP 684
EP 684
DI 10.1016/j.jfma.2016.03.008
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR5YX
UT WOS:000379979400017
PM 27265325
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wong, SSY
AF Wong, Samson Sai-Yin
TI Reply to comments on "Zika virus transmission: What to concern on its
   transmission apart from mosquito control" by Viroj Wiwanitkit
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Wong, Samson Sai-Yin] Univ Hong Kong, Fac Med, Res Ctr Infect & Immunol, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
RP Wong, SSY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Fac Med, Dept Microbiol,Res Ctr Infect & Immunol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM samsonsy@hku.hk
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Suk JE, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25287
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wiwanitkit V, 2016, J FORMOS MED ASSOC, V115, P684, DOI 10.1016/j.jfma.2016.03.008
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
NR 15
TC 0
Z9 0
U1 0
U2 58
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD AUG
PY 2016
VL 115
IS 8
BP 685
EP 686
DI 10.1016/j.jfma.2016.03.007
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR5YX
UT WOS:000379979400018
PM 27174386
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Shah, A
   Kumar, A
AF Shah, Ankit
   Kumar, Anil
TI Zika Virus Infection and Development of a Murine Model
SO NEUROTOXICITY RESEARCH
LA English
DT Editorial Material
DE ZIKV; Mouse model; Neurodegeneration; IFN-alpha/beta
ID GENOME
AB In view of the recent outbreak of Zika virus (ZIKV), there is an urgent need to investigate the pathogenesis of the symptoms associated with ZIKV infection. Since the first identification of the virus in 1947, the pathologies associated with ZIKV infection were thought to be limited with mild illness that presented fever, rashes, muscle aches, and weakness. However, ZIKV infection has been shown to cause Guillain-Barr, Syndrome, and numerous cases of congenital microcephaly in children have been reported when pregnant females were exposed to the virus. The severity and the rate of spread of ZIKV in the last year has drawn alarming interest among researchers to investigate murine models to study viral pathogenesis and develop candidate vaccines. A recent study by Lazear and colleagues, in the May 2016 issue of cell host and microbe, is an effort to study the pathogenesis of contemporary and historical virus strains in various mouse models.
C1 [Shah, Ankit; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, 2464 Charlotte St, Kansas City, MO 64108 USA.
RP Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, 2464 Charlotte St, Kansas City, MO 64108 USA.
EM kumaran@umkc.edu
FU NIAAA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse
   & Alcoholism (NIAAA) [R01 AA020806]
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nandy A, 2016, CURR COMPUT AIDED DR
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 27
TC 8
Z9 8
U1 0
U2 77
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1029-8428
EI 1476-3524
J9 NEUROTOX RES
JI Neurotox. Res.
PD AUG
PY 2016
VL 30
IS 2
BP 131
EP 134
DI 10.1007/s12640-016-9635-3
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA DR6AU
UT WOS:000379984300001
PM 27260223
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Estofolete, CF
   Terzian, ACB
   Parreira, R
   Esteves, A
   Hardman, L
   Greque, GV
   Rahal, P
   Nogueira, ML
AF Estofolete, Cassia Fernanda
   Bernardes Terzian, Ana Carolina
   Parreira, Ricardo
   Esteves, Aida
   Hardman, Lucas
   Greque, Gilmar Valdir
   Rahal, Paula
   Nogueira, Mauricio Lacerda
TI Clinical and laboratory profile of Zika virus infection in dengue
   suspected patients: A case series
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Dengue virus; Chikungunya virus; NS1; Arbovirus
ID NS1 ANTIGEN; CHIKUNGUNYA-VIRUS; OUTBREAK; TRANSMISSION; TESTS
AB Background: The Zika virus (ZIKV) is an emerging arthropod-borne virus related to the dengue virus (DENV), and shows a similar clinical profile as other arboviral diseases, such as dengue and chikungunya virus (CHIKV). Historically, ZIKV has been associated with sporadic cases of human infection, but is now responsible for outbreaks worldwide. In Brazil, cases have been reported since 2015, with some cases causing severe disease.
   Objective: To identify clinical symptoms of Zika in patients in Dengue suspected patients.
   Study design: Description of a series of cases, wherein we analyzed 100 clinical samples collected from patients who exhibited acute febrile disease for <= 5 days, from January to February 2016.
   Results: In this study, we report 13 cases of ZIKV infection in adults presenting dengue-like symptoms in a DENV endemic area. All patients presented with fever, with myalgia being the second most frequently observed symptom. Two patients had rashes, but none of them had conjunctivitis. Other less frequent manifestations included headache, arthralgia, diarrhea, and nausea.
   Conclusion: The co-circulation of ZIKV and DENV is a serious public health concern, since it represents both a clinical and diagnostic challenge in endemic areas, as well as in the field of travel medicine. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Estofolete, Cassia Fernanda; Bernardes Terzian, Ana Carolina; Hardman, Lucas; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, Brazil.
   [Parreira, Ricardo; Esteves, Aida] Univ Nova Lisboa, Global Hlth & Trop Med GHTM, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
   [Greque, Gilmar Valdir] Sao Jose do Rio Preto Reg Sch Med Fdn FUNFARME, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Rahal, Paula] Sao Paulo State Univ, Sao Jose do Rio Preto IBILCE UNESP, Inst Biosci Letters & Exact Sci, Dept Biol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM cassiafestofolete@gmail.com; anacarolinaterzian@gmail.com;
   ricardo@ihmt.unl.pt; aidaesteves@ihmt.unl.pt; lucashardman@hotmail.com;
   greque@terra.com.br; rahalp@yahoo.com.br; mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Rahal, Paula/D-3871-2012; Parreira,
   Ricardo/I-2304-2012; Parreira, Ricardo/AAH-4559-2019; Estofolete,
   Cassia/N-6673-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Rahal,
   Paula/0000-0001-5693-6148; Parreira, Ricardo/0000-0002-4832-9898;
   Parreira, Ricardo/0000-0002-4832-9898; Estofolete,
   Cassia/0000-0001-7324-1591
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0];
   FAPESP Zika Network
FX This work was supported by the Sao Paulo State Research Foundation
   (FAPESP) under Grant # 2013/21719-3 to MLN and the 2015/12295-0
   fellowship to ACBT. The FAPESP Zika Network supported this work. MLN is
   a CNPq fellow.
CR [Anonymous], 1998, Wkly Epidemiol Rec, V73, P182
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   [Anonymous], 2009, DENG NO BRAS INF EP
   Arshad I., 2011, PROF MED J, V18, P7
   Banerjee M., 2008, MJAF, V64, P4
   Bashir A. B., 2015, J INFECT DIS IMMUN, V7, P7
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mallet HP., 2014, 15 JOURN NAT INF BOR, P28
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nhan T. X. M. D., 2015, VIROLOGIE, V19, P11
   Oehler E., 2014, EURO SURVEILLANCE B, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pierson TC, 2013, FIELDS VIROLOGY
   Roth A, 2014, EURO SURVEILLANCE B, V19
   Secretaria de Estado da Saude Publica, 2015, PAIN MON IND 2014, P32
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 26
Z9 29
U1 1
U2 96
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2016
VL 81
BP 25
EP 30
DI 10.1016/j.jcv.2016.05.012
PG 6
WC Virology
SC Virology
GA DR1EE
UT WOS:000379648000005
PM 27289428
OA Green Published
DA 2020-07-08
ER

PT J
AU Weitzel, T
   Cortes, CP
AF Weitzel, Thomas
   Cortes, Claudia P.
TI Zika Virus Infection Presenting with Postauricular Lymphadenopathy
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
C1 [Weitzel, Thomas] Univ Desarrollo, Programa Med Viajero, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile.
   [Weitzel, Thomas] Univ Desarrollo, Clin Lab, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile.
   [Cortes, Claudia P.] Clin Santa Maria, Dept Infectol, Santiago, Chile.
   [Cortes, Claudia P.] Univ Chile, Escuela Med, Dept Med, Santiago, Chile.
   [Weitzel, Thomas] Univ Desarrollo, Clin Alemana Santiago, Fac Med Clin Alemana, Ave Vitacura 5951, Santiago, Chile.
RP Weitzel, T (corresponding author), Univ Desarrollo, Clin Alemana Santiago, Fac Med Clin Alemana, Ave Vitacura 5951, Santiago, Chile.
EM thomas.weitzel@gmail.com; cpcortesm@med.uchile.cl
RI Cortes, Claudia/AAF-7326-2020
OI Cortes, Claudia/0000-0001-9101-9783; Weitzel, Thomas/0000-0002-9804-2123
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, FACTSH HLTH PROF
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization, 2015, EP AL ZIK VIR INF 7
   Tognarelli J, 2015, ARCH VIROL
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 8
TC 7
Z9 7
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD AUG
PY 2016
VL 95
IS 2
BP 255
EP 256
DI 10.4269/ajtmh.16-0096
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3UY
UT WOS:000400206200001
PM 26884455
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Problem of presently available diagnostic tests for Zika virus
   infection: View from Thailand
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD AUG
PY 2016
VL 6
IS 8
BP 639
EP 639
DI 10.1016/j.apjtb.2016.03.015
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA DQ9HV
UT WOS:000379521900001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lucchese, G
   Kanduc, D
AF Lucchese, Guglielmo
   Kanduc, Darja
TI Zika virus and autoimmunity: From microcephaly to Guillain-Barre
   syndrome, and beyond
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Zika virus infection; Microcephaly; Centriolar and centrosomal proteins;
   Ocular anomalies; Brain calcification; Aicardi-Goutieres syndromes;
   Guillain-Barre-like syndromes; Peptide sharing; Crossreactivity;
   Autoimmunity
ID AICARDI-GOUTIERES-SYNDROME; L-SERINE BIOSYNTHESIS; 3-PHOSPHOGLYCERATE
   DEHYDROGENASE; PONTOCEREBELLAR HYPOPLASIA; INTELLECTUAL DISABILITY;
   MUTATIONS; BRAIN; GENE; ANTIBODIES; PHENOTYPE
AB Zika virus (ZIKV) infection during, pregnancy may be linked to fetal neurological complications that include brain damage and microcephaly. How the viral infection relates to fetal brain malformations is unknown. This study analyzes ZIKV polyprotein for peptide sharing with human proteins that, when altered, associate with microcephaly and brain calcifications. Results highlight a vast viral versus human peptide commonality that, in particular, involves centriolar and centrosomal components canonically cataloged as microcephaly proteins, i.e., C2CD3, CASC5, CP131, GCP4, KIF2A, STIL, and TBG. Likewise, a search for ZIKV peptide occurrences in human proteins linked to Guillain-Barre-like syndromes also show a high, unexpected level of peptide sharing. Of note, further analyses using the Immune Epitope DataBase (IEDB) resource show that many of the shared peptides are endowed with immunological potential. The data indicate that immune reactions following ZIKV infection might be a considerable source of crossreactions with brain-specific proteins and might contribute to the ZIKV-associated neuropathologic sequelae. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lucchese, Guglielmo] Free Univ Berlin, Brain & Language Lab, D-14195 Berlin, Germany.
   [Kanduc, Darja] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
RP Kanduc, D (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
EM darja.kanduc@uniba.it
RI Lucchese, Guglielmo/AAL-9860-2020
OI Lucchese, Guglielmo/0000-0002-1809-6376
FU Deutscher Akademischer Austauschdienst (DAAD)Deutscher Akademischer
   Austausch Dienst (DAAD); Deutsche Forschungsgemeinschaft (DFG)German
   Research Foundation (DFG); Freie Universitat Berlin, Germany
FX GL gratefully acknowledges support by the Deutscher Akademischer
   Austauschdienst (DAAD), the Deutsche Forschungsgemeinschaft (DFG), and
   the Freie Universitat Berlin, Germany.
CR Ahmed I, 2015, HUM MOL GENET, V24, P3172, DOI 10.1093/hmg/ddv069
   Ahmed MY, 2015, NEUROLOGY, V84, P1745, DOI 10.1212/WNL.0000000000001523
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664
   Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016
   Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Celato A, 2013, BRAIN DEV-JPN, V35, P675, DOI 10.1016/j.braindev.2012.10.014
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x
   Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357
   Frank A., 2002, IMMUNOLOGY EVOLUTION
   Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844
   Ito H, 2015, MOL PSYCHIATR, V20, P459, DOI 10.1038/mp.2014.69
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jampol LM, 2016, JAMA OPHTHALMOL
   Kanduc D, 2010, SELF NONSELF, V1, P255
   Kanduc D, 2007, AUTOIMMUN REV, V6, P290, DOI 10.1016/j.autrev.2006.09.004
   Kanduc D, 2013, CURR PROTEIN PEPT SC, V14, P111, DOI 10.2174/1389203711314020003
   Kanduc Darja, 2012, Front Biosci (Schol Ed), V4, P1393
   Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886
   Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519
   KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997
   Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee-Kirsch MA, 2014, CLIN EXP IMMUNOL, V175, P17, DOI 10.1111/cei.12160
   Lucchese G, 2014, EPILEPSY RES TREAT, V2014
   Lucchese G, 2016, CURR DRUG DISCOV TEC
   Lucchese G, 2014, SCHIZOPHRENIA BULL, V40, P362, DOI 10.1093/schbul/sbs197
   MacFadden DR, 2016, CMAJ            0208
   Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198
   Martinez-Garay I, 2007, EUR J HUM GENET, V15, P29, DOI 10.1038/sj.ejhg.5201717
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   Mlakar J, 2016, N ENGL J MED     FEB, P10
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030
   Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091
   Pillai-Kastoori L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004491
   Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x
   Querol L, 2015, CURR OPIN NEUROL, V28, P474, DOI 10.1097/WCO.0000000000000233
   Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794
   Rex M, 1998, MOL BRAIN RES, V55, P28, DOI 10.1016/S0169-328X(97)00354-9
   Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
   Rosch RE, 2014, J PERIPHER NERV SYST, V19, P246, DOI 10.1111/jns.12089
   Rubin EJ, 2016, N ENGL J MED     FEB, P10
   Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566
   Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Smith DW, 2016, LANCET, P29
   Stathopoulos P, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.260
   Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wang QQ, 2013, GENE DEV, V27, P615, DOI 10.1101/gad.212308.112
   Wanschitz J, 2008, J NEUROL, V255, P917, DOI 10.1007/s00415-008-0815-9
   Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004
   Yamasaki M, 2001, J NEUROSCI, V21, P7691
   Yonekura K, 2004, J NEUROIMMUNOL, V156, P204, DOI 10.1016/j.jneuroim.2004.07.017
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 63
TC 73
Z9 76
U1 2
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 801
EP 808
DI 10.1016/j.autrev.2016.03.020
PG 8
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300004
PM 27019049
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Four in Florida are infected with Zika from local mosquitoes
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
NR 1
TC 14
Z9 14
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 1
PY 2016
VL 354
AR i4235
DI 10.1136/bmj.i4235
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS9CH
UT WOS:000381079500009
PM 27480321
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Posen, HJ
   Keystone, JS
   Gubbay, JB
   Morris, SK
AF Posen, H. Joshua
   Keystone, Jay S.
   Gubbay, Jonathan B.
   Morris, Shaun K.
TI Epidemiology of Zika virus, 1947-2007
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID YELLOW-FEVER EPIDEMIC; ARBOVIRUS INFECTIONS; SEROLOGICAL SURVEY;
   SEROEPIDEMIOLOGICAL SURVEY; ANTIBODIES; NIGERIA; SERA; FOREST; AREA;
   HUMANS
AB Introduction: Since 1947, Zika virus has been identified sporadically in humans in Africa and Asia; however, clinically consequential Zika virus disease had not been documented prior to the current outbreak in the Americas. Considering 6 decades have passed since the first identification of the virus, it is perhaps unexpected that Zika virus was recognised only recently as capable of causing disease epidemics. Substantial work on understanding the epidemiology of Zika virus has been conducted since the virus' first outbreak in 2007 in Micronesia; however, there has been little study of the earlier data on Zika virus.
   Methods: A systematic literature search was conducted to identify evidence of Zika virus infection in humans from 1947 to 2007. Data extracted included seroprevalence of Zika virus infection, age distributions of positive test results and serologic test modalities used. Country-level and age-specific seroprevalence was calculated. Estimates of seroprevalence by different serologic test modalities were compared.
   Results: 12 026 citations were retrieved by the literature search, and 76 articles were included in this review. Evidence of Zika virus infection in humans was found in 29 countries in Africa, 8 countries in Asia and 1 country in Europe. Country-level seroprevalence of Zika virus infection ranged from 0.4% to 53.3%. Seroprevalence of Zika virus infection was found to increase across the lifespan; 15-40% of reproductive-age individuals may have been previously infected. No significant difference was found between estimates of seroprevalence by different serologic test modalities.
   Discussion: Zika virus has likely been endemic for decades in certain regions of the world; however, the majority of reproductive-age individuals have likely not been infected. Historical evidence of Zika virus infection exists regardless of the serologic test modality used.
C1 [Posen, H. Joshua] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Keystone, Jay S.] Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada.
   [Gubbay, Jonathan B.] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada.
   [Morris, Shaun K.] Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada.
RP Morris, SK (corresponding author), Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada.
EM shaun.morris@sickkids.ca
RI Gubbay, Jonathan/Q-8580-2019
OI Gubbay, Jonathan/0000-0003-0026-3786; Posen, Joshua/0000-0002-4614-6430
FU GlaxoSmithKlineGlaxoSmithKline; Hoffman-La Roche
FX JBG has received research grants from GlaxoSmithKline and Hoffman-La
   Roche to study antiviral resistance in influenza, and from Pfizer to
   conduct microbiological surveillance of Streptococcus pneumoniae.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Berge TO, 1975, INT CATALOGUE ARBOVI, P782
   Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126
   BOTROS BAM, 1989, J MED VIROL, V29, P79, DOI 10.1002/jmv.1890290202
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   BRES P, 1965, ANN I PASTEUR PARIS, V108, P341
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   CHAMBON L, 1967, B WORLD HEALTH ORGAN, V36, P113
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chippaux A, 1981, Med Trop (Mars), V41, P53
   Chippaux A, 1965, Bull Soc Pathol Exot Filiales, V58, P820
   CHIPPAUX A., 1965, BULL SOC PATHOL EXOTIQUE, V58, P34
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   Christophers SR, 2009, AEDES AEGYPTI L YELL
   Corder G.W., 2014, NONPARAMETRIC STAT S
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Digoutte JP, 1968, B SOC PATHOL EXOT, V6, P803
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1978, J HYG EPID MICROB IM, V22, P184
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   FONTENILLE D, 1988, B SOC PATHOL EXOT, V81, P58
   FONTENILLE D, 1988, ANN SOC BELG MED TR, V68, P43
   Georges A J, 1980, Med Trop (Mars), V40, P561
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   GONZALEZ MTG, 1977, AM J TROP MED HYG, V26, P792, DOI 10.4269/ajtmh.1977.26.792
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Henderson BE, 1969, SEROLOGICAL SURVEYS, V18, P35
   Henderson BE, 1968, ARBOVIRUS SEROLOGICA, V17, P29
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   JOHNSON BK, 1979, T ROY SOC TROP MED H, V73, P594, DOI 10.1016/0035-9203(79)90063-4
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Kirya BG, 1971, ARBOVIRUS SEROLOGY, V20, P32
   Kirya BG, 1970, ARBOVIRUS SEROLOGY, V19, P30
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LE GONIDEC G., 1973, Bulletin de la Societe de Pathologie Exotique, V66, P603
   Lozano A, 1998, Rev Esp Salud Publica, V72, P245
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   MONATH TP, 1974, T ROY SOC TROP MED H, V68, P30, DOI 10.1016/0035-9203(74)90248-X
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OMER AHS, 1981, J TROP MED HYG, V84, P63
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   RADDA A, 1973, ZBL BAKT-INT J MED M, V225, P375
   RAOULT D, 1985, MED MALADIES INFECT, V15, P636, DOI 10.1016/S0399-077X(85)80231-6
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Robin Y, 1971, Bull Soc Pathol Exot Filiales, V64, P434
   ROBIN Y, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P833
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   RODHAIN F, 1972, B WORLD HEALTH ORGAN, V47, P295
   RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodier GR, 1996, T ROY SOC TROP MED H, V90, P237, DOI 10.1016/S0035-9203(96)90228-X
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   SPENCE L, 1968, PROG MED VIROL, V10, P415
   SUREAU P, 1977, B SOC PATHOL EXOT, V70, P131
   TSAI TF, 1987, B WORLD HEALTH ORGAN, V65, P855
   VANDERWAALS FW, 1986, TROP GEOGR MED, V38, P203
   VANPEENEN PFD, 1975, ANN TROP MED PARASIT, V69, P475, DOI 10.1080/00034983.1975.11687035
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WOLFE MS, 1982, LANCET, V2, P1306
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Woodall JP, 1962, ENTEBBE REPORT, V12, P25
   World Health Organization, 2016, ZIK VIR MICR GUILL B, P117
NR 105
TC 30
Z9 30
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD AUG
PY 2016
VL 1
IS 2
AR UNSP e000087
DI 10.1136/bmjgh-2016-000087
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FF2FP
UT WOS:000408713600005
PM 28588942
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Araujo, AQC
   Silva, MTT
   Araujo, APQC
AF Araujo, Abelardo Q. C.
   Silva, Marcus Tulius T.
   Araujo, Alexandra P. Q. C.
TI Zika virus-associated neurological disorders: a review
SO BRAIN
LA English
DT Review
DE Zika virus; arbovirus; microcephaly; Guillain-Barr; syndrome;
   neurological complications
ID VERTICAL TRANSMISSION; ENCEPHALITIS-VIRUS; FRENCH-POLYNESIA; DENGUE
   VIRUS; INFECTION; BRAZIL; BRAIN; MICE; PREGNANCY; OUTBREAK
AB Zika virus is spreading rapidly throughout the Americas. A number of neurological manifestations, in particular microcephaly and Guillain-Barr, syndrome, have been associated with infection. Araujo et al. discuss the role of Zika infection in the pathogenesis of these disorders, and highlight the remaining questions and uncertainties.Zika virus is spreading rapidly throughout the Americas. A number of neurological manifestations, in particular microcephaly and Guillain-Barr, syndrome, have been associated with infection. Araujo et al. discuss the role of Zika infection in the pathogenesis of these disorders, and highlight the remaining questions and uncertainties.Zika virus, an arbovirus transmitted by mosquitoes of the Aedes species, is now rapidly disseminating throughout the Americas and the ongoing Brazilian outbreak is the largest Zika virus epidemic so far described. In addition to being associated with a non-specific acute febrile illness, a number of neurological manifestations, mainly microcephaly and Guillain-Barr, syndrome, have been associated with infection. These with other rarer neurological conditions suggest that Zika virus, similar to other flaviviruses, is neuropathogenic. The surge of Zika virus-related microcephaly cases in Brazil has received much attention and the role of the virus in this and in other neurological manifestations is growing. Zika virus has been shown to be transmitted perinatally and the virus can be detected in amniotic fluid, placenta and foetus brain tissue. A significant increase in Guillain-Barr, syndrome incidence has also been reported during this, as well as in previous outbreaks. More recently, meningoencephalitis and myelitis have also been reported following Zika virus infection. In summary, while preliminary studies have suggested a clear relationship between Zika virus infection and certain neurological conditions, only longitudinal studies in this epidemic, as well as experimental studies either in animal models or in vitro, will help to better understand the role of the virus and the pathogenesis of these disorders.
C1 [Araujo, Abelardo Q. C.; Silva, Marcus Tulius T.] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis INI, Lab Clin Res Neuroinfect Lapclin Neuro, Ave Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Araujo, Abelardo Q. C.] Fed Univ Rio de Janeiro UFRJ, Deolindo Couto Inst Neurol INDC, Ave Venceslau Bras 95, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Araujo, Alexandra P. Q. C.] Fed Univ Rio de Janeiro UFRJ, Martagao Gesteira Inst Child Hlth & Paediat IPPMG, Neuropaediat Unit, Rua Bruno Lobo 50, BR-21941901 Rio De Janeiro, RJ, Brazil.
RP Araujo, AQC (corresponding author), Brazilian Minist Hlth, FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Lab Clin Res Neuroinfect Lapclin Neuro, Ave Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM abelardo@ufrj.br
RI de Queiroz-Campos Araujo, Abelardo/N-3637-2013; Silva, Marcus
   Tulius/AAM-1077-2020
OI de Queiroz-Campos Araujo, Abelardo/0000-0001-7694-7223; 
CR ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173, DOI 10.1128/IAI.12.5.1173-1183.1975
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Bahia SdS, 2015, PAN BAH DENG CHIK ZI
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, EM PREP RESP ZIK VIR
   CDC, 2016, AR WITH ZIK
   CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   E.C.D.C, 2015, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Sante Ddl, 2016, SURVEILLANCE DENGUE
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma Chandra Mohan, 2011, J Indian Med Assoc, V109, P682
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   WHO, 2016, GUILL BARR SYNDR BRA
   WHO, 2016, ZIK POT COMPL 2016
   WHO, 2016, NEUR SYNDR CONG ABN
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 63
TC 68
Z9 69
U1 2
U2 65
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD AUG
PY 2016
VL 139
BP 2122
EP 2130
DI 10.1093/brain/aww158
PN 8
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DV8NM
UT WOS:000383193700014
PM 27357348
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Charrel, RN
   Leparc-Goffart, I
   Pas, S
   de Lamballerie, X
   Koopmans, M
   Reusken, C
AF Charrel, Remi N.
   Leparc-Goffart, Isabelle
   Pas, Suzan
   de Lamballerie, Xavier
   Koopmans, Marion
   Reusken, Chantal
TI Background review for diagnostic test development for Zika virus
   infection
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID FRENCH-POLYNESIA; WEST NILE; RT-PCR; PREGNANT-WOMEN; DECEMBER 2013;
   YELLOW-FEVER; TRANSMISSION; OUTBREAK; INACTIVATION; DENGUE
AB Objective To review the state of knowledge about diagnostic testing for Zika virus infection and identify areas of research needed to. address the current gaps in knowledge.
   Methods We made a non-systematic review of the published literkure about Zika virus and supplemented this with information from commercial diagnostic test kits and personal communications with researchers in European preparedness networks. The review covered current knowledge about the geographical spread, pathogen characteristics, life cycle and infection kinetics of the virus. The available molecular and serological tests and biosafety issues are described and discussed in the context of the current outbreak strain.
   Findings We identified the following areas of research to address current knowledge gaps: (i) an urgent assessment of the laboratory capacity and capability of countries to detect Zika virus; (ii) rapid and extensive field validation of the available molecular and serological tests in areas with and without Zika virus transmission, with a focus on pregnant women; (iii) monitoring the genomic diversity of circulating Zika virus strains; (iv) prospective studies into the virus infection kinetics, focusing on diagnostic sampling (specimen types, combinations and timings); and (v) developing external quality assessments for molecular and serological. testing, including differential diagnosis for similar viruses and symptom clusters. The availability of reagents for diagnostic development (virus strains and antigens, quantified viral ribonucleic acid) needs to be facilitated.
   Conclusion An international laboratory response is needed, including preparation of protocols for prospective studies to address the most pressing information needs.
C1 [Charrel, Remi N.; de Lamballerie, Xavier] Aix Marseille Univ, UMR EPV Emergence Pathol Virales, Marseille, France.
   [Leparc-Goffart, Isabelle] Armed Forces Biomed Res Inst, French Natl Reference Ctr Arbovirus, Marseille, France.
   [Pas, Suzan; Koopmans, Marion; Reusken, Chantal] Erasmus MC, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dept Virosci, Wytemaweg 80,Room EE 17-26, NL-3015 CN Rotterdam, Netherlands.
RP Reusken, C (corresponding author), Erasmus MC, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dept Virosci, Wytemaweg 80,Room EE 17-26, NL-3015 CN Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
RI Pas, Suzan D/M-9863-2013; Koopmans, Marion/Y-9170-2019; amsalu,
   ribka/G-8780-2019
OI Pas, Suzan D/0000-0003-1943-1217; Koopmans, Marion/0000-0002-5204-2312; 
FU European Union under PREPARE [602525]; European Union under project
   European Virus Archive goes global [653316]; European Union under
   PRE-DEMICS [278433]; European Union under EDENext FP7 [261504]
FX This work received funding from the European Union under the following
   projects: PREPARE (grant agreement no. 602525), European Virus Archive
   goes global (no. 653316), PRE-DEMICS FP7/2007-2013 (no. 278433) and
   EDENext FP7 (no. 261504). This paper is catalogued by the EDENext
   Steering Committee as EDENext 444. The work of Remi N. Charrel was done
   under the framework of EurNegVec COST Action TD1303.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2016, WHO SIT REP NEUR SYN
   [Anonymous], 2016, EP UPD NEUR SYNDR CO
   [Anonymous], 2016, EPID UPD OUBR ZIK VI
   [Anonymous], 2016, COUNTR TERR ZIK AUT
   [Anonymous], 2016, DEV ZIK ANT RAP TEST
   [Anonymous], 2016, BRAZ CONF BLOOD TRAN
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burke DS, 2001, FLAVIVIRUSES
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fornara C, 2015, J CLIN VIROL, V64, P45, DOI 10.1016/j.jcv.2015.01.004
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kindhauser MK, B WHO
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika virus disease, 2016, WHOZIKVSUR161
NR 71
TC 72
Z9 74
U1 3
U2 41
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD AUG
PY 2016
VL 94
IS 8
BP 574
EP 584
DI 10.2471/BLT.16.171207
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3HM
UT WOS:000382101400013
PM 27516635
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Olagnier, D
   Muscolini, M
   Coyne, CB
   Diamond, MS
   Hiscott, J
AF Olagnier, David
   Muscolini, Michela
   Coyne, Carolyn B.
   Diamond, Michael S.
   Hiscott, John
TI Mechanisms of Zika Virus Infection and Neuropathogenesis
SO DNA AND CELL BIOLOGY
LA English
DT Article
ID CAUSES BIRTH-DEFECTS; CELLS; TRANSMISSION; ORGANOIDS; MODELS; MICE
AB A spotlight has been focused on the mosquito-borne Zika virus (ZIKV) because of its epidemic outbreak in Brazil and Latin America, as well as the severe neurological manifestations of microcephaly and Guillain Barre syndrome associated with infection. In this review, we discuss the recent literature on ZIKV-host interactions, including new mechanistic insight concerning the basis of ZIKV-induced neuropathogenesis.
C1 [Olagnier, David] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.
   [Muscolini, Michela; Hiscott, John] Fdn Cenci Bolognetti, Ist Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
   [Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
RP Hiscott, J (corresponding author), Fdn Cenci Bolognetti, Ist Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
EM john.hiscott@istitutopasteur.it
RI Muscolini, Michela/AAB-3904-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Muscolini,
   Michela/0000-0003-4090-4779; Olagnier, David/0000-0001-6912-0674
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 44
TC 23
Z9 24
U1 0
U2 124
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG
PY 2016
VL 35
IS 8
BP 367
EP 372
DI 10.1089/dna.2016.3404
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA DS5JH
UT WOS:000380817500001
PM 27348136
OA Green Published
DA 2020-07-08
ER

PT J
AU Brault, JB
   Khou, C
   Basset, J
   Coquand, L
   Fraisier, V
   Frenkiel, MP
   Goud, B
   Manuguerra, JC
   Pardigon, N
   Baffet, AD
AF Brault, Jean-Baptiste
   Khou, Cecile
   Basset, Justine
   Coquand, Laure
   Fraisier, Vincent
   Frenkiel, Marie-Pascale
   Goud, Bruno
   Manuguerra, Jean-Claude
   Pardigon, Nathalie
   Baffet, Alexandre D.
TI Comparative Analysis Between Flaviviruses Reveals Specific Neural Stem
   Cell Tropism for Zika Virus in the Mouse Developing Neocortex
SO EBIOMEDICINE
LA English
DT Article
ID WEST NILE VIRUS; INFECTION; ENCEPHALITIS; ORGANOIDS; STRAIN
AB The recent Zika outbreak in South America and French Polynesia was associated with an epidemic of microcephaly, a disease characterized by a reduced size of the cerebral cortex. Other members of the Flavivirus genus, including West Nile virus (WNV), can cause encephalitis but were not demonstrated to cause microcephaly. It remains unclear whether Zika virus (ZIKV) and other flaviviruses may infect different cell populations in the developing neocortex and lead to distinct developmental defects. Here, we describe an assay to infect mouse E15 embryonic brain slices with ZIKV, WNV and dengue virus serotype 4 (DENV-4). We show that this tissue is able to support viral replication of ZIKV and WNV, but not DENV-4. Cell fate analysis reveals a remarkable tropism of ZIKV infection for neural stem cells. Closely related WNV displays a very different tropism of infection, with a bias towards neurons. We further show that ZIKV infection, but not WNV infection, impairs cell cycle progression of neural stem cells. Both viruses inhibited apoptosis at early stages of infection. This work establishes a powerful comparative approach to identify ZIKV-specific alterations in the developing neocortex and reveals specific preferential infection of neural stem cells by ZIKV. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Brault, Jean-Baptiste; Coquand, Laure; Fraisier, Vincent; Goud, Bruno; Baffet, Alexandre D.] PSL Res Univ, Inst Curie, CNRS, UMR144, F-75005 Paris, France.
   [Khou, Cecile; Basset, Justine; Frenkiel, Marie-Pascale; Manuguerra, Jean-Claude; Pardigon, Nathalie] ERI CIBU Arbovirus Grp, Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.
RP Baffet, AD (corresponding author), PSL Res Univ, Inst Curie, CNRS, UMR144, F-75005 Paris, France.
EM alexandre.baffet@curie.fr
RI BAFFET, Alexandre/I-7687-2017
OI Baffet, Alexandre/0000-0001-9194-4258
FU Labex CelTisPhyBio [11-LBX-0038]; Idex Paris Sciences et Lettres
   [ANR-10-IDEX-0001-02 PSL]; Ministry of Defence/Direction Generale de
   l'Armement (DGA); European Research CouncilEuropean Research Council
   (ERC) [339847];  [278433-PREDEMICS]
FX We are grateful to Joseph J. Cockburn and Renata Basto for helpful
   comments and suggestions on the manuscript. We thank Valerie Caro, Laure
   Diancourt and Meriadeg Ar Gouilh for assistance with the phylogenetic
   tree. The Baffet and Goud labs are part of the Labex CelTisPhyBio
   (11-LBX-0038) and the Idex Paris Sciences et Lettres
   (ANR-10-IDEX-0001-02 PSL). Seventh Framework Programme (FP7) provided
   funding under grant number 278433-PREDEMICS to NP, JB and MPF. Ministry
   of Defence/Direction Generale de l'Armement (DGA) provided funding to
   CK. This work was supported by the European Research Council advanced
   grants (project 339847 'MYODYN' to B.G.). We acknowledge the Curie Cell
   and Tissue Imaging Platform-PICT-IBiSA (member of France-Bioimaging) for
   technical assistance.
CR Alsaleh K, 2016, VIROLOGY, V492, P53, DOI 10.1016/j.virol.2016.02.009
   Baffet AD, 2016, METHOD CELL BIOL, V131, P349, DOI 10.1016/bs.mcb.2015.06.013
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Cugola FR, 2016, NATURE, P1
   Dang J., 2016, CELL STEM CELL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fernandez V., 2016, EMBO J
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayden EC, 2016, NATURE, V532, P16
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Roze B, 2016, EURO SURVEILL, P21
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 33
TC 45
Z9 45
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG
PY 2016
VL 10
BP 71
EP 76
DI 10.1016/j.ebiom.2016.07.018
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IE
UT WOS:000386877700018
PM 27453325
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paploski, IAD
   Prates, APPB
   Cardoso, CW
   Kikuti, M
   Silva, MMO
   Waller, LA
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Paploski, Igor A. D.
   Prates, Ana Paula P. B.
   Cardoso, Cristiane W.
   Kikuti, Mariana
   Silva, Monaise M. O.
   Waller, Lance A.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Time Lags between Exanthematous Illness Attributed to Zika Virus,
   Guillain-Barre Syndrome, and Microcephaly, Salvador, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION; CHIKUNGUNYA; OUTBREAK; DENGUE; TRANSMISSION; EMERGENCE;
   ISLAND
AB Zika virus infection emerged as a public health emergency after increasing evidence for its association with neurologic disorders and congenital malformations. In Salvador, Brazil, outbreaks of acute exanthematous illness (AEI) attributed to Zika virus, Guillain-Barre syndrome (GBS), and microcephaly occurred in 2015. We investigated temporal correlations and time lags between these outbreaks to identify a common link between them by using epidemic curves and time series cross-correlations. Number of GBS cases peaked after a lag of 5-9 weeks from the AEI peak. Number of suspected cases of microcephaly peaked after a lag of 30-33 weeks from the AEI peak, which corresponded to time of potential infections of pregnant mothers during the first trimester. These findings support the association of GBS and microcephaly with Zika virus infection and provide evidence for a temporal relationship between timing of arboviral infection of pregnant women during the first trimester and birth outcome.
C1 [Paploski, Igor A. D.; Kikuti, Mariana; Silva, Monaise M. O.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Kikuti, Mariana; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Prates, Ana Paula P. B.; Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Waller, Lance A.; Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Kikuti, Mariana/G-2313-2017; Reis, Mitermayer/AAO-9742-2020; Ribeiro,
   Guilherme/B-6624-2008; amsalu, ribka/G-8780-2019; Paploski, Igor
   AD/D-7015-2014
OI Kikuti, Mariana/0000-0001-8119-7236; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059;
   Paploski, Igor AD/0000-0002-3689-2042; Cardoso,
   Cristiane/0000-0001-5432-1174
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [400830/2013-2]; Bahia Foundation for Research Support; Coordination for
   the Improvement of Higher Education Personnel-Brazilian Ministry of
   Education
FX This study was supported by the National Council for Scientific and
   Technological Development (grant 400830/2013-2 and scholarships to
   I.A.D.P., U.K., M.G.R., and G.S.R); the Bahia Foundation for Research
   Support (scholarship to M.M.O.S.); and the Coordination for the
   Improvement of Higher Education Personnel-Brazilian Ministry of
   Education (scholarship to M.K.).
CR Brasil P, 2016, N ENGL J MED
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET
   Cecatti JG, 2010, REV BRAS GINECOL OBS, V32, P105, DOI 10.1590/S0100-72032010000300002
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diggle P., 1990, TIME SERIES BIOSTATI
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esack A, 1999, W INDIAN MED J, V48, P36
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Government of the State of Bahia, 2015, AL IND EX DIS TRANSM
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ministry of Health of Brazil, 2015, N012015 MIN HLTH BRA
   Ministry of Health of Brazil, 2016, N15 MIN HLTH BRAZ
   Ministry of Health of Brazil, 2016, SURV RESP PROT OCC M
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, CUM ZIK SUSP CONF CA
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stata statistical software, 2015, STAT STAT SOFTW REL
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIKA SITUATION REPOR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 59
Z9 62
U1 0
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2016
VL 22
IS 8
BP 1438
EP 1444
DI 10.3201/eid2208.160496
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DY2PM
UT WOS:000384934500015
PM 27144515
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arauz, D
   De Urriola, L
   Jones, J
   Castillo, M
   Martinez, A
   Murillo, E
   Troncoso, L
   Chen, M
   Abrego, L
   Armien, B
   Pascale, JM
   Sosa, N
   Lopez-Verges, S
   Moreno, B
AF Arauz, Dimelza
   De Urriola, Luis
   Jones, Jose
   Castillo, Marlene
   Martinez, Alexander
   Murillo, Edison
   Troncoso, Leonidas
   Chen, Maria
   Abrego, Leyda
   Armien, Blas
   Pascale, Juan M.
   Sosa, Nestor
   Lopez-Verges, Sandra
   Moreno, Brechla
TI Febrile or Exanthematous Illness Associated with Zika, Dengue, and
   Chikungunya Viruses, Panama
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
C1 [Arauz, Dimelza; Castillo, Marlene; Martinez, Alexander; Chen, Maria; Abrego, Leyda; Armien, Blas; Pascale, Juan M.; Sosa, Nestor; Lopez-Verges, Sandra; Moreno, Brechla] Gorgas Mem Inst Hlth Studies, Ave Justo Arosemena Calle 35 & 36, Panama City 081602593, Panama.
   [De Urriola, Luis] Panama Minist Hlth, Dept Epidemiol, Guna Yala, Panama.
   [Jones, Jose; Murillo, Edison; Troncoso, Leonidas] Hlth Ctr Guna Yala, Guna Yala, Panama.
RP Moreno, B (corresponding author), Gorgas Mem Inst Hlth Studies, Ave Justo Arosemena Calle 35 & 36, Panama City 081602593, Panama.
EM bmoreno@gorgas.gob.pa
CR Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leibovitz Z, 2015, ULTRASOUND OBST GYN, V2, P23
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   World Health Organization, GUILL BARR SYNDR PAN
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 13
Z9 14
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2016
VL 22
IS 8
BP 1515
EP 1517
DI 10.3201/eid2208.160292
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DY2PM
UT WOS:000384934500039
PM 27139219
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gold, CA
   Josephson, SA
AF Gold, Carl A.
   Josephson, S. Andrew
TI Anticipating the Challenges of Zika Virus and the Incidence of
   Guillain-Barre Syndrome
SO JAMA NEUROLOGY
LA English
DT Editorial Material
C1 [Gold, Carl A.; Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.
RP Gold, CA (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.
EM carl.gold@ucsf.edu
CR Ajao A, 2015, DISASTER MED PUBLIC, V9, P634, DOI 10.1017/dmp.2015.105
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Hughes RAC, 2003, NEUROLOGY, V61, P736, DOI 10.1212/WNL.61.6.736
   Orange JS, 2013, J CLIN IMMUNOL, V33, P1033, DOI 10.1007/s10875-013-9912-3
   World Health Organization, 2016, ID MAN GUILL BARR SY
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 7
TC 12
Z9 13
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD AUG
PY 2016
VL 73
IS 8
BP 905
EP 906
DI 10.1001/jamaneurol.2016.1268
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA DX2MS
UT WOS:000384204900001
PM 27272118
OA Bronze
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Maia, M
   Travassos, SB
   Martins, TT
   Patriota, F
   Nunes, ME
   Agra, C
   Torres, VL
   van der Linden, V
   Ramos, RC
   Rocha, MAW
   Silva, PS
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Travassos, Simone B.
   Martins, Thayze T.
   Patriota, Felipe
   Nunes, Marcos Eugenio
   Agra, Cristiana
   Torres, Virginia L.
   van der Linden, Vanessa
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Silva, Paula S.
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Risk Factors Associated With the Ophthalmoscopic Findings Identified in
   Infants With Presumed Zika Virus Congenital Infection
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID TRANSMISSION; CHILD
AB IMPORTANCE The Zika virus (ZIKV) might cause microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy.
   OBJECTIVE To assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection.
   DESIGN, SETTING, AND PARTICIPANTS We conducted a cross-sectional study at the Altino Ventura Foundation in Recife, Brazil, that included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus were ruled out in all of them. Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (60.0%). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison.
   MAIN OUTCOMES AND MEASURES Identification of risk factors for ophthalmoscopic findings in infants born with microcephaly and ZIKV intrauterine infection.
   RESULTS Among the 40 infants, the mean (SD) age was 2.2 (1.2) months (range, 0.1-7.3 months). Of the 24 infants tested, 100% had positive results for ZIKV infection: 14 of 22 infants (63.6%) from the group with ophthalmoscopic findings and 10 of 18 infants (55.6%) from the group without ophthalmoscopic findings. The major symptoms reported in both groups were rash by 26 mothers (65.0%), fever by 9 mothers (22.5%), headache by 9 mothers (22.5%), and arthralgia by 8 mothers (20.0%). No mothers reported conjunctivitis or other ocular symptoms during pregnancy or presented signs of uveitis at the time of examination. Thirty-seven eyes (46.3%) of 22 infants (55.0%) had ophthalmoscopic alterations. Ten mothers (71.4%) of infants with ocular findings reported symptoms during the first trimester (frequency, 0.48; 95% CI, 0.02-0.67; P = .04). A difference was also observed between the groups of infants with and without ocular findings regarding the cephalic perimeter: mean (SD) of 28.8 (1.7) and 30.3 (1.5), respectively (frequency, -1.50; 95% CI, -2.56 to -0.51; P = .004).
   CONCLUSIONS AND RELEVANCE Ocular involvement in infants with presumed ZIKV congenital infection were more often seen in infants with smaller cephalic diameter at birth and in infants whose mothers reported symptoms during the first trimester.
C1 [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Torres, Virginia L.; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Agra, Cristiana; Torres, Virginia L.; Ventura, Liana O.] Pernambucos Eye Hosp HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Silva, Paula S.] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Camila V/N-2654-2018; Ventura, Liana Vieira O/N-6151-2018;
   Torres, Virginia/N-6951-2018; Maia, Mauricio/I-5892-2015
OI Ventura, Camila V/0000-0002-2927-4684; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Torres, Virginia/0000-0002-3744-0961; Maia,
   Mauricio/0000-0002-7034-8091; Martins, Thayze/0000-0002-8082-2623; AGRA,
   CRISTIANA/0000-0002-4400-7744
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil Ministerio da Saude, PROT VIG RESP OC MIC
   Brasil - Ministerio da Saude, SAUD CONF 1 113 CAS
   Centers for Disease Control and Prevention, TRAV HLTH NOT
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   European Centre for Disease Prevention and Control, MICR BRAZ POT LINK Z
   World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 26
TC 84
Z9 84
U1 1
U2 81
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 912
EP 918
DI 10.1001/jamaophthalmol.2016.1784
PG 7
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200015
PM 27228275
OA Bronze
DA 2020-07-08
ER

PT J
AU Moshfeghi, DM
   de Miranda, HA
   Costa, MC
AF Moshfeghi, Darius M.
   de Miranda, Homero Augusto, II
   Costa, Marcelo Cavalcante
TI Zika Virus, Microcephaly, and Ocular Findings
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Moshfeghi, Darius M.] Stanford Univ, Sch Med, Horngren Family Vitreoretinal Ctr, Byers Eye Inst,Dept Ophthalmol, 2452Watson Ct,Room 2277, Palo Alto, CA 94303 USA.
   [de Miranda, Homero Augusto, II; Costa, Marcelo Cavalcante] Ophthalm Telemed Santa Casa Sao Paulo, Sao Paulo, Brazil.
RP Moshfeghi, DM (corresponding author), Stanford Univ, Sch Med, Horngren Family Vitreoretinal Ctr, Byers Eye Inst,Dept Ophthalmol, 2452Watson Ct,Room 2277, Palo Alto, CA 94303 USA.
EM dariusm@stanford.edu
CR Atchaneeyasakul LO, 1998, OPHTHALMIC GENET, V19, P39, DOI 10.1076/opge.19.1.39.2178
   de Paula Freitas B, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 12
Z9 12
U1 0
U2 59
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 945
EP 945
DI 10.1001/jamaophthalmol.2016.1303
PG 1
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200024
PM 27254835
DA 2020-07-08
ER

PT J
AU Jampol, LM
   Goldstein, DA
AF Jampol, Lee M.
   Goldstein, Debra A.
TI Zika Virus, Microcephaly, and Ocular Findings Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Jampol, Lee M.; Goldstein, Debra A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
RP Jampol, LM (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
EM l-jampol@northwestern.edu
NR 0
TC 3
Z9 3
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 946
DI 10.1001/jamaophthalmol.2016.1307
PG 1
WC Ophthalmology
SC Ophthalmology
GA VC0DS
UT WOS:000425669100001
PM 27253432
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI What Does Zika Virus Mean for the Children of the Americas?
SO JAMA PEDIATRICS
LA English
DT Review
ID BRAIN; DISRUPTION; INFECTION
C1 [Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Sabin Vaccine Inst, Houston, TX USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Ctr Vaccine Dev, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James Baker Inst Publ Policy 3, Houston, TX USA.
RP Hotez, PJ (corresponding author), Baylor Coll Med, Natl Sch Trop Med, 1 Baylor Plaza,MS 320, Houston, TX 77030 USA.
EM hotez@bcm.edu
OI Hotez, Peter/0000-0001-8770-1042
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hotez PJ, 2014, JAMA PSYCHIAT, V71, P1099, DOI 10.1001/jamapsychiatry.2014.1045
   Hotez PJ., 2016, NY TIMES, pA19
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 19
TC 8
Z9 8
U1 0
U2 8
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD AUG
PY 2016
VL 170
IS 8
BP 787
EP 789
DI 10.1001/jamapediatrics.2016.1465
PG 3
WC Pediatrics
SC Pediatrics
GA DS9XW
UT WOS:000381137800017
PM 27322491
DA 2020-07-08
ER

PT J
AU da Silva, SR
   Gao, SJ
AF da Silva, Suzane Ramos
   Gao, Shou-Jiang
TI Zika Virus: An Update on Epidemiology, Pathology, Molecular Biology, and
   Animal Model
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE Zika virus; epidemiology; pathology; transmission; animal model
ID SEXUAL CONTACT; DENGUE VIRUSES; WEST-NILE; OUTBREAK; TRANSMISSION;
   BRAZIL; GLYCOSYLATION; INFECTION; CHIKUNGUNYA; ILLNESS
AB Zika virus (ZIKV) was first described in 1947, and became a health emergency problem in 2016 when its association with fetal microcephaly cases was confirmed by Centers for Disease Control and Prevention (CDC) in the United States. To date, ZIKV infection has been documented in 66 countries. ZIKV is recognized as a neurotropic virus and numerous diseases manifested in multiple neurological disorders have been described, mainly in countries that have been exposed to ZIKV after the 2007 outbreak in the Federated States of Micronesia. The most dramatic consequence of ZIKV infection documented is the abrupt increase in fetal microcephaly cases in Brazil. Here, we present an update of the published research progress in the past few months. (C) 2016 Wiley Periodicals, Inc.
C1 [da Silva, Suzane Ramos; Gao, Shou-Jiang] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
RP da Silva, SR; Gao, SJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
EM ramosdas@usc.edu; shoujiag@usc.edu
RI Gao, Shou-Jiang/B-8641-2012
OI Ramos da Silva, Suzane/0000-0002-0768-8421; Gao,
   Shou-Jiang/0000-0001-6194-1742
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01
   CA096512]
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bayer A, 2016, CELL HOST MICROBE
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro M.T., 2016, LANCET, P30254
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   D'Ortenzio E, 2016, N ENGL J ME IN PRESS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Ferreira MLB, 2016, AAN 68 ANN M
   Garcez P. P., 2016, SCIENCE
   Giovanetti M, 2016, INFECT GENET EVOL
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kostyuchenko VA, 2016, NATURE IN PRESS
   Lazear H. M., 2016, J VIROL
   Lazear HM, 2016, CELL HOST MICROBE
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian X., 2016, CELL, V165, P1
   Rasmussen SA, 2016, N ENGL J ME IN PRESS
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Song H, 2016, NAT STRUCT IN PRESS
   Tang H, 2016, CELL STEM CELL
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang L, 2016, CELL HOST MICROBE
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Willison HJ, 2016, LANCET
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 74
TC 24
Z9 25
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2016
VL 88
IS 8
BP 1291
EP 1296
DI 10.1002/jmv.24563
PG 6
WC Virology
SC Virology
GA DW5FU
UT WOS:000383669500002
PM 27124623
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Contreras, D
   Arumugaswami, V
AF Contreras, Deisy
   Arumugaswami, Vaithilingaraja
TI Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic
   Effect of Interferons
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Infection; Issue 114; Zika Virus; ZIKV; microcephaly; Interferon;
   Cytokines; IFN-alpha; IFN-gamma; Zika virus prophylaxis; ZIKV
   inhibitors; Mosquito-borne illness; Flaviviridae; Emerging disease
ID HEPATITIS-C; PREGNANCY
AB Zika Virus (ZIKV) is an emerging pathogen that is linked to fetal developmental abnormalities such as microcephaly, eye defects, and impaired growth. ZIKV is an RNA virus of the Flaviviridae family. ZIKV is mainly transmitted by mosquitoes, but can also be spread by maternal to fetal vertical transmission as well as sexual contact. To date, there are no reliable treatment or vaccine options available to protect those infected by the virus. The development of a reproducible, effective Zika virus infectious cell culture system is critical for studying the molecular mechanisms of ZIKV replication as well as drug and vaccine development. In this regard, a protocol describing a mammalian cell-based in vitro Zika virus culture system for viral production and growth analysis is reported here. Details on the formation of plaques by Zika virus on a cell monolayer and plaque assay for measuring viral titer are presented. Viral genome replication kinetics and double-stranded RNA genome replicatory intermediates are determined. This culture platform was utilized to screen against a library of a small set of cytokines resulting in the identification of interferon-alpha (IFN-alpha), IFN-gamma and IFN-gamma as potent inhibitors of Zika viral growth. In summary, an in vitro infectious Zika viral culture system and various virological assays are demonstrated in this study, which has the potential to greatly benefit the research community in elucidating further the mechanisms of viral pathogenesis and the evolution of viral virulence. Antiviral IFN-alpha can further be evaluated as a prophylactic, post-exposure prophylactic, and treatment option for Zika virus infections in high-risk populations, including infected pregnant women.
C1 [Contreras, Deisy; Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.
   [Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Surg, David Geffen Sch Med, Los Angeles, CA 90024 USA.
RP Arumugaswami, V (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.; Arumugaswami, V (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.; Arumugaswami, V (corresponding author), Univ Calif Los Angeles, Dept Surg, David Geffen Sch Med, Los Angeles, CA 90024 USA.
EM arumugaswami@cshs.org
FU Cedars-Sinai Medical Center Institutional Programmatic Research Award
FX We would like to thank Dr. Aaron Brault and Dr. Brandy Russell of the
   Centers for Disease Control and Prevention (CDC), USA for providing Zika
   viral strain PRVABC59. We thank Nicholas Ten of Yale University for
   copy-editing this manuscript. This work was supported by the
   Cedars-Sinai Medical Center Institutional Programmatic Research Award to
   V.A.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chu D, 2013, J VIROL, V87, P5678, DOI 10.1128/JVI.00840-12
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hiratsuka M, 2000, J PERINAT MED, V28, P372, DOI 10.1515/JPM.2000.047
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti R.S., 2016, EMERG INFECT DIS, V22
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Ozaslan E, 2002, ANN PHARMACOTHER, V36, P1715, DOI 10.1345/aph.1C065
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 19
TC 24
Z9 24
U1 2
U2 14
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2016
IS 114
AR e54767
DI 10.3791/54767
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH4LM
UT WOS:000391742700096
PM 27584546
OA Green Published
DA 2020-07-08
ER

PT J
AU Larsen, GD
AF Larsen, Gregory D.
TI PROMISING VACCINES FOR ZIKA
SO LAB ANIMAL
LA English
DT News Item
RI Larsen, Gregory/P-9942-2016
OI Larsen, Gregory/0000-0002-6572-6473
CR 2016, NATURE, DOI DOI 10.1038/NATURE18952
NR 1
TC 0
Z9 1
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0093-7355
EI 1548-4475
J9 LAB ANIMAL
JI Lab Anim.
PD AUG
PY 2016
VL 45
IS 8
BP 282
EP 282
DI 10.1038/laban.1078
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA DZ8SW
UT WOS:000386142800010
PM 27439088
DA 2020-07-08
ER

PT J
AU Oladapo, OT
   Souza, JP
   De Mucio, B
   de Leon, RGP
   Perea, W
   Gulmezoglu, AM
AF Oladapo, Olufemi T.
   Souza, Joao Paulo
   De Mucio, Bremen
   de Leon, Rodolfo Gomez Ponce
   Perea, William
   Gulmezoglu, A. Metin
CA WHO Guideline Dev Grp
TI WHO interim guidance on pregnancy management in the context of Zika
   virus infection
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Oladapo, Olufemi T.; Souza, Joao Paulo; Gulmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva 27, Switzerland.
   [De Mucio, Bremen; de Leon, Rodolfo Gomez Ponce] Pan Amer Hlth Org, Latin Amer Ctr Perinatol, Montevideo, Uruguay.
   [Perea, William] WHO, Dept Pandem & Epidem Dis, Geneva, Switzerland.
RP Oladapo, OT (corresponding author), WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva 27, Switzerland.
EM oladapoo@who.int
RI Souza, Joao Paulo/G-1982-2010
OI Souza, Joao Paulo/0000-0002-2288-4244
FU World Health OrganizationWorld Health Organization [001]
CR Brasil P, 2016, N ENGL J MED
   Erdman JN, 2012, INT J GYNECOL OBSTET, V118, P83, DOI 10.1016/j.ijgo.2012.04.002
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   WHO, 2016, PREGN MAN CONT ZIK V
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
NR 5
TC 13
Z9 15
U1 0
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2016
VL 4
IS 8
BP E510
EP E511
DI 10.1016/S2214-109X(16)30098-5
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS3RI
UT WOS:000380700000006
PM 27211476
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   Pasquier, C
   Daudin, M
   Chapuy-Regaud, S
   Moinard, N
   Chevreau, C
   Izopet, J
   Mengelle, C
   Bujan, L
AF Mansuy, Jean Michel
   Pasquier, Christophe
   Daudin, Myriam
   Chapuy-Regaud, Sabine
   Moinard, Nathalie
   Chevreau, Christine
   Izopet, Jacques
   Mengelle, Catherine
   Bujan, Louis
TI Zika virus in semen of a patient returning from a non-epidemic area
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mansuy, Jean Michel; Pasquier, Christophe; Chapuy-Regaud, Sabine; Izopet, Jacques; Mengelle, Catherine] Ctr Hosp Univ Toulouse, F-31059 Toulouse, France.
   [Pasquier, Christophe; Chapuy-Regaud, Sabine; Izopet, Jacques] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, INSERM U1043, Toulouse, France.
   [Daudin, Myriam; Moinard, Nathalie; Bujan, Louis] Univ Toulouse, UPS, Grp Rech Fertilite Humaine, Toulouse, France.
   [Daudin, Myriam; Moinard, Nathalie; Bujan, Louis] Ctr Hosp Univ Paule de Viguier, Ctr Etud & Conservat Oeufs & Sperme, Toulouse, France.
   [Chevreau, Christine] Inst Claudius Regaud, Inst Univ Canc Toulouse Oncopole, Med Oncol Serv, Toulouse, France.
RP Mansuy, JM (corresponding author), Ctr Hosp Univ Toulouse, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
OI Bujan, Louis/0000-0003-1540-0536; PASQUIER,
   Christophe/0000-0001-9223-0150; IZOPET, JACQUES/0000-0002-8462-3234;
   DAUDIN, Myriam/0000-0003-3700-5596; MOINARD,
   Nathalie/0000-0003-2127-0993
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
NR 5
TC 60
Z9 61
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2016
VL 16
IS 8
BP 894
EP 895
DI 10.1016/S1473-3099(16)30153-0
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU4XH
UT WOS:000382215700031
PM 27477981
OA Bronze
DA 2020-07-08
ER

PT J
AU Suter, MA
   Aagaard, KM
AF Suter, Melissa A.
   Aagaard, Kjersti M.
TI DISEASE WATCH Zika virus - placental passage and permissivity for
   infection
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Editorial Material
C1 [Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plza, Houston, TX 77030 USA.
RP Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plza, Houston, TX 77030 USA.
EM aagaardt@bcm.tmc.edu
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bialas KM, 2015, CLIN PERINATOL, V42, P61, DOI 10.1016/j.clp.2014.10.006
   Brasil P, 2016, N ENGL J MED
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Quicke KM, 2016, CELL HOST MICROBE
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
NR 10
TC 3
Z9 3
U1 0
U2 67
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
EI 1759-5037
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD AUG
PY 2016
VL 12
IS 8
BP 437
EP U14
DI 10.1038/nrendo.2016.101
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR8WB
UT WOS:000380178000001
PM 27339887
OA Bronze
DA 2020-07-08
ER

PT J
AU Jain, R
   Coloma, J
   Garcia-Sastre, A
   Aggarwal, AK
AF Jain, Rinku
   Coloma, Javier
   Garcia-Sastre, Adolfo
   Aggarwal, Aneel K.
TI Structure of the NS3 helicase from Zika virus
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID CRYSTAL-STRUCTURE; PROTEIN; DOMAIN
AB Zika virus has emerged as a pathogen of major health concern. Here, we present a high-resolution (1.62-angstrom) crystal structure of the RNA helicase from the French Polynesia strain. The structure is similar to that of the RNA helicase from Dengue virus, with variability in the conformations of loops typically involved in binding ATP and RNA. We identify druggable 'hotspots' that are well suited for in silico and/or fragment-based high-throughput drug discovery.
C1 [Jain, Rinku; Coloma, Javier; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
RP Aggarwal, AK (corresponding author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.
EM aneel.aggarwal@mssm.edu
OI Garcia-Sastre, Adolfo/0000-0002-6551-1827; Coloma,
   Javier/0000-0001-9247-4163
FU  [U19AI118610]
FX We thank K. Rajashankar and the staff at NECAT-24ID (APS) for
   facilitating data collection. These studies were partly funded by a
   supplement to the NIAID NIH grant U19AI118610 (to A.G.-S.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   KUKKO E, 1982, EUR J BIOCHEM, V127, P347, DOI 10.1111/j.1432-1033.1982.tb06878.x
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mancini EJ, 2007, PROTEIN SCI, V16, P2294, DOI 10.1110/ps.072843107
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Speroni S, 2008, PROTEINS, V70, P1120, DOI 10.1002/prot.21812
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yadav S, 2015, J STRUCT BIOL, V192, P100, DOI 10.1016/j.jsb.2015.08.004
NR 24
TC 56
Z9 62
U1 1
U2 27
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD AUG
PY 2016
VL 23
IS 8
BP 752
EP +
DI 10.1038/nsmb.3258
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DS8CL
UT WOS:000381010300010
PM 27399257
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Fontes, CAP
   dos Santos, AASMD
   Marchiori, E
AF Pantaleao Fontes, Cristina Asvolinsque
   Damas dos Santos, Alair Augusto S. M.
   Marchiori, Edson
TI Magnetic resonance imaging findings in Guillain-Barr, syndrome caused by
   Zika virus infection
SO NEURORADIOLOGY
LA English
DT Letter
C1 [Pantaleao Fontes, Cristina Asvolinsque; Damas dos Santos, Alair Augusto S. M.] Univ Fed Fluminense, Dept Radiol, Rio De Janeiro, Brazil.
   [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rua Thomaz Cameron 438, BR-25685120 Valparaiso, Brazil.
RP Marchiori, E (corresponding author), Univ Fed Rio de Janeiro, Dept Radiol, Rua Thomaz Cameron 438, BR-25685120 Valparaiso, Brazil.
EM edmarchiori@gmail.com
OI Marchiori, Edson/0000-0001-8797-7380
CR Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Yardimci N, 2009, NEUROL SCI, V30, P431, DOI 10.1007/s10072-009-0120-0
NR 5
TC 35
Z9 38
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-3940
EI 1432-1920
J9 NEURORADIOLOGY
JI Neuroradiology
PD AUG
PY 2016
VL 58
IS 8
BP 837
EP 838
DI 10.1007/s00234-016-1687-9
PG 2
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA DV2NN
UT WOS:000382757400012
PM 27067205
DA 2020-07-08
ER

PT J
AU de Miranda, HA
   Costa, MC
   Frazao, MAM
   Simao, N
   Franchischini, S
   Moshfeghi, DM
AF de Miranda, Homero Augusto, II
   Costa, Marcelo Cavalcante
   Monteiro Frazao, Maria Auxiliadora
   Simao, Natalia
   Franchischini, Sandra
   Moshfeghi, Darius M.
TI Expanded Spectrum of Congenital Ocular Findings in Microcephaly with
   Presumed Zika Infection
SO OPHTHALMOLOGY
LA English
DT Article
ID TORPEDO MACULOPATHY; CHORIORETINOPATHY; VIRUS
AB Purpose: To describe the ocular findings of 3 cases of suspected congenital Zika viral infection with microcephaly and maculopathy.
   Design: Retrospective, consecutive case series.
   Participants: Three male infants born in northern Brazil whose mothers demonstrated a viral syndrome during the first trimester and who subsequently were born with microcephaly.
   Methods: Observational report of macular findings.
   Main Outcome Measures: Continued observation.
   Results: Three male infants were born with microcephaly to mothers who had a viral syndrome during the first trimester of gestation in an area that subsequently has demonstrated epidemic Zika infection, a flavivirus related to Dengue. Ocular examination was performed. All 6 eyes demonstrated a pigmentary maculopathy ranging from mild to pronounced. In 4 eyes, well-delineated macular chorioretinal atrophy with a hyperpigmented ring developed. Three eyes demonstrated vascular tortuosity and 2 eyes demonstrated a pronounced early termination of the retinal vasculature on photographic evaluation. Two eyes demonstrated a washed out peripheral retina with a hypolucent spot. One eye had scattered subretinal hemorrhages external to the macula. Finally, 1 eye demonstrated peripheral pigmentary changes and clustered atrophic lesions resembling grouped congenital albinotic spots (polar bear tracks).
   Conclusions: Zika virus has been linked to microcephaly in children of mothers with a viral syndrome during the first trimester of pregnancy. Ocular findings previously described a pigmentary retinopathy and atrophy that now can be expanded to include torpedo maculopathy, vascular changes, and hemorrhagic retinopathy. Ophthalmologic screening guidelines need to be defined to determine which children would benefit from newborn screening in affected regions. (C) 2016 by the American Academy of Ophthalmology.
C1 [de Miranda, Homero Augusto, II; Costa, Marcelo Cavalcante; Monteiro Frazao, Maria Auxiliadora] Ophthalm Telemed Santa Casa Sao Paulo, Sao Paulo, Brazil.
   [Simao, Natalia] Univ Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Franchischini, Sandra] Univ Santo Amaro, Dept Ophthalmol, Sao Paulo, Brazil.
   [Moshfeghi, Darius M.] Stanford Univ, Sch Med, Dept Ophthalmol, Horngren Family Vitreoretinal Ctr,Byers Eye Inst, Palo Alto, CA 94303 USA.
RP Moshfeghi, DM (corresponding author), Stanford Univ, Horngren Family Vitreoretinal Ctr, Div Pediat Vitreoretinal Dis & Surg, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94303 USA.
EM dariusm@stanford.edu
FU Claire Giannini Foundation (San Francisco, CA); Clarity Medical Systems,
   Inc. (Pleasanton, CA)
FX The author(s) have made the following disclosure(s): D.M.M.: Consultant
   - Genentech (South San Francisco, CA); Alcon (Fort Worth, TX);
   Synergetics, Inc. (O'Fallon, MO); Iconic Therapeutics, Inc. (South San
   Francisco, CA); Intrexon (Germantown, MD); Oraya Therapeutics (Newark,
   CA); Thrombogenics (Leuven, Belgium); Visunex Medical Systems Co. Ltd
   (Grand Cayman, Cayman Islands); Financial support - Claire Giannini
   Foundation (San Francisco, CA); Clarity Medical Systems, Inc.
   (Pleasanton, CA); Board membership - Promisight, Inc. (Palo Alto, CA);
   Versl, Inc. (Palo Alto, CA); Patents - InSitu Therapeutics (Mill Valley,
   CA); Equity owner - Promisight; Versl; Visnuex; Krypton Vision (Fremont,
   CA)
CR Aggarwal A, 2013, J NEUROSCI RURAL PRA, V4, P288, DOI 10.4103/0976-3147.118781
   Atchaneeyasakul LO, 1998, OPHTHALMIC GENET, V19, P39, DOI 10.1076/opge.19.1.39.2178
   Braithwaite T, 2013, BMJ CASE REP
   CANTU JM, 1977, HUM GENET, V36, P243, DOI 10.1007/BF00273265
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996
   Rosa RFM, 2015, SAO PAULO MED J, V133, P377, DOI 10.1590/1516-3180.2013.7930003
   MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NELLHAUS G, 1968, PEDIATRICS, V41, P106
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Pastora N, 2012, OPHTHALMIC GENET, V33, P116, DOI 10.3109/13816810.2011.626012
   Richez F, 2010, J FR OPHTALMOL, V33, P296, DOI 10.1016/j.jfo.2009.12.013
   ROSEMAN RL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1358
   Shields CL, 2010, ARCH OPHTHALMOL-CHIC, V128, P499, DOI 10.1001/archophthalmol.2010.29
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villegas VM, 2014, OSLI RETINA, V45, P222, DOI 10.3928/23258160-20140410-01
   Yzer S, 2013, JAMA OPHTHALMOL, V131, P1324, DOI 10.1001/jamaophthalmol.2013.4349
NR 25
TC 71
Z9 71
U1 0
U2 105
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD AUG
PY 2016
VL 123
IS 8
BP 1788
EP 1794
DI 10.1016/j.ophtha.2016.05.001
PG 7
WC Ophthalmology
SC Ophthalmology
GA DS4MC
UT WOS:000380754200038
PM 27236271
DA 2020-07-08
ER

PT J
AU Lim, SP
   Noble, CG
   Seh, CC
   Soh, TS
   El Sahili, A
   Chan, GKY
   Lescar, J
   Arora, R
   Benson, T
   Nilar, S
   Manjunatha, U
   Wan, KF
   Dong, HP
   Xie, XP
   Shi, Y
   Yokokawa, F
AF Lim, Siew Pheng
   Noble, Christian Guy
   Seh, Cheah Chen
   Soh, Tingjin Sherryl
   El Sahili, Abbas
   Chan, Grace Kar Yarn
   Lescar, Julien
   Arora, Rishi
   Benson, Timothy
   Nilar, Shahul
   Manjunatha, Ujjini
   Wan, Kah Fei
   Dong, Hongping
   Xie, Xuping
   Shi, Yong
   Yokokawa, Fumiaki
TI Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of
   Action and Resistance Profiling
SO PLOS PATHOGENS
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; PROTEIN 5 NS5; CRYSTAL-STRUCTURE; DRUG
   DISCOVERY; NONNUCLEOSIDE INHIBITORS; METHYLTRANSFERASE DOMAIN;
   INITIATION; REPLICATION; CAP; FLAVIVIRUS
AB Flaviviruses comprise major emerging pathogens such as dengue virus (DENV) or Zika virus (ZIKV). The flavivirus RNA genome is replicated by the RNA-dependent-RNA polymerase (RdRp) domain of non-structural protein 5 (NS5). This essential enzymatic activity renders the RdRp attractive for antiviral therapy. NS5 synthesizes viral RNA via a "de novo" initiation mechanism. Crystal structures of the flavivirus RdRp revealed a "closed" conformation reminiscent of a pre-initiation state, with a well ordered priming loop that extrudes from the thumb subdomain into the dsRNA exit tunnel, close to the "GDD" active site. To-date, no allosteric pockets have been identified for the RdRp, and compound screening campaigns did not yield suitable drug candidates. Using fragment-based screening via Xray crystallography, we found a fragment that bound to a pocket of the apo-DENV RdRp close to its active site (termed "N pocket"). Structure-guided improvements yielded DENV pan-serotype inhibitors of the RdRp de novo initiation activity with nano-molar potency that also impeded elongation activity at micro-molar concentrations. Inhibitors exhibited mixed inhibition kinetics with respect to competition with the RNA or GTP substrate. The best compounds have EC50 values of 1-2 mu M against all four DENV serotypes in cell culture assays. Genome-sequencing of compound-resistant DENV replicons, identified amino acid changes that mapped to the N pocket. Since inhibitors bind at the thumb/palm interface of the RdRp, this class of compounds is proposed to hinder RdRp conformational changes during its transition from initiation to elongation. This is the first report of a class of pan-serotype and cell-active DENV RdRp inhibitors. Given the evolutionary conservation of residues lining the N pocket, these molecules offer insights to treat other serious conditions caused by flaviviruses.
C1 [Lim, Siew Pheng; Noble, Christian Guy; Seh, Cheah Chen; Soh, Tingjin Sherryl; Nilar, Shahul; Manjunatha, Ujjini; Wan, Kah Fei; Dong, Hongping; Xie, Xuping; Shi, Yong; Yokokawa, Fumiaki] Novartis Inst Trop Dis, Singapore, Singapore.
   [Soh, Tingjin Sherryl; El Sahili, Abbas; Chan, Grace Kar Yarn; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Lescar, Julien] Ctr Hosp Univ Pitie Salpetriere, Fac Med Pierre & Marie Curie, Ctr Immunol & Malad Infect, CNRS,INSERM,U1135,UPMC UMRS CR7,ERL 8255, Paris, France.
   [Arora, Rishi; Benson, Timothy] Novartis Inst Biomed Res, Cambridge, MA USA.
   [Xie, Xuping; Shi, Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Lim, SP (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.
EM siew_pheng.lim@novartis.com
RI Xie, Xuping/AAD-7406-2019; /AAJ-1244-2020
OI Lim, Siew Pheng/0000-0002-7377-5662; Benson,
   Timothy/0000-0001-8633-2142; El Sahili, Abbas/0000-0003-3973-686X
FU Novartis Institute for Tropical Diseases; Novartis Institute for
   Biomedical Research; Singapore Economic Development Board
FX Funding sources that supported this work were obtained from Novartis
   Institute for Tropical Diseases, Novartis Institute for Biomedical
   Research, and Singapore Economic Development Board. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Keller Thomas H, 2006, Novartis Found Symp, V277, P102, DOI 10.1002/0470058005.ch8
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Niyomrattanakit P, 2015, ANTIVIR RES, V119, P36, DOI 10.1016/j.antiviral.2015.04.007
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2016, J BIOL CHEM, V291, P8541, DOI 10.1074/jbc.M115.710731
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Nomaguchi M, 2004, J BIOL CHEM, V279, P12141, DOI 10.1074/jbc.M310839200
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
NR 50
TC 50
Z9 50
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2016
VL 12
IS 8
AR e1005737
DI 10.1371/journal.ppat.1005737
PG 25
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DW1AV
UT WOS:000383376000009
PM 27500641
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Khater, HF
   Panneerselvam, C
   Benelli, G
AF Govindarajan, Marimuthu
   Khater, Hanem F.
   Panneerselvam, Chellasamy
   Benelli, Giovanni
TI One-pot fabrication of silver nanocrystals using Nicandra physalodes: A
   novel route for mosquito vector control with moderate toxicity on
   non-target water bugs
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Biosafety; Dengue; Filariasis; Malaria; Green-synthesis; Zika virus
ID AEGYPTI DIPTERA-CULICIDAE; LEAF EXTRACT; ANOPHELES-STEPHENSI; GREEN
   SYNTHESIS; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; VETERINARY IMPORTANCE;
   LABORATORY EVALUATION; AQUATIC ORGANISMS; BORNE DISEASES
AB Mosquitoes (Diptera: Culicidae) as vectors for important diseases and parasites causing millions of deaths every year. The use of synthetic pesticides against Culicidae leads to resistance and environmental concerns. Therefore, eco-friendly control tools are a priority. In this research, Nicandra physalodes-mediated synthesis of silver nano particles (Ag NPs) was conducted, in order to control larval populations of three important mosquito vectors, Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. Biofabricated Ag NPs were characterized using UV-vis spectrophotometry, XRD, FTIR spectroscopy, SEM, and TEM analyses. Ag NPs were highly toxic against the three mosquito vectors. Maximum efficacy was detected against A. stephensi (LC50 = 1239 mu g/mL), followed by Ae. aegypti (LC50 = 13.61 mu g/mL) and Cx. quinquefasciatus (LC50 = 14.79 mu g/mL). Interestingly, Ag NPs were safer for the non-target aquatic organism Diplonychus indicus sharing the same aquatic habitats of mosquito larvae. LC50 and LC90 values were 1032.81 and 19,076.59 mu g/mL, respectively. Overall, our results highlight that N. physalodes-fabricated Ag NPs are a promising for development of eco-friendly larvicides against mosquito vectors, with negligible toxicity against non-target aquatic water bugs. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Khater, Hanem F.] Benha Univ, Fac Vet Med, Dept Parasitol, Moshtohor 13736, Toukh, Egypt.
   [Panneerselvam, Chellasamy] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013;
   Khater, Hanem/I-3635-2019
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010; Khater, Hanem/0000-0002-1591-2534;
   Panneerselvam, Chellasamy/0000-0003-3994-8141
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Ankamwar B, 2005, SYNTH REACT INORG M, V35, P19, DOI 10.1081/SIM-200047527
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   CHOPRA RN, 1986, GLOSSARY INDIAN MED
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.T., 1971, PROBIT ANAL
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   GOVINDARAJAN M, 2016, PARASITOLOGY RES MON, P99
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2015, PARASITOL RES, V114, P601, DOI 10.1007/s00436-014-4222-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Kathiresan K, 2009, COLLOID SURFACE B, V71, P133, DOI 10.1016/j.colsurfb.2009.01.016
   KIRSON I, 1972, J CHEM SOC PERK T 1, P2109, DOI 10.1039/p19720002109
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8
   Olga N., 1964, J AGR FOOD CHEM, V12, P55
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Singh BP, 2010, J ENVIRON QUAL, V39, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Veerakumar K, 2014, PARASITOL RES, V113, P4567, DOI 10.1007/s00436-014-4147-7
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   World Health Organization, 2005, GUID LAB FIELD TEST, P13
   Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
NR 47
TC 44
Z9 44
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD AUG
PY 2016
VL 107
BP 95
EP 101
DI 10.1016/j.rvsc.2016.05.017
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA DT5RZ
UT WOS:000381541600015
PM 27473981
DA 2020-07-08
ER

PT J
AU Sheikh, K
AF Sheikh, Knvul
TI Zika-Proofing the Olympics
SO SCIENTIFIC AMERICAN
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0036-8733
J9 SCI AM
JI Sci.Am.
PD AUG
PY 2016
VL 315
IS 2
BP 19
EP 19
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA VI3FA
UT WOS:000470742800001
PM 27459560
DA 2020-07-08
ER

PT J
AU Kim, K
   Shresta, S
AF Kim, Kenneth
   Shresta, Sujan
TI Neuroteratogenic Viruses anc Lessons for Zika Virus Vodels
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID JAPANESE ENCEPHALITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; CACHE VALLEY VIRUS;
   CYTOMEGALOVIRUS-INFECTION; BLUETONGUE VIRUS; VERTICAL TRANSMISSION;
   AKABANE VIRUS; MICE; BRAIN; FETAL
AB The Centers for Disease Control and Prevention has confirmed that Zika virus (ZIKV) causes congenital microcephaly. ZIKV now joins five other neuroteratogenic (NT) viruses in humans and ZIKV research is in its infancy. In addition, there is only one other NT human arbovirus (Venezuelan equine encephalitis virus), which is also poorly understood. But further insight into ZIKV can be found by evaluating arboviruses in domestic animals, of which there are at least seven NT viruses, three of which have been well studied. Here we review two key anatomical structures involved in modeling transplacental NT virus transmission: the placenta and the fetal blood-brain barrier. We then survey major research findings regarding transmission of NT viruses for guidance in establishing a mouse model of Zika disease that is crucial for a better understanding of ZIKV transmission and pathogenesis.
C1 [Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
EM sujan@lji.org
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Akashi H, 1999, ARCH VIROL, V144, P2101, DOI 10.1007/s007050050625
   ANDERSEN AA, 1978, AM J VET RES, V39, P301
   Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343, DOI 10.1590/S0036-46651998000600002
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65
   Bielefeldt-Ohmann H, 2008, J COMP PATHOL, V138, P72, DOI 10.1016/j.jcpa.2007.10.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Burgos JS, 2006, J VIROL, V80, P2823, DOI 10.1128/JVI.80.6.2823-2831.2006
   Cantlle C., 2015, JUBB KENNEDY PALMERS, P280
   CHANTLER JK, 1979, J GEN VIROL, V42, P621, DOI 10.1099/0022-1317-42-3-621
   Coetzee P, 2014, VIRUS RES, V182, P21, DOI 10.1016/j.virusres.2013.12.044
   COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzlo E, 2016, N ENGL J MED
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011
   Donald KA, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-014-0042-7
   Doran KS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010090
   Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3681
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fineberg AM, 2013, BIOL PSYCHIAT, V73, P951, DOI 10.1016/j.biopsych.2013.01.001
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ftaich N, 2015, J VIROL, V89, P10467, DOI 10.1128/JVI.01541-15
   FUCCILLO DA, 1973, BACTERIOL REV, V37, P19, DOI 10.1128/MMBR.37.1.19-31.1973
   FUJISAKI Y, 1982, NATL I ANIM HEALTH Q, V22, P95
   Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776
   Habu A, 1977, Uirusu, V27, P21
   Halstead S.B., 2015, F1000RES, V4, P1353, DOI DOI 10.12688/F1000RESEARCH.7024.1
   HARTLEY WJ, 1977, AUST VET J, V53, P319, DOI 10.1111/j.1751-0813.1977.tb00240.x
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann AR, 2012, J VIROL, V86, P4793, DOI 10.1128/JVI.06858-11
   Kelling CL, 2013, BIOLOGICALS, V41, P20, DOI 10.1016/j.biologicals.2012.09.006
   KIRKLAND PD, 1988, VET REC, V122, P582, DOI 10.1136/vr.122.24.582
   Kosmac K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003200
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Ku CC, 2005, J VIROL, V79, P2651, DOI 10.1128/JVI.79.5.2651-2658.2005
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li RY, 2000, TERATOLOGY, V62, P79
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Maclachlan NJ, 2015, REV SCI TECH OIE, V34, P329, DOI 10.20506/rst.34.2.2360
   MacLachlan NJ, 2000, ANIM REPROD SCI, V60, P643, DOI 10.1016/S0378-4320(00)00105-6
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1986, J GEN VIROL, V67, P945, DOI 10.1099/0022-1317-67-5-945
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murata Y, 2015, J COMP PATHOL, V153, P140, DOI 10.1016/j.jcpa.2015.06.003
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   OBERST RD, 1993, VET CLIN N AM-FOOD A, V9, P23, DOI 10.1016/S0749-0720(15)30668-X
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redwine JM, 2002, CURR TOP MICROBIOL, V265, P119
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Seong G, 2015, ARCH VIROL, V160, P1565, DOI 10.1007/s00705-015-2412-4
   Sever J.L., 1983, TERATOGENESIS REPROD, P65
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sison A.V., 2008, HDB CLIN OBSTET FETU, P94
   Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51
   SPERTZEL RO, 1972, INFECT IMMUN, V6, P339, DOI 10.1128/IAI.6.3.339-343.1972
   Straface Gianluca, 2012, Infect Dis Obstet Gynecol, V2012, P385697, DOI 10.1155/2012/385697
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Tsuda T, 2004, VET RES, V35, P531, DOI 10.1051/vetres:2004029
   Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WALDVOGEL AS, 1987, VET PATHOL, V24, P404, DOI 10.1177/030098588702400507
   Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024744
   Wang ZY, 2003, INTERVIROLOGY, V46, P79, DOI 10.1159/000069742
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wemike K., 2012, PLOS ONE, V7
   Woolf NK, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-26
   YUILL TM, 1970, AM J TROP MED HYG, V19, P513, DOI 10.4269/ajtmh.1970.19.513
NR 96
TC 14
Z9 15
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD AUG
PY 2016
VL 24
IS 8
BP 622
EP 636
DI 10.1016/j.tim.2016.06.002
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DS7OQ
UT WOS:000380973200005
PM 27387029
OA Bronze
DA 2020-07-08
ER

PT J
AU Vasconcelos, PFC
   Monath, TP
AF Vasconcelos, Pedro F. C.
   Monath, Thomas P.
TI Yellow Fever Remains a Potential Threat to Public Health
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Aedes aegypti mosquitoes; Epidemic; Underreporting; Vaccine; Yellow
   fever; Zika virus
AB Yellow fever (YF) remains a serious public health threat in endemic countries. The recent re-emergence in Africa, initiating in Angola and spreading to Democratic Republic of Congo and Uganda, with imported cases in China and Kenya is of concern. There is such a shortage of YF vaccine in the world that the World Health Organization has proposed the use of reduced doses (1/5) during emergencies. In this short communication, we discuss these and other problems including the risk of spread of YF to areas free of YF for decades or never before affected by this arbovirus disease.
C1 [Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Rodovia BR-316,Km 7, BR-67030000 Ananindeua, Brazil.
   [Monath, Thomas P.] NewLink Genet Corp, Div Infect Dis, Devens, MA USA.
RP Vasconcelos, PFC (corresponding author), Minist Hlth, Evandro Chagas Inst, Rodovia BR-316,Km 7, BR-67030000 Ananindeua, Brazil.
EM pedrovasconcelos@iec.pa.gov.br
RI Vasconcelos, Pedro/AAH-3142-2019
CR Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Monath TP, 2016, LANCET, V387, P1816
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Reed W., 1901, AM MED, V2, P15
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   WHO, 2016, 2 TEL WHO GEN APR 28
   World Health Organization (WHO), 2013, WKLY EPIDEMIOL REC, V88, P269, DOI DOI 10.1016/J.IJPORL.2014.03.035
NR 8
TC 35
Z9 36
U1 1
U2 66
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD AUG
PY 2016
VL 16
IS 8
BP 566
EP 567
DI 10.1089/vbz.2016.2031
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DR7VR
UT WOS:000380108300011
PM 27400066
DA 2020-07-08
ER

PT J
AU Tavares, MP
   Foster, AM
AF Tavares, Marilia P.
   Foster, Angel M.
TI Emergency contraception in a public health emergency: exploring pharmacy
   availability in Brazil
SO CONTRACEPTION
LA English
DT Article
DE EC; ECPs; Postcoital contraception; Zika virus; Latin America
ID ABORTION; ACCESS; ZIKA
AB Introduction: Dedicated progestin-only emergency contraceptive pills (ECPs) have been available with a prescription in Brazil since 1999. However, utilization of emergency contraception has been limited. We conducted a mystery client study at retail pharmacies in three regions to assess current availability.
   Methods: Using a predetermined client profile, we approached a random sample of chain and independent pharmacies in urban areas in the southeastern, northeastern and central-west regions. We documented product availability, price and the client-pharmacy representative interaction at each site. We analyzed these data with descriptive statistics and for content and themes.
   Results: We visited 122 pharmacies in early 2016. All but three pharmacies (97.5%) had ECPs in stock at the time of the interaction and offered our client the medication without a prescription. In general, pharmacy representatives did not ask questions or provide our client with information about emergency contraception. When prompted, over one third of the pharmacy representatives (37.7%) inaccurately reported that levonorgestrel ECPs could only be used immediately or within 12, 24 or 48 h from the time of intercourse.
   Conclusion: Despite the current regulatory status, our findings suggest that progestin-only ECPs are widely available without a prescription. Additional efforts to ensure that women have up-to-date and medically accurate information about progestin-only ECPs appear warranted. Our findings suggest that more work needs to be done to align national regulatory policies with international standards and evidence-based practices.
   Implications: The Zika virus epidemic has shined a spotlight on the importance of providing timely access to emergency contraception in Latin America. This public health emergency offers a window of opportunity to advance national policies and practices to ensure that Brazilian women have access to a full range of reproductive health services. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Tavares, Marilia P.; Foster, Angel M.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.
   [Foster, Angel M.] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.
RP Foster, AM (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.; Foster, AM (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.
EM angel.foster@uottawa.ca
RI Angel M. Foster, DPhil/H-6150-2019
OI Angel M. Foster, DPhil/0000-0001-8848-203X
FU Ministry of Health and Long-Term Care in OntarioMinistry of Health and
   Long-Term Care, Ontario
FX Dr. Foster's Endowed Chair in Women's Health Research is funded by the
   Ministry of Health and Long-Term Care in Ontario and we appreciate the
   general support for her time that made this project possible. We thank
   Drs. Sanni Yaya and Raywat Deonandan for their input on early phases of
   this project. The conclusions and opinions expressed in this article are
   those of the authors and do not necessarily represent the views of the
   organizations with which the authors are affiliated or the funders.
CR Alano GM, 2012, CIENC SAUDE COLETIVA, V17, P2397, DOI 10.1590/S1413-81232012000900020
   [Anonymous], 2014, ECONOMIST
   Camargo RS, 2011, INT J GYNECOL OBSTET, V112, P88, DOI 10.1016/j.ijgo.2010.08.013
   Chin-Quee DS, 2006, STUD FAMILY PLANN, V37, P99, DOI 10.1111/j.1728-4465.2006.00089.x
   Cleland K, ACCESS EMER IN PRESS
   Deniz N, 2005, SAGE HDB QUALITATIVE
   Díaz Soledad, 2003, Cad. Saúde Pública, V19, P1729, DOI 10.1590/S0102-311X2003000600017
   Díaz Soledad, 2003, Cad. Saúde Pública, V19, P1507, DOI 10.1590/S0102-311X2003000500029
   Faundes A, 2015, EUR J CONTRACEP REPR, V2015, P1
   Faundes A, 2007, REPROD HEALTH MATTER, V15, P130, DOI 10.1016/S0968-8080(07)29300-0
   GBI Source, BRAZ GOV EV REIMB CO
   Hardy E, 2001, Cad Saude Publica, V17, P1031, DOI 10.1590/S0102-311X2001000400038
   Higgins SJ, 2013, RES SOC ADMIN PHARM, V9, P114, DOI 10.1016/j.sapharm.2012.03.004
   International Consortium, 2012, EM CONTR PILLS MED S
   International Consortium for Emergency Contraception, STAT AV DAT
   Leon FR, 2005, STUD FAMILY PLANN, V36, P117, DOI 10.1111/j.1728-4465.2005.00049.x
   McNeil Jr Donald G., 2016, NY TIMES
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   de Araujo MSP, 2009, CAD SAUDE PUBLICA, V25, P551, DOI 10.1590/S0102-311X2009000300010
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Trussell J, 2012, EMERGENCY CONTRACEPTION: THE STORY OF A GLOBAL REPRODUCTIVE HEALTH TECHNOLOGY, P19
   Borges ALV, 2016, HEALTH CARE WOMEN IN, V37, P170, DOI 10.1080/07399332.2015.1055746
   Borges ALV, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0087-7
   World Bank, BRAZ WORLD DEV IND
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2017, PREV POT SEX TRANSM
   Wynn LL, 2012, EMERGENCY CONTRACEPTION: THE STORY OF A GLOBAL REPRODUCTIVE HEALTH TECHNOLOGY, P3
NR 27
TC 9
Z9 9
U1 0
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD AUG
PY 2016
VL 94
IS 2
BP 109
EP 114
DI 10.1016/j.contraception.2016.04.006
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DQ1SV
UT WOS:000378981600003
PM 27091724
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Halting the Olympics-Zika virus bandwagon
SO LANCET
LA English
DT Editorial Material
NR 0
TC 1
Z9 1
U1 0
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 30
PY 2016
VL 388
IS 10043
BP 437
EP 437
AR PII S1473-3099(16)30230-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2EK
UT WOS:000380559400001
PM 27507741
DA 2020-07-08
ER

PT J
AU Maurice, J
AF Maurice, John
TI The Zika virus public health emergency: 6 months on
SO LANCET
LA English
DT Editorial Material
AB This year, the global health community has given top priority ranking on many research and public health fronts to its battle against the spreading Zika virus epidemic. John Maurice reports.
NR 0
TC 10
Z9 10
U1 0
U2 57
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 30
PY 2016
VL 388
IS 10043
BP 449
EP 450
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2EK
UT WOS:000380559400010
PM 27507747
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI More than 50 UK Zika cases are reported in people returning from abroad
   so far this year
SO BMJ-British Medical Journal
LA English
DT News Item
CR Public Health England, 2016, ZIK VIR INF GUID PRI
NR 1
TC 0
Z9 0
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 29
PY 2016
VL 354
AR i4227
DI 10.1136/bmj.i4227
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS6ZV
UT WOS:000380933000010
PM 27473528
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU de Oliveira, JRM
   Moura, DAP
AF de Oliveira, Joao R. M.
   Moura, Denis A. P.
TI Clarifying samples in Zika analyses
SO SCIENCE
LA English
DT Letter
C1 [de Oliveira, Joao R. M.; Moura, Denis A. P.] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, BR-50670901 Recife, PE, Brazil.
RP de Oliveira, JRM (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, BR-50670901 Recife, PE, Brazil.
EM joao.ricardo@ufpe.br
OI Moura, Denis/0000-0002-7462-5455
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Franca GV, 2016, LANCET
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2444
NR 4
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 29
PY 2016
VL 353
IS 6298
BP 452
EP 452
DI 10.1126/science.aah3733
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS2HC
UT WOS:000380583600026
PM 27471296
DA 2020-07-08
ER

PT J
AU Oduyebo, T
   Igbinosa, I
   Petersen, EE
   Polen, KND
   Pillai, SK
   Ailes, EC
   Villanueva, JM
   Newsome, K
   Fischer, M
   Gupta, PM
   Powers, AM
   Lampe, M
   Hills, S
   Arnold, KE
   Rose, LE
   Shapiro-Mendoza, CK
   Beard, CB
   Munoz, JL
   Rao, CY
   Meaney-Delman, D
   Jamieson, DJ
   Honein, MA
AF Oduyebo, Titilope
   Igbinosa, Irogue
   Petersen, Emily E.
   Polen, Kara N. D.
   Pillai, Satish K.
   Ailes, Elizabeth C.
   Villanueva, Julie M.
   Newsome, Kim
   Fischer, Marc
   Gupta, Priya M.
   Powers, Ann M.
   Lampe, Margaret
   Hills, Susan
   Arnold, Kathryn E.
   Rose, Laura E.
   Shapiro-Mendoza, Carrie K.
   Beard, Charles B.
   Munoz, Jorge L.
   Rao, Carol Y.
   Meaney-Delman, Dana
   Jamieson, Denise J.
   Honein, Margaret A.
TI Update: Interim Guidance for Health Care Providers Caring for Pregnant
   Women with Possible Zika Virus Exposure - United States, July 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID REPRODUCTIVE AGE; GUIDELINES; INFECTION
C1 [Oduyebo, Titilope; Petersen, Emily E.; Shapiro-Mendoza, Carrie K.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Igbinosa, Irogue; Polen, Kara N. D.; Ailes, Elizabeth C.; Newsome, Kim; Arnold, Kathryn E.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Pillai, Satish K.; Villanueva, Julie M.; Rose, Laura E.] CDC, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Fischer, Marc; Powers, Ann M.; Hills, Susan; Beard, Charles B.; Munoz, Jorge L.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Gupta, Priya M.] CDC, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Lampe, Margaret] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Rao, Carol Y.] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Oduyebo, T (corresponding author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Rao,
   Carol/0000-0001-7187-2189; Jamieson, Denise/0000-0003-2597-1201
CR Bocanegra C, 2016, CLIN MICROB IN PRESS
   CDC, 2016, CDC REC SUBS ZIK IGM
   CHHABRA RS, 1993, PEDIATRICS, V91, P88
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franca GV, 2016, LANCET
   Lo YMD, 1996, BLOOD, V88, P4390
   Martines R. B., 2016, LANCET
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/clinchem.2004.036517
   Meaney-Delman D, 2016, OBSTET GYNE IN PRESS
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pacheco O, 2016, N ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
NR 21
TC 122
Z9 123
U1 0
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 29
PY 2016
VL 65
IS 29
BP 739
EP 744
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5XT
UT WOS:000386699200004
PM 27467820
DA 2020-07-08
ER

PT J
AU Brooks, JT
   Friedman, A
   Kachur, RE
   LaFlam, M
   Peters, PJ
   Jamieson, DJ
AF Brooks, John T.
   Friedman, Allison
   Kachur, Rachel E.
   LaFlam, Michael
   Peters, Philip J.
   Jamieson, Denise J.
TI Update: Interim Guidance for Prevention of Sexual Transmission of Zika
   Virus - United States, July 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID SEMEN
C1 [Brooks, John T.; LaFlam, Michael] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Friedman, Allison; Kachur, Rachel E.; Peters, Philip J.] CDC, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
RP Brooks, JT (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
EM zud4@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR CDC, 2016, REPR HLTH CONTR
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freour T., 2016, EURO SURVEILL, V21
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Oduyebo T, 2016, MMWR MORB MORTAL WKL
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prisant N., 2016, LANCET INFECT DIS
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO, 2016, PREV SEX TRANSM ZIK
NR 12
TC 54
Z9 56
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 29
PY 2016
VL 65
IS 29
BP 745
EP 747
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5XT
UT WOS:000386699200005
PM 27466758
OA Bronze
DA 2020-07-08
ER

PT J
AU Lei, J
   Hansen, G
   Nitsche, C
   Klein, CD
   Zhang, LL
   Hilgenfeld, R
AF Lei, Jian
   Hansen, Guido
   Nitsche, Christoph
   Klein, Christian D.
   Zhang, Linlin
   Hilgenfeld, Rolf
TI Crystal structure of Zika virus NS2B-NS3 protease in complex with a
   boronate inhibitor
SO SCIENCE
LA English
DT Article
ID NS3 PROTEASE; DENGUE
AB The ongoing Zika virus (ZIKV) outbreak is linked to severe neurological disorders. ZIKV relies on its NS2B/NS3 protease for polyprotein processing; hence, this enzyme is an attractive drug target. The 2.7 angstrom crystal structure of ZIKV protease in complex with a peptidomimetic boronic acid inhibitor reveals a cyclic diester between the boronic acid and glycerol. The P2 4-aminomethylphenylalanine moiety of the inhibitor forms a salt-bridge with the nonconserved Asp(83) of NS2B; ion-pairing between Asp(83) and the P2 residue of the substrate likely accounts for the enzyme's high catalytic efficiency. The unusual dimer of the ZIKV protease: inhibitor complex seen in the crystal may provide a model for assemblies formed at high local concentrations of protease at the endoplasmatic reticulum membrane, the site of polyprotein processing.
C1 [Lei, Jian; Hansen, Guido; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
   [Lei, Jian; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
   [Nitsche, Christoph; Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Nitsche, Christoph] Australian Natl Univ, Sch Chem, Canberra, ACT 2601, Australia.
RP Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.; Hilgenfeld, R (corresponding author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
EM hilgenfeld@biochem.uni-luebeck.de
RI Hansen, Guido/B-8859-2013
OI Hansen, Guido/0000-0003-3737-5749; Klein, Christian/0000-0003-3522-9182;
   Lei, Jian/0000-0001-9394-8236
FU German Center for Infection Research [DZIF-TTU01, 8011801911]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [KL-1356/3-1]
FX We thank S. Zoske and Y. Gul for assistance, S. Anemuller for recording
   the mass spectra, L. Weigel for the synthesis of precursors of cn-716,
   and D. Graf for testing this compound for cytotoxicity. We are indebted
   to the staff of synchrotron beamlines BL 14.1 (BESSY, Berlin) and P11
   (DESY, Hamburg) for support. The corresponding coordinates and structure
   factors are available from the PDB under accession code 5LC0. Funding
   from the German Center for Infection Research (DZIF-TTU01, grant
   8011801911) is gratefully acknowledged. C.D.K. thanks the Deutsche
   Forschungsgemeinschaft for financial support (KL-1356/3-1).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kuroda D, 2016, BIOINFORMATICS, V32, P2451, DOI 10.1093/bioinformatics/btw197
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445
   Turker L, 2006, INDIAN J CHEM A, V45, P1339
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
NR 16
TC 144
Z9 153
U1 6
U2 74
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 29
PY 2016
VL 353
IS 6298
BP 503
EP 505
DI 10.1126/science.aag2419
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS2HC
UT WOS:000380583600045
PM 27386922
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rastogi, M
   Sharma, N
   Singh, SK
AF Rastogi, Meghana
   Sharma, Nikhil
   Singh, Sunit Kumar
TI Flavivirus NS1: a multifaceted enigmatic viral protein
SO VIROLOGY JOURNAL
LA English
DT Review
DE Flavivirus; Non-structural proteins; Arboviruses; NS1 protein
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; NONSTRUCTURAL GLYCOPROTEIN
   NS1; N-LINKED GLYCOSYLATION; TOLL-LIKE RECEPTOR-3; SIGNAL-TRANSDUCTION;
   PROTECTIVE IMMUNITY; RNA REPLICATION; DENGUE TYPE-2; CELL APOPTOSIS
AB Flaviviruses are emerging arthropod-borne viruses representing an immense global health problem. The prominent viruses of this group include dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus tick borne encephalitis virus and Zika Virus. These are endemic in many parts of the world. They are responsible for the illness ranging from mild flu like symptoms to severe hemorrhagic, neurologic and cognitive manifestations leading to death. NS1 is a highly conserved non-structural protein among flaviviruses, which exist in diverse forms. The intracellular dimer form of NS1 plays role in genome replication, whereas, the secreted hexamer plays role in immune evasion. The secreted NS1 has been identified as a potential diagnostic marker for early detection of the infections caused by flaviviruses. In addition to the diagnostic marker, the importance of NS1 has been reported in the development of therapeutics. NS1 based subunit vaccines are at various stages of development. The structural details and diverse functions of NS1 have been discussed in detail in this review.
C1 [Rastogi, Meghana; Singh, Sunit Kumar] Banaras Hindu Univ, Fac Med, Mol Biol Unit, IMS,Lab Human Mol Virol & Immunol, Varanasi 221005, Uttar Pradesh, India.
   [Sharma, Nikhil] CSIR, Lab Neurovirol & Inflammat Biol, CCMB, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.
RP Singh, SK (corresponding author), Banaras Hindu Univ, Fac Med, Mol Biol Unit, IMS,Lab Human Mol Virol & Immunol, Varanasi 221005, Uttar Pradesh, India.
EM sunitsingh2000@gmail.com
RI Rastogi, Meghana/AAD-8842-2019
OI Singh, Sunit/0000-0002-8802-1169
FU Department of Biotechnology, Govt. of India, New DelhiDepartment of
   Biotechnology (DBT) India [BT/PR8706/AGR/36/767/2013]
FX The support through the Department of Biotechnology, Govt. of India, New
   Delhi, Grant no: BT/PR8706/AGR/36/767/2013 is highly acknowledged.
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chang HH, 2002, J INFECT DIS, V186, P743, DOI 10.1086/342600
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Chuang YC, 2013, THROMB HAEMOSTASIS, V110, P358, DOI 10.1160/TH13-02-0149
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dechtawewat T, 2016, BIOCH BIOPHYS ACTA
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   Fan Jingjing, 2014, Virologica Sinica, V29, P162, DOI 10.1007/s12250-014-3459-1
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990
   Hu DM, 2013, BIOSENSORS-BASEL, V3, P297, DOI 10.3390/bios3030297
   Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]
   Hukkanen RR, 2006, COMPARATIVE MED, V56, P46
   Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f
   Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482
   Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657
   Lin TS, 2010, MICROB PATHOGENESIS, V49, P67, DOI 10.1016/j.micpath.2010.04.002
   Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998
   Linares EM, 2013, BIOSENS BIOELECTRON, V41, P180, DOI 10.1016/j.bios.2012.08.005
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Robinson PJ, 1997, ADV EXP MED BIOL, V419, P365
   Satchidanandam V., 2006, NOVART FDN SYMP, V277, P251
   Satchidanandam V, 2006, NOVART FDN SYMP, V277, P45
   Satchidanandam Vijaya, 2006, Novartis Found Symp, V277, P136, DOI 10.1002/0470058005.ch10
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Scholle F, 2005, VIROLOGY, V342, P77, DOI 10.1016/j.virol.2005.07.021
   Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Sinawang PD, 2016, BIOSENS BIOELECTRON, V77, P400, DOI 10.1016/j.bios.2015.09.048
   SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V
   Sun EC, 2013, VET MICROBIOL, V166, P145, DOI 10.1016/j.vetmic.2013.05.026
   Sun J, 2012, MICROBES INFECT, V14, P930, DOI 10.1016/j.micinf.2012.03.007
   Tajima S, 2008, VIRUS GENES, V36, P323, DOI 10.1007/s11262-008-0211-7
   Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Vazquez S, 2007, J CLIN VIROL, V39, P194, DOI 10.1016/j.jcv.2007.04.003
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Wan SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092495
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Winkelmann ER, 2011, VIROLOGY, V421, P96, DOI 10.1016/j.virol.2011.09.007
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yen LC, 2016, J VIROL, V90, P1178, DOI 10.1128/JVI.02057-15
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Young LB, 2015, J GEN VIROL, V96, P1042, DOI 10.1099/vir.0.000053
   Young LB, 2013, J VIROL, V87, P9384, DOI 10.1128/JVI.01101-13
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014
   Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3
NR 96
TC 57
Z9 63
U1 1
U2 82
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 29
PY 2016
VL 13
AR 131
DI 10.1186/s12985-016-0590-7
PG 10
WC Virology
SC Virology
GA DS6DF
UT WOS:000380871200001
PM 27473856
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pessoa, R
   Patriota, JV
   de Souza, MD
   Abd El Wahed, A
   Sanabani, SS
AF Pessoa, R.
   Patriota, J. V.
   de Souza, M. dL
   Abd El Wahed, A.
   Sanabani, S. S.
TI Detection of Zika virus in Brazilian patients during the first five days
   of infection - urine versus plasma
SO EUROSURVEILLANCE
LA English
DT Article
ID OUTBREAK; DENGUE; CHIKUNGUNYA; ILLNESS
AB Advantages of testing for Zika virus (ZIKV) in urine have been reported, such as the persistence of ZIKV in this type of specimen for up to 20 days after ZIKV disease onset. We investigate 61 patients in the first 5 days post-symptom onset and find more patients testing positive for ZIKV in plasma samples (n=46),than in corresponding urine samples (n=37). For patients respectively testing positive in both plasma and urine (n=28), respective viral loads appeared similar.
   Results of recent studies have suggested that after Zika virus (ZIKV) disease onset, the virus persists at higher levels and for a longer period in urine (up to ca 20 days) than in serum (up to ca 5 days) [1,2]. To provide further data, we tested for the presence of ZIKV in the urine and corresponding plasma specimens of 61 patients presenting symptoms of ZIKV disease in Brazil. The samples were collected between 1 and 5 days after symptom onset. During this phase of infection, the proportion of patients testing positive in plasma samples (46/61) appeared to be higher than those testing positive in urine samples (37/61).
C1 [Pessoa, R.; Sanabani, S. S.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol, Sao Paulo, Brazil.
   [Patriota, J. V.; de Souza, M. dL] Municipal Hosp Tuparetama, Pernambuco, Brazil.
   [Abd El Wahed, A.] Univ Gottingen, Div Microbiol & Anim Hyg, Gottingen, Germany.
RP Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol, Sao Paulo, Brazil.
EM sabyem_63@yahoo.com
RI Sanabani, Sabri Saeed/F-5600-2012; Pessoa, Rodrigo/B-7206-2018
OI Sanabani, Sabri Saeed/0000-0002-8876-8262; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2014/24596-2]
FX This work was partially supported by grants 2014/24596-2 from the
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no
   role in design of the study, data collection and analysis, decision to
   publish, or preparation of the manuscript. We would like to acknowledge
   our colleague Shereen Petersen, DPZ, for English proofreading of the
   manuscript.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, TRAV NOT
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Lan Nguyen Thi Phuong, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-S08
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
NR 13
TC 6
Z9 6
U1 0
U2 2
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 28
PY 2016
VL 21
IS 30
BP 2
EP 5
DI 10.2807/1560-7917.ES.2016.21.30.30302
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DS4NW
UT WOS:000380758800001
PM 27494130
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Aiken, ARA
   Scott, JG
   Gomperts, R
   Trussell, J
   Worrell, M
   Aiken, CE
AF Aiken, Abigail R. A.
   Scott, James G.
   Gomperts, Rebecca
   Trussell, James
   Worrell, Marc
   Aiken, Catherine E.
TI Requests for Abortion in Latin America Related to Concern about Zika
   Virus Exposure
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Aiken, Abigail R. A.; Scott, James G.] Univ Texas Austin, Austin, TX 78712 USA.
   [Gomperts, Rebecca; Worrell, Marc] Women Web, Amsterdam, Netherlands.
   [Trussell, James] Princeton Univ, Princeton, NJ 08544 USA.
   [Aiken, Catherine E.] Univ Cambridge, Cambridge, England.
RP Aiken, ARA (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.
EM araa2@utexas.edu
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R24 HD042849, P2C
   HD042849, P2C HD047879]
CR [Anonymous], 2015, FACT SHEET AB LAT AM
   Gerdts C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053346
   Gomperts RJ, 2008, BJOG-INT J OBSTET GY, V115, P1171, DOI 10.1111/j.1471-0528.2008.01787.x
   Pan American Health Organization / World Health Organization, 2015, EP AL INCR MICR NE B
   Post C, 2016, PERU REPORTS    0125
NR 5
TC 55
Z9 56
U1 0
U2 14
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 28
PY 2016
VL 375
IS 4
BP 396
EP 398
DI 10.1056/NEJMc1605389
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0UV
UT WOS:000380313200031
PM 27331661
OA Green Published, Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Furtado, JM
   Esposito, DL
   Klein, TM
   Teixeira-Pinto, T
   da Fonseca, BA
AF Furtado, Joao M.
   Esposito, Danillo L.
   Klein, Taline M.
   Teixeira-Pinto, Tomas
   da Fonseca, Benedito A.
TI Uveitis Associated with Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Furtado, Joao M.; Esposito, Danillo L.; Klein, Taline M.; Teixeira-Pinto, Tomas; da Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RP Furtado, JM (corresponding author), Univ Sao Paulo, Ribeirao Preto, Brazil.
EM furtadojm@gmail.com
RI Furtado, Joao/D-4436-2012; Esposito, Danillo L.A./N-9261-2017; Fonseca,
   Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
NR 5
TC 85
Z9 86
U1 1
U2 35
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 28
PY 2016
VL 375
IS 4
BP 394
EP 396
DI 10.1056/NEJMc1603618
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0UV
UT WOS:000380313200030
PM 27332784
OA Bronze
DA 2020-07-08
ER

PT J
AU Dawes, BE
   Smalley, CA
   Tiner, BL
   Beasley, DWC
   Milligan, GN
   Reece, LM
   Hombach, J
   Barrett, ADT
AF Dawes, Brian E.
   Smalley, Claire A.
   Tiner, Bethany L.
   Beasley, David W. C.
   Milligan, Gregg N.
   Reece, Lisa M.
   Hombach, Joachim
   Barrett, Alan D. T.
TI Research and development of Zika virus vaccines
SO NPJ VACCINES
LA English
DT Article
ID MURINE MODEL; TRANSMISSION; INFECTION; OUTBREAK; AUTOIMMUNITY;
   CHIKUNGUNYA; AMERICA; ISLAND
AB Zika virus (ZIKV) is a member of the family Flaviviridae, genus Flavivirus, and is transmitted by Aedes sp. mosquitoes. There are three genetic lineages of ZIKV: the East African, West African and Asian lineages. Until recently, Zika fever (ZF) has normally been considered a rare, mild febrile disease, but reports since 2012 have shown potentially severe complications associated with ZIKV infection, including microcephaly and Guillain-Barre syndrome. There are no licensed vaccines for ZIKV; however, many vaccine platforms/approaches that have been utilised for other flavivirus vaccines are being applied to ZIKV. Given the current outbreak of ZIKV in the Americas with its associated risks to pregnancy, we summarise what is known about the virus, how knowledge of currently licensed flavivirus vaccines can be applied to ZIKV vaccine development and the assessments of potential challenges for ZIKV vaccine testing and evaluation.
C1 [Dawes, Brian E.; Tiner, Bethany L.; Beasley, David W. C.; Milligan, Gregg N.; Barrett, Alan D. T.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Smalley, Claire A.; Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Beasley, David W. C.; Milligan, Gregg N.; Reece, Lisa M.; Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Beasley, David W. C.; Milligan, Gregg N.; Reece, Lisa M.; Barrett, Alan D. T.] Univ Texas Med Branch, WHO, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA.
   [Beasley, David W. C.] Univ Texas Med Branch, Inst Off Regulated Nonclin Studies, Galveston, TX 77555 USA.
   [Milligan, Gregg N.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Hombach, Joachim] WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, Geneva, Switzerland.
RP Barrett, ADT (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, WHO, Collaborating Ctr Vaccine Res Evaluat & Training, Galveston, TX 77555 USA.
EM abarrett@utmb.edu
OI Reece, Lisa/0000-0001-9147-1833; Dawes, Brian/0000-0001-7847-7376
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barrett A. D. T., 2015, VACCINOLOGY ESSENTIA, P175
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chokephaibulkit K, 2010, PEDIATR INFECT DIS J, V29, P1111, DOI 10.1097/INF.0b013e3181f68e9c
   Craig A. T., 2016, B WHO
   Cumming-Bruce N., 2016, NY TIMES
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   [Division of Vector-Borne Diseases Centers for Disease Control and Prevention], 2016, MEM UPD DIAGN TEST Z
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP POT A
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Focosi D., 2016, CLIN INFECT DIS, V210, P1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guy B, 2010, HUM VACCINES, V6, P696, DOI 10.4161/hv.6.9.12739
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   Hughes S, 2016, ZIKA VIRUS NOW LINKE
   Kasabi GS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002025
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Maurice J, 2016, LANCET, V387, P733, DOI 10.1016/S0140-6736(16)00390-1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1212
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Porter KR, 2015, VACCINE, V33, P7135, DOI 10.1016/j.vaccine.2015.09.102
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricketson R., 2016, WEBMEDCENTRAL VIROL, V7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwan K., 2014, ZIKA VIRUS PACIFIC 0
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WOLFE MS, 1982, LANCET, V2, P1306
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, 113 WHO
   Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 92
TC 16
Z9 16
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD JUL 28
PY 2016
VL 1
AR 16007
DI 10.1038/npjvaccines.2016.7
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FK1PR
UT WOS:000413254700001
PM 29263851
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI Sixty seconds on ... Zika and the Olympics
SO BMJ-British Medical Journal
LA English
DT News Item
CR Jaleta KT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1386-3
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
NR 2
TC 0
Z9 0
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 27
PY 2016
VL 354
AR i4133
DI 10.1136/bmj.i4133
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS6ZH
UT WOS:000380931600007
PM 27815235
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Paploski, IAD
   Rodrigues, MS
   Mugabe, VA
   Kikuti, M
   Tavares, AS
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Dexheimer Paploski, Igor Adolfo
   Rodrigues, Moreno S.
   Mugabe, Vanio Andre
   Kikuti, Mariana
   Tavares, Aline S.
   Reis, Mitermayer Galvao
   Kitron, Uriel
   Ribeiro, Guilherme Sousa
TI Storm drains as larval development and adult resting sites for Aedes
   aegypti and Aedes albopictus in Salvador, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Epidemiology; Entomology; Arboviruses; Insect vectors; Disease vectors
ID CATCH BASINS; ZIKA VIRUS; BREEDING SITES; VECTOR CONTROL; DRY SEASON;
   URBAN AREA; DENGUE; CULICIDAE; DIPTERA; CULEX
AB Background: Dengue (DENV), Chikungunya (CHIKV), Zika (ZIKV), as well as yellow fever (YFV) viruses are transmitted to humans by Aedes spp. females. In Salvador, the largest urban center in north-eastern Brazil, the four DENV types have been circulating, and more recently, CHIKV and ZIKV have also become common. We studied the role of storm drains as Aedes larval development and adult resting sites in four neighbourhoods of Salvador, representing different socioeconomic, infrastructure and topographic conditions.
   Results: A sample of 122 storm drains in the four study sites were surveyed twice during a 4-month period in 2015; in 49.0 % of the visits, the storm drains contained water. Adults and immatures of Aedes aegypti were captured in two of the four sites, and adults and immatures of Aedes albopictus were captured in one of these two sites. A total of 468 specimens were collected: 148 Ae. aegypti (38 adults and 110 immatures), 79 Ae. albopictus (48 adults and 31 immatures), and 241 non-Aedes (mainly Culex spp.) mosquitoes (42 adults and 199 immatures). The presence of adults or immatures of Ae. aegypti in storm drains was independently associated with the presence of non-Aedes mosquitoes and with rainfall of <= 50 mm during the preceding week.
   Conclusions: We found that in Salvador, one of the epicentres of the 2015 ZIKV outbreak, storm drains often accumulate water and serve as larval development sites and adult resting areas for both Ae. aegypti and Ae. albopictus. Vector control campaigns usually overlook storm drains, as most of the effort to prevent Ae. agypti reproduction is directed towards containers in the domicile environment. While further studies are needed to determine the added contribution of storm drains for the maintenance of Aedes spp. populations, we advocate that vector control programs incorporate actions directed at storm drains, including regular inspections and use of larvicides, and that human and capital resources are mobilized to modify storm drains, so that they do not serves as larval development sites for Aedes (and other) mosquitoes.
C1 [Dexheimer Paploski, Igor Adolfo; Rodrigues, Moreno S.; Mugabe, Vanio Andre; Kikuti, Mariana; Tavares, Aline S.; Reis, Mitermayer Galvao; Kitron, Uriel; Ribeiro, Guilherme Sousa] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Dexheimer Paploski, Igor Adolfo; Rodrigues, Moreno S.; Mugabe, Vanio Andre; Kikuti, Mariana; Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Mugabe, Vanio Andre] Univ Pedag Quelimane, Quelimane, ZB, Mozambique.
   [Reis, Mitermayer Galvao] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Paploski, Igor AD/D-7015-2014; Reis, Mitermayer/AAO-9742-2020; Kikuti,
   Mariana/G-2313-2017; Ribeiro, Guilherme/B-6624-2008
OI Paploski, Igor AD/0000-0002-3689-2042; Reis,
   Mitermayer/0000-0002-3051-9060; Kikuti, Mariana/0000-0001-8119-7236;
   Ribeiro, Guilherme/0000-0002-6798-2059; Mugabe,
   Vanio/0000-0001-6676-4378; Rodrigues, Moreno/0000-0002-1594-2311
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [400830/2013-2]; Coordination for the Improvement of Higher Education
   Personnel - Brazilian Ministry of Education
FX This study was supported by the National Council for Scientific and
   Technological Development (grant 400830/2013-2 and scholarships to IADP,
   MSR, VAM, UK, MGR and GSR); and the Coordination for the Improvement of
   Higher Education Personnel - Brazilian Ministry of Education
   (scholarship to MK).
CR Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1
   [Anonymous], 2015, STAT STAT SOFTW REL
   Arana-Guardia R, 2014, ACTA TROP, V134, P33, DOI 10.1016/j.actatropica.2014.01.011
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chang MS, 2011, W PACIFIC SURVEILL R, V2, pe1
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   GEERY PR, 1989, J AM MOSQUITO CONTR, V5, P537
   GOLDBERG LJ, 1977, MOSQ NEWS, V37, P355
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Instituto Nacional de Meteorologia, 2009, NORM CLIM BRAS 1961
   Instituto Nacional de Metereologia, 2016, EST MET OBS SUP AUT
   Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P164, DOI 10.2987/12-6320R.1
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Ministerio da Saude, 2013, LEV RAP IND AED AEG
   Montgomery BL, 2004, J AM MOSQUITO CONTR, V20, P365
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Rey JR, 2006, J VECTOR ECOL, V31, P334, DOI 10.3376/1081-1710(2006)31[334:FAMPFS]2.0.CO;2
   Russell BM, 2002, J MED ENTOMOL, V39, P143, DOI 10.1603/0022-2585-39.1.143
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Rydzanicz K, 2016, PARASITOL RES, V115, P1711, DOI 10.1007/s00436-016-4912-x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2
   TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 36
TC 11
Z9 11
U1 1
U2 27
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 27
PY 2016
VL 9
AR 419
DI 10.1186/s13071-016-1705-0
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DS1DL
UT WOS:000380335900001
PM 27464886
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cauchemez, S
   Besnard, M
   Garel, C
   Fontanet, A
   Mallet, HP
AF Cauchemez, Simon
   Besnard, Marianne
   Garel, Catherine
   Fontanet, Arnaud
   Mallet, Henri-Pierre
TI Could clinical symptoms be a predictor of complications in Zika virus
   infection? reply
SO LANCET
LA English
DT Letter
C1 [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis, F-75015 Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth, F-75015 Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Besnard, Marianne] French Polynesia Hosp Ctr, Neonatal Care Dept, Pirae, Tahiti, French Guiana.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Pediat Radiol, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
   [Mallet, Henri-Pierre] Direct Sante, Bur Veille Sanitaire, Papeete, Tahiti, French Guiana.
RP Cauchemez, S (corresponding author), Inst Pasteur, Math Modelling Infect Dis, F-75015 Paris, France.; Cauchemez, S (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.; Cauchemez, S (corresponding author), CNRS, URA3012, Paris, France.
EM simon.cauchemez@pasteur.fr
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   COES-Microcefalias, INF EP N15 SEM EP 08
   COES-Microcefalias, INF EP N31 SEM EP 24
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 6
TC 4
Z9 4
U1 0
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 338
EP 339
DI 10.1016/S0140-6736(16)31017-0
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900028
PM 27477157
OA Bronze
DA 2020-07-08
ER

PT J
AU Freitas, ARR
   Napimoga, MH
   Donalisio, MR
AF Ribas Freitas, Andre Ricardo
   Napimoga, Marcelo Henrique
   Donalisio, Maria Rita
TI Could clinical symptoms be a predictor of complications in Zika virus
   infection?
SO LANCET
LA English
DT Letter
ID OUTBREAK; STATES
C1 [Ribas Freitas, Andre Ricardo; Napimoga, Marcelo Henrique] Sao Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, BR-13015904 Sao Paulo, Brazil.
   [Donalisio, Maria Rita] Univ Estadual Campinas, Sch Med Sci, Lab Spatial Anal Epidemiol Data, Sao Paulo, Brazil.
   [Ribas Freitas, Andre Ricardo] Campinas Dept Hlth, Div Hlth Surveillance, Sao Paulo, Brazil.
RP Freitas, ARR (corresponding author), Sao Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, BR-13015904 Sao Paulo, Brazil.; Freitas, ARR (corresponding author), Campinas Dept Hlth, Div Hlth Surveillance, Sao Paulo, Brazil.
EM arrfreitas2010@gmail.com
RI Napimoga, Marcelo Henrique/S-2434-2019; Freitas, Andre Ricardo
   Ribas/L-1969-2016; Donalisio, Maria Rita/C-5263-2012; Donalisio, Maria
   Rita/Z-3934-2019
OI Napimoga, Marcelo Henrique/0000-0003-4472-365X; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771; Donalisio, Maria Rita/0000-0003-4457-9897;
   Donalisio, Maria Rita/0000-0003-4457-9897
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 5
TC 1
Z9 1
U1 0
U2 42
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 338
EP 338
DI 10.1016/S0140-6736(16)31104-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900027
PM 27477156
OA Bronze
DA 2020-07-08
ER

PT J
AU Meda, N
   Salinas, S
   Kagone, T
   Simonin, Y
   Van de Perre, P
AF Meda, Nicolas
   Salinas, Sara
   Kagone, Therese
   Simonin, Yannick
   Van de Perre, Philippe
TI Zika virus epidemic: Africa should not be neglected
SO LANCET
LA English
DT Letter
C1 [Meda, Nicolas; Kagone, Therese] Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Salinas, Sara; Simonin, Yannick; Van de Perre, Philippe] Univ Montpellier, Etab Francais Sang, INSERM, UMR 1058,Pathogenesis & Control Chron Infect, Montpellier, France.
   [Van de Perre, Philippe] CHU Montpellier, Dept Bacterioloy Virol, Montpellier, France.
RP Van de Perre, P (corresponding author), Univ Montpellier, Etab Francais Sang, INSERM, UMR 1058,Pathogenesis & Control Chron Infect, Montpellier, France.; Van de Perre, P (corresponding author), CHU Montpellier, Dept Bacterioloy Virol, Montpellier, France.
EM p-van_de_perre@chu-montpellier.fr
RI Salinas, Sara/O-1150-2019; Van de Perre, Philippe/B-9692-2008; Salinas,
   Sara/O-1856-2013
OI Salinas, Sara/0000-0003-4492-2093; Van de Perre,
   Philippe/0000-0002-3912-0427; Salinas, Sara/0000-0003-4492-2093;
   simonin, yannick/0000-0002-3475-1369
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Meda N, 2016, LANCET, V387, P2196, DOI 10.1016/S0140-6736(16)30015-0
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
NR 6
TC 9
Z9 9
U1 0
U2 86
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 337
EP 338
DI 10.1016/S0140-6736(16)31103-5
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900026
PM 27477155
OA Bronze
DA 2020-07-08
ER

PT J
AU Paniz-Mondolfi, AE
   Rodriguez-Morales, AJ
   Blohm, G
   Marquez, M
   Villamil-Gomez, WE
AF Paniz-Mondolfi, Alberto E.
   Rodriguez-Morales, Alfonso J.
   Blohm, Gabriela
   Marquez, Marilianna
   Villamil-Gomez, Wilmer E.
TI ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections
   in the midst of concurrent epidemics
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; INFORMATION-SYSTEM GIS; OUTBREAK IMPLICATIONS;
   CLIMATE VARIABILITY; CHIKUNGUNYA FEVER; DENGUE INCIDENCE;
   CO-CIRCULATION; PUBLIC-HEALTH; YELLOW-FEVER; ONE COASTAL
C1 [Paniz-Mondolfi, Alberto E.; Marquez, Marilianna] Hosp Int, Dept Pathol & Lab Med, Barquisimeto, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Inst Biomed IVSS, Biochem Lab, Caracas, Venezuela.
   [Rodriguez-Morales, Alfonso J.; Villamil-Gomez, Wilmer E.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Rodriguez-Morales, Alfonso J.; Villamil-Gomez, Wilmer E.] Asociac Colombiana Infectol ACIN, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Blohm, Gabriela] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Programa Doctorado Med Trop, Barranquilla, Atlantico, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Barreiro P, 2016, AIDS REV, V18, P112
   Benitez JA, 2013, J INFECT DEV COUNTR, V7, P638, DOI 10.3855/jidc.3620
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Gomez P C F, 2014, OPEN FORUM INFECT DI, V1
   Herrera-Martinez AD, 2010, TROP BIOMED, V27, P280
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Kasper Dennis L., 2015, HARRISONS PRINCIPLES
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021
   McFarlane R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028374
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Noel H, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.28.20855
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rifakis PM, 2008, J TRAVEL MED, V15, P119, DOI 10.1111/j.1708-8305.2007.00178.x
   Rifakis PM, 2006, ANN NY ACAD SCI, V1081, P57, DOI 10.1196/annals.1373.005
   Rodriguez-Morales AJ, 2015, ARCH MED, V11, pe3
   Rodriguez-Morales AJ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.014
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Rodriguez-Morales Alfonso J, 2008, Travel Med Infect Dis, V6, P162, DOI 10.1016/j.tmaid.2008.02.009
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P244, DOI 10.1016/j.jiph.2016.05.002
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Zambrano LI, 2012, TROP BIOMED, V29, P499
NR 44
TC 32
Z9 35
U1 0
U2 24
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD JUL 22
PY 2016
VL 15
AR 42
DI 10.1186/s12941-016-0157-x
PG 4
WC Microbiology
SC Microbiology
GA DR7QV
UT WOS:000380095700001
PM 27449770
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI US probes first apparent non-sexual person-to-person Zika transmission
   and first domestic outbreak
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3991
NR 2
TC 1
Z9 1
U1 0
U2 29
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 22
PY 2016
VL 354
AR i4107
DI 10.1136/bmj.i4107
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0WQ
UT WOS:000380317900021
PM 27458114
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Grills, A
   Morrison, S
   Nelson, B
   Miniota, J
   Watts, A
   Cetron, MS
AF Grills, Ardath
   Morrison, Stephanie
   Nelson, Bradley
   Miniota, Jennifer
   Watts, Alexander
   Cetron, Martin S.
TI Projected Zika Virus Importation and Subsequent Ongoing Transmission
   after Travel to the 2016 Olympic and Paralympic Games - Country-Specific
   Assessment, July 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Grills, Ardath; Morrison, Stephanie; Nelson, Bradley; Cetron, Martin S.] CDC, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.
   [Morrison, Stephanie] Eagle Med Serv, Atlanta, GA USA.
   [Miniota, Jennifer; Watts, Alexander] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
RP Cetron, MS (corresponding author), CDC, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.
EM mcetron@cdc.gov
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CDC, 2016, TRAV HLTH
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, 2016, GEOGR DISTR CONF AUT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sports Reference, 2016, OL SPORTS
   World Health Organization, 2016, ZIK VIR OL PAR GAM 2
NR 9
TC 13
Z9 13
U1 0
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 22
PY 2016
VL 65
IS 28
BP 711
EP 715
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR7AD
UT WOS:000380051500003
PM 27442184
OA Bronze
DA 2020-07-08
ER

PT J
AU Davidson, A
   Slavinski, S
   Komoto, K
   Rakeman, J
   Weiss, D
AF Davidson, Alexander
   Slavinski, Sally
   Komoto, Kendra
   Rakeman, Jennifer
   Weiss, Don
TI Suspected Female-to-Male Sexual Transmission of Zika Virus - New York
   City, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Davidson, Alexander; Slavinski, Sally; Komoto, Kendra; Rakeman, Jennifer; Weiss, Don] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.
RP Slavinski, S (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.
EM sslavins@health.nyc.gov
CR CDC, 2016, ZIK MAC ELISA INSTR
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Prisant N., 2016, LANCET INFECT DIS
NR 6
TC 202
Z9 205
U1 1
U2 24
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 22
PY 2016
VL 65
IS 28
BP 716
EP 717
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR7AD
UT WOS:000380051500004
PM 27442327
OA Bronze
DA 2020-07-08
ER

PT J
AU Ferguson, NM
   Cucunuba, ZM
   Dorigatti, I
   Nedjati-Gilani, GL
   Donnelly, CA
   Basanez, MG
   Nouvellet, P
   Lessler, J
AF Ferguson, Neil M.
   Cucunuba, Zulma M.
   Dorigatti, Ilaria
   Nedjati-Gilani, Gemma L.
   Donnelly, Christl A.
   Basanez, Maria-Gloria
   Nouvellet, Pierre
   Lessler, Justin
TI Countering the Zika epidemic in Latin America
SO SCIENCE
LA English
DT Editorial Material
ID PUERTO-RICO; VIRUS
C1 [Ferguson, Neil M.; Cucunuba, Zulma M.; Dorigatti, Ilaria; Nedjati-Gilani, Gemma L.; Donnelly, Christl A.; Basanez, Maria-Gloria; Nouvellet, Pierre] Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
   [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
RP Ferguson, NM (corresponding author), Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
EM neil.ferguson@imperial.ac.uk
RI Cucunuba, Zulma M./L-4076-2016; Cucunuba, Zulma/X-5670-2019; Ferguson,
   Neil/B-8578-2008
OI Cucunuba, Zulma M./0000-0002-8165-3198; Cucunuba,
   Zulma/0000-0002-8165-3198; Ferguson, Neil/0000-0002-1154-8093;
   Dorigatti, Ilaria/0000-0001-9959-0706; Lessler,
   Justin/0000-0002-9741-8109
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K010174/1B]; Department of HealthDiabetes UK; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_PC_15091, MR/K010174/1];
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U01 GM110721]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Schuck-Paim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041918
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 11
TC 124
Z9 125
U1 0
U2 68
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 22
PY 2016
VL 353
IS 6297
BP 353
EP 354
DI 10.1126/science.aag0219
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS2HB
UT WOS:000380583400024
PM 27417493
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU FitzSimmons, J
   Shah, S
AF FitzSimmons, Jack
   Shah, Shailen
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [FitzSimmons, Jack; Shah, Shailen] Virtua Hlth, Voorhees, NJ 08043 USA.
RP FitzSimmons, J (corresponding author), Virtua Hlth, Voorhees, NJ 08043 USA.
CR Dionne-Odom J, 2016, AM J OBSTET GYNECOL, V214, P6, DOI 10.1016/j.ajog.2015.09.100
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pilu G, 2003, DIAGNOSTIC IMAGING F, P275
   Woodward PJ, 2008, DIAGNOSTIC IMAGING O, P2
NR 4
TC 5
Z9 5
U1 1
U2 63
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 293
EP 294
DI 10.1056/NEJMc1606769
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400031
PM 27482562
DA 2020-07-08
ER

PT J
AU Kass, DE
   Merlino, M
AF Kass, Daniel E.
   Merlino, Mario
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Kass, Daniel E.; Merlino, Mario] New York City Dept Hlth & Mental Hyg, New York, NY USA.
RP Kass, DE (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.
EM dkass@health.nyc.gov
CR Monaghan Ai., 2016, PLOS CURR, V8
NR 1
TC 3
Z9 3
U1 0
U2 51
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 294
EP 294
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400032
PM 27355411
DA 2020-07-08
ER

PT J
AU Petersen, LR
   Jamieson, DJ
   Honein, MA
AF Petersen, Lyle R.
   Jamieson, Denise J.
   Honein, Margaret A.
TI Zika Virus REPLY
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Petersen, Lyle R.] Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
   [Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
EM lxp2@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR [Anonymous], 2013, HLTH COMM REP DENG V
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hahn M. B., 2016, J MED ENTOMOL
NR 4
TC 52
Z9 53
U1 0
U2 3
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 294
EP 295
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400033
PM 27355409
DA 2020-07-08
ER

PT J
AU Song, JZ
   Mauk, MG
   Hackett, BA
   Cherry, S
   Bau, HH
   Liu, CC
AF Song, Jinzhao
   Mauk, Michael G.
   Hackett, Brent A.
   Cherry, Sara
   Bau, Haim H.
   Liu, Changchun
TI Instrument-Free Point-of-Care Molecular Detection of Zika Virus
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; VISUAL DETECTION; DIAGNOSTICS;
   DENGUE; LAMP; PCR
AB The recent outbreak of Zika virus (ZIKV) infection in the Americas and its devastating impact on fetal development have prompted the World Health Organization (WHO) to declare the ZIKV pandemic as a Public Health Emergency of International Concern. Rapid and reliable diagnostics for ZIKV are vital because ZIKV-infected individuals display no symptoms or nonspecific symptoms similar to other viral infections. Because immunoassays lack adequate sensitivity and selectivity and are unable to identify active state of infection, molecular diagnostics are an effective means to detect ZIKV soon after infection and throughout pregnancy. We report on a highly sensitive reverse-transcription loop-mediated, isothermal amplification (RT-LAMP) assay for rapid detection of ZIKV and its implementation in a simple, easy-to-use, inexpensive, point-of-care (POC) disposable cassette that carries out all the unit operations from sample introduction to detection. For thermal control of the cassette, we use a chemically heated cup without a need for electrical power. Amplification products are detected with leuco crystal violet (LCV) dye by eye without a need for instrumentation. We demonstrated the utility of our POC diagnostic system by detecting ZIKV in oral samples with sensitivity of 5 plaque-forming units (PFU) in less than 40 min. Our system is particularly suitable for resource-poor settings, where centralized laboratory facilities, funds, and trained personnel are in short supply, and for use in doctors' offices, clinics, and at home.
C1 [Song, Jinzhao; Mauk, Michael G.; Bau, Haim H.; Liu, Changchun] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
   [Hackett, Brent A.; Cherry, Sara] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Liu, CC (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
EM lchangc@seas.upenn.edu
RI , 星翼/AAP-2910-2020; Song, Jinzhao/Q-7866-2016; Bau, Haim H/D-1161-2009
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K25AI099160, R21-AI-112713-01]; Penn
   CFAR Pilot Grant [AI045008]
FX Viruses were provided by the NIH NIAID WRCEVA. The work was supported,
   in part, by NIH Grants K25AI099160 and R21-AI-112713-01, and Penn CFAR
   Pilot Grant AI045008.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso TC, 2010, MOL CELL PROBE, V24, P415, DOI 10.1016/j.mcp.2010.08.003
   Charrel R. N., STATE KNOWLEDGE ZIKA
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hart RW, 2011, ORAL DIS, V17, P745, DOI 10.1111/j.1601-0825.2011.01808.x
   Kim J, 2009, LAB CHIP, V9, P606, DOI 10.1039/b807915c
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Liu CC, 2013, ANAL CHEM, V85, P10463, DOI 10.1021/ac402459h
   Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b
   Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a
   Liu CC, 2009, LAB CHIP, V9, P768, DOI 10.1039/b814322f
   Luo L, 2011, J CLIN MICROBIOL, V49, P3545, DOI 10.1128/JCM.00930-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nie K, 2011, J VIROL METHODS, V175, P283, DOI 10.1016/j.jviromet.2011.05.020
   Ocwieja KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117852
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Qiu XB, 2009, BIOMED MICRODEVICES, V11, P1175, DOI 10.1007/s10544-009-9334-4
   Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693
   Song JZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004318
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180
   World Health Organization, 2016, CURR ZIK PROD PIP
NR 35
TC 119
Z9 119
U1 15
U2 134
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 19
PY 2016
VL 88
IS 14
BP 7289
EP 7294
DI 10.1021/acs.analchem.6b01632
PG 6
WC Chemistry, Analytical
SC Chemistry
GA DS0OO
UT WOS:000380296800046
PM 27306491
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Martins, KAO
   Dye, JM
   Bavari, S
AF Martins, K. A. O.
   Dye, J. M.
   Bavari, S.
TI Considerations for the development of Zika virus vaccines
SO VACCINE
LA English
DT Editorial Material
ID ORIGINAL ANTIGENIC SIN; INFECTION; DENGUE; YELLOW
C1 [Martins, K. A. O.; Dye, J. M.; Bavari, S.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA.
   [Martins, K. A. O.] Ke Aki Technol, 5301 Buckeystown Pike,Suite 460, Frederick, MD 21704 USA.
RP Martins, KAO (corresponding author), Ke Aki Technol, USAMRIID, 1425 Porter St, Frederick, MD 21704 USA.
EM karen.a.martins2.ctr@mail.mil
RI Bavari, Sina/L-3642-2019
OI Bavari, Sina/0000-0001-8424-5635; Dye, John/0000-0002-0883-5016
CR Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i630
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Izurieta RO, 2009, J GLOB INFECT DIS, V1, P111, DOI 10.4103/0974-777X.56257
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mizumoto K, 2014, J VECTOR DIS, V51, P153
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Paul L., 2016, BIORXIV
NR 13
TC 10
Z9 11
U1 0
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUL 19
PY 2016
VL 34
IS 33
BP 3711
EP +
DI 10.1016/j.vaccine.2016.06.012
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DS1XN
UT WOS:000380418600001
PM 27318417
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US Congress fails to agree Zika virus funding before summer break
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 19
PY 2016
VL 354
AR i3991
DI 10.1136/bmj.i3991
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0VP
UT WOS:000380315200011
PM 27435990
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Buekens, P
   Alger, J
   Althabe, F
   Bergel, E
   Berrueta, AM
   Bustillo, C
   Cafferata, ML
   Harville, E
   Rosales, K
   Wesson, DM
   Zuniga, C
AF Buekens, Pierre
   Alger, Jackeline
   Althabe, Fernando
   Bergel, Eduardo
   Berrueta, Amanda M.
   Bustillo, Carolina
   Cafferata, Maria-Luisa
   Harville, Emily
   Rosales, Karla
   Wesson, Dawn M.
   Zuniga, Concepcion
CA ZIPH Working Grp
TI Zika virus infection in pregnant women in Honduras: study protocol
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Honduras; Microcephaly; Pregnancy; Zika virus
ID GESTATIONAL-AGE
AB Background: Although there is increasing evidence for a relationship between symptomatic Zika virus (ZIKV) maternal infection, and microcephaly, a firm causal relation has yet to be established by epidemiologic studies. Studies also need to be conducted in recently infected settings. Our objectives are to assess the frequency of ZIKV infection during pregnancy in Honduras and the association of microcephaly with ZIKV infection.
   Methods/Design: We will perform a prospective study enrolling pregnant women at their first antenatal visit and following them up until delivery. At the time of enrollment, women will be interviewed to collect socio-demographic data, data needed to locate them for potential additional follow-up, and data about ZIKV symptoms during pregnancy. We will also collect maternal blood as soon as possible after enrollment. A probable maternal ZIKV infection will be defined as positive for maternal ZIKV IgM. A confirmed maternal ZIKV infection will be defined as positive for ZIKV IgM confirmed by plaque reduction neutralization test. Microcephaly at birth will be defined as an occipito-frontal circumference <2SD for sex and gestational age. Our objective is to enroll 2000 pregnant women. In a first step, we will follow a case cohort design and only analyze blood samples for cases and a sub-cohort of 200 women randomly selected. Blood samples for the entire population will be analyzed at a later stage if funds are available.
   Discussion: This protocol was designed to be implemented with minimal resources. It allows a cohort to be built, which could be a foundation for future in-depth and follow-up studies.
C1 [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St,Ste 2430, New Orleans, LA 70112 USA.
   [Alger, Jackeline] UNAH, Hosp Escuela Univ, Fac Ciencias Med, Inst Enfermedades Infecciosas & Parasitol Antonio, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
   [Althabe, Fernando; Bergel, Eduardo; Berrueta, Amanda M.] IECS, Dr Emilio Ravignani 2024,C1414CPV, Buenos Aires, DF, Argentina.
   [Bustillo, Carolina] Hosp Escuela Tegucigalpa, Dept Ginecol & Obstet, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
   [Cafferata, Maria-Luisa] Hosp Clin Montevideo, Unidad Invest Clin & Epidemiol Montevideo UNICEM, Ave Italia S-N,Piso 4, Montevideo 11600, Uruguay.
   [Harville, Emily] Tulane Univ, Dept Epidemiol, Tulane Sch Publ Hlth & Trop Med, Ste 2012,1440 Canal St, New Orleans, LA 70112 USA.
   [Rosales, Karla] Reg Sanit Metropolitana Dist Cent Francisco Moraz, Tegucigalpa, Honduras.
   [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, 1324 Tulane Ave,JBJ Bldg,Room 509, New Orleans, LA 70112 USA.
   [Zuniga, Concepcion] Hosp Escuela Univ, Inst Enfermedades Infecciosas & Parasitol Antonio, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
RP Buekens, P (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St,Ste 2430, New Orleans, LA 70112 USA.
EM pbuekens@tulane.edu
OI Alger, Jackeline/0000-0001-9244-0668; Harville,
   Emily/0000-0003-0319-0922
FU Tulane University
FX This study is funded by Tulane University. The funding body had no role
   in the design of the study and in writing the manuscript.
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Secretaria de Salud, 2016, B EPIDEMIOLOGICO
   Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO, 2016, WHO STAT 2 M IHR EM
   World Health Organization, 1993, INT STAT CLASS DIS R, V2
   Zambrano LI, 2012, TROP BIOMED, V29, P499
NR 17
TC 4
Z9 4
U1 0
U2 70
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JUL 16
PY 2016
VL 13
AR 82
DI 10.1186/s12978-016-0200-6
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR9UW
UT WOS:000380242600002
PM 27423687
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Quest Diagnostics Says Its Zika Virus Test Gets US Approval
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2016
VL 63
IS 2
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FT
UT WOS:000381227800002
DA 2020-07-08
ER

PT J
AU Focosi, D
   Maggi, F
   Pistello, M
AF Focosi, Daniele
   Maggi, Fabrizio
   Pistello, Mauro
TI Zika Virus: Implications for Public Health
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; ZIKAV; microcephaly; Aedes aegypti; Aedes albopictus
ID WEST NILE VIRUS; RT-PCR; AEDES-ALBOPICTUS; VIRAL-INFECTIONS;
   TRANSMISSION; CHIKUNGUNYA; BRAZIL; FLAVIVIRUSES; INACTIVATION;
   ISOLATIONS
AB The World Health Organization has declared the current Zika virus (ZIKV) epidemic a public health emergency of international concern. Lack of vaccines and reliable diagnostic tests, broad geographical distribution of mosquito species that can transmit the virus, and absence of population immunity in newly affected countries are causes for concern. Although most infected persons are asymptomatic, ZIKV has been associated with a rise in cases of neurological complications and fetal central nervous system malformations. This defines such an arbovirus as something whose transmission should be prevented. This review summarizes the current understanding of ZIKV biology and epidemiology, as well as possible interventions to prevent contagion and transmission.
C1 [Focosi, Daniele] Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Italy.
   [Maggi, Fabrizio; Pistello, Mauro] Pisa Univ Hosp, Virol Unit, Pisa, Italy.
   [Pistello, Mauro] Univ Pisa, Dept Translat Res, Retrovirus Ctr, I-56100 Pisa, Italy.
   [Pistello, Mauro] Univ Pisa, Virol Sect, I-56100 Pisa, Italy.
RP Focosi, D (corresponding author), Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Italy.
EM d.focosi@ao-pisa.toscana.it
RI maggi, fabrizio/L-2974-2013
OI Maggi, Fabrizio/0000-0001-7489-5271
FU FAS Salute Regione Toscana "UNAVIR: Malattie virali rare: una strategia
   innovativa per combatterle con un unico agente antivirale"
FX This study was supported in part by grants of FAS Salute 2014 Regione
   Toscana "UNAVIR: Malattie virali rare: una strategia innovativa per
   combatterle con un unico agente antivirale".
CR Amnesty International, SALV TOT AB BAN SENT
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Center for Infectious Disease Research and Policy, BRAZ CONF BLOOD TRAN
   Centers for Disease Control and Prevention, TRANSCR CDC TEL ZIK
   CNN, ZIK VIR SPREAD ALL 2
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Dallas County Department of Health and Human Services, DCHHS REP 1 ZIK VIR
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faddy HM, 2016, TRANSFUSION, V56, P1503, DOI 10.1111/trf.13443
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   International Agency for Research on Cancer (IARC), IARC MALATH
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
   Ministry of Health Brazil, INF SYST DIS COMP DE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Office of the United Nations High Commissioner for Human Rights, UPH WOM HUM RIGHTS E
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Robert SL, 2016, EMERG INFECT DIS J, V22
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Saude A., MICROCEFALIA MINISTE
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2013, EURO SURVEILL, V19
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weselak M, 2007, J TOXICOL ENV HEAL B, V10, P41, DOI 10.1080/10937400601034571
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, WHOZIKVHS161
   World Health Organization, DIS OUTBR NEWS ZIK V
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 92
TC 20
Z9 20
U1 0
U2 36
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2016
VL 63
IS 2
BP 227
EP 233
DI 10.1093/cid/ciw210
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FT
UT WOS:000381227800016
PM 27048745
OA Bronze
DA 2020-07-08
ER

PT J
CA Eurosurveillance Editorial Team
TI Note from the editors: Articles on Zika preparedness
SO EUROSURVEILLANCE
LA English
DT Editorial Material
C1 [Eurosurveillance Editorial Team] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
RP European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
CR Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   ECDC (European Centre for Disease Prevention and Control), 2016, POT RISKS PUBL HLTH
   European Centre for Disease Prevention and Control (ECDC), 2016, MOSQ MAPS MAPS SEL V
   Gautret P, 2016, EUROSURVEILLANCE, V21, P14, DOI 10.2807/1560-7917.ES.2016.21.27.30278
   Larrieu S, 2016, EUROSURVEILLANCE, V21, P4, DOI 10.2807/1560-7917.ES.2016.21.28.30281
   Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
NR 8
TC 0
Z9 0
U1 0
U2 38
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 2
EP 3
AR 30289
DI 10.2807/1560-7917.ES.2016.21.28.30289
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700001
PM 27447397
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Larrieu, S
   Filleul, L
   Reilhes, O
   Jaffar-Bandjee, M
   Dumont, C
   Abossolo, T
   Thebault, H
   Brottet, E
   Pages, F
   Vilain, P
   Leparc-Goffart, I
   Antok, E
   Vandroux, D
   Poubeau, P
   Moiton, M
   Von Theobald, P
   Chieze, F
   Gallay, A
   De Valk, H
   Bourdillon, F
AF Larrieu, S.
   Filleul, L.
   Reilhes, O.
   Jaffar-Bandjee, M.
   Dumont, C.
   Abossolo, T.
   Thebault, H.
   Brottet, E.
   Pages, F.
   Vilain, P.
   Leparc-Goffart, I.
   Antok, E.
   Vandroux, D.
   Poubeau, P.
   Moiton, M.
   Von Theobald, P.
   Chieze, F.
   Gallay, A.
   De Valk, H.
   Bourdillon, F.
TI Reunion Island prepared for possible Zika virus emergence, 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID ALBOPICTUS SKUSE; AEDES-ALBOPICTUS; SURVEILLANCE; INFECTION; OUTBREAK;
   SPREADS; AMERICA; VECTOR
AB Zika virus (ZIKV) has recently spread widely and turned into a major international public health threat. Reunion appears to offer conditions particularly favourable to its emergence and therefore prepared to face possible introduction of the virus. We designed a scaled surveillance and response system with specific objectives, methods and measures for various epidemiological phases including a potential epidemic. Several tools were developed in order to (i) detect individual cases (including a large information campaign on the disease and suspicion criteria), (ii) monitor an outbreak through several complementary systems allowing to monitor trends in disease occurrence and geographic spread and (iii) detect severe forms of the disease in collaboration with hospital clinicians. We put the emphasis on detecting the first cases in order to contain the spread of the virus as much as possible and try to avoid progress towards an epidemic. Our two main strengths are a powerful vector control team, and a close collaboration between clinicians, virologists, epidemiologists, entomologists and public health authorities. Our planned surveillance system could be relevant to Europe and island settings threatened by Zika virus all over the world.
C1 [Larrieu, S.; Filleul, L.; Brottet, E.; Pages, F.; Vilain, P.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, Reunion, France.
   [Reilhes, O.; Thebault, H.; Chieze, F.] Agence Sante Ocean Indien, St Denis, Reunion, France.
   [Jaffar-Bandjee, M.] CHU Reunion, Ctr Natl Reference Arbovirus, Allee Des Topazes, Reunion, France.
   [Dumont, C.; Abossolo, T.; Von Theobald, P.] CHU Reunion, Ctr Diagnost Prenatal, Allee Des Topazes, Reunion, France.
   [Leparc-Goffart, I.] Ctr Natl Reference Arbovirus, Irba, Marseille, France.
   [Antok, E.; Vandroux, D.] CHU Reunion, Serv Reanimat, Allee Des Topazes, Reunion, France.
   [Poubeau, P.; Moiton, M.] CHU Reunion, Serv Malad Infect, Allee Des Topazes, Reunion, France.
   [Gallay, A.; De Valk, H.; Bourdillon, F.] Sante Publ France, French Natl Publ Hlth Agcy, St Maurice, France.
RP Larrieu, S (corresponding author), Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, Reunion, France.
EM sophie.larrieu@ars.sante.fr
RI Vandroux, David/AAK-2574-2020
OI antok, emmanuel/0000-0003-4462-0052
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Bogoch I, 2016, LANCET
   Brottet E, 2015, MED MALADIES INFECT, V45, P21, DOI 10.1016/j.medmal.2014.11.004
   Caillere N, 2013, EUROSURVEILLANCE, V18, P8
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DISIMPSON, 1964, T R SOC TROP MED HYG, V58, P335, DOI DOI 10.1016/0035-9203(64)90201-9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marguerite N, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.26.30271
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, EURO SURVEILLANCE B, V19
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2011, INT STAT CLASS DIS R, V2
NR 26
TC 1
Z9 1
U1 0
U2 4
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 4
EP 10
AR 30281
DI 10.2807/1560-7917.ES.2016.21.28.30281
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700002
PM 27546187
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Daudens-Vaysse, E
   Ledrans, M
   Gay, N
   Ardillon, V
   Cassadou, S
   Najioullah, F
   Leparc-Goffart, I
   Rousset, D
   Herrmann, C
   Cesaire, R
   Maquart, M
   Flusin, O
   Matheus, S
   Huc-Anais, P
   Jaubert, J
   Criquet-Hayot, A
   Hoen, B
   Djossou, F
   Locatelli-Jouans, C
   Blateau, A
   McKenzie, A
   Melin, M
   Saint-Martin, P
   Dorleans, F
   Suivant, C
   Carvalho, L
   Petit-Sinturel, M
   Andrieu, A
   Noel, H
   Septfons, A
   Gallay, A
   Paty, M
   Filleul, L
   Cabie, A
AF Daudens-Vaysse, E.
   Ledrans, M.
   Gay, N.
   Ardillon, V.
   Cassadou, S.
   Najioullah, F.
   Leparc-Goffart, I.
   Rousset, D.
   Herrmann, C.
   Cesaire, R.
   Maquart, M.
   Flusin, O.
   Matheus, S.
   Huc-Anais, P.
   Jaubert, J.
   Criquet-Hayot, A.
   Hoen, B.
   Djossou, F.
   Locatelli-Jouans, C.
   Blateau, A.
   McKenzie, A.
   Melin, M.
   Saint-Martin, P.
   Dorleans, F.
   Suivant, C.
   Carvalho, L.
   Petit-Sinturel, M.
   Andrieu, A.
   Noel, H.
   Septfons, A.
   Gallay, A.
   Paty, M.
   Filleul, L.
   Cabie, A.
CA Zika Surveillance Working Grp
TI Zika emergence in the French Territories of America and description of
   first confirmed cases of Zika virus infection on Martinique, November
   2015 to February 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID OUTBREAK; REGION
AB Following of the emergence of Zika virus in Brazil in 2015, an epidemiological surveillance system was quickly implemented in the French overseas Territories of America (FTA) according to previous experience with dengue and chikungunya and has detected first cases of Zika. General practitioners and medical microbiologists were invited to report all clinically suspected cases of Zika, laboratory investigations were systematically conducted (RT-PCR). On 18 December, the first autochthonous case of Zika virus infection was confirmed by RT-PCR on French Guiana and Martinique, indicating introduction of Zika virus in FTA. The viral circulation of Zika virus was then also confirmed on Guadeloupe and Saint-Martin. We report here early findings on 203 confirmed cases of Zika virus infection identified by RT- PCR or seroneutralisation on Martinique Island between 24 November 2015 and 20 January 2016. All cases were investigated. Common clinical signs were observed (maculopapular rash, arthralgia, fever, myalgia and conjunctival hyperaemia) among these patients, but the rash, the foundation of our case definition, may be absent in a significant proportion of patients (16%). These results are important for the implementation of a suspected case definition, the main tool for epidemiological surveillance, in territories that may be affected by ZIKV emergence, including Europe.
C1 [Daudens-Vaysse, E.; Ledrans, M.; Gay, N.; Ardillon, V.; Cassadou, S.; Dorleans, F.; Suivant, C.; Carvalho, L.; Petit-Sinturel, M.; Andrieu, A.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Antilles Guyane, St Maurice, France.
   [Leparc-Goffart, I.; Maquart, M.; Flusin, O.] Univ Hosp Martinique, Virol Lab, Fort De France, Martinique, France.
   [Rousset, D.; Huc-Anais, P.] Natl Reference Ctr Arboviruses, Inst Rech Biomed Armees, Marseille, France.
   [Herrmann, C.] Inst Pasteur Guyane, Natl Reference Ctr Arboviruses Influenza Virus &, Cayenne, France.
   [Huc-Anais, P.] Univ Hosp Guadeloupe, Microbiol Lab, Pointe A Pitre, Guadeloupe, France.
   [Jaubert, J.] Lab Lepers, St Martin Dheres, France.
   [Criquet-Hayot, A.] Private Hosp St Paul, Fort De France, Martinique, France.
   [Hoen, B.] Reg Union Independent Med Practitioners Martiniqu, Fort De France, Martinique, France.
   [Djossou, F.] Univ Hosp Guadeloupe, Infect & Trop Dis Unit, Pointe a Pitre, Guadeloupe, France.
   [Locatelli-Jouans, C.; Blateau, A.] Univ Hosp Andree Rosemon, Infect & Trop Dis Unit, Cayenne, France.
   [McKenzie, A.] Reg Hlth Agcy ARS Martinique, Fort De France, Martinique, France.
   [Saint-Martin, P.] Reg Hlth Agcy ARS French Guiana, Cayenne, French Guiana, France.
   [Saint-Martin, P.] Reg Hlth Agcy ARS Guadeloupe, St Martin Dheres, Gourbeyre, France.
   [Noel, H.; Septfons, A.; Gallay, A.; Paty, M.] Reg Hlth Agcy ARS Guadeloupe, St Barthelemy, Gourbeyre, France.
   [Filleul, L.] Sante Publ France, French Natl Publ Hlth Agcy, St Maurice, France.
   [Cabie, A.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, France.
   Univ Hosp Martinique, Infect & Trop Dis Unit, Fort De France, Martinique, France.
RP Daudens-Vaysse, E (corresponding author), Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Antilles Guyane, St Maurice, France.
EM elise.daudens-vaysse@ars.sante.fr
RI Rousset, Dominique/S-5400-2019; Djossou, Felix/AAM-8640-2020
OI Rousset, Dominique/0000-0002-1473-3147; Cabie,
   Andre/0000-0003-0117-3061; Noel, Harold/0000-0003-3011-9267
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gardner LM, 2016, LANCET INFECT DIS
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 14
Z9 14
U1 0
U2 7
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 11
EP 16
AR 30285
DI 10.2807/1560-7917.ES.2016.21.28.30285
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700003
PM 27447300
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rojas, DP
   Dean, NE
   Yang, Y
   Kenah, E
   Quintero, J
   Tomasi, S
   Ramirez, EL
   Kelly, Y
   Castro, C
   Carrasquilla, G
   Halloran, ME
   Longini, IM
AF Rojas, D. P.
   Dean, N. E.
   Yang, Y.
   Kenah, E.
   Quintero, J.
   Tomasi, S.
   Ramirez, E. L.
   Kelly, Y.
   Castro, C.
   Carrasquilla, G.
   Halloran, M. E.
   Longini, I. M.
TI The epidemiology and transmissibility of Zika virus in Girardot and San
   Andres island, Colombia, September 2015 to January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; INTERIM GUIDELINES; SOUTH-PACIFIC;
   UNITED-STATES; OUTBREAK; BRAZIL; INFECTION; DIPTERA; URINE
AB Transmission of Zika virus (ZIKV) was first detected in Colombia in September 2015. As of April 2016, Colombia had reported over 65,000 cases of Zika virus disease (ZVD). We analysed daily surveillance data of ZVD cases reported to the health authorities of San Andres and Girardot, Colombia, between September 2015 and January 2016. ZVD was laboratory-confirmed by reverse transcription-polymerase chain reaction (RT-PCR) in the serum of acute cases within five days of symptom onset. We use daily incidence data to estimate the basic reproductive number (R-o) in each population. We identified 928 and 1,936 reported ZVD cases from San Andres and Girardot, respectively. The overall attack rate for reported ZVD was 12.13 cases per 1,000 residents of San Andres and 18.43 cases per 1,000 residents of Girardot. Attack rates were significantly higher in females in both municipalities (p < 0.001). Cases occurred in all age groups with highest rates in 20 to 49 year-olds. The estimated R 0 for the Zika outbreak was 1.41 (95% confidence interval (CI): 1.15-1.74) in San Andres and 4.61 (95% CI: 4.11-5.16) in Girardot. Transmission of ZIKV is ongoing in the Americas. The estimated R-o from Colombia supports the observed rapid spread.
C1 [Rojas, D. P.] Univ Florida, Dept Epidemiol, Gainesville, FL 32611 USA.
   [Dean, N. E.; Yang, Y.; Kenah, E.; Longini, I. M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Quintero, J.; Tomasi, S.; Carrasquilla, G.] Fdn Santa Fe Bogota, Ctr Estudios & Invest Salud, Bogota, Colombia.
   [Ramirez, E. L.] Secretaria Municipal Salud, Girardot, Colombia.
   [Kelly, Y.] IPS Univ, San Andres, Colombia.
   [Castro, C.] Secretaria Dept Salud, San Andres, Colombia.
   [Halloran, M. E.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Halloran, M. E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
RP Rojas, DP (corresponding author), Univ Florida, Dept Epidemiol, Gainesville, FL 32611 USA.
EM dprojas@ufl.edu
RI Rojas, Diana Patricia/AAC-2469-2019
OI Rojas, Diana Patricia/0000-0003-0241-6416
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U54GM111274];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R37 AI032042]; Colombian Department of
   Science and Technology (Fulbright-Colciencias scholarship)
FX This work was supported by National Institutes of Health (NIH)
   U54GM111274, NIH R37 AI032042 and the Colombian Department of Science
   and Technology (Fulbright-Colciencias scholarship to D.P.R).
CR Alcala L, 2015, BIOMEDICA, V35, P258, DOI [10.7705/biomedica.v35i2.2567, 10.1590/S0120-41572015000200014]
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   *DANE, 2016, EST PROYECC PROBL NA
   DAY JF, 1994, J MED ENTOMOL, V31, P611, DOI 10.1093/jmedent/31.4.611
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   *EHO, 2016, WHO DIR GEN SUMM OUT
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   *INC, 2016, VIG INT SINDR NEUR G
   *INS, 2015, 061 MINSAD INS
   *INS, 2015, REP ZIKK ILLN COL
   *INS, 2016, 007 INS
   *INS, 2016, 004 INS
   *INS, 2016, B EP SEM SEM EP 08 2
   *INS, 2015, CHIK WEEK 52 2015
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   *MINSAD, 2011, AN SIT SAL ASIS ARCH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   *PAHO, GEOGR DISTR CONF CAS
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   R Core Team, 2016, R LANG ENV STAT COMP
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SALAS D, 2014, INFORME FINAL EVENTO
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   WHO, 2016, GUILL BARR SYNDR BRA
   *WHO, CAS DEF ZIK
   World Health Organization, 2016, ZIK SIT REP
   Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 49
TC 18
Z9 18
U1 0
U2 31
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 26
EP 35
AR 30283
DI 10.2807/1560-7917.ES.2016.21.28.30283
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700005
PM 27452806
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Dalla Bona, AC
   Chitolina, RF
   Fermino, ML
   Poncio, LD
   Weiss, A
   Lima, JBP
   Paldi, N
   Bernardes, ES
   Henen, J
   Maori, E
AF Dalla Bona, Ana Caroline
   Chitolina, Rodrigo Faitta
   Fermino, Marise Lopes
   Poncio, Lisiane de Castro
   Weiss, Avital
   Pereira Lima, Jose Bento
   Paldi, Nitzan
   Bernardes, Emerson Soares
   Henen, Jonathan
   Maori, Eyal
TI Larval application of sodium channel homologous dsRNA restores
   pyrethroid insecticide susceptibility in a resistant adult mosquito
   population
SO PARASITES & VECTORS
LA English
DT Article
DE Insecticide resistance; Pyrethroids; Voltage-gated sodium channel; RNAi;
   Aedes aegypti; Mosquitoes
ID AEDES-AEGYPTI POPULATIONS; RNA INTERFERENCE; ZIKA VIRUS; KNOCKDOWN
   RESISTANCE; BORNE DISEASES; GENE; MUTATION; MECHANISMS; VECTOR; THAILAND
AB Background: Mosquitoes host and pass on to humans a variety of disease-causing pathogens such as infectious viruses and other parasitic microorganisms. The emergence and spread of insecticide resistance is threatening the effectiveness of current control measures for common mosquito vector borne diseases, such as malaria, dengue and Zika. Therefore, the emerging resistance to the widely used pyrethroid insecticides is an alarming problem for public health. Herein we demonstrated the use of RNA interference (RNAi) to increase susceptibility of adult mosquitoes to a widely used pyrethroid insecticide.
   Methods: Experiments were performed on a field-collected pyrethroid resistant strain of Ae. aegypti (Rio de Janeiro; RJ). Larvae from the resistant Ae. aegypti population were soaked with double-stranded RNAs (dsRNAs) that correspond either to voltage-gate sodium channel (VGSC), P-glycoprotein, or P450 detoxification genes and reared to adulthood. Adult mortality rates in the presence of various Deltamethrin pyrethroid concentrations were used to assess mosquito insecticide susceptibility.
   Results: We characterized the RJ Ae. aegypti strain with regard to its level of resistance to a pyrethroid insecticide and found that it was approximately 6 times more resistant to Deltamethrin compared to the laboratory Rockefeller strain. The RJ strain displayed a higher frequency of Val1016Ile and Phe1534Cys substitutions of the VGSC gene. The resistant strain also displayed a higher basal expression level of VGSC compared to the Rockefeller strain. When dsRNA-treated mosquitoes were subjected to a standard pyrethroid contact bioassay, only dsRNA targeting VGSC increased the adult mortality of the pyrethroid resistant strain. The dsRNA treatment proved effective in increasing adult mosquito susceptibility over a range of pyrethroid concentrations and these results were associated with dsRNA-specific small interfering RNAs in treated adults, and the corresponding specific down regulation of VGSC gene expression level. Finally, we demonstrated that the efficiency of our approach was further improved by 'tiling' along the VGSC gene in order to identify the most potent dsRNA sequences.
   Conclusions: These results demonstrate that dsRNA applied to mosquito larvae retains its biological activity into adulthood. Thus, the RNAi system reported here could be a useful approach to control the widespread insecticide resistance in mosquitoes and other insect vectors of human diseases.
C1 [Dalla Bona, Ana Caroline; Chitolina, Rodrigo Faitta; Fermino, Marise Lopes; Poncio, Lisiane de Castro; Bernardes, Emerson Soares] Forrest Brasil Tecnol Ltda, Curitiba, Parana, Brazil.
   [Weiss, Avital; Paldi, Nitzan; Henen, Jonathan; Maori, Eyal] Forrest Innovat Ltd, Caesarea, Israel.
   [Pereira Lima, Jose Bento] Inst Oswaldo Cruz, FIOCRUZ, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.
   [Bernardes, Emerson Soares] Inst Nucl Energy Res, Radiopharm Ctr, Sao Paulo, Brazil.
RP Maori, E (corresponding author), Forrest Innovat Ltd, Caesarea, Israel.
EM Eyal@forrestinnovations.com
RI Bernardes, Emerson Soares/D-3711-2017
OI Bernardes, Emerson Soares/0000-0002-0029-7313
FU Forrest Innovations' internal resources
FX The study was supported by Forrest Innovations' internal resources.
   Forrest Innovations' funders had no role in the design of the study and
   collection, analysis, and interpretation of data as well as in writing
   the manuscript.
CR Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bing ZS, 2016, EXP PARASITOL, V162, P35
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brogdon W., 2010, METHODS ANOPHELES RE
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Butler D, 2011, NATURE, V475, P19, DOI 10.1038/475019a
   Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052
   Garbian Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003035
   Gates B, 2014, DEADLIEST ANIMAL WOR
   Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2
   Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160
   Katoch R, 2013, APPL BIOCHEM BIOTECH, V169, P1579, DOI 10.1007/s12010-012-0046-5
   Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Mysore K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004213
   Paldi N, 2010, APPL ENVIRON MICROB, V76, P5960, DOI 10.1128/AEM.01067-10
   Pan ZH, 2015, GENE, V565, P56, DOI 10.1016/j.gene.2015.03.069
   Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840
   Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014
   Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887, DOI 10.4269/ajtmh.1965.14.887
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404
   World Health Organization (WHO), 1998, WHOCDSCPCMAL9812
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Zhang X, 2016, CELL, V165, P683
NR 57
TC 14
Z9 15
U1 1
U2 67
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 14
PY 2016
VL 9
AR 397
DI 10.1186/s13071-016-1634-y
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DS0ZU
UT WOS:000380326300001
PM 27416771
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Butler, D
AF Butler, D.
TI Zika raises wider birth-defect issue (vol 535, pg 17, 2016)
SO NATURE
LA English
DT Correction
CR Butler D, 2016, NATURE, V535, P17, DOI 10.1038/535017a
NR 1
TC 0
Z9 0
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 14
PY 2016
VL 535
IS 7611
BP 213
EP 213
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR4ZN
UT WOS:000379912600064
DA 2020-07-08
ER

PT J
AU Adibi, JJ
   Zhao, YQ
   Cartus, AR
   Gupta, P
   Davidson, LA
AF Adibi, Jennifer J.
   Zhao, Yaqi
   Cartus, Abigail R.
   Gupta, Phalguni
   Davidson, Lance A.
TI Placental Mechanics in the Zika-Microcephaly Relationship
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS-INFECTION
AB How the Zika virus (ZIKV) accesses the embryo remains unknown. In this issue, Quicke et al. (2016) use an in vitro model of the human placenta to show that placental macrophages are more permissive to ZIKV infection than trophoblasts, which may be refractory to infection (Bayer et al., 2016).
C1 [Adibi, Jennifer J.; Zhao, Yaqi; Cartus, Abigail R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
   [Adibi, Jennifer J.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.
   [Gupta, Phalguni] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA.
RP Adibi, JJ (corresponding author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
EM adibij@pitt.edu
RI Adibi, Jennifer/I-8077-2016
OI Adibi, Jennifer/0000-0001-6562-8315
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, N ENGL J MED
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Jaenisch T., 2016, B WHO
   Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 8
Z9 8
U1 0
U2 59
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 13
PY 2016
VL 20
IS 1
BP 9
EP 11
DI 10.1016/j.chom.2016.06.013
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DS3UC
UT WOS:000380707200005
PM 27414496
OA Bronze
DA 2020-07-08
ER

PT J
AU Quicke, KM
   Bowen, JR
   Johnson, EL
   McDonald, CE
   Ma, HL
   O'Neal, JT
   Rajakumar, A
   Wrammert, J
   Rimawi, BH
   Pulendran, B
   Schinazi, RF
   Chakraborty, R
   Suthar, MS
AF Quicke, Kendra M.
   Bowen, James R.
   Johnson, Erica L.
   McDonald, Circe E.
   Ma, Huailiang
   O'Neal, Justin T.
   Rajakumar, Augustine
   Wrammert, Jens
   Rimawi, Bassam H.
   Pulendran, Bali
   Schinazi, Raymond F.
   Chakraborty, Rana
   Suthar, Mehul S.
TI Zika Virus Infects Human Placental Macrophages
SO CELL HOST & MICROBE
LA English
DT Article
ID HOFBAUER CELLS; IMMUNITY; REPLICATION; VACCINE; BIOLOGY; BRAIN; HIV-1
AB The recent Zika virus (ZIKV) outbreak in Brazil has been directly linked to increased cases of microcephaly in newborns. Current evidence indicates that ZIKV is transmitted vertically from mother to fetus. However, the mechanism of intrauterine transmission and the cell types involved remain unknown. We demonstrate that the contemporary ZIKV strain PRVABC59 (PR 2015) infects and replicates in primary human placental macrophages, called Hofbauer cells, and to a lesser extent in cytotrophoblasts, isolated from villous tissue of full-term placentae. Viral replication coincides with induction of type I interferon (IFN), pro-inflammatory cytokines, and antiviral gene expression, but with minimal cell death. Our results suggest a mechanism for intrauterine transmission in which ZIKV gains access to the fetal compartment by directly infecting placental cells and disrupting the placental barrier.
C1 [Quicke, Kendra M.; Bowen, James R.; Johnson, Erica L.; McDonald, Circe E.; O'Neal, Justin T.; Wrammert, Jens; Schinazi, Raymond F.; Chakraborty, Rana; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Quicke, Kendra M.; Bowen, James R.; McDonald, Circe E.; Ma, Huailiang; O'Neal, Justin T.; Wrammert, Jens; Pulendran, Bali; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Ma, Huailiang; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Rajakumar, Augustine; Rimawi, Bassam H.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med & Reprod Infect Dis, Atlanta, GA 30329 USA.
   [Schinazi, Raymond F.] Emory Univ, Sch Med, Ctr AIDS Res, Biochem Pharmacol Lab, Atlanta, GA 30322 USA.
RP Suthar, MS (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.; Suthar, MS (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
RI Schinazi, Raymond F/B-6777-2017; Ma, Huailiang/C-3403-2017
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI083019, R56AI110516, R21AI113485,
   2U19AI090023, 5R37DK057665, 5R37AI048638, 2U19AI057266]; Children's
   Healthcare of Atlanta; Emory Vaccine Center; Georgia Research Alliance;
   Multi-Center NICHD International Maternal Pediatric Adolescent AIDS
   Clinical Trials Network; Center for AIDS Research at Emory University
   [P30AI050409]
FX We thank A. Price for the OAS1 qRT-PCR reagents. This work was funded in
   part by NIH grants U19AI083019 (M.S.S), R56AI110516 (M.S.S), R21AI113485
   (M.S.S.), 2U19AI090023 (B.P), 5R37DK057665 (B.P), 5R37AI048638 (B.P),
   and 2U19AI057266 (B.P); Children's Healthcare of Atlanta (M.S.S); Emory
   Vaccine Center (M.S.S); The Georgia Research Alliance (M.S.S);
   Multi-Center NICHD International Maternal Pediatric Adolescent AIDS
   Clinical Trials Network (R.C); and P30AI050409 Center for AIDS Research
   at Emory University (R.F.S).
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Calvet G., 2016, LANCET INFECT DIS
   Chiuppesi F, 2015, J VIROL, V89, P11884, DOI 10.1128/JVI.01701-15
   Cordeiro M.T., 2016, LANCET, P30254
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Driggers RW, 2016, N ENGL J MED
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Koi H, 2001, ANN NY ACAD SCI, V943, P148, DOI 10.1111/j.1749-6632.2001.tb03798.x
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Noronha L., 2016, MEM I O CRUZ
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 28
TC 203
Z9 207
U1 0
U2 111
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 13
PY 2016
VL 20
IS 1
BP 83
EP 90
DI 10.1016/j.chom.2016.05.015
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DS3UC
UT WOS:000380707200012
PM 27247001
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Shuchman, M
AF Shuchman, Miriam
TI Canada's support lags for research on Zika
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD JUL 12
PY 2016
VL 188
IS 10
BP E203
EP E204
DI 10.1503/cmaj.109-5284
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS7XT
UT WOS:000380997200003
PM 27270120
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Priyamvada, L
   Quicke, KM
   Hudson, WH
   Onlamoon, N
   Sewatanon, J
   Edupuganti, S
   Pattanapanyasat, K
   Chokephaibulkit, K
   Mulligan, MJ
   Wilson, PC
   Ahmed, R
   Suthar, MS
   Wrammert, J
AF Priyamvada, Lalita
   Quicke, Kendra M.
   Hudson, William H.
   Onlamoon, Nattawat
   Sewatanon, Jaturong
   Edupuganti, Srilatha
   Pattanapanyasat, Kovit
   Chokephaibulkit, Kulkanya
   Mulligan, Mark J.
   Wilson, Patrick C.
   Ahmed, Rafi
   Suthar, Mehul S.
   Wrammert, Jens
TI Human antibody responses after dengue virus infection are highly
   cross-reactive to Zika virus
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; cross-reactivity; antibodies; B-cell responses
ID FUSION LOOP; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; DEPENDENT
   ENHANCEMENT; DISEASE SEVERITY; GLYCOPROTEIN; MICRONESIA; EPITOPES;
   BURDEN; STATES
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus of significant public health concern. ZIKV shares a high degree of sequence and structural homology compared with other flaviviruses, including dengue virus (DENV), resulting in immunological cross-reactivity. Improving our current understanding of the extent and characteristics of this immunological cross-reactivity is important, as ZIKV is presently circulating in areas that are highly endemic for dengue. To assess the magnitude and functional quality of cross-reactive immune responses between these closely related viruses, we tested acute and convalescent sera from nine Thai patients with PCR-confirmed DENV infection against ZIKV. All of the sera tested were cross-reactive with ZIKV, both in binding and in neutralization. To deconstruct the observed serum cross-reactivity in depth, we also characterized a panel of DENV-specific plasmablast-derived monoclonal antibodies (mAbs) for activity against ZIKV. Nearly half of the 47 DENV-reactive mAbs studied bound to both whole ZIKV virion and ZIKV lysate, of which a subset also neutralized ZIKV. In addition, both sera and mAbs from the dengue-infected patients enhanced ZIKV infection of Fc gamma receptor (Fc gamma R)-bearing cells in vitro. Taken together, these findings suggest that preexisting immunity to DENV may impact protective immune responses against ZIKV. In addition, the extensive cross-reactivity may have implications for ZIKV virulence and disease severity in DENV-experienced populations.
C1 [Priyamvada, Lalita; Quicke, Kendra M.; Hudson, William H.; Sewatanon, Jaturong; Ahmed, Rafi; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Priyamvada, Lalita; Quicke, Kendra M.; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Hudson, William H.; Sewatanon, Jaturong; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Onlamoon, Nattawat; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok 10700, Thailand.
   [Sewatanon, Jaturong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.
   [Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Emory Vaccine Ctr, Hope Clin, Atlanta, GA 30322 USA.
   [Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand.
   [Wilson, Patrick C.] Univ Chicago, Dept Med, Knapp Ctr Lupus & Immunol Res, Rheumatol Sect, Chicago, IL 60637 USA.
RP Ahmed, R; Wrammert, J (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Wrammert, J (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
EM rahmed@emory.edu; jwramme@emory.edu
RI Mulligan, Mark/V-9275-2019; Hudson, William/E-6622-2012; Onlamoon,
   Nattawat/AAR-8390-2020; Priyamvada, Lalita/J-6252-2019
OI Hudson, William/0000-0002-2513-1213; Priyamvada,
   Lalita/0000-0002-0479-0164; Onlamoon, Nattawat/0000-0002-8784-3005
FU NIH/National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI057266, 1U01AI115651, U19AI083019, R56AI110516];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R01AI099385-01]; Faculty of Medicine
   Siriraj Hospital; Faculty of Medicine Siriraj Hospital, Mahidol
   University [R015636002]
FX This work was funded in part by NIH/National Institute of Allergy and
   Infectious Diseases (NIAID) Grants U19AI057266 (to R.A., P.C.W., and
   J.W.), 1U01AI115651 (to R.A. and J.W.), U19AI083019 (to M.S.S.), and
   R56AI110516 (to M.S.S.). K.P. is supported by NIH Grant 1R01AI099385-01.
   K.P. and N.O. are supported by a Chalermphrakiat Grant from the Faculty
   of Medicine Siriraj Hospital. N.O. is also supported by Grant R015636002
   from the Faculty of Medicine Siriraj Hospital, Mahidol University.
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Priyamvada L, 2016, J VIROL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 40
TC 282
Z9 289
U1 1
U2 75
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 12
PY 2016
VL 113
IS 28
BP 7852
EP 7857
DI 10.1073/pnas.1607931113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR1VX
UT WOS:000379694100052
PM 27354515
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Budd, H
   Massa, L
AF Budd, Herb
   Massa, Lou
TI Using computer simulations to fight Zika
SO CHEMICAL & ENGINEERING NEWS
LA English
DT Letter
NR 0
TC 0
Z9 0
U1 1
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUL 11
PY 2016
VL 94
IS 28
BP 4
EP 4
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DQ9YL
UT WOS:000379565100002
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Beyond Zika
SO NATURE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 8
EP 8
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600003
DA 2020-07-08
ER

PT J
AU Butler, D
AF Butler, Declan
TI Zika raises wider birth-defect issue
SO NATURE
LA English
DT News Item
CR Cannon MJ, 2012, PREV MED, V54, P351, DOI 10.1016/j.ypmed.2012.03.009
NR 1
TC 5
Z9 5
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 17
EP 17
DI 10.1038/535017a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600006
PM 27383962
OA Bronze
DA 2020-07-08
ER

PT J
AU Rossi, SL
   Vasilakis, N
AF Rossi, Shannan L.
   Vasilakis, Nikos
TI Modeling Zika Virus Infection in Mice
SO CELL STEM CELL
LA English
DT Editorial Material
ID ORGANOIDS
C1 [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Rossi, SL; Vasilakis, N (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM slrossi@utmb.edu; nivasila@utmb.edu
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 10
TC 12
Z9 12
U1 0
U2 66
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD JUL 7
PY 2016
VL 19
IS 1
BP 4
EP 6
DI 10.1016/j.stem.2016.06.009
PG 4
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6UT
UT WOS:000381620500003
PM 27392219
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, C
   Xu, D
   Ye, Q
   Hong, S
   Jiang, YS
   Liu, XY
   Zhang, N
   Shi, L
   Qin, CF
   Xu, ZH
AF Li, Cui
   Xu, Dan
   Ye, Qing
   Hong, Shuai
   Jiang, Yisheng
   Liu, Xinyi
   Zhang, Nana
   Shi, Lei
   Qin, Cheng-Feng
   Xu, Zhiheng
TI Zika Virus Disrupts Neural Progenitor Development and Leads to
   Microcephaly in Mice
SO CELL STEM CELL
LA English
DT Article
ID STEM
AB The link between Zika virus (ZIKV) infection and microcephaly has raised urgent global alarm. The historical African ZIKV MR766 was recently shown to infect cultured human neural precursor cells (NPCs), but unlike the contemporary ZIKV strains, it is not believed to cause microcephaly. Here we investigated whether the Asian ZIKV strain SZ01 could infect NPCs in vivo and affect brain development. We found that SZ01 replicates efficiently in embryonic mouse brain by directly targeting different neuronal linages. ZIKV infection leads to cell-cycle arrest, apoptosis, and inhibition of NPC differentiation, resulting in cortical thinning and microcephaly. Global gene expression analysis of infected brains reveals upregulation of candidate flavirus entry receptors and dysregulation of genes associated with immune response, apoptosis, and microcephaly. Our model provides evidence for a direct link between Zika virus infection and microcephaly, with potential for further exploration of the underlying mechanisms and management of ZIKV-related pathological effects during brain development.
C1 [Li, Cui; Hong, Shuai; Jiang, Yisheng; Liu, Xinyi; Shi, Lei; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Li, Cui; Ye, Qing; Jiang, Yisheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Ye, Qing; Zhang, Nana; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
   [Xu, Dan] Fuzhou Univ, Inst Life Sci, Fuzhou 350116, Peoples R China.
   [Zhang, Nana] Guangxi Med Univ, Nanning 530021, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM qincf@bmi.ac.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Xu, Zhiheng/0000-0002-4809-2851;
   Li, Cui/0000-0001-9777-9628
FU NSF (China)National Natural Science Foundation of China
   [31430037/31271156/81522025/8151101191]; MOST (China) "973" program
   [2014CB942801/2013DFA31990/2012YQ03026006]
FX We thank Drs. Fu Gao, Xia Jin, Weixiang Guo, Lloyd Greene, and Feng
   Zhang for valuable advice, and we thank Fu-Chun Zhang for serum from the
   ZIKV patient. This work was supported by grants from NSF (China)
   (31430037/31271156/81522025/8151101191) and the MOST (China) "973"
   program (2014CB942801/2013DFA31990/2012YQ03026006).
CR Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155
   Calvet G., 2016, LANCET INFECT DIS
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Driggers RW, 2016, N ENGL J MED
   Garcez P.P., 2016, SCIENCE
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   iQian X., 2016, CELL IN PRESS
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marrs C, 2016, AM J PERINATOL
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Tang H, 2016, CELL STEM CELL
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6815
NR 19
TC 286
Z9 303
U1 5
U2 104
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD JUL 7
PY 2016
VL 19
IS 1
BP 120
EP 126
DI 10.1016/j.stem.2016.04.017
PG 7
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6UT
UT WOS:000381620500016
PM 27179424
OA Bronze
DA 2020-07-08
ER

PT J
AU Marceau, CD
   Puschnik, AS
   Majzoub, K
   Ooi, YS
   Brewer, SM
   Fuchs, G
   Swaminathan, K
   Mata, MA
   Elias, JE
   Sarnow, P
   Carette, JE
AF Marceau, Caleb D.
   Puschnik, Andreas S.
   Majzoub, Karim
   Ooi, Yaw Shin
   Brewer, Susan M.
   Fuchs, Gabriele
   Swaminathan, Kavya
   Mata, Miguel A.
   Elias, Joshua E.
   Sarnow, Peter
   Carette, Jan E.
TI Genetic dissection of Flaviviridae host factors through genome-scale
   CRISPR screens
SO NATURE
LA English
DT Article
ID HEPATITIS-C VIRUS; HUMAN-CELLS; N-GLYCOSYLATION; DENGUE VIRUS;
   REPLICATION; INFECTION; PROTEIN; HUR; OLIGOSACCHARYLTRANSFERASE;
   MEMBRANE
AB The Flaviviridae are a family of viruses that cause severe human diseases. For example, dengue virus (DENV) is a rapidly emerging pathogen causing an estimated 100 million symptomatic infections annually worldwide(1). No approved antivirals are available to date, and clinical trials with a tetravalent dengue vaccine showed disappointingly low protection rates(2). Hepatitis C virus (HCV) also remains a major medical problem, with 160 million chronically infected patients worldwide and only expensive treatments available(3). Despite distinct differences in their pathogenesis and modes of transmission, the two viruses share common replication strategies(4). A detailed understanding of the host functions that determine viral infection is lacking. Here we use a pooled CRISPR genetic screening strategy(5,6) to comprehensively dissect host factors required for these two highly important Flaviviridae members. For DENV, we identified endoplasmic-reticulum (ER)-associated multi-protein complexes involved in signal sequence recognition, N-linked glycosylation and ER-associated degradation. DENV replication was nearly completely abrogated in cells deficient in the oligosaccharyltransferase (OST) complex. Mechanistic studies pinpointed viral RNA replication and not entry or translation as the crucial step requiring the OST complex. Moreover, we show that viral non-structural proteins bind to the OST complex. The identified ER-associated protein complexes were also important for infection by other mosquito-borne flaviviruses including Zika virus, an emerging pathogen causing severe birth defects(7). By contrast, the most significant genes identified in the HCV screen were distinct and included viral receptors, RNA-binding proteins and enzymes involved in metabolism. We found an unexpected link between intracellular flavin adenine dinucleotide (FAD) levels and HCV replication. This study shows notable divergence in host-dependency factors between DENV and HCV, and illuminates new host targets for antiviral therapy.
C1 [Marceau, Caleb D.; Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Brewer, Susan M.; Fuchs, Gabriele; Mata, Miguel A.; Sarnow, Peter; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Swaminathan, Kavya; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.
RP Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM carette@stanford.edu
OI Fuchs, Gabriele/0000-0002-6838-2100; Carette, Jan/0000-0002-5187-8070;
   Ooi, Yaw Shin/0000-0001-9014-1365; Majzoub, Karim/0000-0001-7345-6840;
   Swaminathan, Kavya/0000-0001-7715-5375
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [DP2 AI104557];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI109662]; David and Lucile Packard
   FoundationThe David & Lucile Packard Foundation; Stanford Graduate
   FellowshipStanford University; Boehringer Ingelheim FondsBoehringer
   Ingelheim; NSF-GFRP
FX The authors thank T. Brummelkamp, J. Idoyaga and S. Einav for critically
   reading the manuscript and discussions; X. Ji and the Stanford
   Functional Genomics Facility; The Stanford Transmission Electron
   Microscope Facility; The Stanford Shared FACS Facility, and members of
   the Carette laboratory for discussions and support. S. Einav, K.
   Kirkegaard, F. Chisari, J. F. Anderson, C. Rice, H. Ploegh, R. Kopito,
   E. Harris, M. Ivessa, S. Weaver, R. Tesh and E. Campeau are acknowledged
   for providing materials. The work was funded in part by National
   Institutes of Health (NIH) DP2 AI104557 (J. E. C.), NIH AI109662 (J. E.
   C.), David and Lucile Packard Foundation (J. E. C.), Stanford Graduate
   Fellowship (A.S.P.), Boehringer Ingelheim Fonds (A.S.P.) and NSF-GFRP
   (C.D.M.).
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854
   Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095
   Fuchs G, 2015, P NATL ACAD SCI USA, V112, P319, DOI 10.1073/pnas.1421328111
   Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330
   Hasan M, 2015, IMMUNITY, V43, P463, DOI 10.1016/j.immuni.2015.07.022
   Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513
   Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x
   Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375
   Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005
   Shwetha S, 2015, J VIROL, V89, P11356, DOI 10.1128/JVI.01714-15
   Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Thomas SJ, 2015, AM J PREV MED, V49, pS334, DOI 10.1016/j.amepre.2015.09.006
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
NR 42
TC 167
Z9 170
U1 4
U2 102
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 159
EP +
DI 10.1038/nature18631
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600044
PM 27383987
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, R
   Miner, JJ
   Gorman, MJ
   Rausch, K
   Ramage, H
   White, JP
   Zuiani, A
   Zhang, P
   Fernandez, E
   Zhang, Q
   Dowd, KA
   Pierson, TC
   Cherry, S
   Diamond, MS
AF Zhang, Rong
   Miner, Jonathan J.
   Gorman, Matthew J.
   Rausch, Keiko
   Ramage, Holly
   White, James P.
   Zuiani, Adam
   Zhang, Ping
   Fernandez, Estefania
   Zhang, Qiang
   Dowd, Kimberly A.
   Pierson, Theodore C.
   Cherry, Sara
   Diamond, Michael S.
TI A CRISPR screen defines a signal peptide processing pathway required by
   flaviviruses
SO NATURE
LA English
DT Article
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; HEPATITIS-C VIRUS;
   MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; HUMAN-CELLS; INFECTION; GENES;
   NEUTRALIZATION; IDENTIFICATION
AB Flaviviruses infect hundreds of millions of people annually, and no antiviral therapy is available(1,2). We performed a genome-wide CRISPR/Cas9-based screen to identify host genes that, when edited, resulted in reduced flavivirus infection. Here, we validated nine human genes required for flavivirus infectivity, and these were associated with endoplasmic reticulum functions including translocation, protein degradation, and N-linked glycosylation. In particular, a subset of endoplasmic reticulum-associated signal peptidase complex (SPCS) proteins was necessary for proper cleavage of the flavivirus structural proteins (prM and E) and secretion of viral particles. Loss of SPCS1 expression resulted in markedly reduced yield of all Flaviviridae family members tested (West Nile, dengue, Zika, yellow fever, Japanese encephalitis, and hepatitis C viruses), but had little impact on alphavirus, bunyavirus, or rhabdovirus infection or the surface expression or secretion of diverse host proteins. We found that SPCS1 dependence could be bypassed by replacing the native prM protein leader sequences with a class I major histocompatibility complex (MHC) antigen leader sequence. Thus, SPCS1, either directly or indirectly via its interactions with host proteins, preferentially promotes the processing of specific protein cargo, and Flaviviridae have a unique dependence on this signal peptide processing pathway. SPCS1 and other signal processing pathway members could represent pharmacological targets for inhibiting infection by the expanding number of flaviviruses of medical concern.
C1 [Zhang, Rong; Miner, Jonathan J.; Gorman, Matthew J.; White, James P.; Zuiani, Adam; Zhang, Ping; Fernandez, Estefania; Zhang, Qiang; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Rausch, Keiko; Ramage, Holly; Cherry, Sara] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Zhang, Ping] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Guangdong, Peoples R China.
   [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Zhang, Rong/J-5434-2018
OI Diamond, Michael/0000-0002-8791-3165; Zhang, Rong/0000-0003-2941-4808;
   Ramage, Holly/0000-0002-0390-6786
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19 AI083019, U19 AI106772, R01
   AI104972, T32 AI007163]; Washington University Institute of Clinical and
   Translational Sciences from the National Center for Advancing
   Translational Sciences [UL1 TR000448]; Washington University Institute
   of Clinical and Translational Sciences from the National Institute of
   General Medical Sciences [P41 GM103422-35]; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
FX This work was supported by NIH grants U19 AI083019 (M.S.D.), U19
   AI106772 (M.S.D.), R01 AI104972 (M.S.D.), and T32 AI007163 (E.F.) and by
   the Washington University Institute of Clinical and Translational
   Sciences (UL1 TR000448 from the National Center for Advancing
   Translational Sciences and P41 GM103422-35 from the National Institute
   of General Medical Sciences). T.C.P and K.A.D are supported by the
   intramural program of NIAID. We thank R. Kuhn, A. Garcia-Sastre, H.
   Zhao, D. Fremont, X. Wang, and R. Townsend for reagents, experimental
   advice, and data analysis; P. Erdmann-Gilmore, R. Connors, Y. Mi, and H.
   Lin for expert technical assistance; and X. de Lamballerie and the
   European Virus Archive goes Global (EVAg) for consenting to the use of
   H/PF/2013 ZIKV strain for this study under a material transfer agreement
   with the EVAg parter, Aix-Marseille Universite.
CR BARTH BU, 1995, J CELL BIOL, V128, P283, DOI 10.1083/jcb.128.3.283
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998
   Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Lin TY, 2012, J VIROL, V86, P3501, DOI 10.1128/JVI.06435-11
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lober C, 2001, VIROLOGY, V289, P224, DOI 10.1006/viro.2001.1171
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159
   Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777
   Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Suzuki R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003589
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
NR 49
TC 161
Z9 169
U1 7
U2 112
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 164
EP +
DI 10.1038/nature18625
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600045
PM 27383988
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Johansson, MA
   Mier-y-Teran-Romero, L
   Reefhuis, J
   Gilboa, SM
   Hills, SL
AF Johansson, Michael A.
   Mier-y-Teran-Romero, Luis
   Reefhuis, Jennita
   Gilboa, Suzanne M.
   Hills, Susan L.
TI Zika and the Risk of Microcephaly
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID VIRUS
C1 [Johansson, Michael A.; Mier-y-Teran-Romero, Luis; Hills, Susan L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   [Reefhuis, Jennita; Gilboa, Suzanne M.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
RP Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.; Johansson, MA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
OI Johansson, Michael/0000-0002-5090-7722
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U54 GM088558]
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 5
TC 253
Z9 255
U1 0
U2 11
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 7
PY 2016
VL 375
IS 1
BP 1
EP 4
DI 10.1056/NEJMp1605367
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL8VA
UT WOS:000394897200001
PM 27222919
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Shi, WF
   Zhang, ZJ
   Ling, C
   Carr, MJ
   Tong, YG
   Gao, GF
AF Shi, Weifeng
   Zhang, Zhenjie
   Ling, Cheng
   Carr, Michael J.
   Tong, Yigang
   Gao, George F.
TI Increasing genetic diversity of Zika virus in the Latin American
   outbreak
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
C1 [Shi, Weifeng; Zhang, Zhenjie] Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
   [Ling, Cheng] Beijing Univ Chem Technol, Coll Informat Sci & Technol, Beijing 100029, Peoples R China.
   [Carr, Michael J.] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido 0010020, Japan.
   [Carr, Michael J.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 4, Ireland.
   [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.
RP Shi, WF (corresponding author), Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn
OI Tong, Yigang/0000-0002-8503-8045; Carr, Michael/0000-0003-0011-6209
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 10
TC 20
Z9 22
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 6
PY 2016
VL 5
AR e68
DI 10.1038/emi.2016.68
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DT7IB
UT WOS:000381659200003
PM 27381219
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Horovitz, DDG
   Pone, MVD
   Pone, SM
   Salles, TRDS
   Boechat, MCB
AF Gandelman Horovitz, Dafne Dain
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Dias Saad Salles, Tania Regina
   Bastos Boechat, Marcia Cristina
TI Cranial bone collapse in microcephalic infants prenatally exposed to
   Zika virus infection
SO NEUROLOGY
LA English
DT Editorial Material
AB Brazil has been experiencing an outbreak of Zika virus, a flavivirus transmitted by Aedes mosquitoes. Since October 2015, more than 4,000 infants,(1) born to mothers suspected to have contracted this infection during pregnancy, have microcephaly(1,2) and CNS malformations (figure 1), including parenchymal and periventricular calcifications, ventriculomegaly, and cortical migration anomalies.(2) This suggests marked viral neurotropism. Upon performing CT, cranial malformations (figure 2) with a pointed occiput are also observed.
C1 [Gandelman Horovitz, Dafne Dain; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Dias Saad Salles, Tania Regina; Bastos Boechat, Marcia Cristina] Fundacao Oswaldo Cruz Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
RP Horovitz, DDG (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
EM dafne@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019
OI Moura Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
CR Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 1
TC 10
Z9 10
U1 0
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUL 5
PY 2016
VL 87
IS 1
BP 118
EP 119
DI 10.1212/WNL.0000000000002814
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA DR7VH
UT WOS:000380107300026
PM 27378805
OA Bronze
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Obama presses Congress to agree to Zika funding
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 4
PY 2016
VL 354
AR i3709
DI 10.1136/bmj.i3709
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR0EA
UT WOS:000379579600006
PM 27378764
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shah, S
AF Shah, Sonia
TI ZIKA. BIRD FLU. ANTIBIOTIC-RESISTANT SUPERBUGS.
SO NATION
LA English
DT Article
NR 0
TC 0
Z9 0
U1 0
U2 44
PU NATION CO INC
PI NEW YORK
PA 33 IRVING PLACE, 8TH FLOOR, NEW YORK, NY 10003 USA
SN 0027-8378
J9 NATION
JI Nation
PD JUL 4
PY 2016
VL 303
IS 1-2
BP 12
EP 15
PG 4
WC Political Science
SC Government & Law
GA DP4DL
UT WOS:000378445600009
DA 2020-07-08
ER

PT J
AU Lazarus, C
   Guichard, M
   Philippe, JM
   Paux, T
   Vallet, B
AF Lazarus, Clement
   Guichard, Marie
   Philippe, Jean-Marc
   Paux, Thierry
   Vallet, Benoit
TI The French experience of the threat posed by Zika virus
SO LANCET
LA English
DT Editorial Material
C1 [Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc] Gen Directorate Hlth, Publ Hlth Emergency Operat Ctr, F-75007 Paris, France.
   [Paux, Thierry] Gen Directorate Hlth, Monitoring & Hlth Safety Dept, F-75007 Paris, France.
   [Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc; Paux, Thierry; Vallet, Benoit] Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France.
RP Vallet, B (corresponding author), Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France.
EM benoit.vallet@sante.gouv.fr
CR Altona Diagnostics EN, REALSTAR ZIK VIR RT
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Conseil National Professionnel de Gynecologie et Obstetrique, ZIK GROSS
   Delfraissy JF, 2016, LANCET, V387, P2183, DOI 10.1016/S0140-6736(16)30059-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Haut Conseil de la Sante Publique, 2016, INF VIR ZIK PRIS CHA
   Haut Conseil de la Sante Publique, 2016, INF VIR ZIK INSCR LI
   Haut Conseil de la Sante Publique, 2016, PERS ATT VIR ZIK ACT
   Haut Conseil de la Sante Publique, 2016, MES GEST UT DELT DEP
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ministere des Aff aires etrangeres et du Developpement international, 2016, CONS VOYAG
   Ministere des Aff aires Sociales et de la Sante, 2015, MAL VIR ZIK MAL INF
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 2
Z9 2
U1 0
U2 62
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 2
PY 2016
VL 388
IS 10039
BP 9
EP 11
DI 10.1016/S0140-6736(16)30509-8
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9PM
UT WOS:000378828400008
PM 27397775
OA Bronze
DA 2020-07-08
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic
   Games?
SO LANCET
LA English
DT Letter
ID FOREIGN VISITORS; BRAZIL; DENGUE; CARNIVAL
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.
EM edmassad@usp.br
RI Wilder-Smith, Annelies/F-8751-2015; Massad, Eduardo/B-1169-2012
OI Massad, Eduardo/0000-0002-7200-2916
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Public Health England, ZIK VIR UPD TRAV ADV
   WHO, 2016, PREGN MAN CONT ZIK V
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 8
TC 18
Z9 18
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 2
PY 2016
VL 388
IS 10039
BP 25
EP 25
DI 10.1016/S0140-6736(16)30842-X
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9PM
UT WOS:000378828400016
PM 27323918
OA Bronze
DA 2020-07-08
ER

PT J
AU Bocanegra, C
   Sulleiro, E
   Soriano-Arandes, A
   Pou, D
   Suy, A
   Llurba, E
   Rodo, C
   Espasa, M
   Campins, M
   Martin, A
   Rodrigo, C
   Vazquez, A
   De Ory, F
   Sanchez-Seco, MP
   Pumarola, T
   Carreras, E
   Molina, I
AF Bocanegra, C.
   Sulleiro, E.
   Soriano-Arandes, A.
   Pou, D.
   Suy, A.
   Llurba, E.
   Rodo, C.
   Espasa, M.
   Campins, M.
   Martin, A.
   Rodrigo, C.
   Vazquez, A.
   De Ory, F.
   Sanchez-Seco, M. P.
   Pumarola, T.
   Carreras, E.
   Molina, I.
TI Zika virus infection in pregnant women in Barcelona, Spain
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Bocanegra, C.; Pou, D.] PROSICS Barcelona, Vall Hebron Drassanes, Trop Med & Int Hlth Unit, Barcelona, Spain.
   [Sulleiro, E.; Espasa, M.] Univ Hosp Vall Hebron, PROSICS Barcelona, Microbiol Dept, Barcelona, Spain.
   [Soriano-Arandes, A.] PROSICS Barcelona, Vall Hebron Drassanes, Trop Med & Int Hlth Unit, Pediat Dept, Barcelona, Spain.
   [Suy, A.; Llurba, E.; Rodo, C.; Carreras, E.] Univ Hosp Vall Hebron, Gynecol & Obstet Dept, Barcelona, Spain.
   [Campins, M.] Vall Hebron Univ Hosp, Prevent Med & Epidemiol Dept, Barcelona, Spain.
   [Martin, A.; Rodrigo, C.] Vall Hebron Univ Hosp, Pediat Dept, Barcelona, Spain.
   [Vazquez, A.; De Ory, F.; Sanchez-Seco, M. P.] Inst Salud Carlos III, Natl Microbiol Ctr, Madrid, Spain.
   [Pumarola, T.] Vall Hebron Univ Hosp, Microbiol Dept, Barcelona, Spain.
   [Molina, I.] Vall Hebron Univ Hosp, PROSICS Barcelona, Infect Dis Dept, Barcelona, Spain.
RP Bocanegra, C (corresponding author), PROSICS Barcelona, Vall Hebron Drassanes, Trop Med & Int Hlth Unit, Barcelona, Spain.
EM cristinabocanegra@gmail.com
RI Arandes, Antonio Soriano/Q-3348-2016; Rodrigo, Carlos/F-7602-2017;
   ESPASA, MATEU/L-4587-2014; Vazquez, Ana/H-4911-2013; Sune, Tomas
   Pumarola/F-7583-2017; Campins-Marti, Magda/N-9934-2017; RODO,
   CARLOTA/K-9179-2017; Pumarola, Tomas/AAB-5532-2019; Carreras,
   Elena/N-7698-2016; Soriano-Arandes, Antoni/G-6851-2013
OI Arandes, Antonio Soriano/0000-0001-9613-7228; Rodrigo,
   Carlos/0000-0003-1140-2585; ESPASA, MATEU/0000-0003-4822-1024; Vazquez,
   Ana/0000-0002-9872-3316; Sune, Tomas Pumarola/0000-0002-5171-7461;
   Campins-Marti, Magda/0000-0002-8841-6195; RODO,
   CARLOTA/0000-0001-8801-5677; Pumarola, Tomas/0000-0002-5171-7461;
   Carreras, Elena/0000-0003-3471-7248; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704; Llurba Olive, Elisa/0000-0003-4048-6407; Molina
   Romero, Israel/0000-0001-6642-7515; Sulleiro, Elena/0000-0002-9783-6060;
   Martin, Andrea/0000-0002-1715-153X; Suy Franch, Anna/0000-0003-2987-6105
FU Spanish Network on Tropical Diseases Research [RD12/0018/0021,
   RD12/0018/0006]
FX The authors particularly acknowledge the Spanish Network on Tropical
   Diseases Research, especially groups RD12/0018/0021 and RD12/0018/0006.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 4
TC 8
Z9 8
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUL
PY 2016
VL 22
IS 7
BP 648
EP 650
DI 10.1016/j.cmi.2016.03.025
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EX7JV
UT WOS:000403425400021
PM 27063354
OA Bronze
DA 2020-07-08
ER

PT J
AU Hennessey, MJ
   Fischer, M
   Panella, AJ
   Kosoy, OI
   Laven, JJ
   Lanciotti, RS
   Staples, JE
AF Hennessey, Morgan J.
   Fischer, Marc
   Panella, Amanda J.
   Kosoy, Olga I.
   Laven, Janeen J.
   Lanciotti, Robert S.
   Staples, J. Erin
TI Zika Virus Disease in Travelers Returning to the United States,
   2010-2014
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANSMISSION; CHIKUNGUNYA; INFECTIONS; DENGUE
AB Zika virus is an emerging mosquito-borne flavivirus that typically causes a mild febrile illness with rash, arthralgia, or conjunctivitis. Zika virus has recently caused large outbreaks of disease in southeast Asia, Pacific Ocean Islands, and the Americas. We identified all positive Zika virus test results performed at U.S. Centers for Disease Control and Prevention from 2010 to 2014. For persons with test results indicating a recent infection with Zika virus, we collected information on demographics, travel history, and clinical features. Eleven Zika virus disease cases were identified among travelers returning to the United States. The median age of cases was 50 years (range: 29-74 years) and six (55%) were male. Nine (82%) cases had their illness onset from January to April. All cases reported a travel history to islands in the Pacific Ocean during the days preceding illness onset, and all cases were potentially viremic while in the United States. Public health prevention messages about decreasing mosquito exposure, preventing sexual exposure, and preventing infection in pregnant women should be targeted to individuals traveling to or living in areas with Zika virus activity. Health-care providers and public health officials should be educated about the recognition, diagnosis, and prevention of Zika virus disease.
C1 [Hennessey, Morgan J.; Fischer, Marc; Panella, Amanda J.; Kosoy, Olga I.; Laven, Janeen J.; Lanciotti, Robert S.; Staples, J. Erin] Ctr Dis Control & Prevent CDC, Arboviral Dis Branch, Ft Collins, CO USA.
   [Hennessey, Morgan J.; Fischer, Marc; Panella, Amanda J.; Kosoy, Olga I.; Laven, Janeen J.; Lanciotti, Robert S.; Staples, J. Erin] Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Staples, JE (corresponding author), Ctr Dis Control & Prevent, Arboviral Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM estaples@cdc.gov
RI amsalu, ribka/G-8780-2019
CR Beaty B, 1995, DIAGNOSTIC PROCEDURE, P189
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2015, CHIK VIR 2014 FIN DA
   Centers for Disease Control and Prevention, 2015, ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Korhonen E, 2015, EUROSURVEILLANCE, V21, P30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, CHIK PAHO WHO DAT MA
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 34
TC 14
Z9 14
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2016
VL 95
IS 1
BP 212
EP 215
DI 10.4269/ajtmh.16-0049
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3UX
UT WOS:000400206100040
PM 27139440
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yadav, S
   Rawal, G
   Baxi, M
AF Yadav, Sankalp
   Rawal, Gautam
   Baxi, Mudit
TI Zika Virus: An Emergence of a New Arbovirus
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Article
DE Aedes; Flavivirus; French polynesia; Serum; Yap
ID INFECTIONS; TRANSMISSION; OUTBREAK; MOSQUITOS; NIGERIA; STATES; FEVER
AB The world is facing a new pandemic in progress due to a mosquito-borne flavivirus popularly known as Zika virus. The emergence of this new virus is really alarming with the sudden increment in the cases of microcephaly reported from Brazil. The findings attributing the involvement of Zika virus as the reason for congenital deformations in the babies born in afflicted areas have really shocked the world. The present knowledge about this virus is very limited and in the absence of further studies the precautions seems to be the best way of protection from this virus. The present article is a short review about this new virus.
C1 [Yadav, Sankalp] North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi 1100015, India.
   [Rawal, Gautam] Max Super Specialty Hosp, Resp Intens Care, New Delhi, India.
   [Baxi, Mudit] Sri Aurobindo Med Coll & Postgrad Inst, Dept Orthoped, Indore, Madhya Pradesh, India.
RP Yadav, S (corresponding author), North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi 1100015, India.
EM drsankalpyadav@gmail.com
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, ALL COUNTR TERR ACT
   Chan Melissa, NEW ZIKA VIRUS CASES
   Chatterjee P., ZIKA VIRUS HERES EVE
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Rawal G, 2016, INDIAN J IMMUNOLOGY, V1, P9
   Reuters Staff, EL SALV URG PREGN 20
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Sanders L., VIRUS SPREAD MOSQUIT
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P139
   Yadav S, 2015, INT J HLTH SCI RES, V5, P368
   Yadav S, 2015, INT J SCI RES REV, V4, P101
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P46
   Yadav S, 2016, J COMMUNITY HLTH MAN, V3, P41, DOI DOI 10.5958/2394-2770.2016.00014.4
   Yadav S, 2016, INT J HLTH SCI RES, V6, P364
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
   Yadav S, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.118.6455
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 54
TC 3
Z9 4
U1 0
U2 1
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD JUL
PY 2016
VL 10
IS 7
BP DM1
EP DM3
DI 10.7860/JCDR/2016/19170.8133
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EQ3KY
UT WOS:000397972300075
PM 27630846
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Brain Organoids Used for Zika Research
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT News Item
CR Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Toledo K., 2016, MINIBRAINS HELP UNDE
NR 2
TC 0
Z9 0
U1 0
U2 0
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUL
PY 2016
VL 44
IS 3
BP 181
EP 181
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EQ2UR
UT WOS:000397926800003
DA 2020-07-08
ER

PT J
AU Pacheco-Romero, J
AF Pacheco-Romero, Jose
TI ZIKA VIRUS - A NEW CHALENGE FOR OBSTETRICIANS AND GYNECOLOGISTS.
   CONTINUATION
SO REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA
LA English
DT Article
ID SEXUAL TRANSMISSION
C1 [Pacheco-Romero, Jose] Univ Nacl Mayor San Marcos, Fac Med, Gynecol & Obstet, Lima, Peru.
RP Pacheco-Romero, J (corresponding author), Univ Nacl Mayor San Marcos, Fac Med, Gynecol & Obstet, Lima, Peru.
EM jpachecoperu@yahoo.com
CR [Anonymous], 2016, US TODAY
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Franca GV, 2016, LANCET
   Goodman B., 2016, NEW ZIKA THREAT INFA
   Goodman B., 2016, MEDSCAPE OB GYN 0811
   Grills A, 2016, MORBI MORTAL WEEKLY, V65
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Li H, 2016, CELL STEM CELL
   Martines RB, 2015, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6506e1er
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Medscape Ob/Gyn & Women's Health, 2016, REUTERS HLTH IN 0725
   Ministerio de Salud, 2016, SEMANA EPIDEMIO 0801
   Nicks BA, 2016, MEDSCAPE
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Pacheco-Romero J, 2016, REV PERU GINECOL OBS, V62, P219
   Pan American Health Organization/World Health Organization, 2015, GEOGR DISTR CONF AUT
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ramsey L, 2016, BUSINESS ISNIDE 0727
   Retallach H, ZIKA VIRUS HUMAN PLA
   Russell K, 2016, MORBIDITY MORTALITY
   Sun LH, 2016, WASHINGTON POST 0728
   The American College of Obstetricians and Gynecologists, 2016, PRACT ACT NEW TRAV R
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387
   Whitman H, 2016, MEDSCAPE OB GYN 0805
NR 26
TC 4
Z9 4
U1 0
U2 4
PU SOC PERUANA OBSTETRICIA & GINECOLOGIA
PI LIMA
PA AV ARUMBURU 321, OFICINA 4, SAN ISIDRO, LIMA, 27, PERU
SN 2304-5124
J9 REV PERU GINECOL OBS
JI Rev. Peru. Ginecol. Obstet.
PD JUL-SEP
PY 2016
VL 62
IS 3
BP 247
EP 260
PG 14
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EM3VN
UT WOS:000395242800006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Thurston, MM
   Nykamp, D
AF Thurston, Maria Miller
   Nykamp, Diane
TI Insect Repellents for Zika Virus Prevention
SO US PHARMACIST
LA English
DT Article
ID EFFICACY
AB Zika virus, a growing global public-health concern, is primarily transmitted by infected Aedes species mosquitoes and has been associated with microcephaly in infants whose mothers were infected during pregnancy. Prevention of Zika virus is imperative, as there is currently no vaccine or specific treatment. In addition to practicing exposure avoidance and using physical barriers, persons at risk should also apply topical mosquito repellents and insecticides for optimal protection. DEET, IR3535, oil of lemon eucalyptus, and picaridin are the insect repellents recommended by the CDC. It is important to advise patients to follow label instructions and to reapply the product as directed for maximal efficacy and safety. Permethrin may be sprayed on gear and clothing for extra protection.
C1 [Thurston, Maria Miller; Nykamp, Diane] Mercer Univ, Pharm Practice, Coll Pharm, Macon, GA 31207 USA.
   [Thurston, Maria Miller] WellStar Atlanta Med Ctr, Atlanta, GA 30312 USA.
   [Nykamp, Diane] Emory St Josephs Hosp, Atlanta, GA USA.
RP Thurston, MM (corresponding author), Mercer Univ, Pharm Practice, Coll Pharm, Macon, GA 31207 USA.; Thurston, MM (corresponding author), WellStar Atlanta Med Ctr, Atlanta, GA 30312 USA.
CR American Academy of Pediatrics, 2016 SUMM SAF TIPS
   Buff W, 2015, HDB NONPRESCRIPTION
   Byrne S., CONSUMER REPORTS
   CDC, TRANSM RUSKS
   CDC, DIAGN TEST
   CDC, PREGN WOM
   CDC, ZIK VIR DIS
   CDC, AV MOSQ BIT
   CDC, AR ZIK
   CDC, SYMPT DIAGN TREATM
   CDC, HEALTHC PROV
   DEET, 2016, DEET LEX DRUGS
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Environmental Protection Agency (EPA), REG SKIN APPL REP
   EPA, FIND INS REP IS RIGH
   EPA, US INS REP SAF EFF
   EPA, 2016, MIN RISK PEST EX FIF
   FDA, INS REP US SAF CHILD
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Health Alert Network, REC MAN REP ZIK VIR
   Merck Veterinary Manual, ECT US SMALL AN
   National Institute for Occupational Safety and Health, MOSQ BORN DIS
   National Institute of Allergy and Infectious Diseases, NIAID RES APPR ZIK V
   NLM Outreach and Specific Populations Branch, ZIK VIR HLTH
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rutledge CR, MOSQUITO REPELLENTS
   The Centers for Disease Control and Prevention (CDC), YELLOW BOOK
   World Health Organization, ZIK OR SPREAD MOSQ B
NR 29
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD JUL
PY 2016
VL 41
IS 7
BP 47
EP 50
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EF1XD
UT WOS:000390117500021
DA 2020-07-08
ER

PT J
AU Lowe, NK
AF Lowe, Nancy K.
TI The Threat of the Zika Virus to Fetal Development
SO JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING
LA English
DT Editorial Material
ID UNITED-STATES; INTERIM GUIDELINES; PREGNANT-WOMEN; INFECTION
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Centers for Disease Control and Prevention, 2016, ZIK GUILL BARR SYNDR
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   U.S. Department of Health and Human Services, 2016, ZIK VIR HLTH INF RES
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0884-2175
EI 1552-6909
J9 JOGNN-J OBST GYN NEO
JI JOGNN
PD JUL-AUG
PY 2016
VL 45
IS 4
BP 463
EP 464
DI 10.1016/j.jogn.2016.06.005
PG 2
WC Nursing; Obstetrics & Gynecology
SC Nursing; Obstetrics & Gynecology
GA ED4SW
UT WOS:000388842700002
PM 27289006
DA 2020-07-08
ER

PT J
AU Naeem, Z
AF Naeem, Zahid
TI Zika - Global Concern
SO INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS
LA English
DT Editorial Material
ID VIRUS
C1 [Naeem, Zahid] Qassim Univ, Coll Med, Dept Family & Community Med, Buraydah, Saudi Arabia.
RP Naeem, Z (corresponding author), Qassim Univ, Coll Med, Dept Family & Community Med, Buraydah, Saudi Arabia.
EM zahidnaeem@qumed.edu.sa
CR Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Rasooldeen Mohammed, ARAB NEWS
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   World Health Organization, ZIK VIR FACT SHEET
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ACAD PUBLISHING & TRANSLATION
PI BURAIDAH
PA COLL MEDICINE, QASSIM UNIV, PO BOX 6655, BURAIDAH, 51432, SAUDI ARABIA
SN 1658-3639
J9 INT J HEALTH SCI-IJH
JI Int. J. Health Sci.-IJHS
PD JUL-SEP
PY 2016
VL 10
IS 3
BP V
EP VII
DI 10.12816/0048726
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB0YU
UT WOS:000387073700001
PM 27610070
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Emerging Zika virus infection and bioethical considerations
SO EINSTEIN-SAO PAULO
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Surin Rajabhat Univ, Surin, Thailand.
CR Capua I, 2016, NATURE, V534, P326, DOI 10.1038/534326c
   Donovan GK, 2014, PHILOS ETHICS HUM ME, V9, DOI 10.1186/1747-5341-9-15
   Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Bueno MAS, 2016, EINSTEIN-SAO PAULO, V14, pXIII, DOI 10.1590/S1679-45082016ED3725
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 6
TC 0
Z9 0
U1 0
U2 3
PU INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN
PI SAO PAULO SP
PA AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL
SN 1679-4508
EI 2317-6385
J9 EINSTEIN-SAO PAULO
JI Einstein
PD JUL-SEP
PY 2016
VL 14
IS 3
BP 450
EP 450
DI 10.1590/S1679-45082016CE3822
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ3CD
UT WOS:000385720600029
PM 27759838
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Maia, M
   Ventura, BV
   Linden, VVD
   Araojo, EB
   Ramos, RC
   Rocha, MAW
   Carvalho, DCG
   Belfort, R
   Ventura, LO
AF Ventura, Camila V.
   Maia, Mauricio
   Ventura, Bruna V.
   Linden, Vanessa V. D.
   Araojo, Eveline B.
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Carvalho, Durce C. G.
   Belfort, Rubens, Jr.
   Ventura, Liana O.
TI Response letter: Serological evidence confirms the presumed diagnosis of
   Zika virus congenital infection in infants with microcephaly and ocular
   findings
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
C1 [Ventura, Camila V.; Ventura, Bruna V.; Araojo, Eveline B.; Ventura, Liana O.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Bruna V.; Araojo, Eveline B.; Ventura, Liana O.] Hosp Olhos HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Ventura, Bruna V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Maia, Mauricio; Belfort, Rubens, Jr.] Inst Visiao, Sao Paulo, SP, Brazil.
   [Linden, Vanessa V. D.] Hosp Barao de Lucena, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Carvalho, Durce C. G.] HUOC, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ventura, Liana Vieira/N-6151-2018; Ventura,
   Bruna/N-2724-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Liana
   Vieira/0000-0001-6529-6883; Ventura, Bruna/0000-0003-4333-3932
CR Cugola F. R., 2016, NATURE
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2016, JAMA IN PRESS
   Yakob L., 2016, LANCET GLOB HLTH
NR 5
TC 0
Z9 0
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JUL-AUG
PY 2016
VL 79
IS 4
BP 280
EP 280
PG 1
WC Ophthalmology
SC Ophthalmology
GA DX4EN
UT WOS:000384334100025
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Ocular finding in Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ilesha, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pimpri, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House Bangkhae, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
RI Ventura, Bruna/N-2724-2018; Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Bruna/0000-0003-4333-3932; Ventura, Liana Vieira
   O/0000-0001-6529-6883
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 1
Z9 1
U1 0
U2 4
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JUL-AUG
PY 2016
VL 79
IS 4
BP 280
EP 280
DI 10.5935/0004-2749.20160081
PG 1
WC Ophthalmology
SC Ophthalmology
GA DX4EN
UT WOS:000384334100024
PM 27626161
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Basundra, S
   Hiremath, RN
   Khajuria, R
   Ghodke, S
AF Basundra, Sumeena
   Hiremath, Ravishekar N.
   Khajuria, Rakesh
   Ghodke, Sandhya
TI Zika Virus: An Emerging Public Health Challenge
SO JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY
LA English
DT Review
DE Zika virus (ZIKV); congenital microcephaly; Integrated Vector Management
   (IVM)
ID DENGUE; CONTAINMENT; INFECTIONS; WOLBACHIA; THAILAND; EBOLA
AB Emerging infectious diseases comprise a substantial proportion of global morbidity and mortality. The world has been hit by Zika virus (ZIKV) after it was able to surmount an effective public health response for its control. ZIKV disease is an emerging mosquito-borne disease which occurred as large outbreaks in Yap since 2007, Polynesia in 2013 and Brazil in 2015. ZIKV infection in pregnant women has been observed to be associated with congenital microcephaly with neurological and autoimmune sequelae in general population of Brazil. The incubation period of ZIKV varies from few days to weeks. Only 20% of infected cases have symptoms like any other arboviral illness. ZIKV is diagnosed using RT-PCR (reverse transcriptase-polymerase chain reaction) and virus isolation from blood samples. The treatment comprises of relief of symptoms by conservative management with no specific vaccine being available. The prevention and control of ZIKV is based on reduction of vector density by Integrated Vector Management and personal protection measures. As per Indian scenario, Ministry of Health had issued guidelines based on effective surveillance, risk communication, laboratory and travel regulations. Approaches to such a potential global health security threat should be consistent, proactive, and should involve coordinated, multi-pronged, multilateral collaborative efforts since the concern is at the highest and immediate because of Global epidemic, Rio de Janeiro Olympic Games starting from Aug 5-21, 2016 and strong association with microcephaly. Most importantly the need of the hour is the development of vaccine for protection especially the young women who are in the reproductive age groups. The research for which is ongoing as far as the current situation of global epidemic response is concerned.
C1 [Basundra, Sumeena] Maulana Azad Med Coll, Dept Community Med, New Delhi 110002, Delhi, India.
   [Hiremath, Ravishekar N.] BLDE Univ, Shri BM Patil Med Coll, Dept Community Med, Vijayapur 562135, Karnataka, India.
   [Khajuria, Rakesh] Dept Hlth, Mathura 281001, Uttar Pradesh, India.
   [Ghodke, Sandhya] Dept Hlth, Jammu Div 182101, Jammu & Kashmir, India.
RP Hiremath, RN (corresponding author), BLDE Univ, Shri BM Patil Med Coll, Dept Community Med, Vijayapur 562135, Karnataka, India.
EM drshekar80@gmail.com
RI amsalu, ribka/G-8780-2019
CR [Anonymous], 2015, PAHO WHO EP AL ZIK V
   [Anonymous], 2014, 1 M IHR EM COMM 2014
   [Anonymous], 2016, CDC ZIK VIR
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bennett John E., 2014, PRINCIPLES PRACTICE, P1881
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, CDC HLTH ADV REC MAN
   Cha AE, 2016, WHO ZIKA VIRUS SPREA
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Eliminate_ Dengue_ Program, 2016, EL DENG PROGR WOLB
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Grenoble R, 2016, WHO DECLARES PUBLIC
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kalra S, 2014, J GLOB INFECT DIS, V6, P164, DOI 10.4103/0974-777X.145247
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maron DF, 2015, SCI AM
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oxitec_ Ltd, 2016, AED AEG OX513A
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, WHO EXP PRIOR VACC D
NR 40
TC 0
Z9 0
U1 0
U2 15
PU KRISHNA INST MEDICAL SCIENCES UNIV
PI MAHARASHTRA
PA MALKAPUR, KARAD, MAHARASHTRA, 415 539, INDIA
SN 2231-4261
J9 J KRISHNA INST MED S
JI J. Krishna Inst. Med. Sci. Univ.
PD JUL-SEP
PY 2016
VL 5
IS 3
BP 5
EP 12
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DY1VK
UT WOS:000384882300002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Engel, J
AF Engel, Jeffrey
TI Of Mosquito Nets and Condoms: The Zika Virus Challenge
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Editorial Material
ID UNITED-STATES; TRANSMISSION; DENGUE
C1 [Engel, Jeffrey] Council State & Terr Epidemiologists, 2872 Woodcock Blvd,Ste 250, Atlanta, GA 30341 USA.
RP Engel, J (corresponding author), Council State & Terr Epidemiologists, 2872 Woodcock Blvd,Ste 250, Atlanta, GA 30341 USA.
EM jengel@cste.org
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
NR 9
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JUL-AUG
PY 2016
VL 22
IS 4
BP 323
EP 325
DI 10.1097/PHH.0000000000000431
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS5PA
UT WOS:000380833100005
PM 27223311
DA 2020-07-08
ER

PT J
AU Allen, M
   Blumenstock, JS
AF Allen, Meredith
   Blumenstock, James S.
TI State of Public Health Public Health Acts to Detect, Respond to, and
   Prevent the Latest Public Health Threat-Zika Virus Disease
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Editorial Material
C1 [Allen, Meredith; Blumenstock, James S.] Assoc State & Terr Hlth Officials, 2231 Crystal Dr,Ste 450, Arlington, VA 22202 USA.
RP Blumenstock, JS (corresponding author), Assoc State & Terr Hlth Officials, 2231 Crystal Dr,Ste 450, Arlington, VA 22202 USA.
EM jblumenstock@astho.org
CR Hadler JL, 2014, MMWR-MORBID MORTAL W, V63, P281
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JUL-AUG
PY 2016
VL 22
IS 4
BP 424
EP 426
DI 10.1097/PHH.0000000000000432
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS5PA
UT WOS:000380833100020
PM 27223315
DA 2020-07-08
ER

PT J
AU Pomin, VH
AF Pomin, Vitor H.
TI The contribution of Glycobiology to the Zika outbreak in the Americas
SO GLYCOBIOLOGY
LA English
DT Editorial Material
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ANTI-HIV ACTIVITY; HEPARAN-SULFATE
   PROTEOGLYCANS; MOLECULAR-WEIGHT CARRAGEENANS; HERPES-SIMPLEX-VIRUS;
   ANTI-HIV-1 ACTIVITY; DEXTRAN SULFATE; INFECTION; BINDING; TRANSMISSION
C1 [Pomin, Vitor H.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Program Glycobiol, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Pomin, Vitor H.] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941913 Rio De Janeiro, RJ, Brazil.
RP Pomin, VH (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Program Glycobiol, BR-21941590 Rio De Janeiro, RJ, Brazil.; Pomin, VH (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho, BR-21941913 Rio De Janeiro, RJ, Brazil.
EM pominvh@bioqmed.ufrj.br
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Ahmadi A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825203
   Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3
   Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k
   BABA M, 1988, ANTIVIR RES, V9, P335, DOI 10.1016/0166-3542(88)90035-6
   BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132
   BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742
   BARZU T, 1993, J MED CHEM, V36, P3546, DOI 10.1021/jm00075a009
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BUSSO ME, 1990, ANTIMICROB AGENTS CH, V34, P1991, DOI 10.1128/AAC.34.10.1991
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Connell BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00385
   Connell BJ, 2012, CHEM BIOL, V19, P131, DOI 10.1016/j.chembiol.2011.12.009
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   D'Ortenzio E, 2016, N ENGL J ME IN PRESS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARTMAN NR, 1990, AIDS RES HUM RETROV, V6, P805, DOI 10.1089/aid.1990.6.805
   JURKIEWICZ E, 1989, AIDS, V3, P423, DOI 10.1097/00002030-198907000-00003
   Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MCCLURE M O, 1991, Antiviral Chemistry and Chemotherapy, V2, P149
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NAGUMO T, 1988, JPN J CANCER RES, V79, P9, DOI 10.1111/j.1349-7006.1988.tb00003.x
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167
   Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848
   Pomin VH, 2016, CURR TOP MED CHEM
   Pomin VH, 2015, MED RES REV, V35, P1195, DOI 10.1002/med.21356
   Pomin VH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00005
   Pomin VH, 2014, MAR DRUGS, V12, P232, DOI 10.3390/md12010232
   Seeberger PH, 2005, NAT REV DRUG DISCOV, V4, P751, DOI 10.1038/nrd1823
   SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song BH, 2001, J GEN VIROL, V82, P2405, DOI 10.1099/0022-1317-82-10-2405
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200
   Wang SC, 2007, INT J BIOL MACROMOL, V41, P369, DOI 10.1016/j.ijbiomac.2007.05.008
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Yamada T, 1997, CARBOHYD POLYM, V32, P51, DOI 10.1016/S0144-8617(96)00128-2
   Yamada T, 2000, CARBOHYD POLYM, V41, P115, DOI 10.1016/S0144-8617(99)00083-1
NR 48
TC 2
Z9 2
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0959-6658
EI 1460-2423
J9 GLYCOBIOLOGY
JI Glycobiology
PD JUL
PY 2016
VL 26
IS 7
BP 680
EP 682
DI 10.1093/glycob/cww057
PG 3
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DY0DB
UT WOS:000384766000001
PM 27261195
OA Bronze
DA 2020-07-08
ER

PT J
AU Storrs, C
AF Storrs, Carina
TI As Zika Reaches US Shores, States And Cities Struggle To Respond
SO HEALTH AFFAIRS
LA English
DT Article
EM storrsc@gmail.com
CR Brasil P, 2016, N ENGL J MED
   CDC, TOP 10 ZIK RESP PLAN
   CDC, ZIK ACT PLAN ZAP SUM
   CDC, ZIK VIR DIS US 2015
   CDC, 2011, PUBL HLTH PREP CAP N
   CDC, ESTIMATED RANG AED A
   CDC, ZIK VIR RISK BAS PRE
   Cohn M., 2016, BALTIMORE SUN
   Florida Department of Health, DENG FEV
   Gardner Timothy, 2016, REUTERS
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hauser C, 2016, NY TIMES
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Trust for America's Health, 2015, OUTBR PROT AM INF DI
NR 14
TC 0
Z9 0
U1 0
U2 2
PU PROJECT HOPE
PI BETHESDA
PA 7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA
SN 0278-2715
J9 HEALTH AFFAIR
JI Health Aff.
PD JUL
PY 2016
VL 35
IS 7
BP 1156
EP 1159
DI 10.1377/hlthaff.2016.0627
PG 4
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA DY0QN
UT WOS:000384801400002
PM 27385228
OA Bronze
DA 2020-07-08
ER

PT J
AU Bateman, C
AF Bateman, Chris
TI Zika - a wake-up call for continuous fetal monitoring
SO SAMJ SOUTH AFRICAN MEDICAL JOURNAL
LA English
DT News Item
EM chrisb@hmpg.co.za
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SA MEDICAL ASSOC
PI PRETORIA
PA BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3,
   PRETORIA, 0002, SOUTH AFRICA
SN 0256-9574
EI 2078-5135
J9 SAMJ S AFR MED J
JI SAMJ S. Afr. Med. J.
PD JUL
PY 2016
VL 106
IS 7
BP 18
EP 18
DI 10.7196/SAMJ.2016.v106i7.11094
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX1XG
UT WOS:000384159700011
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Preparing for Local Mosquito-borne Transmission of Zika Virus-United
   States, 2016
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
CR 2016, MMWR, V65, P352
NR 1
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2016
VL 63
IS 1
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FH
UT WOS:000381226600003
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI FDA Allows Use of Investigational Test to Screen Blood Donations for
   Zika Virus
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2016
VL 63
IS 1
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FH
UT WOS:000381226600004
DA 2020-07-08
ER

PT J
AU Moreira, J
   Lamas, CC
   Siqueira, A
AF Moreira, Jose
   Lamas, Cristiane C.
   Siqueira, Andre
TI Sexual Transmission of Zika Virus: Implications for Clinical Care and
   Public Health Policy
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
C1 [Moreira, Jose; Lamas, Cristiane C.; Siqueira, Andre] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Av Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
   [Moreira, Jose] Minist Saude, Inst Nacl Saude, Maputo, Mozambique.
RP Moreira, J (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Av Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM jose.moreira@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010
OI Siqueira, Andre M/0000-0003-2208-0294
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 9
TC 10
Z9 10
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 1
PY 2016
VL 63
IS 1
BP 141
EP U168
DI 10.1093/cid/ciw211
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FH
UT WOS:000381226600026
PM 27048746
OA Bronze
DA 2020-07-08
ER

PT J
AU Alkhaibari, AM
   Carolino, AT
   Yavasoglu, SI
   Maffeis, T
   Mattoso, TC
   Bull, JC
   Samuels, RI
   Butt, TM
AF Alkhaibari, Abeer M.
   Carolino, Aline T.
   Yavasoglu, Sare I.
   Maffeis, Thierry
   Mattoso, Thalles C.
   Bull, James C.
   Samuels, Richard I.
   Butt, Tariq M.
TI Metarhizium brunneum Blastospore Pathogenesis in Aedes aegypti Larvae:
   Attack on Several Fronts Accelerates Mortality
SO PLOS PATHOGENS
LA English
DT Article
ID PAECILOMYCES-FUMOSOROSEUS DEUTEROMYCOTINA; LIQUID CULTURE PRODUCTION;
   ENTOMOPATHOGENIC FUNGUS; TOLYPOCLADIUM-CYLINDROSPORUM;
   ANOPHELES-GAMBIAE; IN-VITRO; SURFACE CHARACTERISTICS; LARVICIDAL
   ACTIVITY; INVASIVE MOSQUITOS; ISRAELENSIS BTI
AB Aedes aegypti is the vector of a wide range of diseases (e.g. yellow fever, dengue, Chikungunya and Zika) which impact on over half the world's population. Entomopathogenic fungi such as Metarhizium anisopliae and Beauveria bassiana have been found to be highly efficacious in killing mosquito larvae but only now are the underlying mechanisms for pathogenesis being elucidated. Recently it was shown that conidia of M. anisopliae caused stress induced mortality in Ae. aegypti larvae, a different mode of pathogenicity to that normally seen in terrestrial hosts. Blastospores constitute a different form of inoculum produced by this fungus when cultured in liquid media and although blastospores are generally considered to be more virulent than conidia no evidence has been presented to explain why. In our study, using a range of biochemical, molecular and microscopy methods, the infection process of Metarhizium brunneum (formerly M. anisopliae) ARSEF 4556 blastospores was investigated. It appears that the blastospores, unlike conidia, readily adhere to and penetrate mosquito larval cuticle. The blastospores are readily ingested by the larvae but unlike the conidia are able infect the insect through the gut and rapidly invade the haemocoel. The fact that pathogenicity related genes were upregulated in blastospores exposed to larvae prior to invasion, suggests the fungus was detecting host derived cues. Similarly, immune and defence genes were upregulated in the host prior to infection suggesting mosquitoes were also able to detect pathogen-derived cues. The hydrophilic blastospores produce copious mucilage, which probably facilitates adhesion to the host but do not appear to depend on production of Pr1, a cuticle degrading subtilisin protease, for penetration since protease inhibitors did not significantly alter blastospore virulence. The fact the blastospores have multiple routes of entry (cuticle and gut) may explain why this form of the inoculum killed Ae. aegypti larvae in a relatively short time (12-24hrs), significantly quicker than when larvae were exposed to conidia. This study shows that selecting the appropriate form of inoculum is important for efficacious control of disease vectors such as Ae. aegypti.
C1 [Alkhaibari, Abeer M.; Bull, James C.; Butt, Tariq M.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.
   [Carolino, Aline T.; Mattoso, Thalles C.; Samuels, Richard I.] State Univ North Fluminense, Dept Entomol & Plant Pathol, Rio De Janeiro, Brazil.
   [Yavasoglu, Sare I.] Adnan Menderes Univ, Fac Arts & Sci, Dept Biol, Aydin, Turkey.
   [Maffeis, Thierry] Swansea Univ, Coll Engn, Swansea, W Glam, Wales.
RP Butt, TM (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.
EM t.butt@swansea.ac.uk
RI Alkhaibari, Abeer/R-8963-2017; Samuels, Richard I/R-6042-2017; Samuels,
   Richard/I-2108-2019
OI Alkhaibari, Abeer/0000-0003-4376-2438; Samuels, Richard
   I/0000-0003-1814-2456; Samuels, Richard/0000-0003-1814-2456; Bull,
   James/0000-0002-4373-6830; Teixeira Carolino, Aline/0000-0001-5240-5171;
   Cardoso Mattoso, Thalles/0000-0001-5675-1493; Butt,
   Tariq/0000-0002-8789-9543
FU ERASMUS; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); European Regional Development Fund, Ireland-Wales
   Programme (INTERREG 4A); Saudi Arabian Cultural Bureau, London; Tabuk
   University, Kingdom of Saudi Arabia; ERASMUS; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de JaneiroCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); European Regional
   Development Fund, Ireland-Wales Programme (INTERREG 4A); Saudi Arabian
   Cultural Bureau, London; Tabuk University, Kingdom of Saudi Arabia
FX Funding for this research was obtained from ERASMUS
   (http://www.erasmusprogramme.com) for SIY, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior www.capes.gov.br for RIS
   ATC TCM, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   www.cnpq.br for RIS, Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro www.faperj.br for RIS, European Regional Development Fund,
   Ireland-Wales Programme (INTERREG 4A)
   http://wefo.wales.gov.uk/programmes/territorial/irelandwales/?lang=en)
   for TMB, Saudi Arabian Cultural Bureau, London
   http://uksacb.org/uk-en1313/ for AMA, and Tabuk University, Kingdom of
   Saudi Arabia https://www.ut.edu.sa/web/university for AMA. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ADAMEK L, 1965, FOLIA MICROBIOL, V10, P255, DOI 10.1007/BF02875956
   [Anonymous], 2010, Wkly Epidemiol Rec, V85, P33
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Barelli L, 2011, FUNGAL BIOL-UK, V115, P1174, DOI 10.1016/j.funbio.2011.08.003
   Behle RW, 2006, SOUTHWEST ENTOMOL, V31, P289
   BOUCIAS DG, 1982, J INVERTEBR PATHOL, V39, P338, DOI 10.1016/0022-2011(82)90058-1
   Bukhari T, 2012, PARASITE VECTOR, V4, P1
   Bukhari T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-22
   Butt TM, 2016, ADV GENET, V94, P307, DOI 10.1016/bs.adgen.2016.01.006
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5
   Butt TM, 2001, FUNGI AS BIOCONTROL
   Doss RP, 1999, APPL ENVIRON MICROB, V65, P404
   Eastwood DC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-66
   Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014
   Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046
   Greenfield BPJ, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140193
   Greenfield BPJ, 2015, BIOCONTROL SCI TECHN, V25, P487, DOI 10.1080/09583157.2014.989813
   HALL RA, 1979, ENTOMOPHAGA, V24, P191, DOI 10.1007/BF02375133
   HEGEDUS DD, 1992, APPL MICROBIOL BIOT, V36, P785, DOI 10.1007/BF00172195
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Holder DJ, 2007, MICROBIOL-SGM, V153, P3448, DOI 10.1099/mic.0.2007/008524-0
   Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005
   Ikeda K, 2012, ROLE EXTRACELLULAR M
   Jackson M, 1999, ARTHROPOD MANAGEMENT, V24, pL8, DOI 10. 1371/ journal. pone. 0081686
   Jackson MA, 1997, J IND MICROBIOL BIOT, V19, P180, DOI 10.1038/sj.jim.2900426
   Jackson MA, 1997, MYCOL RES, V101, P35, DOI 10.1017/S0953756296002067
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kannan SK, J BIOTECHNOLOGY, V7
   Lacey LA, 1998, MYCOPATHOLOGIA, V142, P17, DOI 10.1023/A:1006963016316
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MAGALHAES BP, 1990, J INVERTEBR PATHOL, V55, P284, DOI 10.1016/0022-2011(90)90065-E
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MIRANPURI GS, 1990, VET PARASITOL, V37, P155, DOI 10.1016/0304-4017(90)90070-R
   Mohanty SS, 2008, WORLD J MICROB BIOT, V24, P2283, DOI 10.1007/s11274-008-9742-2
   Morgan G.A., 2012, IBM SPSS INTRO STAT
   NADEAU MP, 1994, J AM MOSQUITO CONTR, V10, P487
   Ortiz-Urquiza Almudena, 2013, Insects, V4, P357, DOI 10.3390/insects4030357
   Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046
   PENDLAND JC, 1993, J BACTERIOL, V175, P5962, DOI 10.1128/JB.175.18.5962-5969.1993
   Pendland JC, 1996, CELL TISSUE RES, V285, P57, DOI 10.1007/s004410050620
   Pendland JC, 1991, ATTACHMENT MYCOPATHO, P101
   Pereira CR, 2009, BIOCONTROL SCI TECHN, V19, P881, DOI 10.1080/09583150903147659
   R Core Team, 2015, LANG ENV STAT COMP
   Rangel DEN, 2005, J INVERTEBR PATHOL, V88, P116, DOI 10.1016/j.jip.2004.11.007
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   RIBA G, 1986, J AM MOSQUITO CONTR, V2, P469
   Robinson R. K., 1966, Pesticides Abstracts, V12, P131
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Scholte EJ, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-45
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Screen S, 1998, GENE, V221, P17, DOI 10.1016/S0378-1119(98)00430-2
   Shapiro-Ilan DI, 2008, J INVERTEBR PATHOL, V99, P312, DOI 10.1016/j.jip.2008.07.001
   Shockley M., 2014, MASS PRODUCTION BENE
   SOARES GG, 1982, ENTOMOPHAGA, V27, P283, DOI 10.1007/BF02374812
   STLEGER RJ, 1989, EXP MYCOL, V13, P274, DOI 10.1016/0147-5975(89)90049-2
   Tilquin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003432
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Vega FE, 1999, MYCOPATHOLOGIA, V147, P33, DOI 10.1023/A:1007011801491
   Vega FE, 1997, J INVERTEBR PATHOL, V70, P209, DOI 10.1006/jipa.1997.4693
   Vestergaard S, 1999, J INVERTEBR PATHOL, V73, P25, DOI 10.1006/jipa.1998.4802
   Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0
   Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200
   Wang YB, 2013, WORLD J MICROB BIOT, V29, P2429, DOI 10.1007/s11274-013-1433-y
   WHO, 2015, DENG SEV DENG
   WHO, 2015, EP UPD ZIK VIR INF 1
   Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6
NR 70
TC 20
Z9 20
U1 2
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2016
VL 12
IS 7
AR e1005715
DI 10.1371/journal.ppat.1005715
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DW0XN
UT WOS:000383366400015
PM 27389584
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Graul, A
   Tremosa, L
   Dulsat, C
AF Graul, A.
   Tremosa, L.
   Dulsat, C.
TI ZIKA TESTING: ANIMAL MODELS AND ASSAYS
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Zika virus; Animal models; Assays; Tests
ID VIRUS
AB The abrupt appearance last year of Zika virus disease and its rapid spread throughout the American continent caught scientists unprepared, with a pipeline devoid of any effective drugs and vaccines. Recent publications and reports concerning novel animal models of Zika-essential for the preclinical testing of new drugs and biologics-as well as diagnostic tests for use in research and in the field indicate early progress in facing this new viral threat, although much work remains to be done.
C1 [Graul, A.; Tremosa, L.; Dulsat, C.] Thomson Reuters, Barcelona, Spain.
RP Graul, A (corresponding author), Thomson Reuters, Barcelona, Spain.
EM ann.graul@thomsonreuters.com
CR [Anonymous], 2016, DON SCREEN REC RED R
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Julander J., 2016, 29 INT C ANT RES ICA
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
NR 6
TC 0
Z9 0
U1 0
U2 3
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD JUL
PY 2016
VL 41
IS 7
BP 423
EP 427
DI 10.1358/dof.2016.041.07.2516438
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DV8EJ
UT WOS:000383170000004
DA 2020-07-08
ER

PT J
AU Frazer, C
   Hussey, LC
   Whitworth, BS
   Paleo, N
AF Frazer, Christine
   Hussey, Leslie C.
   Whitworth, Bobbie Sue
   Paleo, Nicole
TI In the Midst of Zika: The Role of Childbirth Professionals
SO INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION
LA English
DT Article
DE Zika virus; Aedes mosquitos; Aedes aegypti mosquito; microcephaly; fetal
   outcomes; childbirth professional role
ID VIRUS; OUTBREAK
AB The rapid spread of Zika virus presents a public health crisis. Zika is a mosquito-borne virus transmitted through the bite of infected Aedes mosquitoes. Symptoms of Zika virus develop 2 to 12 days after the bite and range from no symptoms to maculopapular rash, fever, arthralgia, muscle pain, headache, and conjunctivitis. Zika virus is especially dangerous to pregnant women as it can cause fetal brain defects, hearing loss, ocular abnormalities, and central nervous system defects. Because there is no vaccine or specific treatment, it is imperative for childbirth professionals to arm themselves with the most up-to-date information. This article aims to provide childbirth professionals with an overview of Zika virus, the recommended prevention measures, and their role in preventing the spread of Zika virus and its consequences.
C1 [Frazer, Christine; Hussey, Leslie C.] Walden Univ, Minneapolis, MN 55401 USA.
   [Hussey, Leslie C.] Walden Univ, Nursing Program, Minneapolis, MN USA.
   [Whitworth, Bobbie Sue] Walden Univ, Core Acad Program, Minneapolis, MN USA.
   [Whitworth, Bobbie Sue] Walden Univ, MSN Program, Minneapolis, MN USA.
RP Frazer, C (corresponding author), Walden Univ, Minneapolis, MN 55401 USA.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Center for Disease Control and Prevention, 2016, ZIK VIR DIS US 2016
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, 2016, TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, PREVENTION
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   LaFrance A, 2016, ATLANTIC
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCabe ERB, 2016, ZIKA VIRUS INFECT EV
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2016, PREGN MAN CONT ZIK V
   WHO (World Health Organization) report, 2016, NEUR SYNDR CONG AN
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, BREASTF CONT ZIK VIR
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 27
TC 0
Z9 0
U1 0
U2 9
PU INT CHILDBIRTH EDUCATION ASSOC
PI RALEIGH
PA 1500 SUNDAY DR, STE 102, RALEIGH, NC 27607 USA
SN 0887-8625
J9 INT J CHILDBIRTH EDU
JI Int. J. Childbirth Educ.
PD JUL
PY 2016
VL 31
IS 3
BP 7
EP 12
PG 6
WC Nursing
SC Nursing
GA DV3TF
UT WOS:000382845700004
DA 2020-07-08
ER

PT J
AU Tsetsarkin, KA
   Kenney, H
   Chen, RB
   Liu, GP
   Manukyan, H
   Whitehead, SS
   Laassri, M
   Chumakov, K
   Pletnev, AG
AF Tsetsarkin, Konstantin A.
   Kenney, Heather
   Chen, Rubing
   Liu, Guangping
   Manukyan, Hasmik
   Whitehead, Stephen S.
   Laassri, Majid
   Chumakov, Konstantin
   Pletnev, Alexander G.
TI A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic
   in Brazil as a Genetic Platform for Studies of Virus-Host Interactions
   and Vaccine Development
SO MBIO
LA English
DT Article
ID JAPANESE-ENCEPHALITIS-VIRUS; COOPERATIVE INTERACTIONS; RT-PCR; RNA; DNA;
   ROBUSTNESS; EVOLUTION; AMERICA; AMPLIFICATION; TRANSMISSION
AB An arthropod-borne virus, Zika virus (ZIKV), has recently emerged as a major human pathogen. Associated with complications during perinatal development and Guillain-Barr syndrome in adults, ZIKV raises new challenges for understanding the molecular determinants of flavivirus pathogenesis. This underscores the necessity for the development of a reverse genetic system based on an epidemic ZIKV strain. Here, we describe the generation and characterization in cell cultures of an infectious cDNA clone of ZIKV isolated from the 2015 epidemic in Brazil. The cDNA-derived ZIKV replicated efficiently in a variety of cell lines, including those of both neuronal and placental origin. We observed that the growth of cDNA-derived virus was attenuated compared to the growth of the parental isolate in most cell lines, which correlates with substantial differences in sequence heterogeneity between these viruses that were determined by deep-sequencing analysis. Our findings support the role of genetic diversity in maintaining the replicative fitness of viral populations under changing conditions. Moreover, these results indicate that caution should be exercised when interpreting the results of reverse-genetics experiments in attempts to accurately predict the biology of natural viruses. Finally, a Vero cell-adapted cDNA clone of ZIKV was generated that can be used as a convenient platform for studies aimed at the development of ZIKV vaccines and therapeutics.
   IMPORTANCE The availability of genetic tools and laboratory models determines the progress in understanding mechanisms of virus emergence and pathogenesis. Recent large-scale outbreaks of Zika virus (ZIKV) that were linked to complications during perinatal development and Guillain-Barre syndrome in adults emphasize the urgency for the development of a reverse-genetics system based on an epidemic ZIKV strain. Here, we report a stable infectious cDNA clone for ZIKV isolated during the 2015 epidemic in Brazil, as well as a Vero cell-adapted version of it, which will be used for virus-host interaction studies and vaccine development.
C1 [Tsetsarkin, Konstantin A.; Kenney, Heather; Liu, Guangping; Whitehead, Stephen S.; Pletnev, Alexander G.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Chen, Rubing] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Manukyan, Hasmik; Laassri, Majid; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Pletnev, AG (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
EM apletnev@niaid.nih.gov
RI Whitehead, Stephen/AAG-2787-2019
FU Division of Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID)
FX This work was supported by the Division of Intramural Research Program
   of the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health
CR Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072
   Grubaugh ND, 2013, AM J TROP MED HYG, V88, P245, DOI 10.4269/ajtmh.2012.12-0048
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN
   Tsetsarkin KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004852
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   World Health Organization, 2016, ZIK SIT REP
   Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zhang FQ, 2001, J VIROL METHODS, V96, P171, DOI 10.1016/S0166-0934(01)00331-7
   Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0
NR 44
TC 70
Z9 70
U1 1
U2 65
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2016
VL 7
IS 4
AR e01114
DI 10.1128/mBio.01114-16
PG 8
WC Microbiology
SC Microbiology
GA DW1YQ
UT WOS:000383440500060
PM 27555311
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castro, MC
AF Castro, Marcia C.
TI Zika virus and the 2016 Olympic Games - Evidence-based projections
   derived from dengue do not support cancellation
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
ID FIFA WORLD CUP; RIO-DE-JANEIRO; HEALTH-RISKS; TRAVELERS
C1 [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,Room 1113, Boston, MA 02115 USA.
RP Castro, MC (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,Room 1113, Boston, MA 02115 USA.
EM mcastro@hsph.harvard.edu
RI Castro, Marcia/S-2681-2019
OI Castro, Marcia/0000-0003-4606-2795
CR Attaran A, 2016, HARVARD PUBLIC H MAY
   Brasil. Ministerio da Saude. Boletim Epidemiologico, 2016, B EPIDEMIOLOGICO
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   European Centre for Disease Prevention and Control, 2016, POT RISKS PUBL HLTH
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Secretaria de Estado de Saude do Rio de Janeiro, 2016, MON EM SAUD PUBL SIN
   Secretaria de Saude do Estado de Pernambuco, MICR OUTR ALT SIST N
   The Lancet Infectious, 2016, LANCET INFECT DIS, V16, P619
   Wilson ME, 2016, TRAVEL MED INFECT DI, V14, P1, DOI 10.1016/j.tmaid.2016.01.010
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
NR 12
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 384
EP 388
DI 10.1016/j.tmaid.2016.06.007
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000010
PM 27363326
OA Other Gold
DA 2020-07-08
ER

PT J
AU Venkatraman, A
   Mukhija, D
   Kumar, N
   Nagpal, SJS
AF Venkatraman, Anand
   Mukhija, Dhruvika
   Kumar, Nilay
   Nagpal, Sajan Jiv Singh
TI Zika virus misinformation on the internet
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Internet; Misinformation
ID EBOLA
C1 [Venkatraman, Anand] Univ Alabama Birmingham, Dept Neurol, 401 20th St South,Unit 216, Birmingham, AL 35233 USA.
   [Mukhija, Dhruvika; Nagpal, Sajan Jiv Singh] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA.
   [Kumar, Nilay] Harvard Med Sch, Cambridge Hlth Alliance, Dept Internal Med, Boston, MA USA.
RP Venkatraman, A (corresponding author), Univ Alabama Birmingham, Dept Neurol, 401 20th St South,Unit 216, Birmingham, AL 35233 USA.
EM anandv123@gmail.com
RI Venkatraman, Anand/F-3190-2017
OI Venkatraman, Anand/0000-0003-4429-2271; Nagpal, Sajan Jiv
   Singh/0000-0003-3724-2081
CR Fox S.D., 2013, MAEVE INFORM TRIAGE
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Venkatraman A, 2015, VACCINE, V33, P1422, DOI 10.1016/j.vaccine.2015.01.078
NR 4
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 421
EP 422
DI 10.1016/j.tmaid.2016.05.018
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000017
PM 27267799
DA 2020-07-08
ER

PT J
AU Porrino, P
AF Porrino, Pedro
TI Zika virus infection and once again the risk from other neglected
   diseases
SO TROPICAL DOCTOR
LA English
DT Article
DE Zika; neglected diseases; dengue; uutbreaks; epidemiological
   surveillance
ID AFRICA; DENGUE
AB Since the first cases of Zika were identified and reported in Brazil, the magnitude and consequences of the outbreak in the Americas have increased tremendously, leading the World Health Organization to consider Zika and its link with clusters of microcephaly a Public Health Emergency of International Concern. Only a previous large outbreak in French Polynesia was known and no neurological anomalies have been reported. Differences in African and Asian lineage and differences in genetic evolution of the Zika virus may possibly provide an explanation for the development of the recent outbreaks and their variable presentation. However, the similar clinical presentation between Zika and other diseases like Dengue and Chikungunya can support that Zika has been circulating and spreading inadvertently. This hypothesis gains strength when rates of laboratory confirmation diagnosis for Dengue are observed in Brazil and Colombia, two of the most affected countries by Zika virus (ZIKV) infection. The lack of attention and resources on neglected diseases supposes a huge risk that new lethal pathogens camouflage themselves to spread into large areas and populations.
C1 [Porrino, Pedro] The World, Trop Med, London, England.
   [Porrino, Pedro] The World, Mission, London, England.
RP Porrino, P (corresponding author), The World, Trop Med, London, England.; Porrino, P (corresponding author), The World, Mission, London, England.
EM pedro.porrino@gmail.com
OI Porrino, Pedro/0000-0003-2648-056X
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2015, DENG VIR INF 2015 CA
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control, 2015, ARB DIS NEUR NONN 20
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franco L, 2015, TROP MED INT HEALTH, V20, P107
   Instituto Nacional de Salud de Colombia Direccion de Vigilancia y Analisis del Riesgo en Salud Publica, 2015, B EP SEM SEM EP
   Jaenisch T, 2014, EMERG INFECT DIS, P20
   Johansson MA, RISK ESTIMATES MICRO
   Kindhauser MK, 2016, B WHO
   Ministerio da Saude (Brazil), 2015, CONF ZIK VIR BRAS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, ZIK VIR INF
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, CHIK FACT SHEET
NR 20
TC 1
Z9 1
U1 0
U2 22
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD JUL
PY 2016
VL 46
IS 3
BP 159
EP 165
DI 10.1177/0049475516656101
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DS0LO
UT WOS:000380287300012
PM 27390166
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika and sexual transmission
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUL
PY 2016
VL 94
IS 7
BP 485
EP 485
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS4EE
UT WOS:000380733400005
DA 2020-07-08
ER

PT J
AU Paul, RE
AF Paul, Richard E.
TI The When and the Where of Zika Epidemic Potential in Europe - An
   Evidence Base for Public Health Preparedness
SO EBIOMEDICINE
LA English
DT Editorial Material
DE Zika; Flavivirus; Aedes; Mosquitoes
ID VIRUS
C1 [Paul, Richard E.] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
RP Paul, RE (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Cao-Lormeau V. M., 2016, LANCET, V387
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 10
TC 1
Z9 3
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL
PY 2016
VL 9
BP 17
EP +
DI 10.1016/j.ebiom.2016.06.020
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DT6VL
UT WOS:000381622500009
PM 27333025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ulrich, JN
   Beier, JC
   Devine, GJ
   Hugo, LE
AF Ulrich, Jill N.
   Beier, John C.
   Devine, Gregor J.
   Hugo, Leon E.
TI Heat Sensitivity of wMelWolbachia during Aedes aegypti Development
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; WOLBACHIA INFECTION; ANOPHELES-STEPHENSI;
   BACTERIAL DENSITY; DENGUE VIRUS; ENDOSYMBIONT WOLBACHIA; BLOCKS DENGUE;
   DROSOPHILA; DIPTERA; TEMPERATURE
AB The wMel strain of Wolbachia bacteria is known to prevent dengue and Zika virus transmission in the mosquito vector Aedes aegypti. Accordingly, the release of wMel-infected A. aegypti in endemic regions has been recommended by the World Health Organization as a potential strategy for controlling dengue and Zika outbreaks. However, the utility of this approach could be limited if high temperatures in the aquatic habitats where A. aegypti develop are detrimental to Wolbachia. We exposed wMel-infected A. aegypti eggs and larvae to fluctuating daily temperatures of 30-40 degrees C for three, five, or seven days during their development. We found that Wolbachia levels in females emerging from heat treatments were significantly lower than in the controls that had developed at 20-30 degrees C. Notably, seven days of high temperatures starting at the egg stage reduced Wolbachia levels in emerging females to less than 0.1% of the wMel control levels. However, after adult females returned to 20-30 degrees C for 4-7 days, they experienced differing degrees of Wolbachia recovery. Our findings suggest that the spread of Wolbachia in wild A. aegypti populations and any consequent protection from dengue and Zika viruses might be limited in ecosystems that experience periods of extreme heat, but Wolbachia levels recover partially after temperatures return to normal.
C1 [Ulrich, Jill N.; Devine, Gregor J.; Hugo, Leon E.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Ulrich, Jill N.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
   [Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
RP Ulrich, JN (corresponding author), Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Ulrich, JN (corresponding author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
EM j.ulrich1@umiami.edu
RI Fernandes, Jill/J-3068-2017; Devine, Gregor J/H-1141-2014; Hugo, R. Leon
   E/O-3013-2018
OI Fernandes, Jill/0000-0001-7704-072X; Devine, Gregor
   J/0000-0001-6312-0390; Hugo, R. Leon E/0000-0002-6767-9850
FU Leonard and Jayne Abess Center for Ecosystem Science and Policy at the
   University of Miami, Florida; Australian Infectious Diseases Research
   Centre; National Science Foundation Graduate Research Fellowship
   ProgramNational Science Foundation (NSF) [2015178889]
FX This study was supported by the Leonard and Jayne Abess Center for
   Ecosystem Science and Policy at the University of Miami, Florida, the
   Australian Infectious Diseases Research Centre
   (http://www.aidrc.org.au/), and by the National Science Foundation
   Graduate Research Fellowship Program (https://www.nsfgrfp.org/) under
   Grant No. 2015178889. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achee NL, 2015, PLOS NEGL TROP DIS, V9
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bhatt S, 2013, NATURE, V496, P504
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 1996, GENETICS, V144, P1063
   Bourtzis K, 2016, ACTA TROP, V78, DOI [10.1016/j.cell.2009.11.042, DOI 10.1016/J.CELL.2009.11.042]
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587
   Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998
   BREEUWER JAJ, 1993, GENETICS, V135, P565
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629
   Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761
   Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096
   Dutra H.L.C., 2016, CELL HOST MICROBE
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Eliminate Dengue, 2016, PROGR 2016
   Feder ME, 1999, AM ZOOL, V39, P363
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hoffmann AA, 2014, AUSTRAL ENTOMOL, V53, P125, DOI 10.1111/aen.12068
   Hugo LE, 2010, J MED ENTOMOL, V47, P1044, DOI 10.1603/ME10030
   Hurst GDD, 2000, GENETICS, V156, P699
   Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x
   Jeyaprakash A, 2010, FLA ENTOMOL, V93, P464, DOI 10.1653/024.093.0326
   Kessler S, 2008, J VECTOR ECOL, V33, P145, DOI 10.3376/1081-1710(2008)33[145:ROAGAS]2.0.CO;2
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McCall P., 2006, SPECIAL PROGRAMME RE, P110
   MERCOT H, 1995, GENETICS, V141, P1015
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590
   Nairn J., 2013, DEFINING HEATWAVES H
   NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716
   Nguyen HT, 2009, J AM MOSQUITO CONTR, V25, P74, DOI 10.2987/08-5752.1
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9
   Patil NS, 1996, MED VET ENTOMOL, V10, P277, DOI 10.1111/j.1365-2915.1996.tb00743.x
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   R Development Core Team, 2010, R A LANGUAGE AND ENV
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119
   SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461
   STEVENS L, 1989, J INVERTEBR PATHOL, V53, P78, DOI 10.1016/0022-2011(89)90076-1
   Sugimoto TN, 2015, J INSECT PHYSIOL, V81, P48, DOI 10.1016/j.jinsphys.2015.06.016
   TRPIS M, 1981, J HERED, V72, P313, DOI 10.1093/oxfordjournals.jhered.a109513
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Turley AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-36
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004
   Veneti Z, 2003, GENETICS, V164, P545
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2006, PEST THEIR APPL CONT
   WHO Vector Control Advisory Group, 2016, MOSQ VECT CONTR EM R
   Wiwatanaratanabutr I, 2009, J INVERTEBR PATHOL, V102, P220, DOI 10.1016/j.jip.2009.08.009
   World Health Organization, 2013, FACTSH DENG SERV DEN
   World Health Organization, 2016, QUEST ANS DENG VACC
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Yixin HY, 2016, AM J TROP MED HYG
   Zhukova M. V., 2008, Cell and Tissue Biology, V2, P546, DOI 10.1134/S1990519X08050131
   Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 91
TC 27
Z9 28
U1 1
U2 73
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2016
VL 10
IS 7
AR e0004873
DI 10.1371/journal.pntd.0004873
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DS8FC
UT WOS:000381017800062
PM 27459519
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinez, ME
AF Martinez, Micaela Elvira
TI Preventing Zika Virus Infection during Pregnancy Using a Seasonal Window
   of Opportunity for Conception
SO PLOS BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; DYNAMICS; AMERICA; EPIDEMIOLOGY; DENGUE
AB It has come to light that Zika virus (ZIKV) infection during pregnancy can result in trans-placental transmission to the fetus along with fetal death, congenital microcephaly, and/or Central Nervous System (CNS) malformations. There are projected to be >9,200,000 births annually in countries with ongoing ZIKV transmission. In response to the ZIKV threat, the World Health Organization (WHO) is strategically targeting prevention of infection in pregnant women and funding contraception in epidemic regions. I propose that the damaging effects of ZIKV can be reduced using a seasonal window of opportunity for conception that may minimize maternal exposure. Like other acute viral infections-including the related flavivirus, dengue virus (DENV)-the transmission of ZIKV is anticipated to be seasonal. By seasonally planning pregnancy, this aspect of pathogen ecology can be leveraged to align sensitive periods of gestation with the low-transmission season.
C1 [Martinez, Micaela Elvira] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Martinez, Micaela Elvira] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Global Hlth Program, Princeton, NJ 08544 USA.
RP Martinez, ME (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Martinez, ME (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Global Hlth Program, Princeton, NJ 08544 USA.
EM micaelam@princeton.edu
RI amsalu, ribka/G-8780-2019; Martinez, Micaela/J-3721-2013
OI Martinez, Micaela/0000-0002-9248-9450
FU US National Science FoundationNational Science Foundation (NSF)
   [1523757]
FX MEM is supported by a US National Science Foundation Postdoctoral
   Fellowship in Biology Award Number 1523757. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, MORBIDITY MORTALITY
   Cugola FR, 2016, NATURE, P1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dowell SF, 2012, EPIDEMIOL INFECT, V140, P87, DOI 10.1017/S0950268811001695
   Dowell SF, 2001, EMERG INFECT DIS, V7, P369
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128
   Frieden T., 2016, ZIK ACT PLAN SUMM AP
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hazin AN, 2016, NEW ENGL J MED, V374, P1
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   King AA, 2015, J STAT SOFT IN PRESS
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Bakker M, 2015, TRENDS ECOL EVOL, V30, P314, DOI 10.1016/j.tree.2015.03.012
   Martinez-Bakker M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002172
   Martinez-Bakker M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2438
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   McNeil Jr Donald G., 2016, NY TIMES
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   [National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases Centers for Disease Control and Prevention], ZIK VIR WOM THEIR PA
   Obama B., 2016, COMMUNICATION
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P89, DOI 10.1007/s00430-006-0031-0
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   SEVER J, 1968, ANNU REV MED, V19, P471, DOI 10.1146/annurev.me.19.020168.002351
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453
   Tavernise S, 2016, NY TIMES
   United Nations Statistics Division: Demographics Statistics, 2016, DEM STAT LIV BIRTHS
   US Central Intelligence Agency, 2016, WORLD FACTB 2016
   World Health Organization, 2016, WHO ZIK Q A
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
NR 47
TC 11
Z9 11
U1 0
U2 80
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JUL
PY 2016
VL 14
IS 7
AR e1002520
DI 10.1371/journal.pbio.1002520
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA DS4RN
UT WOS:000380768700016
PM 27467271
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuehnert, MJ
   Epstein, JS
AF Kuehnert, Matthew J.
   Epstein, Jay S.
TI Assuring blood safety and availability: Zika virus, the latest emerging
   infectious disease battlefront
SO TRANSFUSION
LA English
DT Editorial Material
C1 [Kuehnert, Matthew J.] Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Zoonot & Infect Dis, Atlanta, GA 30333 USA.
   [Epstein, Jay S.] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Kuehnert, MJ (corresponding author), Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Zoonot & Infect Dis, Atlanta, GA 30333 USA.
EM mkuehnert@cdc.gov
OI Epstein, Jay/0000-0003-2293-9062
NR 0
TC 7
Z9 7
U1 0
U2 51
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1669
EP 1672
DI 10.1111/trf.13673
PG 4
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100001
PM 27389990
DA 2020-07-08
ER

PT J
AU Barjas-Castro, ML
   Angerami, RN
   Cunha, MS
   Suzuki, A
   Nogueira, JS
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   Katz, G
   Boin, IFSF
   Stucchi, RSB
   Resende, MR
   Esposito, DLA
   de Souza, RP
   da Fonseca, BA
   Addas-Carvalho, M
AF Barjas-Castro, Maria L.
   Angerami, Rodrigo N.
   Cunha, Mariana S.
   Suzuki, Akemi
   Nogueira, Juliana S.
   Rocco, Iray M.
   Maeda, Adriana Y.
   Vasami, Fernanda G. S.
   Katz, Gizelda
   Boin, Ilka F. S. F.
   Stucchi, Raquel S. B.
   Resende, Mariangela R.
   Esposito, Danillo L. A.
   de Souza, Renato P.
   da Fonseca, Benedito A.
   Addas-Carvalho, Marcelo
TI Probable transfusion-transmitted Zika virus in Brazil
SO TRANSFUSION
LA English
DT Article
ID WEST NILE VIRUS; BLOOD-TRANSFUSION; FRENCH-POLYNESIA; TRANSMISSION;
   DENGUE; OUTBREAK
AB BACKGROUNDZika virus (ZIKV) is an emerging arthropod-borne flavivirus transmitted by Aedes mosquitoes. Recent commentaries regarding ZIKV routes of transmission describe a potential transmission by transfusion. Herein, we report a probable case of transfusion-transmitted ZIKV infection through a platelet transfusion that was detected from postdonation information.
   CASE REPORTA blood donor made a voluntary telephone report to the blood donor facility 3 days after donation and informed the facility of a febrile illness (fever, malaise, and headaches). Due to the ongoing dengue epidemic, the initial clinical investigation included dengue among other possible diagnoses. The serology and molecular laboratory results excluded dengue infection. However, stored samples from the donation were positive for ZIKV on reverse transcription-polymerase chain reaction (RT-PCR) analysis. A retrospective investigation demonstrated that the platelet concentrate, which was part of a pool, had been transfused after a liver transplantation. A physician had evaluated the patient 4 days after surgery. Laboratory investigation showed enzyme-linked immunosorbent assay results that were negative for dengue immunoglobulin M antibodies; however, the results were positive for hemagglutination inhibition antibodies against flavivirus. ZIKV RT-PCR and virus isolation analyses in cell cultures from recipient serum were both positive. The sequencing confirmed ZIKV in the donor and patient samples. Ten partial nucleotide sequences from the ZIKV strain that were detected in the donor were aligned and compared with the ZIKV genome detected in the recipient, revealing a 99.8% homology between the two strains.
   CONCLUSIONSThis is a case of probable transmission of ZIKV through blood transfusion. The patient had been transfused with the blood product from an infected donor, most likely in the incubation period after ZIKV infection but prior to clinical disease onset. This report emphasizes the importance of postdonation information and recipient investigations during outbreaks of potentially blood-borne infections.
C1 [Barjas-Castro, Maria L.; Addas-Carvalho, Marcelo] Univ Estadual Campinas UNICAMP, Hematol & Transfus Ctr, Campinas, SP, Brazil.
   [Angerami, Rodrigo N.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Suzuki, Akemi; Nogueira, Juliana S.; Rocco, Iray M.; Maeda, Adriana Y.; Vasami, Fernanda G. S.; de Souza, Renato P.] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Katz, Gizelda] Infect Dis Surveillance Ctr Prof Alexandre Vranja, Sao Paulo, SP, Brazil.
   [Boin, Ilka F. S. F.; Stucchi, Raquel S. B.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Dept Clin Med, Fac Med Sci, Campinas, SP, Brazil.
   [Esposito, Danillo L. A.; da Fonseca, Benedito A.] Univ Estadual Sao Paulo, Fac Ciencias Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Barjas-Castro, ML (corresponding author), Univ Estadual Campinas UNICAMP, Hemoctr Unicamp, Rua Carlos Chagas 480,Cidade Univ Zeferino Vaz, Campinas, SP, Brazil.
EM maluz@unicamp.br
RI Angerami, Rodrigo Nogueira/A-8926-2013; Boin, Ilka/M-7184-2019; Resende,
   Mariangela/U-9938-2019; Esposito, Danillo L.A./N-9261-2017;
   Addas-Carvalho, Marcelo/D-9654-2018; Boin, Ilka FSF/C-7811-2009;
   Fonseca, Benedito/F-3252-2012
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Esposito, Danillo
   L.A./0000-0002-2755-4471; Addas-Carvalho, Marcelo/0000-0003-0178-6191;
   Fonseca, Benedito/0000-0003-3159-5687; Pereira de Souza,
   Renato/0000-0003-1315-7085
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, B EPIDEMIOLOGICO, V46
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Healthcare Safety Network [NHSN], 2016, NHSN BIOV COMP HEM M
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   US Food and Drug Administration (FDA), 2016, FDA GUID REC DON SCR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 114
Z9 117
U1 0
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1684
EP 1688
DI 10.1111/trf.13681
PG 5
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100006
PM 27329551
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh RamBihariLal
   Shrivastava, Prateek Saurabh
   Ramasamy, Jegadeesh
TI Standardized management of Zika virus infection during pregnancy
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Shrivastava, Saurabh RamBihariLal; Shrivastava, Prateek Saurabh; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
NR 5
TC 0
Z9 0
U1 0
U2 7
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2016
VL 9
IS 4
BP 217
EP +
DI 10.4103/1755-6783.184814
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DR9VP
UT WOS:000380244500002
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Coinfection between dengue virus and Zika virus: A complex situation
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Med Sci, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Dept Biol Sci, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Dept Community Med, Pune, Maharashtra, India.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 1
Z9 1
U1 0
U2 5
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2016
VL 9
IS 4
BP 302
EP +
DI 10.4103/1755-6783.184810
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DR9VP
UT WOS:000380244500033
DA 2020-07-08
ER

PT J
AU Shadgan, B
   Khodaee, M
AF Shadgan, Babak
   Khodaee, Morteza
TI Smart Clothing is the Best Protection Against Zika During Rio Olympic
   and Paralympic Games
SO CLINICAL JOURNAL OF SPORT MEDICINE
LA English
DT Letter
C1 [Shadgan, Babak] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada.
   [Khodaee, Morteza] Univ Colorado, Sch Med, Dept Family Med, Denver, CO USA.
RP Shadgan, B (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada.
CR [Anonymous], 2016, LIFE
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Shadgan B, CURR SPORTS IN PRESS, P15
NR 4
TC 2
Z9 2
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1050-642X
EI 1536-3724
J9 CLIN J SPORT MED
JI Clin. J. Sport Med.
PD JUL
PY 2016
VL 26
IS 4
BP 345
EP 346
DI 10.1097/JSM.0000000000000365
PG 3
WC Orthopedics; Physiology; Sport Sciences
SC Orthopedics; Physiology; Sport Sciences
GA DQ8DC
UT WOS:000379438300016
PM 27359297
DA 2020-07-08
ER

PT J
AU Sarmento, UC
   Miguita, CH
   Almeida, LHD
   Gaban, CRG
   da Silva, LMGE
   de Souza, AS
   Garcez, WS
   Garcez, FR
AF Sarmento, Ulana Chaves
   Miguita, Carlos Henrique
   de Oliveira Almeida, Luis Henrique
   Garcia Gaban, Cleusa Rocha
   Grespan Estodutto da Silva, Lilliam May
   de Souza, Albert Schiaveto
   Garcez, Walmir Silva
   Garcez, Fernanda Rodrigues
TI Larvicidal efficacies of plants from Midwestern Brazil: melianodiol from
   Guarea kunthiana as a potential biopesticide against Aedes aegypti
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Guarea kunthiana; mosquito control; dengue; Zika; chikungunya;
   protolimonoid
ID DIPTERA-CULICIDAE; VECTOR; DENGUE; RESISTANCE; LIMONOIDS; FRUITS
AB A total of 36 ethanol extracts from different anatomical parts of 27 plant species (18 families), native to the Pantanal and Cerrado biomes in Midwest Brazil, was assessed for their effect against Aedes aegypti larvae, the vector of dengue, hemorrhagic dengue, Zika and chikungunya fevers. Only the extract obtained from seeds of Guarea kunthiana (Meliaceae) proved active (LC50 = 169.93 mu g/mL). A bioassay-guided investigation of this extract led to the isolation and identification of melianodiol, a protolimonoid, as the active constituent (LC50 = 14.44 mu g/mL). Meliantriol, which was also obtained from the bioactive fraction, was nevertheless devoid of any larval toxicity, even at the highest concentration tested (LC50 > 100.0 mu g/mL). These results indicate that the larvicidal activity of melianodiol stems from the presence of the carbonyl moiety at C-3 in the 21,23-epoxy-21,24,25-trihydroxy-tirucall-7-ene-type skeleton. The structures of both protolimonoids were established on the basis of spectral methods (H-1 and C-13 NMR and MS). This is the first report on the toxicity of melianodiol against Ae. aegypti larvae. Based on the results, melianodiol can be regarded as a potential candidate for use as an ecologically sound biocontrol agent for reducing the larval population of this vector.
C1 [Sarmento, Ulana Chaves; Miguita, Carlos Henrique; de Oliveira Almeida, Luis Henrique; Garcia Gaban, Cleusa Rocha; Grespan Estodutto da Silva, Lilliam May; Garcez, Walmir Silva; Garcez, Fernanda Rodrigues] Univ Fed Mato Grosso do Sul, Inst Quim, Campo Grande, MS, Brazil.
   [de Souza, Albert Schiaveto] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil.
RP Garcez, FR (corresponding author), Univ Fed Mato Grosso do Sul, Inst Quim, Campo Grande, MS, Brazil.
EM fernandargarcez@gmail.com
RI GARCEZ, FERNANDA RODRIGUES/H-1081-2013
OI GARCEZ, FERNANDA RODRIGUES/0000-0002-3995-4472
FU FUNDECT-MSFundect; PROPP-UFMS; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX FUNDECT-MS, PROPP-UFMS, CNPq.
CR Anholeti MC, 2015, MEM I OSWALDO CRUZ, V110, P629, DOI 10.1590/0074-02760150103
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Bezerra-Silva PC, 2015, EXP PARASITOL, V153, P160, DOI 10.1016/j.exppara.2015.03.018
   CNN-Cable News Network, 2016, CNN CABLE NEWS NETWO
   Gois RWD, 2013, PARASITOL RES, V112, P2753, DOI 10.1007/s00436-013-3407-2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Garcez FR, 2004, J BRAZIL CHEM SOC, V15, P767, DOI 10.1590/S0103-50532004000500025
   Garcez WS, 2013, REV VIRTUAL QUIM, V5, P363, DOI 10.5935/1984-6835.20130034
   Garcez WS, 2009, BIORESOURCE TECHNOL, V100, P6647, DOI 10.1016/j.biortech.2009.06.092
   Geris R, 2012, STUD NAT PROD CHEM, V37, P277, DOI 10.1016/B978-0-444-59514-0.00010-9
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kurimoto SI, 2014, FITOTERAPIA, V92, P200, DOI 10.1016/j.fitote.2013.11.004
   Miguita CH, 2015, MOLECULES, V20, P111, DOI 10.3390/molecules20010111
   Miguita CH, 2014, REC NAT PROD, V8, P290
   PAHO: Pan American Health Organization, 2016, CHIK
   PAHO-Pan American Health Organization, 2016, ZIK VIR SPREADS PAHO
   PAHO - Pan American Health Organization, 2016, ZIK EP UPD 24 MARCH
   PAHO - Pan American Health Organization, 2016, DENGUE
   Puripattanavong J, 2000, PLANTA MED, V66, P740, DOI 10.1055/s-2000-9901
   Reegan AD, 2014, ACTA TROP, V139, P67, DOI 10.1016/j.actatropica.2014.07.002
   Chaves TDS, 2012, EMERG INFECT DIS, V18, P529, DOI 10.3201/eid1803.110838
   Stappen I, 2014, PLANTA MED, V80, P1079, DOI 10.1055/s-0034-1382957
   Tan QG, 2011, CHEM REV, V111, P7437, DOI 10.1021/cr9004023
   TAYLOR DAH, 1984, PROG CHEM ORG NAT PR, V45, P1
   Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1
   *WHO, 1981, INSTR DET SUSC RES M
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, WHO REP GLOB SURV EP
   World Health Organization (WHO), 2016, CHIK
   World Health Organization (WHO), 2016, DENG SEV DENG
NR 31
TC 2
Z9 2
U1 0
U2 10
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2016
VL 111
IS 7
BP 469
EP 474
DI 10.1590/0074-02760160134
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DR7XH
UT WOS:000380112500008
PM 27333366
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mortimer, PP
AF Mortimer, Philip P.
TI Maternal Zika infection: like rubella but worse
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Editorial Material
EM pandjmortimer@gmail.com
CR Brasil P, 2016, ZIKA VIRUS INFECT PR
   Christie AB, 1969, INFECT DIS EPIDEMIOL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
NR 5
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD JUL
PY 2016
VL 26
IS 4
BP 219
EP +
DI 10.1002/rmv.1886
PG 2
WC Virology
SC Virology
GA DR6VX
UT WOS:000380040500001
PM 27119589
DA 2020-07-08
ER

PT J
AU Jin, J
   Simmons, G
AF Jin, Jing
   Simmons, Graham
TI Inhibitory Antibodies Targeting Emerging Viruses: Advancements and
   Mechanisms
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID DENGUE VIRUS; NONNEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; HIGHLY
   POTENT; ALPHAVIRUS; EPITOPE; DESIGN; ENTRY
AB From Ebola virus outbreaks in Western Africa to the introduction of chikungunya and Zika viruses in the Americas, new and neglected viruses continue to emerge and spread around the world. Due to a lack of existing vaccines or specific therapeutics, little other than supportive care and attempts to interrupt transmission can be provided during initial outbreaks. This has prompted a shift in vaccine design and development to identify novel epitopes and mechanisms of protection that may offer a broader range of protection against groups or whole families of viruses. Receptor-binding domains and other motifs within viral envelope proteins represent one excellent opportunity to target communal epitopes shared by related viruses. Similarly, for viruses where envelope participates in driving viral egress from infected cells, shared epitopes need to be identified to guide the development of broadly protective antibodies and vaccines. Here, we discuss recent advances in our understanding of broadly protective humoral responses for emerging viruses.
C1 [Simmons, Graham] Blood Syst Res Inst, San Francisco, CA 94118 USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Simmons, G (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.
EM gsimmons@bloodsystems.org
RI Simmons, Graham/G-3523-2012
OI Simmons, Graham/0000-0002-9615-7023; Jin, Jing/0000-0003-3994-8600
FU HHS \ NIH \ National Institute of Allergy and Infectious Diseases
   (NIAID) [R01 AI119056]
FX This work, including the efforts of Jing Jin and Graham Simmons, was
   funded by HHS vertical bar NIH vertical bar National Institute of
   Allergy and Infectious Diseases (NIAID) (R01 AI119056).
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15
   Dai L, 2016, CELL HOST MICROBE
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Furuyama W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20514
   Halbherr SJ, 2015, J VIROL, V89, P1550, DOI 10.1128/JVI.02949-14
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Long F, 2015, P NATL ACAD SCI USA, V112, P13898, DOI 10.1073/pnas.1515558112
   Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038
   McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283
   Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534
   Porta J, 2014, J VIROL, V88, P9616, DOI 10.1128/JVI.01286-14
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Simmons G, 2013, ADV EXP MED BIOL, V790, P83, DOI 10.1007/978-1-4614-7651-1_5
   Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435
   Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044
NR 24
TC 5
Z9 5
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD JUL
PY 2016
VL 23
IS 7
BP 535
EP 539
DI 10.1128/CVI.00136-16
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DQ9GB
UT WOS:000379517300002
PM 27226280
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Shadgan, B
   Pakravan, A
   Zaeimkohan, H
   Shahpar, FM
   Khodaee, M
AF Shadgan, Babak
   Pakravan, Amir
   Zaeimkohan, Hamid
   Shahpar, Farhad Moradi
   Khodaee, Morteza
TI Zika and Rio Olympic Games
SO CURRENT SPORTS MEDICINE REPORTS
LA English
DT Review
ID REPRODUCTIVE AGE; VIRUS EXPOSURE; UNITED-STATES; OUTBREAK; WOMEN
AB Zika virus (ZIKV) is an arthropod-borne virus that is mainly transmitted via a bite from a female mosquito of the Aedes species. However, ZIKV can be transmitted sexually or via blood. Due to the recent ZIKV outbreak in South and Central America, many national and international organizations are concerned about the safety of athletes, coaches, staff, and spectators during the Olympic and Paralympic Games. Infected individuals are generally asymptomatic or have mild symptoms. However, ZIKV infection can potentially cause serious complications such as Guillain-Barre syndrome and congenital defects. Preferred diagnosis is based on real-time reverse-transcription polymerase chain reaction from blood and urine. Currently, there is no treatment or immunization available for ZIKV infection, and disease control is limited to preventing mosquito bites.
C1 [Shadgan, Babak] Med & Anti Doping Commiss, UWW, Vancouver, BC, Canada.
   [Pakravan, Amir] ECOSEP, London, England.
   [Zaeimkohan, Hamid] Med & Anti Doping Commiss, WKF, Madrid, Spain.
   [Shahpar, Farhad Moradi] Federat Int Natat FINA, Sports Med Comm, Tehran, Iran.
   [Khodaee, Morteza] Univ Colorado, Sch Med, Dept Family Med, Denver, CO USA.
RP Khodaee, M (corresponding author), AFW Clin, 3055 Roslyn St, Denver, CO 80238 USA.
EM morteza.khodaee@ucdenver.edu
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   CDC, 2016, ZIK VIR
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Hayden EC, NATURE NEWS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, ZIK VIR
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 12
TC 2
Z9 2
U1 0
U2 39
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1537-890X
EI 1537-8918
J9 CURR SPORT MED REP
JI Curr. Sport. Med. Rep.
PD JUL-AUG
PY 2016
VL 15
IS 4
BP 298
EP 300
PG 3
WC Sport Sciences
SC Sport Sciences
GA DR2SH
UT WOS:000379753700014
PM 27399828
OA Bronze
DA 2020-07-08
ER

PT J
AU Gioula, G
   Nunes, ML
   Zafeiriou, DI
AF Gioula, Georgia
   Nunes, Magda Lahorgue
   Zafeiriou, Dimitrios I.
TI An emerging cause of concern in Europe: Zika virus, the developing CNS
   and the pediatric neurologist
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Editorial Material
ID BRAZIL
C1 [Gioula, Georgia] Aristotle Univ Thessaloniki, Dept Microbiol 2, Thessaloniki, Greece.
   [Nunes, Magda Lahorgue] Pontificia Univ Catolica Rio Grande do Sul, Div Neurol, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue; Zafeiriou, Dimitrios I.] Brain Inst Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Zafeiriou, Dimitrios I.] Aristotle Univ Thessaloniki, Dept Pediat 1, Thessaloniki, Greece.
RP Zafeiriou, DI (corresponding author), Aristotle Univ Thessaloniki, Dept Pediat 1, Thessaloniki, Greece.
EM jeff@med.auth.gr
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nunes ML, 2016, J PEDIAT RIO J
   Salvador FS, 2015, TRAVEL MED INFECT DI, VS1477-8939
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 12
TC 2
Z9 2
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD JUL
PY 2016
VL 20
IS 4
BP 497
EP 499
DI 10.1016/j.ejpn.2016.04.017
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DQ3MP
UT WOS:000379106700001
PM 27160366
DA 2020-07-08
ER

PT J
AU Caragata, EP
   Dutra, HLC
   Moreira, LA
AF Caragata, Eric Pearce
   Carneiro Dutra, Heverton Leandro
   Moreira, Luciano Andrade
TI Inhibition of Zika virus by Wolbachia in Aedes aegypti
SO MICROBIAL CELL
LA English
DT Editorial Material
DE Zika virus; mosquito-transmitted disease; Aedes aegypti; Wolbachia
AB Through association with cases of microcephaly in 2015, Zika virus (ZIKV) has transitioned from a relatively unknown mosquito-transmitted pathogen to a global health emergency, emphasizing the need to improve existing mosquito control programs to prevent future disease outbreaks. The response to Zika must involve a paradigm shift from traditional to novel methods of mosquito control, and according to the World Health Organization should incorporate the release of mosquitoes infected with the bacterial endosymbiont Wolbachia pipientis. In our recent paper [Dutra, HLC et al., Cell Host & Microbe 2016] we investigated the potential of Wolbachia infections in Aedes aegypti to restrict infection and transmission of Zika virus recently isolated in Brazil. Wolbachia is now well known for its ability to block or reduce infection with a variety of pathogens in different mosquito species including the dengue (DENV), yellow fever, and chikungunya viruses, and malaria-causing Plasmodium, and consequently has great potential to control mosquito- transmitted diseases across the globe. Our results demonstrated that the wMel Wolbachia strain in Brazilian Ae. aegypti is a strong inhibitor of ZIKV infection, and furthermore appears to prevent transmission of infectious viral particles in mosquito saliva, which highlights the bacterium's suitability for more widespread use in Zika control.
C1 [Caragata, Eric Pearce; Carneiro Dutra, Heverton Leandro; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
RP Moreira, LA (corresponding author), 1715 Ave Augusto de Lima, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI Dutra, Heverton Leandro Carneiro/V-7517-2019
OI Dutra, Heverton Leandro Carneiro/0000-0002-0917-4512
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES;
   Brazilian Ministry of Health (DECIT/SVS); Foundation for the National
   Institutes of Health through the Vector-Based Transmission of Control:
   Discovery Research (VCTR) program of the Grand Challenges in Global
   Health Initiatives of the Bill and Melinda Gates Foundation
FX This work was supported by FAPEMIG, CNPq, CAPES, the Brazilian Ministry
   of Health (DECIT/SVS), and a grant to Monash University from the
   Foundation for the National Institutes of Health through the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health Initiatives of the Bill and
   Melinda Gates Foundation.
NR 0
TC 22
Z9 24
U1 0
U2 62
PU SHARED SCIENCE PUBLISHERS OG
PI GRAZ
PA AM BLUMENHAG 25-4, GRAZ, 8010, AUSTRIA
SN 2311-2638
J9 MICROB CELL
JI Microb. Cell
PD JUL
PY 2016
VL 3
IS 7
BP 293
EP 295
DI 10.15698/mic2016.07.513
PG 3
WC Cell Biology
SC Cell Biology
GA DR4LE
UT WOS:000379872200004
PM 28357366
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nguyen, HN
   Qian, XY
   Song, HJ
   Ming, GL
AF Ha Nam Nguyen
   Qian, Xuyu
   Song, Hongjun
   Ming, Guo-li
TI Neural stem cells attacked by Zika virus
SO CELL RESEARCH
LA English
DT Editorial Material
ID INFECTION
AB The current outbreak of Zika virus-associated diseases in South America and its threat to spread to other parts of the world has emerged as a global health emergency. Insights from cell and animal models to understand how Zika virus causes severe birth defects may lead to treatments and prevention of these diseases.
C1 [Ha Nam Nguyen; Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
RP Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM gming1@jhmi.edu
RI Qian, Xuyu/C-1240-2017
OI Qian, Xuyu/0000-0001-5944-3816; Ming, Guo-li/0000-0002-2517-6075
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32 GM008752]; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [T32 MH015330]
CR Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 10
TC 15
Z9 15
U1 0
U2 33
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD JUL
PY 2016
VL 26
IS 7
BP 753
EP 754
DI 10.1038/cr.2016.68
PG 2
WC Cell Biology
SC Cell Biology
GA DQ8XP
UT WOS:000379495300002
PM 27283801
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kallas, EG
   O'Connor, DH
AF Kallas, Esper G.
   O'Connor, David H.
TI Real-Time Sharing of Zika Virus Data in an Interconnected World
SO JAMA PEDIATRICS
LA English
DT Editorial Material
C1 [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [O'Connor, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 555 Sci Dr, Madison, WI 53711 USA.
EM doconnor@primate.wisc.edu
OI Kallas, Esper/0000-0003-2026-6925
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116382]
CR Athavaley A, ZIKA VIRUS TRENDING
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Francis DP, 2012, J PUBLIC HEALTH POL, V33, P290, DOI 10.1057/jphp.2012.14
   Google Trends, WORLD SEARCH ZIK VIR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nelson EK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-71
   Wellcome Trust, DAT SHAR PUBL HLTH E
NR 10
TC 5
Z9 5
U1 0
U2 55
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JUL
PY 2016
VL 170
IS 7
BP 633
EP 634
DI 10.1001/jamapediatrics.2016.0857
PG 2
WC Pediatrics
SC Pediatrics
GA DQ2OK
UT WOS:000379041800003
PM 27031608
OA Bronze
DA 2020-07-08
ER

PT J
AU Han, JF
   Jiang, T
   Ye, Q
   Li, XF
   Liu, ZY
   Qin, CF
AF Han, Jian-Feng
   Jiang, Tao
   Ye, Qing
   Li, Xiao-Feng
   Liu, Zhong-Yu
   Qin, Cheng-Feng
TI Homologous recombination of Zika viruses in the Americas
SO JOURNAL OF INFECTION
LA English
DT Letter
ID BRAZIL
C1 [Han, Jian-Feng; Jiang, Tao; Ye, Qing; Li, Xiao-Feng; Liu, Zhong-Yu; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926;
   Liu, Zhong-Yu/0000-0001-7385-5681
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2016, PLOS NEGLECT TROP D, V6, pe1477
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
NR 10
TC 3
Z9 3
U1 0
U2 15
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUL
PY 2016
VL 73
IS 1
BP 87
EP 88
DI 10.1016/j.jinf.2016.04.011
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DQ3RC
UT WOS:000379118700012
PM 27105655
OA Bronze
DA 2020-07-08
ER

PT J
AU Heringer, L
   Johnson, BJ
   Fikrig, K
   Oliveira, BA
   Silva, RD
   Townsend, M
   Barrera, R
   Eiras, AE
   Ritchie, SA
AF Heringer, Laila
   Johnson, Brian J.
   Fikrig, Kara
   Oliveira, Bruna A.
   Silva, Richard D.
   Townsend, Michael
   Barrera, Roberto
   Eiras, Alvaro E.
   Ritchie, Scott A.
TI Evaluation of Alternative Killing Agents for Aedes aegypti (Diptera:
   Culicidae) in the Gravid Aedes Trap (GAT)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; dengue; Zika; mosquito trap; entomological surveillance
ID FIELD-EVALUATION; DENGUE VECTORS; CONTROLLED-TRIAL; INSECTICIDE;
   WOLBACHIA; ALBOPICTUS; MOSQUITOS; STICKY; METOFLUTHRIN; RESISTANCE
AB The Gravid Aedes Trap (GAT) uses visual and olfactory cues to attract gravid Aedes aegypti (L.) that are then captured when knocked down by a residual pyrethroid surface spray. However, the use of surface sprays can be compromised by poor availability of the spray and pesticide resistance in the target mosquito. We investigated several "alternative" insecticide and insecticide-free killing agents for use in the GAT. This included long-lasting insecticide-impregnated nets (LLINs), vapor-active synthetic pyrethroids (metofluthrin), canola oil, and two types of dry adhesive sticky card. During bench top assays LLINs, metofluthrin, and dry sticky cards had 24-h knockdown (KD) percentages >80% (91.2 +/- 7.2%, 84.2 +/- 6.8%, and 83.4 +/- 6.1%, respectively), whereas the 24-h KD for canola oil was 70 +/- 7.7%, which improved to 90.0 +/- 3.7% over 48 h. Importantly, there were no significant differences in the number of Ae. aegypti collected per week or the number of traps positive for Ae. aegypti between the sticky card and canola oil treatments compared with the surface spray and LLIN treatments in semifield and field trials. These results demonstrate that the use of inexpensive and widely available insecticide-free agents such as those described in this study are effective alternatives to pyrethroids in regions with insecticide-resistant populations. The use of such environmentally friendly insecticide-free alternatives will also be attractive in areas where there is substantial resistance to insecticide use due to environmental and public health concerns.
C1 [Heringer, Laila; Oliveira, Bruna A.; Silva, Richard D.; Eiras, Alvaro E.] Univ Fed Minas Gerais, Dept Parasitol, Lab Ecol Quim Insetos Vetores LabEQ, Belo Horizonte, MG, Brazil.
   [Heringer, Laila; Johnson, Brian J.; Fikrig, Kara; Townsend, Michael; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, POB 6811, Cairns, Qld 4870, Australia.
   [Johnson, Brian J.; Townsend, Michael; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, POB 6811, Cairns, Qld 4870, Australia.
   [Fikrig, Kara] Yale Univ, Yale Sch Publ Hlth, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Barrera, Roberto] Ctr Dis Control & Prevent, Entomol & Ecol Act, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
RP Ritchie, SA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, POB 6811, Cairns, Qld 4870, Australia.; Ritchie, SA (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, POB 6811, Cairns, Qld 4870, Australia.
EM pequeninissima@gmail.com; brian.johnson@jcu.edu.au;
   kara.fikrig@yale.edu; brunaoliveira1601@gmail.com;
   richardcbdio-go@outlook.com; michael.townsend@jcu.edu.au; amz9@cdc.gov;
   alvaro.eiras@gmail.com; scott.ritchie@jcu.edu.au
RI Eiras, Alvaro/Z-6023-2019
OI Eiras, Alvaro/0000-0002-3045-0673
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); National Health and Medical Research Council Senior Research
   FellowshipNational Health and Medical Research Council of Australia
   [1044698]
FX We thank Doreen Weatherby for providing the BestNet NetProtect LLINs,
   and John Lucas and Garry Webb of Sumitomo for providing the Olyset Plus
   LLIN. We also thank Biogents (Germany) for providing the BG-GAT
   prototype for testing. AEE thanks CAPES and CNPq for providing funding.
   Sponsorship was provided by CAPES, CNPq, FAPEMIG, and National Health
   and Medical Research Council Senior Research Fellowship 1044698
   (www.nhmrc.gov.au last accessed 01/11/2015 (Nov 1st 2015)).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Andrade CFS, 2010, J AM MOSQUITO CONTR, V26, P112, DOI 10.2987/09-5994.1
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dame DA, 2014, J AM MOSQUITO CONTR, V30, P31, DOI 10.2987/13-6379.1
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Fakoorziba MR, 2009, ENVIRON TOXICOL, V24, P19, DOI 10.1002/tox.20386
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Gubler D.J., 2008, VECTOR BORNE DIS UND
   Hapairai LK, 2013, J MED ENTOMOL, V50, P731, DOI 10.1603/ME12270
   Heath RR, 1997, J ECON ENTOMOL, V90, P1584, DOI 10.1093/jee/90.6.1584
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Lloyd Aaron M, 2013, US Army Med Dep J, P80
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Odhiambo MTO, 2013, J TROP MED, V2013, P1
   Pennetier C., 2014, PLOS ONE, V8
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Salazar FV, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-145
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Xue RD, 2012, J MED ENTOMOL, V49, P652, DOI 10.1603/ME10227
NR 41
TC 6
Z9 6
U1 1
U2 26
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2016
VL 53
IS 4
BP 873
EP 879
DI 10.1093/jme/tjw051
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DQ4WL
UT WOS:000379204800017
PM 27247350
DA 2020-07-08
ER

PT J
AU Unlu, I
   Faraji, A
   Indelicato, N
   Rochlin, I
AF Unlu, Isik
   Faraji, Ary
   Indelicato, Nicholas
   Rochlin, Ilia
TI TrapTech R-Octenol Lure Does Not Improve the Capture Rates of Aedes
   albopictus (Diptera: Culicidae) and Other Container-Inhabiting Species
   in Biogents Sentinel Traps
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito surveillance; trap evaluation; BGS trap; olfactory kairomone;
   New Jersey
ID NORTH CENTRAL FLORIDA; CARBON-DIOXIDE; FIELD-EVALUATION; MOSQUITO TRAPS;
   LACTIC-ACID; SURVEILLANCE; 1-OCTEN-3-OL; ATTRACTANTS; CHIKUNGUNYA;
   JAPONICUS
AB Aedes albopictus (Skuse) and other container-inhabiting species have become important public health concerns due to the transmission of dengue, chikungunya, and Zika viruses. Effective surveillance is dependent on the ability to collect a sufficient number of mosquitoes for population monitoring and pathogen isolation. The Biogents Sentinel (BGS) trap supplied with a proprietary human skin lure has become the standard tool for container-inhabiting Aedes species collections worldwide. Recently, R-octenol, a single isomer of the well characterized mosquito attractant octenol, was shown to greatly improve the capture rate of some Aedes species when utilized with the Center for Disease Control and Prevention (CDC) light traps and Mosquito Magnet traps. This study evaluated the effectiveness of the TrapTech lure (TT lure), containing R-octenol, alone or in combination with the human skin lure in a BGS trap to capture Ae. albopictus and other species. BGS traps with human skin lures or a combination of the two lures collected approximately twice as many Ae. albopictus females compared to those with TT lures. Unlike previous studies, baiting BGS traps with TT lures did not result in increased diversity of mosquito species, or in higher numbers of other container-inhabiting Aedes species. Although human skin lures were clearly superior to TT R-octenol lures in BGS traps, R-octenol lures are more widely available and might still be used as an alternative lure, especially when Ae. albopictus populations are high.
C1 [Unlu, Isik; Faraji, Ary; Rochlin, Ilia] Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.
   [Unlu, Isik; Indelicato, Nicholas] Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT 84116 USA.
   [Rochlin, Ilia] Suffolk Cty Vector Control, 335 Yaphank Ave, Yaphank, NY 11980 USA.
RP Unlu, I (corresponding author), Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.; Unlu, I (corresponding author), Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
EM iunlu@mercercounty.org; ary@slcmad.org; nindelicato@mercercounty.org;
   ilia.rochlin@suffolkcountyny.gov
CR Anderson JF, 2012, J AM MOSQUITO CONTR, V28, P184, DOI 10.2987/12-6260R.1
   Beals E. W, 1984, ADV ECOL RES, V14, P55
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Hoel DF, 2007, J AM MOSQUITO CONTR, V23, P11, DOI 10.2987/8756-971X(2007)23[11:EOCDOA]2.0.CO;2
   HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661
   Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x
   KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x
   Kline DL, 2002, J VECTOR ECOL, V27, P1
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Luhken R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-268
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Obenauer PJ, 2010, ENVIRON ENTOMOL, V39, P1608, DOI 10.1603/EN09322
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Rochlin I, 2016, J MED ENTOMOL, V53, P454, DOI 10.1093/jme/tjv171
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Unlu Isik, 2012, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V40, P23
NR 25
TC 3
Z9 3
U1 0
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2016
VL 53
IS 4
BP 982
EP 985
DI 10.1093/jme/tjw068
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DQ4WL
UT WOS:000379204800035
PM 27273239
DA 2020-07-08
ER

PT J
AU Killion, MM
AF Killion, Molly M.
TI Zika Virus Update
SO MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING
LA English
DT Editorial Material
C1 [Killion, Molly M.] Univ Calif San Francisco, Benioff Childrens Hosp, Birth Ctr, San Francisco, CA 94143 USA.
RP Killion, MM (corresponding author), Univ Calif San Francisco, Benioff Childrens Hosp, Birth Ctr, San Francisco, CA 94143 USA.
EM molly.killion@ucsf.edu
CR [American College of Obstetricians and Gynecologists Society for Maternal-Fetal Medicine], 2016, PRACT ADV INT GUID C
   Centers for Disease Control and Prevention, 2016, UPD INT GUID HLTH CA
   Centers for Disease Control and Prevention, 2016, QUEST ANSW ZIK VIR I
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 4
TC 1
Z9 1
U1 0
U2 50
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0361-929X
EI 1539-0683
J9 MCN-AM J MATERN-CHIL
JI MCN-Am. J. Matern.-Child Nurs.
PD JUL-AUG
PY 2016
VL 41
IS 4
BP 252
EP 252
DI 10.1097/NMC.0000000000000246
PG 1
WC Nursing
SC Nursing
GA DQ4ID
UT WOS:000379166500009
PM 26927699
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Hoti, SL
   Rajeswary, M
   Benelli, G
AF Govindarajan, Marimuthu
   Hoti, S. L.
   Rajeswary, Mohan
   Benelli, Giovanni
TI One-step synthesis of polydispersed silver nanocrystals using Malva
   sylvestris: an eco-friendly mosquito larvicide with negligible impact on
   non-target aquatic organisms
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Biosafety; Biosynthesis; Mosquito-borne diseases; Nanotechnology; Zika
   virus
ID AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; GREEN
   SYNTHESIS; VETERINARY IMPORTANCE; LEAF EXTRACT; PLANT LATEX;
   NANOPARTICLES; MALARIA; LEAVES
AB The synthesis of eco-friendly nanoparticles is evergreen branch of nanoscience with a growing number of biomedical implications. In this study, we investigated the synthesis of polydisperse and stable silver nanoparticles (AgNP) using a cheap leaf extract of Malva sylvestris (Malvaceae). Bio-reduced AgNP were characterized by UV-visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), atomic force microscopy (AFM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The acute toxicity of M. sylvestris leaf extract and green-synthesized AgNP was evaluated against larvae of the malaria vector Anopheles stephensi, the dengue vector Aedes aegypti and the filariasis vector Culex quinquefasciatus. Compared to the leaf aqueous extract, AgNP showed higher toxicity against A. stephensi, A. aegypti, and C. quinquefasciatus with LC50 values of 10.33, 11.23, and 12.19 mu g/mL, respectively. Green-synthesized AgNP were found safer to non-target organisms Diplonychus indicus and Gambusia affinis, with respective LC50 values ranging from 813.16 to 1044.52 mu g/mL. Overall, this research firstly shed light on the mosquitocidal potential of M. sylvestris, a potential bio-resource for rapid, cheap and effective synthesis of polydisperse and highly stable silver nanocrystals.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Hoti, S. L.] Reg Med Res Ctr, Nehru Nagar, Belgaum 590010, Karnataka, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovindzoo@yahoo.com; g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931
CR Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BILLETER M, 1991, PHYTOCHEMISTRY, V30, P987, DOI 10.1016/0031-9422(91)85292-8
   DEO P G, 1988, International Pest Control, V30, P118
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI 10.1021/nl015673+
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Machalova Z, 2015, IND CROP PROD, V67, P310, DOI 10.1016/j.indcrop.2015.01.070
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pirbalouti AG, 2010, ACTA POL PHARM, V67, P511
   Raghvendra K, 2002, ICMR B, V32
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Sarwar M, 2009, PAK J BOT, V41, P3047
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Smith SL, 2008, SPECTROCHIM ACTA A, V71, P186, DOI 10.1016/j.saa.2007.12.002
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   TOMODA M, 1989, CHEM PHARM BULL, V37, P3029, DOI 10.1248/cpb.37.3029
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   WHO, 2005, WHOCDSWHOPESGCDPP13
NR 43
TC 10
Z9 10
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUL
PY 2016
VL 115
IS 7
BP 2685
EP 2695
DI 10.1007/s00436-016-5038-x
PG 11
WC Parasitology
SC Parasitology
GA DQ2MO
UT WOS:000379036600018
PM 27075309
OA Bronze
DA 2020-07-08
ER

PT J
AU Qin, XF
AF Qin, Xiao-Feng
TI Understanding the pathogenic evolution of Zika virus
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
C1 [Qin, Xiao-Feng] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Qin, Xiao-Feng] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Qin, Xiao-Feng] Suzhou Inst Syst Med, Suzhou 215123, Peoples R China.
RP Qin, XF (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Qin, XF (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Qin, XF (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Peoples R China.
EM fqin1@foxmail.com
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 5
TC 3
Z9 3
U1 0
U2 75
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD JUL
PY 2016
VL 59
IS 7
BP 737
EP 739
DI 10.1007/s11427-016-5069-7
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DQ2OX
UT WOS:000379043200013
PM 27207138
OA Other Gold
DA 2020-07-08
ER

PT J
AU Gong, Z
   Gao, YX
   Han, GZ
AF Gong, Zhen
   Gao, Yuxia
   Han, Guan-Zhu
TI Zika Virus: Two or Three Lineages?
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
ID EVOLUTION
AB Zika virus (ZIKV) infection has become an emerging concern of global public health. Several recent studies provide new insights into the evolution and diversity of ZIKV, with important implications for ongoing surveillance and control measures.
C1 [Gong, Zhen; Gao, Yuxia; Han, Guan-Zhu] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing 210046, Jiangsu, Peoples R China.
RP Han, GZ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing 210046, Jiangsu, Peoples R China.
EM guanzhu@email.arizona.edu
RI Han, Guan-Zhu/A-6818-2011; Han, Guan-Zhu/P-4188-2019
OI Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07
NR 8
TC 19
Z9 19
U1 1
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD JUL
PY 2016
VL 24
IS 7
BP 521
EP 522
DI 10.1016/j.tim.2016.05.002
PG 2
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DQ3KD
UT WOS:000379100300004
PM 27220937
OA Bronze
DA 2020-07-08
ER

PT J
AU Meagher, RJ
   Negrete, OA
   Van Rompay, KK
AF Meagher, Robert J.
   Negrete, Oscar A.
   Van Rompay, Koen K.
TI Engineering Paper-Based Sensors for Zika Virus
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
ID AMPLIFICATION
AB The emergence of Zika virus (ZIKV) infections in Latin America and Southeast Asia has created an urgent need for new, simple, yet sensitive, diagnostic tests. We highlight recent work using paper-based sensors coupled with CRISPR/Cas9 to detect ZIKV RNA as a new approach to achieve rapid development and deployment of field-ready diagnostics for emerging infectious diseases.
C1 [Meagher, Robert J.; Negrete, Oscar A.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.
   [Van Rompay, Koen K.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
RP Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.
EM rmeaghe@sandia.gov
OI Meagher, Robert/0000-0002-6262-2126
CR Ball CS, 2016, ANAL CHEM, V88, P3562, DOI 10.1021/acs.analchem.5b04054
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Faye O, 2015, EUROSURVEILLANCE, V20, P10, DOI 10.2807/1560-7917.ES.2015.20.44.30053
   Klevits T., 1991, J VIROL METHODS, V35, P273
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Perkins MD, 2015, NAT BIOTECHNOL, V33, P464, DOI 10.1038/nbt.3215
NR 9
TC 13
Z9 14
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD JUL
PY 2016
VL 22
IS 7
BP 529
EP 530
DI 10.1016/j.molmed.2016.05.009
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DQ3ID
UT WOS:000379095100001
PM 27255410
OA Bronze
DA 2020-07-08
ER

PT J
AU Vahlne, A
AF Vahlne, Anders
TI How Zika virus made the transition from being a virtually unknown virus
   to a high-profile public health threat
SO ACTA PAEDIATRICA
LA English
DT Editorial Material
ID AMERICA
C1 [Vahlne, Anders] Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Stockholm, Sweden.
RP Vahlne, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Stockholm, Sweden.
EM anders.vahlne@ki.se
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Tang H, 2016, CELL STEM C IN PRESS
   Willison HJ, 2016, LANCET IN PRESS
NR 8
TC 0
Z9 0
U1 0
U2 79
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD JUL
PY 2016
VL 105
IS 7
BP 728
EP 729
DI 10.1111/apa.13436
PG 2
WC Pediatrics
SC Pediatrics
GA DP5VC
UT WOS:000378565100008
PM 27272625
DA 2020-07-08
ER

PT J
AU Dasti, JI
AF Dasti, Javid Iqbal
TI Zika virus infections: an overview of current scenario
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Neurological complications; microcephaly; Guillain-Barre
   syndrome; Aedes aegypti; Aedes albopictus
ID DENGUE VIRUS; YELLOW-FEVER; AEDES-ALBOPICTUS; TRANSMISSION; MOSQUITOS;
   OUTBREAK; ORGANIZATION; TEMPERATURE; CHIKUNGUNYA; AEGYPTI
AB Zika virus (ZIKV) was discovered more than half a century ago, recently it has gained unprecedented attention by the global health community. Until 2007, only 14 cases of human ZIKV infections were reported around the globe, while during the current outbreak, estimated cases mounted to approximately 1.5 million in Brazil alone, the virus was disseminated to wider South-American territories and travel-associated ZIKV infections were reported in USA, Europe and recently in China. ZIKV infections remain asymptomatic in approximately 80% of the individuals, and no anti-viral treatments were recommended. Yet, neurological complications associated with the infections, such as infant microcephaly and Guillain-Barre syndrome are major cause of the concern. Although, based on small numbers of cases, existing evidence strongly supports an exclusive link of viral infection and observed neurological complications. However, much work remains to assign exact numbers of complications caused by ZIKV. Regarding its structural attributes ZIKV shows remarkable resemblance with dengue virus and West-Nile virus. Despite, genomes of different ZIKV strains have already been decoded; role of the viral components in infection process and particularly pathogenesis of the disease remain widely unclear. In vulnerable areas, most viable strategy to ensure public health safety is vector control and enhanced public awareness about the transmission of the disease.
C1 [Dasti, Javid Iqbal] Qauid I Azam Univ, Dept Microbiol, Islamabad, Pakistan.
RP Dasti, JI (corresponding author), Qauid I Azam Univ, Dept Microbiol, Islamabad, Pakistan.
EM iqba178@hushmail.com
FU Higher Education Commission of PakistanHigher Education Commission of
   Pakistan
FX The author would like to acknowledge Higher Education Commission of
   Pakistan for supporting this study.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   D'Ortenzio E, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1604449, DOI 10.1056/NEJMC160/1119]
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Du Toit A, 2016, NAT REV MICROBIOL, V14, P268, DOI 10.1038/nrmicro.2016.47
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Finlay C, 1937, Yale J Biol Med, V9, P589
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.16.171082
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 2013, FIELDS VIROLOGY
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Monath T.P., 1989, ARBOVIRUSES EPIDEMIO, VV
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Robin Y, 1974, B SOC PATHOL EXOT, V68, P249
   Saluzzo JF, 1980, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P1
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 53
TC 17
Z9 17
U1 0
U2 81
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 601
EP 605
DI 10.1016/j.apjtm.2016.05.010
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500001
PM 27393087
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Predicted pattern of Zika virus infection distribution with reference to
   rainfall in Thailand
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Infection; Rainfall
AB Zika virus infection is the present global medical problem. The disease appears in several countries around the world. The relationship between rainfall and occurrence of Zika virus infection was previously mentioned. Here, the authors use the mathematical modeling technique to reappraise on the previous data on immunoreactivity rate of Zika virus, dengue virus and Ckikungunya virus in Thailand and the reported interrelationship between arboviral infections and rainfall in Thailand for constructing of the predicted pattern of Zika virus distribution in Thailand. This data can be a useful tool for further disease surveillance in this area.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou 571199, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit S, 2013, J ARTHROPOD-BORNE DI, V7, P185
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
NR 7
TC 8
Z9 8
U1 0
U2 105
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 698
EP 699
DI 10.1016/j.apjtm.2016.05.014
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500019
PM 27393105
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Humidity that is appropriate for Zika virus infection: A summary from
   Thai cases
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Zika virus; Humidity; Infection
ID CLIMATE
AB In the present day, Zika virus infection is a big problem in medicine. As a mosquito borne infectious disease, the climate parameters including humidity can affect the disease suitability. However, there is no previous data on the appropriate humidity level that can promote Zika virus infection. Here, the authors analyze the data on humidity where the Zika infections are detected in Thailand and found that the average humidity is equal to (66.14%+/- 19.86%), which is the level that can be seen in several areas of the world including to non-tropical countries. This implies that there is a possible risk of Zika virus infection in the non-tropical country with appropriate humidity level.
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 7
TC 2
Z9 2
U1 0
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 700
EP 700
DI 10.1016/j.apjtm.2016.05.016
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500020
PM 27393106
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Witkin, SS
AF Witkin, S. S.
TI The Zika virus epidemic: professionals and the public search for answers
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Witkin, S. S.] Weill Cornell Med Obstet & Gynecol, Infect & Immunol Ob Gyn, New York, NY 10065 USA.
RP Witkin, SS (corresponding author), Weill Cornell Med Obstet & Gynecol, Infect & Immunol Ob Gyn, New York, NY 10065 USA.
EM switkin@med.cornell.edu
RI Witkin, Steven/AAF-3812-2019
NR 0
TC 0
Z9 0
U1 0
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1255
EP 1255
DI 10.1111/1471-0528.14076
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500002
PM 27151254
OA Bronze
DA 2020-07-08
ER

PT J
AU Burke, RM
   Candfield, S
   Gothard, P
AF Burke, R. M.
   Candfield, S.
   Gothard, P.
TI Zika virus and microcephaly - more questions than answers?
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Burke, R. M.; Candfield, S.; Gothard, P.] Univ Coll London Hosp FT, Hosp Trop Dis, Infect Div, London, England.
RP Burke, RM (corresponding author), Univ Coll London Hosp FT, Hosp Trop Dis, Infect Div, London, England.
OI Burke, Rachael/0000-0002-2156-5030; Candfield,
   Sophie/0000-0002-6543-7276
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HILLS, 2016, MMWR-MORBID MORTAL W, V8, P215
   LISSAUER S, 2016, BJOG, V123, P1258
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
NR 5
TC 0
Z9 0
U1 0
U2 50
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1264
EP 1264
DI 10.1111/1471-0528.14073
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500004
PM 27150736
DA 2020-07-08
ER

PT J
AU Moron, AF
   Cavalheiro, S
   Milani, HJF
   Sarmento, SGP
   Tanuri, C
   de Souza, FF
   Richtmann, R
   Witkin, SS
AF Moron, A. F.
   Cavalheiro, S.
   Milani, H. J. F.
   Sarmento, S. G. P.
   Tanuri, C.
   de Souza, F. F.
   Richtmann, R.
   Witkin, S. S.
TI Microcephaly associated with maternal Zika virus infection
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
ID BRAZIL
C1 [Moron, A. F.; Milani, H. J. F.; Sarmento, S. G. P.] Hosp & Maternidade Santa Joana, Dept Fetal Med, Rua Leandro Dupret,334 Apto 81, BR-04025011 Sao Paulo, Brazil.
   [Cavalheiro, S.] Hosp & Maternidade Santa Joana, Dept Paediat Neurosurg, Sao Paulo, Brazil.
   [Tanuri, C.] Hosp & Maternidade Santa Joana, Neonatal Intens Care Unit, Sao Paulo, Brazil.
   [de Souza, F. F.] Hosp & Maternidade Santa Joana, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [Richtmann, R.] Hosp & Maternidade Santa Joana, Dept Infect Dis, Sao Paulo, Brazil.
   [Witkin, S. S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Moron, AF (corresponding author), Hosp & Maternidade Santa Joana, Dept Fetal Med, Rua Leandro Dupret,334 Apto 81, BR-04025011 Sao Paulo, Brazil.
EM doutormoron.consultorio@gmail.com
RI Witkin, Steven/AAF-3812-2019; MORON, ANTONIO F./H-4987-2013
OI MORON, ANTONIO F./0000-0002-7963-1758
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil Ministry of Health, 15 BRAZ MIN HLTH
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMFM Statement, 2016, AM J OBSTET GYNECOL
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 19
Z9 19
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1265
EP 1269
DI 10.1111/1471-0528.14072
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500005
OA Bronze
DA 2020-07-08
ER

PT J
AU Marrs, CC
AF Marrs, Caroline C.
TI The ultrasound standards for head measurements are appropriate for use
   in the Zika epidemic : FOR: Standards are the best tools that are
   currently available
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
CR BRASIL, 2016, N ENGL J MED
   CHERVENAK, 1987, OBSTET GYNECOL, V69, P908
   LEIBOVITZ, 2015, OBSTET GYNECOL
   MARRS, 2016, AM J PERINATOL
   MLAKAR, 2016, N ENGL J MED
   SMFM, 2016, AM J OBSTET GYNECOL, DOI 10.1016/j.ajog.2016.02.043
NR 6
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1270
EP 1270
DI 10.1111/1471-0528.14075
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500006
PM 27151137
OA Bronze
DA 2020-07-08
ER

PT J
AU Saade, GR
AF Saade, George R.
TI The ultrasound standards for head measurements are appropriate for use
   in the Zika epidemic: AGAINST: Current standards are inadequate
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
CR BRASIL, 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA1602412
   Deloison B, 2012, PRENATAL DIAG, V32, P869, DOI 10.1002/pd.3923
   FREITAS D, 2016, JAMA OPHTHALMOL, DOI DOI 10.1001/JAMAOPHTHAL-MOL.2016.0267
   MARRS, 2016, AM J PERINAT, DOI DOI 10.1055/S-0036-1580089
   Melamed N, 2011, ULTRASOUND OBST GYN, V37, P65, DOI 10.1002/uog.7760
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1270
EP 1270
DI 10.1111/1471-0528.14070
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500007
PM 27150274
DA 2020-07-08
ER

PT J
AU Papageorghiou, AT
AF Papageorghiou, A. T.
TI Fetal assessment after Zika exposure
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Papageorghiou, A. T.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
   [Papageorghiou, A. T.] St Georges Healthcare NHS Fdn Trust, London, England.
RP Papageorghiou, AT (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.; Papageorghiou, AT (corresponding author), St Georges Healthcare NHS Fdn Trust, London, England.
CR ARMSTRONG, 2016, MMWR
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   *ISUOG, 2016, ULTRASOUND OBST GYN, V47, P530
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   2016, BJOG, DOI DOI 10.1111/1471-0528.14070
NR 7
TC 0
Z9 0
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1271
EP 1271
DI 10.1111/1471-0528.14074
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500008
PM 27150951
OA Bronze
DA 2020-07-08
ER

PT J
AU Saade, GR
AF Saade, George R.
TI Asymptomatic pregnant women returning to the United States from
   countries experiencing a Zika virus outbreak should be tested for Zika
   virus : FOR: Importance of identification in ALL pregnant women
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
CR DASGUPTA, 2016, MMWR-MORBID MORTAL W, V65, P395
   FLEMINGDUTRA, 2016, MMWR-MORBID MORTAL W, V65, P182
   ODUYEBO, 2016, MMWR-MORBID MORTAL W, V65, P122
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
NR 4
TC 1
Z9 1
U1 0
U2 54
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1272
EP 1272
DI 10.1111/1471-0528.14068
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500010
PM 27150136
OA Bronze
DA 2020-07-08
ER

PT J
AU Sheffield, JS
AF Sheffield, Jeanne S.
TI Asymptomatic pregnant women returning to the United States from
   countries experiencing a Zika virus outbreak should be tested for Zika
   virus: AGAINST: Not so fast
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Sheffield, Jeanne S.] Johns Hopkins Med, Maternal Fetal Med, Baltimore, MD 21287 USA.
RP Sheffield, JS (corresponding author), Johns Hopkins Med, Maternal Fetal Med, Baltimore, MD 21287 USA.
CR ODUYEBO, 2016, MMWR-MORBID MORTAL W, V65, P122
   SCHULERFACCINI, 2016, MMWR-MORBID MORTAL W, V65, P59
NR 2
TC 0
Z9 0
U1 0
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1272
EP 1272
DI 10.1111/1471-0528.14069
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500009
PM 27149896
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus infection: Control and prevention
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Letter
ID PUBLIC-HEALTH
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Dept Publ Hlth Curriculum, Mueang Surin Dist, Surin, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House,140 Bangkhae 7, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Wiwanitkit S, 2016, ASIAN PAC J IN PRESS
NR 5
TC 2
Z9 2
U1 0
U2 21
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD JUL
PY 2016
VL 79
IS 7
BP 409
EP 409
DI 10.1016/j.jcma.2016.04.002
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6BY
UT WOS:000378583100011
PM 27221543
OA Other Gold
DA 2020-07-08
ER

PT J
AU Graham, DM
AF Graham, Dustin M.
TI New models for Zika pathology
SO LAB ANIMAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0093-7355
EI 1548-4475
J9 LAB ANIMAL
JI Lab Anim.
PD JUL
PY 2016
VL 45
IS 7
BP 242
EP 242
DI 10.1038/laban.1053
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA DP8OQ
UT WOS:000378757900001
PM 27327000
DA 2020-07-08
ER

PT J
AU Rochat, R
AF Rochat, Roger W.
TI Commentary on Obstetric Care in Rural Georgia
SO MATERNAL AND CHILD HEALTH JOURNAL
LA English
DT Article
DE Rural; Georgia; Obstetric care; Policy; Midwifery; Family planning;
   LARC; Zika
ID HEALTH
AB This is an invited commentary on five articles on obstetric care in rural Georgia.
C1 [Rochat, Roger W.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
RP Rochat, R (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
EM rrochat@emory.edu
RI Rochat, Roger/J-9802-2012
CR ALLEN DT, 1970, FAM PLANN PERSPECT, V2, P32, DOI 10.2307/2133836
   [Anonymous], 2006, MORBIDITY MORTALITY, V55, P745
   Brown P., 2014, ASTHO LARC M
   Hotez PJ, 2016, NY TIMES
   Kroelinger CD, 2015, J WOMENS HEALTH, V24, P693, DOI 10.1089/jwh.2015.5401
   Meyer E, 2016, MATERN CHILD HLTH J, V20, P1358, DOI 10.1007/s10995-016-1997-x
   Pinto M, 2016, MATERN CHILD HLTH J, V20, P1349, DOI 10.1007/s10995-016-1995-z
   Rochat R, 2008, MATERN CHILD HLTH J, V12, pS126, DOI 10.1007/s10995-008-0397-2
   Serbanescu F., 1995, PRELIMINARY REPORT 1
   Smulian EA, 2016, MATERN CHILD HLTH J, V20, P1341, DOI 10.1007/s10995-016-1998-9
   Spelke B, 2016, MATERN CHILD HLTH J, V20, P1333, DOI 10.1007/s10995-016-1999-8
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Zertuche AD, 2016, MATERN CHILD HLTH J, V20, P1323, DOI 10.1007/s10995-016-1996-y
NR 13
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1092-7875
EI 1573-6628
J9 MATERN CHILD HLTH J
JI Matern. Child Health J.
PD JUL
PY 2016
VL 20
IS 7
BP 1321
EP 1322
DI 10.1007/s10995-016-2024-y
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP8MK
UT WOS:000378752000001
PM 27230287
OA Bronze
DA 2020-07-08
ER

PT J
AU O'Malley, PA
AF O'Malley, Patricia Anne
TI Zika Virus What We Know and Do Not Know
SO CLINICAL NURSE SPECIALIST
LA English
DT Article
ID UNITED-STATES
C1 [O'Malley, Patricia Anne] Premier Hlth Miami Valley Hosp, Ctr Nursing Excellence, Dayton, OH 45409 USA.
RP O'Malley, PA (corresponding author), Premier Hlth Miami Valley Hosp, 1 Wyoming St, Dayton, OH 45409 USA.
EM pomalley@premierhealth.com
RI O'Malley, Patricia/AAI-2145-2019
OI O'Malley, Patricia/0000-0001-9355-6873
CR [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P352
   CDC, 2016, ZIK VIR AR ZIK
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Tang H, CELL STEM CELL
   World Health Organization, 2016, ZIK VIR ZIK VIR FACT
   World Health Organization, MICR FACT SHEET
   World Health Organization, 2016, GUILL BARR SYNDR FAC
NR 10
TC 2
Z9 2
U1 0
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0887-6274
EI 1538-9782
J9 CLIN NURSE SPEC
JI Clin. Nurse Spec.
PD JUL-AUG
PY 2016
VL 30
IS 4
BP 194
EP 197
DI 10.1097/NUR.0000000000000218
PG 4
WC Nursing
SC Nursing
GA DO8TA
UT WOS:000378055500005
PM 27309781
DA 2020-07-08
ER

PT J
AU Steele, RW
AF Steele, Russell W.
TI Zika Virus: An Explosive Pandemic and a New TORCH Agent
SO CLINICAL PEDIATRICS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES
C1 [Steele, Russell W.] Univ Queensland, Sch Med, Herston, Qld, Australia.
   [Steele, Russell W.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Steele, Russell W.] Ochsner Childrens Hlth Ctr, 1315 Jefferson Highway, New Orleans, LA 70121 USA.
RP Steele, RW (corresponding author), Ochsner Childrens Hlth Ctr, 1315 Jefferson Highway, New Orleans, LA 70121 USA.
EM RWSteele@aol.com
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Centers for Disease Control and Prevention, 2016, EM PREP RESP REC MAN
   Centers for Disease Control and Prevention, ZIK VIR DIAGN TEST
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ministry of Health-Manuatu Hauora, ZIK VIR
   Pan American Health Organization, ZIK VIR INF
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 10
TC 7
Z9 7
U1 0
U2 51
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD JUL
PY 2016
VL 55
IS 8
BP 698
EP 700
DI 10.1177/0009922816638660
PG 3
WC Pediatrics
SC Pediatrics
GA DP3NV
UT WOS:000378402500002
PM 27000068
DA 2020-07-08
ER

PT J
AU Grigoraki, L
   Balabanidou, V
   Meristoudis, C
   Miridakis, A
   Ranson, H
   Swevers, L
   Vontas, J
AF Grigoraki, Linda
   Balabanidou, Vassileia
   Meristoudis, Christos
   Miridakis, Antonis
   Ranson, Hilary
   Swevers, Luc
   Vontas, John
TI Functional and immunohistochemical characterization of CCEae3a, a
   carboxylesterase associated with temephos resistance in the major
   arbovirus vectors Aedes aegypti and Ae. albopictus
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Aedes; Arbovirus; Insecticide resistance; Detoxification; Diagnostics
ID INSECTICIDE RESISTANCE; ORGANOPHOSPHORUS RESISTANCE; CYTOCHROME-P450;
   EXPRESSION; ESTERASE
AB Temephos is a major organophosphate (OP) larvicide that has been used extensively for the control of Aedes albopictus and Aedes aegypti, the major vectors for viral diseases, such as dengue fever, zika and chikungunya. Resistance to temephos has been recently detected and associated with the upregulation of carboxylesterases (CCEs) through gene amplification, in both species. Here, we expressed the CCEae3a genes which showed the most striking up-regulation in resistant Aedes strains, using the baculovirus system. All CCEae3a variants encoded functional enzymes, with high activity and preference for p-nitrophenyl butyrate, a substrate that was shown capable to differentiate temephos resistant from susceptible Aedes larvae. Enzyme kinetic studies showed that CCEae3as from both Ae. aegypti and Ae. albopictus (CCEae3a_aeg and CCEae3a_alb, respectively) strongly interact with temephos oxon and slowly released the OP molecule, indicating a sequestration resistance mechanism. No difference was detected between resistant and susceptible CCEae3a_aeg variants (CCEae3a_aegR and CCEae3a_aegS, respectively), indicating that previously reported polymorphism is unlikely to play a role in temephos resistance. HPLC/MS showed that CCEae3as were able to metabolize temephos oxon to the temephos monoester [(4-hydroxyphenyl) sulfanyl] phenyl O,O-dimethylphosphorothioate. Western blot and immunolocalization studies, based on a specific antibody raised against the CCEae3a_alb showed that the enzyme is expressed at higher levels in resistant insects, primarily in malpighian tubules (MT) and nerve tissues. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Grigoraki, Linda; Balabanidou, Vassileia] Univ Crete, Dept Biol, Iraklion 73100, Greece.
   [Grigoraki, Linda; Balabanidou, Vassileia; Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 73100, Greece.
   [Meristoudis, Christos; Swevers, Luc] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol, Athens, Greece.
   [Miridakis, Antonis] Univ Crete, Dept Chem, ECPL, Iraklion 71003, Greece.
   [Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Vontas, John] Agr Univ Athens, Dept Crop Sci, Pesticide Sci Lab, GR-11855 Athens, Greece.
RP Vontas, J (corresponding author), Agr Univ Athens, Pesticide Sci Lab, Iera Odos 75, GR-11855 Athens, Greece.
EM vontas@imbb.forth.gr
OI Ranson, Hilary/0000-0003-2332-8247; Vontas, John/0000-0002-8704-2574;
   Grigoraki, Linda/0000-0001-8997-0406
FU European Union FP7European Union (EU) [228421]; Greece-France
   Cooperation Program [1641]
FX We thank Prof Kostas Iatrou (National Centre for Scientific Research
   'Demokritos') for kindly providing the expression vectors used in this
   study. We also thank Prof Evripidis Stefanou (University of Crete) for
   his help with the HPLC/MS, Dr Rodolphe Poupardin (University of
   Veterinary Medicine, Austria) for providing his help in CCE cloning, and
   Anastasia Kampouraki, Stella Kounadi and Dimitra Tsakirelli (University
   of Crete) for their help with the immunolocalisation and protein work.
   The research received funding from the European Union FP7 (2013) under
   grant agreement no 228421 to INFRAVEC (http://www.infravec.eu/) and a
   bilateral Greece-France Cooperation Program (no 1641) (www.gsrt.gr).
CR Aldridge W.N., 1972, ENZYME INHIBITORS SU, V26
   Chen ZZ, 2001, INSECT BIOCHEM MOLEC, V31, P805, DOI 10.1016/S0965-1748(00)00186-7
   DEVONSHIRE AL, 1977, BIOCHEM J, V167, P675, DOI 10.1042/bj1670675
   Devonshire AL, 2003, PESTIC BIOCHEM PHYS, V76, P1, DOI 10.1016/S0048-3575(03)00054-3
   DEVONSHIRE AL, 1986, B ENTOMOL RES, V76, P97, DOI 10.1017/S0007485300015327
   Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Ingham VA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1018
   Karunaratne SHPP, 2000, MED VET ENTOMOL, V14, P430, DOI 10.1046/j.1365-2915.2000.00252.x
   KARUNARATNE SHPP, 1993, BIOCHEM J, V294, P575, DOI 10.1042/bj2940575
   KETTERMAN AJ, 1992, BIOCHEM J, V287, P355, DOI 10.1042/bj2870355
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   McCarroll L, 2002, INSECT BIOCHEM MOLEC, V32, P1345, DOI 10.1016/S0965-1748(02)00097-8
   Nauen R, 2015, PESTIC BIOCHEM PHYS, V121, P3, DOI 10.1016/j.pestbp.2014.12.023
   Newcomb RD, 1997, INSECT BIOCHEM MOLEC, V27, P15, DOI 10.1016/S0965-1748(96)00065-3
   Pasteur N, 2001, J MED ENTOMOL, V38, P791, DOI 10.1603/0022-2585-38.6.791
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Ranson H, 2010, INSECTICIDE RESISTAN, P1
   Teese MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065951
   Van Leeuwen T, 2005, PEST MANAG SCI, V61, P499, DOI 10.1002/ps.1001
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   World Health Organization, 2009, DENG GUID DIAGN
   World Health Organization, 2012, DENG SERV DENG, V117
   World Health Organization, 1998, WHOCDSCPCMAL986
   Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107
NR 29
TC 17
Z9 19
U1 0
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD JUL
PY 2016
VL 74
BP 61
EP 67
DI 10.1016/j.ibmb.2016.05.007
PG 7
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA DP4FD
UT WOS:000378450800007
PM 27180726
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wasserman, S
   Tambyah, PA
   Lim, PL
AF Wasserman, Sean
   Tambyah, Paul Anantharajah
   Lim, Poh Lian
TI Yellow fever cases in Asia: primed for an epidemic
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Yellow fever; Aedes aegypti; Arboviruses; Flaviviruses; Emerging
   infectious diseases
ID AEDES-AEGYPTI; CHANGING EPIDEMIOLOGY; ZIKA VIRUS; DENGUE; RISK; AFRICA;
   SPREAD; EVOLUTIONARY; REEMERGENCE; CHIKUNGUNYA
AB There is currently an emerging outbreak of yellow fever in Angola. Cases in infected travellers have been reported in a number of other African countries, as well as in China, representing the first ever documented cases of yellow fever in Asia. There is a large Chinese workforce in Angola, many of whom may be unvaccinated, increasing the risk of ongoing importation of yellow fever into Asia via busy commercial airline routes. Large parts of the region are hyperendemic for the related Flavivirus dengue and are widely infested by Aedes aegypti, the primary mosquito vector of urban yellow fever transmission. The combination of sustained introduction of viraemic travellers, an ecology conducive to local transmission, and an unimmunized population raises the possibility of a yellow fever epidemic in Asia. This represents a major global health threat, particularly in the context of a depleted emergency vaccine stockpile and untested surveillance systems in the region. In this review, the potential for a yellow fever outbreak in Asia is discussed with reference to the ecological and historical forces that have shaped global yellow fever epidemiology. The limitations of surveillance and vector control in the region are highlighted, and priorities for outbreak preparedness and response are suggested. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Wasserman, Sean] Univ Cape Town, Dept Med, Div Infect Dis, ZA-7925 Cape Town, South Africa.
   [Wasserman, Sean] Univ Cape Town, Dept Med, HIV Med, ZA-7925 Cape Town, South Africa.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore.
   [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore.
   [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RP Wasserman, S (corresponding author), Univ Cape Town, Dept Med, Div Infect Dis, ZA-7925 Cape Town, South Africa.; Wasserman, S (corresponding author), Univ Cape Town, Dept Med, HIV Med, ZA-7925 Cape Town, South Africa.
EM sean.wasserman@gmail.com
CR Abrao E, 2006, VIRUS REV RES, V2006, P130
   Abrao E.P., 2007, 26 ANN M AM SOC VIR, V1, P273
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   [Anonymous], 2008, Wkly Epidemiol Rec, V83, P105
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   BEATY BJ, 1979, MOSQ NEWS, V39, P232
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   Cathey JT, 2014, T ROY SOC TROP MED H, V108, P252, DOI 10.1093/trstmh/tru043
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lim PL, 2013, J TRAVEL MED, V20, P211, DOI 10.1111/jtm.12031
   MAHAFFY A. F., 1941, ANN TROP MED AND PARASITOL, V35, P141
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Monath T P, 2006, Bull Soc Pathol Exot, V99, P341
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   MONATH TP, 1991, AM J TROP MED HYG, V45, P1
   Monath TP, 2002, CLIN INFECT DIS, V34, P1369, DOI 10.1086/340104
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K
   Pan American Health Organization, 2013, TECHN REP REC SCI EV
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   ProMED, 2016, YELL FEV AFR 02 ANG
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644, DOI 10.4269/ajtmh.1998.59.644
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   THEILER M, 1975, AM J TROP MED HYG, V24, P115, DOI 10.4269/ajtmh.1975.24.115
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Tomori Oyewale, 2002, Biomedica, V22, P178
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, YELL FEV KEN 6 APR 2
   World Health Organization, 2015, GLOB REG IMM PROF AF
   World Health Organization (WHO), 2014, RISK ASS YELL FEV VI
   World Health Organization (WHO), 2016, YELL FEV DEM REP CON
   Xiao SY, 2003, AM J TROP MED HYG, V68, P695, DOI 10.4269/ajtmh.2003.68.695
NR 58
TC 43
Z9 44
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2016
VL 48
BP 98
EP 103
DI 10.1016/j.ijid.2016.04.025
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DO8PW
UT WOS:000378046700025
PM 27156836
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Nawas, ZY
   Tong, Y
   Kollipara, R
   Peranteau, AJ
   Woc-Colburn, L
   Yan, AC
   Lupi, O
   Tyring, SK
AF Nawas, Zeena Y.
   Tong, Yun
   Kollipara, Ramya
   Peranteau, Andrew J.
   Woc-Colburn, Laila
   Yan, Albert C.
   Lupi, Omar
   Tyring, Stephen K.
TI Emerging infectious diseases with cutaneous manifestations Viral and
   bacterial infections
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Article
DE Acinetobacter baumannii; Chikungunya; dengue; Ebola; emerging
   infections; HFMD; Lyme; measles; melioidosis; rickettsia;
   trichodysplasia spinulosa; Zika
ID MOUNTAIN-SPOTTED-FEVER; ZIKA VIRUS OUTBREAK; TICK-BORNE LYMPHADENOPATHY;
   RICKETTSIA-FELIS INFECTION; UPDATE INTERIM GUIDANCE; UNITED-STATES;
   TRICHODYSPLASIA-SPINULOSA; MOUTH-DISEASE; ACINETOBACTER-BAUMANNII;
   HEALTH-CARE
AB Given increased international travel, immigration, and climate change, bacterial and viral infections that were once unrecognized or uncommon are being seen more frequently in the Western Hemisphere. A delay in diagnosis and treatment of these diseases can lead to significant patient morbidity and mortality. However, the diagnosis and management of these infections is fraught with a lack of consistency because there is a dearth of dermatology literature on the cutaneous manifestations of these infections. We review the epidemiology, cutaneous manifestations, diagnosis, and management of these emerging bacterial and viral diseases.
C1 [Nawas, Zeena Y.; Tong, Yun; Peranteau, Andrew J.; Tyring, Stephen K.] Ctr Clin Studies, Houston, TX USA.
   [Kollipara, Ramya] Texas Tech Hlth Sci Ctr, Dept Dermatol, Lubbock, TX USA.
   [Woc-Colburn, Laila] Baylor Coll Med, Natl Sch Trop Med, Dept Med, Houston, TX 77030 USA.
   [Yan, Albert C.] Childrens Hosp Philadelphia, Dermatol Sect, Philadelphia, PA USA.
   [Lupi, Omar] Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
   [Lupi, Omar] Policlin Geral Rio Janeiro, Rio De Janeiro, Brazil.
   [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA.
RP Nawas, ZY (corresponding author), Dermatol Assoc, 1401 Binz St,Ste 200, Houston, TX 77030 USA.
EM znawas@ccstexas.com
RI Lupi, Omar/AAA-3653-2019
OI Woc-Colburn, Laila/0000-0003-2888-7806; Tong, Yun/0000-0003-2003-1843
CR Abarca K, 2014, REV CHIL INFECTOL, V31, P569, DOI 10.4067/S0716-10182014000500009
   Abdullah S, 2015, EUR REV MED PHARMACO, V19, P2983
   Abrao EP, 2015, REV SAUDE PUBL, P49
   Adler BL, 2014, JAMA DERMATOL, V150, P905, DOI 10.1001/jamadermatol.2013.8855
   Allegue F, 2009, CLIN EXP DERMATOL, V34, pe246, DOI 10.1111/j.1365-2230.2008.03115.x
   [Anonymous], CHIK VIR US CHIK VIR
   [Anonymous], MEL C
   [Anonymous], 2014 FIN DAT US CHIK
   [Anonymous], GEOGR DISTR ZIK VIR
   [Anonymous], CLIN EV DIS ZIK VIR
   [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P351
   [Anonymous], MAN PEOPL GET LYM DI
   [Anonymous], 2015 PROV DAT US CHI
   [Anonymous], 2008, MEL CAS SEL REP OCC
   [Anonymous], ZIK VIR CAR AL LEV 2
   [Anonymous], ZIK VIR S AM AL LEV
   [Anonymous], TRANSM MEL
   [Anonymous], ZI9K VIR US ZIK VIR
   [Anonymous], SIGNS SYMPT LYM DIS
   [Anonymous], AR ZIK ZIK VIR
   [Anonymous], ZIK VIR CENTR AM AL
   [Anonymous], MEASL HEALTHC PROF
   [Anonymous], TRENDS TUB US
   [Anonymous], ZIK VIR PUERT RIC AL
   [Anonymous], 2015, ABCS BACT SURV 2012
   [Anonymous], SIGNS SYMPT MEL
   [Anonymous], STAT EHRL
   [Anonymous], ZIK VIR MEX AL LEV 2
   [Anonymous], SYMPT DIAGN TREATM Z
   Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71
   Atkinson B, 2016, EMERG INFECT DIS J, V22
   Bachmeyer C, 2005, CLIN EXP DERMATOL, V30, P256, DOI 10.1111/j.1365-2230.2005.01743.x
   Bandyopadhyay Debabrata, 2010, Indian J Dermatol, V55, P64, DOI 10.4103/0019-5154.60356
   Benoit TJ, 2015, AM J TROP MED HYG, V93, P1134, DOI 10.4269/ajtmh.15-0405
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011
   Blattner CM, 2015, DERMATOL ONLINE J, P21
   Campbell RM, 2006, ARCH DERMATOL, V142, P1645
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, ROCK MOUNT SPOTT FEV
   CDC, 2012, REP CAS LYM DIS STAT
   CDC, INT MAPS LYM DIS
   CDC, HAND FOOT MOUTH DIS
   Centers for Disease Control and Prevention, EB HEM FEV
   Centers for Disease Control and Prevention website, CAS DEF DENG
   Centers for Disease Control and Prevention website, DENG CHAPT 3 2016 YE
   Centers for Disease Control and Prevention website, DIAGN EB HEM FEV
   Centres for Disease Control and Prevention, DENGUE
   Chen SM, 2015, ASIA-PAC J PUBLIC HE, V27, P715, DOI 10.1177/1010539515579123
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6
   Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900
   David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09
   Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043
   Downing C, 2014, J CLIN VIROL, V60, P381, DOI 10.1016/j.jcv.2014.04.023
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR FR
   Edouard S, 2014, EMERG INFECT DIS, V20, P1780, DOI 10.3201/eid2010.140905
   Elston D, WHATS EATING YOUR 1
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   Fischer MK, 2012, ARCH DERMATOL, V148, P726, DOI 10.1001/archdermatol.2011.3298
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foldvari G, 2013, DIAGN MICR INFEC DIS, V76, P387, DOI 10.1016/j.diagmicrobio.2013.03.005
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202
   Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980
   Garnacho-Montero J, 2015, INTENS CARE MED, V41, P2057, DOI 10.1007/s00134-015-4079-4
   Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HALSTEAD SB, 1984, REV INFECT DIS, V6, P251
   Haycox CL, 1999, J INVEST DERM SYMP P, V4, P268, DOI 10.1038/sj.jidsp.5640227
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480
   Holzer AM, 2009, J AM ACAD DERMATOL, V60, P169, DOI 10.1016/j.jaad.2008.07.051
   Ibarra V, 2006, ANN NY ACAD SCI, V1078, P206, DOI 10.1196/annals.1374.040
   Ibarra V, 2005, ANN NY ACAD SCI, V1063, P257, DOI 10.1196/annals.1355.040
   Inamadar AC, 2008, INT J DERMATOL, V47, P154, DOI 10.1111/j.1365-4632.2008.03478.x
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996
   KAPLAN JE, 1986, AM J TROP MED HYG, V35, P840, DOI 10.4269/ajtmh.1986.35.840
   Kazem S, 2013, APMIS, V121, P770, DOI 10.1111/apm.12092
   KIRKLAND KB, 1995, CLIN INFECT DIS, V20, P1118, DOI 10.1093/clinids/20.5.1118
   Kumsa B, 2014, AM J TROP MED HYG, V90, P457, DOI 10.4269/ajtmh.13-0010
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007
   Lupi O, 2011, DERMATOL CLIN, V29, P33, DOI 10.1016/j.det.2010.09.009
   Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Mathes EF, 2013, PEDIATRICS, V132, pE149, DOI 10.1542/peds.2012-3175
   Mediannikov O, 2014, AM J TROP MED HYG, V91, P1015, DOI 10.4269/ajtmh.13-0629
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Nassef C, 2015, CURR OPIN PEDIATR, V27, P486, DOI 10.1097/MOP.0000000000000246
   Ng Geraldine, 2004, J Perinatol, V24, P526, DOI 10.1038/sj.jp.7211133
   Nkoghe D, 2012, INFECT DIS REP, V4, P11, DOI 10.4081/idr.2012.e5
   Nkoghe D, 2012, INT J DERMATOL, V51, P1037, DOI 10.1111/j.1365-4632.2011.05379.x
   Olano JP, 2006, TROPICAL DERMATOLOGY, P297
   Openshaw JJ, 2010, AM J TROP MED HYG, V83, P174, DOI 10.4269/ajtmh.2010.09-0752
   Osswald SS, 2007, J CUTAN PATHOL, V34, P721, DOI 10.1111/j.1600-0560.2006.00693.x
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035
   PAHO WHO, EP AL NEUR SYNDR CON
   Pal Gautam, 2011, J Indian Med Assoc, V109, P666
   Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13
   Passi D, 2015, J CLIN DIAGN RES, V9, pLE1, DOI 10.7860/JCDR/2015/13062.6100
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Portillo A, 2015, MICROBES INFECT, V17, P834, DOI 10.1016/j.micinf.2015.09.009
   Prashant Soma, 2009, Indian J Dermatol, V54, P128, DOI 10.4103/0019-5154.53186
   Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8
   Procop GW, 1997, ARCH PATHOL LAB MED, V121, P894
   Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694
   Rieg S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-167
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sadler GM, 2007, AUSTRALAS J DERMATOL, V48, P110, DOI 10.1111/j.1440-0960.2007.00348.x
   Saidani N, 2015, TRAVEL MED INFECT DI, V13, P367, DOI 10.1016/j.tmaid.2015.08.007
   Sarma N, 2013, INDIAN J DERMATOL VE, V79, P165, DOI 10.4103/0378-6323.107631
   Schweizer HP, 2014, EMERG INFECT DIS, V20
   Schwieger-Briel A, 2010, PEDIATR DERMATOL, V27, P509, DOI 10.1111/j.1525-1470.2010.01278.x
   Sebeny PJ, 2008, CLIN INFECT DIS, V47, P444, DOI 10.1086/590568
   Silva-Pinto A, 2014, TICKS TICK-BORNE DIS, V5, P656, DOI 10.1016/j.ttbdis.2014.04.016
   Sinha N, 2014, CASE REP INFECT DIS, DOI 10.1155/2014/705279
   Sperling LC, 2004, J AM ACAD DERMATOL, V50, P318, DOI 10.1016/S0190-9622(03)01490-7
   Stewart CL, 2013, JAMA DERMATOL, V149, P1419, DOI 10.1001/jamadermatol.2013.6777
   Sueblinvong V, 2015, CRIT CARE MED, V43, P2066, DOI 10.1097/CCM.0000000000001197
   Sulis G, 2015, J TRAVEL MED, V22, P276, DOI 10.1111/jtm.12207
   Tay ST, 2014, MED VET ENTOMOL, V28, P104, DOI 10.1111/mve.12075
   van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024
   Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011
   WALKER DH, 1995, CLIN INFECT DIS, V20, P1111, DOI 10.1093/clinids/20.5.1111
   Wanat KA, 2012, ARCH DERMATOL, V148, P219, DOI 10.1001/archdermatol.2011.1413
   WHO (World Health Organization), EB VIR DIS
   World Health Organization, 2016, LAT EB OUTBR LIB W A
   World Health Organization, EB SIT REP
   World Health Organization, 2015, 2015 GLOB TUB REP
   World Health Organization, EB VACC THER DIAGN
   Wormser GP, 2015, INFECT DIS CLIN N AM, V29, P371, DOI 10.1016/j.idc.2015.02.009
   Yao X, 2015, J MED VIROL, V87, P2009, DOI 10.1002/jmv.24275
   Zhao YY, 2015, EPIDEMIOL INFECT, V143, P3094, DOI 10.1017/S095026881500028X
NR 144
TC 8
Z9 10
U1 0
U2 84
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUL
PY 2016
VL 75
IS 1
BP 1
EP +
DI 10.1016/j.jaad.2016.04.033
PG 19
WC Dermatology
SC Dermatology
GA DO9GN
UT WOS:000378093300018
PM 27317512
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI The right(s) approach to Zika
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
NR 0
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUL
PY 2016
VL 4
IS 7
BP E427
EP E427
DI 10.1016/S2214-109X(16)30109-7
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP0IG
UT WOS:000378172700001
PM 27339992
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Ximenes, R
   Quam, M
   Wilder-Smith, A
   Massad, E
AF Burattini, M. N.
   Coutinho, F. A. B.
   Lopez, L. F.
   Ximenes, R.
   Quam, M.
   Wilder-Smith, A.
   Massad, E.
TI Potential exposure to Zika virus for foreign tourists during the 2016
   Carnival and Olympic Games in Rio de Janeiro, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
C1 [Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Ximenes, R.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Burattini, M. N.] Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Lopez, L. F.] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Quam, M.] Umea Univ, Epidemiol & Global Hlth, Umea, Sweden.
   [Wilder-Smith, A.] Lee Kong Chian Sch Med, Nanyang, Singapore.
   [Wilder-Smith, A.] Nanyang Technol Univ, Singapore 639798, Singapore.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Ximenes, Raphael/G-2881-2014; Wilder-Smith, Annelies/F-8751-2015;
   Massad, Eduardo/B-1169-2012; Burattini, Marcelo N/J-9272-2014; Coutinho,
   Francisco A B/H-5644-2011; Lopez, Luis F/C-4721-2012
OI Ximenes, Raphael/0000-0003-2536-951X; Massad,
   Eduardo/0000-0002-7200-2916; Burattini, Marcelo N/0000-0002-5407-6890;
   Coutinho, Francisco A B/0000-0003-3127-3071; Lopez, Luis
   F/0000-0003-4097-6887
FU HSP/ UNIFESP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2012/18463-4]; Ministry of Health (Fundo Nacional de
   Saude) [27835/2012]; DengueTools under Health theme of Seventh Framework
   Programme of the European Community [282589]; DengueTools: innovative
   tools and strategies for the surveillance and control of dengue; 
   [LIM01-HCFMUSP]
FX This study received partial funding from LIM01-HCFMUSP, HSP/ UNIFESP,
   CNPq, FAPESP (grant no. 2012/18463-4), Ministry of Health (Fundo
   Nacional de Saude, grant no. 27835/2012), and was also partially funded
   by DengueTools under the Health theme of the Seventh Framework Programme
   of the European Community (grant agreement no. 282589), DengueTools:
   innovative tools and strategies for the surveillance and control of
   dengue.
CR Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   WHO, DENGUE
   World Health Organization, ZIK VIR POT COMPL
NR 7
TC 18
Z9 18
U1 0
U2 41
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2016
VL 144
IS 9
BP 1904
EP 1906
DI 10.1017/S0950268816000649
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO5JV
UT WOS:000377820300013
PM 27040593
OA Bronze
DA 2020-07-08
ER

PT J
AU Vouga, M
   Musso, D
   Panchaud, A
   Baud, D
AF Vouga, Manon
   Musso, Didier
   Panchaud, Alice
   Baud, David
TI Clinical management of pregnant women exposed to Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Vouga, Manon; Baud, David] Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva & Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
RP Baud, D (corresponding author), Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496; panchaud, alice/0000-0001-6086-2401
CR Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 5
TC 11
Z9 11
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 773
EP 773
DI 10.1016/S1473-3099(16)30083-4
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600022
PM 27352750
OA Bronze
DA 2020-07-08
ER

PT J
AU Brasil, P
   Calvet, GA
   de Souza, RV
   Siqueira, AM
AF Brasil, Patricia
   Calvet, Guilherme A.
   de Souza, Rogerio V.
   Siqueira, Andre M.
TI Exanthema associated with Zika virus infection
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia; Calvet, Guilherme A.; de Souza, Rogerio V.; Siqueira, Andre M.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP Brasil, P (corresponding author), Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010; Calvet, Guilherme/G-6959-2013
OI Siqueira, Andre M/0000-0003-2208-0294; Calvet,
   Guilherme/0000-0002-3545-5238
NR 0
TC 7
Z9 7
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 866
EP 866
DI 10.1016/S1473-3099(16)30117-7
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600043
PM 27352763
OA Bronze
DA 2020-07-08
ER

PT J
AU Hofer, U
AF Hofer, Ursula
TI Tracing the steps of Zika virus
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Editorial Material
NR 0
TC 7
Z9 7
U1 0
U2 62
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD JUL
PY 2016
VL 14
IS 7
BP 401
EP 401
DI 10.1038/nrmicro.2016.80
PG 1
WC Microbiology
SC Microbiology
GA DO8ZD
UT WOS:000378073200001
PM 27211788
OA Bronze
DA 2020-07-08
ER

EF